Citrus Sinensis ID: 004912
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 724 | 2.2.26 [Sep-21-2011] | |||||||
| O81905 | 850 | Receptor-like serine/thre | yes | no | 0.951 | 0.810 | 0.455 | 1e-168 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.941 | 0.805 | 0.451 | 1e-165 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.933 | 0.811 | 0.425 | 1e-160 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.953 | 0.818 | 0.439 | 1e-159 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.965 | 0.823 | 0.433 | 1e-159 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.937 | 0.803 | 0.423 | 1e-155 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.912 | 0.844 | 0.416 | 1e-155 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.957 | 0.808 | 0.418 | 1e-153 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.941 | 0.799 | 0.428 | 1e-150 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.946 | 0.813 | 0.417 | 1e-146 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 593 bits (1530), Expect = e-168, Method: Compositional matrix adjust.
Identities = 330/724 (45%), Positives = 462/724 (63%), Gaps = 35/724 (4%)
Query: 22 SLAADTVTPAS--FIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVWVAN 78
S++A+T++ + I +VS FELGFF PG YLGI ++ I VWVAN
Sbjct: 26 SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVAN 85
Query: 79 RDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNP-VAQLRDDGNLVIRDNS 136
RD P+S + L IS++ NLV+L+Q++ +WSTN++ +V++P VA+L D+GN V+RD S
Sbjct: 86 RDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD-S 143
Query: 137 SGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHV 196
+A + LWQSFD+PTDTLL +MKLGWD K R++ SW+S DDPS G+F+++L+
Sbjct: 144 KNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEG 203
Query: 197 LPKICTFNGSVKFTCSGHWDGAGFVSALSYTDFLYKQF-MMENKDECVYWYEAYNRPSIM 255
P+I +N + SG W+G F F Y F +K+E Y +
Sbjct: 204 FPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYS 263
Query: 256 TLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFK 315
L ++ SG + R W E + W++ + P C +Y CG C + P+C C++GFK
Sbjct: 264 RLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFK 323
Query: 316 LES-QV--NQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECL 372
+ QV + G C R L C GD F+ L ++K PD S+++ + +++C+ +CL
Sbjct: 324 PRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCL 383
Query: 373 KNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKLLW 429
++C+C A+AN++++ S SGC+ W G+L D IRN+ GQ +Y+R+ A+ L +K+
Sbjct: 384 RDCNCTAFANTDIRGSGSGCVTWTGELFD----IRNYAKGGQDLYVRLAATDLEDKRNRS 439
Query: 430 ILVI---LVIPVVLLPSFYVFYRRRRKCQEKETENVETY---QDLLAFDINMN---ITTR 480
+I + + V+LL SF +F+ +RK +K + +ET L + D+ MN I++R
Sbjct: 440 AKIIGSSIGVSVLLLLSFIIFFLWKRK--QKRSILIETPIVDHQLRSRDLLMNEVVISSR 497
Query: 481 TNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEV 540
+ E N D D LPL + AT NFS KLG+GGFG VYKG+LL+GQE+
Sbjct: 498 RHISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEM 551
Query: 541 AVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL 600
AVKRLS S QG EFKNE+ LIA+LQH NLVRLL CCV+ GEK+LI EY+ N SL+ L
Sbjct: 552 AVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHL 611
Query: 601 FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660
FD ++ LNWQ R II GIA+GLLYLHQ SRFRIIHRDLKASNILLDK M PKISDFG
Sbjct: 612 FDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFG 671
Query: 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720
+AR+FG DE + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +SSK+N G
Sbjct: 672 MARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFY 731
Query: 721 SMER 724
+ +R
Sbjct: 732 NSDR 735
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 582 bits (1499), Expect = e-165, Method: Compositional matrix adjust.
Identities = 324/718 (45%), Positives = 447/718 (62%), Gaps = 36/718 (5%)
Query: 27 TVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWVANRDRPISD 85
+ T + I + ++S SQ FELGFF+P S YLGI ++ IP VWVANRD P+S
Sbjct: 31 SATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSS 90
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNPVA-QLRDDGNLVIRDNSSGNATES 143
+N L IS+N NLV+ +Q++ +WSTN++ +V++PVA +L D GN V+RD S N
Sbjct: 91 SNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD-SKNNKPSG 148
Query: 144 YLWQSFDYPTDTLLQDMKLGWDFKNR-LERYLSSWRSADDPSPGNFTYRLDIHVLPKICT 202
+LWQSFD+PTDTLL DMK+GWD K+ R L SW++ DDPS G+F+ +L P+
Sbjct: 149 FLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYI 208
Query: 203 FNGSVKFTCSGHWDGAGF--VSALSYTDFLYKQFMMENKDECVYWYEAYNRPSIMTLKLN 260
+N SG W G F V + D++ F EN + VY Y L L+
Sbjct: 209 YNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFT-ENNQQVVYSYRVNKTNIYSILSLS 267
Query: 261 PSGFVTRQIWNENSNKWDELFSVP----DQY--CGKYGYCGANTICSLDQKPMCECLEGF 314
+G + R W E + W +L+ P D Y CG YGYC ANT P+C C++GF
Sbjct: 268 STGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANT------SPICNCIKGF 321
Query: 315 KL--ESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECL 372
+ E + + C R L C D F+ L +++ PD + S+++ + L++C+ CL
Sbjct: 322 EPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCL 381
Query: 373 KNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKLLW 429
K C+C A+AN++++ SGC++W G L D IRN+ GQ +Y+RV A L +K++
Sbjct: 382 KGCNCTAFANTDIRNGGSGCVIWSGGLFD----IRNYAKGGQDLYVRVAAGDLEDKRIKS 437
Query: 430 ILVI---LVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGE 486
+I + + ++LL SF +F+ +RK + T + + D MN + +
Sbjct: 438 KKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYT 497
Query: 487 ANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS 546
+ + D + LPL ++ AT NFS KLG+GGFG VYKG LL+G+E+AVKRLS
Sbjct: 498 SKENKTDYLE---LPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLS 554
Query: 547 NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKK 606
S QG EF NE+ LIAKLQH NLVRLLGCCV++GEK+LI EY+ N SL+ LFD T+
Sbjct: 555 KMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRS 614
Query: 607 RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666
LNWQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK+M PKISDFG+AR+FG
Sbjct: 615 SNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFG 674
Query: 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSMER 724
+E + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +S K+N G + R
Sbjct: 675 REETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 732
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 567 bits (1462), Expect = e-160, Method: Compositional matrix adjust.
Identities = 308/724 (42%), Positives = 438/724 (60%), Gaps = 48/724 (6%)
Query: 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVWVANRDR 81
++ DT+ +RDGE ++S+ +RF GFFS G S+ RY+GI + QI +VWVANRD
Sbjct: 17 ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76
Query: 82 PISDNNAVLTISNNGNLVLLNQTNGT--IWSTNVSSEVKNP--VAQLRDDGNLVIRDNSS 137
PI+D + ++ SN GNL + N T IWSTNVS + P VA L D GNLV+ D +
Sbjct: 77 PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVT 136
Query: 138 GNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVL 197
G + W+SFD+PTDT L M+LG+ K+ L+R L+SW+S DP G+ R++
Sbjct: 137 GRS----FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGF 192
Query: 198 PKICTFNGSVKFTCSGHWDGAGFVSALSY-TDFLYKQFMMENKDECVYWYEAYNRPSIMT 256
P++ + G + G W G + +++ + N+DE + Y + I
Sbjct: 193 PQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITR 252
Query: 257 LKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPM--CECLEGF 314
+N +G + R W +W++ +SVP + C Y +CG N C C CL GF
Sbjct: 253 TMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGF 312
Query: 315 KLES------QVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCK 368
+ + + + G K +R+ C D F++L +K PD D S++ + L++CK
Sbjct: 313 EPKFPRHWFLRDSSGGCTKKKRASI--CSEKDGFVKLKRMKIPDTSDASVDMNITLKECK 370
Query: 369 AECLKNCSCRAYANS---NVKESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKL--- 422
CLKNCSC AYA++ + + + GCL W+G ++DAR + +GQ Y+RV +L
Sbjct: 371 QRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLN--SGQDFYIRVDKEELARW 428
Query: 423 ------GNKKLLWILVILVIPVVLLPS-FYVFYRRRRKCQEKETENVETYQDLLAFDINM 475
G +++L IL+ L+ V+LL + R RRK + + FD +
Sbjct: 429 NRNGLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESF 488
Query: 476 NITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLL 535
+DK+++ LPLF L +I AAT NFS Q KLG GGFGPVYKG L
Sbjct: 489 RFE-------------QDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQ 535
Query: 536 NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS 595
N E+AVKRLS SGQG++EFKNE+ LI+KLQHRNLVR+LGCCVE EK+L+ EY+PNKS
Sbjct: 536 NRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKS 595
Query: 596 LNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655
L+ F+F ++ L+W R+ I+ GIA+G+LYLHQ SR RIIHRDLKASNILLD +M PK
Sbjct: 596 LDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPK 655
Query: 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
ISDFG+AR+FGG++++G T ++VGT+GYM+PEYA++G FSIKSDV+SFG+LMLE ++ KK
Sbjct: 656 ISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKK 715
Query: 716 NTGL 719
N+
Sbjct: 716 NSAF 719
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 563 bits (1452), Expect = e-159, Method: Compositional matrix adjust.
Identities = 318/724 (43%), Positives = 450/724 (62%), Gaps = 34/724 (4%)
Query: 18 SMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWV 76
+ VS + T + I + ++S SQ FELGFF+P S YLGI ++ IP VWV
Sbjct: 22 AFSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWV 81
Query: 77 ANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNPVA-QLRDDGNLVIRD 134
ANRD P+S +N L IS N NLV+ +Q++ +WSTN++ +V++PVA +L D+GN ++RD
Sbjct: 82 ANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD 140
Query: 135 NSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDI 194
+++ LWQSFD+PTDTLL +MKLGWD K R L SW++ DDPS G F+ +L+
Sbjct: 141 SNN-----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLET 195
Query: 195 HVLPKICTFNGSVKFTCSGHWDGAGF--VSALSYTDFLYKQFMMENKDECVYWYEAYNRP 252
P+ + SG W+G F V D++ F +K+E Y Y
Sbjct: 196 SEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTA-SKEEVTYSYRINKTN 254
Query: 253 SIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLE 312
L LN +G + R W E + W +L+ P C Y CG C + P C C++
Sbjct: 255 LYSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIK 314
Query: 313 GFKLESQVN---QPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKA 369
GFK ++ + G C R L C D F L +K PD +++ + L+ CK
Sbjct: 315 GFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKE 374
Query: 370 ECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLGNKKLL 428
CL++C+C A+AN++++ SGC++W +++D R + GQ +Y+R+ A++L +K++
Sbjct: 375 RCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKG--GQDLYVRLAAAELEDKRIK 432
Query: 429 WILVI---LVIPVVLLPSFYVFY---RRRRKCQEKETENVETY--QDLLAFDINMNITTR 480
+I + + ++LL SF +F+ R++++ +T NV+ QD L D+ ++
Sbjct: 433 NEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGY 492
Query: 481 TNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEV 540
T++ + KS+ LPL L ++ AT NFS KLG+GGFG VYKGRLL+G+E+
Sbjct: 493 TSK--------EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEI 544
Query: 541 AVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL 600
AVKRLS S QG EF NE+ LIAKLQH NLVRLLGCCV++GEK+LI EY+ N SL+ L
Sbjct: 545 AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHL 604
Query: 601 FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660
FD T+ LNWQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK+M PKISDFG
Sbjct: 605 FDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFG 664
Query: 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720
+AR+FG +E + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +S K+N G
Sbjct: 665 MARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFY 724
Query: 721 SMER 724
+ R
Sbjct: 725 NSNR 728
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 561 bits (1446), Expect = e-159, Method: Compositional matrix adjust.
Identities = 320/738 (43%), Positives = 458/738 (62%), Gaps = 39/738 (5%)
Query: 13 LIFLLSMKVSLAADTVTPASFIRDG---EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQI 69
++ + S+AA+T+ +RDG + LVS + FELGFFSPG S R+LGI + I
Sbjct: 14 FLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNI 73
Query: 70 PD-AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEV---KNPVAQLR 125
D AVVWVANR PISD + VL ISN+GNLVLL+ N T+WS+N+ S N V +
Sbjct: 74 EDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIH 133
Query: 126 DDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP 185
D GN V+ + T+ +W+SF++PTDT L M++ + + SWRS DPSP
Sbjct: 134 DTGNFVLSETD----TDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSP 189
Query: 186 GNFTYRLDIHVLPKICTFNGS-VKFTCSGHWDGAGFVSALSY---TDFLYKQFMMENKDE 241
GN++ +D P+I + G+ + SG W+ A F + T++LY + DE
Sbjct: 190 GNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDE 249
Query: 242 C--VYWYEAYNRPSIM-TLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANT 298
VY+ + PS++ K+ +G WNE KW + S PD C +Y CG
Sbjct: 250 TGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFG 309
Query: 299 ICSLD-QKPMCECLEGFKLESQVN------QPGPIKCERSHSLECKSGDQFIELDEIKAP 351
IC + +C C+ G++ S N + P+KCER+ S+ D+F+ L +K P
Sbjct: 310 ICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISV---GEDEFLTLKSVKLP 366
Query: 352 DFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFTGQ 411
DF ++ + ++ E C+ CL+NCSC AY+ + GC++W DL+D ++ G
Sbjct: 367 DF-EIPEHNLVDPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVDLQQ--FEAGGS 420
Query: 412 SVYLRVPASKLGN--KKLLWILVILVIPVVLLPSFYVFYRR--RRKCQEKETENVETYQD 467
S+++R+ S++G K + ++V +++ V+L+ F + R R+K T
Sbjct: 421 SLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTS 480
Query: 468 LLAFDINMNITTRTNEYGEANGDGKDKSKD-SWLPLFSLASITAATENFSMQCKLGEGGF 526
++ D+ + T + G + + K+ + S LP+FSL +I AT +F + +LG GGF
Sbjct: 481 VVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGF 540
Query: 527 GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586
GPVYKG L +G+E+AVKRLS +SGQG+ EFKNE++LIAKLQHRNLVRLLGCC E EK+L
Sbjct: 541 GPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKML 600
Query: 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 646
+ EYMPNKSL+ FLFD TK+ L++W+ R IIEGIA+GLLYLH+ SR RIIHRDLK SN+
Sbjct: 601 VYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNV 660
Query: 647 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGIL 706
LLD +MNPKISDFG+AR+FGG++ + NT ++VGTYGYMSPEYA++GLFS+KSDV+SFG+L
Sbjct: 661 LLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVL 720
Query: 707 MLETLSSKKNTGLGSMER 724
+LE +S K+NT L S E
Sbjct: 721 LLEIVSGKRNTSLRSSEH 738
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 550 bits (1416), Expect = e-155, Method: Compositional matrix adjust.
Identities = 305/720 (42%), Positives = 446/720 (61%), Gaps = 41/720 (5%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVWVANRDRPIS 84
+T+ + ++DG+ + S +RF GFFS G SK RY+GI + Q+ + +VWVANRD PI+
Sbjct: 23 NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82
Query: 85 DNNAVLTISNNGNLVLLNQTNGT--IWSTNVSSEVKNP--VAQLRDDGNLVIRDNSSGNA 140
D + ++ S GNL + NGT IWST+V ++ P VA+L D GNLV+ D +G +
Sbjct: 83 DTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTGKS 142
Query: 141 TESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKI 200
W+SF++PT+TLL MK G+ ++ ++R ++SWRS DP GN TYR++ P++
Sbjct: 143 ----FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQM 198
Query: 201 CTFNGSVKFTCSGHWDGAGFVSALSYTD-FLYKQFMMENKDECVYWYEAYNRPSIMTLKL 259
+ G + +G W G + T+ F++ + N DE Y + + L
Sbjct: 199 MMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVL 258
Query: 260 NPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTIC--SLDQKPMCECLEGFKLE 317
N +G + R WN KW +S P+ C Y +CG N C + +K C CL G++ +
Sbjct: 259 NETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPK 318
Query: 318 SQVN---QPGPIKCERSHSLE-CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK 373
+ + + C R + C + F +L +K P+ V+++ + L++C+ CLK
Sbjct: 319 TPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLK 378
Query: 374 NCSCRAYANSNVKE---SSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKL-------- 422
NCSC AYA++ + + GCL W+G+++D R + +GQ YLRV S+L
Sbjct: 379 NCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLS--SGQDFYLRVDKSELARWNGNGA 436
Query: 423 -GNKKLLWILVILV-IPVVLLPSFYVFYRRRR-KCQEKETENVETYQDLLAFDINMNITT 479
G K+L+ IL+ L+ + ++LL SF+ + R+RR + Q + +FD+ +
Sbjct: 437 SGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFIL 496
Query: 480 RTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQE 539
E DKS+ LPLF L++I AT NF+ Q KLG GGFGPVYKG L NG E
Sbjct: 497 EELE---------DKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGME 547
Query: 540 VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVF 599
+AVKRLS SGQG++EFKNE+ LI+KLQHRNLVR+LGCCVE EK+L+ EY+PNKSL+ F
Sbjct: 548 IAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYF 607
Query: 600 LFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659
+F ++ L+W R+ II GI +G+LYLHQ SR RIIHRDLKASN+LLD +M PKI+DF
Sbjct: 608 IFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADF 667
Query: 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719
GLAR+FGG++++G+T ++VGTYGYMSPEYA+DG FSIKSDV+SFG+L+LE ++ K+N+
Sbjct: 668 GLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAF 727
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 549 bits (1415), Expect = e-155, Method: Compositional matrix adjust.
Identities = 307/737 (41%), Positives = 441/737 (59%), Gaps = 76/737 (10%)
Query: 1 MEKIPCLNIFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSR 60
ME L++ +F ++ ++ A D + ++DG+ +VS FE+GFFSPG S++R
Sbjct: 1 MEATNVLHLLIISLFS-TILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNR 59
Query: 61 YLGIRFQQIP-DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNV-----S 114
YLGI +++I VVWVANRD P+ D + L +S NG+L L N N IWS++
Sbjct: 60 YLGIWYKKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQK 119
Query: 115 SEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYL 174
+ ++NP+ Q+ D GNLV+R+ SG+ + Y+WQS DYP D L MK G +F L R+L
Sbjct: 120 ASLRNPIVQILDTGNLVVRN--SGD-DQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFL 176
Query: 175 SSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYT-DFLYKQ 233
+SWR+ DDPS GN+T ++D + +P+ SV +G W+G F + + +Y+
Sbjct: 177 TSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRY 236
Query: 234 FMMENKDECVYWYEAYNRPSIMT-LKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYG 292
+ ++E Y Y+ N PS++T ++LNP+G + R W +N W+ S C +Y
Sbjct: 237 EYVFTEEEVYYTYKLEN-PSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYT 295
Query: 293 YCGANTICSLDQKPMCECLEGFKLESQ---VNQPGPIKCERSHSLECKSG-DQFIELDEI 348
CG+ C++++ P C CL+GF ++ V C R L+C G D F+++ ++
Sbjct: 296 LCGSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKL 355
Query: 349 KAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESS-GCLMWYGDLIDARRPIRN 407
K PD ++ M+L +CK CL+NC+C AY+ ++++ GC++W+GDLID R N
Sbjct: 356 KLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIRE--YN 413
Query: 408 FTGQSVYLRVPASKLGNKKLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQD 467
GQ +Y+ R E ET E+ +
Sbjct: 414 ENGQDLYV-----------------------------------RLASSEIETLQRESSR- 437
Query: 468 LLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFG 527
+++R K + +D LP L +++ AT FS KLG+GGFG
Sbjct: 438 ---------VSSR-----------KQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFG 477
Query: 528 PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587
PVYKG L GQEVAVKRLS S QG++EFKNE+ LIAKLQHRNLV++LG CV++ E++LI
Sbjct: 478 PVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLI 537
Query: 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647
EY PNKSL+ F+FD ++R L+W RV II+GIA+G+LYLH+ SR RIIHRDLKASN+L
Sbjct: 538 YEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVL 597
Query: 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707
LD DMN KISDFGLAR GGDE + NT ++VGTYGYMSPEY +DG FS+KSDVFSFG+L+
Sbjct: 598 LDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLV 657
Query: 708 LETLSSKKNTGLGSMER 724
LE +S ++N G + E
Sbjct: 658 LEIVSGRRNRGFRNEEH 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 541 bits (1395), Expect = e-153, Method: Compositional matrix adjust.
Identities = 307/734 (41%), Positives = 450/734 (61%), Gaps = 41/734 (5%)
Query: 13 LIFLLSMKVSLAADTV--TPASFIRDGEKLVSSSQRFELGFFSPGKSKSR-YLGIRFQQI 69
++ L+ +S+ +T+ T + I + LVS FE+GFF ++ SR YLG+ ++++
Sbjct: 21 VMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFF---RTNSRWYLGMWYKKV 77
Query: 70 PD-AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVS--SEVKNPVAQLRD 126
D VWVANRD P+S+ L IS N NLVLL+ +N +W TN++ +E VA+L
Sbjct: 78 SDRTYVWVANRDNPLSNAIGTLKISGN-NLVLLDHSNKPVWWTNLTRGNERSPVVAELLA 136
Query: 127 DGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPG 186
+GN V+RD+S+ +A+E YLWQSFDYPTDTLL +MKLG++ K L R+L+SWRS+DDPS G
Sbjct: 137 NGNFVMRDSSNNDASE-YLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSG 195
Query: 187 NFTYRLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYTDFLYKQF-MMENKDECVYW 245
NF+Y+L+ LP+ + SG W+G F Y + +EN +E Y
Sbjct: 196 NFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNEEVAYT 255
Query: 246 YEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVP-DQYCGKYGYCGANTICSLDQ 304
+ N L L G+ R W + W+ +S P D C Y CG C ++
Sbjct: 256 FRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCDVNT 315
Query: 305 KPMCECLEGF------KLESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSL 358
P+C C++GF + + +V G C R L C SGD F + ++K P+ ++
Sbjct: 316 SPVCNCIQGFNPRNIQQWDQRVWAGG---CIRRTQLSC-SGDGFTRMKKMKLPETTMATV 371
Query: 359 NQRMNLEQCKAECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT-----GQS 412
++ + +++CK C+ +C+C A+AN++++ SGC++W L D IRN+ GQ
Sbjct: 372 DRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLED----IRNYATDAIDGQD 427
Query: 413 VYLRVPASKLGNKKLL---WILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLL 469
+Y+R+ A+ + K+ I + + + V+LL + ++R++K + ++ Q
Sbjct: 428 LYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIANTQRNQ 487
Query: 470 AFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPV 529
+N + + E+ G+ K ++ LPL + ++ ATENFS KLG+GGFG V
Sbjct: 488 NLPMNEMVLSSKREFS-----GEYKFEELELPLIEMETVVKATENFSSCNKLGQGGFGIV 542
Query: 530 YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589
YKGRLL+G+E+AVKRLS S QG EF NE+ LIA+LQH NLV++LGCC+E EK+LI E
Sbjct: 543 YKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYE 602
Query: 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649
Y+ N SL+ +LF T++ LNW R I G+A+GLLYLHQ SRFRIIHRDLK SNILLD
Sbjct: 603 YLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLD 662
Query: 650 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
K+M PKISDFG+AR+F DE + NT ++VGTYGYMSPEYA+ G+FS KSDVFSFG+++LE
Sbjct: 663 KNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFGVIVLE 722
Query: 710 TLSSKKNTGLGSME 723
+S KKN G +++
Sbjct: 723 IVSGKKNRGFYNLD 736
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 533 bits (1373), Expect = e-150, Method: Compositional matrix adjust.
Identities = 309/721 (42%), Positives = 446/721 (61%), Gaps = 39/721 (5%)
Query: 19 MKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVWVA 77
+ +S+ + T + I + +VS FELGFF S YLGI +++I VWVA
Sbjct: 28 LSISVNTLSATESLTISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTYVWVA 86
Query: 78 NRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPV-AQLRDDGNLVIRDNS 136
NRD P+S+ +L ISN NLV+L+ ++ +WSTN++ V++ V A+L D+GN V+R S
Sbjct: 87 NRDTPLSNPIGILKISN-ANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLR-GS 144
Query: 137 SGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHV 196
N ++ +LWQSFD+PTDTLL MKLG D K L R+++SW+S+ DPS G+F ++L+
Sbjct: 145 KINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLG 204
Query: 197 LPKICTFNGSVKFTCSGHWDG---AGFVSALSYTDFLYKQFMMENKDECVYWYEAYNRPS 253
LP+ F ++ SG WDG +G + + D +Y EN++E Y + + S
Sbjct: 205 LPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYN--FTENREEVAYTFRVTDHNS 262
Query: 254 IMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEG 313
L +N G + +W +W+ + +P C YG CG C + P C C++G
Sbjct: 263 YSRLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCIKG 322
Query: 314 FK-LESQVNQPGPI--KCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAE 370
F+ L Q G + +C R L C D+F L +K P +++R+ L++C+ +
Sbjct: 323 FQPLSPQDWASGDVTGRCRRKTQLTCGE-DRFFRLMNMKIPATTAAIVDKRIGLKECEEK 381
Query: 371 CLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKL 427
C +C+C AYANS+++ SGC++W G+ R IRN+ GQ +++R+ A++ G ++
Sbjct: 382 CKTHCNCTAYANSDIRNGGSGCIIWIGEF----RDIRNYAADGQDLFVRLAAAEFGERRT 437
Query: 428 LWILVILVI---PVVLLPSF--YVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTN 482
+ +I +I ++L+ SF Y F+++++K + + T Y+D + I N
Sbjct: 438 IRGKIIGLIIGISLMLVLSFIIYCFWKKKQK-RARATAAPIGYRDRIQELIITN------ 490
Query: 483 EYGEANGDGK---DKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQE 539
G G+ + +D LPL ++ ATENFS LG GGFG VYKGRLL+GQE
Sbjct: 491 --GVVMSSGRRLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQE 548
Query: 540 VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVF 599
+AVKRLS S QG EFKNE+ LIA+LQH NLVRLL CC+ EKILI EY+ N SL+
Sbjct: 549 IAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSH 608
Query: 600 LFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 658
LF++T+ LNWQ R II GIA+GLLYLHQ SRF+IIHRDLKASN+LLDK+M PKISD
Sbjct: 609 LFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISD 668
Query: 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718
FG+AR+F DE + NT+++VGTYGYMSPEYA++G+FS+KSDVFSFG+L+LE +S K+N G
Sbjct: 669 FGMARIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRG 728
Query: 719 L 719
Sbjct: 729 F 729
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 518 bits (1334), Expect = e-146, Method: Compositional matrix adjust.
Identities = 308/738 (41%), Positives = 430/738 (58%), Gaps = 53/738 (7%)
Query: 6 CLNIFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIR 65
C N+ CS +++ T IR+G+ L+S + FELGFF+P S RY+GI
Sbjct: 21 CSNVSCS-----------TSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIW 69
Query: 66 FQQI-PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQL 124
++ I P VVWVANR++P+ D+ L I+++GNLV++N N TIWSTNV E N VA L
Sbjct: 70 YKNIEPQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVL 129
Query: 125 RDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS 184
G+LV+ +S + W+SF+ PTDT L M++ + R W+S DPS
Sbjct: 130 FKTGDLVLCSDSD---RRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPS 186
Query: 185 PGNFTYRLDIHVLPKICTFNGSVKFTCSGHWDGA---GFVSALSYTDFLY--KQFMMENK 239
PG ++ +D +I + G + SG W+ A G L +T+++Y K ++
Sbjct: 187 PGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDR 246
Query: 240 DECVYW-YEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANT 298
D VY+ Y A + + + P G + WN++ W+ L P C KY CG +
Sbjct: 247 DGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYS 306
Query: 299 ICSLDQKPM----CECLEGFKLESQV---NQPGPIKCERSHSLECKSG------DQFIEL 345
+C D K C C++GF+ Q N+ C+R L C D F L
Sbjct: 307 VCD-DSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVL 365
Query: 346 DEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPI 405
IK PDF V L+ N E CK C ++CSC+AYA + GC++W DLID
Sbjct: 366 KGIKVPDFGSVVLHN--NSETCKDVCARDCSCKAYA---LVVGIGCMIWTRDLIDMEHFE 420
Query: 406 RNFTGQSVYLRVPASKLGNKK---LLWILVILVIPVVLLP-SFYVFYRRRRKCQEKETEN 461
R G S+ +R+ SKLG K LWI+V VI LL ++ ++ ++ +
Sbjct: 421 RG--GNSINIRLAGSKLGGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAF---- 474
Query: 462 VETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKL 521
+ +D+ DI N ++ GD D LP+FS S+ +AT +F+ + KL
Sbjct: 475 LWKKKDITVSDIIENRDYSSSPIKVLVGDQVDTPD---LPIFSFDSVASATGDFAEENKL 531
Query: 522 GEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581
G+GGFG VYKG G+E+AVKRLS +S QGL+EFKNE++LIAKLQHRNLVRLLGCC+E
Sbjct: 532 GQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIED 591
Query: 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL 641
EK+L+ EYMPNKSL+ FLFD +K+ L+W+ R +I GIA+GLLYLH+ SR +IIHRDL
Sbjct: 592 NEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDL 651
Query: 642 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVF 701
KASNILLD +MNPKISDFG+AR+F + NT ++VGTYGYM+PEYA++G+FS KSDV+
Sbjct: 652 KASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVY 711
Query: 702 SFGILMLETLSSKKNTGL 719
SFG+L+LE +S +KN
Sbjct: 712 SFGVLILEIVSGRKNVSF 729
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 724 | ||||||
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.936 | 0.845 | 0.487 | 0.0 | |
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.908 | 0.608 | 0.495 | 0.0 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.946 | 0.819 | 0.491 | 0.0 | |
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.917 | 0.809 | 0.486 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.947 | 0.825 | 0.472 | 1e-180 | |
| 359493723 | 867 | PREDICTED: G-type lectin S-receptor-like | 0.946 | 0.790 | 0.467 | 1e-179 | |
| 147816068 | 819 | hypothetical protein VITISV_030742 [Viti | 0.941 | 0.832 | 0.463 | 1e-178 | |
| 255587572 | 822 | S-locus-specific glycoprotein S6 precurs | 0.964 | 0.849 | 0.477 | 1e-178 | |
| 224113149 | 820 | predicted protein [Populus trichocarpa] | 0.929 | 0.820 | 0.476 | 1e-178 | |
| 224122978 | 831 | predicted protein [Populus trichocarpa] | 0.936 | 0.815 | 0.461 | 1e-175 |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 671 bits (1731), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/730 (48%), Positives = 473/730 (64%), Gaps = 52/730 (7%)
Query: 1 MEKIPCLNIFCSLIFLLSMK-VSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKS 59
ME +P IF S +F+ S+ +S +AD +TP ++DG+ L+S SQ FELGFFSPG SK
Sbjct: 1 MESLPFF-IFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKY 59
Query: 60 RYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKN 119
RY+GI +++ P+ VVWVANR+ P++D+ VLTI N GNLVLL+Q IWS+N SS +
Sbjct: 60 RYVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAG 119
Query: 120 PVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRS 179
PVAQL D GNLV+RDN S TESY WQSFD P+DTLL MKLGW+ K ERYL +WRS
Sbjct: 120 PVAQLLDSGNLVVRDNGSSRNTESYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRS 179
Query: 180 ADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYTDFLYKQFMMENK 239
DPSPG+FTYRLDIH LP++ GSVK SG W+G F + +++ ++ N+
Sbjct: 180 ISDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNE 239
Query: 240 DECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTI 299
DE Y Y N L LN SG V R + ++ W ++SVP C YG CGAN I
Sbjct: 240 DEIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGI 299
Query: 300 CSLDQKPMCECLEGFK------LESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDF 353
C P+CECL+GFK L+ Q N G KCE +L+C+SG+ F++L +K PD
Sbjct: 300 CRTRTSPICECLKGFKSIPEEELDIQ-NFYGSRKCETRLTLDCQSGEGFLKLPGVKLPDL 358
Query: 354 IDVSLNQRMNLEQCKAECLKNCSCRAYANSNVK---ESSGCLMWYGDLIDARRPIRNFTG 410
++ LN+ MNL++C+AEC KNCSC A+A +N+ + SGCLMW+G+LID R + G
Sbjct: 359 LEFRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIG 418
Query: 411 QSVYLRVPASKLGNKKLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLA 470
Q +++RVPAS+L R ++ + +T V + LL
Sbjct: 419 QDIHIRVPASEL-----------------------EMARSSKRKKMLKTALVASMSALLG 455
Query: 471 FDINMNITTRTNEYGEANGDGKDKSKDSW-LPLFSLASITAATENFSMQCKLGEGGFGPV 529
++ G D+ K+ PLF L +I AT NF+ +G GGFG V
Sbjct: 456 IFVS----------------GMDRRKEGMEAPLFDLDTIATATNNFAPDSIIGAGGFGSV 499
Query: 530 YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589
YKG+LL GQE+AVK+LS SGQG++EF+NE++LIAKLQHRNLV LLG C+ + E++LI E
Sbjct: 500 YKGKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHRNLVGLLGSCIHREERMLIYE 559
Query: 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649
YMPNKSL+ F+FD + LL W+ R II GIA+GLLYLHQ S+ +I+HRDLK SN+LLD
Sbjct: 560 YMPNKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLHQDSKLQIVHRDLKPSNVLLD 619
Query: 650 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
++ PKISDFGLAR+ G D + T++++GTYGYM+PEYA+DG FS+KSDVFS G+L+LE
Sbjct: 620 SNLIPKISDFGLARISGDDGKETKTRRVIGTYGYMAPEYAIDGKFSVKSDVFSLGVLLLE 679
Query: 710 TLSSKKNTGL 719
+S KKN G
Sbjct: 680 IISGKKNRGF 689
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1719), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/709 (49%), Positives = 452/709 (63%), Gaps = 51/709 (7%)
Query: 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPIS 84
AD++ I D E LVSS Q FELGFFSPG SK+RYLGI ++ P VWVANR+ PI+
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355
Query: 85 DNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESY 144
D+ VLTI NNG LVLLNQ+ IWS N+S +NPVAQL + GNLV+RD S+ ++SY
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRDGSN-ETSKSY 414
Query: 145 LWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFN 204
+WQSFD P+DT+L MK+GW+ K L+R L+SW+S+DDPS G+F+Y DI+VLP +
Sbjct: 415 IWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLGV 474
Query: 205 GSVKFTCSGHWDGAGFVSALSYTDFLYKQFMMENKDECVYWYEAYNRPSIMTLKLNPSGF 264
GS K SG W+G F + +YK + N DE YE+ N I L LN SGF
Sbjct: 475 GSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSGF 534
Query: 265 VTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFKLESQVNQP- 323
+ R + + S+ WDEL+S+P + C YG+CGAN IC + + +CECL GF +SQ
Sbjct: 535 LQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQEEWDM 594
Query: 324 --GPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYA 381
C R L+C+ + F+++ +K PD ID + ++L +CK CL NCSC AYA
Sbjct: 595 FNTSSGCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCTAYA 654
Query: 382 NSNVKESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLG------NKKLLWILVILV 435
+N S GCLMW GDLID R + +Y+R+ S+LG KKL+ ILVI
Sbjct: 655 YTNPNGSGGCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIILVIST 714
Query: 436 IPVVL---LPSFYVFYRRRRKC--QEKETENVETYQDLLAFDINMNITTRTNEYGEANGD 490
+L L ++ F+++R QE + EN+E
Sbjct: 715 FSGILTLGLSFWFRFWKKRTMGTDQESKKENLE--------------------------- 747
Query: 491 GKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG 550
LPLF L +I AT NFS K+G GGFG VYKG L G VAVKRLS S
Sbjct: 748 ---------LPLFDLPTIATATNNFSNTNKIGAGGFGSVYKGNLPEGVAVAVKRLSKNSA 798
Query: 551 QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLN 610
QG++EFKNE +LIAKLQH+NLVRLLGCC++ E+IL+ EYMPNKSL+ F+FD ++ LL
Sbjct: 799 QGVQEFKNEAVLIAKLQHKNLVRLLGCCIQGEERILLYEYMPNKSLDYFIFDQNRRALLA 858
Query: 611 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670
W R I+ GIA+GLLYLHQ SRF+IIHRDLK SNILLD ++NPKISDFGLAR+FG +E+
Sbjct: 859 WDKRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFGLARIFGENEM 918
Query: 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719
+ TK+IVGTYGYMSPEY +DG FSIK DVFSFG+L+LE +S +KN G
Sbjct: 919 ETRTKRIVGTYGYMSPEYVIDGHFSIKLDVFSFGVLLLEIVSGEKNRGF 967
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 650 bits (1678), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/726 (49%), Positives = 474/726 (65%), Gaps = 41/726 (5%)
Query: 24 AADTVTPASFIRDG--EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWVANRD 80
A+T+T + IRDG LVS FELGFFSPG S++RY+GI ++ IP VVWVANR+
Sbjct: 18 TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 77
Query: 81 RPISDNNAVLTISNNGNLVLLNQTNGTI-WSTNVSSEVKNPVAQLRDDGNLVIRDNSSGN 139
PI+D++ L + N GNLVL++ N T+ WS+N ++ + +L D GNLV+RD N
Sbjct: 78 NPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQSAMGELLDSGNLVLRDEKDVN 137
Query: 140 ATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPK 199
+ SYLWQSFDYP+DT+L MKLGWD + L+R LS+W+S DDPS G+FT+ + P+
Sbjct: 138 SG-SYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 196
Query: 200 ICTFNGSVKFTCSGHWDGAGFV--SALSYTDFLYKQFMMENKDECVYWYEAYNRPSIMTL 257
+ + GS K+ SG W+G GF +AL Y F+ +N +E Y Y N+ I L
Sbjct: 197 LVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDFV-DNGEEVYYTYNLKNKSLITRL 255
Query: 258 KLN-PSGFV-TRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGF- 314
+N +GF+ R WNE S W+ VP YC Y CGA C + Q P+CECLE F
Sbjct: 256 VMNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGNCIISQSPVCECLEKFT 315
Query: 315 --KLESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECL 372
ES + C R+ L+C+ GD F++ +K PD + +N+ MNL++C+++CL
Sbjct: 316 PKSPESWNSMNWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSKCL 375
Query: 373 KNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASK------LGN 424
+NCSC AY +++KE SGC +W+GDLID IR F GQ +Y+R+ AS+ L
Sbjct: 376 QNCSCMAYTATDIKERSGCAIWFGDLID----IRQFPDGGQEIYIRMNASESSECLSLIK 431
Query: 425 KKLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVET-YQDLLAF---DINMNITTR 480
++ L I V +LL ++Y+F K TE ++ Y LL + D + ++ +
Sbjct: 432 MEMGIALSIFVACGMLLVAYYIF---------KRTEKLKAHYSFLLVYHVCDSHSLLSEK 482
Query: 481 TNEYGEANGDGKDKS--KDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQ 538
T E N D D +D LPLF +I AT FS+ K+GEGGFGPVYKG L +GQ
Sbjct: 483 TGGNREEN-DQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIGEGGFGPVYKGTLEDGQ 541
Query: 539 EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNV 598
E+AVK LS SGQGL EFKNE++LI KLQHRNLV+LLGCC++ EKIL+ EYMPN+SL+
Sbjct: 542 EIAVKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNRSLDS 601
Query: 599 FLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 658
F+FD T+ +LL+W R II GIA+GLLYLHQ SR RI+HRDLKASN+LLDKDMNPKISD
Sbjct: 602 FIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISD 661
Query: 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718
FGLARM GGD+ +GNT +++GTYGYM+PEYA DGLFS+KSDVFSFGILMLE +S KK+ G
Sbjct: 662 FGLARMVGGDQTEGNTTRVIGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRG 721
Query: 719 LGSMER 724
+R
Sbjct: 722 FYHPDR 727
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 646 bits (1667), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/715 (48%), Positives = 456/715 (63%), Gaps = 51/715 (7%)
Query: 24 AADTVTPASFIRDG--EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWVANRD 80
A+T+T + IRDG LVS FELGFFSPG S++RY+GI ++ IP VVWVANR+
Sbjct: 24 TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 83
Query: 81 RPISDNNAVLTISNNGNLVLLNQTNGTI-WSTNVSSEVKNPVAQLRDDGNLVIRDNSSGN 139
PI+D++ L + N GN VL++ N T+ WS+N ++ + +L+D GNLV+RD N
Sbjct: 84 NPINDSSGFLMLDNTGNFVLVSNNNSTVVWSSNSKKAAQSAMGELQDSGNLVLRDEKDDN 143
Query: 140 ATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPK 199
+ YLWQSFDYP+DTLL MKLGWD + L+R LS+W+S DDPS G+FT+ + P+
Sbjct: 144 SG-IYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 202
Query: 200 ICTFNGSVKFTCSGHWDGAGFVS--ALSYTDFLYKQFMMENKDECVYWYEAYNRPSIMTL 257
+ + GS K+ SG W+G GF AL Y F +++ +E Y Y N+ I +
Sbjct: 203 LVMWKGSKKYYRSGPWNGIGFSGGLALRINPVFYFDF-VDDGEEVYYTYNLKNKSLITRI 261
Query: 258 KLNPSG-FVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGF-- 314
+N + F R WNE + W +VP YC Y CGA C + Q P+C+CLE F
Sbjct: 262 VMNQTTYFRQRYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNCIMSQSPVCQCLEKFTP 321
Query: 315 -KLESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK 373
ES + C R+ L+C+ GD F++ +K PD + +N+ MNL++C+++CL+
Sbjct: 322 RSPESWNSMDWSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSKCLQ 381
Query: 374 NCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKLLWI- 430
NCSC AY +N+KE SGC +W+GDLID IR F+ GQ +Y+R+ AS+ K I
Sbjct: 382 NCSCMAYTATNIKERSGCAVWFGDLID----IRQFSAAGQEIYIRLNASESRAKAASKIK 437
Query: 431 ------LVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEY 484
L I V +LL ++Y+F R+ + EN +
Sbjct: 438 MTVGSALSIFVACGILLVAYYIFKRKAKHIGGNREENDQI-------------------- 477
Query: 485 GEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR 544
D K +D LPLF +I AT FS KLGEGGFGPVYKG L +GQE+A K
Sbjct: 478 -----DSGPK-EDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKT 531
Query: 545 LSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDST 604
LS SGQGL EFKNE++LI KLQHRNLV+LLGCC++ EKIL+ EYMPNKSL+ F+FD T
Sbjct: 532 LSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQT 591
Query: 605 KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664
+ +LL+W R II GIA+GLLYLHQ SR RI+HRDLKASN+LLDKDMNPKISDFGLARM
Sbjct: 592 RGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARM 651
Query: 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719
FGGD+ +GNT ++VGTYGYM+PEYA DGLFS+KSDVFSFGILMLE +S KK+ G
Sbjct: 652 FGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGF 706
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 638 bits (1646), Expect = e-180, Method: Compositional matrix adjust.
Identities = 346/733 (47%), Positives = 466/733 (63%), Gaps = 47/733 (6%)
Query: 12 SLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD 71
S++F LS+ S A +++ + DG+ LVSS FELGFFSPG S++RY+GI +++I
Sbjct: 18 SIVFFLSIP-STAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYKKISS 76
Query: 72 -AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNL 130
VVWVANR+ P++D++ +L ++GNL +N TNGTIWS+N+S NPVAQL D GNL
Sbjct: 77 FTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAINPVAQLLDTGNL 136
Query: 131 VIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTY 190
V+R + N E++LWQSFDYP D+ L MK G F L RYL+SW+S DPS G +T
Sbjct: 137 VVRAEND-NDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPSTGKYTN 195
Query: 191 RLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYT-DFLYKQFMMENKDECVYWYEAY 249
+LD + LP+ GSV SG W+G F ++ + +Y + N++E Y Y+
Sbjct: 196 KLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEFVFNQEEIYYKYQIA 255
Query: 250 NRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCE 309
N + + L+P G + R W + + W + C ++ CGA+ +C+++ P C+
Sbjct: 256 NSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCGAHGVCNINNSPACD 315
Query: 310 CLEGFK---LESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQ 366
CL+ F+ LE C R L+C +G+ FI+ IK PD N+ +NLE+
Sbjct: 316 CLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSWYNKTINLEE 375
Query: 367 CKAECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKL--- 422
C+ CLKNCSC AYAN +V++ SGC++W+GDLID R+ N GQ +Y+R+ AS +
Sbjct: 376 CEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQ--YNENGQDIYIRIAASVIDKP 433
Query: 423 ----GNKKLLWILVILVIPVVL-------LPSFYVFYRRRRKCQEKETENVETYQDLLAF 471
G K++ I+VIPV L L F F R+ ++ Q NV T +
Sbjct: 434 VKSRGKKRVR----IIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREGNVVTNPE---- 485
Query: 472 DINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYK 531
RT E +++D LPLF LA++T AT FS+ KLG+GGFGPVYK
Sbjct: 486 ------QDRTKE---------SRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYK 530
Query: 532 GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591
G L +GQE+AVKRLS +S QG+ EF+NE++ IAKLQHRNLV+LLGCC+E E++LI EYM
Sbjct: 531 GILQDGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYM 590
Query: 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD 651
PNKSL+ F+FD + LL+W R II GIA+GLLYLHQ SR RIIHRDLKASNILLD +
Sbjct: 591 PNKSLDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYE 650
Query: 652 MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
MNPKISDFG+AR FGGDE NT +IVGTYGYMSPEYA+DGLFS+KSDVFSFG+L+LE +
Sbjct: 651 MNPKISDFGMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 710
Query: 712 SSKKNTGLGSMER 724
S +KN G E
Sbjct: 711 SGRKNRGFRHAEH 723
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493723|ref|XP_002280706.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1637), Expect = e-179, Method: Compositional matrix adjust.
Identities = 342/731 (46%), Positives = 459/731 (62%), Gaps = 46/731 (6%)
Query: 9 IFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQ- 67
+ + +F L +++S+ DT+T I D E + S+ FELGFFSP SK RYLGIR++
Sbjct: 9 VIFTYVFSL-LRISIGVDTITVNQLITDAETITSAGGSFELGFFSPANSKHRYLGIRYKK 67
Query: 68 QIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDD 127
++ AVVWVANR+ P++D++ VL +++ G LV+L+ N T+WS+ S +NP AQL D
Sbjct: 68 ELNRAVVWVANRENPLNDSSGVLKVTSQGILVVLDGANKTLWSSTSSRPAQNPNAQLLDS 127
Query: 128 GNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGN 187
GNLV+++ + GN E++LWQSFDYP +TLL MKLGW+ L+RYLSSW+SADDPS G
Sbjct: 128 GNLVMKNGNDGNP-ENFLWQSFDYPCNTLLPGMKLGWNRVTGLDRYLSSWKSADDPSIGT 186
Query: 188 FTYRLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYT-DFLYKQFMMENKDECVYWY 246
FTY +D P+I N SV SG W+G F +T + +Y + N+ E + Y
Sbjct: 187 FTYGIDPSGSPQIFVRNVSVVTFRSGPWNGIRFSGYPHFTPNPVYTYDFVLNEKEIYFIY 246
Query: 247 EAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKP 306
N + L L P G+ R W + +W + SV + C Y CGAN IC +DQ P
Sbjct: 247 YLVNSSLLTRLVLTPDGYAQRFTWIDEKGQWVKYSSVQNDDCDNYALCGANGICKIDQSP 306
Query: 307 MCECLEGFKLESQVN---QPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMN 363
CEC++GF+ Q N C RS L+C+ GD+F++ +K PD N+ MN
Sbjct: 307 KCECMKGFRPRFQSNWDMADWSDGCVRSTPLDCQKGDRFVKFSGVKLPDTRTSWFNESMN 366
Query: 364 LEQCKAECLKNCSCRAYANSNVK-ESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKL 422
L++C + CL+NCSC AY NSN+ E SGCL+W+G+L D R N GQ Y+R+ AS+
Sbjct: 367 LKECASLCLRNCSCTAYVNSNISGEGSGCLLWFGNLTDIREFAEN--GQEFYVRMSASES 424
Query: 423 G-----------NKKLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAF 471
+K + ++ I + +VLL +Y ++ Q+ + +
Sbjct: 425 DAFSSTNISSKKKQKQVIVISISITGIVLLILVLTWYMLKKMKQQLKRKG---------- 474
Query: 472 DINMNITTRTNEYGEANGDGKDKSKDSW---LPLFSLASITAATENFSMQCKLGEGGFGP 528
Y E N DG + S+ LPLF LA++ AT NFS KLGEGGFGP
Sbjct: 475 ------------YMEHNSDGGETSEGQEHLELPLFELATLLNATNNFSSDNKLGEGGFGP 522
Query: 529 VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588
VYKG L +G+E+AVKRLS S QGLKEFKNE+ IAKLQHRNLV+LLGCC+ EK+LI
Sbjct: 523 VYKGILEDGEEIAVKRLSKTSRQGLKEFKNEVESIAKLQHRNLVKLLGCCICGREKMLIY 582
Query: 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648
EY+PNKSL++F+FD + +L+W R II GIA+GLLYLHQ SR RIIHRDLKA N+LL
Sbjct: 583 EYLPNKSLDLFIFDQMRGIVLDWPKRFLIINGIARGLLYLHQDSRLRIIHRDLKAENVLL 642
Query: 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708
D DMNPKISDFG+AR FGG+EL +T ++ GT GYMSPEYA +GL+S KSDV+SFG+L+L
Sbjct: 643 DNDMNPKISDFGIARSFGGNELGASTTRVAGTLGYMSPEYASEGLYSTKSDVYSFGVLVL 702
Query: 709 ETLSSKKNTGL 719
E LS K+N G
Sbjct: 703 EILSGKRNRGF 713
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147816068|emb|CAN61538.1| hypothetical protein VITISV_030742 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 632 bits (1631), Expect = e-178, Method: Compositional matrix adjust.
Identities = 340/734 (46%), Positives = 463/734 (63%), Gaps = 52/734 (7%)
Query: 9 IFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQ- 67
+ + +F L +++S+ DT+T I D E + S+ FELGFFSP SK RYLGIR++
Sbjct: 9 VIFTYVFSL-LRISIGVDTITVNQLITDAETITSAGGSFELGFFSPANSKHRYLGIRYKK 67
Query: 68 QIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDD 127
++ AVVWVANR+ P++D++ VL +++ G LV+L+ N T+WS+ S +NP AQL D
Sbjct: 68 ELNRAVVWVANRENPLNDSSGVLKVTSQGILVVLDGANKTLWSSTSSRPAQNPNAQLLDS 127
Query: 128 GNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGN 187
GNLV+++ + GN E++LWQSFDYP +TLL MKLGW+ L+RYLSSW+SADDPS G
Sbjct: 128 GNLVMKNGNDGNP-ENFLWQSFDYPCNTLLPGMKLGWNRVTGLDRYLSSWKSADDPSIGT 186
Query: 188 FTYRLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYT-DFLYKQFMMENKDECVYWY 246
FTY +D P+I N SV SG W+G F +T + +Y + N+ E + Y
Sbjct: 187 FTYGIDPSGSPQIFVRNVSVVTFRSGPWNGIRFSGYPHFTPNPVYTYDFVLNEKEIYFIY 246
Query: 247 EAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKP 306
N + L L P G+ R W + +W + SV + C Y CGAN IC +DQ P
Sbjct: 247 YLVNSSLLTRLVLTPDGYAQRFTWIDEKGQWVKYSSVQNDDCDNYALCGANGICKIDQSP 306
Query: 307 MCECLEGFKLESQVN---QPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMN 363
CEC++GF+ Q N C RS L+C+ GD+F++ +K PD N+ MN
Sbjct: 307 KCECMKGFRPRFQSNWDMADWSDGCVRSTPLDCQKGDRFVKFSGVKLPDTRTSWFNESMN 366
Query: 364 LEQCKAECLKNCSCRAYANSNVK-ESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASK- 421
L++C + CL+NCSC AY NSN+ E SGCL+W+G+L D R N GQ Y+R+ AS+
Sbjct: 367 LKECASLCLRNCSCTAYVNSNISGEGSGCLLWFGNLTDIREFAEN--GQEFYVRMSASES 424
Query: 422 -------LGNKK------LLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDL 468
+ +KK ++ I + ++ ++L+ ++Y+ + +++ + K
Sbjct: 425 DAFSSTNISSKKKQKQVIVISISITGIVLLILVLTWYMLKKMKQQLKRKG---------- 474
Query: 469 LAFDINMNITTRTNEYGEANGDGKDKSKDSW---LPLFSLASITAATENFSMQCKLGEGG 525
Y E N DG + S+ LPLF LA++ AT NFS KLGEGG
Sbjct: 475 ---------------YMEHNSDGGETSEGQEHLELPLFELATLLNATNNFSSDNKLGEGG 519
Query: 526 FGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585
FGPVYKG L +G+E+AVKRLS S QGLKEFKNE+ IAKLQHRNLV+LLGCC+ EK+
Sbjct: 520 FGPVYKGILEDGEEIAVKRLSKTSRQGLKEFKNEVESIAKLQHRNLVKLLGCCICGREKM 579
Query: 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645
LI EY+PNKSL++F+FD + +L+W R II GIA+GLLYLHQ SR RIIHRDLKA N
Sbjct: 580 LIYEYLPNKSLDLFIFDQMRGIVLDWPKRFLIINGIARGLLYLHQDSRLRIIHRDLKAEN 639
Query: 646 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGI 705
+LLD DMNPKISDFG+AR FGG+EL +T ++ GT GYMSPEYA +GL+S KSDV+SFG+
Sbjct: 640 VLLDNDMNPKISDFGIARSFGGNELXASTTRVAGTLGYMSPEYASEGLYSTKSDVYSFGV 699
Query: 706 LMLETLSSKKNTGL 719
L+LE S K+N G
Sbjct: 700 LVLEIXSGKRNRGF 713
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 632 bits (1630), Expect = e-178, Method: Compositional matrix adjust.
Identities = 344/721 (47%), Positives = 459/721 (63%), Gaps = 23/721 (3%)
Query: 19 MKVSLAA-DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWV 76
++VS A +T+ P ++DGE L+S+ FELGFFS G S+SRYLGI +++IP VVWV
Sbjct: 2 LRVSAAQLETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVWV 61
Query: 77 ANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNS 136
NR+ P DN VL ++ G ++L N T G IWS+N S KNPV QL D GNL+++D +
Sbjct: 62 GNREVPSFDNLGVLQVNEQGVIILQNSTKGIIWSSNSSRTAKNPVLQLLDSGNLIVKDGN 121
Query: 137 SGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHV 196
GN ++ +WQSFD+P +TLL MKLGW+ L RYL+SW+S DDP+ GNF+ +D+
Sbjct: 122 -GNNPDNIVWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRG 180
Query: 197 LPKICTFNGSVKFTCSGHWDGAGFVSALSYT-DFLYKQFMMENKDECVYWYEAYNRPSIM 255
P++ G SG W+G F + + ++ + NK E Y YE N +
Sbjct: 181 FPQLFMKKGDAVQVRSGPWNGLQFTGSPQLNPNPVFNFSFVSNKHEIYYSYELKNTSVVS 240
Query: 256 TLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFK 315
L ++ G + R W + + W FSVP C Y CGA C+++ P+C CLEGF
Sbjct: 241 RLIVSEKGALERHNWIDRTQSWTLFFSVPTDQCDTYLLCGAYASCNINSYPVCSCLEGFV 300
Query: 316 LESQVNQPGPI---KCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECL 372
+S + C R L C +GD F +L +K PD ++ M+L++C+ CL
Sbjct: 301 PKSPTDWSASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGMCL 360
Query: 373 KNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLG-----NK 425
+NCSC AYANS+++ SGCL+W+ LID R+ FT GQ +Y+R+ AS+L K
Sbjct: 361 RNCSCLAYANSDIR-GSGCLLWFDHLIDMRK----FTEGGQDLYIRIAASELAKGKSHGK 415
Query: 426 KLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITT--RTNE 483
++ I+ L+I + + + Y R+RK + + V + +F I+ I +
Sbjct: 416 RVAIIVSCLIIGMGMTALGSLLYTRKRK-RNILGQAVPLVLLVSSFAIHFYIISGLAKET 474
Query: 484 YGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVK 543
Y E GD K +D+ L F L +I AT NFS KLGEGGFGPVYKG LL+GQE+AVK
Sbjct: 475 YIENYGDNGAK-EDTELIAFDLITIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQEIAVK 533
Query: 544 RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS 603
RLS SGQG KEFKNE++LIA+LQHRNLV+LLGCC+ EK+LI EYMPNKSL+ F+FD
Sbjct: 534 RLSETSGQGGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSFIFDK 593
Query: 604 TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663
+ LL+W RII GIA+GLLYLHQ SR RIIHRDLKASNILLD DMNPKISDFGLAR
Sbjct: 594 KRSMLLDWHMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKISDFGLAR 653
Query: 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSME 723
FG D+ NTK++VGTYGYMSPEYA+DGLFS+KSDVFSFG+L+LE +S K+N G ++
Sbjct: 654 TFGKDQNAANTKRVVGTYGYMSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRNRGFSHLD 713
Query: 724 R 724
Sbjct: 714 H 714
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1626), Expect = e-178, Method: Compositional matrix adjust.
Identities = 339/712 (47%), Positives = 451/712 (63%), Gaps = 39/712 (5%)
Query: 24 AADTVTPASFIRDG--EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWVANRD 80
A+T+T + + DG LVS FELGFFSPG S++RY+GI ++ IP VVWVANR+
Sbjct: 18 TANTLTLSQSVCDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 77
Query: 81 RPISDNNAVLTISNNGNLVLLNQTNGTI-WSTNVSSEVKNPVAQLRDDGNLVIRDNSSGN 139
PI+D++ L + N GNLVL++ N T+ WS+N ++ + +L D GNLV+RD N
Sbjct: 78 NPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQSAMGELLDSGNLVLRDEKDAN 137
Query: 140 ATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPK 199
+ YLWQSFDYP+DTLL MKLGWD + L+R LS+W+S DDPS G+FT+ + P+
Sbjct: 138 SG-IYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 196
Query: 200 ICTFNGSVKFTCSGHWDGAGFVSA--LSYTDFLYKQFMMENKDECVYWYEAYNRPSIMTL 257
+ + GS ++ SG W+G GF L Y F+ ++ +E Y Y N+ I +
Sbjct: 197 LVMWKGSKEYYRSGPWNGIGFSGGPELRINPVFYFDFV-DDGEEVYYTYNLKNKSLITRI 255
Query: 258 KLNPSG-FVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGF-- 314
+N S F R WNE + W +VP YC Y CGA C + Q P+CECLE F
Sbjct: 256 VMNQSTYFRQRYTWNEINQTWVLYANVPRDYCDTYSLCGAYGNCIISQSPVCECLEKFTP 315
Query: 315 -KLESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK 373
ES + C R+ L+C+ GD F++ +K PD + +N+ MNL++C++ CL+
Sbjct: 316 KSPESWNSMDWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSICLE 375
Query: 374 NCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLGNKKLLWILV- 432
NCSC AY +N+KE SGC +W+GDLID + GQ +Y+R+ AS+ L ++
Sbjct: 376 NCSCMAYTATNIKERSGCAIWFGDLIDITQ--LPAAGQEIYIRMNASESSECLSLVLMAV 433
Query: 433 -----ILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGEA 487
I V +LL ++Y+F R+ + L + + + E +
Sbjct: 434 GIALSIFVACGILLVAYYIFKRKAK----------------LIGKVTLTAFSNREENDQI 477
Query: 488 NGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN 547
+ K+ D LPLF +I AT FS KLGEGGFGPVYKG L +GQE+A K S
Sbjct: 478 DSGPKE---DLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKTHSR 534
Query: 548 QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR 607
SGQG+ EFKNE++LI KLQHRNLV+LLGCC++ EKIL+ EYMPNKSL+ F+FD T+
Sbjct: 535 SSGQGINEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQTRGE 594
Query: 608 LLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667
LL+W R II GIA+GLLYLHQ SR RI+HRDLKASN+LLDKDMNPKISDFGLARMFGG
Sbjct: 595 LLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMFGG 654
Query: 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719
D+ +GNT ++VGTYGYM+PEYA DGLFS+KSDVFSFGILMLE +S KK+ G
Sbjct: 655 DQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGF 706
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122978|ref|XP_002330411.1| predicted protein [Populus trichocarpa] gi|222871796|gb|EEF08927.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 623 bits (1606), Expect = e-175, Method: Compositional matrix adjust.
Identities = 334/723 (46%), Positives = 455/723 (62%), Gaps = 45/723 (6%)
Query: 15 FLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQI-PDAV 73
FLL + + DT+TP IRDG+ LVS+ FELGFFSPG SK RYLGI +Q+I V
Sbjct: 16 FLLISAIRASTDTLTPGQSIRDGDLLVSADGSFELGFFSPGISKGRYLGIWYQKISAGTV 75
Query: 74 VWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIR 133
VWVANR+ P++D++ L +++ G L+LLN + IWS+N S +NPV +L D GNLV++
Sbjct: 76 VWVANRETPLNDSSGALIVTDQGILILLNSSKDAIWSSNASRTAQNPVMKLLDSGNLVVK 135
Query: 134 DNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLD 193
D + + +E++LWQSFDYP DTLL MK G + L+RYLSSW+S++DP+ G FT+R+D
Sbjct: 136 DIN--DNSENFLWQSFDYPGDTLLPGMKWGRNMVTGLDRYLSSWKSSNDPAQGEFTFRID 193
Query: 194 IHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYT-DFLYKQFMMENKDECVYWYEAYNRP 252
++ G +G W+G + + LY + E Y ++ N
Sbjct: 194 PRGNTQMLLMRGPKILYRTGTWNGYRWTGTPQLEPNMLYTYGFISTATEMYYKFDLINSS 253
Query: 253 SIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLE 312
+ +N SG R W +N W +V C Y CGA C+++++P+C CLE
Sbjct: 254 VASRIVMNSSGAAQRFTWITRTNSWARFSAVLLDQCDDYALCGAYGSCNVNKQPVCACLE 313
Query: 313 GFKLESQVN---QPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKA 369
GF +S + Q C R L+C GD+F++ +K PD I ++ L++CK
Sbjct: 314 GFIPKSPKDWSIQEWSDGCVRRTKLDCDKGDRFLQHGGVKLPDMIKSWVDTSKGLKECKD 373
Query: 370 ECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLGN---- 424
CLKNCSC AYANS+++ SGCL+W+ +LID R GQ +Y+R+ AS+L N
Sbjct: 374 LCLKNCSCVAYANSDIRGGGSGCLLWFDELIDTRELTTG--GQDLYIRIAASELYNIEKN 431
Query: 425 -----KKLLWILVILVIPVVLLPSFYVFYRRRRKCQEK---ETENVETYQDLLAFDINMN 476
K+L I+ ++ V +L ++ Y RR+K +++ +T +++ Y+D
Sbjct: 432 RSSDKKQLGIIVGTIITIVGVLVLAFILYARRKKLKKQANMKTSHLQNYED--------- 482
Query: 477 ITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLN 536
+ +D LP F L++I AT+NFS + KLGEGGFG VYKG L+
Sbjct: 483 --------------EDQRKEDMELPTFDLSTIANATDNFSSRNKLGEGGFGSVYKGTLIE 528
Query: 537 GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596
GQEVAVKRLS SGQGL EFKNE++LIAKLQHRNLV+LLGCC+E E+ILI EYMPNKSL
Sbjct: 529 GQEVAVKRLSKNSGQGLTEFKNEVILIAKLQHRNLVKLLGCCIEGDERILIYEYMPNKSL 588
Query: 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656
+ F+FD + +W+ + I+ GIA+GLLYLHQ SR RIIHRDLKA+N+LLD MNPKI
Sbjct: 589 DYFIFDKKTRNSSDWRIWINIVGGIARGLLYLHQDSRLRIIHRDLKAANVLLDNGMNPKI 648
Query: 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 716
SDFGLAR FGGD+ + NT +IVGTYGYMSPEYA+DG FS+KSDVFSFG+L+LE +S KKN
Sbjct: 649 SDFGLARTFGGDQTEANTNKIVGTYGYMSPEYAVDGFFSVKSDVFSFGVLVLEIVSGKKN 708
Query: 717 TGL 719
G
Sbjct: 709 RGF 711
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 724 | ||||||
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.968 | 0.824 | 0.445 | 2.6e-157 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.955 | 0.817 | 0.448 | 1.7e-155 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.359 | 0.332 | 0.590 | 1.3e-154 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.961 | 0.825 | 0.442 | 5.1e-154 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.968 | 0.825 | 0.432 | 1.9e-147 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.933 | 0.829 | 0.422 | 7.8e-142 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.298 | 0.268 | 0.648 | 4e-136 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.953 | 0.819 | 0.418 | 8.8e-134 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.341 | 0.305 | 0.538 | 1.8e-129 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.935 | 0.831 | 0.404 | 5.2e-129 |
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1533 (544.7 bits), Expect = 2.6e-157, P = 2.6e-157
Identities = 328/736 (44%), Positives = 458/736 (62%)
Query: 10 FCSLIFLLSMKVSLAADTVTPASF--IRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQ 67
F + +L S++A+T++ + I +VS FELGFF PG YLGI ++
Sbjct: 14 FFFFLLILFPAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYK 73
Query: 68 QIPDAV-VWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNP-VAQL 124
I VWVANRD P+S + L IS++ NLV+L+Q++ +WSTN++ +V++P VA+L
Sbjct: 74 AISKRTYVWVANRDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAEL 132
Query: 125 RDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS 184
D+GN V+RD S +A + LWQSFD+PTDTLL +MKLGWD K R++ SW+S DDPS
Sbjct: 133 LDNGNFVLRD-SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPS 191
Query: 185 PGNFTYRLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYTDFLYKQF-MMENKDECV 243
G+F+++L+ P+I +N + SG W+G F F Y F +K+E
Sbjct: 192 SGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVT 251
Query: 244 YWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLD 303
Y + L ++ SG + R W E + W++ + P C +Y CG C +
Sbjct: 252 YSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSN 311
Query: 304 QKPMCECLEGFKLES-QV--NQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQ 360
P+C C++GFK + QV + G C R L C GD F+ L ++K PD S+++
Sbjct: 312 TSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDR 371
Query: 361 RMNLEQCKAECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--GQSVYLRV 417
+ +++C+ +CL++C+C A+AN++++ S SGC+ W G+L D IRN+ GQ +Y+R+
Sbjct: 372 GIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFD----IRNYAKGGQDLYVRL 427
Query: 418 PASKLGNKKXXXXXXXXXXXXXXXX---SFYVFYRRRRKCQEKETENVETY---QDLLAF 471
A+ L +K+ SF +F+ +RK +K + +ET L +
Sbjct: 428 AATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRK--QKRSILIETPIVDHQLRSR 485
Query: 472 DINMN---ITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGP 528
D+ MN I++R + E N D D LPL + AT NFS KLG+GGFG
Sbjct: 486 DLLMNEVVISSRRHISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGI 539
Query: 529 VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588
VYKG+LL+GQE+AVKRLS S QG EFKNE+ LIA+LQH NLVRLL CCV+ GEK+LI
Sbjct: 540 VYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIY 599
Query: 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648
EY+ N SL+ LFD ++ LNWQ R II GIA+GLLYLHQ SRFRIIHRDLKASNILL
Sbjct: 600 EYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILL 659
Query: 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708
DK M PKISDFG+AR+FG DE + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+L
Sbjct: 660 DKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLL 719
Query: 709 ETLSSKKNTGLGSMER 724
E +SSK+N G + +R
Sbjct: 720 EIISSKRNKGFYNSDR 735
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1516 (538.7 bits), Expect = 1.7e-155, P = 1.7e-155
Identities = 330/736 (44%), Positives = 458/736 (62%)
Query: 13 LIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-D 71
+I L+ V + + T + I + ++S SQ FELGFF+P S YLGI ++ IP
Sbjct: 17 IILFLAFSVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIR 76
Query: 72 AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNPVA-QLRDDGN 129
VWVANRD P+S +N L IS+N NLV+ +Q++ +WSTN++ +V++PVA +L D GN
Sbjct: 77 TYVWVANRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGN 135
Query: 130 LVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNR-LERYLSSWRSADDPSPGNF 188
V+RD S N +LWQSFD+PTDTLL DMK+GWD K+ R L SW++ DDPS G+F
Sbjct: 136 FVLRD-SKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDF 194
Query: 189 TYRLDIHVLPKICTFNG-SVKFTCSGHWDGAGF--VSALSYTDFLYKQFMMENKDECVYW 245
+ +L P+ +N S+ + SG W G F V + D++ F EN + VY
Sbjct: 195 STKLRTSGFPEFYIYNKESITYR-SGPWLGNRFSSVPGMKPVDYIDNSFT-ENNQQVVYS 252
Query: 246 YEAYNRPSIMT-LKLNPSGFVTRQIWNENSNKWDELFSVP----DQY--CGKYGYCGANT 298
Y N+ +I + L L+ +G + R W E + W +L+ P D Y CG YGYC ANT
Sbjct: 253 YRV-NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANT 311
Query: 299 ICSLDQKPMCECLEGFKL--ESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDV 356
P+C C++GF+ E + + C R L C D F+ L +++ PD +
Sbjct: 312 ------SPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTET 365
Query: 357 SLNQRMNLEQCKAECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--GQSV 413
S+++ + L++C+ CLK C+C A+AN++++ SGC++W G L D IRN+ GQ +
Sbjct: 366 SVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFD----IRNYAKGGQDL 421
Query: 414 YLRVPASKLGNKKXXXXXXXXXXXXXXXX---SFYVFYRRRRKCQEKETENVET-YQDLL 469
Y+RV A L +K+ SF +F+ +RK +K + ++T DL+
Sbjct: 422 YVRVAAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRK--QKRSITIQTPIVDLV 479
Query: 470 -AFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGP 528
+ D MN + + + + D + LPL ++ AT NFS KLG+GGFG
Sbjct: 480 RSQDSLMNELVKASRSYTSKENKTDYLE---LPLMEWKALAMATNNFSTDNKLGQGGFGI 536
Query: 529 VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588
VYKG LL+G+E+AVKRLS S QG EF NE+ LIAKLQH NLVRLLGCCV++GEK+LI
Sbjct: 537 VYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIY 596
Query: 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648
EY+ N SL+ LFD T+ LNWQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LL
Sbjct: 597 EYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLL 656
Query: 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708
DK+M PKISDFG+AR+FG +E + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+L
Sbjct: 657 DKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLL 716
Query: 709 ETLSSKKNTGLGSMER 724
E +S K+N G + R
Sbjct: 717 EIISGKRNKGFYNSNR 732
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 778 (278.9 bits), Expect = 1.3e-154, Sum P(2) = 1.3e-154
Identities = 154/261 (59%), Positives = 192/261 (73%)
Query: 463 ETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLG 522
E QDL + I T E + K + +D LP L +++ AT FS KLG
Sbjct: 414 ENGQDLYVRLASSEIETLQRESSRVSSR-KQEEEDLELPFLDLDTVSEATSGFSAGNKLG 472
Query: 523 EGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 582
+GGFGPVYKG L GQEVAVKRLS S QG++EFKNE+ LIAKLQHRNLV++LG CV++
Sbjct: 473 QGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEE 532
Query: 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642
E++LI EY PNKSL+ F+FD ++R L+W RV II+GIA+G+LYLH+ SR RIIHRDLK
Sbjct: 533 ERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLK 592
Query: 643 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFS 702
ASN+LLD DMN KISDFGLAR GGDE + NT ++VGTYGYMSPEY +DG FS+KSDVFS
Sbjct: 593 ASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFS 652
Query: 703 FGILMLETLSSKKNTGLGSME 723
FG+L+LE +S ++N G + E
Sbjct: 653 FGVLVLEIVSGRRNRGFRNEE 673
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1502 (533.8 bits), Expect = 5.1e-154, P = 5.1e-154
Identities = 326/736 (44%), Positives = 455/736 (61%)
Query: 9 IFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQ 68
IF LI L+ VS + T + I + ++S SQ FELGFF+P S YLGI ++
Sbjct: 13 IFLILILFLAFSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKI 72
Query: 69 IP-DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNPVA-QLR 125
IP VWVANRD P+S +N L IS N NLV+ +Q++ +WSTN++ +V++PVA +L
Sbjct: 73 IPIRTYVWVANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELL 131
Query: 126 DDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP 185
D+GN ++RD+++ LWQSFD+PTDTLL +MKLGWD K R L SW++ DDPS
Sbjct: 132 DNGNFLLRDSNN-----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSS 186
Query: 186 GNFTYRLDIHVLPK--ICTFNGSVKFTCSGHWDGAGF--VSALSYTDFLYKQFMMENKDE 241
G F+ +L+ P+ IC+ S+ + SG W+G F V D++ F +K+E
Sbjct: 187 GEFSTKLETSEFPEFYICS-KESILYR-SGPWNGMRFSSVPGTIQVDYMVYNFTA-SKEE 243
Query: 242 CVYWYEAYNRPSIMT-LKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTIC 300
Y Y N+ ++ + L LN +G + R W E + W +L+ P C Y CG C
Sbjct: 244 VTYSYRI-NKTNLYSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYC 302
Query: 301 SLDQKPMCECLEGFK-LESQV--NQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVS 357
+ P C C++GFK + Q + G C R L C D F L +K PD
Sbjct: 303 DSNSLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATI 362
Query: 358 LNQRMNLEQCKAECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFTGQSVYLR 416
+++ + L+ CK CL++C+C A+AN++++ SGC++W +++D R + GQ +Y+R
Sbjct: 363 VDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKG--GQDLYVR 420
Query: 417 VPASKLGNKKXXXXXXXXXXXXXXXX---SFYVFYRRRRKCQEK---ETENVETY--QDL 468
+ A++L +K+ SF +F+ +RK + +T NV+ QD
Sbjct: 421 LAAAELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDS 480
Query: 469 LAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGP 528
L D+ + +R G + + K + + LPL L ++ AT NFS KLG+GGFG
Sbjct: 481 LINDV---VVSRR---GYTSKEKKSEYLE--LPLLELEALATATNNFSNDNKLGQGGFGI 532
Query: 529 VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588
VYKGRLL+G+E+AVKRLS S QG EF NE+ LIAKLQH NLVRLLGCCV++GEK+LI
Sbjct: 533 VYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIY 592
Query: 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648
EY+ N SL+ LFD T+ LNWQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LL
Sbjct: 593 EYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLL 652
Query: 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708
DK+M PKISDFG+AR+FG +E + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+L
Sbjct: 653 DKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLL 712
Query: 709 ETLSSKKNTGLGSMER 724
E +S K+N G + R
Sbjct: 713 EIISGKRNKGFYNSNR 728
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1440 (512.0 bits), Expect = 1.9e-147, P = 1.9e-147
Identities = 322/745 (43%), Positives = 460/745 (61%)
Query: 8 NIFCSL-IFLLSMKVSLAADTVTPASFIRDG---EKLVSSSQRFELGFFSPGKSKSRYLG 63
+++ SL ++ + S+AA+T+ +RDG + LVS + FELGFFSPG S R+LG
Sbjct: 8 SLYLSLFLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLG 67
Query: 64 IRFQQIPD-AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEV---KN 119
I + I D AVVWVANR PISD + VL ISN+GNLVLL+ N T+WS+N+ S N
Sbjct: 68 IWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNN 127
Query: 120 PVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRS 179
V + D GN V+ + T+ +W+SF++PTDT L M++ + + SWRS
Sbjct: 128 RVVSIHDTGNFVLSETD----TDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRS 183
Query: 180 ADDPSPGNFTYRLDIHVLPKICTFNGS-VKFTCSGHWDGAGF--VSALSY-TDFLYKQFM 235
DPSPGN++ +D P+I + G+ + SG W+ A F + +S T++LY +
Sbjct: 184 ETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKL 243
Query: 236 MENKDEC--VYWYEAYNRPSIMT-LKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYG 292
DE VY+ + PS++ K+ +G WNE KW + S PD C +Y
Sbjct: 244 SSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYN 303
Query: 293 YCGANTICSLD-QKPMCECLEGFKLESQVN-QPG-----PIKCERSHSLECKSGDQFIEL 345
CG IC + +C C+ G++ S N G P+KCER+ S+ D+F+ L
Sbjct: 304 RCGKFGICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISV---GEDEFLTL 360
Query: 346 DEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPI 405
+K PDF ++ + ++ E C+ CL+NCSC AY+ + GC++W DL+D ++
Sbjct: 361 KSVKLPDF-EIPEHNLVDPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVDLQQ-- 414
Query: 406 RNFTGQSVYLRVPASKLG-NKKXXXXXXXXXXXXXXXXSFY--VFYRRRRKCQEKET--- 459
G S+++R+ S++G N+K + + +R +RK
Sbjct: 415 FEAGGSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCG 474
Query: 460 ENVETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKD-SWLPLFSLASITAATENFSMQ 518
+N +T ++ D+ + T + G + + K+ + S LP+FSL +I AT +F +
Sbjct: 475 KNTDT--SVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKE 532
Query: 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
+LG GGFGPVYKG L +G+E+AVKRLS +SGQG+ EFKNE++LIAKLQHRNLVRLLGCC
Sbjct: 533 NELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCC 592
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
E EK+L+ EYMPNKSL+ FLFD TK+ L++W+ R IIEGIA+GLLYLH+ SR RIIH
Sbjct: 593 FEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIH 652
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 698
RDLK SN+LLD +MNPKISDFG+AR+FGG++ + NT ++VGTYGYMSPEYA++GLFS+KS
Sbjct: 653 RDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKS 712
Query: 699 DVFSFGILMLETLSSKKNTGLGSME 723
DV+SFG+L+LE +S K+NT L S E
Sbjct: 713 DVYSFGVLLLEIVSGKRNTSLRSSE 737
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1387 (493.3 bits), Expect = 7.8e-142, P = 7.8e-142
Identities = 310/733 (42%), Positives = 436/733 (59%)
Query: 8 NIFCSLIFLLSMKVSLAAD--TVTPASFIRDGEKLVSSSQRFELGFFSPGKSKS---RYL 62
++F +FL+S +S+A D +TP F++DG+ L S Q F+LGFFS + + R+L
Sbjct: 6 SLFSLSLFLISSSLSVALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFL 65
Query: 63 GIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWS-----TNVSSEV 117
G+ + + P AVVWVANR+ P+ + L +S+ G+L L + + +WS T S
Sbjct: 66 GLWYME-PFAVVWVANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTA 124
Query: 118 KNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSW 177
NP+ ++ GNL+ S + E+ LWQSFDYP +T+L MKLG +FK ++E LSSW
Sbjct: 125 NNPLLKISCSGNLI-----SSDGEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSW 179
Query: 178 RSADDPSPGNFTYRLDIHVLPK-ICTFNGSVKFTCS-GHWDGAGFVSA--LSYTDFLYKQ 233
++ DPSPG+FT LD LP+ I NG ++ G W+G F A + + L+
Sbjct: 180 KTLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDY 239
Query: 234 FMMENKDECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGY 293
+ E Y + +R + L LN +G + R I ++ N+W + P+ C Y
Sbjct: 240 KFTSSAQEVNYSWTPRHR-IVSRLVLNNTGKLHRFIQSKQ-NQWILANTAPEDECDYYSI 297
Query: 294 CGANTICSLDQK--PMCECLEGFKLES--QVN-QPGPIKCERSHSLECKSGDQFIELDEI 348
CGA +C ++ K P C CL+GFK +S + N G C C+ D F++ +
Sbjct: 298 CGAYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGL 357
Query: 349 KAPD--FIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESS-GCLMWYGDLIDARRPI 405
K PD + M LE CK +C NCSC AYAN++++E GCL+W+GDL+D R
Sbjct: 358 KLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMRE-Y 416
Query: 406 RNFTGQSVYLRVPASKLGNKKXXXXXXXXXXXXXXXXSFYVFYRRRRKCQEKETENVETY 465
+F GQ VY+R+ +K+ K V + C K+ ++ Y
Sbjct: 417 SSF-GQDVYIRMGFAKIEFKGREVVGMVVGSVVAIAVVLVVVFA----CFRKKI--MKRY 469
Query: 466 QDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGG 525
+ GE G ++ +D LP+F +I+ AT++FS LG GG
Sbjct: 470 R------------------GENFRKGIEE-EDLDLPIFDRKTISIATDDFSYVNFLGRGG 510
Query: 526 FGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585
FGPVYKG+L +GQE+AVKRLS SGQG++EFKNE+ LIAKLQHRNLVRLLGCC++ E +
Sbjct: 511 FGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECM 570
Query: 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645
LI EYMPNKSL+ F+FD + L+W+ R+ II G+A+G+LYLHQ SR RIIHRDLKA N
Sbjct: 571 LIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGN 630
Query: 646 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGI 705
+LLD DMNPKISDFGLA+ FGGD+ + +T ++VGTYGYM PEYA+DG FS+KSDVFSFG+
Sbjct: 631 VLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGV 690
Query: 706 LMLETLSSKKNTG 718
L+LE ++ K N G
Sbjct: 691 LVLEIITGKTNRG 703
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 740 (265.6 bits), Expect = 4.0e-136, Sum P(2) = 4.0e-136
Identities = 140/216 (64%), Positives = 176/216 (81%)
Query: 500 LPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 559
L F + +I AT NFS+ KLG+GGFG VYKG+L +G+E+AVKRLS+ SGQG +EF NE
Sbjct: 476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535
Query: 560 MMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE 619
++LI+KLQHRNLVR+LGCC+E+ EK+LI E+M NKSL+ FLFDS K+ ++W R II+
Sbjct: 536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQ 595
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
GIA+GLLYLH SR R+IHRDLK SNILLD+ MNPKISDFGLARM+ G E Q NT+++VG
Sbjct: 596 GIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 655
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
T GYMSPEYA G+FS KSD++SFG+LMLE +S +K
Sbjct: 656 TLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEK 691
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1311 (466.6 bits), Expect = 8.8e-134, P = 8.8e-134
Identities = 304/726 (41%), Positives = 422/726 (58%)
Query: 13 LIF-LLSMKVSLA-ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQI- 69
LIF L VS + +++ T IR+G+ L+S + FELGFF+P S RY+GI ++ I
Sbjct: 15 LIFHQLCSNVSCSTSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIE 74
Query: 70 PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGN 129
P VVWVANR++P+ D+ L I+++GNLV++N N TIWSTNV E N VA L G+
Sbjct: 75 PQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGD 134
Query: 130 LVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFT 189
LV+ +S + W+SF+ PTDT L M++ + R W+S DPSPG ++
Sbjct: 135 LVLCSDSD---RRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYS 191
Query: 190 YRLDIHVLPKICTFNGSVKFTCSGHWDGA---GFVSALSYTDFLY--KQFMMENKDECVY 244
+D +I + G + SG W+ A G L +T+++Y K ++D VY
Sbjct: 192 MGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVY 251
Query: 245 W-YEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLD 303
+ Y A + + + P G + WN++ W+ L P C KY CG ++C D
Sbjct: 252 FTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCD-D 310
Query: 304 QKPM----CECLEGFKLESQV---NQPGPIKCERSHSLECKSG------DQFIELDEIKA 350
K C C++GF+ Q N+ C+R L C D F L IK
Sbjct: 311 SKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKV 370
Query: 351 PDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFTG 410
PDF V L+ N E CK C ++CSC+AYA + GC++W DLID R G
Sbjct: 371 PDFGSVVLHN--NSETCKDVCARDCSCKAYA---LVVGIGCMIWTRDLIDMEHFERG--G 423
Query: 411 QSVYLRVPASKLGNKKXXXXXXXXXXXXXXXXSFYVFYRRRRKCQEKETENVETYQDLLA 470
S+ +R+ SKLG K + K ++ + +D+
Sbjct: 424 NSINIRLAGSKLGGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAFLWKKKDITV 483
Query: 471 FDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVY 530
DI N ++ GD D + D LP+FS S+ +AT +F+ + KLG+GGFG VY
Sbjct: 484 SDIIENRDYSSSPIKVLVGDQVD-TPD--LPIFSFDSVASATGDFAEENKLGQGGFGTVY 540
Query: 531 KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590
KG G+E+AVKRLS +S QGL+EFKNE++LIAKLQHRNLVRLLGCC+E EK+L+ EY
Sbjct: 541 KGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEY 600
Query: 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK 650
MPNKSL+ FLFD +K+ L+W+ R +I GIA+GLLYLH+ SR +IIHRDLKASNILLD
Sbjct: 601 MPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDT 660
Query: 651 DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 710
+MNPKISDFG+AR+F + NT ++VGTYGYM+PEYA++G+FS KSDV+SFG+L+LE
Sbjct: 661 EMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEI 720
Query: 711 LSSKKN 716
+S +KN
Sbjct: 721 VSGRKN 726
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 710 (255.0 bits), Expect = 1.8e-129, Sum P(2) = 1.8e-129
Identities = 134/249 (53%), Positives = 187/249 (75%)
Query: 469 LAFDINMNITTRTNEYGEANGDGKD-KSKD-SWLPLFSLASITAATENFSMQCKLGEGGF 526
L + + ++ + ++ D + +D S L F + +I AT+NFS+ KLG+GGF
Sbjct: 448 LRYKVKHTVSAKISKIASKEAWNNDLEPQDVSGLKFFEMNTIQTATDNFSLSNKLGQGGF 507
Query: 527 GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586
G VYKG+L +G+E+AVKRLS+ SGQG +EF NE++LI+KLQH+NLVR+LGCC+E E++L
Sbjct: 508 GSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLL 567
Query: 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 646
+ E++ NKSL+ FLFDS K+ ++W R IIEGIA+GL YLH+ S R+IHRDLK SNI
Sbjct: 568 VYEFLLNKSLDTFLFDSRKRLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNI 627
Query: 647 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGIL 706
LLD+ MNPKISDFGLARM+ G E Q NT+++ GT GYM+PEYA G+FS KSD++SFG++
Sbjct: 628 LLDEKMNPKISDFGLARMYQGTEYQDNTRRVAGTLGYMAPEYAWTGMFSEKSDIYSFGVI 687
Query: 707 MLETLSSKK 715
+LE ++ +K
Sbjct: 688 LLEIITGEK 696
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1266 (450.7 bits), Expect = 5.2e-129, P = 5.2e-129
Identities = 299/739 (40%), Positives = 425/739 (57%)
Query: 1 MEKIPCLNIFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSR 60
M KI + F SL+FLL + S A +T AS + G+ L S + +ELGFFSP S+++
Sbjct: 1 MGKIGIV-FFASLLFLLIIFPSCAFAAITRASPLSIGQTLSSPNGTYELGFFSPNNSRNQ 59
Query: 61 YLGIRFQQI-PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKN 119
Y+GI F+ I P VVWVANRD+P+++N A LTI++NG+L+L+ + +WS +
Sbjct: 60 YVGIWFKNITPRVVVWVANRDKPVTNNAANLTINSNGSLILVEREQNVVWSIGETFSSNE 119
Query: 120 PVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRS 179
A+L ++GNLV+ D S E LW+SF++ DT+L + + +D N +R LSSW++
Sbjct: 120 LRAELLENGNLVLIDGVS----ERNLWESFEHLGDTMLLESSVMYDVPNNKKRVLSSWKN 175
Query: 180 ADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGHWDGAGF-----VSALSYTDFLYKQF 234
DPSPG F L V P+ GS + G W F + + F Q
Sbjct: 176 PTDPSPGEFVAELTTQVPPQGFIMRGSRPYWRGGPWARVRFTGIPEMDGSHVSKFDISQD 235
Query: 235 MMENKDECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYC 294
+ Y E N ++ L +G + + IWN N + W P C Y C
Sbjct: 236 VAAGTGSLTYSLERRNS-NLSYTTLTSAGSL-KIIWN-NGSGWVTDLEAPVSSCDVYNTC 292
Query: 295 GANTICSLDQKPMCECLEGF--KLESQVNQPGPIK-CERSHSLEC----------KSGDQ 341
G +C P CECL+GF K + + N+ C R +L C +GD
Sbjct: 293 GPFGLCIRSNPPKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQANNGDI 352
Query: 342 FIELDEIKAPDFID-VSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLID 400
F + +K PDF + +SL +N E C+ CL NCSC A+ S + E GCL+W +L+D
Sbjct: 353 FDIVANVKPPDFYEYLSL---INEEDCQQRCLGNCSCTAF--SYI-EQIGCLVWNRELVD 406
Query: 401 ARRPIRNFTGQSVYLRVPASKLG--NKKXXXXXXXXXXXXXXXXSF--YVFYRRRRKCQE 456
+ + G+++ +R+ +S+L N+ F Y ++R + K +
Sbjct: 407 VMQFVAG--GETLSIRLASSELAGSNRVKIIVASIVSISVFMILVFASYWYWRYKAKQND 464
Query: 457 KETENVETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFS 516
+ET QD A+ +++ K + F + +I T NFS
Sbjct: 465 SNPIPLETSQD--AW--------------------REQLKPQDVNFFDMQTILTITNNFS 502
Query: 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
M+ KLG+GGFGPVYKG L +G+E+A+KRLS+ SGQGL+EF NE++LI+KLQHRNLVRLLG
Sbjct: 503 MENKLGQGGFGPVYKGNLQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLG 562
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
CC+E EK+LI E+M NKSLN F+FDSTKK L+W R II+GIA GLLYLH+ S R+
Sbjct: 563 CCIEGEEKLLIYEFMANKSLNTFIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRV 622
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 696
+HRD+K SNILLD++MNPKISDFGLARMF G + Q NT+++VGT GYMSPEYA G+FS
Sbjct: 623 VHRDMKVSNILLDEEMNPKISDFGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFSE 682
Query: 697 KSDVFSFGILMLETLSSKK 715
KSD+++FG+L+LE ++ K+
Sbjct: 683 KSDIYAFGVLLLEIITGKR 701
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81905 | SD18_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4558 | 0.9516 | 0.8105 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 724 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-53 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-53 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-41 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 1e-40 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 2e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-37 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-35 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 4e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-30 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-27 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-27 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-27 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-26 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-26 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-25 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-24 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 4e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-23 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-22 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-22 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-20 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 6e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-19 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 3e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-12 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| PTZ00163 | 230 | PTZ00163, PTZ00163, hypothetical protein; Provisio | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 3e-53
Identities = 76/205 (37%), Positives = 111/205 (54%), Gaps = 16/205 (7%)
Query: 516 SMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHR 569
++ KLGEG FG VYKG+L EVAVK L + S Q ++EF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N+V+LLG C E+ +++EYM L +L + L+ + IA+G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL--QGNTKQIVGTYGYMSPE 687
IHRDL A N L+ +++ KISDFGL+R D+ + K +M+PE
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGK---LPIRWMAPE 173
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
+G F+ KSDV+SFG+L+ E +
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 4e-53
Identities = 78/205 (38%), Positives = 114/205 (55%), Gaps = 15/205 (7%)
Query: 516 SMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHR 569
++ KLGEG FG VYKG L EVAVK L + S Q ++EF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N+V+LLG C E+ ++++EYMP L +L + + L+ + IA+G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL--QGNTKQIVGTYGYMSPE 687
S+ IHRDL A N L+ +++ KISDFGL+R D+ K +M+PE
Sbjct: 121 --SK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGK---LPIRWMAPE 174
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
+G F+ KSDV+SFG+L+ E +
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 4e-52
Identities = 83/205 (40%), Positives = 117/205 (57%), Gaps = 16/205 (7%)
Query: 520 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRL 574
KLGEG FG VYKG+L EVAVK L S + K+F E ++ KL H N+VRL
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLYL 628
LG C E+ L+LEYM L +L F S +K L+ + + IA+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNTKQIVGTYGYMSPE 687
S+ + +HRDL A N L+ +D+ KISDFGL+R ++ D + T + +M+PE
Sbjct: 122 A--SK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPE 177
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
DG+F+ KSDV+SFG+L+ E +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 6e-51
Identities = 77/193 (39%), Positives = 110/193 (56%), Gaps = 11/193 (5%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 578
LGEGGFG VY R G++VA+K + + L E E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
++ L++EY SL L ++ K L+ +RI+ I +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 639 RDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSI 696
RDLK NILLD D K++DFGL+++ D+ T IVGT YM+PE L G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 697 KSDVFSFGILMLE 709
KSD++S G+++ E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 7e-51
Identities = 76/207 (36%), Positives = 110/207 (53%), Gaps = 17/207 (8%)
Query: 515 FSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQH 568
+ KLGEG FG VYKG L +VAVK L + + +EF E ++ KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
N+VRLLG C + ++ EYMP L FL L + +++ IA+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG---YMS 685
S+ +HRDL A N L+ +++ KISDFGL+R D+ ++ G +M+
Sbjct: 119 E--SK-NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWMA 172
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
PE DG F+ KSDV+SFG+L+ E +
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 9e-49
Identities = 71/199 (35%), Positives = 106/199 (53%), Gaps = 12/199 (6%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
KLG G FG VYK + G+ VAVK L ++ + + + E+ ++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
++ L++EY L +L ++ L+ +I I +GL YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL-FS 695
IHRDLK NILLD++ KI+DFGLA+ + VGT YM+PE L G +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 696 IKSDVFSFGILMLETLSSK 714
K DV+S G+++ E L+ K
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 3e-47
Identities = 69/197 (35%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLV 572
+ + KLGEG FG VY R G+ VA+K + + + +E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
RL ++ + L++EY L L + RL +AR + I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEAR-FYLRQILSALEYLHSK- 116
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
I+HRDLK NILLD+D + K++DFGLAR E VGT YM+PE L
Sbjct: 117 --GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171
Query: 693 LFSIKSDVFSFGILMLE 709
+ D++S G+++ E
Sbjct: 172 GYGKAVDIWSLGVILYE 188
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 8e-41
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 519 CKLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
LG G FG VY G+ +AVK LS S + L+ + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 576 GCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
G ++ + L LEY+ SL+ L +L R + I +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQ-ILEGLAYLH---S 119
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 693
I+HRD+K +NIL+D D K++DFG A+ G E T + GT +M+PE
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 694 FSIKSDVFSFGILMLETLSSK 714
+ +D++S G ++E + K
Sbjct: 180 YGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 1e-40
Identities = 53/115 (46%), Positives = 70/115 (60%), Gaps = 6/115 (5%)
Query: 70 PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGN 129
VVWVANR P++D++ L + ++GNLVL + +WS+N S + VA L+DDGN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 130 LVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS 184
LV+ DNS LWQSFD+PTDTLL K G + R L+SW+S DPS
Sbjct: 61 LVLYDNSG-----KVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 50/119 (42%), Positives = 69/119 (57%), Gaps = 6/119 (5%)
Query: 34 IRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTIS 93
+ G+ LVSS FELGFF Y I ++ VVWVANRD P S ++ LT+
Sbjct: 4 LSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQ 62
Query: 94 NNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYP 152
++GNLV+ + + +WS+N + N V L DDGNLV+ D+ ++LWQSFDYP
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLS--NQSGQGLKEFKNEMMLIAKLQHRN 570
N+ + +G G FG VYKG L G VA+K++S + LK E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYL 628
+V+ +G +ILEY N SL K+ + + + + QGL YL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLR-----QIIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H+ +IHRD+KA+NIL KD K++DFG+A + +VGT +M+PE
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEV 170
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
S SD++S G ++E L+
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 79/201 (39%), Positives = 106/201 (52%), Gaps = 14/201 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG G FG V+ G +VAVK L + F E ++ KL+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 573 RLLGCCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+L C + E I I+ EYM SL FL K+L V + IA+G+ YL
Sbjct: 65 QLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKKL-RLPQLVDMAAQIAEGMAYLE-- 120
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEY 688
IHRDL A NIL+ +++ KI+DFGLAR+ DE +G I T +PE
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEA 175
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
A G F+IKSDV+SFGIL+ E
Sbjct: 176 ANYGRFTIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 66/191 (34%), Positives = 105/191 (54%), Gaps = 9/191 (4%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
K+G+GGFG VYK R G+EVA+K + +S + ++ NE+ ++ K +H N+V+ G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+++ E +++E+ SL L ST + L Q + + + +GL YLH IIH
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAY-VCKELLKGLEYLHSN---GIIH 121
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 698
RD+KA+NILL D K+ DFGL+ +VGT +M+PE + K+
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 699 DVFSFGILMLE 709
D++S GI +E
Sbjct: 179 DIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-35
Identities = 51/120 (42%), Positives = 70/120 (58%), Gaps = 7/120 (5%)
Query: 32 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLT 91
+ + G+ LVS + FELGFF+ Y I ++ VVWVANRD P+SD+ LT
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSSSRTVVWVANRDNPVSDS-CTLT 59
Query: 92 ISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151
+ ++GNLVL + +WS+N + N V L DDGNLVI D+ ++LWQSFDY
Sbjct: 60 LQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDG-----NFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 67/203 (33%), Positives = 103/203 (50%), Gaps = 16/203 (7%)
Query: 520 KLGEGGFGPVYKGRLLN-----GQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVR 573
+LGEG FG V R G++VAVK L+ + Q +F+ E+ ++ L H N+V+
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 574 LLGCCVEQGEKI--LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
G C + G + LI+EY+P+ SL +L + ++ + + I +G+ YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRL-LLFSSQICKGMDYLGSQ 128
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEYA 689
R IHRDL A NIL++ + KISDFGLA++ D + Y +PE
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
FS SDV+SFG+ + E +
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 72/207 (34%), Positives = 109/207 (52%), Gaps = 20/207 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E F+++ KLG G FG V++G N VA+K L + ++F+ E+ + +L+H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------LNWQARVRIIEGIAQGL 625
L C +I E M SL FL + L + Q +A+G+
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------VAEGM 117
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
YL + IHRDL A NIL+ +D+ K++DFGLAR+ D + K+I Y + +
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTA 172
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
PE A G FS KSDV+SFGIL+ E +
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 4e-32
Identities = 77/215 (35%), Positives = 112/215 (52%), Gaps = 29/215 (13%)
Query: 521 LGEGGFGPVYKGRL--LNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVR 573
LGEG FG VYKG L N + VA+K L N + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFLF-------------DSTKKRLLNWQARVRIIEG 620
LLG C ++ ++ EY+ + L+ FL D T K L+ + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTKQI 677
IA G+ YL S +HRDL A N L+ + + KISDFGL+R ++ D +Q +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
V +M PE L G F+ +SD++SFG+++ E S
Sbjct: 190 V---RWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 570
+ LG+G G VYK R G+ A+K++ + + K+ E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYL 628
+V+ G ++GE ++LEYM SL L K++ V I I +GL YL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYL 115
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H IIHRD+K SN+L++ KI+DFG++++ + VGT YMSPE
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPER 171
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
+S +D++S G+ +LE
Sbjct: 172 IQGESYSYAADIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 13/193 (6%)
Query: 520 KLGEGGFGPVYKG-RLLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
K+GEG G VYK G+EVA+K RL Q+ + + NE++++ +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYD 82
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+ E +++EYM SL + R+ Q + + QGL YLH +
Sbjct: 83 SYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQI-AYVCREVLQGLEYLHS---QNV 137
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 696
IHRD+K+ NILL KD + K++DFG A + + +VGT +M+PE +
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 697 KSDVFSFGILMLE 709
K D++S GI+ +E
Sbjct: 196 KVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 15/194 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 580
+G+G FG V G GQ+VAVK L + S + F E ++ L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRD 640
++ EYM SL +L S + ++ ++ + +G+ YL + +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 641 LKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY--GYMSPEYALDGLFSIKS 698
L A N+L+ +D+ K+SDFGLA+ + + Q G + +PE + FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 699 DVFSFGILMLETLS 712
DV+SFGIL+ E S
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 77/210 (36%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 521 LGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLV 572
LG G FG VY+G + VAVK L + Q KEF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR----LLNWQARVRIIEGIAQGLLYL 628
+LLG C+ + +I+E M L +L D+ +R LL + + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 629 HQYSRFRIIHRDLKASNILL-----DKDMNPKISDFGLAR-MFGGDELQGNTKQIVGTYG 682
Q IHRDL A N L+ D D KI DFGLAR ++ D + + ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE LDG F+ +SDV+SFG+LM E L+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 27/203 (13%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
++G+G FG VY R +G+ +K LSN S + ++ NE+ ++ KL H N+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKR--------LLNW--QARVRIIEGIAQGLL 626
E+G+ +++EY L+ KK +L+W Q + L
Sbjct: 67 SFEEKGKLCIVMEYADGGDLS-QKIKKQKKEGKPFPEEQILDWFVQ--------LCLALK 117
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
YLH SR +I+HRD+K NI L + K+ DFG++++ T +VGT Y+SP
Sbjct: 118 YLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSP 172
Query: 687 EYALDGLFSIKSDVFSFGILMLE 709
E + ++ KSD++S G ++ E
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYE 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 22/203 (10%)
Query: 521 LGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 574
LG G FG VYKG + VA+K L ++ + KE +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 575 LGCCVEQGEKI-LILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLH 629
LG C+ ++ LI + MP L ++ + + LLNW IA+G+ YL
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC------VQIAKGMSYLE 126
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
+ R++HRDL A N+L+ + KI+DFGLA++ DE + + + +M+ E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
L +++ KSDV+S+G+ + E ++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (303), Expect = 1e-29
Identities = 72/213 (33%), Positives = 108/213 (50%), Gaps = 17/213 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH-R 569
++ + KLGEG FG VY R + + VA+K L+ + + ++ F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N+V+L ++G L++EY+ SL L +K L+ + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 630 QYSRFRIIHRDLKASNILLDKDMN-PKISDFGLARMFGGD----ELQGNTKQIVGTYGYM 684
IIHRD+K NILLD+D K+ DFGLA++ + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 685 SPEYALDGLF---SIKSDVFSFGILMLETLSSK 714
+PE L S SD++S GI + E L+
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 71/197 (36%), Positives = 100/197 (50%), Gaps = 14/197 (7%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
+ KLG G FG V++G N VAVK L + K+F E ++ KL+H L++L
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 577 CCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
C E I I+ E M SL +L R L + + +A G+ YL +
Sbjct: 69 VCT-LEEPIYIVTELMKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQN--- 123
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT---YGYMSPEYALDG 692
IHRDL A N+L+ ++ K++DFGLAR+ D + G + +PE AL
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYN 179
Query: 693 LFSIKSDVFSFGILMLE 709
FSIKSDV+SFGIL+ E
Sbjct: 180 RFSIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 72/204 (35%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 521 LGEGGFGPVYKG--RLLNGQE--VAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
LG G FG V KG + +G+E VAVK L G KEF E ++A+L H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
G C + +L++E P L +L L +V A G+ YL
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES-K 114
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARM--FGGDELQGNT--KQIVGTYGYMSPEY 688
F +HRDL A N+LL KISDFG++R G D + T + + Y +PE
Sbjct: 115 HF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APEC 169
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
G FS KSDV+S+G+ + E S
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 68/217 (31%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 521 LGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVR 573
LGEG FG V+ G + + VAVK L + ++ F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFL------------FDSTKKRLLNWQARVRIIEGI 621
G C E I++ EYM + LN FL DS L ++I I
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQLLQIAVQI 131
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTKQIV 678
A G++YL + +HRDL N L+ D+ KI DFG++R ++ D + G+T +
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
+M PE + F+ +SDV+SFG+++ E + K
Sbjct: 189 ---RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 71/196 (36%), Positives = 106/196 (54%), Gaps = 10/196 (5%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 578
K+G+G FG VYKG L EVAVK + LK F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
V++ +++E +P SL FL KK L + +++ A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGD--ELQGNTKQIVGTYGYMSPEYALDGLFSI 696
RDL A N L+ ++ KISDFG++R G + KQI + +PE G ++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTS 174
Query: 697 KSDVFSFGILMLETLS 712
+SDV+S+GIL+ ET S
Sbjct: 175 ESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
E F + KLGEG +G VYK GQ VA+K + + L+E E+ ++ + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYI 60
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
V+ G + + +++EY S++ + T K L + I+ +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAA-ILYQTLKGLEYLHSN 118
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+ IHRD+KA NILL+++ K++DFG++ ++GT +M+PE +
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAKRNTVIGTPFWMAPEVIQE 173
Query: 692 GLFSIKSDVFSFGILMLE 709
++ K+D++S GI +E
Sbjct: 174 IGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 72/198 (36%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLL 575
+G G FG V +GRL L G++ VA+K L S + +F E ++ + H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 576 GCCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
G V + ++I+ EYM N SL+ FL ++ K V ++ GIA G+ YL S
Sbjct: 72 GV-VTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL---SEM 125
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 694
+HRDL A NIL++ ++ K+SDFGL+R E TK + +PE F
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 695 SIKSDVFSFGILMLETLS 712
+ SDV+SFGI+M E +S
Sbjct: 186 TSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 64/202 (31%), Positives = 108/202 (53%), Gaps = 15/202 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 570
+F + K+G+G FG V+K R + + A+K+ LS + + +E +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL---LNWQARVRIIEGIAQGLLY 627
++R +++G+ +++EY N L+ L + L W R I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH +I+HRD+K+ N+ LD N KI D G+A++ + NT IVGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 688 YALDGLFSIKSDVFSFGILMLE 709
D ++ KSDV++ G+++ E
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 77/204 (37%), Positives = 107/204 (52%), Gaps = 15/204 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E + KLG G FG V+ G +VA+K L Q + F E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 573 RLLGCCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
RL V E I I+ EYM N SL FL +L + + IA+G+ ++
Sbjct: 65 RLYA--VVTQEPIYIITEYMENGSLVDFLKTPEGIKL-TINKLIDMAAQIAEGMAFIE-- 119
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEY 688
R IHRDL+A+NIL+ + + KI+DFGLAR+ +E +G I T +PE
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEA 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
G F+IKSDV+SFGIL+ E ++
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQH 568
+ ++GEG +G VYK R G+ VA+K++ ++ KE E+ L+ KL+H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRH 57
Query: 569 RNLVRLLGCCVE--QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
N+VRL +G ++ EYM + L L DS + + Q + ++ + +GL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTESQIK-CYMKQLLEGLQ 114
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
YLH I+HRD+K SNIL++ D K++DFGLAR + T +++ T Y P
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170
Query: 687 EYAL-DGLFSIKSDVFSFGILMLETLSSK 714
E L + + D++S G ++ E K
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 579
++G G FG V+ G L ++VA+K + + ++F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 580 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 639
E+ L+ E+M + L+ +L ++ + + + + + +G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 640 DLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT---YGYMSPEYALDGLFSI 696
DL A N L+ ++ K+SDFG+ R D+ +T GT + SPE +S
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 697 KSDVFSFGILMLETLSSKK 715
KSDV+SFG+LM E S K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 31/219 (14%)
Query: 521 LGEGGFGPVYKGR---LLNGQE---VAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVR 573
+G+G FG V++ R LL + VAVK L + S +F+ E L+A+ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------------------LNWQAR 614
LLG C L+ EYM LN FL + + L+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGN 673
+ I + +A G+ YL S + +HRDL N L+ ++M KI+DFGL+R ++ D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +M PE ++ +SDV+++G+++ E S
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 69/217 (31%), Positives = 113/217 (52%), Gaps = 19/217 (8%)
Query: 511 ATENFSMQCKLGEGGFGPVYKG--RLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLI 563
++ ++ LG G FG VY+G R +G +VAVK L + S Q +F E +++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR----LLNWQARVRIIE 619
+K H+N+VRL+G E+ + ++LE M L FL ++ + L + +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLAR-MFGGDELQGNTK 675
+A+G YL + IHRD+ A N LL KI+DFG+AR ++ + +
Sbjct: 124 DVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
++ +M PE LDG+F+ K+DV+SFG+L+ E S
Sbjct: 181 AML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 66/209 (31%), Positives = 109/209 (52%), Gaps = 22/209 (10%)
Query: 521 LGEGGFGPVYKGRL----LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LGEG FG V +G+L + +VAVK +L + ++EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 575 LGCCVEQGEK------ILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGL 625
+G C E ++IL +M + L+ FL S L Q ++ + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDEL-QGNTKQIVGTYGY 683
YL S IHRDL A N +L +DM ++DFGL++ ++ GD QG ++ +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLS 712
++ E D +++ KSDV++FG+ M E +
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 69/197 (35%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 580
LG G FG V+ G+ +VA+K + + +F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRD 640
Q ++ EYM N L +L +K L + + + + + + YL IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 641 LKASNILLDKDMNPKISDFGLARMFGGDEL--QGNTKQIVGTYGYMSPEYALDGLFSIKS 698
L A N L+ +D K+SDFGLAR D+ TK V + PE FS KS
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV---KWAPPEVFDYSRFSSKS 182
Query: 699 DVFSFGILMLETLSSKK 715
DV+SFG+LM E S K
Sbjct: 183 DVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-26
Identities = 76/216 (35%), Positives = 114/216 (52%), Gaps = 29/216 (13%)
Query: 520 KLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLV 572
+LGE FG VYKG L Q VA+K L +++ L+E FK+E M+ ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLF-------------DSTKKRLLNWQARVRIIE 619
LLG ++ +I Y + L+ FL D T K L V I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTKQ 676
IA G+ +L S ++H+DL N+L+ +N KISD GL R ++ D +L GN+
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +MSPE + G FSI SD++S+G+++ E S
Sbjct: 189 PI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 521 LGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVR 573
LG G FG V+ + +E V VK L + EF+ E+ + KL H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLY 627
LLG C E +ILEY L FL + K L+ + +V + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
L S R +HRDL A N L+ K+S L++ E ++ +++PE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSKK 715
+ FS KSDV+SFG+LM E + +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGE 216
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGL-KEFKNEMMLIAKLQHRN 570
E +LGEG G V K RL N + A+K ++ L K+ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 571 LVRLLGCCVE--QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV------RIIEGIA 622
+V+ G ++ + +EY SL DS K++ R+ +I E +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-----DSIYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
+GL YLH +IIHRD+K SNILL + K+ DFG++ G+ + GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSF 168
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLE 709
YM+PE +SI SDV+S G+ +LE
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 6e-26
Identities = 77/205 (37%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 517 MQCKLGEGGFGPV--YKGRLLN---GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 570
LGEG FG V Y N G+ VAVK L + GQ +K E+ ++ L H N
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 571 LVRLLGCCVEQGEKI--LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+V+ GCC EQG K LI+EY+P SL +L K LN + + I +G+ YL
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF-GGDELQGNTKQIVGTYGYMSPE 687
H IHRDL A N+LLD D KI DFGLA+ G E + + + E
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
+ FS SDV+SFG+ + E L+
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 67/197 (34%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQHRNLVRLLG 576
LG+G FG V R + G+ A+K L + KE E +++++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 577 CCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
+ EK+ L+LEY P L F S + R +AR E I L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGEL--FSHLSKEGRFSEERARFYAAE-IVLALEYLHSL---G 113
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
II+RDLK NILLD D + K++DFGLA+ + + T GT Y++PE L +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLAPEVLLGKGYG 171
Query: 696 IKSDVFSFGILMLETLS 712
D +S G+L+ E L+
Sbjct: 172 KAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 72/194 (37%), Positives = 108/194 (55%), Gaps = 15/194 (7%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
+GEG FG V +G GQ+VAVK + + + Q F E ++ KL H+NLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+ G I ++E M +L FL + + L++ ++ +A+G+ YL +++H
Sbjct: 69 LHNGLYI-VMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 698
RDL A NIL+ +D K+SDFGLAR+ G N+K V + +PE FS KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPV---KWTAPEALKHKKFSSKS 178
Query: 699 DVFSFGILMLETLS 712
DV+S+G+L+ E S
Sbjct: 179 DVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 516 SMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
+M+ KLG G +G VY+G VAVK L + ++EF E ++ +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
LG C + +I E+M +L +L + ++ +N + + I+ + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY--GYMSPEYALDG 692
IHRDL A N L+ ++ K++DFGL+R+ GD T + + +PE
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYN 180
Query: 693 LFSIKSDVFSFGILMLE 709
FSIKSDV++FG+L+ E
Sbjct: 181 KFSIKSDVWAFGVLLWE 197
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 77/205 (37%), Positives = 108/205 (52%), Gaps = 13/205 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
E+ + KLG G FG V+ G +VAVK L + + F E ++ KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
LV+L E+ I + EYM SL FL D + R L V + +A G+ Y+
Sbjct: 63 LVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE- 119
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPE 687
R IHRDL+++NIL+ + KI+DFGLAR+ +E QG I T +PE
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APE 173
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
AL G F+IKSDV+SFGIL+ E ++
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-25
Identities = 79/206 (38%), Positives = 112/206 (54%), Gaps = 16/206 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64
Query: 573 RLLGCCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+L E E I I+ EYM SL FL K L V + IA G+ Y+
Sbjct: 65 QLYAVVSE--EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE-- 119
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEY 688
R +HRDL+A+NIL+ +++ K++DFGLAR+ +E QG I T +PE
Sbjct: 120 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEA 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
AL G F+IKSDV+SFGIL+ E L++K
Sbjct: 175 ALYGRFTIKSDVWSFGILLTE-LTTK 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 39/217 (17%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN-----EMMLIAKLQ 567
+ KLGEG + VYK R G+ VA+K++ + K+ N E+ L+ +L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRIIEGI 621
H N++ LL + L+ E+M K ++ L + K +
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYM-LM--------T 111
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG--GDELQGNTKQIVG 679
+GL YLH I+HRDLK +N+L+ D K++DFGLAR FG ++ T Q+V
Sbjct: 112 LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM---THQVV- 164
Query: 680 TYGYMSPEYALDGLFSIKS-----DVFSFGILMLETL 711
T Y +PE LF + D++S G + E L
Sbjct: 165 TRWYRAPEL----LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAK 565
+ ++ LGEG FG V K + VAVK L + + + L + +EM ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 566 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG---- 620
+ +H+N++ LLG C ++G +++EY + +L FL R E
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 621 ---------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671
+A+G+ +L + IHRDL A N+L+ +D KI+DFGLAR +
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
T +M+PE D +++ +SDV+SFG+L+ E +
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 63/209 (30%), Positives = 111/209 (53%), Gaps = 26/209 (12%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQG---LKEFKNEMMLIAKLQHRNLVR 573
LG G F Y+ R + G +AVK+++ N S + ++ + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+LG E L +E+M S++ L + + K+ ++ E + +GL YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRGLSYLHEN 122
Query: 632 SRFRIIHRDLKASNILLDKD-MNPKISDFGLA-----RMFGGDELQGNTKQIVGTYGYMS 685
+IIHRD+K +N+L+D +I+DFG A + G E QG Q++GT +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSK 714
PE + DV+S G +++E ++K
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 68/230 (29%), Positives = 112/230 (48%), Gaps = 33/230 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLKEFKNEMMLIAK 565
E ++ +LG+G FG VY+G VA+K ++ N S + EF NE ++ +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYM-------------PNKSLNVFLFDSTKKRLLNWQ 612
++VRLLG ++++E M P N L T ++ +
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 613 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQ 671
A IA G+ YL + +HRDL A N ++ +D+ KI DFG+ R ++ D +
Sbjct: 126 AE------IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGL 719
K ++ +M+PE DG+F+ KSDV+SFG+++ E TL+ + GL
Sbjct: 177 KGGKGLLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 75/206 (36%), Positives = 108/206 (52%), Gaps = 12/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E+ + KLG G FG V+ G N +VAVK L + ++ F E L+ LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 64
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
RL ++ +I EYM SL FL ++L + IA+G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE--- 120
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEYA 689
R IHRDL+A+N+L+ + + KI+DFGLAR+ +E +G I T +PE
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAI 176
Query: 690 LDGLFSIKSDVFSFGILMLETLSSKK 715
G F+IKSDV+SFGIL+ E ++ K
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 14/198 (7%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--EMMLIAKLQHRNLVRLLG 576
K+GEG +G VYK R L G+ VA+K++ + E+ L+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGLLYLHQYSRFR 635
+G+ L+ E+M +++ ++R L ++ ++ + + QGL + H +
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLP-ESLIKSYLYQLLQGLAFCHSH---G 118
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLF 694
I+HRDLK N+L++ + K++DFGLAR FG V T Y +PE L D +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKGY 176
Query: 695 SIKSDVFSFGILMLETLS 712
S D++S G + E LS
Sbjct: 177 STPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 8/202 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 570
+++ + +G G VY L N ++VA+KR+ + + E + E+ +++ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V+ V E L++ Y+ SL + S + L+ +++ + +GL YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEY 688
+ IHRD+KA NILL +D + KI+DFG++ GGD + K VGT +M+PE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 689 ALDGL-FSIKSDVFSFGILMLE 709
+ K+D++SFGI +E
Sbjct: 178 MEQVHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-24
Identities = 27/65 (41%), Positives = 43/65 (66%)
Query: 336 CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWY 395
C GD F+ L +K PD +++ + L++C+ CL NCSC AYA ++++ SGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWT 60
Query: 396 GDLID 400
G+L+D
Sbjct: 61 GELVD 65
|
Length = 66 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 35/222 (15%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLKEFKNEMM 561
KLGEG FG V+ Q+ VAVK L + S ++F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL--------FDSTKKRLLNWQA 613
++++L N+ RLLG C +I+EYM N LN FL + + L++
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--EL 670
+ + IA G+ YL +HRDL N L+ K+ KI+DFG++R ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
QG +M+ E L G F+ KSDV++FG+ + E L+
Sbjct: 189 QGRA---PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 34/215 (15%)
Query: 521 LGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 576 GCCVEQGEK--ILILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLY 627
G C G + L++EY+P SL +L D K L Q I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ-----IVGTYG 682
L R +HRDL NIL++ + KI DFGL ++ D+ ++ I
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF---- 176
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKN 716
+ +PE + FS+ SDV+SFG+++ E + S K+
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKR-----LSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+G FG VY ++ G+E+AVK+ S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
GC + + +EYMP S+ L L R + I +G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTR-KYTRQILEGVEYLH---SN 123
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN-TKQIVGTYGYMSPEYALDGL 693
I+HRD+K +NIL D N K+ DFG ++ G K + GT +MSPE
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 694 FSIKSDVFSFGILMLETLSSK 714
+ K+DV+S G ++E L+ K
Sbjct: 184 YGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 33/219 (15%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFK-----NEMMLIAKL-QHRNLVR 573
+GEG F V + +E A+K L + Q +KE K E ++ +L H +++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
L ++ +LEY PN L ++ K L+ + I L YLH
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLHSK-- 121
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI---------------- 677
IIHRDLK NILLDKDM+ KI+DFG A++ + + K
Sbjct: 122 -GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 678 --VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
VGT Y+SPE + SD+++ G ++ + L+ K
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 69/203 (33%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLS----NQSGQG-LKEFKNEMMLIAKLQHRNLVRL 574
LG G FG VY+G L +G AVK +S Q+GQ +K+ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
LG E+ + LE +P SL L + S + ++ R I GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH--D 120
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD- 691
R +HRD+K +NIL+D + K++DFG+A+ K G+ +M+PE
Sbjct: 121 R-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 692 GLFSIKSDVFSFGILMLETLSSK 714
G + + +D++S G +LE + K
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 14/194 (7%)
Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRLL 575
+LG G G V K G+ +AVK + + K + ++ K +V
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
G G+ + +EYM SL+ L + R+ + +I + +GL YLH + +
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL-KEVQGRI-PERILGKIAVAVLKGLTYLH--EKHK 121
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
IIHRD+K SNIL++ K+ DFG++ G + K VGT YM+PE +S
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPERIQGNDYS 177
Query: 696 IKSDVFSFGILMLE 709
+KSD++S G+ ++E
Sbjct: 178 VKSDIWSLGLSLIE 191
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-24
Identities = 78/207 (37%), Positives = 112/207 (54%), Gaps = 15/207 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 571
E+ + KLG+G FG V+ G +VA+K L + G + E F E ++ KL+H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
V L E+ I + E+M SL FL + K L Q V + IA G+ Y+
Sbjct: 64 VPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIE-- 119
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEY 688
R IHRDL+A+NIL+ ++ KI+DFGLAR+ +E QG I + +PE
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI----KWTAPEA 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKK 715
AL G F+IKSDV+SFGIL+ E ++ +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 521 LGEGGFGPVYKGRLLNGQ-EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 579
LG+G +G VY R L+ Q +A+K + + + ++ E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 580 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 639
E G + +E +P SL+ L N Q + + I +GL YLH +I+HR
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHR 132
Query: 640 DLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL--FSI 696
D+K N+L++ KISDFG ++ G + T+ GT YM+PE G +
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGYGA 190
Query: 697 KSDVFSFGILMLETLSSK 714
+D++S G ++E + K
Sbjct: 191 PADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 73/215 (33%), Positives = 116/215 (53%), Gaps = 22/215 (10%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 574
LG G FG VYKG + E VA+K L+ +G + EF +E +++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQ 630
LG C+ + L+ + MP+ L ++ + + LLNW + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
R++HRDL A N+L+ + KI+DFGLAR+ GDE + N +M+ E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 691 DGLFSIKSDVFSFGILMLE--TLSSKKNTGLGSME 723
F+ +SDV+S+G+ + E T K G+ + E
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 73/208 (35%), Positives = 109/208 (52%), Gaps = 30/208 (14%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQ----SGQGLKEFKNEMMLIAKLQHRNLV 572
KLGEG +G VYK R G+ VA+K RL N+ L+E L+ +L+H N+V
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS----LLKELKHPNIV 61
Query: 573 RLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA----QGLLY 627
+LL K+ L+ EY + L +L + L+ +I+ I +GL Y
Sbjct: 62 KLLDVIH-TERKLYLVFEYC-DMDLKKYL--DKRPGPLS----PNLIKSIMYQLLRGLAY 113
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
H + RI+HRDLK NIL+++D K++DFGLAR F G L+ T ++V T Y +PE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPE 168
Query: 688 YAL-DGLFSIKSDVFSFGILMLETLSSK 714
L +S D++S G + E ++ K
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 24/210 (11%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQG-------LKEFKNEMMLIAKLQHRN 570
+G G FG VY G +G+ +AVK+ L + S L E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+V+ LG ++ + LEY+P S+ L + + ++ L+ + I +GL YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-----NFVRQILKGLNYL 122
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ----IVGTYGYM 684
H +R IIHRD+K +NIL+D KISDFG+++ + L T + G+ +M
Sbjct: 123 H--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSK 714
+PE ++ K+D++S G L++E L+ K
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 73/214 (34%), Positives = 111/214 (51%), Gaps = 25/214 (11%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVR 573
+LGE FG +YKG L + Q VA+K L + + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFLF--------------DSTKKRLLNWQARVRIIE 619
LLG ++ ++ EY+ L+ FL D T K L+ + I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNTKQIV 678
IA G+ YL S F +H+DL A NIL+ + ++ KISD GL+R ++ D + K ++
Sbjct: 132 QIAAGMEYLS--SHF-FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M PE + G FS SD++SFG+++ E S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL-------SNQSGQGLKEFKNEMMLI 563
NF ++ K+G+G F VYK LL+G+ VA+K++ + LKE L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIA 622
+L H N+++ L +E E ++LE L+ + K KRL+ + + +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
L ++H RI+HRD+K +N+ + K+ D GL R F ++ VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPY 171
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLE 709
YMSPE + ++ KSD++S G L+ E
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 6e-23
Identities = 72/201 (35%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 579
+LG G FG V G+ +VA+K + S EF E ++ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 580 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL--HQYSRFRII 637
+Q ++ EYM N L +L KR Q + + + + +G+ YL Q+ I
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQL-LEMCKDVCEGMAYLESKQF-----I 122
Query: 638 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT---YGYMSPEYALDGLF 694
HRDL A N L+D K+SDFGL+R DE + VG+ + PE L F
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKF 178
Query: 695 SIKSDVFSFGILMLETLSSKK 715
S KSDV++FG+LM E S K
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 6e-23
Identities = 69/194 (35%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLLGCCV 579
LG+G FG V+KG L + VAVK Q LK +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 580 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 639
++ +++E +P FL KK L + V+ A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 640 DLKASNILLDKDMNPKISDFGLARMF-GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 698
DL A N L+ ++ KISDFG++R G KQI + +PE G +S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 699 DVFSFGILMLETLS 712
DV+S+GIL+ ET S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 7e-23
Identities = 77/223 (34%), Positives = 114/223 (51%), Gaps = 26/223 (11%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLI 563
+ + LGEG FG V K R VAVK L N + + L + +EM L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 564 AKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-----------FDSTK--KRLL 609
+ +H+N++ LLG C ++G +I+EY +L FL FD TK + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669
+++ V +A+G+ YL SR R IHRDL A N+L+ +D KI+DFGLAR +
Sbjct: 132 SFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
T +M+PE D +++ +SDV+SFGILM E +
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+ + +G+G FG V G G +VAVK + N + + F E ++ +L+H NLV
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62
Query: 573 RLLGCCVEQ-GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+LLG VE+ G ++ EYM SL +L S + +L ++ + + + YL
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+ +HRDL A N+L+ +D K+SDFGL + Q K V + +PE +
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALRE 173
Query: 692 GLFSIKSDVFSFGILMLETLS 712
FS KSDV+SFGIL+ E S
Sbjct: 174 KKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 63/204 (30%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 520 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 574
KLG+G FG V +G VAVK L + + +F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKK-----RLLNWQARVRIIEGIAQGLLYLH 629
G V +++ E P SL L L ++ + IA G+ YL
Sbjct: 62 YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMRYLE 114
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG-GDELQGNTKQIVGTYGYMSPEY 688
R IHRDL A NILL D KI DFGL R ++ + + + + +PE
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
FS SDV+ FG+ + E +
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 66/195 (33%), Positives = 108/195 (55%), Gaps = 13/195 (6%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 576
K+GEG +G VYK R L G+ VA+K++ +G+ E+ L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 577 CCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
V K+ L+ E++ + L ++ DS+ L+ + + QG+ Y H + R
Sbjct: 66 V-VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---R 119
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LF 694
++HRDLK N+L+D++ K++DFGLAR F G ++ T ++V T Y +PE L +
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGSRQY 177
Query: 695 SIKSDVFSFGILMLE 709
S D++S G + E
Sbjct: 178 STPVDIWSIGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 508 ITAATENFSMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRLSNQSGQ-GLKEFKNEMM 561
I + + ++ L EG FG ++ G L++ +EV VK + + + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS-LNVFL-----FDSTKKRLLNWQARV 615
L+ L H+N++ +L C+E GE +L N L +FL ++ + L+ Q V
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDE--LQG 672
+ IA G+ YLH+ +IH+D+ A N ++D+++ KI+D L+R +F D L
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
N + V +M+ E ++ +S SDV+SFG+L+ E
Sbjct: 178 NENRPV---KWMALESLVNKEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+ + + +LG+G FG VYK + G A K + +S + L++F E+ ++++ +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V L + + +++E+ +L+ + ++ L Q R + + + L +LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH- 120
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
++IHRDLKA NILL D + K++DFG++ LQ +GT +M+PE
Sbjct: 121 --SHKVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQ-KRDTFIGTPYWMAPEVVA 176
Query: 691 -----DGLFSIKSDVFSFGILMLE 709
D + K+D++S GI ++E
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 7e-22
Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 25/221 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN---GQE---VAVKRLSNQSGQGLKEFKNEMMLIAKLQ 567
N ++ +LGEG FG V+ N Q+ VAVK L + S K+F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL----------FDSTKKRLLNWQARVRI 617
H ++V+ G CVE I++ EYM + LN FL + + L + I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNT 674
+ IA G++YL + +HRDL N L+ +++ KI DFG++R ++ D + G+T
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
+ +M PE + F+ +SDV+S G+++ E + K
Sbjct: 183 MLPI---RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 7e-22
Identities = 68/227 (29%), Positives = 111/227 (48%), Gaps = 31/227 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGRL--LNGQ----EVAVKRL-SNQSGQGLKEFKNEMMLIAKL 566
N + LGEG FG V K L G+ VAVK L N S L++ +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--------------------- 605
H ++++L G C + G +LI+EY SL FL +S K
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 606 KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665
+R L + I++G+ YL + +++HRDL A N+L+ + KISDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
++ + +M+ E D +++ +SDV+SFG+L+ E ++
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 67/205 (32%), Positives = 115/205 (56%), Gaps = 21/205 (10%)
Query: 521 LGEGGFGPVYKGRLLNGQ---EVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
LGEG FG V +G+L +VAVK +++ + +++F +E + + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 576 GCCVEQGEK------ILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGLL 626
G C++ E ++IL +M + L+ FL S + L Q V+ + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDEL-QGNTKQIVGTYGYM 684
YL S IHRDL A N +L+++MN ++DFGL+ +++ GD QG ++ ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWI 181
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
+ E D +++ KSDV+SFG+ M E
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWE 206
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 517 MQCKLGEGGFGPVYKGR---LLNGQE---VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
++ +LGEG FG V+ LL Q+ VAVK L S ++F+ E L+ LQH++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFL---------FDSTKKRL---LNWQARVRII 618
+VR G C E +++ EYM + LN FL + L + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNTKQI 677
IA G++YL + +HRDL N L+ + + KI DFG++R ++ D + + +
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
+ +M PE L F+ +SD++SFG+++ E + K
Sbjct: 186 LPIR-WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 520 KLGEGGFGPVYK------GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 573
+G+G FG V K G++L +E+ ++ + Q L +E+ ++ +L+H N+VR
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIVR 63
Query: 574 LLGCCV-EQGEKI-LILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLH- 629
+ + + +++EY L + K ++ + + RI+ + L H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 630 -QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
++HRDLK +NI LD + N K+ DFGLA++ G D K VGT YMSPE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPYYMSPEQ 181
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
+ KSD++S G L+ E
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 21/205 (10%)
Query: 514 NFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 570
+F + KLG+G +G VYK RL + Q A+K L + S + ++ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 571 LVR-----LLGCCVEQGEKILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQG 624
++ L G + +++EY P L+ + K ++L+ Q RI + +G
Sbjct: 61 IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
L LH+ +I+HRDLK++NILL + KI D G++++ + K +GT YM
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYM 168
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
+PE +S KSD++S G L+ E
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 22/203 (10%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 574
LG G FG V+KG + + VA+K + ++SG Q +E + M+ + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 575 LGCCVEQGEKI-LILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGIAQGLLYLH 629
LG C G + L+ + P SL + +RLLNW + IA+G+ YL
Sbjct: 75 LGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLE 126
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
++ R++HR+L A NILL D +I+DFG+A + D+ + + +M+ E
Sbjct: 127 EH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
L G ++ +SDV+S+G+ + E +S
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 70/200 (35%), Positives = 106/200 (53%), Gaps = 12/200 (6%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
K+GEG +G VYKGR GQ VA+K RL ++ E+ L+ +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGLLYLHQYSRFR 635
+++ LI E++ + L +L DS K V+ + I QG+L+ H R
Sbjct: 67 VLMQESRLYLIFEFL-SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCHSR---R 121
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LF 694
++HRDLK N+L+D K++DFGLAR F G ++ T ++V T Y +PE L +
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGSPRY 179
Query: 695 SIKSDVFSFGILMLETLSSK 714
S D++S G + E + K
Sbjct: 180 STPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 66/203 (32%), Positives = 111/203 (54%), Gaps = 21/203 (10%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
+G G FG V++G L + G++ VA+K L + + ++F +E ++ + H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
G + ++I EYM N +L+ +L D + + V ++ GIA G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGE--FSSYQLVGMLRGIAAGMKYL---SDMN 127
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMSPEYA 689
+HRDL A NIL++ ++ K+SDFGL+R+ L+ + + T G + +PE
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
F+ SDV+SFGI+M E +S
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 579
+LG G FG V+ G+ +VA+K + N+ ++F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 580 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 639
+Q ++ E+M N L +L ++ L+ + + + + +G+ YL + S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 640 DLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMSPEYALDGL 693
DL A N L+ K+SDFG+ R D + + G + PE
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDD-------EYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 694 FSIKSDVFSFGILMLETLSSKK 715
+S KSDV+SFG+LM E + K
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 41/198 (20%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ------GLKEFKNEMMLI 563
++ + KLGEG FG VYK R + G+ VA+K++ + + L+E K ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61
Query: 564 AKLQHRNLVRLLGCCVEQGEKI--------LILEYMPNKSLNVFLFDSTKKRLLNWQARV 615
KL+H N+V L+ VE+ +K ++ YM D LL V
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM----------DHDLSGLLE-NPSV 110
Query: 616 R--------IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667
+ + + +G+ YLH+ I+HRD+KA+NIL+D KI+DFGLAR + G
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 668 DELQGNTKQIVGTYGYMS 685
GT Y +
Sbjct: 168 PPPNPKGGGGGGTRKYTN 185
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 71/208 (34%), Positives = 110/208 (52%), Gaps = 23/208 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG G FG V+ +VAVK + S ++ F E ++ LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR-----LLNWQARVRIIEGIAQGLLY 627
+L V + +I E+M SL FL + L+++ A+ IA+G+ +
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAF 117
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYM 684
+ Q + IHRDL+A+NIL+ + KI+DFGLAR+ +E +G I T
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT---- 170
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLS 712
+PE G F+IKSDV+SFGIL++E ++
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 57/175 (32%), Positives = 94/175 (53%), Gaps = 18/175 (10%)
Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG------LKEFKNEMMLIAKLQHRNLV 572
++GEG G V+K + G+ VA+K+++ + +G L+E K + QH +V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+LL +L++EYMP+ L+ L D + L Q + + + +G+ Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERP-LPEAQVK-SYMRMLLKGVAYMHA-- 117
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
I+HRDLK +N+L+ D KI+DFGLAR+F +E + + Q V T Y +PE
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 69/203 (33%), Positives = 107/203 (52%), Gaps = 18/203 (8%)
Query: 521 LGEGGFGPV----YKGRLLN-GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 574
LGEG FG V Y N G++VAVK L +SG + + K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 575 LGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL--HQ 630
G C E G LI+E++P+ SL +L K +N + +++ I +G+ YL Q
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT-YGYMSPEYA 689
Y +HRDL A N+L++ + KI DFGL + D+ K + + + +PE
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
+ F I SDV+SFG+ + E L+
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
+G G FG V +GRL L G+ VA+K L S + + ++F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQ----ARVRIIEGIAQGLLYLHQY 631
G + ++I E+M N +L+ FL R + Q V ++ GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFL------RQNDGQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG---TYGYMSPEY 688
S +HRDL A NIL++ ++ K+SDFGL+R D +G + +PE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
F+ SDV+S+GI+M E +S
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 7e-21
Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 25/205 (12%)
Query: 520 KLGEGGFGPVYKG--RLLNGQ-EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR----NLV 572
+LG G FG V KG ++ Q +VA+K L N++ K ++EMM A++ H+ +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIV 58
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
R++G C E +L++E LN FL S KK + V ++ ++ G+ YL +
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG-----YMSPE 687
+HRDL A N+LL KISDFGL++ G D+ + + G + +PE
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR----SAGKWPLKWYAPE 168
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
FS +SDV+S+GI M E S
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRN 570
NF K+GEG +G VYK R L G+ VA+K RL ++ E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V+LL + + L+ E++ ++ L F+ D++ + + + QGL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
+ R++HRDLK N+L++ + K++DFGLAR F G ++ T ++V T Y +PE L
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILL 173
Query: 691 DG-LFSIKSDVFSFGILMLETLSSK 714
+S D++S G + E ++ +
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 9e-21
Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 35/222 (15%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRLSNQSGQGLK-EFKNEMM 561
KLGEG FG V+ ++ VAVK L + + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL--------FDSTKKRLLNWQA 613
++++L+ N++RLL C+ +I EYM N LN FL + +++
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--EL 670
+ + IA G+ YL S +HRDL N L+ K+ KI+DFG++R ++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
QG + V +MS E L G F+ SDV++FG+ + E L+
Sbjct: 189 QG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLV 572
F++ +G+G FG VYK Q VA+K + ++ +++ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+ G ++ + +I+EY S D K L+ I+ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
IHRD+KA+NILL ++ + K++DFG++ + NT VGT +M+PE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQS 173
Query: 693 LFSIKSDVFSFGILMLE 709
+ K+D++S GI +E
Sbjct: 174 GYDEKADIWSLGITAIE 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
++G G FG VY R + + VA+K++S QS + ++ E+ + +L+H N +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
GC + + L++EY + ++ + KK L + I G QGL YLH + R
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDIL--EVHKKPLQEVEIAA-ICHGALQGLAYLHSHER-- 136
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL---DG 692
IHRD+KA NILL + K++DFG A L VGT +M+PE L +G
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVILAMDEG 189
Query: 693 LFSIKSDVFSFGILMLETLSSKK 715
+ K DV+S GI +E L+ +K
Sbjct: 190 QYDGKVDVWSLGITCIE-LAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 1e-20
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 521 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+G FG VY GR L ++V S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 575 LGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKR-LLNWQARVRIIEGIAQGLLYLHQY 631
GC ++ EK L +EYMP S+ D K L + I +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN-TKQIVGTYGYMSPEYAL 690
I+HRD+K +NIL D N K+ DFG ++ + G + + GT +MSPE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 691 DGLFSIKSDVFSFGILMLETLSSK 714
+ K+DV+S G ++E L+ K
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 37/217 (17%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVK------RLSNQSGQGLKE----FKNEMMLIAKLQHR 569
+G+G +G VY + G+ +AVK ++ + K+ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 570 NLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIA 622
N+V+ LG E E+ L LEY+P S+ L F+ R Q +
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VL 118
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN--TKQIVGT 680
+GL YLH I+HRDLKA N+L+D D KISDFG+++ D++ N + G+
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGS 173
Query: 681 YGYMSPEY-ALDGL-FSIKSDVFSFGILMLETLSSKK 715
+M+PE +S K D++S G ++LE + ++
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
+G G FG V GRL L G+ VA+K L + + + ++F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
G + +++ EYM N SL+ FL + V ++ GIA G+ YL S
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--FTVIQLVGMLRGIASGMKYL---SDMG 126
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMSPEYA 689
+HRDL A NIL++ ++ K+SDFGL+R+ D T T G + +PE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT-----TRGGKIPIRWTAPEAI 181
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
F+ SDV+S+GI+M E +S
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 72/240 (30%), Positives = 118/240 (49%), Gaps = 43/240 (17%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLKEFKNEMM 561
KLGEG FG V+ ++N Q+ VAVK L + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVF-----LFDSTKKR--------- 607
++++L+ N++RLLG CV++ +I EYM N LN F L D +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 608 --LLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-M 664
+++ + + + IA G+ YL S +HRDL N L+ +++ KI+DFG++R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 665 FGGD--ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 722
+ GD +QG + V +M+ E L G F+ SDV++FG+ + E L K G +
Sbjct: 189 YAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 520 KLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 573
+LGEG FG V+ N VAVK L + + K+F+ E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQAR-----------VRIIEG 620
G C + I++ EYM + LN FL L++ Q R + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTKQI 677
IA G++YL + +HRDL N L+ ++ KI DFG++R ++ D + G+T
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
+ +M PE + F+ +SDV+SFG+++ E + K
Sbjct: 189 I---RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSGQGLKE-FKNEMMLIAK 565
N S LG G FG V + L +VAVK L + +E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 566 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
L H N+V LLG C G ++I EY L FL ++ L + + +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQIVGTY 681
+ +L + IHRDL A N+LL KI DFGLAR D ++GN + V
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-- 208
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE + +++ +SDV+S+GIL+ E S
Sbjct: 209 -WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 64/205 (31%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGC- 577
+GEG +G VYK R GQ VA+K + +E K E ++ K H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 578 -----CVEQGEKILILEYMPNKSLN--VFLFDSTKKRLL-NWQARVRIIEGIAQGLLYLH 629
+ L++E S+ V KRL W A I+ +GL YLH
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILRETLRGLAYLH 130
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE-- 687
+ ++IHRD+K NILL K+ K+ DFG++ D G +GT +M+PE
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTFIGTPYWMAPEVI 185
Query: 688 ---YALDGLFSIKSDVFSFGILMLE 709
D + +SDV+S GI +E
Sbjct: 186 ACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 67/197 (34%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLLGC 577
++G G FG V+ GRL + VAVK LK +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 578 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 637
C ++ +++E + FL T+ L + ++++E A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 638 HRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
HRDL A N L+ + KISDFG++R G G KQI + +PE G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174
Query: 696 IKSDVFSFGILMLETLS 712
+SDV+SFGIL+ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 70/215 (32%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG G FG VYKG + E VA+K L S + KE +E ++A + + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQ 630
LG C+ + LI + MP L ++ + + LLNW + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEE 127
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
R++HRDL A N+L+ + KI+DFGLA++ G DE + + + +M+ E L
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 691 DGLFSIKSDVFSFGILMLE--TLSSKKNTGLGSME 723
+++ +SDV+S+G+ + E T SK G+ + E
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-20
Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 332 HSLECKSG---DQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKES 388
L C D F++L ++K PD ++LE+C+ CL NCSC AYA +N S
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPDNASAITA--ISLEECREACLSNCSCTAYAYNNG--S 56
Query: 389 SGCLMWYGDLIDARRPIRNFTGQSVYLRVP 418
GCL+W G L + R + G ++YLR+
Sbjct: 57 GGCLLWNGLLNNLRSL--SSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 520 KLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG--LKEFKNEMMLIAKLQHRNLVRLLG 576
K+G G FG VY L+ E+ AVK + Q +KE +EM ++ L+H NLV+ G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
V + + + +EY +L L R+L+ + +GL YLH + I
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQLLEGLAYLHSH---GI 120
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFG------GDELQGNTKQIVGTYGYMSPEYAL 690
+HRD+K +NI LD + K+ DFG A G+E+Q + GT YM+PE
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGTPAYMAPEVIT 176
Query: 691 DGLFSIK---SDVFSFGILMLETLSSKK 715
G +D++S G ++LE + K+
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
LG+GGFG V ++ G+ A K+L + +G + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+ + L++ M L +++ + +A + I GL +LHQ RI
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQR---RI 116
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 696
++RDLK N+LLD N +ISD GLA G K GT GYM+PE ++
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 697 KSDVFSFGILMLETLSSK 714
D F+ G + E ++ +
Sbjct: 174 SVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLL--NGQEV--AVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLL 575
+G+G FG VY G L+ +GQ++ AVK L+ + + +++F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 576 GCCV-EQGEKILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQ 630
G C+ +G +++L YM + L F+ T K L+ + +V A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG--NTKQIVGTYGYMSPEY 688
+ +HRDL A N +LD+ K++DFGLAR E N +M+ E
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
F+ KSDV+SFG+L+ E ++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 36/211 (17%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIAK 565
+ + +LG+G FG VY R G+ VA+K++ K+F + E+ + K
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRK 53
Query: 566 LQ-HRNLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVR-IIEGIA 622
L H N+V+L E E + EYM N++ L K + + ++ +R II I
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEG---NLYQLMKDRKGKPFS-ESVIRSIIYQIL 109
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN---TKQIVG 679
QGL ++H++ F HRDLK N+L+ KI+DFGLAR E++ T V
Sbjct: 110 QGLAHIHKHGFF---HRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYT-DYVS 160
Query: 680 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLE 709
T Y +PE L +S D+++ G +M E
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAE 191
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 69/221 (31%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 520 KLGEGGFGPVYKGRLLNGQE---------------VAVKRL-SNQSGQGLKEFKNEMMLI 563
KLGEG FG V+ E VAVK L ++ + +F E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL----FDSTKKRLLN-----WQAR 614
++L++ N++RLLG CV +I EYM N LN FL +ST N
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQ 671
+ + IA G+ YL + +HRDL N L+ KI+DFG++R ++ GD +Q
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
G + V +M+ E L G F+ SDV++FG+ + E +
Sbjct: 189 G---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 25/202 (12%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
+LG+G FG VYK + G A K + +S + L+++ E+ ++A H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
G+ +++E+ P +++ + + + L Q +V I + + L YLH +IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI------VGTYGYMSPEYAL-- 690
RDLKA N+LL D + K++DFG++ N K + +GT +M+PE +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS--------AKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 691 ---DGLFSIKSDVFSFGILMLE 709
D + K+D++S GI ++E
Sbjct: 186 TMKDTPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 63/197 (31%), Positives = 100/197 (50%), Gaps = 19/197 (9%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
GC + + L++EY + ++ K+ L + G QGL YLH ++
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL---DG 692
+IHRD+KA NILL + K+ DFG A + VGT +M+PE L +G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVILAMDEG 189
Query: 693 LFSIKSDVFSFGILMLE 709
+ K DV+S GI +E
Sbjct: 190 QYDGKVDVWSLGITCIE 206
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 28/219 (12%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-QH 568
+ Q +GEG FG V K R+ + A+KR+ + + ++F E+ ++ KL H
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-------------TKKRLLNWQARV 615
N++ LLG C +G L +EY P+ +L FL S + L+ Q +
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675
+A+G+ YL Q + IHRDL A NIL+ ++ KI+DFGL+R G E+ K
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VK 179
Query: 676 QIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +G +M+ E +++ SDV+S+G+L+ E +S
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLLGC 577
+G G FG V+ R Q++ + + E +NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 578 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 637
+E ++++EY P +L + +KR + I+ Q LL LH I+
Sbjct: 68 FLEDKALMIVMEYAPGGTL----AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 638 HRDLKASNILLDK-DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 696
HRDLK NILLDK M KI DFG++++ + +VGT Y+SPE ++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 697 KSDVFSFGILMLETLSSKK 715
KSD+++ G ++ E S K+
Sbjct: 181 KSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 67/218 (30%), Positives = 114/218 (52%), Gaps = 28/218 (12%)
Query: 515 FSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQH 568
F++ LG+G FG V + +L + Q+VAVK L S ++EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 569 RNLVRLLGCCVEQGEK------ILILEYMPNKSLNVFLFDSTKKRL------LNWQARVR 616
N+++L+G + K ++IL +M + L+ FL S R+ L Q VR
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMS---RIGEEPFTLPLQTLVR 117
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDEL-QGNT 674
+ IA G+ YL S IHRDL A N +L+++M ++DFGL++ ++ GD QG
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
++ +++ E D +++ SDV++FG+ M E ++
Sbjct: 175 SKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHR 569
NF ++ K+G G F VY+ LL+ + VA+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLN-VFLFDSTKKRLLN----WQARVRIIEGIAQG 624
N+++ L +E E ++LE L+ + + +KRL+ W+ V++ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
H +SR R++HRD+K +N+ + K+ D GL R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
SPE + ++ KSD++S G L+ E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 69/204 (33%), Positives = 104/204 (50%), Gaps = 23/204 (11%)
Query: 520 KLGEGGFGPVYKG--RLLNGQE-VAVKRLSNQSGQGLKEFKNEMMLIAK----LQHRNLV 572
+LG G FG V KG ++ ++ VAVK L N + K+E++ A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
R++G C E +L++E LN FL K + + + ++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQIVGTYGYMSPEY 688
+HRDL A N+LL KISDFGL++ G DE + + K V Y +PE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APEC 169
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
FS KSDV+SFG+LM E S
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-19
Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS---NQSGQGLKEFKNEMMLIAKLQHRN 570
F+ ++G G FG VY R + EV A+K++S QS + ++ E+ + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+ GC + + L++EY + + L + KK L + I G QGL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-ITHGALQGLAYLHS 143
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
++ +IHRD+KA NILL + K++DFG A + VGT +M+PE L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194
Query: 691 ---DGLFSIKSDVFSFGILMLETLSSK 714
+G + K DV+S GI +E K
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 25/208 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
E++ + ++G G +G VYK R + G+ VA+K + + G + + E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA-------QG 624
V G + + + +++EY SL ++ T+ L Q IA +G
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQ--------IAYVCRETLKG 113
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
L YLH+ IHRD+K +NILL +D + K++DFG++ + + +GT +M
Sbjct: 114 LAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWM 168
Query: 685 SPEYA---LDGLFSIKSDVFSFGILMLE 709
+PE A G + K D+++ GI +E
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 63/200 (31%), Positives = 106/200 (53%), Gaps = 19/200 (9%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG-QGLKEFK-NEMMLIAKLQ---HRNLVRL 574
+GEG +G VYK R L G+ VA+K++ +G+ E+ L+ +L+ H N+VRL
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 575 LGCC-VEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
L C + ++ L+ E++ ++ L +L K L + ++ + +G+ +LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFLH 124
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
+ RI+HRDLK NIL+ D KI+DFGLAR++ + T +V T Y +PE
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVV-TLWYRAPEVL 178
Query: 690 LDGLFSIKSDVFSFGILMLE 709
L ++ D++S G + E
Sbjct: 179 LQSSYATPVDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQHR 569
+F + +G+G FG V + + +++ A+K ++ Q ++ NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 570 NLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
LV L + E + L+++ + L L S K + Q + I E I L YL
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYL 116
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H IIHRD+K NILLD+ + I+DF +A D T GT GYM+PE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEV 170
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKK 715
+S+ D +S G+ E L K+
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 17/212 (8%)
Query: 513 ENFSMQCKLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 566
N+ + LG G FG VY GR L ++V S ++ + + + E+ L+ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 567 QHRNLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKR-LLNWQARVRIIEGIAQ 623
+H +V+ GC + EK L +EYMP S+ D K L R I Q
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQ 117
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN-TKQIVGTYG 682
G+ YLH I+HRD+K +NIL D N K+ DFG ++ + G K + GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
+MSPE + K+DV+S ++E L+ K
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 7e-19
Identities = 66/215 (30%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRN 570
LGEG FG V K + VAVK L + + + L + +EM ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFL-----------FDSTK--KRLLNWQARVRI 617
++ LLG C + G +++EY +L +L FD+ K + L ++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677
+A+G+ YL + + IHRDL A N+L+ +D KI+DFGLAR + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE D +++ +SDV+SFG+L+ E +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-19
Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKL-QHRN 570
LGEG FG V K + VAVK L + + + L + +EM ++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFL-----------FDSTK--KRLLNWQARVRI 617
++ LLG C + G +I+EY +L +L +D + + ++ V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677
+A+G+ YL + + IHRDL A N+L+ ++ KI+DFGLAR + T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE D +++ +SDV+SFG+LM E +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 9e-19
Identities = 56/201 (27%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 521 LGEGGFGP--VYK----GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+G FG +Y+ L+ +EV + RLS + ++ NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
++ ++ +EY +L + K +L + + + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 694
I+HRD+K NI L K K+ DFG++++ G + T +VGT YMSPE +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 695 SIKSDVFSFGILMLETLSSKK 715
+ KSD+++ G ++ E L+ K+
Sbjct: 179 NFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-19
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 17/211 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRL-----SNQSGQGLKEFKNEMMLIAKLQ 567
N+ + LG+G FG VY + G+E+AVK++ S ++ + + + E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 568 HRNLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKR-LLNWQARVRIIEGIAQG 624
H +V+ GC + E+ L +E+MP S+ D K L + I +G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN-TKQIVGTYGY 683
+ YLH I+HRD+K +NIL D N K+ DFG ++ L G K + GT +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
MSPE + K+D++S G ++E L+ K
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 71/227 (31%), Positives = 120/227 (52%), Gaps = 23/227 (10%)
Query: 511 ATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQSGQGLK-EFKNEMMLI 563
A E +M +LG+G FG VY KG + + E VA+K ++ + + EF NE ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 564 AKLQHRNLVRLLGCCVEQGEKIL-ILEYMPNKSLNVFLF-------DSTKKRLLNWQARV 615
+ ++VRLLG V QG+ L I+E M L +L ++ + + + +
Sbjct: 64 KEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNT 674
++ IA G+ YL+ + +HRDL A N ++ +D KI DFG+ R ++ D +
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGL 719
K ++ +MSPE DG+F+ SDV+SFG+++ E TL+ + G+
Sbjct: 180 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 32/222 (14%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLN---GQEVAVKRL--SNQSGQGLKEFK-NEMMLIAKLQH 568
+ ++ +G G +G VYK + N G+E A+K+ + G+ + E+ L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 569 RNLVRLLGCCVEQGEKI--LILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGL 625
N+V L+ +E +K L+ +Y + + F KR+ + V+ ++ I G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNP----KISDFGLARMF--------GGDELQGN 673
YLH S + ++HRDLK +NIL+ + KI D GLAR+F D
Sbjct: 122 HYLH--SNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD----- 173
Query: 674 TKQIVGTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSSK 714
+V T Y +PE L K+ D+++ G + E L+ +
Sbjct: 174 --PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 22/216 (10%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRL----SNQ--SGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+G +G VY G GQ +AVK++ SN + + ++ + E+ L+ L+H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYLHQYS 632
LG C++ + +E++P S++ L R V + + I G+ YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL-----NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV----GTYGYMSPEY 688
++HRD+K +N++L + K+ DFG AR L G ++ GT +M+PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSMER 724
+ + KSD++S G + E + K L SM+R
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP--LASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNL 571
NF KLGEG + VYKGR G+ VA+K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
VRL + + +L+ EYM +K L ++ + L+ + +G+ + H+
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT-KQIVGTYGYMSPEYAL 690
R++HRDLK N+L++K K++DFGLAR FG + NT V T Y +P+ L
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLWYRAPDVLL 173
Query: 691 DG-LFSIKSDVFSFGILMLETLSSK 714
+S D++S G +M E ++ +
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 521 LGEGGFGPVYKGRLLNGQE--------VAVKRL-SNQSGQGLKEFKNEMMLIAKL-QHRN 570
LGEG FG V + + VAVK L S+ + + L + +EM ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLF-------------DSTKKRLLNWQARVRI 617
++ LLG C + G +I+EY +L +L + L+++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677
+A+G+ YL + + IHRDL A N+L+ +D KI+DFGLAR + T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE D +++ +SDV+SFG+L+ E +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCV 579
+G G +G VYKGR + ++A ++ + +G +E K E+ ++ K HRN+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 580 EQG------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
++ + L++E+ S+ L +TK L + I I +GL +LHQ+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL--- 690
++IHRD+K N+LL ++ K+ DFG++ D G +GT +M+PE
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 691 --DGLFSIKSDVFSFGILMLE 709
D + KSD++S GI +E
Sbjct: 188 NPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG G FG VYKG + E VA+K L N S + KE +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQ 630
LG C+ + L+ + MP L ++ ++ + LLNW + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
R++HRDL A N+L+ + KI+DFGLAR+ DE + + +M+ E L
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
F+ +SDV+S+G+ + E ++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 66/220 (30%), Positives = 110/220 (50%), Gaps = 28/220 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-Q 567
E+ + +GEG FG V + + A+K L + + ++F E+ ++ KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQAR 614
H N++ LLG C +G + +EY P +L FL S L Q
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674
++ +A G+ YL S + IHRDL A N+L+ +++ KI+DFGL+R G+E+
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY--V 173
Query: 675 KQIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
K+ +G +M+ E +++ KSDV+SFG+L+ E +S
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 14/210 (6%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
K+GEG G V R +G++VAVK + + Q + NE++++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+ E +++E++ +L D + LN + + E + Q L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 698
RD+K+ +ILL D K+SDFG D + K +VGT +M+PE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 699 DVFSFGILMLETLSSK----KNTGLGSMER 724
D++S GI+++E + + ++ + +M+R
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 7e-18
Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 12/210 (5%)
Query: 502 LFSLASITAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFK-NE 559
L ++ S+ + ++ K+G+G G VY + GQEVA+K++ N Q KE NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINE 66
Query: 560 MMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE 619
++++ + +H N+V L + E +++EY+ SL D + ++ +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
Q L +LH ++IHRD+K+ NILL D + K++DFG ++ + +T +VG
Sbjct: 123 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
T +M+PE + K D++S GI+ +E
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQHR 569
NF ++ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLL-----NWQARVRIIEGIAQG 624
N+++ +E E ++LE L+ + K++ L W+ V++ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
H +SR R++HRD+K +N+ + K+ D GL R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
SPE + ++ KSD++S G L+ E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 60/199 (30%), Positives = 105/199 (52%), Gaps = 11/199 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 570
E F+ ++G+G FG VYKG +EV A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+ R G ++ + +I+EY+ S D K L I+ I +GL YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHS 119
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
R IHRD+KA+N+LL + + K++DFG+A +++ NT VGT +M+PE
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 174
Query: 691 DGLFSIKSDVFSFGILMLE 709
+ K+D++S GI +E
Sbjct: 175 QSAYDFKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 65/204 (31%), Positives = 111/204 (54%), Gaps = 20/204 (9%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 576
K+GEG +G VYK R + + +A+K++ Q +G+ E+ L+ ++QH N+VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG----IAQGLLYLHQYS 632
+ L+ EY+ + L + DS+ ++ R+I+ I +G+ Y H +
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHM-DSSP----DFAKNPRLIKTYLYQILRGIAYCHSH- 121
Query: 633 RFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
R++HRDLK N+L+D+ N K++DFGLAR F G ++ T ++V T Y +PE L
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPEILLG 177
Query: 692 GL-FSIKSDVFSFGILMLETLSSK 714
+S D++S G + E ++ K
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRLLG 576
LG+GGFG V ++ G+ A K+L+ + + K ++ M+ ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKK-------RLLNWQARVRIIEGIAQGLLYLH 629
+ + L++ M L +++ ++ R + A+ I GL +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ------IISGLEHLH 114
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
Q RII+RDLK N+LLD D N +ISD GLA + Q TK GT G+M+PE
Sbjct: 115 QR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELL 169
Query: 690 LDGLFSIKSDVFSFGILMLETLSSK 714
+ D F+ G+ + E ++++
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-VAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
++G G FG VY + E VAVK++S Q+ + ++ E+ + +L+H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
GC +++ L++EY + ++ K+ L I G QGL YLH ++
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL---DG 692
+IHRD+KA NILL + K++DFG A VGT +M+PE L +G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 693 LFSIKSDVFSFGILMLETLSSK 714
+ K DV+S GI +E K
Sbjct: 196 QYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 53/231 (22%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG------------------LKEFKNEMM 561
LGEG +G V K L G+ VA+K++ L+E K
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK---- 72
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN---KSLN--VFLFDSTKKRLLNWQARVR 616
++ +++H N++ L+ VE L+++ M + K ++ + L +S K +L Q
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL-LQ---- 127
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676
I GL LH++ +HRDL +NI ++ KI+DFGLAR +G +
Sbjct: 128 ----ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 677 I------------VGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSK 714
V T Y +PE + + D++S G + E L+ K
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
LG GGFG V ++ + A+K + ++GQ + +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVKLY 59
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
++ +++EY L L D + + AR I + YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLHNRG--- 113
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
II+RDLK N+LLD + K+ DFG A+ + T GT Y++PE L+ +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYD 170
Query: 696 IKSDVFSFGILMLETL 711
D +S GIL+ E L
Sbjct: 171 FSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 520 KLGEGGFGPVYKG--RLLNGQE--VAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRL 574
+GEG FG VY+G ++ VAVK N + ++E F E ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+G E I ++E P L +L K L+ + + ++ L YL S+
Sbjct: 73 IGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLE--SK- 126
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 694
R +HRD+ A N+L+ K+ DFGL+R + +K + +M+PE F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPESINFRRF 185
Query: 695 SIKSDVFSFGILMLETLS 712
+ SDV+ FG+ M E L
Sbjct: 186 TSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLKEFK---NEMMLIAKLQHRN 570
F + ++G+GG+G V+ + + E VA+KR+ L E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
LV+LL + L +EY+P L + L AR + E + LH+
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALHE 119
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
IHRDLK N L+D + K++DFGL++ G +VG+ YM+PE
Sbjct: 120 LG---YIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTY---ANSVVGSPDYMAPEVLR 171
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
+ D +S G ++ E L
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 4e-17
Identities = 57/214 (26%), Positives = 111/214 (51%), Gaps = 10/214 (4%)
Query: 502 LFSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM 560
L ++ SI + ++ K+G+G G V+ + GQEVA+K+++ Q + NE+
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 561 MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG 620
+++ +L++ N+V L + E +++EY+ SL D + ++ +
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRE 123
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
Q L +LH ++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
+M+PE + K D++S GI+ +E + +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 15/198 (7%)
Query: 521 LGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGL-KEFKNEMMLIAKLQHRNLVRLLGCC 578
LG G G V K + G +A K + + + K+ E+ ++ + + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYLHQYSRFRI 636
+ + + +E+M SL D K+ + +I + +GL YL Y+ RI
Sbjct: 73 LNENNICMCMEFMDCGSL-----DRIYKKGGPIPVEILGKIAVAVVEGLTYL--YNVHRI 125
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 696
+HRD+K SNIL++ K+ DFG++ G+ + VGT YMSPE G +++
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 697 KSDVFSFGILMLETLSSK 714
KSDV+S GI ++E K
Sbjct: 182 KSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 30/206 (14%)
Query: 524 GGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLLGCCV 579
G +G V+ + G A+K + + + E ++++ Q +V+L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF- 62
Query: 580 EQGEKILIL--EYMPN---KSL--NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
QG+K L L EY+P SL NV D AR+ I E I L YLH
Sbjct: 63 -QGKKNLYLVMEYLPGGDLASLLENVGSLDED-------VARIYIAE-IVLALEYLHSNG 113
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLA------RMFGGDELQGNTKQIVGTYGYMSP 686
IIHRDLK NIL+D + + K++DFGL+ R ++ + K+IVGT Y++P
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 687 EYALDGLFSIKSDVFSFGILMLETLS 712
E L S D +S G ++ E L
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 5e-17
Identities = 57/214 (26%), Positives = 107/214 (50%), Gaps = 10/214 (4%)
Query: 502 LFSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM 560
L S+ S+ + ++ K+G+G G VY + GQEVA+++++ Q + NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 561 MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG 620
+++ + ++ N+V L + E +++EY+ SL D + ++ +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
Q L +LH ++IHRD+K+ NILL D + K++DFG + Q +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
+M+PE + K D++S GI+ +E + +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 5e-17
Identities = 58/214 (27%), Positives = 110/214 (51%), Gaps = 10/214 (4%)
Query: 502 LFSLASITAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFKNEM 560
L S+ S+ + ++ K+G+G G VY + GQEVA+K+++ Q + NE+
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 561 MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG 620
+++ + ++ N+V L + E +++EY+ SL D + ++ +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
Q L +LH ++IHRD+K+ NILL D + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
+M+PE + K D++S GI+ +E + +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 20/207 (9%)
Query: 520 KLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS---GQGLKEFKNEMML--IAKLQHRNLV 572
++GEG +G V+K R L G+ VA+KR+ Q+ G L + +L + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 573 RLLGCCV-----EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
RL C + + L+ E++ ++ L +L D + + + ++ + +GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH + R++HRDLK NIL+ K++DFGLAR++ Q +V T Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSK 714
L ++ D++S G + E K
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-17
Identities = 67/212 (31%), Positives = 110/212 (51%), Gaps = 28/212 (13%)
Query: 521 LGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-QHRNLVRLL 575
+GEG FG V K R+ + A+KR+ + + ++F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIA 622
G C +G L +EY P+ +L FL S L+ Q + +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
+G+ YL S+ + IHRDL A NIL+ ++ KI+DFGL+R G E+ K+ +G
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VKKTMGRLP 174
Query: 683 --YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+ E +++ SDV+S+G+L+ E +S
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQ 567
+ + +GEG +G V K R G+ VA+K+ + + ++ K E+ ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLR 58
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIA 622
H N+V L +G L+ EY+ L + R WQ +
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LL 110
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ----IV 678
Q + Y H IIHRD+K NIL+ + K+ DFG AR L+ V
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYV 162
Query: 679 GTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLS 712
T Y +PE + D + DV++ G +M E L
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 515 FSMQCKLGEGGFGPVY---------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIA 564
+ +Q +LG+G FG VY + RL +E+ V L+ N++ Q E L++
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA----NQEAQLLS 57
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIA 622
KL H +V+ +E+ +I EY + L+ L T K L + ++ E
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL----SENQVCEWFI 113
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
Q LL +H + RI+HRDLKA NI L ++ KI DFG++R+ G T GT
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPY 170
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLE 709
YMSPE + KSD++S G ++ E
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 65/227 (28%), Positives = 117/227 (51%), Gaps = 23/227 (10%)
Query: 511 ATENFSMQCKLGEGGFGPVYKG---RLLNGQ---EVAVKRLSNQSGQGLK--EFKNEMML 562
+ E ++ +LG+G FG VY+G ++ G+ VAVK + N+S + EF NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNEASV 62
Query: 563 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLF-------DSTKKRLLNWQARV 615
+ ++VRLLG + ++++E M + L +L ++ + Q +
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNT 674
++ IA G+ YL+ + +HRDL A N ++ D KI DFG+ R ++ D +
Sbjct: 123 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGL 719
K ++ M+PE DG+F+ SD++SFG+++ E +L+ + GL
Sbjct: 180 KGLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 25/202 (12%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
+LG+G FG VYK + G A K + +S + L+++ E+ ++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+ +++E+ +++ + + ++ L Q RV + + + L YLH+ +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN---KIIH 126
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI------VGTYGYMSPEYAL-- 690
RDLKA NIL D + K++DFG++ NT+ I +GT +M+PE +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 691 ---DGLFSIKSDVFSFGILMLE 709
D + K+DV+S GI ++E
Sbjct: 179 TSKDRPYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
K+GEG G V + G++VAVK++ + Q + NE++++ QH N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
V + + E +++E++ +L D +N + + + + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+IHRD+K+ +ILL D K+SDFG + + K +VGT +M+PE
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISR 189
Query: 692 GLFSIKSDVFSFGILMLE 709
+ + D++S GI+++E
Sbjct: 190 LPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 24/212 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRN 570
+ + K+GEG FG +Y + + E V + + + +KE K E++L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSL-------NVFLFDSTKKRLLNWQARVRIIEGIAQ 623
+V E G +++EY L LF ++ ++L+W + I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSWFVQ------ISL 112
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
GL ++H +I+HRD+K+ NI L K+ M K+ DFG+AR T VGT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPY 167
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
Y+SPE + ++ K+D++S G ++ E + K
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 65/201 (32%), Positives = 105/201 (52%), Gaps = 14/201 (6%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLK-EFKNEMMLIAKLQHRNLVRLLG 576
++GEG +G VY+ R +G+ VA+K++ + G+ E+ L+ L+H N+V L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 577 CCV-EQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
V + + I L++EY + L D+ Q + ++ + +GL YLH F
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLAS--LLDNMPTPFSESQVKC-LMLQLLRGLQYLH--ENF 128
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 694
IIHRDLK SN+LL KI+DFGLAR + G + T ++V T Y +PE L
Sbjct: 129 -IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYRAPELLLGCTT 185
Query: 695 SIKS-DVFSFGILMLETLSSK 714
+ D+++ G ++ E L+ K
Sbjct: 186 YTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 31/203 (15%)
Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 577
++G G G VYK G+ A+K + N ++ E+ ++ + H N+V+
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 578 CVEQGEKILILEYMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
GE ++LE+M SL + T ++ L AR +I+ GIA YLH R
Sbjct: 141 FDHNGEIQVLLEFMDGGSL-----EGTHIADEQFLADVAR-QILSGIA----YLH---RR 187
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY------ 688
I+HRD+K SN+L++ N KI+DFG++R+ N+ VGT YMSPE
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERINTDLN 245
Query: 689 --ALDGLFSIKSDVFSFGILMLE 709
A DG D++S G+ +LE
Sbjct: 246 HGAYDGY---AGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 71/215 (33%), Positives = 114/215 (53%), Gaps = 28/215 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSG---QGLKEFKNEMMLIAK 565
+ + ++ EG +G VY+ R G+ VA+K+L + G L+E N ++ K
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI-NILL---K 60
Query: 566 LQHRNLVRLLGCCVEQG-EKI-LILEYMPN--KSLNVFLFDSTKKRLLNWQARVR-IIEG 620
LQH N+V + V +KI +++EY+ + KSL ++ K+ L Q+ V+ ++
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSL----METMKQPFL--QSEVKCLMLQ 114
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
+ G+ +LH I+HRDLK SN+LL+ KI DFGLAR + G L+ T Q+V T
Sbjct: 115 LLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYT-QLVVT 169
Query: 681 YGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 714
Y +PE L +S D++S G + E L+ K
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 54/195 (27%), Positives = 103/195 (52%), Gaps = 15/195 (7%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQH---RNLVRLL 575
+G G +G VY+G+ + G+ VA+K ++ + + + + E+ L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
G ++ +I+EY S+ + K + + II + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG--- 121
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LF 694
+IHRD+KA+NIL+ N K+ DFG+A + + + +T VGT +M+PE +G +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKYY 179
Query: 695 SIKSDVFSFGILMLE 709
K+D++S GI + E
Sbjct: 180 DTKADIWSLGITIYE 194
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 64/197 (32%), Positives = 92/197 (46%), Gaps = 19/197 (9%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLLG 576
LG G FG V R + A+K LS LK+ NE ++ ++H LV L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKK--RLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+ L++EY+P L F +K R AR + + L YLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGEL----FSHLRKSGRFPEPVARFYAAQ-VVLALEYLHSLD-- 121
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 694
I++RDLK N+LLD D KI+DFG A+ ++G T + GT Y++PE L +
Sbjct: 122 -IVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGY 175
Query: 695 SIKSDVFSFGILMLETL 711
D ++ GIL+ E L
Sbjct: 176 GKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 3e-16
Identities = 35/109 (32%), Positives = 48/109 (44%), Gaps = 9/109 (8%)
Query: 212 SGHWDGAGF-----VSALSYTDFLYKQFMMENKDECVYWYEAYNRPSIMTLKLNPSGFVT 266
SG W+G F + LSY + + EN +E Y Y N L L+ G +
Sbjct: 3 SGPWNGIRFSGIPEMQKLSYYVYNFT----ENNEEVYYTYRMTNNSIYSRLTLSSEGSLE 58
Query: 267 RQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFK 315
R W NS W+ +S P C YG CG C ++ P C C++GF
Sbjct: 59 RFTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFV 107
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 37/211 (17%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 577
+G G +G V G++VA+K+LS QS K E+ L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 578 CVEQGEKILILEYMPNKSLNVF-------------LFDSTKKRLLNWQARVRIIEGIAQG 624
+ P SL F L + K + L+ ++ I +G
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRG 130
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
L Y+H IIHRDLK SNI +++D KI DFGLAR DE+ G V T Y
Sbjct: 131 LKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG----YVATRWYR 182
Query: 685 SPEYALDGLFSIKS-DVFSFGILMLETLSSK 714
+PE L+ + ++ D++S G +M E L+ K
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 48/150 (32%), Positives = 84/150 (56%), Gaps = 9/150 (6%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-VAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 576
K+GEG +G V+K + E VA+KR+ + +G+ E+ L+ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+ L+ EY ++ L + FDS + + + + + +GL + H + +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDIDPEIVKSFMFQ-LLKGLAFCHSH---NV 120
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFG 666
+HRDLK N+L++K+ K++DFGLAR FG
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKR-LSNQSGQG-----LKEFKNEMMLIAKLQHRNLV 572
K+G+G FG V+K R Q VA+K+ L +G L+E K ++ L+H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 74
Query: 573 RLLGCCVEQGEK--------ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
L+ C + L+ E+ + L L S K ++++ + G
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL--SNKNVKFTLSEIKKVMKMLLNG 131
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI--VGTYG 682
L Y+H R +I+HRD+KA+NIL+ KD K++DFGLAR F + + V T
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 683 YMSPEYAL-DGLFSIKSDVFSFGILMLE 709
Y PE L + + D++ G +M E
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 8e-16
Identities = 77/304 (25%), Positives = 129/304 (42%), Gaps = 53/304 (17%)
Query: 418 PASKLGNKKLLWILV---ILVIPVVLLPSF-YVFYRRRRKCQEKETENVETYQDLLAFDI 473
P ++ W + + V+ L +F +VF R R + K EN + +L FD
Sbjct: 618 PCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD- 676
Query: 474 NMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSM--QCKLGEGGFGPVYK 531
SK S SIT S+ + + G G YK
Sbjct: 677 ---------------------SKVS-------KSITINDILSSLKEENVISRGKKGASYK 708
Query: 532 GRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590
G+ + NG + VK +++ + E + + KLQH N+V+L+G C + LI EY
Sbjct: 709 GKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEY 764
Query: 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK 650
+ K+L+ L R L+W+ R +I GIA+ L +LH ++ +L I++D
Sbjct: 765 IEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG 818
Query: 651 DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 710
P + L + D I + Y++PE + KSD++ FG++++E
Sbjct: 819 KDEPHLR-LSLPGLLCTD----TKCFI--SSAYVAPETRETKDITEKSDIYGFGLILIEL 871
Query: 711 LSSK 714
L+ K
Sbjct: 872 LTGK 875
|
Length = 968 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 505 LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIA 564
L+++ F + +G G +G VYKGR + ++A ++ + + +E K E+ ++
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67
Query: 565 KL-QHRNLVRLLGCCVEQG------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRI 617
K HRN+ G +++ + L++E+ S+ L +TK L I
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYI 126
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677
I +GL +LH + ++IHRD+K N+LL ++ K+ DFG++ D G
Sbjct: 127 CREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTF 181
Query: 678 VGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLE 709
+GT +M+PE D + +SD++S GI +E
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQH 568
++ +G G FG V+ R ++ A+K ++ LK+ NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
++RL +Q +++EY+P L F + R N E I L YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCALEYL 117
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H I++RDLK NILLDK+ + K++DFG A+ +L+ T + GT Y++PE
Sbjct: 118 HSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPE- 168
Query: 689 ALDGLFSIKS-------DVFSFGILMLETLSSK 714
I+S D ++ GIL+ E L
Sbjct: 169 ------VIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 519 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--EMMLIAKLQ-HRNLVRL 574
K+GEG F V K + G+ A+K + + + L++ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 575 LGCCVEQ--GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGLLYLHQY 631
+ ++ G L+ E M +N++ +KR L + RV+ + + + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMH-- 117
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL- 690
R I HRD+K NIL+ D K++DFG R G T+ I T Y +PE L
Sbjct: 118 -RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECLLT 172
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
DG + K D+++ G + E LS
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQ---HRNLV 572
++G G +G VYK R +G VA+K + +N+ G L + E+ L+ +L+ H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIV 65
Query: 573 RLLGCC----VEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
RL+ C ++ K+ L+ E++ ++ L +L D L + ++ +GL +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH I+HRDLK NIL+ K++DFGLAR++ Q +V T Y +PE
Sbjct: 124 LHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPE 177
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSK 714
L ++ D++S G + E K
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 519 CKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
K+GEG +G V+K R GQ VA+K+ S K E+ ++ +L+H NLV L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
+ + L+ EY + LN R + +II Q + + H+++
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--- 120
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLF 694
IHRD+K NIL+ K K+ DFG AR+ G + V T Y +PE + D +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPELLVGDTQY 178
Query: 695 SIKSDVFSFGILMLETLSS 713
DV++ G + E L+
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 11/199 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 570
E F+ K+G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+ + G ++ + +I+EY+ S D + L+ I+ I +GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
+ IHRD+KA+N+LL + K++DFG+A +++ N VGT +M+PE
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIK 174
Query: 691 DGLFSIKSDVFSFGILMLE 709
+ K+D++S GI +E
Sbjct: 175 QSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 28/206 (13%)
Query: 519 CKLGEGGFGPVYKGR-LLNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQH-RNLVRLL 575
+LG G +G V K R + G +AVKR+ + + Q K ++ + + V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV------RIIEGIAQGLLYLH 629
G +G+ + +E M + SL+ F K++ + + +I I + L YLH
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFY-----KKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI-VGTYGYMSPEY 688
S+ +IHRD+K SN+L++++ K+ DFG++ G + K I G YM+PE
Sbjct: 121 --SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDAGCKPYMAPE- 173
Query: 689 ALDGL-----FSIKSDVFSFGILMLE 709
++ + +KSDV+S GI M+E
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIE 199
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 41/213 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMML 562
+ + KLG+G +G V+K + VA+K++ F+N E+M
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMF 59
Query: 563 IAKL-QHRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE 619
+ +L H N+V+LL + +K L+ EYM V + +L + I+
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVI-----RANILEDVHKRYIMY 114
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI-- 677
+ + L Y+H S +IHRDLK SNILL+ D K++DFGLAR EL+ N +
Sbjct: 115 QLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVL 169
Query: 678 ---VGTYGYMSPEYALDGLFSIKSDVFSFGILM 707
V T Y +PE L S ++ G+ M
Sbjct: 170 TDYVATRWYRAPEILL------GSTRYTKGVDM 196
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
F + ++GEG +G VYK R G+ VA+K RL N+ E+ ++ +L HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 572 VRLLGCCV----------EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 621
V L ++G L+ EYM + + + + + ++ +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL---ESGLVHFSEDHIKSFMKQL 125
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 681
+GL Y H+ + +HRD+K SNILL+ K++DFGLAR++ +E + T +++ T
Sbjct: 126 LEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TL 181
Query: 682 GYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSK 714
Y PE L + + DV+S G ++ E + K
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 520 KLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 573
K+GEG FG G+ +E+ + ++S + + E + E+ +++ ++H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQ 63
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV-----RIIEGIAQGLLYL 628
E G ++++Y L + +N Q V +I++ Q L L
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDL---------YKKINAQRGVLFPEDQILDWFVQICLAL 114
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD-ELQGNTKQIVGTYGYMSPE 687
+I+HRD+K+ NI L KD K+ DFG+AR+ EL + +GT Y+SPE
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---ARTCIGTPYYLSPE 171
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSME 723
+ ++ KSD+++ G ++ E + K G+M+
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 54/199 (27%), Positives = 106/199 (53%), Gaps = 11/199 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 570
E F+ ++G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+ + G ++ + +I+EY+ S D + + +++ I +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
+ IHRD+KA+N+LL + + K++DFG+A +++ NT VGT +M+PE
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174
Query: 691 DGLFSIKSDVFSFGILMLE 709
+ K+D++S GI +E
Sbjct: 175 QSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 30/205 (14%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGC 577
+G G FG V K G +AVKR+ S + K ++ ++ + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 578 CVEQGEKILILEYMPNKSLNVF---LFDSTKKRLLNWQARVRIIEGIA----QGLLYLHQ 630
+G+ + +E M + SL+ F +++ K + I+ IA + L YL +
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE-----EILGKIAVATVKALNYLKE 125
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI--VGTYGYMSPE- 687
+IIHRD+K SNILLD++ N K+ DFG++ +L + + G YM+PE
Sbjct: 126 --ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPER 178
Query: 688 ---YALDGLFSIKSDVFSFGILMLE 709
A DG + ++SDV+S GI + E
Sbjct: 179 IDPSARDG-YDVRSDVWSLGITLYE 202
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 51/221 (23%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMMLIAKLQHRN 570
+G G +G V G++VA+K++SN F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLN----VF-LFDSTKKRLLNWQARVRIIEGIAQ-- 623
++ LL IL + N V L ++ +++ ++ + + Q
Sbjct: 61 IIGLL----------DILRPPSPEDFNDVYIVTELMETDLHKVI--KSPQPLTDDHIQYF 108
Query: 624 ------GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK-Q 676
GL YLH +IHRDLK SNIL++ + + KI DFGLAR DE + +
Sbjct: 109 LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 677 IVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSK 714
V T Y +PE L +I D++S G + E L+ K
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 12/201 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
E+F + ++G G +G VYK R +N G+ A+K + + G+ + E++++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
V G + + + + +E+ SL ++ T L+ + QGL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYLHSK 125
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL- 690
+ +HRD+K +NILL + + K++DFG++ K +GT +M+PE A
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAV 180
Query: 691 --DGLFSIKSDVFSFGILMLE 709
G ++ D+++ GI +E
Sbjct: 181 ERKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 521 LGEGGFGPVYK-------GRLLNGQEVAVKRLS-----NQSGQGLKEFKNEMMLIAK-LQ 567
LG G FG VYK LL +E+ V + + + + + +E+ +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNW-QARV-RIIEGIAQGL 625
H N+VR +E ++++ + L F+S K++ + + R+ I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
YLH+ R I+HRDL +NI+L +D I+DFGLA+ + +VGT Y
Sbjct: 127 RYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSC 181
Query: 686 PEYALDGLFSIKSDVFSFGILMLET 710
PE + + K+DV++FG ++ +
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 505 LASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMM 561
++ T + +G G FG V R L GQ VA+K++ + K E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 621
L+ L+H N++ L + E I + + L+ L R L Q + I
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFIQYFLYQI 117
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-----MFGGDELQGNTKQ 676
+GL Y+H ++HRDLK SNIL++++ + KI DFGLAR M G
Sbjct: 118 LRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG---------- 164
Query: 677 IVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 714
V T Y +PE L + ++ D++S G + E L K
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 56/191 (29%), Positives = 91/191 (47%), Gaps = 16/191 (8%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
LG G G VYK LL + +AVK + + + + K+ +E+ ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+ + E+M SL+V+ R + RI + +GL YL +I+H
Sbjct: 69 FVENRISICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS---LKILH 118
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 698
RD+K SN+L++ K+ DFG++ + K VGT YM+PE + I S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 699 DVFSFGILMLE 709
DV+S GI +E
Sbjct: 175 DVWSLGISFME 185
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 521 LGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLK-----EFKNEMMLIAKLQHRNL 571
LG+G FG V+ R + GQ A+K L + LK K E ++A++ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRI-IEGIAQGLLYLHQ 630
V+L +G+ LIL+++ L F K ++ + V+ + +A L +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 115
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
II+RDLK NILLD++ + K++DFGL++ E + GT YM+PE
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVN 171
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
+ +D +SFG+LM E L+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 5e-14
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 27/234 (11%)
Query: 485 GEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR 544
A+ D D +P A A+ +++ L G G V+ GQ V
Sbjct: 39 DSASES-DDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPDPVVL 96
Query: 545 LSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDST 604
Q G L E ML+ + H +++R+ V ++L P+ S +++ + +
Sbjct: 97 KIGQKGTTLIE----AMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTK 149
Query: 605 KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR- 663
+ R L + I + I +GL YLH RIIHRD+K NI ++ I D G A+
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF 206
Query: 664 -----MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
F G + GT +PE ++ K+D++S GI++ E L+
Sbjct: 207 PVVAPAFLG---------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+ L+L M L ++ + +A E I GL LHQ
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLHQE--- 121
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEYALDGL 693
RI++RDLK NILLD + +ISD GLA + G ++G VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER 177
Query: 694 FSIKSDVFSFGILMLETLSSK 714
++ D ++ G L+ E ++ +
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 521 LGEGGFGPVYKG--RLLNGQE--VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
LG G FG + +G +L + +E VA+ L + S + + F E + + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
G +++ EYM N +L+ FL + L + ++ G+A G+ YL S
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLASGMKYL---SEMG 127
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS---------P 686
+H+ L A +L++ D+ KIS F + + Y MS P
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR----------RLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 687 EYALDGLFSIKSDVFSFGILMLETLS 712
E FS SDV+SFGI+M E +S
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+GGFG V G++ + + KR+ + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDS-----TKKRLLNWQARVRIIEGIAQGLLYLH 629
+ L+L M L +++ ++R L + A I GL LH
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE------ILCGLEDLH 119
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEY 688
+ + ++RDLK NILLD + +ISD GLA ++ G+ ++G VGT GYM+PE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEV 172
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
+ +++ D + G L+ E + +
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
++ + ++G G +G VYK R L G+ AVK + + G + E+ ++ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 572 VRLLGCCVEQGEKILILEYMPNKSL-NVFLFDSTKKRL-LNWQARVRIIEGIAQGLLYLH 629
V G + + + + +EY SL +++ L + + R + QGL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
+ +HRD+K +NILL + + K++DFG+A K +GT +M+PE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVA 178
Query: 690 L---DGLFSIKSDVFSFGILMLE 709
+G ++ D+++ GI +E
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 53/191 (27%), Positives = 95/191 (49%), Gaps = 10/191 (5%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
K+GEG G V + +G+ VAVK++ + Q + NE++++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+ E +++E++ +L D +N + + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 698
RD+K+ +ILL D K+SDFG E+ K +VGT +M+PE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVP-RRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 699 DVFSFGILMLE 709
D++S GI+++E
Sbjct: 198 DIWSLGIMVIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 520 KLGEGGFGPVYKG---RLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLL 575
++G G FG V G R ++ V VK L + F E+ +L H N+++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYLHQYSR 633
G C+E +L+LE+ P L +L + Q V R+ +A GLL+LHQ
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD- 120
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA---- 689
IH DL N L D++ KI D+GLA ++ +++PE
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 690 ---LDGLFSIKSDVFSFGILMLE 709
L + KS+++S G+ M E
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 51/149 (34%), Positives = 72/149 (48%), Gaps = 9/149 (6%)
Query: 520 KLGEGGFGPVYKGRL---LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
++G G FG V G + +V VK L + S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYLHQYSR 633
G C E +L++E+ P L +L K L+ R+ IA GLL+LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLA 662
IH DL N LL D+ KI D+GL+
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 52/196 (26%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 520 KLGEGGFGPV-YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
K+GEG G V G++VAVK++ + Q + NE++++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+ E +++E++ +L D +N + + + + L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 698
RD+K+ +ILL D K+SDFG + + K +VGT +M+PE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 699 DVFSFGILMLETLSSK 714
D++S GI+++E + +
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 25/208 (12%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKR-LSNQSGQGLKEFK-NEMMLIAKLQHRN-LVRLL 575
K+GEG +G VYK R G+ VA+K+ +G+ E+ L+ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 576 GCCVEQGEK-------ILILEYMPNKSLNVFLFDSTKK---RLLNWQARVRIIEGIAQGL 625
VE E+ L+ EY+ + L F+ DS + R L + + + +G+
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYM 684
+ H++ ++HRDLK N+L+DK KI+D GL R F ++ T +IV T Y
Sbjct: 124 AHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWYR 178
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETL 711
+PE L +S D++S G + E
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
+G G +G V Y RL Q+VAVK+LS QS + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 576 -----GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+E ++ ++ + LN + K + L+ + +I + +GL Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLN----NIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
IIHRDLK SN+ +++D +I DFGLAR DE+ G V T Y +PE L
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWYRAPEIML 188
Query: 691 DGL-FSIKSDVFSFGILMLETLSSK 714
+ + ++ D++S G +M E L K
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL-- 575
+G G +G V G VAVK+LS QS K E+ L+ ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 576 ---GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+E+ + ++ ++ LN + K + L +I I +GL Y+H
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 140
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
IIHRDLK SN+ +++D KI DFGLAR DE+ G V T Y +PE L+
Sbjct: 141 ---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYRAPEIMLNW 192
Query: 693 L-FSIKSDVFSFGILMLETLSSK 714
+ ++ D++S G +M E L+ +
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIV 678
I GL +LH+ II+RDLK N+LLD + + KI+DFG+ + + GG T
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
GT Y++PE + D ++ G+L+ E L
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-13
Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 20/191 (10%)
Query: 537 GQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLL--GCCVEQGEKILILEYM 591
G EVA+K L + + + F+ E L A+L H N+V LL G G + EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL--- 648
P ++L L L R++ + L H I+HRDLK NI++
Sbjct: 62 PGRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115
Query: 649 DKDMNPKISDFGLARMFGG----DELQGN-TKQIVGTYGYMSPEYALDGLFSIKSDVFSF 703
+ K+ DFG+ + G D T +++GT Y +PE + SD++++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 704 GILMLETLSSK 714
G++ LE L+ +
Sbjct: 176 GLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRLSN----QSGQGLKEFKNEMMLIAK 565
NF + LG G +G V+ R + G + A+K L Q + + + E ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 566 LQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
++ + L + K+ LIL+Y+ L L+ + VR+ IA+
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE----SEVRVY--IAEI 114
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
+L L + II+RD+K NILLD + + ++DFGL++ F +E + GT YM
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 685 SPEYAL--DGLFSIKSDVFSFGILMLETLS 712
+PE G D +S G+L E L+
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDS-----TKKRLLNWQARVRIIEGIAQGLLYLH 629
+ L+L M L +++ ++R + + A I GL LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE------ITCGLEDLH 119
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEY 688
R RI++RDLK NILLD + +ISD GLA + G+ ++G VGT GYM+PE
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPEV 172
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
+ ++ D + G L+ E + K
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL--KEFKNEMMLIAKLQHRN 570
++F +LG G G V K + + ++L + + + E+ ++ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYL 628
+V G GE + +E+M SL+ L ++ + + +L +V I + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEIL---GKVSI--AVLRGLAYL 119
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
+ + +I+HRD+K SNIL++ K+ DFG++ G + VGT YMSPE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
+S++SD++S G+ ++E
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-13
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHR 569
E ++ ++G G +G V G++VA+K+LS QS K E+ L+ +QH
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 570 NLVRLLGCCVEQG------EKILILEYMPNKSLNV--FLFDSTKKRLLNWQARVRIIEGI 621
N++ LL + L++ YM + K + L +Q +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ--------M 126
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 681
GL Y+H IIHRDLK N+ +++D KI DFGLAR E+ G V T
Sbjct: 127 LCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTR 178
Query: 682 GYMSPEYALDGLFSIKS-DVFSFGILMLETLSSK 714
Y +PE L+ + ++ D++S G +M E L+ K
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 59/183 (32%), Positives = 87/183 (47%), Gaps = 24/183 (13%)
Query: 537 GQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------GEKILIL 588
GQ VA+K+LS Q+ K E++L+ + H+N++ LL Q + L++
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100
Query: 589 EYMPNKSLNVFLFDSTKKRL--LNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 646
E M V D +R+ L +Q + G+ +LH IIHRDLK SNI
Sbjct: 101 ELMDANLCQVIQMDLDHERMSYLLYQ--------MLCGIKHLHSAG---IIHRDLKPSNI 149
Query: 647 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGIL 706
++ D KI DFGLAR G + T +V Y Y +PE L + D++S G +
Sbjct: 150 VVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCI 206
Query: 707 MLE 709
M E
Sbjct: 207 MGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 51/147 (34%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
KLGEG + VYKGR L VA+K RL ++ G + E+ L+ L+H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+ L+ EY+ +K L +L D +N + + +GL Y H R ++
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCH---RRKV 125
Query: 637 IHRDLKASNILLDKDMNPKISDFGLAR 663
+HRDLK N+L+++ K++DFGLAR
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKL 566
+ +GEG +G V G +VA+K++S Q L+E K ++ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60
Query: 567 QHRNLVRLLGC----CVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 621
+H N++ +L E + ++ E M L+ K + L+ + I
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQI 115
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI---V 678
+GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR+ D +T + V
Sbjct: 116 LRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYV 170
Query: 679 GTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSSK 714
T Y +PE L+ K+ D++S G ++ E LS++
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+GGFG V G++ +++ KRL +SG+ + + E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKK-----RLLNWQARVRIIEGIAQGLLYLH 629
+ L++ M L +++ ++ R++++ A+ I G+L+LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLH 112
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEY 688
I++RD+K N+LLD N ++SD GLA + G Q GT GYM+PE
Sbjct: 113 S---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGTNGYMAPEI 165
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
+ +S D F+ G + E ++ +
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 38/209 (18%)
Query: 521 LGEGGFGPV----YKGRLLNGQEVAVKRL------SNQSGQGLKEFKNEMMLIAKLQHRN 570
LG G FG V YK G+ A+K L + + L K +H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSL------NVFLFDSTKKRLLNWQARVRIIEGIAQG 624
LV L C + ++EY L +VF ++ R + + A V + G
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF----SEPRAVFYAACVVL------G 113
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYG 682
L YLH+ +I++RDLK N+LLD + KI+DFGL + M GD T GT
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TSTFCGTPE 166
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETL 711
+++PE + ++ D + G+L+ E L
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 569
E + +GEG +G V K + GQ VA+K+ S K E+ ++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVF------LFDSTKKRLLNWQARVRIIEGIAQ 623
NLV L+ + L+ E++ + L+ L +S ++ L +Q I+ GI
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL-FQ----ILRGIE- 114
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
+ H ++ IIHRD+K NIL+ + K+ DFG AR V T Y
Sbjct: 115 ---FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYTDYVATRWY 166
Query: 684 MSPEYAL-DGLFSIKSDVFSFGILMLETLS 712
+PE + D + D+++ G L+ E L+
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 53/154 (34%), Positives = 77/154 (50%), Gaps = 22/154 (14%)
Query: 519 CKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
KLGEG + VYKGR L GQ VA+K RL ++ G + E L+ L+H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69
Query: 576 GCCVEQGEKILILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
+ L+ EY+ + L ++ RL +Q + +GL Y H
Sbjct: 70 DIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ--------LLRGLAYCH 120
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663
Q R++HRDLK N+L+ + K++DFGLAR
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 9/139 (6%)
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V G GE + +E+M SL+ L K + +I + +GL YL +
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
+ +I+HRD+K SNIL++ K+ DFG++ G + VGT YMSPE
Sbjct: 118 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 171
Query: 691 DGLFSIKSDVFSFGILMLE 709
++++SD++S G+ ++E
Sbjct: 172 GTHYTVQSDIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 18/210 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLKEFKNEMMLIAK 565
NF + LG G +G V+ R ++G + A+K L Q + + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 566 LQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
++ + L + K+ LIL+Y+ L F S ++R + ++ E I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGE-IVLA 117
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
L +LH + II+RD+K NILLD + + ++DFGL++ F DE++ GT YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 685 SPEYAL--DGLFSIKSDVFSFGILMLETLS 712
+P+ DG D +S G+LM E L+
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 521 LGEGGFGPVYKGRLLNGQE----VAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNLV 572
LG+GG+G V++ R + G + A+K L ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 573 RLLGCCVEQGEKILILEYMPNKSL-------NVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
L+ G+ LILEY+ L +F+ D+ L I+ L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE----------ISLAL 113
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN--TKQIVGTYGY 683
+LHQ II+RDLK NILLD + K++DFGL + + + T GT Y
Sbjct: 114 EHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEY 166
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLS 712
M+PE + D +S G LM + L+
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIV 678
IA GL +LH II+RDLK N++LD + + KI+DFG+ + +FGG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
GT Y++PE + D ++FG+L+ E L+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 28/213 (13%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFK--NEMMLIAKL 566
AAT +++ KLGEG + VYKG +NGQ VA+K +S ++ +G+ F E L+ L
Sbjct: 3 AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGL 60
Query: 567 QHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIE 619
+H N+V LL + E + + EYM + L ++ RL +Q
Sbjct: 61 KHANIV-LLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ------- 111
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
+ +GL Y+H I+HRDLK N+L+ K++DFGLAR Q + ++V
Sbjct: 112 -LLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV- 165
Query: 680 TYGYMSPEYALDGL-FSIKSDVFSFGILMLETL 711
T Y P+ L +S D++ G + +E L
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 68/226 (30%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 502 LFSLASITAATENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLKEFKNEM 560
+ L S+ T+ + + +G+G +G VYK +G AVK L S +E + E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 561 MLIAKL-QHRNLVRLLGCCVEQ-----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQAR 614
++ L H N+V+ G + G+ L+LE S+ + K LL R
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124
Query: 615 VR------IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668
+ I+ G GL +LH RIIHRD+K +NILL + K+ DFG++
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181
Query: 669 ELQGNTKQIVGTYGYMSPEY-----ALDGLFSIKSDVFSFGILMLE 709
L+ NT VGT +M+PE D + + DV+S GI +E
Sbjct: 182 RLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNLVRLLGC 577
CK+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 578 CVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY-----LHQ 630
+ ++ L+ +Y + ++ F K + V++ G+ + LLY +H
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHY 123
Query: 631 YSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGD-ELQGNTKQIVGTYGYMS 685
++HRDLK +NIL+ + KI+D G AR+F + + +V T+ Y +
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 686 PEYALDGLFSIKS-DVFSFGILMLETLSSK 714
PE L K+ D+++ G + E L+S+
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+ L+L M L +++ +A E + GL L R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-LCCGLEDLQ---RE 121
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEYALDGL 693
RI++RDLK NILLD + +ISD GLA ++ G+ ++G VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNEK 177
Query: 694 FSIKSDVFSFGILMLETL 711
++ D + G L+ E +
Sbjct: 178 YTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 38/99 (38%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQI 677
+AQG+ +L + IHRD+ A N+LL KI DFGLAR D ++GN +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 716
V +M+PE D +++++SDV+S+GIL+ E S K+
Sbjct: 278 VK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM--LIAKLQHR--NLVRLL 575
+G G G VYK R G +AVK++ + +E K +M + H +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNW---QARVRIIEGIAQGLLYLHQYS 632
G + + + +E M D KR+ ++ I + L YL +
Sbjct: 81 GYFITDSDVFICMELMST------CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE-- 132
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+ +IHRD+K SNILLD N K+ DFG++ R+ + + T+ G YM+PE +D
Sbjct: 133 KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRS-AGCAAYMAPE-RID 187
Query: 692 -----GLFSIKSDVFSFGILMLE 709
+ I++DV+S GI ++E
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
KLGEG + V+KGR L VA+K RL ++ G + E+ L+ L+H N+V L
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
L+ EY+ +K L ++ D +++ + I +GL Y H R ++
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCH---RRKV 125
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLFS 695
+HRDLK N+L+++ K++DFGLAR + + ++V T Y P+ L +S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSSEYS 183
Query: 696 IKSDVFSFGILMLETLSSK 714
+ D++ G + E S +
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 521 LGEGGFGPV--YKGRLLNGQEVAVK-RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 577
+G+G +G V + R Q V K L N S + K + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 578 CV-EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
E G +++ + L L + K L Q ++ IA L YLH+ I
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ-IAMALQYLHEK---HI 123
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 696
+HRDLK N+ L + K+ D G+AR+ +T ++GT YMSPE + ++
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNY 181
Query: 697 KSDVFSFGILMLETLSSK 714
KSDV++ G + E + K
Sbjct: 182 KSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 17/210 (8%)
Query: 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNLVRLLGC 577
CK+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 578 CVEQGEK--ILILEYMPNKSLNVFLF----DSTKKRLLNWQARVR-IIEGIAQGLLYLHQ 630
+ ++ L+ +Y + ++ F + KK + ++ V+ ++ I G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 631 YSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGD-ELQGNTKQIVGTYGYMS 685
++HRDLK +NIL+ + KI+D G AR+F + + +V T+ Y +
Sbjct: 127 N---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 686 PEYALDGLFSIKS-DVFSFGILMLETLSSK 714
PE L K+ D+++ G + E L+S+
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 25/195 (12%)
Query: 537 GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL--------------LGCCVEQG 582
+ VAVK++ Q +K E+ +I +L H N+V++ +G E
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642
++ EYM NV + L AR+ + + + +GL Y+H + ++HRDLK
Sbjct: 90 SVYIVQEYMETDLANVL----EQGPLSEEHARLFMYQ-LLRGLKYIHSAN---VLHRDLK 141
Query: 643 ASNILLD-KDMNPKISDFGLARMFGGD-ELQGNTKQIVGTYGYMSPEYALDGLFSIKS-D 699
+N+ ++ +D+ KI DFGLAR+ +G + + T Y SP L K+ D
Sbjct: 142 PANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAID 201
Query: 700 VFSFGILMLETLSSK 714
+++ G + E L+ K
Sbjct: 202 MWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 51/196 (26%), Positives = 96/196 (48%), Gaps = 18/196 (9%)
Query: 521 LGEGGFG-PVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
+GEG FG + + + Q+ A+K + +S +++ + E +L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 579 VEQGEKILILEYMPNKSLNVFLFDS-----TKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
G +++EY L + + +L W + + G+ ++H+
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK-- 119
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 693
R++HRD+K+ NI L ++ K+ DFG AR+ T VGT Y+ PE +
Sbjct: 120 -RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMP 176
Query: 694 FSIKSDVFSFGILMLE 709
++ KSD++S G ++ E
Sbjct: 177 YNNKSDIWSLGCILYE 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 27/208 (12%)
Query: 521 LGEGGFGPVYK---GRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
+G G FG V+ R +G+ VA+K++ N Q+ K E+ ++ +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 576 GC-------CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
E E ++ E M + + + + + L + +V + + I +GL YL
Sbjct: 66 DILQPPHIDPFE--EIYVVTELMQSDLHKIIV---SPQPLSSDHVKVFLYQ-ILRGLKYL 119
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H I+HRD+K N+L++ + KI DFGLAR+ DE + T+++V Y Y +PE
Sbjct: 120 HSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEI 175
Query: 689 ALDGL--FSIKSDVFSFGILMLETLSSK 714
L G ++ D++S G + E L +
Sbjct: 176 -LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 55/201 (27%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRN 570
++F +LG G G V+K +G +A K + + ++ + E+ ++ +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYL 628
+V G GE + +E+M SL+ L + + +++L +V I + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL---GKVSI--AVIKGLTYL 119
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
+ + +I+HRD+K SNIL++ K+ DFG++ G + VGT YMSPE
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
+S++SD++S G+ ++E
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 28/204 (13%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVK-----RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
+G GGFG VY R + G+ A+K R+ + G+ L + M+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 575 LGCCVEQGEKI-LILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+ +K+ IL+ M L+ L F + R II G+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY----AAEIILGLE------ 111
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H ++RF +++RDLK +NILLD+ + +ISD GLA F + + VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 689 ALDGL-FSIKSDVFSFGILMLETL 711
G+ + +D FS G ++ + L
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIV 678
I GL +LH+ II+RDLK N+LLDKD + KI+DFG+ + M G +G
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFC 157
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
GT Y++PE ++ D +SFG+L+ E L
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 55/181 (30%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 537 GQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKILIL 588
G VAVK+LS Q+ K E++L+ + H+N++ LL Q + L++
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648
E M V + +R+ ++ + G+ +LH IIHRDLK SNI++
Sbjct: 106 ELMDANLCQVIHMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156
Query: 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708
D KI DFGLAR + + T +V Y Y +PE L + D++S G +M
Sbjct: 157 KSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMG 213
Query: 709 E 709
E
Sbjct: 214 E 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-11
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 37/224 (16%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRL-SNQSGQGL--KEFKNEMMLIAKLQHRNLVRLL 575
+G+GG G VY + + VA+K++ + S L K F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 576 GCCVEQGEKILILEYMPN------KSL--NVFLFDSTKKRL---LNWQARVRIIEGIAQG 624
C G+ + MP KSL +V+ +S K L + A + I I
Sbjct: 69 SIC-SDGD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE-----LQGNTK---- 675
+ Y+H S+ ++HRDLK NILL I D+G A +E + + +
Sbjct: 126 IEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 676 -------QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+IVGT YM+PE L S +D+++ G+++ + L+
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
LG+G FG V RL +G+ AVK L Q + +L H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 576 GCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSR 633
CC + +++ ++E++ L +F K R + +AR R I L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEITSALMFLHDKG- 116
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALD 691
II+RDLK N+LLD + + K++DFG+ + +F G T GT Y++PE +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK----TTSTFCGTPDYIAPEILQE 170
Query: 692 GLFSIKSDVFSFGILMLETLS 712
L+ D ++ G+L+ E L
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 521 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 575
+G+G FG V R +G AVK L ++ KE + M +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 576 GCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+ EK+ +L+Y+ L F ++ L +AR E +A + YLH +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHSLN-- 116
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 694
II+RDLK NILLD + ++DFGL + G E + T GT Y++PE +
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 695 SIKSDVFSFGILMLETL 711
D + G ++ E L
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 48/147 (32%), Positives = 80/147 (54%), Gaps = 10/147 (6%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
KLGEG + V+KGR L VA+K RL ++ G + E+ L+ L+H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+ L+ EY+ + L +L D+ + ++ + + + +GL Y H + +I
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCH---KRKI 124
Query: 637 IHRDLKASNILLDKDMNPKISDFGLAR 663
+HRDLK N+L+++ K++DFGLAR
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 18/203 (8%)
Query: 516 SMQCKLGE----GGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHR 569
+ +G+ + K + VAVK+ L + S + LK + E++ +LQH
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N++ + + E ++ M S L + L A I++ + L Y+H
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYIH 118
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQ----GNTKQIVGTYGYM 684
IHR +KAS+ILL D +S + M + Q K V ++
Sbjct: 119 SKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175
Query: 685 SPEYALDGL--FSIKSDVFSFGI 705
SPE L ++ KSD++S GI
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 52/192 (27%), Positives = 90/192 (46%), Gaps = 10/192 (5%)
Query: 521 LGEGGFGPVYKGRLLNGQE-VAVKRLSNQSG-QGLKEFK-NEMMLIAKLQHRNLVRLLGC 577
+GEG +G V K R +E VA+K+ + + +KE E+ ++ L+ N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 578 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 637
+G+ L+ EY+ L + + + N ++ I Q + +H + I+
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELL------EEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV 122
Query: 638 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIK 697
HRD+K N+L+ + K+ DFG AR + N + V T Y SPE L +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 698 SDVFSFGILMLE 709
D++S G ++ E
Sbjct: 182 VDMWSVGCILGE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
+LG+G +G VYK G +A+K RL + + E+ ++ K +V G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+G + +EYM SL+ + RI + +GL +L + I
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY------AL 690
IHRD+K +N+L++ + K+ DFG++ G+ + K +G YM+PE
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 691 DGLFSIKSDVFSFGILMLE 709
+ ++++SDV+S G+ +LE
Sbjct: 181 NPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 521 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
+G GGFG VY G++ + + KR+ + G+ L + M+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 575 LGCCVEQGEKI-LILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+ +K+ IL+ M L+ L F + R II G+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY----ATEIILGLE------ 111
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H ++RF +++RDLK +NILLD+ + +ISD GLA F + + VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 689 ALDGL-FSIKSDVFSFGILMLETL 711
G + +D FS G ++ + L
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 56/173 (32%), Positives = 84/173 (48%), Gaps = 15/173 (8%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 575
+G+G FG V + +G+ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 576 GCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+ +K+ +L+Y+ L F ++ +AR E IA L YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---L 115
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
II+RDLK NILLD + ++DFGL + G E T GT Y++PE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLKEFKNEMMLIAK 565
NF + LG G +G V+ R + G + A+K L Q + ++ + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 566 LQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQ 623
++ + L + K+ LIL+Y+ + L+ +R + VR G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIIL 116
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
L +LH + I++RD+K NILLD + + ++DFGL++ F +E + T GT Y
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEY 172
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLE--------TLSSKKNT 717
M+PE K+ D +S GIL+ E TL ++NT
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 33/93 (35%), Positives = 53/93 (56%)
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
Q LL +H +IHRD+K++NILL + K+ DFG ++M+ + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
Y++PE +S K+D+FS G+L+ E L+ K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 38/95 (40%), Positives = 58/95 (61%), Gaps = 9/95 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQI 677
+A+G+ +L SR + IHRDL A NILL ++ KI DFGLAR D +G+ +
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +M+PE D +++ +SDV+SFG+L+ E S
Sbjct: 239 L---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 51/147 (34%), Positives = 80/147 (54%), Gaps = 10/147 (6%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
KLGEG + VYKG+ +NG+ VA+K RL + G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+ L+ EY+ + L ++ D L ++ + + + +GL Y+HQ R+ I
Sbjct: 71 IIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFLFQ-LLRGLSYIHQ--RY-I 124
Query: 637 IHRDLKASNILLDKDMNPKISDFGLAR 663
+HRDLK N+L+ K++DFGLAR
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 55/185 (29%), Positives = 87/185 (47%), Gaps = 20/185 (10%)
Query: 538 QEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKILILE 589
+ VA+K+LS Q+ K E++L+ + H+N++ LL Q + L++E
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102
Query: 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649
M V + +R+ ++ + G+ +LH IIHRDLK SNI++
Sbjct: 103 LMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 153
Query: 650 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
D KI DFGLAR G + T +V Y Y +PE L + D++S G +M E
Sbjct: 154 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 710 TLSSK 714
+ K
Sbjct: 211 MVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
+A+G+ +L SR + IHRDL A NILL ++ KI DFGLAR D
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQ--EVAVKRLSNQSGQGLKEFK---NEMMLIAKLQ 567
E+F+ LG G FG V N VA+KR K+ +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLN-----WQARVRIIEGIA 622
H V L G ++ L+LE++ F F KR N + A++ +I
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEF--FTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
Q L I++RDLK N+LLDKD K++DFG A++ + T + GT
Sbjct: 148 QSL---------NIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPE 193
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETL 711
Y++PE L+ +D ++ GI + E L
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQI 677
+A+G+ +L + IHRDL A NILL KI DFGLAR D ++GN +
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
V +M+PE + +++ +SDV+S+GIL+ E S
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 27/198 (13%)
Query: 524 GGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQHRNLVRLLGCC 578
G FG VY + G A+K L + N +++ + + + +L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRL----LNWQARVRIIEGIAQGLLYLHQYSRF 634
+ L++EY+ + K L +W A+ I E + G+ LHQ
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDW-AKQYIAE-VVLGVEDLHQRG-- 117
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 694
IIHRD+K N+L+D+ + K++DFGL+R G E K+ VGT Y++PE + G+
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDYLAPE-TILGVG 169
Query: 695 SIK-SDVFSFGILMLETL 711
K SD +S G ++ E L
Sbjct: 170 DDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 521 LGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCC 578
+G+G +G V+K NG + AVK L +E + E ++ L H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 579 ----VEQGEKI-LILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQYS 632
V+ G+++ L+LE S+ + K+ + I+ GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY---- 688
+ IHRD+K +NILL + K+ DFG++ L+ NT VGT +M+PE
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIACE 199
Query: 689 -ALDGLFSIKSDVFSFGILMLE 709
LD + + DV+S GI +E
Sbjct: 200 QQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 64/199 (32%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM----LIAKLQHRNLVRLL 575
LG+G FG V+ L Q A+K L + + M+ L +H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 576 GCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
C + E + ++EY+ L +F S K L +A E I GL +LH
Sbjct: 63 -CTFQTKENLFFVMEYLNGGDL-MFHIQSCHKFDLP-RATFYAAE-IICGLQFLHSKG-- 116
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALDG 692
I++RDLK NILLD D + KI+DFG+ + M G T GT Y++PE L
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLGQ 171
Query: 693 LFSIKSDVFSFGILMLETL 711
++ D +SFG+L+ E L
Sbjct: 172 KYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 38/95 (40%), Positives = 58/95 (61%), Gaps = 9/95 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQI 677
+A+G+ +L SR + IHRDL A NILL ++ KI DFGLAR D +G+ +
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +M+PE D +++ +SDV+SFG+L+ E S
Sbjct: 240 L---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 39/212 (18%)
Query: 521 LGEGGFGPV-YKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 577
+G G +G V G +VA+K+L QS K E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 578 CVEQGEKILILEYMPNKSLNVF-------------LFDSTKKRLLNWQARVR-IIEGIAQ 623
+ P+ SL+ F L K L+ + R++ ++ + +
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS-EDRIQFLVYQMLK 129
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
GL Y+H IIHRDLK N+ +++D KI DFGLAR E+ G V T Y
Sbjct: 130 GLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSEMTG----YVVTRWY 181
Query: 684 MSPEYALDGL-FSIKSDVFSFGILMLETLSSK 714
+PE L+ + ++ D++S G +M E L+ K
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 521 LGEGGFGPVYKGRLLN---------GQEVAVKR-LSNQSGQGLKEFKNEMMLIAKLQHRN 570
LG+G F +YKG L GQEV+V + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
LV+L G CV E I++ EY+ L+VFL L+W+ V + +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119
Query: 631 YSRFRIIHRDLKASNILLDKDMNP-------KISDFGLARMFGGDELQGNTKQIVGTYGY 683
+++H ++ NIL+ + K+SD G+ E + V +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE------ERVERIPW 170
Query: 684 MSPEYALDGLFSIKS--DVFSFGILMLE 709
++PE +G S+ D +SFG +LE
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLE 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 46/222 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM---------- 561
E+F + +G G FG V R + ++V A+K LS K EM+
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS----------KFEMIKRSDSAFFWE 92
Query: 562 ---LIAKLQHRNLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFL--FDSTKKRLLNWQAR 614
++A +V+L Q +K L ++EYMP L + +D +K W AR
Sbjct: 93 ERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----W-AR 145
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGN 673
E + L +H IHRD+K N+LLDK + K++DFG +M ++ +
Sbjct: 146 FYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201
Query: 674 TKQIVGTYGYMSPEYAL----DGLFSIKSDVFSFGILMLETL 711
T VGT Y+SPE DG + + D +S G+ + E L
Sbjct: 202 TA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 20/185 (10%)
Query: 538 QEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKILILE 589
+ VA+K+LS Q+ K E++L+ + H+N++ LL Q + +++E
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649
M V + +R+ ++ + G+ +LH IIHRDLK SNI++
Sbjct: 110 LMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 650 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
D KI DFGLAR G + T +V Y Y +PE L + D++S G +M E
Sbjct: 161 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 710 TLSSK 714
+
Sbjct: 218 MIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 514 NFSMQCKLGEGGFGPV----YKGRLLNGQEVAVKRLSNQSGQGLKEFKN---EMMLIAKL 566
+F M LG G FG V +KG G+ A+K L + +K+ ++ E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
H +V ++ ++ +LE++ L F R N A+ E +
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAE-LVLAFE 132
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
YLH II+RDLK N+LLD + K++DFG A+ ++ T + GT Y++P
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 687 EYALDGLFSIKSDVFSFGILMLETL 711
E D ++ G+L+ E +
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 575
LG+G FG V L EV A+K L + M +L +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 576 GCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSR 633
CC + +++ ++EY+ L +F + R + + R R + L++LH++
Sbjct: 63 -CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-EPRSRFYAAEVTLALMFLHRHG- 116
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALD 691
+I+RDLK NILLD + + K++DFG+ + + G T GT Y++PE +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPDYIAPEILQE 170
Query: 692 GLFSIKSDVFSFGILMLETLSSK 714
+ D ++ G+LM E ++ +
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 61/234 (26%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIAKLQHRNLV 572
+G G FG V+ R + +V A+K L NQ + E ++A +V
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH----VRAERDILADADSPWIV 64
Query: 573 RLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG------IAQG 624
+L Q E+ L ++EYMP L +N R + IA+
Sbjct: 65 KLY--YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAEL 110
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA--------RMFGGDELQGNTKQ 676
+L L + IHRD+K NIL+D D + K++DFGL R + ++ +
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 677 -------------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
VGT Y++PE + ++ D +S G+++ E L
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---EMMLIAKLQHRNLVRLLG 576
LG+G FG V R +G+ A+K L + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSRFR 635
+ ++EY+ L F +++R+ + + R R I L YLH +
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFS-EDRTRFYGAEIVSALDYLHSG---K 115
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
I++RDLK N++LDKD + KI+DFGL + G K GT Y++PE D +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 696 IKSDVFSFGILMLETLSSK 714
D + G++M E + +
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 56/181 (30%), Positives = 90/181 (49%), Gaps = 26/181 (14%)
Query: 543 KRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE---YMPNK----S 595
KR+ S + + +NE++ + +L H N++++ E+IL E YM +
Sbjct: 198 KRVKAGS-RAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFD 248
Query: 596 LNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 652
L F++D K R L Q R I++ + + Y+H ++IHRD+K NI L+ D
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304
Query: 653 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLETL 711
+ DFG A F E + VGT SPE A DG I +D++S G+++L+ L
Sbjct: 305 KIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDML 362
Query: 712 S 712
S
Sbjct: 363 S 363
|
Length = 501 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 55/221 (24%)
Query: 520 KLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLV 572
+G G +G V +G++VA+K++ + + L+E K ++ +H N++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRHFKHDNII 67
Query: 573 RLLGCCVEQGEKILILEYMPNKSL--NVFL-FDSTKKRLLNWQARVRIIEG--------- 620
+ IL P + +V++ D + L II
Sbjct: 68 AIR--------DIL----RPPGADFKDVYVVMDLMESDLH------HIIHSDQPLTEEHI 109
Query: 621 ------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQG 672
+ +GL Y+H + +IHRDLK SN+L+++D +I DFG+AR E +
Sbjct: 110 RYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166
Query: 673 NTKQIVGTYGYMSPE--YALDGLFSIKSDVFSFGILMLETL 711
+ V T Y +PE +L ++ D++S G + E L
Sbjct: 167 FMTEYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 6/97 (6%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIV 678
I GL Y+H + ++HRDLK N+L++ D KI DFGLAR F E G + V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 679 GTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSSK 714
T Y +PE L K+ DV+S G ++ E L K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVA---VKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
++G G FG V + VA VK L +N S + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKR----LLNWQARVRIIEGIAQGLLYLHQY 631
G CVE +L+ EY L +L R LL Q R+ IA G+ ++H++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMHKH 118
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEYAL 690
+ +H DL N L D+ K+ D+G+ + D ++ + V +++PE
Sbjct: 119 N---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVG 174
Query: 691 ---DGLFSIK----SDVFSFGILMLE 709
GL + + S+V++ G+ + E
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWE 200
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRLLG 576
LG+G FG V L G+ AVK L + + M+ ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 577 CCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
C + E + ++E++ L + D K R ++A E I GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAE-IVCGLQFLHSKG--- 116
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALDGL 693
II+RDLK N++LD+D + KI+DFG+ + +FG GT Y++PE
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPDYIAPEILQGLK 172
Query: 694 FSIKSDVFSFGILMLETL 711
++ D +SFG+L+ E L
Sbjct: 173 YTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
+A+G+ +L + +HRDL A N+LL + KI DFGLAR D +
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE D L++ SDV+S+GIL+ E S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 21/187 (11%)
Query: 548 QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR 607
++ G K E+ ++ + HR ++ L+ K + MP ++F + +
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTY-VDRSG 180
Query: 608 LLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667
L + + I + + L YLH IIHRD+K NI LD+ N + DFG A
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237
Query: 668 DELQGNTKQIVGTYGYM---SPEY-ALDGLFSIKSDVFSFGILMLE------TLSSKKNT 717
+T Q G G + SPE ALD + K+D++S G+++ E TL K+
Sbjct: 238 HP---DTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293
Query: 718 GLGSMER 724
S R
Sbjct: 294 SSSSQLR 300
|
Length = 392 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
IA GL +LH II+RDLK N++LD + + KI+DFG+ + D + TK GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
Y++PE + D ++FG+L+ E L+ +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 575
+G+G FG V R ++ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
+ +L+Y+ L F ++ L +AR E IA L YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS---LN 116
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
I++RDLK NILLD + ++DFGL + E G T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 696 IKSDVFSFGILMLETL 711
D + G ++ E L
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 14/147 (9%)
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLL-NWQARVRIIEGIAQGLLYLH 629
LV L C L++EY+ L +F ++R L AR E I L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLH 113
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPE 687
+ II+RDLK N+LLD D + K++D+G+ + + GD T GT Y++PE
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPE 166
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSK 714
+ D ++ G+LM E ++ +
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-08
Identities = 29/83 (34%), Positives = 46/83 (55%), Gaps = 7/83 (8%)
Query: 337 KSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK-NCSCRAYANSNVKESSGCLMWY 395
KS D F+ L K P F + ++ +LE+C ++CL NCSCR++ +N + GCL+W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNNG--TKGCLLWS 57
Query: 396 -GDLIDARRPIRNFTGQSVYLRV 417
L DAR + G +Y ++
Sbjct: 58 ESSLGDAR--LFPSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 40/130 (30%), Positives = 65/130 (50%), Gaps = 9/130 (6%)
Query: 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSRFRIIHRDLKAS 644
++EY L F +++R+ + + R R I L YLH S +++RDLK
Sbjct: 72 FVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALDYLH--SEKNVVYRDLKLE 125
Query: 645 NILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 704
N++LDKD + KI+DFGL + G + K GT Y++PE D + D + G
Sbjct: 126 NLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 183
Query: 705 ILMLETLSSK 714
++M E + +
Sbjct: 184 VVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H LV L C + ++EY+ L + +++L AR E I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNY 111
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMS 685
LH+ II+RDLK N+LLD + + K++D+G+ + + GD T GT Y++
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPNYIA 164
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSK 714
PE + D ++ G+LM E ++ +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 5/91 (5%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
I L YLH +++RDLK N++LDKD + KI+DFGL + G K GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 158
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
Y++PE D + D + G++M E +
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF------KNEMMLIAKLQHRNLVR 573
+G+G FG VY+ R + + + A+K LS + KE +N ++ + +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
L + L+ +YM L F + R +A+ I E + L +LH+Y
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAE-LVLALEHLHKYD- 116
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 693
I++RDLK NILLD + + DFGL++ D NT GT Y++PE LD
Sbjct: 117 --IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLAPEVLLDEK 172
Query: 694 -FSIKSDVFSFGILMLE 709
++ D +S G+L+ E
Sbjct: 173 GYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 38/130 (29%), Positives = 62/130 (47%), Gaps = 10/130 (7%)
Query: 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSRFRIIHRDLKAS 644
++EY L F +++R+ + R R I L YLH +++RD+K
Sbjct: 72 FVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHSRD---VVYRDIKLE 124
Query: 645 NILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 704
N++LDKD + KI+DFGL + D K GT Y++PE D + D + G
Sbjct: 125 NLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 705 ILMLETLSSK 714
++M E + +
Sbjct: 183 VVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 29/146 (19%), Positives = 58/146 (39%), Gaps = 13/146 (8%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCC 578
L G VY ++ +K ++ +E + ++ + + V ++L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
G L++E++ ++L+ ++ + + I E +A+ L LHQ + H
Sbjct: 63 ESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLCH 112
Query: 639 RDLKASNILLDKDMNPKISDFGLARM 664
DL NIL+D I D+ A
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 58/196 (29%), Positives = 88/196 (44%), Gaps = 13/196 (6%)
Query: 521 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 575
+G+G FG V R L+G+ AVK L + KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
+ +L+++ L F ++ +AR E IA L YLH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---IN 116
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
I++RDLK NILLD + ++DFGL + G T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 696 IKSDVFSFGILMLETL 711
D + G ++ E L
Sbjct: 175 NTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 68/240 (28%), Positives = 111/240 (46%), Gaps = 35/240 (14%)
Query: 492 KDKSKDSWLPLFS-----LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL 545
K+K+ D++L + + + E++ + +G G FG V R + Q+V A+K L
Sbjct: 17 KNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL 76
Query: 546 SN-----QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL--ILEYMPNKSLNV 598
S +S F E ++A +V+L C Q +K L ++EYMP L
Sbjct: 77 SKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLF--CAFQDDKYLYMVMEYMPGGDLVN 132
Query: 599 FL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656
+ +D +K + A V +L L +IHRD+K N+LLDK + K+
Sbjct: 133 LMSNYDVPEKWAKFYTAEV---------VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKL 183
Query: 657 SDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEY----ALDGLFSIKSDVFSFGILMLETL 711
+DFG +M ++ +T VGT Y+SPE DG + + D +S G+ + E L
Sbjct: 184 ADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIV 678
I+ GL +LH+ II+RDLK N++LD + + KI+DFG+ + M G T+
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFC 162
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
GT Y++PE + D +++G+L+ E L+ +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 36/97 (37%), Positives = 52/97 (53%), Gaps = 10/97 (10%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
+ +GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR E + V T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVT 171
Query: 681 YGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSK 714
Y +PE L + +I DV+S G + E L K
Sbjct: 172 RWYRAPELLLNCSEYTTAI--DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 51/217 (23%)
Query: 521 LGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLKEFKN-EMMLIAKLQHRNLVRLLGC- 577
+G G FG VY+ ++ E VA+K++ ++KN E++++ L H N++ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYY 128
Query: 578 ---CVEQGEKIL----ILEYMP-------------NKSLNVFLFDSTKKRLLNWQARVRI 617
C ++ EK + ++E++P N +L +FL +L ++Q
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV-----KLYSYQ----- 178
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLAR-MFGGDELQGNTK 675
+ + L Y+H S+F I HRDLK N+L+D + + K+ DFG A+ + G Q +
Sbjct: 179 ---LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSVS 229
Query: 676 QIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETL 711
I + Y +PE L ++ D++S G ++ E +
Sbjct: 230 YICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 2/92 (2%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
A+ L L +F +I+RDLK NILLD + + DFGL ++ D+ + NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
Y++PE L ++ D ++ G+L+ E L+
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 521 LGEGGFGPVYKG--------RLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
LG+G F ++KG L+ EV +K L + F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
G CV E I++ EY+ SL+ +L K L+N ++ + + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 633 RFRIIHRDLKASNILL-----DKDMNP---KISDFGLA 662
+ H ++ A N+LL K NP K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H LV L C + ++E++ L + +++L AR E I+ L +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNF 111
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMS 685
LH+ II+RDLK N+LLD + + K++D+G+ + + GD T GT Y++
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIA 164
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSK 714
PE + D ++ G+LM E ++ +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 40/156 (25%), Positives = 75/156 (48%), Gaps = 2/156 (1%)
Query: 557 KNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR 616
++E+ +A H +V+ + +LI+EY LN + K+ L + V
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676
++ Q +L L + +++HRDLK++NI L K+ DFG ++ +
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
GT Y++PE +S K+D++S G+++ E L+
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 43/196 (21%), Positives = 91/196 (46%), Gaps = 22/196 (11%)
Query: 529 VYKGRLLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK- 584
+YKG N +EV ++ + +NE+ + ++ N++++ G ++ +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 585 ---ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL 641
LILEY L L K++ L+++ ++ + +GL L++Y+ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNL 149
Query: 642 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS---IKS 698
+ + L+ ++ KI GL ++ L + V Y S + D +FS IK
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYKMLND-IFSEYTIKD 203
Query: 699 DVFSFGILMLETLSSK 714
D++S G+++ E + K
Sbjct: 204 DIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
+A G+ +L + +HRDL A N+L+ + KI DFGLAR D +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE + L++ SDV+SFGIL+ E +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQ 567
++F + +G G FG V ++ + + + ++ N+ + LK F+ E ++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNK-WEMLKRAETACFREERNVLVNGD 59
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
+ + L ++ L+++Y L + L + RL AR I A+ +L
Sbjct: 60 CQWITTLHYAFQDENYLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYI----AEMVLA 114
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFG-LARMFGGDELQGNTKQIVGTYGYMSP 686
+H + +HRD+K N+LLD + + +++DFG +M +Q + VGT Y+SP
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VGTPDYISP 172
Query: 687 EY--ALD---GLFSIKSDVFSFGILMLETL 711
E A++ G + + D +S G+ M E L
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 16/100 (16%)
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM---------FGG----DELQ 671
L YLH Y I+HRDLK N+L+ + K++DFGL+++ + G D +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
KQ+ GT Y++PE L + D ++ GI++ E L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG-LARMFGGDELQGNTKQIVG 679
+A+ +L + + +HRD+K N+LLDK+ + +++DFG R+ +Q N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 680 TYGYMSPEY--ALD---GLFSIKSDVFSFGILMLETL 711
T Y+SPE A++ G + + D +S G+ M E L
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 2e-06
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIA-----KLQHRNLVRL 574
K+G G FG V+ + QE + S +GLKE + ++I +L+H+N+VR
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 575 LGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQY 631
+ + + + L ++E+ L+ + K + A V I + L Y H
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNL 137
Query: 632 ----SRFRIIHRDLKASNILLD-------------KDMN----PKISDFGLARMFGGDEL 670
+ R++HRDLK NI L ++N KI DFGL++ G +
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG---I 194
Query: 671 QGNTKQIVGTYGYMSPEYALDGLFSI--KSDVFSFGILMLETLSSK 714
+ VGT Y SPE L S KSD+++ G ++ E S K
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 37/97 (38%), Positives = 46/97 (47%), Gaps = 10/97 (10%)
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNTKQIVGTY 681
+ L Y+H + F HRDLK NIL + D KI DFGLAR F V T
Sbjct: 114 RALKYIHTANVF---HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 682 GYMSPEYALDGLFSIKS----DVFSFGILMLETLSSK 714
Y +PE L G F K D++S G + E L+ K
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 29/237 (12%)
Query: 492 KDKSKDSWLPLFS-----LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL 545
K+K+ D++L + + + E++ + +G G FG V R + ++V A+K L
Sbjct: 17 KNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL 76
Query: 546 SN-----QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL 600
S +S F E ++A +V+L + +++EYMP L +
Sbjct: 77 SKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 134
Query: 601 --FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 658
+D +K + A V +L L IHRD+K N+LLDK + K++D
Sbjct: 135 SNYDVPEKWARFYTAEV---------VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLAD 185
Query: 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEY----ALDGLFSIKSDVFSFGILMLETL 711
FG + + VGT Y+SPE DG + + D +S G+ + E L
Sbjct: 186 FGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 36/138 (26%), Positives = 67/138 (48%), Gaps = 24/138 (17%)
Query: 586 LILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 639
L++EY P L L FD + +A+ +L +H + +HR
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----------LAELVLAIHSVHQMGYVHR 126
Query: 640 DLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY--ALDG----L 693
D+K N+L+D+ + K++DFG A +++ N+K VGT Y++PE ++G
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 694 FSIKSDVFSFGILMLETL 711
+ ++ D +S G++ E +
Sbjct: 186 YGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQ 567
E+F + +G G FG V +L N +V ++ N+ + LK F+ E ++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK-WEMLKRAETACFREERDVLVNGD 59
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
++ + L ++ L+++Y L + L + RL AR + A+ ++
Sbjct: 60 NQWITTLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYL----AEMVIA 114
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFG-LARMFGGDELQGNTKQIVGTYGYMSP 686
+ + +HRD+K NIL+D + + +++DFG ++ +Q + VGT Y+SP
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISP 172
Query: 687 EY--ALD---GLFSIKSDVFSFGILMLETL 711
E A++ G + + D +S G+ M E L
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 38/151 (25%), Positives = 68/151 (45%), Gaps = 8/151 (5%)
Query: 559 EMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 618
E ++ + H ++++L G LIL P +++ + + K+ + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDI-LAIE 188
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 678
+ + + YLH+ RIIHRD+KA NI ++ + + DFG A F D
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
GT +PE + D++S GI++ E
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFE 275
|
Length = 391 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 60/263 (22%), Positives = 98/263 (37%), Gaps = 85/263 (32%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH 568
E+F +G+G FG V RL+ G+ A+K L K+EM +L H
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTL----------LKSEMFKKDQLAH 47
Query: 569 ----RNL---------VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV 615
R++ V L + LI+E++P L L + +
Sbjct: 48 VKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFS 99
Query: 616 RIIEG--IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA----------- 662
+ +A+ +L + + IHRD+K NIL+D+ + K+SDFGL+
Sbjct: 100 EDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159
Query: 663 --RMFGGDELQ------------------GNTKQI--------------VGTYGYMSPEY 688
++ G + + QI VGT Y++PE
Sbjct: 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI 219
Query: 689 ALDGLFSIKSDVFSFGILMLETL 711
L + + D +S G +M E L
Sbjct: 220 FLQQGYGQECDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 60/225 (26%), Positives = 90/225 (40%), Gaps = 39/225 (17%)
Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN---EMMLIAKLQHRNLVRLL 575
LG+G G V+ RL G+ A+K L + + K E ++A L H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
+ L+++Y P L L K L AR E + L YLH
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLLG--- 123
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARM---------------------------FGGD 668
I++RDLK NILL + + +SDF L++ +
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 669 ELQGNTKQIVGTYGYMSPEY-ALDG-LFSIKSDVFSFGILMLETL 711
E + VGT Y++PE + DG ++ D ++ GIL+ E L
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 15/122 (12%)
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLL 626
+ N ++L +LI++Y+ + L FD KK L+ +II + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
LH++ IIH D+K N+L D+ + + D+GL ++ G GT Y S
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFS 174
Query: 686 PE 687
PE
Sbjct: 175 PE 176
|
Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 32/167 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
E F + + G FG VY GR N + AVK + + N+ M+ R+
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKK------ADMINKNMVHQVQAERDA 57
Query: 572 VRL--------LGCCVEQGEKI-LILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRI 617
+ L L ++ + L++EY+ + L FD + V+
Sbjct: 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE--------EMAVKY 109
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664
I +A L YLH++ IIHRDLK N+L+ + + K++DFGL+++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 47/160 (29%), Positives = 67/160 (41%), Gaps = 40/160 (25%)
Query: 521 LGEGGFGPVYKGRL----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH----RNL- 571
+G G FG V RL G A+K+L K+EM+ ++ H R++
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHIYAMKKLR----------KSEMLEKEQVAHVRAERDIL 55
Query: 572 --------VRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 621
V+L Q E LI+EY+P + L K + R I E I
Sbjct: 56 AEADNPWVVKLY--YSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETI 111
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661
L + + IHRD+K N+LLD + K+SDFGL
Sbjct: 112 ----LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIAKLQHRNLV 572
+G G FG V R ++ + A+K L NQ+ K E ++A+ + +V
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAH----VKAERDILAEADNEWVV 64
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+L ++ +++Y+P + L ++ L AR I E + + +H
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL----ARFYIAE-LTCAIESVH- 118
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665
+ IHRD+K NIL+D+D + K++DFGL F
Sbjct: 119 --KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 40/159 (25%), Positives = 65/159 (40%), Gaps = 39/159 (24%)
Query: 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645
LI+E++P + L KK L + I A+ +L + + IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLLM---KKDTLTEEETQFYI---AETVLAIDSIHQLGFIHRDIKPDN 131
Query: 646 ILLDKDMNPKISDFGLARMF-----------------------------GGDELQGNTKQ 676
+LLD + K+SDFGL + + N +Q
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 677 I----VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
+ VGT Y++PE + ++ D +S G++M E L
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 517 MQCKLGEG--GFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
+Q ++G G VY R G V V+ L N + + LK +NE++L +H N+
Sbjct: 2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI 61
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGLLYLHQ 630
+ +I +M S N L + + +A + I+ G +GL YLHQ
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMS--EALIGNILFGALRGLNYLHQ 119
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL-----QGNTKQIVGTY---- 681
IHR++KAS+IL IS GL + G L G ++V +
Sbjct: 120 NG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFS 168
Query: 682 ----GYMSPEYALDGL--FSIKSDVFSFGILMLE 709
++SPE L +++KSD++S GI E
Sbjct: 169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACE 202
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 39/159 (24%)
Query: 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645
LI+E++P + L KK L+ +A I + +HQ IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDN 131
Query: 646 ILLDKDMNPKISDFGLARMF-----------------------------GGDELQGNTKQ 676
+LLD + K+SDFGL + + N +Q
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 677 I----VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
+ VGT Y++PE + ++ D +S G++M E L
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 56/242 (23%), Positives = 96/242 (39%), Gaps = 59/242 (24%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
LG G FG V ++ + A+K L + + + K E ++A+ + +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 577 CCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
++ +++Y+P + L + + L + IA+ L + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFY--------IAELTLAIESVHKM 120
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFG---------------------------- 666
IHRD+K NIL+D D + K++DFGL F
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 667 -----GDEL----QGNTKQ--------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
GD L Q TKQ +VGT Y++PE L ++ D +S G+++ E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 710 TL 711
L
Sbjct: 241 ML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 52/240 (21%), Positives = 96/240 (40%), Gaps = 55/240 (22%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLG 576
LG G FG V R ++ + + A+K L + + K E ++A+ + +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
++ +++Y+P + L R+ + + IA+ + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI-----RMGIFPEDLARFY-IAELTCAVESVHKMGF 122
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMF----------GGDELQGNT------------ 674
IHRD+K NIL+D+D + K++DFGL F GD ++ ++
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 675 -----------------------KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
+VGT Y++PE L ++ D +S G+++ E L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 40/156 (25%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 621
L++++ H +L + G CV E I++ E++ + L+V L + + W ++ + + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDK-----DMNP--KISDFGLARMFGGDELQGNT 674
A L YL + ++H ++ A NILL + +P K+SD G++ F +
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERV 181
Query: 675 KQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLE 709
++I +++PE G S +D +SFG +LE
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 14/157 (8%)
Query: 558 NEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRI 617
+E L+ +L H ++ LL V G L+L P +++ + + R L
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVL---PKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 618 IEGIAQGLL----YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673
+ +A+ LL Y+H IIHRD+K N+L++ + + DFG A G
Sbjct: 262 VTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 710
I GT +PE ++ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|185490 PTZ00163, PTZ00163, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 26/83 (31%), Positives = 38/83 (45%), Gaps = 10/83 (12%)
Query: 111 TNVSSEVKNPVAQLRD-------DGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLG 163
T++ S KNP + R D V DN+ N E+++ S D P D L+ D
Sbjct: 62 TSIFSGNKNPQKRERKNEEENQKDNTKVDNDNNMENEMENHIDDSIDDPMDDLMNDK--- 118
Query: 164 WDFKNRLERYLSSWRSADDPSPG 186
W+ N LE + + + DPS G
Sbjct: 119 WEHHNSLEDRIKEYYTLTDPSDG 141
|
Length = 230 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 31/88 (35%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 521 LGEGGFGPVYK------GRLLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKL-QHRNLV 572
LG G FG V + G+ N VAVK L + +E +E+ +++ L QH+N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFL 600
LLG C G ++I EY L FL
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 29/161 (18%)
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 621
++ ++ H+++V L G CV E I++ E++ L++F+ + W+ +V + +
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKV--AKQL 114
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILL-----DKDMNP--KISDFG-----LARMFGGDE 669
A L YL ++H ++ NILL D + P K+SD G L+R
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------ 165
Query: 670 LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLE 709
++ V +++PE D SI +D +SFG + E
Sbjct: 166 -----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWE 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 724 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.98 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.98 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.98 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.98 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.98 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.98 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.98 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.98 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.98 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.7 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.52 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.44 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.88 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.74 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.66 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.56 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.52 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.41 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.4 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.33 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.3 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.25 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.25 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.18 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.09 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.08 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.0 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.0 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.98 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.96 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.96 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.9 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.86 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.84 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.84 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.82 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.67 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.66 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.47 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.37 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.35 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.13 | |
| PLN02236 | 344 | choline kinase | 97.1 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.06 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.01 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.01 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.91 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.9 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.88 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.46 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.42 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.35 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.32 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.15 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.15 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=388.08 Aligned_cols=219 Identities=48% Similarity=0.815 Sum_probs=196.0
Q ss_pred CCCccchhhHHHhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEE
Q 004912 499 WLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578 (724)
Q Consensus 499 ~~~~~~~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~ 578 (724)
....|++.++..+|++|...+.||+|+||.||+|.+.+++.||||++.....+..++|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46679999999999999999999999999999999999999999998765543156699999999999999999999999
Q ss_pred EecC-eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEE
Q 004912 579 VEQG-EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 657 (724)
Q Consensus 579 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 657 (724)
.+.+ +.+||||||++|+|.++|+..... .|+|..+++|+.++|+||+|||+....+||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875544 89999999999999999999999888889999999999999999999999
Q ss_pred ecCCccccCCCccccccccc-ccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 658 DFGLARMFGGDELQGNTKQI-VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+..
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 99999765321 1111222 8999999999999999999999999999999999999988754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.63 Aligned_cols=202 Identities=30% Similarity=0.530 Sum_probs=182.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
..+|++.+.||+|+||+||+|++. ++.+||||.+... ..+..+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888889999999999999885 4789999999765 5666778899999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC------CCEEEEecCCc
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD------MNPKISDFGLA 662 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~------~~~kL~DFGla 662 (724)
||+.+|+|..+++. .+.+++..+..++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999954 346999999999999999999999998 9999999999999765 46899999999
Q ss_pred cccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
+.+.... ...+.+|++-|||||++...+|+.|+|+||+|+||||+++|+.||...+.
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 9986443 34568999999999999999999999999999999999999999986553
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=343.55 Aligned_cols=204 Identities=29% Similarity=0.435 Sum_probs=183.4
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
..++|++.++||+|+||+||.++.. .++.+|+|++++.. ....+...+|..||.+++||+||+++-.+++.+..||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3578999999999999999999775 47899999997653 2356778999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
|+||+.||.|..+| ++++.+++..+.-++.+|+.||.|||+++ ||||||||+|||||++|+++|+|||+++.--
T Consensus 103 Vld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999999 45667999999999999999999999999 9999999999999999999999999998642
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
.. ...+.+.+||+.|||||++.+..|+..+|.||||+++|||++|.+||...+.
T Consensus 177 ~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~ 230 (357)
T KOG0598|consen 177 KD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV 230 (357)
T ss_pred cC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH
Confidence 22 2345568999999999999999999999999999999999999999987763
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=352.30 Aligned_cols=204 Identities=38% Similarity=0.611 Sum_probs=177.8
Q ss_pred cCcceeeeeccCCceeEEeeeecCCceeEEEeccccCh--hhHHHHHHHHHHHHHccCCceeeEeeEEEecC-eEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-EKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~-~~~lV~E 589 (724)
+.+.+.+.||+|+||+||+|.......||||++..... ...++|.+|+.+|.+++|||||+++|+|.+.. ..++|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 34455567999999999999986555599999976532 22669999999999999999999999999888 7999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC-CEEEEecCCccccCCC
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGGD 668 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~~~~~ 668 (724)
||++|+|..+++.. .+..+++..+++|+.|||+||.|||++++ ||||||||+||||+.+. ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999999764 46679999999999999999999999874 99999999999999997 9999999999876432
Q ss_pred cccccccccccccCccCccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYAL--DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. ...+...||+.|||||++. ..+|+.|+|||||||+||||+||+.||...+
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~ 250 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA 250 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence 1 2233478999999999999 6699999999999999999999999998654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=350.84 Aligned_cols=202 Identities=30% Similarity=0.464 Sum_probs=185.9
Q ss_pred cCcceeeeeccCCceeEEeeee-cCCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
..|+..+.||+|+|+.||+++. ..|..||+|++.+. .....+...+|++|.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999988 77999999999763 4556788999999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
|++++++|.+++. +.+.+++.+++.++.||+.||.|||+++ |||||||..|+||+++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999983 5667999999999999999999999998 999999999999999999999999999988654
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
. .+..+.+|||.|+|||++....++..+||||+|||||-||.|++||+..++
T Consensus 172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v 223 (592)
T KOG0575|consen 172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV 223 (592)
T ss_pred c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH
Confidence 3 234568999999999999999999999999999999999999999997754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=333.60 Aligned_cols=202 Identities=28% Similarity=0.429 Sum_probs=174.7
Q ss_pred hccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChh-------hHHHHHHHHHHHHHccCCceeeEeeEEEecC
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ-------GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 582 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~-------~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~ 582 (724)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||+++++... ......+|+++|++|+|||||++++++.+.+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 356788999999999999999965 46999999999764221 1233579999999999999999999999999
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC---CCEEEEec
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDF 659 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~DF 659 (724)
..|||||||+||+|.+++. ..+.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999984 3445777777889999999999999999 9999999999999766 77999999
Q ss_pred CCccccCCCcccccccccccccCccCcccccCCCC---CchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF---SIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
|+|+..+. ...+.+.|||+.|.|||++..+.+ ..|+|+||+|||||-+|+|-+||+...
T Consensus 324 GlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 324 GLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred chhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 99998753 335677899999999999987653 458899999999999999999998654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=327.68 Aligned_cols=197 Identities=30% Similarity=0.422 Sum_probs=177.3
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC-eEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-EKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~-~~~lV~Ey 590 (724)
+++..+.||+|.-|+|||++++ +++.+|+|.+... ++...+++.+|++++.+.+||+||.++|.|.... +..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4556689999999999999986 5788999999543 4556789999999999999999999999999998 59999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|.+|+|+.++... +.+++..+.+|+.+|++||.|||+ ++ ||||||||+||||+..|++||+|||.++.+.+.
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999998433 569999999999999999999996 54 999999999999999999999999999887443
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.||...
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 446689999999999999999999999999999999999999999764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=314.03 Aligned_cols=199 Identities=30% Similarity=0.421 Sum_probs=181.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh---hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
-++|+..+.||.|+||.|.+++.+ +|.-+|+|++++..- .+.+...+|..+|+.+.||+++++.+.+.+.+..+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 467889999999999999999876 477899999987543 3455678999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||++||.|..+|+ +.+.++++.+..++.||+.||+|||+.+ |++|||||+|||||++|.+||+|||+|+....
T Consensus 123 meyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999994 3455999999999999999999999998 99999999999999999999999999998643
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.+.+.||||.|+|||.+..+.|..++|.|||||++|||+.|..||..++
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 3667899999999999999999999999999999999999999998765
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=358.11 Aligned_cols=208 Identities=34% Similarity=0.516 Sum_probs=184.2
Q ss_pred hccCcceeeeeccCCceeEEeeeecC------CceeEEEeccccChh-hHHHHHHHHHHHHHccCCceeeEeeEEEecCe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~-~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~ 583 (724)
...+.+..+.||+|+||+||+|+... ...||||.++..... ..++|++|+++|+.++|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 34566778999999999999997542 457999999887655 78899999999999999999999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC
Q 004912 584 KILILEYMPNKSLNVFLFDST-------K----KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 652 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 652 (724)
.+||+|||..|+|.+||.... . ..+|+..+.+.|+.|||.||+||-++. +|||||.++|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 999999999999999996321 1 334899999999999999999999987 99999999999999999
Q ss_pred CEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 653 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 653 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.|||+||||++.+...++.+......-+.+|||||.++.++||.++|||||||+|||++| |+.||..-+
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS 710 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence 999999999999877776665545566889999999999999999999999999999999 999985433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=339.43 Aligned_cols=205 Identities=38% Similarity=0.563 Sum_probs=181.4
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
..+.+.+.+.||+|.||.|+.|.+.....||||.++... ...+.|.+|+++|.+|+|+|||+++++|..++..+|||||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 344566778999999999999999888899999997653 3457899999999999999999999999998899999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
|+.|+|.++|.. ..+..+...+++.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+....+.+
T Consensus 283 m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 999999999966 34556899999999999999999999998 99999999999999999999999999997665554
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.. .....-+..|.|||.+....|+.|+|||||||+||||+| |+.||+.-+
T Consensus 359 ~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms 409 (468)
T KOG0197|consen 359 TA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS 409 (468)
T ss_pred ee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC
Confidence 33 233445789999999999999999999999999999999 999987544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=316.56 Aligned_cols=207 Identities=28% Similarity=0.448 Sum_probs=180.3
Q ss_pred cCcceeeeeccCCceeEEeeee-cCCceeEEEeccc--cChhhHHHHHHHHHHHHHccCCceeeEee-EEEecCe-EEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLG-CCVEQGE-KILI 587 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~--~~~~~~~~f~~E~~il~~l~Hpniv~l~~-~~~~~~~-~~lV 587 (724)
.+|++.++||+|.||.|||+.. .+|..+|.|.++- .+.+..+.+..|+.+|++|+|||||++++ -+.++.+ .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4688999999999999999964 6899999998863 34566788999999999999999999998 4445555 7899
Q ss_pred EEeeCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 588 LEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYS-RFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~-~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
|||+..|+|..++...+ .++.++++.+++++.|+++||.++|.+- +..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999986533 3567999999999999999999999832 224999999999999999999999999999998
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.... ......+|||.||+||.+.+..|+.|+||||+||++|||..-+.||..++
T Consensus 179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN 232 (375)
T ss_pred cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc
Confidence 6543 23456799999999999999999999999999999999999999998764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=329.35 Aligned_cols=206 Identities=30% Similarity=0.436 Sum_probs=181.4
Q ss_pred HhccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~ 584 (724)
....+|..++.||+|+|++|++|+.. .++++|||++.+. .+.-.+-...|-.+|.+| .||.|++|+-.|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34568999999999999999999764 5889999999753 223344567888999999 899999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
|+|+||+++|+|.++|. +.+.+++.....++.||+.||+|||+.| ||||||||+|||||+++++||+|||.|+.
T Consensus 150 YFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999995 4466999999999999999999999999 99999999999999999999999999999
Q ss_pred cCCCccc---------cc--ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 665 FGGDELQ---------GN--TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 665 ~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.+.... .. ...++||..|.+||++.....+..+|+|+||||||+|+.|++||...+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 8643211 11 245899999999999999999999999999999999999999998765
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=307.61 Aligned_cols=201 Identities=26% Similarity=0.372 Sum_probs=176.3
Q ss_pred cCcceeeeeccCCceeEEeeeecC-CceeEEEeccccCh--hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
+.|+...++|+|+||.|||+++++ |+.||||++....+ ...+-.++|+++|++++|||+|.|+.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 467788899999999999999865 89999999976543 234556899999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|++..-|+++-. ....++.+.+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+...
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 999888877652 3345889999999999999999999998 999999999999999999999999999998632
Q ss_pred ccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
....+..+.|..|.|||.+.+ ..|...+||||+||++.||++|++-|...|
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S 206 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS 206 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc
Confidence 223456788999999999988 679999999999999999999999986544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=320.70 Aligned_cols=203 Identities=29% Similarity=0.417 Sum_probs=175.8
Q ss_pred hccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 585 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~~ 585 (724)
..+.|+.+++||+|.||+||||+. .+|+.||+|++.-.. +....-..+||.||++|+||||++|.+...+. ...|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 356788899999999999999976 568999999986543 44456668999999999999999999998877 6899
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
||+|||++ +|.-++... .-.+++.++..++.|++.||+|+|.++ |+|||||..|||||.+|.+||+|||||+++
T Consensus 195 lVFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 99999976 677776432 234999999999999999999999999 999999999999999999999999999988
Q ss_pred CCCcccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
...... ..+..+-|..|.|||.+.+. .|+.++|+||.||||.||+.|++.|...
T Consensus 269 ~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~ 323 (560)
T KOG0600|consen 269 TPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR 323 (560)
T ss_pred cCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc
Confidence 665433 35566789999999999886 5999999999999999999999998654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=320.50 Aligned_cols=207 Identities=26% Similarity=0.372 Sum_probs=181.5
Q ss_pred HhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
...++|+++++||+|+||.||+++-+ .|..+|+|++++.. ..+.+..+.|-.+|....+|.||+|+-.|++.+..|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35688999999999999999999765 58899999998753 345667889999999999999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
|||||+|||++-.+| .+...|++..+..++.+++-|++.||+.| +|||||||+|+|||..|++||+||||+.-+
T Consensus 218 LiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999999 46678999999999999999999999999 999999999999999999999999998543
Q ss_pred CC----------------------Ccccc-----------------------cccccccccCccCcccccCCCCCchhhH
Q 004912 666 GG----------------------DELQG-----------------------NTKQIVGTYGYMSPEYALDGLFSIKSDV 700 (724)
Q Consensus 666 ~~----------------------~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DV 700 (724)
.. .+... .....+|||.|||||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 01110 0112489999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCC
Q 004912 701 FSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 701 wSlGvil~elltG~~p~~~~~~ 722 (724)
||||||+||||.|-+||..++.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp 393 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETP 393 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999987763
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=328.56 Aligned_cols=206 Identities=25% Similarity=0.393 Sum_probs=183.0
Q ss_pred HHhccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccC---hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCe
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGE 583 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~ 583 (724)
...-++|.+.++||+|+||+|+++..+. ++.+|||.+++.. .+..+..+.|.+|+... +||.|++|+.+++..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3445789999999999999999998864 6789999998753 45677888999999888 49999999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.+.||||+.||++..+ .....+++..+..++..|+.||.|||+++ ||+||||.+|||||.+|++||+||||++
T Consensus 444 l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999995433 34456999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSME 723 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~~e 723 (724)
.--. ....+++.+|||.|||||++.+..|+.++|.|||||+|||||.|+.||..++.|
T Consensus 517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe 574 (694)
T KOG0694|consen 517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE 574 (694)
T ss_pred ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 7432 233677899999999999999999999999999999999999999999988764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.83 Aligned_cols=207 Identities=31% Similarity=0.477 Sum_probs=183.1
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChh-hHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
..+...++++||+|.||.|.+++...+..||||+++..... ...+|.+|+++|.+++||||++|+|+|..++..++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 34567788999999999999999977899999999876544 45899999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
||++|+|.+|+..+.... +......+|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||+++.+...+
T Consensus 616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999997654332 455667789999999999999998 9999999999999999999999999999876666
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt--G~~p~~~~~ 721 (724)
+.......+-+.+|||||.+..++++.++|||+||+.|||+++ .++||+.-+
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt 745 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT 745 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence 6555555667899999999999999999999999999999876 888987544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=322.02 Aligned_cols=203 Identities=27% Similarity=0.446 Sum_probs=179.5
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc----Ch-hhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ----SG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGE 583 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~----~~-~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~ 583 (724)
...+|.+.+.||+|+||.|++|.+. ++..||||++.+. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568999999999999999999764 5799999977553 12 23556778999999999 9999999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC-CCEEEEecCCc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLA 662 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DFGla 662 (724)
.++||||+.+|+|.+++.. .+.+.+.++.+++.|++.|++|+|+++ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999954 456889999999999999999999999 9999999999999999 99999999999
Q ss_pred cccCCCcccccccccccccCccCcccccCCC-CC-chhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGL-FS-IKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 9873 1223456789999999999999988 86 78999999999999999999998754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=321.41 Aligned_cols=200 Identities=32% Similarity=0.466 Sum_probs=179.7
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+. .++..+.+.+|++|+++++||||+.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778889999999999999765 5788999998653 45567889999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+.+ +|..+|.. .+.++++.+..|+.++..||.|||+.+ |+|||+||+|||++.++.+|++|||+|+.+..+.
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 99999954 345999999999999999999999998 9999999999999999999999999999876532
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
...+.+.|||-|||||+..+.+|+..+|.||+||||||+.+|++||-..+
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s 204 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS 204 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH
Confidence 23456789999999999999999999999999999999999999996544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=338.25 Aligned_cols=200 Identities=32% Similarity=0.522 Sum_probs=176.9
Q ss_pred ccCcceeeeeccCCceeEEeeeecC----CceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.....+.++||.|.||.|++|+++- ...||||.|+.. .++...+|+.|+.||.+++||||++|.|+.......++
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 3456778999999999999998853 347999999875 55678899999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
|.|||++|+|+.||... .+.+++.++.-++++||.||.||.+.+ +|||||.++||||+.+..+|++|||+++.+.
T Consensus 708 iTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999999653 456999999999999999999999998 9999999999999999999999999999885
Q ss_pred CCcccccccccc--cccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 004912 667 GDELQGNTKQIV--GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNT 717 (724)
Q Consensus 667 ~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~ 717 (724)
++. ....+... -+.+|.|||.+...++|.++|||||||+|||.++ |++||
T Consensus 783 dd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 783 DDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred cCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 543 22222222 2679999999999999999999999999999998 99998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.25 Aligned_cols=201 Identities=28% Similarity=0.429 Sum_probs=180.8
Q ss_pred cCcceeeeeccCCceeEEeeee-cCCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
.-|++++.||.|+.|.|-.|++ .+|+.+|||++.+.. ......+.+|+.||+.+.|||++++++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3578899999999999999987 469999999997652 233466889999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|.|.+++ .+++.+++.+.++++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||||.+--+
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~- 164 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP- 164 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence 999999999998 45677999999999999999999999998 99999999999999999999999999987432
Q ss_pred cccccccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
.....+.||++.|.|||++.+.+| ..++||||.|||||.||+|+.||+.+++
T Consensus 165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi 217 (786)
T KOG0588|consen 165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI 217 (786)
T ss_pred --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH
Confidence 234566799999999999999998 5789999999999999999999997764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.46 Aligned_cols=210 Identities=33% Similarity=0.532 Sum_probs=181.6
Q ss_pred hhHHHhccCcceeeeeccCCceeEEeeeecCCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe
Q 004912 506 ASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (724)
Q Consensus 506 ~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~ 583 (724)
.+.....+.+.+.+.||+|.||+||+|++. ..||||.+.-. +++..+.|++|+..+++.+|.||+-+.|+|..++.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 444555667788899999999999999884 36999999654 45678999999999999999999999999998877
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.+|..++++-+|+.+|+... ..++..+.+.|+.|||+||.|||.++ |||||||..||+|.+++.|||.|||++.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 99999999999999997544 45888999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCcccccccccccccCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGLGSME 723 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltG~~p~~~~~~e 723 (724)
.-....-..+.....|..-|||||++.. .+|+..+||||||+++|||++|..||+....|
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d 599 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD 599 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh
Confidence 6543333334455678899999999864 56999999999999999999999999976655
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=310.22 Aligned_cols=198 Identities=33% Similarity=0.543 Sum_probs=169.7
Q ss_pred cCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHc--cCCceeeEeeEEEecC----eEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL--QHRNLVRLLGCCVEQG----EKIL 586 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l--~Hpniv~l~~~~~~~~----~~~l 586 (724)
+..++.++||+|.||.||||.+ +++.||||++.. +..+.|++|-.|.+.. +|+||++++++-...+ +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 4456678999999999999999 458999999964 4567788888887764 8999999999876555 8899
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh------cCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ------YSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~------~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
|+||.+.|+|.++| +...++|.+..+|+..|++||+|||+ +.+++|+|||||.+||||.+++++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999 45569999999999999999999996 345689999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCcccccCCC-CC-----chhhHHHHHHHHHHHHcCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGL-FS-----IKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~k~DVwSlGvil~elltG~~p~~ 718 (724)
+|..+............+||.+|||||++.+.. +. .+.||||+|.|||||++...-+.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~ 425 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD 425 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 999987665555566689999999999997754 22 36899999999999999876654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=343.00 Aligned_cols=207 Identities=36% Similarity=0.588 Sum_probs=182.4
Q ss_pred ccCcceeeeeccCCceeEEeeeecC--Cc----eeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN--GQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~--g~----~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~ 584 (724)
.++.++.+.||+|+||.||+|...+ +. .||||.+++. +.+...+|.+|+.+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4566788999999999999997643 43 4899999775 556788999999999999999999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 585 ILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
++++|||++|+|..||.+... ...|+..+++.++.|||+|+.||+++. +|||||.++|+||++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999976421 345899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
||+.+...++........-+..|||||.+.+..|+.|+|||||||+|||++| |..||..-+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~ 909 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS 909 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc
Confidence 9997766655554444455679999999999999999999999999999999 999997543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=310.46 Aligned_cols=203 Identities=31% Similarity=0.465 Sum_probs=173.6
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC--eEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EKILIL 588 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~--~~~lV~ 588 (724)
..++...+.||+|+||.||++...+ |...|||..........+.+.+|+.+|.+++|||||+.+|...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3457778999999999999998765 8899999987654334778999999999999999999999855444 588999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-CCCEEEEecCCccccCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGG 667 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~ 667 (724)
||+++|+|.+++..... .+++..+.++++||++||+|||+++ ||||||||+||||+. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999965432 5999999999999999999999998 999999999999999 79999999999988753
Q ss_pred -CcccccccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 668 -DELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 668 -~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
...........||+.|||||++..+. ...++|||||||++.||+||++||..
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 12222344578999999999999643 33599999999999999999999974
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=286.86 Aligned_cols=201 Identities=31% Similarity=0.463 Sum_probs=174.1
Q ss_pred cCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChh--hHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~--~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++|...++||+|.||.||+|++ ..|+.||||+++..... ......+|++.|+.++|+||+.+++++-..+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677889999999999999976 46899999999765322 23456899999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
||+ .+|...+.+ +...++..++..++.++++|++|||.+. |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 488888854 3456999999999999999999999998 9999999999999999999999999999987644
Q ss_pred ccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.. .+..+-|..|.|||.+.+. .|+..+||||.|||+.||+-|.+-|..++
T Consensus 156 ~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s 206 (318)
T KOG0659|consen 156 RI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS 206 (318)
T ss_pred cc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc
Confidence 22 2233779999999999885 58999999999999999999998885443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=319.22 Aligned_cols=202 Identities=30% Similarity=0.456 Sum_probs=181.4
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
...|...++||+|+.|.||.++. ..++.||||++........+-+.+|+.+|+..+|+|||++++.+...++.++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 34566678999999999999965 46889999999776655567789999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
|++|+|.+.+ ....+++.++..|.+++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+.....
T Consensus 352 m~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999988 3445999999999999999999999999 99999999999999999999999999988865443
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
.....+||+.|||||++..+.|..|+||||||++++||+-|++||=.++.
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P 474 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP 474 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh
Confidence 45668999999999999999999999999999999999999999976543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=319.58 Aligned_cols=203 Identities=25% Similarity=0.351 Sum_probs=175.9
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|+||.||+++.. +++.||||+++... ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999775 47899999996532 234567889999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999853 346899999999999999999999998 999999999999999999999999999765321
Q ss_pred cc---------------------------------cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 004912 669 EL---------------------------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715 (724)
Q Consensus 669 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~ 715 (724)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 000123579999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 004912 716 NTGLGS 721 (724)
Q Consensus 716 p~~~~~ 721 (724)
||...+
T Consensus 235 Pf~~~~ 240 (363)
T cd05628 235 PFCSET 240 (363)
T ss_pred CCCCCC
Confidence 997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=312.76 Aligned_cols=207 Identities=30% Similarity=0.435 Sum_probs=173.2
Q ss_pred hccCcceeeeeccCCceeEEeeee------cCCceeEEEeccccC-hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecC
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 582 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~ 582 (724)
..++|++.++||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 356899999999999999999964 235689999997543 33456799999999999 8999999999887654
Q ss_pred -eEEEEEEeeCCCChhHHHhhcCC--------------------------------------------------------
Q 004912 583 -EKILILEYMPNKSLNVFLFDSTK-------------------------------------------------------- 605 (724)
Q Consensus 583 -~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 605 (724)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999864211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccC
Q 004912 606 ---KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682 (724)
Q Consensus 606 ---~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~ 682 (724)
...+++.++.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.............+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134788899999999999999999998 99999999999999999999999999987643322222233456789
Q ss_pred ccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 683 y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
|+|||++.+..++.++||||||++||||++ |+.||...
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=310.10 Aligned_cols=200 Identities=30% Similarity=0.431 Sum_probs=175.3
Q ss_pred hccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHH--HHHHHHHHHHcc-CCceeeEeeEEEecC-eEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKE--FKNEMMLIAKLQ-HRNLVRLLGCCVEQG-EKI 585 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~--f~~E~~il~~l~-Hpniv~l~~~~~~~~-~~~ 585 (724)
..++|.+.++||.|.||.||+|+. ..+..||||++++.-.. .++ =++|++.|++|+ ||||++|.+++.+.+ ..+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 356899999999999999999975 45889999999875432 333 368999999998 999999999999988 899
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+|||||+. +|.+++.++ +..+++.++..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+|+.+
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999954 788888654 678999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
... ...+..+.|+.|.|||++.. ..|+.+.|+||+|||++|+.+-++.|..-
T Consensus 161 ~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~ 213 (538)
T KOG0661|consen 161 RSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA 213 (538)
T ss_pred ccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC
Confidence 543 34567889999999999865 56899999999999999999999988543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.56 Aligned_cols=204 Identities=27% Similarity=0.393 Sum_probs=177.7
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.+.|++.++||.|..++||+|+. +.+..||||++.-.. ....+.+.+|+..|..++||||++++..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 57899999999999999999975 567899999996543 2347899999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC-
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD- 668 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~- 668 (724)
||.+|++.+++...-. ..+++..+..|++++++||.|||++| .||||||+.||||+.+|.+||+|||.+..+...
T Consensus 105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999976443 34999999999999999999999999 999999999999999999999999987655332
Q ss_pred cccc-cccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 669 ELQG-NTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 669 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.... ......||+.|||||+++. ..|+.|+||||||+...||.+|..||.-
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k 234 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK 234 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence 1111 2266799999999999544 3589999999999999999999999964
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.72 Aligned_cols=202 Identities=24% Similarity=0.444 Sum_probs=183.2
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+++. +++..-.+.+|++||..|+||||+.++.+|...+..++|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45789999999999999999965 67999999999764 455667789999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||..+|.|.+++ ...+.|++.+...+++||..|+.|+|.++ ++|||||.+|||||+++++||+|||++.++..
T Consensus 132 MEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999 45567999999999999999999999987 99999999999999999999999999988754
Q ss_pred CcccccccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
. ....+++|++-|.+||.+.+.+| .+.+|-|||||+||-|+.|.-||+.-+.
T Consensus 206 ~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh 258 (668)
T KOG0611|consen 206 K---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH 258 (668)
T ss_pred c---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH
Confidence 3 34667899999999999999998 5789999999999999999999986553
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=283.68 Aligned_cols=203 Identities=31% Similarity=0.426 Sum_probs=180.9
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.-++|++++.||+|.||.||.|+.+ ++..||+|++.+.. .+...++.+|++|-+.|+||||+++++++.++...||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3578999999999999999999875 46789999986542 2345678999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
++||.+.|+|...|... ....+++.....++.|+|.||.|+|..+ +|||||||+|+|++..+.+||+|||.+..-.
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999642 3445888889999999999999999998 9999999999999999999999999987632
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....+.+||..|++||...+..++.++|+|++|++.||+|.|.+||+..+
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 344567899999999999999999999999999999999999999998655
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=307.01 Aligned_cols=198 Identities=26% Similarity=0.340 Sum_probs=175.3
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999875 58899999986432 234567889999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999853 345889999999999999999999998 999999999999999999999999999875332
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 223578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=317.52 Aligned_cols=202 Identities=24% Similarity=0.352 Sum_probs=173.8
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999764 57899999996532 3345678999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999853 345889999999999999999999998 9999999999999999999999999986432100
Q ss_pred c---------------------------------------------cccccccccccCccCcccccCCCCCchhhHHHHH
Q 004912 670 L---------------------------------------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 704 (724)
Q Consensus 670 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlG 704 (724)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 004912 705 ILMLETLSSKKNTGLGS 721 (724)
Q Consensus 705 vil~elltG~~p~~~~~ 721 (724)
|++|||++|+.||...+
T Consensus 236 ~il~elltG~~Pf~~~~ 252 (381)
T cd05626 236 VILFEMLVGQPPFLAPT 252 (381)
T ss_pred hHHHHHHhCCCCCcCCC
Confidence 99999999999997544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=312.11 Aligned_cols=185 Identities=33% Similarity=0.503 Sum_probs=166.8
Q ss_pred eeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCChh
Q 004912 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN 597 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~ 597 (724)
++-||.|+-|.||+|++ .++.||||+++... ..+++-|++|+||||+.+.|+|.....+++||||++.|.|.
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 46899999999999999 56899999986433 25788999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccccccc
Q 004912 598 VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677 (724)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 677 (724)
+.|. ...+++...+..+..+||.||.|||.+. |||||||.-||||..+..+||+|||-++.+... ...-.+
T Consensus 201 ~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 201 EVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred HHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 9993 4566888999999999999999999987 999999999999999999999999999887543 122347
Q ss_pred ccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 678 ~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
+||..|||||++.+.+.+.|+|||||||||||||||+.||..
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence 899999999999999999999999999999999999999953
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.60 Aligned_cols=198 Identities=25% Similarity=0.407 Sum_probs=176.5
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999876 47899999997542 234567889999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999843 346889999999999999999999998 99999999999999999999999999986532
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 2344679999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.85 Aligned_cols=199 Identities=27% Similarity=0.375 Sum_probs=175.7
Q ss_pred ccCcceeeeeccCCceeEEeeeecC--CceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4679999999999999999997643 358999998643 23345678899999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+.
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999853 345899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||...+
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 22 234579999999999999999999999999999999999999997654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=317.15 Aligned_cols=203 Identities=26% Similarity=0.344 Sum_probs=174.0
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.++||+|+||.||+++.. +++.||||++... .....+.+.+|+.++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999764 5889999998643 2334567899999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999853 345889999999999999999999998 999999999999999999999999999643210
Q ss_pred cc------------cc---------------------------------cccccccccCccCcccccCCCCCchhhHHHH
Q 004912 669 EL------------QG---------------------------------NTKQIVGTYGYMSPEYALDGLFSIKSDVFSF 703 (724)
Q Consensus 669 ~~------------~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSl 703 (724)
.. .. .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 00 0012469999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 004912 704 GILMLETLSSKKNTGLGS 721 (724)
Q Consensus 704 Gvil~elltG~~p~~~~~ 721 (724)
||++|||++|+.||...+
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (377)
T cd05629 235 GAIMFECLIGWPPFCSEN 252 (377)
T ss_pred chhhhhhhcCCCCCCCCC
Confidence 999999999999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.79 Aligned_cols=203 Identities=25% Similarity=0.367 Sum_probs=175.6
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46899999999999999999875 58899999996532 234567889999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999853 345899999999999999999999998 999999999999999999999999999765321
Q ss_pred cccc------------------------------------cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc
Q 004912 669 ELQG------------------------------------NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712 (724)
Q Consensus 669 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt 712 (724)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112469999999999999999999999999999999999
Q ss_pred CCCCCCCCC
Q 004912 713 SKKNTGLGS 721 (724)
Q Consensus 713 G~~p~~~~~ 721 (724)
|+.||...+
T Consensus 235 G~~Pf~~~~ 243 (364)
T cd05599 235 GYPPFCSDN 243 (364)
T ss_pred CCCCCCCCC
Confidence 999997543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.35 Aligned_cols=199 Identities=24% Similarity=0.350 Sum_probs=176.5
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|++.+.||+|+||.||+|+.. +++.||||.++... ....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 467899999999999999999875 57899999986532 23456789999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999853 345888999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 2 223578999999999999999999999999999999999999997544
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.09 Aligned_cols=202 Identities=25% Similarity=0.375 Sum_probs=173.5
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.|++.++||+|+||.||+|+.. +++.+|||++.... ....+.+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999874 57889999986532 2345678999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999853 345888999999999999999999998 9999999999999999999999999986431100
Q ss_pred ---------------------------------------------ccccccccccccCccCcccccCCCCCchhhHHHHH
Q 004912 670 ---------------------------------------------LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 704 (724)
Q Consensus 670 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlG 704 (724)
........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00011234799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 004912 705 ILMLETLSSKKNTGLGS 721 (724)
Q Consensus 705 vil~elltG~~p~~~~~ 721 (724)
|+||||++|+.||...+
T Consensus 236 vil~elltG~~Pf~~~~ 252 (382)
T cd05625 236 VILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.26 Aligned_cols=204 Identities=30% Similarity=0.512 Sum_probs=169.6
Q ss_pred CCCCccchhhHHHhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHH--ccCCceeeEe
Q 004912 498 SWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLL 575 (724)
Q Consensus 498 ~~~~~~~~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~--l~Hpniv~l~ 575 (724)
+.+|.+-...+ .+...+.+.||+|.||.||+|++ .|..||||++...++ +.+.+|.+|... |+|+||+.++
T Consensus 199 SGlplLVQRTi---arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 199 SGLPLLVQRTI---ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred CCchhHhHHhh---hheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhh
Confidence 45666655544 56788999999999999999988 678999999986554 445666666655 5999999999
Q ss_pred eEEEecC----eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCceEeccCCCCCE
Q 004912 576 GCCVEQG----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-----YSRFRIIHRDLKASNI 646 (724)
Q Consensus 576 ~~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-----~~~~~iiH~Dlkp~NI 646 (724)
+.-..+. +.+||.+|.+.|+|.+|| ....++....++++..+|.||++||. +|++.|.|||||++||
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI 347 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 347 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence 9876553 679999999999999999 34679999999999999999999994 6888999999999999
Q ss_pred EEcCCCCEEEEecCCccccCCC--cccccccccccccCccCcccccCCC----CC--chhhHHHHHHHHHHHHc
Q 004912 647 LLDKDMNPKISDFGLARMFGGD--ELQGNTKQIVGTYGYMSPEYALDGL----FS--IKSDVFSFGILMLETLS 712 (724)
Q Consensus 647 Ll~~~~~~kL~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~s--~k~DVwSlGvil~ellt 712 (724)
||..++.+.|+|+|+|...... .........+||.+|||||++.... |. ..+||||||.|+||+..
T Consensus 348 LVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 348 LVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred EEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 9999999999999999877543 3344556679999999999985532 32 35999999999999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=299.14 Aligned_cols=200 Identities=28% Similarity=0.397 Sum_probs=174.2
Q ss_pred CcceeeeeccCCceeEEeeee-cCCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.|+..+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999986 468899999986432 2334568899999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++|+|..++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..+....
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998887543 2345899999999999999999999998 9999999999999999999999999998754322
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 123457899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=287.71 Aligned_cols=204 Identities=28% Similarity=0.385 Sum_probs=174.3
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChh--hHHHHHHHHHHHHHccCCceeeEeeEEEec--CeEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 585 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~~ 585 (724)
..+.|+..+.|++|.||.||+|+++ +++.||+|+++-..+. ---.-.+|+.+|.+++|||||.+-.+.... +..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3467899999999999999999875 5788999999754322 122347899999999999999999887644 5799
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
|||||++. +|..++.... ..+...++.-++.|+++|++|||... |+||||||+|+|+...|.+||+|||+|+.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 99999965 7888885433 56888999999999999999999998 999999999999999999999999999998
Q ss_pred CCCcccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
+.. ....+..+-|..|.|||.+.+. .|+...|+||+|||+.||+++++.|...+.
T Consensus 228 gsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE 283 (419)
T KOG0663|consen 228 GSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE 283 (419)
T ss_pred cCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch
Confidence 654 2345667889999999999886 599999999999999999999999976653
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.27 Aligned_cols=202 Identities=24% Similarity=0.364 Sum_probs=173.6
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
+|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++.+++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6899999999999999999875 47899999986532 2345678899999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999843 345888999999999999999999998 9999999999999999999999999985431100
Q ss_pred -----------------------------------------ccccccccccccCccCcccccCCCCCchhhHHHHHHHHH
Q 004912 670 -----------------------------------------LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708 (724)
Q Consensus 670 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ 708 (724)
.........||+.|||||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000112357999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCC
Q 004912 709 ETLSSKKNTGLGS 721 (724)
Q Consensus 709 elltG~~p~~~~~ 721 (724)
||++|+.||...+
T Consensus 236 ell~G~~Pf~~~~ 248 (376)
T cd05598 236 EMLVGQPPFLADT 248 (376)
T ss_pred ehhhCCCCCCCCC
Confidence 9999999997554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.62 Aligned_cols=205 Identities=24% Similarity=0.309 Sum_probs=176.1
Q ss_pred HHhccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeE
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~ 584 (724)
....++|++.+.||+|+||.||+++.. +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.++...
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999875 4788999998642 223345688999999999999999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999999843 24788999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccCccCcccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+..... .......||+.|||||++.+.. ++.++|||||||+||||++|+.||...+
T Consensus 192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 643221 1223467999999999987643 7889999999999999999999997654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.95 Aligned_cols=195 Identities=27% Similarity=0.333 Sum_probs=170.3
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 594 (724)
+.||+|+||.||+++.. +++.||||+++... ......+.+|+.++.+++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999874 58899999987532 234567889999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccc
Q 004912 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674 (724)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 674 (724)
+|..++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence 99988843 346899999999999999999999998 999999999999999999999999999753221 1223
Q ss_pred cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 675 ~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 34679999999999999999999999999999999999999996544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=305.58 Aligned_cols=195 Identities=26% Similarity=0.337 Sum_probs=169.8
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 594 (724)
+.||+|+||.||+++.. +++.||+|+++.. .......+.+|+.++.+++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999874 5889999998753 2334567789999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccc
Q 004912 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674 (724)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 674 (724)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 99888843 346899999999999999999999998 9999999999999999999999999987542221 122
Q ss_pred cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 675 ~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 34578999999999999999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.50 Aligned_cols=203 Identities=33% Similarity=0.477 Sum_probs=174.1
Q ss_pred hccCcceeeeeccCCceeEEeeeecCC----ce-eEEEeccc---cChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNG----QE-VAVKRLSN---QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 582 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g----~~-vAVK~l~~---~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~ 582 (724)
.-++..+.++||+|+||.||+|++..+ .. ||||..+. ......++|.+|+++|++++|||||+++|++..+.
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 345566679999999999999987532 23 89999875 34667889999999999999999999999999999
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
..++|||++.||+|+++|.... ..++..++++++.+.|.||+|||+++ +|||||.++|+|++.++.+||+|||++
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence 9999999999999999995432 25999999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
+.-. .+........-+..|+|||.+....|+.++|||||||++||+++ |..||..-
T Consensus 310 ~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~ 366 (474)
T KOG0194|consen 310 RAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM 366 (474)
T ss_pred cCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence 7632 11111112235679999999999999999999999999999999 88898643
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=305.27 Aligned_cols=195 Identities=27% Similarity=0.338 Sum_probs=170.3
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 594 (724)
+.||+|+||.||+++.. +++.||||++... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 5889999999753 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccc
Q 004912 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674 (724)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 674 (724)
+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 99888743 345899999999999999999999998 9999999999999999999999999987642211 123
Q ss_pred cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 675 ~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 34579999999999999999999999999999999999999996544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=310.83 Aligned_cols=203 Identities=25% Similarity=0.360 Sum_probs=175.3
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|+||.||+++.. +++.||||+++.. .....+.+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999875 5789999998643 2334567889999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999843 345899999999999999999999998 999999999999999999999999998755321
Q ss_pred cc---------------------------------cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 004912 669 EL---------------------------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715 (724)
Q Consensus 669 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~ 715 (724)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 000123579999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 004912 716 NTGLGS 721 (724)
Q Consensus 716 p~~~~~ 721 (724)
||...+
T Consensus 235 Pf~~~~ 240 (360)
T cd05627 235 PFCSET 240 (360)
T ss_pred CCCCCC
Confidence 997544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=295.52 Aligned_cols=205 Identities=27% Similarity=0.421 Sum_probs=170.9
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh--------------hhHHHHHHHHHHHHHccCCceeeEe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--------------QGLKEFKNEMMLIAKLQHRNLVRLL 575 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--------------~~~~~f~~E~~il~~l~Hpniv~l~ 575 (724)
.-++|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+...+|+.||++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3578999999999999999999874 588999999965321 1246789999999999999999999
Q ss_pred eEEEec--CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC
Q 004912 576 GCCVEQ--GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (724)
Q Consensus 576 ~~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 653 (724)
.+-.+. +..|||+||+..|.+...- .....+++.++.++++++..||+|||.++ ||||||||.|+||+++|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 987654 5789999999998875442 23333899999999999999999999999 999999999999999999
Q ss_pred EEEEecCCccccCCC---cccccccccccccCccCcccccCCC---C-CchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 654 PKISDFGLARMFGGD---ELQGNTKQIVGTYGYMSPEYALDGL---F-SIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 654 ~kL~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~---~-s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+||+|||.+..+... .........+|||.|||||.+.++. + +.+.||||+||.||-|+.|+.||-.+.
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 999999999876221 2223344579999999999998733 3 567899999999999999999997543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.12 Aligned_cols=205 Identities=31% Similarity=0.504 Sum_probs=172.6
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-----------------CceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVR 573 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~ 573 (724)
.++|++.++||+|+||.||++.+.+ +..||+|.+.... .....+|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578899999999999999997532 2369999987643 345678999999999999999999
Q ss_pred EeeEEEecCeEEEEEEeeCCCChhHHHhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceE
Q 004912 574 LLGCCVEQGEKILILEYMPNKSLNVFLFDST----------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 637 (724)
Q Consensus 574 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ii 637 (724)
+++++.+.+..++||||+++++|.+++.... ....+++.++.+++.||+.||+|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999985421 1134788899999999999999999998 99
Q ss_pred eccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc--CCC
Q 004912 638 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKK 715 (724)
Q Consensus 638 H~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt--G~~ 715 (724)
||||||+|||++.++.+||+|||+++.+.............++..|||||++....++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999987644332222333456789999999998999999999999999999987 556
Q ss_pred CCCC
Q 004912 716 NTGL 719 (724)
Q Consensus 716 p~~~ 719 (724)
||..
T Consensus 241 p~~~ 244 (304)
T cd05096 241 PYGE 244 (304)
T ss_pred CCCc
Confidence 7753
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=302.35 Aligned_cols=193 Identities=24% Similarity=0.332 Sum_probs=169.3
Q ss_pred eccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCCh
Q 004912 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (724)
Q Consensus 521 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (724)
||+|+||.||+++.. +++.||+|+++.. .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 4788999998643 234456788999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccc
Q 004912 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676 (724)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 676 (724)
.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 999853 345899999999999999999999998 9999999999999999999999999998643221 12334
Q ss_pred cccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 679999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=315.31 Aligned_cols=205 Identities=20% Similarity=0.255 Sum_probs=178.6
Q ss_pred CcceeeeeccCCceeEEeeeec-C-CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999754 3 5678999876555555677889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 592 PNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 592 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
++|+|.+++... .....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988643 23446899999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~ 275 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 223345679999999999999999999999999999999999999997543
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=309.65 Aligned_cols=207 Identities=24% Similarity=0.304 Sum_probs=177.4
Q ss_pred hHHHhccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC
Q 004912 507 SITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 582 (724)
Q Consensus 507 ~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~ 582 (724)
.+....++|++.+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34455689999999999999999999875 4788999998642 2233456889999999999999999999999999
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
..++||||+++|+|..++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999999843 34788899999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.+..... .......||+.|||||++.... ++.++|||||||++|||++|+.||...+
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 87643221 1223467999999999987543 7899999999999999999999997654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=310.15 Aligned_cols=203 Identities=26% Similarity=0.326 Sum_probs=174.7
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
..++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999875 5789999998642 22334567899999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 34788889999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCcccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 3221 122346799999999998654 37899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=286.37 Aligned_cols=204 Identities=29% Similarity=0.423 Sum_probs=173.2
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh--hhHHHHHHHHHHHHHccCCc-eeeEeeEEEecC-----
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQG----- 582 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~il~~l~Hpn-iv~l~~~~~~~~----- 582 (724)
...|+..++||+|.||+||+|+.. +|+.||+|++.-..+ .......+|+.+|++++|+| |++|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345666788999999999999874 588999999875533 23345689999999999999 999999998877
Q ss_pred -eEEEEEEeeCCCChhHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 583 -EKILILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 583 -~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
..++|+||+ ..+|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||++.|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 788999998 55898888654322 45777889999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+|+.+.-.. ...+..++|..|.|||++.+. .|+...||||+|||+.||++++.-|..++
T Consensus 166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s 225 (323)
T KOG0594|consen 166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS 225 (323)
T ss_pred hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence 999764221 224567889999999999987 68999999999999999999999997665
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=288.12 Aligned_cols=208 Identities=25% Similarity=0.328 Sum_probs=180.0
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
-++|++.+.||+|.-|+||++++.+ +..+|+|++.+.. .+...+.+.|-+||+.++||.+..|+..++.+...+||
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 4568888999999999999999875 4789999997653 33456778899999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||++||+|..+++. +..+.+++..+..++.+++-||+|||-.| ||.|||||+||||.++|++.|+||.++.....
T Consensus 156 meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999998754 45567999999999999999999999999 99999999999999999999999998764311
Q ss_pred C----------------------------------c--------------------ccccccccccccCccCcccccCCC
Q 004912 668 D----------------------------------E--------------------LQGNTKQIVGTYGYMSPEYALDGL 693 (724)
Q Consensus 668 ~----------------------------------~--------------------~~~~~~~~~gt~~y~aPE~~~~~~ 693 (724)
. . ...+....+||-.|+|||++.+.-
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 001123468999999999999999
Q ss_pred CCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 004912 694 FSIKSDVFSFGILMLETLSSKKNTGLGSME 723 (724)
Q Consensus 694 ~s~k~DVwSlGvil~elltG~~p~~~~~~e 723 (724)
++.++|.|+|||+|||||.|+.||...+.+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~ 341 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNK 341 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCch
Confidence 999999999999999999999999877654
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=300.45 Aligned_cols=200 Identities=26% Similarity=0.355 Sum_probs=171.8
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCC-ceeeEeeEEEecCeEEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHR-NLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hp-niv~l~~~~~~~~~~~lV~ 588 (724)
+|++.+.||+|+||.||+|+.. +++.||||+++.. .....+.+..|+.++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999875 4678999998753 234556788999999999765 5888999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999988843 345889999999999999999999998 999999999999999999999999998753211
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 1 12334578999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=299.40 Aligned_cols=199 Identities=26% Similarity=0.374 Sum_probs=175.6
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.++|++.+.||+|+||.||+++.. ++..+|+|.+... .....+++.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999875 5778999998754 33455789999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ .|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999853 345889999999999999999999853 3999999999999999999999999999865332
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
......|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 22345789999999999999999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=308.69 Aligned_cols=203 Identities=26% Similarity=0.404 Sum_probs=178.1
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999875 58899999987532 234567899999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 56899999999999999999999988 999999999999999999999999999876432
Q ss_pred c---------------------------ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 E---------------------------LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. .........||+.|+|||.+.+..++.++|||||||+||||++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0112334579999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=300.43 Aligned_cols=200 Identities=27% Similarity=0.359 Sum_probs=171.9
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
+|++.+.||+|+||.||+|+.. +++.||||++++.. ....+.+..|..++..+ +||+|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999875 46789999987532 23345677788888887 5899999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988843 345889999999999999999999998 999999999999999999999999999754321
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 1 12334678999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.77 Aligned_cols=195 Identities=30% Similarity=0.407 Sum_probs=168.8
Q ss_pred eeeccCCceeEEeeeec----CCceeEEEeccccC----hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 519 CKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~----~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+.||+|+||.||+++.. .++.||||.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999753 47889999986532 23345678999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++.. ...+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 999999998843 345788899999999999999999998 9999999999999999999999999987543221
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 12334578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=290.62 Aligned_cols=197 Identities=30% Similarity=0.433 Sum_probs=163.0
Q ss_pred CcceeeeeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe-----EEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE-----KILI 587 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~-----~~lV 587 (724)
.|...+++|.|+||.||+|.+.. +..||||+.-..... =.+|+.+|++++|||||+|+-++....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46677899999999999998754 689999987543321 1478999999999999999998875432 3489
Q ss_pred EEeeCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC-CCEEEEecCCcccc
Q 004912 588 LEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMF 665 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DFGla~~~ 665 (724)
|||||. +|.+.+... ..+..++..++.-+..||.+||+|||+.+ |+||||||.|+|+|.+ +.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 677777542 22455888888889999999999999988 9999999999999976 89999999999998
Q ss_pred CCCcccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
...+.+ ....-|..|.|||.+.+. .|+.+.||||.|||+.||+-|+.-|..++
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s 230 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS 230 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence 654422 234568899999999885 59999999999999999999999997765
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=294.67 Aligned_cols=202 Identities=24% Similarity=0.360 Sum_probs=174.5
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+.++.+++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36899999999999999999885 47889999986532 3345678899999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|++++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987765542 2345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
........|++.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 155 -NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred -cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 112334578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=300.88 Aligned_cols=203 Identities=25% Similarity=0.341 Sum_probs=174.0
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|+||.||+++.. +++.||||++.+. .....+.|.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46899999999999999999875 4789999998642 2234566889999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998532 345889999999999999999999998 999999999999999999999999999765432
Q ss_pred cccccccccccccCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.. .......||+.|||||++.. ..++.++|||||||++|||++|+.||...+
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 21 11223468999999999863 457889999999999999999999997544
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=293.84 Aligned_cols=201 Identities=27% Similarity=0.389 Sum_probs=171.8
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++|++.++||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56899999999999999999875 57899999986543 23345778999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++ +|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 985 888887432 345789999999999999999999998 9999999999999999999999999997653221
Q ss_pred cccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......+++.|+|||++.+ ..++.++||||+|+++|||++|+.||...+
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12234568999999998865 568999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.15 Aligned_cols=203 Identities=23% Similarity=0.314 Sum_probs=174.5
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|+||.||+++.. +++.||+|.+.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999875 4778999998652 2233456889999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|..++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 345889999999999999999999998 999999999999999999999999999876433
Q ss_pred cccccccccccccCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.. .......||+.|+|||++.+ ..++.++||||||++||||++|+.||...+
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 21 12233579999999999876 467899999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.17 Aligned_cols=200 Identities=28% Similarity=0.393 Sum_probs=171.4
Q ss_pred CcceeeeeccCCceeEEeeeec----CCceeEEEecccc----ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~----~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~ 584 (724)
+|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+..|+.++.++ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788999999999999998753 5789999998643 223456688999999999 599999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999853 345899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcccccccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
+..... .......||+.|||||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 533221 1223457999999999988754 789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.89 Aligned_cols=198 Identities=26% Similarity=0.401 Sum_probs=169.6
Q ss_pred cceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHH---HHccCCceeeEeeEEEecCeEEEE
Q 004912 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLI---AKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il---~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+.++ .+++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999875 58899999997532 23345667776665 456799999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++++|..++. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988873 245899999999999999999999998 99999999999999999999999999875422
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. ........|++.|||||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 1 122344679999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.20 Aligned_cols=197 Identities=27% Similarity=0.380 Sum_probs=172.7
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHcc-C-----CceeeEeeEEEecCeEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-H-----RNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-H-----pniv~l~~~~~~~~~~~l 586 (724)
+|++.+.||+|.||+|.||.+. +++.||||++++.. .-..+-..|+++|..|+ | -|+|++++++..+++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 8999999999999999999764 58899999998754 34456688999999997 5 479999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC--CCEEEEecCCccc
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD--MNPKISDFGLARM 664 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kL~DFGla~~ 664 (724)
|+|.+ ..+|.++|... +...++...++.|+.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.++.
T Consensus 266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99988 56899999654 3455999999999999999999999998 9999999999999654 4699999999987
Q ss_pred cCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
..... ...+.+..|.|||++.+.+|+.+.||||||||++||++|.+.|..++
T Consensus 341 ~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 341 ESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 54332 25688999999999999999999999999999999999998887665
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=306.13 Aligned_cols=208 Identities=32% Similarity=0.468 Sum_probs=174.1
Q ss_pred hccCcceeeeeccCCceeEEeeeec------CCceeEEEeccccC-hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecC
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 582 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~ 582 (724)
..++|++.+.||+|+||.||+++.. ++..||||+++... ....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 4567999999999999999998742 23579999997543 33456789999999999 8999999999999999
Q ss_pred eEEEEEEeeCCCChhHHHhhcC----------------------------------------------------------
Q 004912 583 EKILILEYMPNKSLNVFLFDST---------------------------------------------------------- 604 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 604 (724)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999985321
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccccc
Q 004912 605 ---------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675 (724)
Q Consensus 605 ---------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 675 (724)
....+++.++++++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+..........
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 1124788999999999999999999998 9999999999999999999999999998754322111122
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 676 ~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
...++..|||||++.+..++.++||||||+++|||++ |+.||....
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 2345678999999999999999999999999999997 999996543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=297.92 Aligned_cols=195 Identities=28% Similarity=0.382 Sum_probs=166.6
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+|+||.||+|+.. +++.||||.++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 47789999987532 23345566677777654 899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
|+|..++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999988843 345899999999999999999999998 9999999999999999999999999998643222 22
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 344679999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.47 Aligned_cols=195 Identities=26% Similarity=0.327 Sum_probs=168.9
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 594 (724)
+.||+|+||.||+++.. +++.||+|.++.. .......+.+|++++..++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 5889999998753 2234567788999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
+|..++.. ...+++.++..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 99988743 3468999999999999999999997 66 9999999999999999999999999987542211 12
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~ 200 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence 234579999999999999999999999999999999999999996554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=299.85 Aligned_cols=203 Identities=24% Similarity=0.325 Sum_probs=173.4
Q ss_pred cCcceeeeeccCCceeEEeeeecC-CceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.++||+|+||.||+++... ++.+|+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468899999999999999998754 678999998642 2223456889999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999542 345889999999999999999999998 999999999999999999999999999765332
Q ss_pred cccccccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.. .......||+.|+|||++. ...++.++|||||||+||||++|+.||...+
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 21 1223457999999999986 3468899999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=312.74 Aligned_cols=210 Identities=22% Similarity=0.326 Sum_probs=179.3
Q ss_pred HHhccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC---
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--- 582 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~--- 582 (724)
....++|.+.+.||+|+||.||+++.. +++.||||++... .......+.+|+.++..++|+|+++++..+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345679999999999999999999764 6889999998643 3455677899999999999999999988765432
Q ss_pred -----eEEEEEEeeCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEE
Q 004912 583 -----EKILILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (724)
Q Consensus 583 -----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 656 (724)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 3679999999999999986533 2356899999999999999999999998 999999999999999999999
Q ss_pred EecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+|||+++.+.............||+.|+|||++.+..++.++||||||++||||++|+.||...+
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999987654322223345679999999999999999999999999999999999999997654
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.16 Aligned_cols=203 Identities=23% Similarity=0.390 Sum_probs=175.7
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999875 58899999997542 234567889999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998543 245899999999999999999999998 999999999999999999999999999876433
Q ss_pred cccccccccccccCccCccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYAL------DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 211 223357899999999986 4567899999999999999999999997554
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=299.11 Aligned_cols=195 Identities=25% Similarity=0.359 Sum_probs=168.8
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+|+||.||+|+.. +++.||||+++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 4789999998753 233456678899999876 799999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
++|...+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 999988843 345889999999999999999999998 9999999999999999999999999997643221 12
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 334578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=294.09 Aligned_cols=200 Identities=28% Similarity=0.370 Sum_probs=170.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh-hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.++|++.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+.++++++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 588999999875432 234567889999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 577777643 2345889999999999999999999998 9999999999999999999999999997643221
Q ss_pred ccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 12234568999999998875 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=291.15 Aligned_cols=191 Identities=21% Similarity=0.353 Sum_probs=166.3
Q ss_pred eeeccCCceeEEeeeecCCceeEEEeccccChhh---HHHHHHHHHHHHHccCCceeeEeeEEEe----cCeEEEEEEee
Q 004912 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKILILEYM 591 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~---~~~f~~E~~il~~l~Hpniv~l~~~~~~----~~~~~lV~Ey~ 591 (724)
..|++|+++.||+|.. +|+.||||+++...... .+.|.+|+.+|.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999988 78899999997643322 5778899999999999999999999877 34678999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
++|+|.+++.. ...+++...++++.|++.||+|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999953 34688999999999999999999985 5 8899999999999999999999999998654321
Q ss_pred cccccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 23467899999999976 679999999999999999999999997654
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=297.32 Aligned_cols=200 Identities=25% Similarity=0.369 Sum_probs=171.5
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~lV~ 588 (724)
+|+..+.||+|+||.||+++.. +++.||||+++.. .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999875 5789999998753 2234566788999998885 577888999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999998843 345899999999999999999999998 999999999999999999999999999764322
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 1 12234568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=277.30 Aligned_cols=205 Identities=27% Similarity=0.407 Sum_probs=177.1
Q ss_pred hccCcceeeeeccCCceeEEeeee-cCCceeEEEeccc--cChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~--~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
..+.|++.++||+|.|+.|++..+ +.|+.+|+|++.. -+..+.+++.+|+.|-..|+||||++|+....+....+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 357788999999999999999965 5688999888743 2344778899999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC---CCCEEEEecCCccc
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLARM 664 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFGla~~ 664 (724)
+|+|.|++|..-+-. +-..++..+-..++||+++|.|.|..+ |||||+||+|+||-+ .--+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999765532 245778888899999999999999998 999999999999953 34599999999998
Q ss_pred cCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSMER 724 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~~e~ 724 (724)
+.... ..-...|||+|||||++...+|+..+|||+.|||||-||.|..||-.++.+|
T Consensus 163 l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r 219 (355)
T KOG0033|consen 163 VNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 219 (355)
T ss_pred eCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH
Confidence 86332 2345789999999999999999999999999999999999999998766553
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=303.26 Aligned_cols=206 Identities=31% Similarity=0.416 Sum_probs=173.4
Q ss_pred ccCcceeeeeccCCceeEEeeee------cCCceeEEEeccccC-hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGE 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~ 583 (724)
.++|++.++||+|+||.||+|.. ..+..||||+++... ....+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788999999999999999963 235689999997543 33456789999999999 89999999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCC----------------------------------------------------------
Q 004912 584 KILILEYMPNKSLNVFLFDSTK---------------------------------------------------------- 605 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 605 (724)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999854211
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 606 --------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 606 --------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
...+++..+.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788999999999999999999998 999999999999999999999999999876433221
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
.......++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 22222345678999999999999999999999999999998 88998643
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.12 Aligned_cols=200 Identities=26% Similarity=0.374 Sum_probs=175.1
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.++|++.++||+|+||.||++.+. ++..+|+|.++.. .....+.+.+|++++.+++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999876 5778999988654 33445779999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++++|.+++.. ...+++..+..++.|+++||+|||+.+ +|+|+||||+|||+++++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999853 345889999999999999999999753 3999999999999999999999999999765322
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123356899999999999989999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=297.38 Aligned_cols=195 Identities=26% Similarity=0.395 Sum_probs=168.7
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+|+||.||+++.. +++.||||++++. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 4789999998653 233456778898898877 699999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999988843 345899999999999999999999998 9999999999999999999999999987642211 12
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 334579999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=297.42 Aligned_cols=202 Identities=28% Similarity=0.420 Sum_probs=182.0
Q ss_pred hccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccChh---hHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~---~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~ 585 (724)
..+.|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||++.+++.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45689999999999999999998865 899999999765433 4568999999999998 999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC----CCEEEEecCC
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD----MNPKISDFGL 661 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kL~DFGl 661 (724)
+|||++.+|.|.+.+... . +++.++..++.||+.+++|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998654 2 999999999999999999999998 9999999999999543 4799999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||...+.
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~ 243 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE 243 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence 998765 3346678999999999999999999999999999999999999999987763
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=295.44 Aligned_cols=202 Identities=26% Similarity=0.395 Sum_probs=179.4
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
..|...+.||+|+||.||||.+. .++.||+|++.-. .+...+++++|+.+|..++|+||.++++.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34666689999999999999764 5789999999654 345678899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+.+|++.+.| +....+++.++.-|+++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999998 34455688899999999999999999998 99999999999999999999999999988755433
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
+..+.+||+.|||||++....|+.|+||||||+.++||.+|.+|+.--..
T Consensus 167 --rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 167 --RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred --ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 33678999999999999988999999999999999999999999975443
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=297.71 Aligned_cols=201 Identities=25% Similarity=0.360 Sum_probs=168.6
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC-----eEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKI 585 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~-----~~~ 585 (724)
+|++.++||+|+||.||+|+.. +++.||||+++.. ......++.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4888999999999999999875 5889999998643 2234567889999999999999999999886432 479
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||++ ++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68888874 3345899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcc-cccccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 666 GGDEL-QGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 32211 112234578999999999876 678999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=302.05 Aligned_cols=193 Identities=22% Similarity=0.283 Sum_probs=167.6
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
..+|++.+.||+|+||.||++... .++.||+|... .+.+.+|+.++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 468999999999999999999874 57899999753 24568899999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+. ++|..++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 85 678887743 345889999999999999999999998 9999999999999999999999999997543211
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+-
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 122334679999999999999999999999999999999999998763
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=297.77 Aligned_cols=193 Identities=23% Similarity=0.368 Sum_probs=168.2
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+|+||.||+++.. +++.||||+++.. .....+.+..|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999875 5789999999753 233456788999999999 799999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence 999888743 346899999999999999999999998 999999999999999999999999998753211 112
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 3346799999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=283.34 Aligned_cols=203 Identities=29% Similarity=0.437 Sum_probs=175.0
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccc--cChhhHHHHHHHHHHHHHccCCceeeEeeEEEe-----cCe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-----QGE 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~--~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~-----~~~ 583 (724)
...|...+.||+|++|.|..+... +|..||||++.. ......++..+|+++|+.++|+||+.+.+.+.- -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 455666789999999999999774 588999999973 344567888999999999999999999998764 347
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.|+|+|+| ..+|...+. .+..|+...+..++.||++||.|+|+.+ |+||||||.|+|++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 89999999 678888883 3445999999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
...........+..+.|..|.|||.+.. ..|+.+.||||.||||.|||+|+.-|...+
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d 232 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD 232 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence 8864433445577889999999998865 579999999999999999999999996554
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=298.04 Aligned_cols=192 Identities=24% Similarity=0.382 Sum_probs=167.2
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+|+||.||+++.. +++.+|+|++++. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 4788999998753 233456688899998887 799999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 999888743 345899999999999999999999998 9999999999999999999999999997532211 12
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 334678999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.82 Aligned_cols=195 Identities=29% Similarity=0.427 Sum_probs=169.5
Q ss_pred eccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCCh
Q 004912 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (724)
Q Consensus 521 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (724)
||+|+||+||++... +++.+|+|.+.... ....+.+..|+.++++++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999765 57899999986532 22346778899999999999999999999999999999999999999
Q ss_pred hHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccccc
Q 004912 597 NVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675 (724)
Q Consensus 597 ~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 675 (724)
..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 98875432 3456899999999999999999999998 99999999999999999999999999987643321 233
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 676 ~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 457899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=293.98 Aligned_cols=195 Identities=27% Similarity=0.380 Sum_probs=167.1
Q ss_pred eeeccCCceeEEeeeecC-CceeEEEeccccC---hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+|+||.||+|+..+ ++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999998754 7789999987542 23345667788888765 899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
|+|..++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999999843 345889999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 334578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=316.90 Aligned_cols=205 Identities=25% Similarity=0.344 Sum_probs=174.9
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.++||+|+||.||+|... .++.||||++... .....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999875 4889999998653 2234567999999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 589 EYMPNKSLNVFLFDST--------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
||+++++|.+++.... ....+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999985421 1234667788999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcc----------------cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 661 LARMFGGDEL----------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 661 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
+++....... ........||+.|||||.+.+..++.++|||||||++|||++|+.||...
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9987621100 01112357999999999999999999999999999999999999999653
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=295.59 Aligned_cols=193 Identities=26% Similarity=0.399 Sum_probs=168.0
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+|+||.||+++.. +++.+|||+++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 4788999999754 233456788999999988 699999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 999988743 345899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.....||+.|+|||++.+..++.++||||||++||||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 3346799999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=287.64 Aligned_cols=201 Identities=29% Similarity=0.404 Sum_probs=174.3
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
+|++.++||+|+||.||++... +++.||||++.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999874 58899999986532 2234567889999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++++|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887543 2345899999999999999999999998 9999999999999999999999999998753322
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......|++.|+|||++.+..++.++||||+|+++|||++|+.||...+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 1223478999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=297.70 Aligned_cols=195 Identities=26% Similarity=0.330 Sum_probs=165.9
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHH-HHHHccCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~-il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+|+||.||+++.. +++.+|||++.... ....+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 58899999986532 233345555654 46778999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
++|..++. +...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence 99988874 3446899999999999999999999998 999999999999999999999999998753221 122
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 344679999999999999999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=294.59 Aligned_cols=195 Identities=27% Similarity=0.375 Sum_probs=167.4
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+|+||.||+++.. +++.||||.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999875 57899999987532 23445667788888765 899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
++|..++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence 999988843 345889999999999999999999998 999999999999999999999999998753211 112
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 344678999999999999999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=284.86 Aligned_cols=203 Identities=27% Similarity=0.405 Sum_probs=172.7
Q ss_pred ccCcceeeeeccCCceeEEeeeec----CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457899999999999999999753 35689999997653 3445679999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++++|.+++... ...+++.+++.++.||+.||+|||+++ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999998542 346899999999999999999999998 9999999999999999999999999876542
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
.... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||...
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 2211 11112345678999999999999999999999999999886 99999643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.40 Aligned_cols=204 Identities=28% Similarity=0.443 Sum_probs=182.4
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccc--cChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe-EEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE-KILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~--~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~-~~lV~ 588 (724)
++|+..+++|+|+||.++..+++ +++.+++|.+.- .++...+...+|+.++++++|||||.+.+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999775 467899998753 344555678899999999999999999999999988 89999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
+|++||+|.+.+.... ...++++.+.+++.||+.|+.|||+.. |+|||||+.||+++.+..+||.|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999996543 566899999999999999999999876 999999999999999999999999999998765
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
. .......||+.||+||.+.+.+|..|+|||||||++|||++=+++|...++
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m 211 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM 211 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence 4 234568999999999999999999999999999999999999999987764
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.75 Aligned_cols=203 Identities=31% Similarity=0.494 Sum_probs=171.6
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCc----eeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.+|++.+.||+|+||.||+|++. ++. .||||.++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999764 333 48999987543 34567899999999999999999999998765 5679
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
|+||+++|+|.+++... ...+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998543 335889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 4322222222345678999999999999999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=295.84 Aligned_cols=195 Identities=27% Similarity=0.331 Sum_probs=165.5
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHH-HHHHccCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~-il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+|+||.||+|+.. +++.||||++.... ....+++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999875 58899999986532 122344555544 56789999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
++|..++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence 999998843 346889999999999999999999998 999999999999999999999999998754221 122
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 344679999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=287.93 Aligned_cols=200 Identities=28% Similarity=0.444 Sum_probs=166.9
Q ss_pred cCcceeeeeccCCceeEEeeeec--CCceeEEEeccccC--hhhHHHHHHHHHHHHHc---cCCceeeEeeEEEe-----
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVE----- 580 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l---~Hpniv~l~~~~~~----- 580 (724)
++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++..+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46889999999999999999863 46789999886432 22334566777777766 69999999999853
Q ss_pred cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
....++||||++ ++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999996 5888888543 2345899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
+++..... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 212 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence 99876432 2234457899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=299.39 Aligned_cols=206 Identities=30% Similarity=0.436 Sum_probs=174.0
Q ss_pred hccCcceeeeeccCCceeEEeeeecC------CceeEEEeccccC-hhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecC
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQG 582 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~ 582 (724)
..++|++.++||+|+||.||+|.... +..||||+++... ....+.|.+|+.+++++. ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 46688999999999999999997532 3469999997543 334567999999999996 999999999999999
Q ss_pred eEEEEEEeeCCCChhHHHhhcCC---------------------------------------------------------
Q 004912 583 EKILILEYMPNKSLNVFLFDSTK--------------------------------------------------------- 605 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 605 (724)
..++||||+++|+|.+++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998854210
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc
Q 004912 606 ------------------------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649 (724)
Q Consensus 606 ------------------------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 649 (724)
...+++.++.+++.||++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 124788889999999999999999998 99999999999999
Q ss_pred CCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004912 650 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 719 (724)
Q Consensus 650 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~ 719 (724)
.++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 999999999999987643322222233456788999999999999999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=295.16 Aligned_cols=195 Identities=27% Similarity=0.328 Sum_probs=165.0
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHH-HHHHccCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~-il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
++||+|+||.||+|+.. +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 57899999986532 122344555554 67889999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
++|...+.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 999888743 345888999999999999999999998 9999999999999999999999999987532211 22
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 334578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=287.69 Aligned_cols=206 Identities=31% Similarity=0.505 Sum_probs=176.7
Q ss_pred ccCcceeeeeccCCceeEEeeeecC------CceeEEEeccccChh-hHHHHHHHHHHHHHccCCceeeEeeEEEecCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~-~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~ 584 (724)
.++|.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.|.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568888999999999999997643 478999999765444 567899999999999999999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC
Q 004912 585 ILILEYMPNKSLNVFLFDST-----------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 653 (724)
++||||+++++|.+++.... ....+++.++..++.||+.||+|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999986432 2345889999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 654 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
+||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999986543322222233456788999999999999999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=295.08 Aligned_cols=195 Identities=27% Similarity=0.337 Sum_probs=164.0
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHH-HHHHHccCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEM-MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~-~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+|+||.||+++.. +++.||+|++.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999875 46789999986532 12233444444 456788999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
++|..++.. ...+.+..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence 999998843 345788888999999999999999998 999999999999999999999999999754221 122
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 344679999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=297.46 Aligned_cols=195 Identities=30% Similarity=0.375 Sum_probs=169.7
Q ss_pred eeeccCCceeEEeeee----cCCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeC
Q 004912 519 CKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 592 (724)
+.||+|+||.||+++. .+++.+|+|++.... ......+.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999865 357899999997542 2234567889999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccc
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 672 (724)
+++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999998843 345899999999999999999999998 9999999999999999999999999998653321 2
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 2334678999999999999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=292.36 Aligned_cols=195 Identities=26% Similarity=0.352 Sum_probs=168.5
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+|+||.||+++.. +++.||||++++.. ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 47789999997532 33456678899999888 699999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
++|..++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999988843 345899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 234578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=286.30 Aligned_cols=205 Identities=34% Similarity=0.533 Sum_probs=175.2
Q ss_pred cCcceeeeeccCCceeEEeeeecC------CceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
++|++.+.||+|+||.||+|.... ...||+|.+.... .....+|.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999997643 2579999986543 344567999999999999999999999999988999
Q ss_pred EEEEeeCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC
Q 004912 586 LILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 652 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 652 (724)
++|||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999864321 145889999999999999999999998 99999999999999999
Q ss_pred CEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 653 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 653 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999987644333223344566889999999999999999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=284.54 Aligned_cols=204 Identities=33% Similarity=0.490 Sum_probs=174.0
Q ss_pred cCcceeeeeccCCceeEEeeee-----cCCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
+.|++.+.||+|+||.||+|.. ..+..+|+|.+.... .+...+|.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999974 245789999997533 3445789999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC
Q 004912 587 ILEYMPNKSLNVFLFDST--------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 652 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 652 (724)
||||+++++|.+++.... ....+++.+++.++.||+.||+|||+++ |+|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 1235888999999999999999999998 99999999999999999
Q ss_pred CEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004912 653 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 719 (724)
Q Consensus 653 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~ 719 (724)
.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999999987644332222333456778999999998899999999999999999999 9999854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=302.69 Aligned_cols=200 Identities=30% Similarity=0.446 Sum_probs=175.8
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecC------eEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKI 585 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~------~~~ 585 (724)
.+...+.||+|+||.||+|+++ .|+.||||.+.... ....+...+|+++|++++|||||++++.-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 4566689999999999999964 69999999997643 345677889999999999999999999865433 568
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc--CCC--CEEEEecCC
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDM--NPKISDFGL 661 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~--~~kL~DFGl 661 (724)
+||||+.+|+|...|..+.+...|++.+.+.++..+..||.|||+++ |+||||||.||++- ++| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999998888889999999999999999999999988 99999999999993 223 479999999
Q ss_pred ccccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
|+.+..+. ......||..|++||+..+ +.|+.-+|.|||||++||..||..||..
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 99986654 5667899999999999985 8899999999999999999999999954
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=284.71 Aligned_cols=208 Identities=29% Similarity=0.465 Sum_probs=174.6
Q ss_pred hccCcceeeeeccCCceeEEeeeec------CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~ 583 (724)
..++|++.+.||+|+||.||+|... .+..||||++.... .....+|.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999998753 24679999986432 2345678999999999999999999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEE
Q 004912 584 KILILEYMPNKSLNVFLFDSTK-------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 656 (724)
.++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854221 234678899999999999999999988 999999999999999999999
Q ss_pred EecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999986643332222223355788999999999999999999999999999999 788886543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=306.83 Aligned_cols=210 Identities=27% Similarity=0.373 Sum_probs=177.7
Q ss_pred HHhccCcceeeeeccCCceeEEeeeecCC-ceeEEEeccccChhhHHHHHHHHHHHHHcc-CCceeeEee-EEEe-----
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLG-CCVE----- 580 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-Hpniv~l~~-~~~~----- 580 (724)
.....++++.+.|.+|||+.||.|.+..+ ..+|+|++-..++...+..++|+.+|++|+ |+|||.+++ ....
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 44567889999999999999999998776 999999997778889999999999999997 999999999 3322
Q ss_pred -cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEec
Q 004912 581 -QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659 (724)
Q Consensus 581 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF 659 (724)
.-+.+|.|||+++|.|-+++..+...+ |++.++++|+.++++|+++||... ++|||||||-|||||..+++.|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence 136789999999999999997655444 999999999999999999999885 67999999999999999999999999
Q ss_pred CCccccCCCcccc-cc------cccccccCccCcccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 660 GLARMFGGDELQG-NT------KQIVGTYGYMSPEYA---LDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 660 Gla~~~~~~~~~~-~~------~~~~gt~~y~aPE~~---~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
|.|.......... .. -...-|+.|.|||++ .+..++.|+|||+|||+||-|+....||+.+
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 9986532211000 00 012358999999987 5778999999999999999999999999865
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=285.07 Aligned_cols=206 Identities=31% Similarity=0.503 Sum_probs=177.1
Q ss_pred ccCcceeeeeccCCceeEEeeeec------CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++.+++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 457889999999999999999742 24568999998766666788999999999999999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEE
Q 004912 586 LILEYMPNKSLNVFLFDST----------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 655 (724)
+||||+++++|.+++.... ....+++..+++++.|++.||+|||+++ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999986432 2235899999999999999999999998 99999999999999999999
Q ss_pred EEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 656 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
|+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999986643322222233445788999999998999999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=295.92 Aligned_cols=196 Identities=29% Similarity=0.441 Sum_probs=166.4
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++|+..++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677789999999999999875 58899999986543 33457799999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.... ...+..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999985432 3567788899999999999999998 9999999999999999999999999998764321
Q ss_pred cccccccccccCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.......||..|+|||.+.. ...+.++|||||||++|||++|+.||...
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 12234578999999998743 23456899999999999999999999743
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=282.33 Aligned_cols=201 Identities=39% Similarity=0.589 Sum_probs=169.4
Q ss_pred ceeeeeccCCceeEEeeeec-----CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 516 SMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++.+.||.|.||.||+|.+. .+..|+||.++.. ..+..+.|.+|++++.+++||||++++|++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 45689999999999999876 2568999999654 34457899999999999999999999999998888999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++|+|.++|... ....+++..+.+|+.||++||+|||+.+ ++|+||+++||++++++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999764 2345899999999999999999999998 9999999999999999999999999998873322
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
.............|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2222333457789999999999999999999999999999999 78888643
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=296.18 Aligned_cols=197 Identities=22% Similarity=0.320 Sum_probs=171.5
Q ss_pred ccCcceeeeeccCCceeEEeeeec---CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
..+|++.+.||+|+||.||++... .+..||||.+... +.+.+|+.++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 467999999999999999999653 3568999988643 23568999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
|++. ++|.+++ .....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 5787777 23456899999999999999999999998 999999999999999999999999999876544
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
..........||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 3333334567999999999999999999999999999999999999999654
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=268.75 Aligned_cols=200 Identities=29% Similarity=0.410 Sum_probs=173.7
Q ss_pred HhccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-----C---hhhHHHHHHHHHHHHHc-cCCceeeEeeEEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----S---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCV 579 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-----~---~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~ 579 (724)
....+|+-.+.||+|..+.|.++.++ .++++|+|++... . ..-.++-..|+.||+++ -||+|+.+.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34567788889999999999998764 5789999988432 1 12245567899999998 5999999999999
Q ss_pred ecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEec
Q 004912 580 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659 (724)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF 659 (724)
.+...++|+|.|+.|.|.++| ...-.+++++..+|++|+.+|++|||..+ ||||||||+|||++++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 999999999999999999999 45567999999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCcccccccccccccCccCcccccC------CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
|+|+.+.+.+ .....+|||+|+|||.+.- ..|+..+|+|++|||||-||.|.+||=
T Consensus 168 GFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 168 GFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred ceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 9999886543 4566899999999998843 247888999999999999999999983
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=279.75 Aligned_cols=203 Identities=34% Similarity=0.492 Sum_probs=176.4
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46789999999999999999998888899999986543 34578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++++|.+++... ....+++.+++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+......
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999998643 2345888999999999999999999988 999999999999999999999999999876432211
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 1222345678999999998999999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=278.51 Aligned_cols=202 Identities=31% Similarity=0.455 Sum_probs=174.2
Q ss_pred cCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeC
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 592 (724)
+.|++.+.||+|+||.||+++..++..+|+|.+.... ...++|.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4578889999999999999998888899999986432 334678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccc
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 672 (724)
+++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99999988542 235889999999999999999999998 999999999999999999999999999865432221
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 1122345678999999998899999999999999999999 899997543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=284.20 Aligned_cols=206 Identities=31% Similarity=0.491 Sum_probs=177.7
Q ss_pred cCcceeeeeccCCceeEEeeeec------CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.+|.+.+.||+|+||.||+++.. ++..+++|.++.......+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999742 345699999987766667789999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC
Q 004912 587 ILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 653 (724)
||||+++++|.+++.... ....+++..+++++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986432 1234899999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 654 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999987644332222334556789999999999999999999999999999999 999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-32 Score=278.25 Aligned_cols=203 Identities=33% Similarity=0.478 Sum_probs=175.5
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.++|++.+.||+|++|.||+|...+++.||||.++... ...++|.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46789999999999999999988778899999987543 34577999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++++|.+++.... ...+++.++.+++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+......
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985432 346899999999999999999999998 999999999999999999999999999876532211
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
.......+..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 208 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 1122233468999999999999999999999999999999 99998653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=300.19 Aligned_cols=199 Identities=21% Similarity=0.378 Sum_probs=163.8
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEec--------
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-------- 581 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~-------- 581 (724)
..++|++.+.||+|+||.||+|... .++.||||++.... ....+|+.+|++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3568999999999999999999875 57899999885432 2345799999999999999999887532
Q ss_pred CeEEEEEEeeCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC-CEEEEec
Q 004912 582 GEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDF 659 (724)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DF 659 (724)
...++||||+++ +|..++... .....+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999985 566665432 23456899999999999999999999998 99999999999998664 6999999
Q ss_pred CCccccCCCcccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
|+|+.+.... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||...
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9998764322 22335789999999998764 6899999999999999999999999754
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=295.17 Aligned_cols=200 Identities=28% Similarity=0.385 Sum_probs=169.7
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC-----eEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKI 585 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~-----~~~ 585 (724)
+|++.++||+|+||.||++... +++.||||++... .....+++.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999864 6889999998653 2334577899999999999999999999998776 789
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+|+||+. ++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 57777763 3346899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
..... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 43221 122334678999999998874 47999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=285.75 Aligned_cols=201 Identities=27% Similarity=0.403 Sum_probs=170.7
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++|++.++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57899999999999999999875 57789999986543 22345678899999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++ +|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 975 787777432 345889999999999999999999998 9999999999999999999999999997653322
Q ss_pred cccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223467899999998865 468999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=279.66 Aligned_cols=192 Identities=28% Similarity=0.418 Sum_probs=165.8
Q ss_pred eccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCCh
Q 004912 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (724)
Q Consensus 521 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (724)
||+|+||.||+++.. +++.+|+|.+.... ....+.+..|++++.+++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 58899999986422 12234566799999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccc
Q 004912 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676 (724)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 676 (724)
..++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++..+.... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 9887543 2335889999999999999999999998 9999999999999999999999999998764322 1233
Q ss_pred cccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
..|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 5689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=289.91 Aligned_cols=205 Identities=31% Similarity=0.474 Sum_probs=171.7
Q ss_pred ccCcceeeeeccCCceeEEeeeec------CCceeEEEeccccC-hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEec-C
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ-G 582 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~-~ 582 (724)
.++|++.+.||+|+||.||+|... .++.||+|+++... ....+.+..|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457899999999999999999642 24689999987543 33456788999999999 899999999988654 5
Q ss_pred eEEEEEEeeCCCChhHHHhhcCC---------------------------------------------------------
Q 004912 583 EKILILEYMPNKSLNVFLFDSTK--------------------------------------------------------- 605 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 605 (724)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999853211
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCcc
Q 004912 606 -KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684 (724)
Q Consensus 606 -~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~ 684 (724)
...+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 126899999999999999999999998 9999999999999999999999999998764332222233345677899
Q ss_pred CcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004912 685 SPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 719 (724)
Q Consensus 685 aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~ 719 (724)
|||++.+..++.++|||||||+||||++ |+.||..
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=297.34 Aligned_cols=194 Identities=24% Similarity=0.311 Sum_probs=167.5
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
...|.+.+.||+|+||.||++.+.. ++.||||... ...+.+|+.+|++++||||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999998754 7789999643 23457899999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+. ++|..++... ...+++.+++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 6888877432 336999999999999999999999998 99999999999999999999999999987644322
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 717 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~ 717 (724)
........||..|||||++.+..++.++|||||||+||||++|..|+
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22233467999999999999999999999999999999999987654
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=279.96 Aligned_cols=199 Identities=30% Similarity=0.405 Sum_probs=172.5
Q ss_pred cceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
|++.+.||+|+||.||++... +++.+|||.+.... ....+.+.+|+.++.+++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677889999999999999775 57899999986532 22345678899999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|..++... ....+++.++..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 9999999988542 2345899999999999999999999988 9999999999999999999999999987653222
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
......|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 122347899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=290.84 Aligned_cols=198 Identities=29% Similarity=0.343 Sum_probs=168.4
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC-----
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----- 582 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~----- 582 (724)
..++|++.+.||+|+||.||++... .+..||||++... .....+++.+|+.++..++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999874 5889999998643 3344567889999999999999999999986543
Q ss_pred -eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCC
Q 004912 583 -EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (724)
Q Consensus 583 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 661 (724)
..++||||+++ +|...+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999976 4555542 23788899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 97643221 223457899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=279.35 Aligned_cols=208 Identities=32% Similarity=0.495 Sum_probs=174.1
Q ss_pred hccCcceeeeeccCCceeEEeeeecC------CceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~ 583 (724)
..++|.+.+.||+|++|.||+|.+.+ +..||+|.+.... ......|.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35679999999999999999998753 4678999886543 3345679999999999999999999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC---CEEE
Q 004912 584 KILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKI 656 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL 656 (724)
.++||||+++++|.+++..... ...+++..+++++.||++||+|||+.+ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999854321 235899999999999999999999998 99999999999998654 5999
Q ss_pred EecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||...+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999987643322222222334568999999999999999999999999999997 999997543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=280.04 Aligned_cols=205 Identities=30% Similarity=0.502 Sum_probs=175.7
Q ss_pred ccCcceeeeeccCCceeEEeeeec------CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
.++|++.++||+|+||.||++... ++..+|+|.+........+.|.+|++++++++||||+++++++.+....+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356788899999999999999642 35689999998777777788999999999999999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC
Q 004912 586 LILEYMPNKSLNVFLFDSTK------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 653 (724)
+||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999864321 135889999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004912 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 719 (724)
Q Consensus 654 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~ 719 (724)
+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999976543322222223345788999999999999999999999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=275.75 Aligned_cols=201 Identities=33% Similarity=0.478 Sum_probs=173.3
Q ss_pred cCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeC
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 592 (724)
++|.+.+.||+|+||.||+++..++..+|||.+.... ...++|.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4678889999999999999988777789999987543 334679999999999999999999999998888999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccc
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 672 (724)
+++|.+++... ...+++..+++++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 99999998542 235899999999999999999999998 999999999999999999999999999876433221
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 1112345678999999998889999999999999999999 99998643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=277.41 Aligned_cols=204 Identities=33% Similarity=0.490 Sum_probs=174.2
Q ss_pred ccCcceeeeeccCCceeEEeeeecC----CceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.++|++.+.||+|+||.||+|.+.. ...||||.++... .....+|.+|+.++++++||||+++++.+.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578899999999999999998743 3579999987543 3445679999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++++|.+++... ...+++.++.+++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998543 236899999999999999999999988 9999999999999999999999999998875
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~ 212 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence 2221111222345678999999999999999999999999999998 99998543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=278.52 Aligned_cols=205 Identities=34% Similarity=0.527 Sum_probs=180.4
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
...+|++.++||.|+||.||+|...+++.+|+|.+.........++.+|+.+++.++||||+++++++.+....++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45678999999999999999999888999999999876665677899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++... ....+++.++.+++.||++||+|||+.+ |+|+||||+||++++++.+||+|||++..+.....
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999653 2346899999999999999999999998 99999999999999999999999999987643321
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 1 123345778999999998999999999999999999998 899996543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=278.61 Aligned_cols=199 Identities=28% Similarity=0.388 Sum_probs=172.8
Q ss_pred cceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
|+..+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.++.+++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999774 58899999986532 22345678899999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999999888543 2345899999999999999999999998 9999999999999999999999999997653221
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 123357899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=279.52 Aligned_cols=207 Identities=27% Similarity=0.414 Sum_probs=176.8
Q ss_pred hccCcceeeeeccCCceeEEeeeecC-----CceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe-cCe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGE 583 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~-~~~ 583 (724)
..++|++.+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46789999999999999999998765 678999998754 33456778999999999999999999998876 467
Q ss_pred EEEEEEeeCCCChhHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEe
Q 004912 584 KILILEYMPNKSLNVFLFDSTKK-----RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 658 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 658 (724)
.++++||+++++|.+++...... ..+++.++..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998653322 46899999999999999999999988 99999999999999999999999
Q ss_pred cCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
||+++.+...+.........++..|+|||.+.+..++.++||||||+++||+++ |+.||...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 999987644332222223456778999999999999999999999999999999 99999654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=281.42 Aligned_cols=201 Identities=26% Similarity=0.431 Sum_probs=177.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
..+|++.+.||+|++|.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 468999999999999999999864 5889999999766555667899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~- 170 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence 999999999842 34789999999999999999999998 9999999999999999999999999988654322
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......+++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred -cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 11233468899999999998889999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=273.48 Aligned_cols=202 Identities=30% Similarity=0.455 Sum_probs=177.1
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+|++.+.||+|++|.||++... +++.|++|.+... .....+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999875 5789999988643 345567899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++... ....+++..+.+++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998653 2356899999999999999999999988 99999999999999999999999999987654321
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......+++.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1233568899999999999999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-33 Score=274.97 Aligned_cols=198 Identities=28% Similarity=0.475 Sum_probs=179.8
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
+-|.+.++||+|+||.|||+.++ .|+.+|||.+... ...+++..|+.||.+.+.|++|+++|.+......++||||+
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 35788899999999999999875 4899999998653 46789999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
.-|+..+++.. ++.+|++.++.-+++..++||+|||... -||||||+.||||+.+|.+||+|||.|-.+.+ ..
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TM 183 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TM 183 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hH
Confidence 99999999853 5667999999999999999999999886 79999999999999999999999999987643 33
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
....++.||+-|||||++..-.|+.++||||||+...||.-|++||..
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD 231 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD 231 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence 455678999999999999999999999999999999999999999964
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=277.81 Aligned_cols=193 Identities=28% Similarity=0.416 Sum_probs=170.3
Q ss_pred cCcceeeeeccCCceeEEeeee-cCCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++|++.++||+|+||.||+|.+ .+++.||+|.+... .....++|.+|+.++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3578889999999999999976 46789999998654 334456799999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999997553 3678889999999999999999998 999999999999999999999999999865432
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 22345789999999999999999999999999999999999999953
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=275.27 Aligned_cols=202 Identities=31% Similarity=0.454 Sum_probs=173.9
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-----hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
++|++.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|+.++.+++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999864 58899999886432 1234678999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
|+||+++++|.+++.. ...+++..+.+++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998843 345889999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccc-cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 667 GDELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 667 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
...... ......++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 321111 113346788999999999999999999999999999999999998643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=280.78 Aligned_cols=206 Identities=28% Similarity=0.471 Sum_probs=172.9
Q ss_pred hccCcceeeeeccCCceeEEeeeecC------CceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~ 583 (724)
..++|++.+.||+|+||.||+|...+ +..||+|.++... ......+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999996532 4579999886543 2344568899999999999999999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEE
Q 004912 584 KILILEYMPNKSLNVFLFDSTK-------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 656 (724)
.++||||+++|+|.+++..... ...+++..+.+++.|++.||+|||+++ |+||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964221 234677888999999999999999998 999999999999999999999
Q ss_pred EecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004912 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 719 (724)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~ 719 (724)
+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~ 224 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999986543332222223345678999999999999999999999999999999 7888864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=280.29 Aligned_cols=201 Identities=29% Similarity=0.410 Sum_probs=178.7
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.+.|..-++||+|+||.|+-++.. +|+.+|.|.+.+. ..++....++|..||.+++.+.||.+--.+...+..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 456788899999999999988764 5889999988553 234556678999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
+..|.||+|.-+|..... +.+++++++.++.+|+-||++||+.. ||.|||||+|||||+.|+++|+|.|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999876543 67999999999999999999999998 99999999999999999999999999998865
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.. .....+||.+|||||++.+..|+...|.|||||+||||+.|+.||..
T Consensus 340 g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 340 GK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred CC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 43 23345899999999999999999999999999999999999999964
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=278.58 Aligned_cols=202 Identities=31% Similarity=0.450 Sum_probs=169.8
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCc----eeEEEeccccCh-hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~~-~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
++|++.+.||+|+||.||+|... +++ .+++|.+..... ....++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46788899999999999999864 343 478888764432 34567888999999999999999999875 455788
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998542 345899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 4332222334567789999999999999999999999999999998 99999643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=283.30 Aligned_cols=207 Identities=30% Similarity=0.488 Sum_probs=174.2
Q ss_pred ccCcceeeeeccCCceeEEeeeecC--------CceeEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEec
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 581 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~ 581 (724)
.++|.+.+.||+|+||.||+++... ...+|+|.++.. ......++.+|+.++.++ +||||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4679999999999999999997532 346999999754 334567788999999999 799999999999999
Q ss_pred CeEEEEEEeeCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE
Q 004912 582 GEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (724)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl 648 (724)
+..++||||+++++|.+++..... ...+++.++++++.||+.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965321 235899999999999999999999988 9999999999999
Q ss_pred cCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 649 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
+.++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 9999999999999986643222222222334578999999999999999999999999999998 889986544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=279.11 Aligned_cols=207 Identities=29% Similarity=0.458 Sum_probs=176.9
Q ss_pred ccCcceeeeeccCCceeEEeeeecC------CceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~ 584 (724)
.++|++.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678899999999999999997643 3689999987543 34456789999999999999999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEE
Q 004912 585 ILILEYMPNKSLNVFLFDSTK-------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 657 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 657 (724)
++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864321 234788999999999999999999988 9999999999999999999999
Q ss_pred ecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 658 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 9999987654333233334456789999999998899999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=281.71 Aligned_cols=198 Identities=26% Similarity=0.355 Sum_probs=173.1
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++|++.+.||+|+||.||++... ++..+|+|.++.. .....+++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999875 4778999988654 334456789999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
+++++|.+++... ..+++..+..++.|+++||+|||+. + ++|+||||+|||++.++.+||+|||++..+...
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 9999999998532 4588999999999999999999974 5 999999999999999999999999998765322
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 123457889999999998888999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=276.67 Aligned_cols=199 Identities=27% Similarity=0.442 Sum_probs=173.0
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++.+++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45789999999999999999986 46789999999765555566788999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++.. ...+++.++..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 999999998843 345899999999999999999999998 9999999999999999999999999998764321
Q ss_pred cccccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
.......++..|+|||.+. ...++.++||||||+++|||++|+.||.
T Consensus 161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 1123356889999999884 3457889999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=281.32 Aligned_cols=204 Identities=33% Similarity=0.492 Sum_probs=172.8
Q ss_pred CcceeeeeccCCceeEEeeeecC------CceeEEEeccccCh-hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~-~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
+|++.++||+|+||.||+|...+ ++.||||+++.... ...+.|.+|+.++.+++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46778899999999999997642 46899999975543 335678999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC
Q 004912 587 ILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 653 (724)
++||+++++|.+++.... ....+++..+.+++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1235888999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 654 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999987644332222333456789999999998899999999999999999998 88888643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=273.36 Aligned_cols=197 Identities=30% Similarity=0.444 Sum_probs=167.0
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCCh
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (724)
+.||+|+||.||+|.+. +++.+|+|.+.... .+....|.+|+.++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999875 68899999886543 34557799999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccc
Q 004912 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676 (724)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 676 (724)
.+++.. ....+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999853 2345899999999999999999999998 99999999999999999999999999976543211111111
Q ss_pred cccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
...+..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~ 200 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL 200 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 223467999999999999999999999999999998 88988643
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=280.45 Aligned_cols=199 Identities=25% Similarity=0.381 Sum_probs=176.0
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
..-|.+.+.||+|.|+.|-+|++ -.|..||||++.+.. ......+.+|++-|+.++|||||+|+.+...+...|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34577889999999999999976 379999999997653 233456789999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc-CCCCEEEEecCCccccCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGG 667 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~~~~~ 667 (724)
|.=.+|+|.+||.++.+ .+.+....+++.||+.|+.|+|+.. +|||||||+||..- .-|-+||.|||++..+.+
T Consensus 97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999976654 4899999999999999999999998 99999999999874 568899999999987754
Q ss_pred CcccccccccccccCccCcccccCCCCC-chhhHHHHHHHHHHHHcCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwSlGvil~elltG~~p~~ 718 (724)
. .+.++.+|+..|.|||++.+..|+ +++||||||||||.|++|+.||.
T Consensus 172 G---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFq 220 (864)
T KOG4717|consen 172 G---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQ 220 (864)
T ss_pred c---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccc
Confidence 3 346678999999999999999996 67999999999999999999995
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=276.14 Aligned_cols=203 Identities=30% Similarity=0.478 Sum_probs=170.0
Q ss_pred cceeeeeccCCceeEEeeeecC----CceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe-----
Q 004912 515 FSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE----- 583 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~----- 583 (724)
|.+.+.||+|+||.||+|.+.. +..||||+++.. .....+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4677899999999999998643 367999998753 23446789999999999999999999999876554
Q ss_pred -EEEEEEeeCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEec
Q 004912 584 -KILILEYMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659 (724)
Q Consensus 584 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF 659 (724)
.++|+||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999985432 2346899999999999999999999988 999999999999999999999999
Q ss_pred CCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
|+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~ 219 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 99987644332222222345678999999998999999999999999999999 88988543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-33 Score=271.77 Aligned_cols=204 Identities=28% Similarity=0.362 Sum_probs=180.1
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
-++|...++||+|.||.|.+++-+ .++.+|+|++++.. .+....-..|-++|...+||.+..|--.++..+..+.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888999999999999999765 58899999998753 23344557899999999999999998888999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||..||.|.-+| .+...+++.....+-..|+.||.|||+++ ||.||||.+|.|||.+|++||+|||+++.-
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~-- 318 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE-- 318 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--
Confidence 9999999998887 45667899888889999999999999998 999999999999999999999999999863
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSME 723 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~~e 723 (724)
-.+...++..+|||.|+|||++....|..++|.|.+||++|||++|+.||-..+.|
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence 22344577899999999999999999999999999999999999999999776655
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=274.49 Aligned_cols=201 Identities=32% Similarity=0.458 Sum_probs=171.9
Q ss_pred cCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeC
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 592 (724)
.+|++.+.||+|+||.||++...++..+|+|.+.... ...++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3577889999999999999988777789999986433 234578899999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccc
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 672 (724)
+++|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 999999985432 35899999999999999999999998 999999999999999999999999999865432211
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 1111234568999999999999999999999999999999 89998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=291.45 Aligned_cols=193 Identities=27% Similarity=0.361 Sum_probs=162.6
Q ss_pred eccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHc---cCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 521 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l---~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
||+|+||.||+|+.. +++.||||++.... ......+..|..++.+. +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 58899999986432 12334455677777665 699999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
++|..++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999988843 445899999999999999999999998 9999999999999999999999999997643221 22
Q ss_pred ccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 3346799999999998765 48999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=275.61 Aligned_cols=201 Identities=31% Similarity=0.519 Sum_probs=167.1
Q ss_pred ceeeeeccCCceeEEeeeecCCc---eeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec------CeE
Q 004912 516 SMQCKLGEGGFGPVYKGRLLNGQ---EVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------GEK 584 (724)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~~~g~---~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~------~~~ 584 (724)
.+.+.||+|+||.||+|...+.. .+|+|.++.. .....+.|.+|+.++++++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 46789999999999999875432 5899988653 344567899999999999999999999987532 246
Q ss_pred EEEEEeeCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCC
Q 004912 585 ILILEYMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 661 (724)
+++|||+++++|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999999874322 2345899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 719 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~ 719 (724)
++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 217 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 987644322222223346778999999999999999999999999999999 8889864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-33 Score=300.59 Aligned_cols=200 Identities=32% Similarity=0.444 Sum_probs=174.8
Q ss_pred eeeeeccCCceeEEeeee-cCCc----eeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 517 MQCKLGEGGFGPVYKGRL-LNGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~-~~g~----~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
..++||+|+||+||||.+ ++|+ +||+|++... ..+..+++.+|+.+|++++||||+||+++|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 357999999999999965 4443 6899998654 4456789999999999999999999999998776 7899999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
|+.|.|.++++.+ +..+-.++++.+..|||+||.|||++. ++||||.++||||.+-.++||.|||+|+.+..+..
T Consensus 779 mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999764 345888999999999999999999987 99999999999999999999999999999877654
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGSM 722 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~~ 722 (724)
........-.+.|||-|.+....|+.++|||||||.+||++| |.+|+..-+.
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~ 906 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA 906 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence 444444455789999999999999999999999999999999 9999976553
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=274.63 Aligned_cols=198 Identities=35% Similarity=0.549 Sum_probs=173.5
Q ss_pred cceeeeeccCCceeEEeeeecC-CceeEEEeccccChhhH--HHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGL--KEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~--~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
|++.+.||+|+||.||+++... ++.+|+|++........ ....+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999998865 56899999987654432 23456999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++++|.+++. ....+++.++..++.||++||++||+.+ |+|+||||+||++++++.++|+|||.+..+. ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence 9999999995 3455899999999999999999999998 9999999999999999999999999998641 122
Q ss_pred ccccccccccCccCccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.......++..|+|||++. +..++.++||||||+++|||++|+.||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3344567899999999998 788999999999999999999999999754
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=279.78 Aligned_cols=205 Identities=31% Similarity=0.492 Sum_probs=172.4
Q ss_pred CcceeeeeccCCceeEEeeeec------CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
+|++.+.||+|+||.||+|... ....+|+|.+.... ....+++.+|+.++++++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999753 23578999887543 3345789999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCC
Q 004912 587 ILEYMPNKSLNVFLFDST---------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~N 645 (724)
|+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999985321 1235889999999999999999999988 9999999999
Q ss_pred EEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 646 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 646 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
||+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999986543322222233455778999999999999999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=274.76 Aligned_cols=203 Identities=26% Similarity=0.443 Sum_probs=175.7
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|+||.||+|+.. +++.||||.++.. .......+.+|+.++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47889999999999999999874 6889999987542 3344567899999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 589 EYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
||+++++|..++.... ....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885432 2345889999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..+
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 221 122346888999999999888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=277.80 Aligned_cols=202 Identities=29% Similarity=0.486 Sum_probs=175.8
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.+.|++.++||+|+||.||+|+... ++.+|+|.+........+.+.+|+.++++++|||++++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 3678899999999999999998754 789999999877777788899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|..++... ...+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 9999998887432 345899999999999999999999988 999999999999999999999999998764321
Q ss_pred cccccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
........++..|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 11223456788999999884 345788999999999999999999999653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=279.43 Aligned_cols=201 Identities=26% Similarity=0.435 Sum_probs=177.7
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.++|++.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++......++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 45799999999999999999976 46889999998765555567889999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|..++.. ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999998842 35899999999999999999999998 99999999999999999999999999887643321
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......++..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1233468889999999999999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=281.66 Aligned_cols=209 Identities=30% Similarity=0.488 Sum_probs=177.1
Q ss_pred HhccCcceeeeeccCCceeEEeeeecC------CceeEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEec
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 581 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~ 581 (724)
...++|++.+.||+|+||.||++...+ ...+|+|.++.. ..+...++.+|+.++.++ +||||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 345678999999999999999997642 357999998753 334556789999999999 799999999999999
Q ss_pred CeEEEEEEeeCCCChhHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE
Q 004912 582 GEKILILEYMPNKSLNVFLFDS-------------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (724)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl 648 (724)
+..+++|||+++++|..++... .....+++..+++++.|++.||+|||+.+ |+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999998542 22346899999999999999999999988 9999999999999
Q ss_pred cCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 649 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
+.++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||...+
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 9999999999999987654332222333345678999999999999999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=279.72 Aligned_cols=201 Identities=26% Similarity=0.418 Sum_probs=177.8
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.++|++.+.||+|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46799999999999999999986 46889999999765555567789999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999999842 35789999999999999999999998 99999999999999999999999999987543321
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1233468889999999999999999999999999999999999996544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=279.63 Aligned_cols=203 Identities=31% Similarity=0.478 Sum_probs=170.0
Q ss_pred cCcceeeeeccCCceeEEeeeecC-C--ceeEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLN-G--QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~-g--~~vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV 587 (724)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.|.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 568889999999999999998754 3 24789988753 344567899999999999 799999999999999999999
Q ss_pred EEeeCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCE
Q 004912 588 LEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 654 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 654 (724)
+||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1235889999999999999999999988 9999999999999999999
Q ss_pred EEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 655 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 655 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
||+|||++...... ........+..|+|||++....++.++||||||+++|||++ |+.||...+
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999998643211 11111233567999999999999999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=274.13 Aligned_cols=202 Identities=33% Similarity=0.514 Sum_probs=172.1
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.++|++.++||+|+||.||+|...++..||+|+++... ...++|.+|+.++.+++||||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 45689999999999999999988777789999997533 23467899999999999999999999874 45678999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||.++.+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999998543 2345789999999999999999999998 999999999999999999999999999876433221
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 1223446778999999998999999999999999999999 88888654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=298.53 Aligned_cols=202 Identities=24% Similarity=0.329 Sum_probs=165.9
Q ss_pred hHHHhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCC------ceeeEeeEEE
Q 004912 507 SITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR------NLVRLLGCCV 579 (724)
Q Consensus 507 ~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hp------niv~l~~~~~ 579 (724)
++....++|++.++||+|+||.||+|.+. .++.||||+++... ...+++..|+.++.+++|. +++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445688999999999999999999875 47789999986432 3345567788888887654 5888998887
Q ss_pred ec-CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeccCCCCCEEEcCCC-----
Q 004912 580 EQ-GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDM----- 652 (724)
Q Consensus 580 ~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~----- 652 (724)
.. ...++|||++ +++|.+++.. ...+++.++..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 65 4678899987 6778887743 34689999999999999999999974 6 99999999999998765
Q ss_pred -----------CEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 653 -----------NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 653 -----------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999886432 12334689999999999999999999999999999999999999997543
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=281.25 Aligned_cols=206 Identities=30% Similarity=0.456 Sum_probs=172.1
Q ss_pred ccCcceeeeeccCCceeEEeeeecC---------------CceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN---------------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLL 575 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~---------------g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~ 575 (724)
.++|++.+.||+|+||.||+++..+ ...||||.++.. .....+.|.+|++++.+++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578999999999999999987532 124899998764 334556799999999999999999999
Q ss_pred eEEEecCeEEEEEEeeCCCChhHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCE
Q 004912 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTK---------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 646 (724)
Q Consensus 576 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NI 646 (724)
+++......++||||+++++|.+++..... ...+++..+++++.|+++||+|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999854321 124788999999999999999999998 99999999999
Q ss_pred EEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCC
Q 004912 647 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGLG 720 (724)
Q Consensus 647 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt--G~~p~~~~ 720 (724)
++++++.+||+|||++..+.............++..|+|||.+.+..++.++||||||+++|||++ +..||...
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 999999999999999986543322222233345779999999999999999999999999999998 66777643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=275.85 Aligned_cols=199 Identities=29% Similarity=0.375 Sum_probs=164.7
Q ss_pred eeeccCCceeEEeeeecC---CceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCC
Q 004912 519 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 594 (724)
+.||+|+||.||+|...+ +..+|+|.++... ......|.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999997643 4579999987543 234457899999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccc
Q 004912 595 SLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (724)
Q Consensus 595 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 672 (724)
+|.+++..... ...+++..+.+++.|+++||+|||+.+ ++|+||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999864322 234677788899999999999999998 9999999999999999999999999997654333222
Q ss_pred cccccccccCccCcccccCC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDG-------LFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~-------~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 22334678899999988643 35789999999999999996 99999654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=278.10 Aligned_cols=198 Identities=30% Similarity=0.426 Sum_probs=175.5
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|++|.||++... +++.+|+|.++... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999875 57899999986532 234567899999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999844 346899999999999999999999988 999999999999999999999999999876433
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 233568899999999988889999999999999999999999997554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=288.76 Aligned_cols=198 Identities=28% Similarity=0.339 Sum_probs=168.7
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec------
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------ 581 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~------ 581 (724)
..++|++.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999864 5788999998753 234456788999999999999999999987543
Q ss_pred CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCC
Q 004912 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (724)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 661 (724)
...++||||+++ +|...+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 5666652 23788899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 98754321 223457899999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=275.18 Aligned_cols=198 Identities=27% Similarity=0.375 Sum_probs=162.3
Q ss_pred eeccCCceeEEeeeecC---CceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCC
Q 004912 520 KLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS 595 (724)
Q Consensus 520 ~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gs 595 (724)
.||+|+||.||+|...+ ...+|+|.+.... ......|.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 69999999999997543 3468888876443 3345678999999999999999999999999999999999999999
Q ss_pred hhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 596 LNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 596 L~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
|.+++..... ....++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999865432 233567888999999999999999998 99999999999999999999999999876433222222
Q ss_pred ccccccccCccCcccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~-------~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
.....++..|+|||++.. ..++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 233456778999998743 456889999999999999999 78888643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=275.93 Aligned_cols=203 Identities=31% Similarity=0.462 Sum_probs=170.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCc----eeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
.++|++.++||+|+||.||+|+.. +++ .||+|.++.. .....+++.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 457888999999999999999753 444 4899998654 33456788999999999999999999999875 4577
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+++||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998542 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 43222111222345678999999999999999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=274.26 Aligned_cols=203 Identities=31% Similarity=0.484 Sum_probs=174.2
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
..|++.+.||+|++|.||+|... .++.||+|.++.. ....+++.+|+.++.+++||||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45888899999999999999865 4788999998754 344678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999998542 2345899999999999999999999988 999999999999999999999999999876443211
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.......+..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 1112234668999999999999999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=290.12 Aligned_cols=206 Identities=30% Similarity=0.450 Sum_probs=172.8
Q ss_pred hccCcceeeeeccCCceeEEeeeec------CCceeEEEeccccC-hhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecC
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQG 582 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~ 582 (724)
..++|.+.++||+|+||.||+|++. .+..||||+++... ....+.+.+|+.+|.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456888899999999999999753 24689999997543 233457899999999997 999999999999999
Q ss_pred eEEEEEEeeCCCChhHHHhhcC----------------------------------------------------------
Q 004912 583 EKILILEYMPNKSLNVFLFDST---------------------------------------------------------- 604 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 604 (724)
..++||||+++|+|.++++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999986421
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEE
Q 004912 605 -------------------------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647 (724)
Q Consensus 605 -------------------------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NIL 647 (724)
....+++..+++++.||+.||+|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 1124778889999999999999999987 999999999999
Q ss_pred EcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004912 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 719 (724)
Q Consensus 648 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~ 719 (724)
+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999986533221112223456789999999999899999999999999999998 8999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=276.38 Aligned_cols=200 Identities=26% Similarity=0.448 Sum_probs=174.7
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.++|++.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 457888899999999999999764 5889999998766555667788999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++.. ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..+....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 999999998843 345899999999999999999999998 9999999999999999999999999997664321
Q ss_pred cccccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.......|+..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 2233457899999999874 45688999999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=281.02 Aligned_cols=208 Identities=30% Similarity=0.496 Sum_probs=175.6
Q ss_pred hccCcceeeeeccCCceeEEeeeec--------CCceeEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 580 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~ 580 (724)
..++|.+.+.||+|+||.||+++.. ++..||+|.+... .....+++.+|+.++..+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567889999999999999999641 2457999998754 234567899999999999 89999999999999
Q ss_pred cCeEEEEEEeeCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEE
Q 004912 581 QGEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647 (724)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NIL 647 (724)
....++||||+++++|.+++..... ...+++.++++++.||++||+|||+.+ |+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999865321 235788999999999999999999998 999999999999
Q ss_pred EcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 648 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
+++++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |..||...+
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999987654332222333456778999999999999999999999999999998 788886443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=273.45 Aligned_cols=201 Identities=30% Similarity=0.441 Sum_probs=170.8
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-----ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 584 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-----~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~ 584 (724)
++|++.+.||+|+||.||++... +++.||||.+... .....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57889999999999999999874 4889999987532 123456789999999999999999999988764 457
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||+++++|.+++... ..+++..+.+++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999998532 34788899999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcc-cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 665 FGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
+..... ........++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 533211 1122335688999999999988899999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=282.49 Aligned_cols=197 Identities=26% Similarity=0.426 Sum_probs=160.7
Q ss_pred eeeeccCCceeEEeeeec---CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEe--cCeEEEEEEeeC
Q 004912 518 QCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKILILEYMP 592 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~--~~~~~lV~Ey~~ 592 (724)
.++||+|+||.||+|+.. +++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 358999999999999864 45789999986542 23457889999999999999999998864 346789999986
Q ss_pred CCChhHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE----cCCCCEEEEecCCc
Q 004912 593 NKSLNVFLFDST------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLA 662 (724)
Q Consensus 593 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kL~DFGla 662 (724)
+ +|..++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 7777764221 1235889999999999999999999998 9999999999999 45678999999999
Q ss_pred cccCCCcc-cccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 663 RMFGGDEL-QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 663 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
+.+..... ........+|+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87643221 1123346789999999998774 5899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=275.37 Aligned_cols=200 Identities=28% Similarity=0.453 Sum_probs=173.8
Q ss_pred CcceeeeeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeC
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 592 (724)
.|++.+.||+|+||.||++.... +..+++|.+........+.+.+|+.++..++|||++++++++..+...++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 36778899999999999998754 67889999977666677889999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccc
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 672 (724)
+++|..++.. ....+++..+..++.||++||+|||+.+ ++|+||||+|||++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 9999988753 2346899999999999999999999998 9999999999999999999999999997653221 1
Q ss_pred cccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
......++..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 223456889999999884 455788999999999999999999999644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=275.53 Aligned_cols=201 Identities=32% Similarity=0.455 Sum_probs=171.4
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+|++.+.||+|++|.||+|+.. ++..||||+++... ....+.+.+|+.++.+++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999875 58899999986432 23346788999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
++ ++|.+++........+++..+..++.||++||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 688888755444467899999999999999999999998 9999999999999999999999999997654321
Q ss_pred cccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 112234568899999988654 4789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=287.52 Aligned_cols=198 Identities=29% Similarity=0.348 Sum_probs=168.7
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec------
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------ 581 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~------ 581 (724)
..++|++.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999764 5789999998753 233456788999999999999999999988643
Q ss_pred CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCC
Q 004912 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (724)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 661 (724)
...++||||+++ +|...+. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 346899999976 5555552 23788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 98654321 223457899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=278.91 Aligned_cols=206 Identities=30% Similarity=0.465 Sum_probs=172.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-----------------CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-----------------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVR 573 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-----------------~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~ 573 (724)
.++|++.+.||+|+||.||+++.. +...+|+|.++.. .....++|.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356899999999999999998532 2346899999754 3345678999999999999999999
Q ss_pred EeeEEEecCeEEEEEEeeCCCChhHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCC
Q 004912 574 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645 (724)
Q Consensus 574 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~N 645 (724)
+++++...+..++||||+++++|.+++..... ...+++..+.+++.||+.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999865321 134778899999999999999999998 9999999999
Q ss_pred EEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCC
Q 004912 646 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGLG 720 (724)
Q Consensus 646 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt--G~~p~~~~ 720 (724)
||++.++.++|+|||+++.+.............++..|+|||......++.++||||||+++|||++ |..||...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999987643322222222344678999999888899999999999999999998 77888643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=279.18 Aligned_cols=205 Identities=31% Similarity=0.448 Sum_probs=173.8
Q ss_pred ccCcceeeeeccCCceeEEeeeec------CCceeEEEeccccC-hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGE 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~ 583 (724)
.++|++.+.||+|+||.||++... .+..+|||.++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 457999999999999999999642 24579999987543 34457899999999999 79999999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.++||||+++++|.+++... ....+++.++..++.||+.||+|||+++ |+|+||||+|||++.++.++|+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999998542 2234899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 6643221111222345778999999999999999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=284.25 Aligned_cols=204 Identities=30% Similarity=0.468 Sum_probs=178.1
Q ss_pred HHHhccCcceeeeeccCCceeEEeeeecC---Cc--eeEEEeccc-cChhhHHHHHHHHHHHHHccCCceeeEeeEEEec
Q 004912 508 ITAATENFSMQCKLGEGGFGPVYKGRLLN---GQ--EVAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (724)
Q Consensus 508 i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~---g~--~vAVK~l~~-~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~ 581 (724)
.....+...+.++||.|-||.||+|...+ |. .||||..+. .+++..+.|..|+.+|++++||||++|+|+|.+.
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ 463 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence 34445666777899999999999997532 32 589999987 4566688999999999999999999999999865
Q ss_pred CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCC
Q 004912 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (724)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 661 (724)
..++|||..+.|.|.++|.. ++..|+...+..++.||+.||+|||+.. +|||||..+|||+.+..-+||+|||+
T Consensus 464 -P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred -ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence 67999999999999999954 4456889999999999999999999997 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTG 718 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~ 718 (724)
++.+..+.+.... ...-+..|||||.+.-..++.++|||-|||.+||+|+ |.+||.
T Consensus 538 SR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfq 594 (974)
T KOG4257|consen 538 SRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQ 594 (974)
T ss_pred hhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccc
Confidence 9998776655443 4456789999999999999999999999999999998 999994
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=277.69 Aligned_cols=203 Identities=27% Similarity=0.434 Sum_probs=177.0
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.++|++.+.||+|++|.||++... ++..+|+|.++.......+.|.+|+.++++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999875 5789999999877666778899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|..++... ...+++.++.+++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 9999999998542 345899999999999999999999998 9999999999999999999999999987653221
Q ss_pred cccccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......+++.|+|||.+. ...++.++||||||+++|||++|+.||...+
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 1223456889999999875 3457889999999999999999999997543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=284.50 Aligned_cols=193 Identities=25% Similarity=0.333 Sum_probs=164.8
Q ss_pred HhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
....+|++.+.||+|+||.||+|+.. .++.||+|..... ....|+.++.+++||||+++++++.+....++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34568999999999999999999875 4678999985432 2356899999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+. ++|..++.. ....+++.++.+|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 578877743 3346899999999999999999999998 999999999999999999999999999753221
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 717 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~ 717 (724)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223457899999999999999999999999999999999865544
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=280.63 Aligned_cols=206 Identities=33% Similarity=0.500 Sum_probs=173.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec--------CCceeEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEec
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 581 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~ 581 (724)
.++|.+.++||+|+||.||+++.. ....+|+|.++.. .....+++.+|+.++.++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457889999999999999999642 2457899998754 334567789999999999 699999999999999
Q ss_pred CeEEEEEEeeCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE
Q 004912 582 GEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (724)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl 648 (724)
...++||||+++++|.+++.... ....+++.++.+++.||+.||+|||+.+ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999986532 1245899999999999999999999998 9999999999999
Q ss_pred cCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 649 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999987643322222222334568999999999999999999999999999999 88998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=270.94 Aligned_cols=203 Identities=28% Similarity=0.456 Sum_probs=177.0
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|++|.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999886 6889999988642 2334678999999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 589 EYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
||+++++|..++.... ....+++.++.+++.|+++||+|||+.+ |+|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986432 2455899999999999999999999998 99999999999999999999999999886543
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..+
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 221 122346888999999999889999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=277.89 Aligned_cols=206 Identities=31% Similarity=0.465 Sum_probs=175.4
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-----------------CceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVR 573 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~ 573 (724)
.++|++.+.||+|+||.||++...+ +..||+|.+.... ....+.+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999987643 2458999987543 345678999999999999999999
Q ss_pred EeeEEEecCeEEEEEEeeCCCChhHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCC
Q 004912 574 LLGCCVEQGEKILILEYMPNKSLNVFLFDST--------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645 (724)
Q Consensus 574 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~N 645 (724)
+++++..++..++|+||+++++|..++.... ....+++..++.++.|++.||+|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986533 1235899999999999999999999998 9999999999
Q ss_pred EEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCC
Q 004912 646 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGLG 720 (724)
Q Consensus 646 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt--G~~p~~~~ 720 (724)
|+++.++.++|+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999987644333333334456789999999998899999999999999999998 67787643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=272.38 Aligned_cols=200 Identities=28% Similarity=0.454 Sum_probs=173.0
Q ss_pred CcceeeeeccCCceeEEeeeecCCceeEEEeccccC------hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~------~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
+|.+.+.||+|+||.||+|...+++.+|||.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367788999999999999988888999999886432 22346689999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999843 235789999999999999999999988 99999999999999999999999999976532
Q ss_pred Cc----ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 668 DE----LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 668 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.. .........++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 11 11122335688999999999998999999999999999999999999964
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=273.14 Aligned_cols=203 Identities=30% Similarity=0.492 Sum_probs=171.4
Q ss_pred cCcceeeeeccCCceeEEeeeecC-C---ceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
..|++.+.||+|+||.||+|.+.. + ..||||.++.. .....++|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 347888999999999999998753 2 36999998764 345567899999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++..+..
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998542 345899999999999999999999998 99999999999999999999999999876643
Q ss_pred Ccccccccc-c--ccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 668 DELQGNTKQ-I--VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 668 ~~~~~~~~~-~--~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
......... . ..+..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 221111111 1 12457999999999999999999999999999997 99998543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=305.53 Aligned_cols=207 Identities=26% Similarity=0.384 Sum_probs=171.3
Q ss_pred hccCcceeeeeccCCceeEEeeeecC-CceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 585 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~~ 585 (724)
..++|++.+.||+|+||.||++++.. +..+|+|.+... .......|..|+.++.+|+||||+++++++.+. ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 35689999999999999999998754 678899988643 334567899999999999999999999988654 4689
Q ss_pred EEEEeeCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CceEeccCCCCCEEEcCC---------
Q 004912 586 LILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSR----FRIIHRDLKASNILLDKD--------- 651 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~----~~iiH~Dlkp~NILl~~~--------- 651 (724)
|||||+++++|..+|.... ....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+..
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999986432 23569999999999999999999998541 249999999999999642
Q ss_pred --------CCEEEEecCCccccCCCcccccccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 652 --------MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 652 --------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
..+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||...
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 348999999998764322 2234578999999999864 45899999999999999999999999643
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=285.47 Aligned_cols=203 Identities=25% Similarity=0.416 Sum_probs=180.7
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
....|.+.+.||+|.|+.|..+++. .+..||||.+.+.. ....+.+.+|+.+|..++|||||+++.+...+...|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3567999999999999999999874 58899999997653 33445688999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||..+|.+.+++..+ +.+.+.++..++.|+.+|++|+|+++ |+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 9999999999999543 44667888899999999999999998 99999999999999999999999999988753
Q ss_pred CcccccccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
.......+|++.|.|||++.+..| .+++|+||+|++||-|+.|..||+..+.
T Consensus 208 ---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l 260 (596)
T KOG0586|consen 208 ---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL 260 (596)
T ss_pred ---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc
Confidence 334567899999999999999887 5889999999999999999999986654
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=274.18 Aligned_cols=201 Identities=30% Similarity=0.516 Sum_probs=170.2
Q ss_pred cCcceeeeeccCCceeEEeeeec-----CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 585 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~~ 585 (724)
++|++.+.||+|+||.||++... +++.||+|+++.......+.|.+|+.++.+++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57888999999999999999742 4778999999877767778899999999999999999999987543 4678
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+|+||+++++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998532 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccc-cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 666 GGDELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 666 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 4322111 1111233456999999999999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=308.46 Aligned_cols=210 Identities=26% Similarity=0.329 Sum_probs=183.8
Q ss_pred hhhHHHhccCcceeeeeccCCceeEEeeeecC-CceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe
Q 004912 505 LASITAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 580 (724)
Q Consensus 505 ~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~ 580 (724)
...+....++|+++++||+|+||.|..++++. ++.+|+|++.+. ......-|..|-.+|.--+.+=|++++-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 44556667899999999999999999998864 778999999762 33455678999999998888999999999999
Q ss_pred cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
+...|||||||+||+|-.++.+. ..+++..+..++..|.-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 99999999999999999999433 36999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCccccc----C-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYAL----D-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.+-.+..+. .......+|||.|++||++. + +.|...+|.||+||++||||.|..||-.++
T Consensus 221 sClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads 285 (1317)
T KOG0612|consen 221 SCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS 285 (1317)
T ss_pred hHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence 998876443 33456679999999999984 2 568999999999999999999999997654
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=285.69 Aligned_cols=198 Identities=30% Similarity=0.398 Sum_probs=168.5
Q ss_pred HhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEec-----
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ----- 581 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~----- 581 (724)
...++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999864 57899999986532 23456688999999999999999999887543
Q ss_pred -CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 582 -GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 582 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
...++++|++ +++|..++. ...+++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 788888773 345899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
+++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 99875432 234578999999999877 56899999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=275.87 Aligned_cols=199 Identities=29% Similarity=0.443 Sum_probs=165.1
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHc---cCCceeeEeeEEEec-----C
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVEQ-----G 582 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l---~Hpniv~l~~~~~~~-----~ 582 (724)
+|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788999999999999999875 57899999986532 12234556777777766 699999999988642 3
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
..++||||+++ +|..++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 788877542 2345899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
+.+.... ......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 8764321 223356889999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=271.46 Aligned_cols=202 Identities=35% Similarity=0.521 Sum_probs=172.3
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.++|++.++||+|+||.||+|...++..+|+|.++.... ..+.|.+|+.++++++|||++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 356888999999999999999888888999999876432 3467999999999999999999999875 45688999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++++|.+++... ....+++.++.+++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999998543 2345899999999999999999999998 999999999999999999999999999876433211
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 207 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 1122345678999999988899999999999999999999 89998653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=279.03 Aligned_cols=197 Identities=27% Similarity=0.433 Sum_probs=160.3
Q ss_pred eeeccCCceeEEeeeecC---CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEe--cCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~--~~~~~lV~Ey~~~ 593 (724)
.+||+|+||.||+|+..+ +..||+|.++... ....+.+|+.++++++||||+++++++.. +...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 589999999999998653 5689999986543 23467899999999999999999998854 4567899999875
Q ss_pred CChhHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE----cCCCCEEEEecCCcc
Q 004912 594 KSLNVFLFDS------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLAR 663 (724)
Q Consensus 594 gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kL~DFGla~ 663 (724)
+|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 666665321 12235889999999999999999999998 9999999999999 566789999999998
Q ss_pred ccCCCccc-ccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 664 MFGGDELQ-GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 664 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.+...... .......+|+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 76443211 123345789999999998764 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=271.22 Aligned_cols=205 Identities=30% Similarity=0.446 Sum_probs=172.8
Q ss_pred HhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
.+++++.....||+|+||.||+|++. ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34555656679999999999999865 57789999988776667788999999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-CCCEEEEecCCccccCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGG 667 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~ 667 (724)
||+++++|..++.........++..+..++.||++||+|||+.+ |+||||||+||+++. .+.++|+|||++..+..
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999999864322212278888999999999999999998 999999999999976 67999999999976543
Q ss_pred CcccccccccccccCccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.. .......++..|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 162 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 162 IN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred CC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 22 1222345789999999986644 78999999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=258.86 Aligned_cols=209 Identities=24% Similarity=0.266 Sum_probs=176.0
Q ss_pred HhccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC-----e
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----E 583 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~-----~ 583 (724)
...++|.+.+.||+|||+-||.++. .+++.+|+|++.-...++.+..++|+..-++++|||+++++++...+. +
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3467899999999999999999974 568899999998777778889999999999999999999998875433 4
Q ss_pred EEEEEEeeCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 584 KILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
.|++++|...|+|.+.+..... +..+++.++++|+.+|++||++||+... +++||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999998865443 4479999999999999999999999864 6999999999999999999999999998
Q ss_pred cccCCCccc-------ccccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 663 RMFGGDELQ-------GNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 663 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
....-.-.. .......-|..|.|||.+. +...+.++|||||||+||+|+.|..||+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 765321000 0011234688999999874 34578999999999999999999999974
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=273.94 Aligned_cols=200 Identities=29% Similarity=0.392 Sum_probs=172.0
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999876 58899999986432 2234668899999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|++++.|..++. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998888763 2335899999999999999999999988 9999999999999999999999999998764432
Q ss_pred ccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 1 1223457889999999876 55889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=283.90 Aligned_cols=205 Identities=30% Similarity=0.468 Sum_probs=170.0
Q ss_pred ccCcceeeeeccCCceeEEeeee------cCCceeEEEeccccC-hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEec-C
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ-G 582 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~-~ 582 (724)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46799999999999999999963 346789999997543 33456788999999999 689999999988654 4
Q ss_pred eEEEEEEeeCCCChhHHHhhcCC---------------------------------------------------------
Q 004912 583 EKILILEYMPNKSLNVFLFDSTK--------------------------------------------------------- 605 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 605 (724)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999854210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccccc
Q 004912 606 -------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 678 (724)
Q Consensus 606 -------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 678 (724)
...+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++..+.............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124788889999999999999999998 9999999999999999999999999998753322212222334
Q ss_pred cccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004912 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 719 (724)
Q Consensus 679 gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~ 719 (724)
++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 284 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 5678999999999999999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=276.71 Aligned_cols=201 Identities=25% Similarity=0.424 Sum_probs=172.8
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++|++.+.||+|+||.||++... .+..+|+|.++.. .....+.+.+|+.++.+++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999875 6889999988654 334457899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
+++++|..++........+++..+.+++.||+.||.|||+. + |+|+||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999986543344689999999999999999999974 5 999999999999999999999999999765322
Q ss_pred ccccccccccccCccCcccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 12334678899999988554 3588999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=277.65 Aligned_cols=202 Identities=28% Similarity=0.391 Sum_probs=171.0
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
-++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..+...++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 357899999999999999999875 57889999986442 2334567899999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|++ ++|..++... ...+++..+..++.||++||+|||+.+ |+|+||||+|||+++++.+||+|||++.......
T Consensus 85 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 997 5888887543 345889999999999999999999998 9999999999999999999999999997643221
Q ss_pred ccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234578899999988664 57899999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=273.65 Aligned_cols=204 Identities=31% Similarity=0.481 Sum_probs=172.4
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-Cc----eeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
..+|++.+.||+|+||.||+|...+ +. .+|+|.+.... .....++.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3568888999999999999998643 32 58999887654 3456789999999999999999999999887 7889
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||+++++|.+++... ...+++..+..++.||++||+|||+.+ |+|+||||+||++++++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999998542 334899999999999999999999987 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.............++..|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 53322112222334678999999988899999999999999999999 999997644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=270.43 Aligned_cols=202 Identities=35% Similarity=0.496 Sum_probs=173.7
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.+.|++.++||+|+||.||+|...+++.||+|.+.... ...++|.+|+.++++++||||+++++++ ..+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 46789999999999999999998889999999987543 3456889999999999999999999986 455789999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++++|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999988543 2346899999999999999999999988 999999999999999999999999999876532221
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
......++..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1122345678999999998999999999999999999999 99999643
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=270.00 Aligned_cols=199 Identities=40% Similarity=0.575 Sum_probs=173.8
Q ss_pred eeeccCCceeEEeeeecC----CceeEEEeccccChh-hHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~-~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+|+||.||++.... +..+|+|.++..... ..+.+.+|+.++.+++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 778999999765433 368899999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 594 KSLNVFLFDSTK------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 594 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
++|.+++..... ...+++.++.+++.|+++||+|||+++ ++|+||||+||++++++.+||+|||.+..+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 367999999999999999999999988 99999999999999999999999999988754
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
...........++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 332223344567889999999988899999999999999999999 69999754
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=269.55 Aligned_cols=202 Identities=27% Similarity=0.445 Sum_probs=177.5
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.++|++.+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 467899999999999999999875 4778999999876666778899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++... ...+++.++..++.|++.||+|||+++ |+|+||+|+||++++++.+||+|||++..+....
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 9999999988542 245899999999999999999999998 9999999999999999999999999998754321
Q ss_pred cccccccccccCccCcccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDG---LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.......++..|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 112335678899999999877 8899999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=284.58 Aligned_cols=205 Identities=30% Similarity=0.479 Sum_probs=179.3
Q ss_pred HHhccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.....++.+..+||.|-||.||.|.++. .-.||||.++... -..++|+.|+.+|+.++|||+|+|+|+|..+...|+|
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 3445667888999999999999998865 5689999997543 4678999999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
.|||.+|+|.++|.+- .+..++.--++.++.||..||+||..++ +|||||.++|+|+.++..+||+|||+++++..
T Consensus 342 TEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 9999999999999653 3345777788999999999999999998 99999999999999999999999999999876
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 719 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~ 719 (724)
+.+.. .....-++.|.|||-+....++.|+|||+|||+||||.| |-.||..
T Consensus 418 DTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 418 DTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred Cceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 54332 223344679999999999999999999999999999999 8888854
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=273.03 Aligned_cols=203 Identities=27% Similarity=0.448 Sum_probs=175.8
Q ss_pred cCcceeeeeccCCceeEEeeee-cCCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|++|.||+++. .+++.+|||.+... .....+++.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999986 47889999987643 2334568899999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 589 EYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
||+++++|.+++.... ....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999885422 2456899999999999999999999998 99999999999999999999999999887643
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 221 122346889999999999989999999999999999999999999644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=278.98 Aligned_cols=203 Identities=33% Similarity=0.484 Sum_probs=170.2
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-Cc--eeEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~l 586 (724)
.++|++.+.||+|+||.||+|++.+ +. .+|+|.++.. .....++|.+|+.++.++ +||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 3578889999999999999998743 43 4688887653 334567889999999999 89999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC
Q 004912 587 ILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 653 (724)
||||+++++|.+++.... ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999986432 1235889999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 654 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
+||+|||+++..... ........+..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 999999998643211 11112234668999999988889999999999999999998 99998644
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=262.87 Aligned_cols=195 Identities=27% Similarity=0.379 Sum_probs=168.8
Q ss_pred eeeccCCceeEEeee-ecCCceeEEEeccccChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEEEEEEeeCCCCh
Q 004912 519 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (724)
+.||+|+++.|--+. +.++.++|||++.+.......+..+|++++...+ |+||++|++++.++...|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 589999999999885 4679999999999887788899999999999995 99999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC---EEEEecCCccccCCC-----
Q 004912 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGLARMFGGD----- 668 (724)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~DFGla~~~~~~----- 668 (724)
..+|.+ ...+++.++.++.++|+.||.+||.+| |.||||||+|||...-.. +||+||.++.-+...
T Consensus 164 LshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999854 445899999999999999999999999 999999999999965544 899999988654221
Q ss_pred cccccccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.......+.+|+..|||||+.. ...|+.++|.||||||||-||+|-.||-.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 1122344578999999999862 24588999999999999999999999954
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=269.69 Aligned_cols=203 Identities=36% Similarity=0.538 Sum_probs=176.0
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
..++|++.+.||+|+||.||++...+++.+|||.++... ...+++.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 357899999999999999999998888899999987543 3457899999999999999999999999988899999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++... ....+++.++..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++..+.....
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999998543 2345899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 719 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~ 719 (724)
. .......+..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 207 (261)
T cd05034 159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207 (261)
T ss_pred h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1122234578999999999999999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=271.15 Aligned_cols=201 Identities=32% Similarity=0.522 Sum_probs=172.1
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh---------hhHHHHHHHHHHHHHccCCceeeEeeEEEecCe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---------~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~ 583 (724)
+|.+.+.||+|++|.||+|... +++.+|+|.+..... +..+.+.+|+.++.+++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 578999998864322 123678899999999999999999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.++||||+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999843 345889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccc----ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 664 MFGGDELQ----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 664 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.+...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 77432111 1112345788999999999999999999999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=272.36 Aligned_cols=199 Identities=27% Similarity=0.403 Sum_probs=175.7
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++|++.+.||.|++|.||+|... +++.+|+|.+.... ......+.+|+.+++.++|||++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999875 57899999986543 34557789999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999999843 26899999999999999999999998 9999999999999999999999999998775331
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 2233456888999999999989999999999999999999999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=268.67 Aligned_cols=194 Identities=32% Similarity=0.489 Sum_probs=162.9
Q ss_pred eeccCCceeEEeeeec---CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCC
Q 004912 520 KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS 595 (724)
Q Consensus 520 ~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gs 595 (724)
.||+|+||.||+|.+. .+..||+|++.... ....++|.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999763 34579999987653 334567999999999999999999999875 457899999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc-ccc
Q 004912 596 LNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ-GNT 674 (724)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~ 674 (724)
|.+++.. ....+++..+++++.||++||+|||+++ ++|+||||+|||++.++.+||+|||+++.+...... ...
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999853 2346899999999999999999999998 999999999999999999999999999865432211 111
Q ss_pred cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004912 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 719 (724)
Q Consensus 675 ~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~ 719 (724)
....++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 201 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKK 201 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCc
Confidence 22234578999999988889999999999999999996 9999964
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=268.73 Aligned_cols=202 Identities=25% Similarity=0.397 Sum_probs=175.6
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
+|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++||||+++++.+.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999875 5789999988543 3345678889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++++|.+++... ....+++..+..++.||+.||.|||+++ |+|+||||+||++++++.++|+|||++..+....
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-- 154 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-- 154 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence 999999987532 3345889999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......+++.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 11233568899999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=273.12 Aligned_cols=202 Identities=29% Similarity=0.483 Sum_probs=171.4
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEec------C
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ------G 582 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~------~ 582 (724)
+...|++.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888899999999999999875 47889999986543 3456788999999999 799999999998753 4
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
..++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 578999999999999998542 3346899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
..+.... .......|+..|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 8653321 2233457899999999986 34688899999999999999999999964
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=267.41 Aligned_cols=202 Identities=25% Similarity=0.412 Sum_probs=176.6
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+|+..+.||+|+||.||.++.. +++.+++|.+... .....+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5788999999999999998764 5788999987643 345567889999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++.... ...+++.++..++.|++++|+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999985432 356899999999999999999999988 99999999999999999999999999987644321
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence 2234568999999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=269.39 Aligned_cols=199 Identities=29% Similarity=0.448 Sum_probs=176.3
Q ss_pred cCcceeeeeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
++|++.+.||+|+||.||+|...+ ++.+|+|.++.... .+++.+|+.++++++||||+++++++.++...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999998865 78999999875433 678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-- 153 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-- 153 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc--
Confidence 99999999853 2356899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1223345788999999999999999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=270.21 Aligned_cols=201 Identities=30% Similarity=0.449 Sum_probs=170.5
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-----hhhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 584 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~ 584 (724)
.+|+..+.||+|+||.||++... .++.||+|++.... .+..+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888899999999999999874 58899999885431 23456789999999999999999999988753 567
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++++||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999843 234889999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCc-ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 665 FGGDE-LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 665 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
+.... .........++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 53211 11112234578899999999998999999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=273.53 Aligned_cols=198 Identities=35% Similarity=0.473 Sum_probs=167.1
Q ss_pred cceeeeeccCCceeEEeeee-----cCCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeEEE
Q 004912 515 FSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKIL 586 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~~l 586 (724)
|++.+.||+|+||.||++.. .+++.||+|.++... ....+.|.+|+.++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 47889999999999987642 357789999987543 34567889999999999999999999988754 35789
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++++|.+++.. ..+++.++..++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999843 34899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccc-cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 667 GDELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 667 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 322111 11223456679999999988999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=275.63 Aligned_cols=204 Identities=29% Similarity=0.490 Sum_probs=173.2
Q ss_pred ccCcceeeeeccCCceeEEeeeec------CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~ 584 (724)
.++|++.+.||+|+||.||++... ++..+|+|.++... ....++|.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888999999999999999763 46789999987543 34457799999999999999999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCC
Q 004912 585 ILILEYMPNKSLNVFLFDST-------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~N 645 (724)
++||||+++++|.+++.... ....+++.+++.++.||+.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986421 1234788999999999999999999998 9999999999
Q ss_pred EEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 004912 646 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTG 718 (724)
Q Consensus 646 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~ 718 (724)
|++++++.++|+|||++..+..............+..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999986543322222223345678999999999999999999999999999998 888884
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=275.78 Aligned_cols=203 Identities=24% Similarity=0.324 Sum_probs=172.5
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|+||.||++... .++.||+|.+.... ....+.+.+|+.++..++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999875 46789999986543 234567889999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 345899999999999999999999998 999999999999999999999999998742110
Q ss_pred c-------------ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 E-------------LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~-------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. .........++..|+|||.+....++.++||||||+++|||++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~ 220 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0 0001122457889999999998899999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=270.68 Aligned_cols=205 Identities=32% Similarity=0.497 Sum_probs=172.6
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-C---ceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.++|+..+.||+|+||.||+|.+.. + ..+|+|.++.. .....+++.+|++++.+++|||++++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3467888999999999999998753 3 36999998754 34456789999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++++|..++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999998542 345899999999999999999999998 9999999999999999999999999998664
Q ss_pred CCccccc-ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 667 GDELQGN-TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
....... ......+..|+|||++....++.++||||||+++|||++ |+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 3221111 111223457999999998899999999999999999998 999996443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=268.59 Aligned_cols=206 Identities=28% Similarity=0.429 Sum_probs=177.9
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++|++.+.||.|+||.||+|... ++..+|+|++.... ....+.+.+|+.+++.++|+|++++++.+..+...++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999864 57889999986532 33567899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865433356899999999999999999999998 99999999999999999999999999987654322
Q ss_pred c--ccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 Q--GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. .......++..|+|||.+... .++.++|+||||+++|||++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 1 122335688999999998877 78999999999999999999999996543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=270.28 Aligned_cols=191 Identities=24% Similarity=0.369 Sum_probs=162.0
Q ss_pred eeeccCCceeEEeeeecC-------------CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 519 CKLGEGGFGPVYKGRLLN-------------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~-------------g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
+.||+|+||.||+|.... ...||+|.+..........|.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 2258999987665556678999999999999999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC-------EEEEe
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-------PKISD 658 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-------~kL~D 658 (724)
+||||+++++|..++.. ....+++..+++++.||++||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988743 2345899999999999999999999998 999999999999987654 89999
Q ss_pred cCCccccCCCcccccccccccccCccCccccc-CCCCCchhhHHHHHHHHHHHH-cCCCCCCCC
Q 004912 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETL-SSKKNTGLG 720 (724)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~ell-tG~~p~~~~ 720 (724)
||++..+.. .....++..|+|||.+. ...++.++||||||+++|||+ .|+.|+...
T Consensus 156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 999876432 12345788999999887 467899999999999999998 588888643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=266.49 Aligned_cols=196 Identities=31% Similarity=0.439 Sum_probs=168.3
Q ss_pred eeeccCCceeEEeeeecCCceeEEEeccccCh-hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCChh
Q 004912 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN 597 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~ 597 (724)
++||+|+||.||+|...+++.+|+|.++.... .....|.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 37999999999999988889999999876543 33457899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccccccc
Q 004912 598 VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677 (724)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 677 (724)
+++... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 988532 345889999999999999999999998 999999999999999999999999999765332211 11122
Q ss_pred ccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 678 ~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
.++..|+|||++....++.++||||||+++|||++ |..||...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 34678999999998899999999999999999999 99998643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=271.31 Aligned_cols=204 Identities=30% Similarity=0.476 Sum_probs=172.3
Q ss_pred ccCcceeeeeccCCceeEEeeeecC----CceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
..+|++.+.||+|+||.||+|+... +..+|+|.++... ....+.|.+|+.++.+++||||+++++++.+++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 3568889999999999999997642 3379999986542 3446789999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++++|.+++... ...+++.++.+++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++..+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999998543 245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccc-cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 667 GDELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 667 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~ 213 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence 322111 1112233568999999999899999999999999999987 99998643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=268.52 Aligned_cols=194 Identities=33% Similarity=0.474 Sum_probs=164.0
Q ss_pred eeccCCceeEEeeee---cCCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCC
Q 004912 520 KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (724)
Q Consensus 520 ~LG~G~fG~Vy~~~~---~~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 594 (724)
+||+|+||.||+|.. .++..+|+|+++... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 346789999986543 335678999999999999999999999875 45678999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc-cc
Q 004912 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ-GN 673 (724)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~ 673 (724)
+|.+++.. ...+++..+.+++.|++.||+|||+++ |+||||||.||++++++.+||+|||+++.+...... ..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999843 345899999999999999999999998 999999999999999999999999999876433211 11
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 122344679999999988889999999999999999998 99999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=280.63 Aligned_cols=207 Identities=30% Similarity=0.486 Sum_probs=173.6
Q ss_pred ccCcceeeeeccCCceeEEeeeecC--------CceeEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEec
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 581 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~ 581 (724)
..+|++.+.||+|+||.||+++... ...||+|.++.. .....+++.+|+.++.++ +||||+++++++.+.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3468899999999999999996421 236899988754 334567899999999999 799999999999999
Q ss_pred CeEEEEEEeeCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE
Q 004912 582 GEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (724)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl 648 (724)
+..++++||+++++|.+++.... ....+++.+++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999986422 2235888999999999999999999998 9999999999999
Q ss_pred cCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 649 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
+.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..||...+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999987644322222223344568999999999999999999999999999998 888886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=267.66 Aligned_cols=201 Identities=34% Similarity=0.518 Sum_probs=171.3
Q ss_pred cCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeC
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 592 (724)
++|++.+.||+|++|.||++....+..+|+|++.... ...+.+.+|+.++++++|||++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688899999999999999988777789999886543 34567899999999999999999999875 456789999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccc
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 672 (724)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++..+......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999998643 2345889999999999999999999998 999999999999999999999999999876433211
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 207 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1122345678999999998999999999999999999999 89998643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=286.93 Aligned_cols=193 Identities=32% Similarity=0.477 Sum_probs=166.0
Q ss_pred eeeeeccCCceeEEeeeec-CCceeEEEecc----ccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe--EEEEEE
Q 004912 517 MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE--KILILE 589 (724)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~----~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~--~~lV~E 589 (724)
..++||+|+|-+||||.+. +|-+||=-.++ .+.+...++|..|+.+|+.|+||||++++..+.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3468999999999999774 47777633222 2355677999999999999999999999999987655 779999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-CCCEEEEecCCccccCCC
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGD 668 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~~ 668 (724)
.|..|+|..|+.++ +.++.+.+.++++||++||.|||++. +||||||||..||+|+. .|.|||+|+|+|..+...
T Consensus 124 L~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999999554 34888999999999999999999987 57999999999999975 589999999999987543
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
. ...+.|||.|||||+.. ..|+..+||||||+.|+||.|+..||.
T Consensus 200 ~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 200 H----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred c----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 2 34479999999999776 889999999999999999999999996
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=268.49 Aligned_cols=196 Identities=32% Similarity=0.435 Sum_probs=169.0
Q ss_pred eeeccCCceeEEeeeecC--C--ceeEEEeccccCh-hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~--g--~~vAVK~l~~~~~-~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+|++|.||+|.+.+ + ..||||.++.... ...++|.+|+.++++++||||+++++.+.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 2 3689999987655 567889999999999999999999999888 889999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc-c
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ-G 672 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~ 672 (724)
++|.+++..... ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865432 46899999999999999999999998 999999999999999999999999999876442211 1
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 719 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~ 719 (724)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 1123456789999999998899999999999999999999 9999854
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=268.12 Aligned_cols=198 Identities=31% Similarity=0.451 Sum_probs=173.3
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-----hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999876 68899999886533 23567899999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
+||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 345889999999999999999999998 99999999999999999999999999887543
Q ss_pred CcccccccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.. ......++..|+|||.+.... ++.++|+||||+++|||++|+.||...
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 22 223456889999999988776 899999999999999999999999654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=277.90 Aligned_cols=199 Identities=21% Similarity=0.278 Sum_probs=165.7
Q ss_pred eeeeeccC--CceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 517 MQCKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 517 ~~~~LG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
+.++||+| +|++||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999774 68899999986542 334567888999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc-
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL- 670 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~- 670 (724)
++++|.+++.... ...+++..+.+++.||+.||+|||+.+ |+||||||+|||++.++.+++.||+.+........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985432 234899999999999999999999998 99999999999999999999999987544321110
Q ss_pred ----cccccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 671 ----QGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 671 ----~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 011122356788999999876 4589999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=277.09 Aligned_cols=200 Identities=26% Similarity=0.409 Sum_probs=173.8
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
+.|.....||+|+||.||++... ++..||||.+........+.+.+|+.++.+++||||+++++.+...+..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 33444568999999999999874 57899999987666566778999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++++|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||++++++.++|+|||++..+....
T Consensus 102 ~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-- 172 (292)
T cd06658 102 EGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-- 172 (292)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence 99999998732 34889999999999999999999998 9999999999999999999999999997654322
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12233568899999999998899999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=266.46 Aligned_cols=198 Identities=33% Similarity=0.471 Sum_probs=169.9
Q ss_pred eeeccCCceeEEeeeecCCceeEEEeccccChh-hHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCChh
Q 004912 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN 597 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~ 597 (724)
++||+|+||.||++.+.+++.||+|+++..... ..+.|.+|+.++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 5678999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccccccc
Q 004912 598 VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677 (724)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 677 (724)
+++... ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998542 235789999999999999999999998 999999999999999999999999999865432222111223
Q ss_pred ccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 678 ~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
..+..|+|||.+.+..++.++||||||+++|||++ |..||...+
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 34667999999998899999999999999999999 889986543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=287.08 Aligned_cols=191 Identities=32% Similarity=0.548 Sum_probs=171.9
Q ss_pred eeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCChhH
Q 004912 520 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNV 598 (724)
Q Consensus 520 ~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 598 (724)
+||+|.||+||-|++.+ ...+|||.+........+-+.+|+.+-++|+|.|||+++|.+.+++..-+.||.+|||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999998865 45799999988777777889999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc-CCCCEEEEecCCccccCCCccccccc
Q 004912 599 FLFDSTKKRLL--NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTK 675 (724)
Q Consensus 599 ~l~~~~~~~~l--~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~ 675 (724)
+|.. +-+++ ++..+-.+.+||++||.|||++. |||||||-.||||+ -.|.+||+|||-++.+.+ ....+.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence 9953 44556 77888899999999999999998 99999999999996 568999999999998854 445567
Q ss_pred ccccccCccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCCC
Q 004912 676 QIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNT 717 (724)
Q Consensus 676 ~~~gt~~y~aPE~~~~~~--~s~k~DVwSlGvil~elltG~~p~ 717 (724)
++.||..|||||++..++ |..++|||||||.+.||.||++||
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF 778 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPF 778 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCe
Confidence 789999999999997764 889999999999999999999999
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=272.43 Aligned_cols=211 Identities=26% Similarity=0.351 Sum_probs=175.6
Q ss_pred chhhHHHhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEE--
Q 004912 504 SLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCV-- 579 (724)
Q Consensus 504 ~~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~-- 579 (724)
.+..+....++|++.+.||+|+||.||++... +++.+|+|.++... ....++.+|+.++.++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34555667889999999999999999999774 47899999886532 2346788999999999 6999999999884
Q ss_pred ---ecCeEEEEEEeeCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEE
Q 004912 580 ---EQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655 (724)
Q Consensus 580 ---~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 655 (724)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 335689999999999999987542 23456889999999999999999999988 99999999999999999999
Q ss_pred EEecCCccccCCCcccccccccccccCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 656 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
|+|||+++.+..... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 999999987643221 2233568999999998753 45789999999999999999999998644
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=264.01 Aligned_cols=205 Identities=27% Similarity=0.383 Sum_probs=169.5
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-----CceeEEEeccccChh--hHHHHHHHHHHHHHccCCceeeEeeEEEe-cCe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGE 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~--~~~~f~~E~~il~~l~Hpniv~l~~~~~~-~~~ 583 (724)
-..|+....||+|.+|.||||.-.+ ...+|+|+++..... ......+|+.+++.++||||+.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4568888999999999999995432 337999999765322 23456789999999999999999999887 778
Q ss_pred EEEEEEeeCCCChhHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC----CCEEEE
Q 004912 584 KILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD----MNPKIS 657 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kL~ 657 (724)
.+|++||.+. +|.++++.+ .+...++...+..|+.||+.|+.|||+.- |+||||||.||||..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999876 677777532 33457899999999999999999999986 9999999999999876 999999
Q ss_pred ecCCccccCCCccc-ccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 658 DFGLARMFGGDELQ-GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 658 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
|||+|+.+...-.. .....++-|..|.|||.+.+. .||.+.|||+.|||+.|||+-++.|...
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999998543211 123456779999999999885 5899999999999999999999888654
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=267.23 Aligned_cols=199 Identities=32% Similarity=0.510 Sum_probs=174.2
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.++|++.+.||+|+||.||++.. .++.||||.+..... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 45788899999999999999987 478999999976543 5678999999999999999999999999889999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 9999999985432 235899999999999999999999998 9999999999999999999999999998763221
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.....+..|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 204 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 12334668999999998899999999999999999997 999986543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=274.86 Aligned_cols=205 Identities=26% Similarity=0.333 Sum_probs=175.7
Q ss_pred cCcceeeeeccCCceeEEeeeecC-CceeEEEeccccCh---hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~---~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|++|.||++...+ ++.+|+|.+..... ...+.+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468889999999999999998764 88999999875432 25567899999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++++|.+++... ....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988532 3356899999999999999999999998 999999999999999999999999998765321
Q ss_pred ccc---------------------------ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQ---------------------------GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
... .......|+..|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 100 01123468899999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=264.81 Aligned_cols=202 Identities=28% Similarity=0.413 Sum_probs=173.3
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe-cCeEEEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEKILILE 589 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~-~~~~~lV~E 589 (724)
+|++.+.||+|++|.||++... +++.+|+|++... .....+.+.+|+.++++++|||++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999875 4678999998643 23455678999999999999999999988764 446789999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++++|.+++... ....+++.++.+++.|++.|+++||+.+ |+|+||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999998643 2345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......+++.|+|||++.+..++.++||||||++++||++|+.||...+
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 22334568899999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=266.64 Aligned_cols=203 Identities=33% Similarity=0.467 Sum_probs=174.2
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.++|++.+.||+|+||.||++...++..+|+|.++... ...+.|.+|+.++++++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 56789999999999999999988778889999887543 345788999999999999999999999887 7789999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++++|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999998543 2345788999999999999999999988 999999999999999999999999999876432211
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
......++..|+|||++....++.++|+||||+++||+++ |+.||...+
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence 1222345678999999998899999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=273.85 Aligned_cols=201 Identities=26% Similarity=0.366 Sum_probs=172.1
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh--hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++|++.++||+|+||.||+|... +++.+|+|++..... ...+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999885 478999999865322 235678899999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++++|..+... ...+++.++..++.||++||+|||+.+ |+|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887632 234899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......++..|+|||++.+ ..++.++||||||+++|||++|++||..++
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 12233467889999998875 457889999999999999999999996443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=276.33 Aligned_cols=196 Identities=29% Similarity=0.437 Sum_probs=171.3
Q ss_pred ceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCC
Q 004912 516 SMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (724)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 594 (724)
+....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 33458999999999999874 58899999987655555677899999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccc
Q 004912 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674 (724)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 674 (724)
+|..++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+.... ...
T Consensus 104 ~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~ 174 (297)
T cd06659 104 ALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKR 174 (297)
T ss_pred CHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccc
Confidence 99988732 35889999999999999999999998 9999999999999999999999999997654322 112
Q ss_pred cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 675 ~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
....++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3356889999999999989999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=269.01 Aligned_cols=203 Identities=27% Similarity=0.401 Sum_probs=171.1
Q ss_pred ccCcceeeeeccCCceeEEeeeecC----CceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.++|.+.++||+|+||.||+|...+ ...||||...... .+..+.|.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568889999999999999997643 2468999987654 4556789999999999999999999998865 45789
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++++|.+++... ...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998542 235899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
...... .....++..|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 432211 122344568999999988889999999999999999996 999996543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=272.05 Aligned_cols=200 Identities=32% Similarity=0.530 Sum_probs=169.7
Q ss_pred cCcceeeeeccCCceeEEeeee-----cCCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 584 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~ 584 (724)
+.|++.+.||+|+||.||+++. .++..||+|.++... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578889999999999999974 247789999987543 44567899999999999999999999998875 567
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||+++++|.+++... ...+++.++..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998532 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004912 665 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 717 (724)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~ 717 (724)
+...... .......++..|+|||++.+..++.++||||||+++|||++++.|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 6432211 1122345677899999999889999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=268.99 Aligned_cols=202 Identities=28% Similarity=0.467 Sum_probs=172.9
Q ss_pred CcceeeeeccCCceeEEeeee-cCCceeEEEeccccC------hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~------~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
+|+..+.||+|++|.||++.. .+++.+|+|.++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999976 458899999986432 2245789999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC-CEEEEecCCcccc
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMF 665 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~~ 665 (724)
|+||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999853 345889999999999999999999998 99999999999998776 5999999999876
Q ss_pred CCCccc--ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 666 GGDELQ--GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
...... .......++..|+|||.+.+..++.++||||+|++++||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 432111 11223468899999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=265.30 Aligned_cols=201 Identities=30% Similarity=0.494 Sum_probs=173.0
Q ss_pred cCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeC
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 592 (724)
.+|++.+.||+|+||.||++...+++.+|+|.++... ....+|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4678889999999999999988778899999986543 234678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccc
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 672 (724)
+++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999988532 245889999999999999999999998 9999999999999999999999999998654332111
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
.....++.+|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 122335678999999998899999999999999999998 99998644
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=278.35 Aligned_cols=195 Identities=28% Similarity=0.462 Sum_probs=170.1
Q ss_pred eeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCC
Q 004912 518 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 594 (724)
.++||.|-||+||-|+++ +|+.||||++.+. ..+...++.+|+.||.+++||.||.+-..|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 378999999999999874 6999999998653 2345578999999999999999999999999999999999999665
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC---CCCEEEEecCCccccCCCccc
Q 004912 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFGla~~~~~~~~~ 671 (724)
-|.-+| . .+++.|++..-..++.||+.||.|||.++ |+|+||||+||||.+ .-.+||+|||+|+.++...+
T Consensus 649 MLEMIL-S-sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMIL-S-SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHH-H-hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 555555 3 34556888888889999999999999999 999999999999964 35799999999999876543
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
...++||+.|+|||++.++.|+..-|+||.|||+|--|+|-.||.-+
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 44579999999999999999999999999999999999999999754
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=274.33 Aligned_cols=203 Identities=33% Similarity=0.515 Sum_probs=169.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCc----eeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
.++|+..+.||+|+||.||+|... ++. .+|+|.+.... .....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356778899999999999999764 343 47999886543 23345789999999999999999999998754 567
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999998542 335889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 54322222233445779999999999999999999999999999997 99998643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=277.50 Aligned_cols=204 Identities=29% Similarity=0.407 Sum_probs=174.7
Q ss_pred HHHhccCcceeeeeccCCceeEEeeeecCCceeEEEecc--ccChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeE
Q 004912 508 ITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS--NQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 508 i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~--~~~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~ 584 (724)
+......|++.++||.||-+.||++...+.+.+|+|+.. ..+.+....|.+|+..|.+|+ |.+|++|++|-..++..
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 344567899999999999999999998888899999764 346677889999999999995 99999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
|||||| ...+|..+|...... ...| .+..+..||+.|+.++|+++ |||.||||.|+|+- .|.+||+|||+|..
T Consensus 436 YmvmE~-Gd~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMEC-GDIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred EEEeec-ccccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 999997 466899998543322 2223 67789999999999999999 99999999999995 46899999999999
Q ss_pred cCCCcccccccccccccCccCcccccCCC-----------CCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYMSPEYALDGL-----------FSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
+..+...-.....+||+.||+||.+.... .++++||||||||||+|+.|+.||+
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~ 573 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG 573 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence 88776666666789999999999885433 4678999999999999999999996
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=267.78 Aligned_cols=196 Identities=33% Similarity=0.495 Sum_probs=164.1
Q ss_pred eeeccCCceeEEeeeecC-Cc--eeEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+|+||.||+|.+.+ +. .+|+|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 33 5788988753 344567899999999999 799999999999999999999999999
Q ss_pred CChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 594 KSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 594 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
++|.+++.... ....+++.++.+++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1235889999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
++..... .........+..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 9864221 111112234567999999988899999999999999999997 99999643
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=271.00 Aligned_cols=201 Identities=29% Similarity=0.359 Sum_probs=168.6
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh-hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++|+||+++++++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999764 588999999865432 23346789999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+. ++|..++... ...+.+.++..++.||+.||+|||+.+ |+|+||||+|||++.++++||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 6776666432 245788889999999999999999998 999999999999999999999999999764322
Q ss_pred cccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
. .......++..|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 112234578899999998764 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=270.32 Aligned_cols=199 Identities=37% Similarity=0.543 Sum_probs=168.2
Q ss_pred eeeccCCceeEEeeeecC-------CceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 519 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+.||+|+||.||+|+..+ +..+|||.+.... .....+|.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997643 2578999886543 34567899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC-----CEEEEecCC
Q 004912 591 MPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-----NPKISDFGL 661 (724)
Q Consensus 591 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-----~~kL~DFGl 661 (724)
+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 2234789999999999999999999988 99999999999999877 899999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
++.+.............++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 987644332222233455789999999999999999999999999999998 99998643
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=265.86 Aligned_cols=198 Identities=32% Similarity=0.496 Sum_probs=169.2
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEE-ecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV-EQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~-~~~~~~lV~Ey 590 (724)
.++|++.+.||+|+||.||++.. .+..+|+|.++... ..+.|.+|+.++++++|+|++++++++. +++..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 35788899999999999999976 47889999986533 3567899999999999999999999765 44578999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++... ....+++..+.+++.||+.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 82 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999998543 2335889999999999999999999998 9999999999999999999999999987653221
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 22344568999999998899999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=266.11 Aligned_cols=202 Identities=31% Similarity=0.444 Sum_probs=171.5
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-----ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 584 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-----~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~ 584 (724)
.+|++.+.||+|+||.||+|... +++.||+|.+... ..+..+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999874 5889999987432 234456889999999999999999999998764 457
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++|+||+++++|.+++.. ...+++..+.+++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998843 234889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcc-cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 665 FGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
+..... ........++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 532111 11122356889999999999888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=268.92 Aligned_cols=203 Identities=32% Similarity=0.442 Sum_probs=173.5
Q ss_pred cCcceeeeeccCCceeEEeeeec------CCceeEEEeccccChh-hHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
++|++.+.||+|+||.||+|+.. +.+.+++|.+...... ..+++.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999864 2457999998765444 5678999999999999999999999999988999
Q ss_pred EEEEeeCCCChhHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEec
Q 004912 586 LILEYMPNKSLNVFLFDSTKK------RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF 659 (724)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998643321 25899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004912 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 719 (724)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~ 719 (724)
|+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99875432221 12233456778999999988889999999999999999999 8888854
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=270.73 Aligned_cols=200 Identities=29% Similarity=0.395 Sum_probs=169.1
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh-hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++|++.+.||+|++|.||+|... +++.||||.+..... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999875 578999999865432 2234577899999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++ +|.+++... ...+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 157 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS- 157 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC-
Confidence 985 898887543 236889999999999999999999998 9999999999999999999999999987543211
Q ss_pred cccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...
T Consensus 158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11122346789999998876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=266.66 Aligned_cols=189 Identities=28% Similarity=0.454 Sum_probs=161.6
Q ss_pred eeeccCCceeEEeeeecCCc-----------eeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 519 CKLGEGGFGPVYKGRLLNGQ-----------EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~-----------~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999886533 5788887654433 6889999999999999999999999988 778999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC-------CEEEEecC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-------NPKISDFG 660 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-------~~kL~DFG 660 (724)
|||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999986432 26899999999999999999999988 99999999999999887 79999999
Q ss_pred CccccCCCcccccccccccccCccCcccccCC--CCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
++..... .....++..|+|||++... .++.++||||||+++|||++ |..|+...
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 9986533 1223567789999998877 78999999999999999999 57777554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=272.09 Aligned_cols=199 Identities=27% Similarity=0.403 Sum_probs=173.8
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++|++.+.||+|+||.||++... +++.+|+|++... .....+.+.+|++++..++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888899999999999999865 5788999987654 334567899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
+++++|..++.. .+.+++..+..++.|++.||.|||+ .+ ++|+||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999998743 3458999999999999999999997 45 999999999999999999999999998754221
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 1223578999999999988899999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=269.50 Aligned_cols=190 Identities=25% Similarity=0.355 Sum_probs=159.7
Q ss_pred eeccCCceeEEeeeecC-------------------------CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeE
Q 004912 520 KLGEGGFGPVYKGRLLN-------------------------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574 (724)
Q Consensus 520 ~LG~G~fG~Vy~~~~~~-------------------------g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l 574 (724)
.||+|+||.||+|.+.. ...||+|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999876555556788999999999999999999
Q ss_pred eeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC--
Q 004912 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-- 652 (724)
Q Consensus 575 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-- 652 (724)
++++.+....++||||+++++|..++.. ....+++..+.+++.||++||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998853 2345889999999999999999999988 99999999999997643
Q ss_pred -----CEEEEecCCccccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHH-cCCCCCCCC
Q 004912 653 -----NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETL-SSKKNTGLG 720 (724)
Q Consensus 653 -----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~ell-tG~~p~~~~ 720 (724)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 3899999988653221 12356788999998865 56899999999999999995 699998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=268.19 Aligned_cols=199 Identities=26% Similarity=0.429 Sum_probs=173.8
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
..|+..+.||.|+||.||+|... .+..||+|.+.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34677789999999999999875 57899999986543 44567899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998842 35889999999999999999999988 99999999999999999999999999987644321
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 122346788999999999889999999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=268.89 Aligned_cols=200 Identities=29% Similarity=0.428 Sum_probs=172.9
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+|++.+.||+|++|.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788999999999999999874 58899999987543 33457899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+ +++|.+++.... ..+++.++..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+.....
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999985433 56899999999999999999999998 99999999999999999999999999987644321
Q ss_pred cccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.......++..|+|||.+.+. .++.++||||+|++++||++|+.||...
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 123345788999999988654 4689999999999999999998888543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=271.21 Aligned_cols=201 Identities=27% Similarity=0.433 Sum_probs=176.6
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.++|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++|||++++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 468899999999999999999764 5788999998755555567889999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..+.....
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999843 34789999999999999999999998 99999999999999999999999999876643322
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2233468889999999998889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=318.41 Aligned_cols=190 Identities=27% Similarity=0.483 Sum_probs=162.2
Q ss_pred cCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
..+...+.||+|+||.||+|+. .++..||||+++..... ..+|++++++++||||++++++|.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4566778999999999999987 46889999998654322 235688999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++|+|.+++. .++|.++.+|+.||++||+|||.....+|+||||||+||+++.++.+++. |+.+.....
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 9999999984 28899999999999999999996644569999999999999999888876 666544321
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.....+|+.|||||++.+..++.|+|||||||++|||++|+.||..
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 1223678999999999999999999999999999999999999853
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=271.66 Aligned_cols=197 Identities=27% Similarity=0.435 Sum_probs=172.0
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4667789999999999999764 47789999986443 345678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++++|.+++. ...+++..+..++.||++|++|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 9999999873 245889999999999999999999988 9999999999999999999999999998764322
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.......++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 112234678899999999999999999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=267.56 Aligned_cols=200 Identities=29% Similarity=0.424 Sum_probs=170.4
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC----------hhhHHHHHHHHHHHHHccCCceeeEeeEEEecC
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS----------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 582 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~----------~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~ 582 (724)
+|.+.+.||+|+||.||+|... +++.+|+|.++... ....+.+.+|+.++.+++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999764 58899999875321 112356889999999999999999999999999
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998543 46899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
+...............++..|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 8654322122233456889999999987655 78999999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=267.72 Aligned_cols=197 Identities=23% Similarity=0.368 Sum_probs=160.1
Q ss_pred eeccCCceeEEeeeecCCc---eeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCC
Q 004912 520 KLGEGGFGPVYKGRLLNGQ---EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS 595 (724)
Q Consensus 520 ~LG~G~fG~Vy~~~~~~g~---~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gs 595 (724)
.||+|+||.||+++..++. .+++|.++... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 6999999999999764433 45677765433 3456789999999999999999999999999999999999999999
Q ss_pred hhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccc
Q 004912 596 LNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674 (724)
Q Consensus 596 L~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 674 (724)
|.+++..... ...+++..+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999865322 234677788899999999999999988 999999999999999999999999998643222222222
Q ss_pred cccccccCccCcccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004912 675 KQIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLS-SKKNTGL 719 (724)
Q Consensus 675 ~~~~gt~~y~aPE~~~~-------~~~s~k~DVwSlGvil~ellt-G~~p~~~ 719 (724)
....++..|+|||++.. ..++.++||||||+++|||++ |..||..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 34567889999998753 245789999999999999997 5678754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=273.85 Aligned_cols=204 Identities=26% Similarity=0.396 Sum_probs=169.9
Q ss_pred CcceeeeeccCCceeEEeeeecC---CceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 585 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~~ 585 (724)
+|++.++||+|++|.||+|.... ++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999998754 7899999997633 34456788999999999999999999999988 7899
Q ss_pred EEEEeeCCCChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC----CCCEEEEec
Q 004912 586 LILEYMPNKSLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK----DMNPKISDF 659 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kL~DF 659 (724)
+||||+++ +|..++..... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 56665533222 236899999999999999999999998 999999999999999 899999999
Q ss_pred CCccccCCCcc-cccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 660 GLARMFGGDEL-QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 660 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
|++..+..... ........++..|+|||.+.+ ..++.++||||||++++||++|+.||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99987643221 112234567899999998876 458999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=268.89 Aligned_cols=212 Identities=28% Similarity=0.370 Sum_probs=176.3
Q ss_pred cchhhHHHhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEe
Q 004912 503 FSLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 580 (724)
Q Consensus 503 ~~~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~ 580 (724)
+...++....++|++.+.||+|+||.||++... +++.+|+|.+.... ...+++.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344556667889999999999999999999874 57899999986543 2346678899999999 89999999999875
Q ss_pred cC-----eEEEEEEeeCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCE
Q 004912 581 QG-----EKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 654 (724)
Q Consensus 581 ~~-----~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 654 (724)
.+ ..++||||+++++|.+++... .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 579999999999999988542 23446899999999999999999999998 9999999999999999999
Q ss_pred EEEecCCccccCCCcccccccccccccCccCcccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 655 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 655 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
||+|||++..+..... ......++..|+|||.+... .++.++|||||||++|||++|+.||...
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 9999999987543221 12234688999999987543 3688999999999999999999998644
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=269.44 Aligned_cols=201 Identities=27% Similarity=0.384 Sum_probs=173.5
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++|++.+.||+|++|.||+|... +++.||||+++.. .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999876 4789999998653 23345788999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|++++.+..++. +...+++.++..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999887776653 2345899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
. .......++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 122345678899999999888 8899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=282.86 Aligned_cols=192 Identities=35% Similarity=0.518 Sum_probs=167.6
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.|+-.+.||.|+||.||-+++. +...||||+++-. +.+.+.++..|+..|.+++|||++.+-|||..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4666689999999999999874 5678999998643 34457789999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+- |+-.+++.-+ +++|.+.++.-|..+.++||+|||+++ .||||||+.||||.+.|.|||+|||.|....+
T Consensus 107 YCl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 994 5666666433 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred ccccccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNT 717 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~p~ 717 (724)
...++|||.|||||++. .+.|+-|+||||||+...||.-.++|.
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence 34579999999999985 467999999999999999999999886
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=268.55 Aligned_cols=199 Identities=29% Similarity=0.378 Sum_probs=176.4
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
+|++.+.||.|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999875 48899999986532 2456789999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++++|..++... ..+++.++..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998432 46899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||...+
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 2233567889999999998889999999999999999999999998665
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=267.56 Aligned_cols=202 Identities=30% Similarity=0.460 Sum_probs=172.5
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh-hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
+|++.+.||+|++|.||+|+.. ++..||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999885 588999999875432 23567788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++ +|.+++........+++..+.+++.||+.||+|||+.+ ++|+||||+||++++++.++|+|||++..+....
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 85 88888765444456899999999999999999999998 9999999999999999999999999997653321
Q ss_pred ccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234578899999988664 57899999999999999999999997554
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=264.41 Aligned_cols=200 Identities=31% Similarity=0.419 Sum_probs=177.6
Q ss_pred cCcceeeeeccCCceeEEeeeecC-CceeEEEeccccCh-hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++|++.+.||+|++|.||++.... ++.+|||++..... ...+.+.+|+.++.+++||||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999998864 88999999876543 4567899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
+++++|.+++... ..+++..+.+++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998543 568999999999999999999999 87 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 21 22456788999999999999999999999999999999999999655
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=267.88 Aligned_cols=199 Identities=26% Similarity=0.463 Sum_probs=172.8
Q ss_pred CcceeeeeccCCceeEEeeee-cCCceeEEEecccc-ChhhHHHHHHHHHHHHHcc---CCceeeEeeEEEecCeEEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~---Hpniv~l~~~~~~~~~~~lV~ 588 (724)
.|+..+.||+|+||.||+|.. .+++.+|+|.+... .....+++.+|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999986 46889999998654 3345678899999999997 999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998843 36899999999999999999999998 999999999999999999999999999876543
Q ss_pred cccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3 22233568899999998865 457899999999999999999999997554
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=264.66 Aligned_cols=201 Identities=31% Similarity=0.484 Sum_probs=174.7
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh--hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+|++.+.||+|+||.||+|... +++.+|+|.++.... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 688999999876543 3678899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999853 345788999999999999999999998 99999999999999999999999999987644322
Q ss_pred ccc--ccccccccCccCcccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 QGN--TKQIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
... .....++..|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 111 22356788999999998776 889999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=262.97 Aligned_cols=195 Identities=36% Similarity=0.507 Sum_probs=163.9
Q ss_pred eeeccCCceeEEeeeecC----CceeEEEeccccCh-hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~-~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
++||+|+||.||+|.... +..+|+|.+..... ...+++.+|+.+++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999996532 26899999876543 34578999999999999999999999875 4568999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccc-
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG- 672 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~- 672 (724)
++|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999999543 35899999999999999999999998 9999999999999999999999999998764332111
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 1112234568999999999999999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=266.43 Aligned_cols=201 Identities=29% Similarity=0.405 Sum_probs=172.9
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~~lV~ 588 (724)
++|+..+.||.|++|.||++.+. +++.+|+|.+.... .....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999875 57889999987543 24567799999999999999999999998654 3689999
Q ss_pred EeeCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 589 EYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
||+++++|.+++... .....+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887532 23455889999999999999999999998 99999999999999999999999999876532
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 21 12345788999999999999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=262.49 Aligned_cols=201 Identities=27% Similarity=0.440 Sum_probs=174.0
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+|+..+.||+|++|.||++... +++.+|||++... .....+.+.+|+.++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788999999999999999774 5788999998653 334567899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC-CCEEEEecCCccccCCCc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDE 669 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DFGla~~~~~~~ 669 (724)
+++++|.+++... ....+++..+.+++.|++++|+|||+++ ++|+||+|+||+++++ ..+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998542 2345899999999999999999999998 9999999999999865 458999999998764332
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 1223568889999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=268.06 Aligned_cols=200 Identities=29% Similarity=0.401 Sum_probs=170.5
Q ss_pred CcceeeeeccCCceeEEeeee----cCCceeEEEeccccC----hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~----~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~ 584 (724)
+|++.+.||+|+||.||+++. .+|+.||+|+++... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999976 367899999986532 22346788999999999 599999999999998899
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||+|+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999843 345889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccCccCcccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
+...... ......|+..|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 6433211 22335688999999998753 4678999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=269.34 Aligned_cols=196 Identities=27% Similarity=0.429 Sum_probs=166.4
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+|++.+.||+|+||.||+|+.. +|+.+|+|+++... ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999875 58899999986432 22345678899999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
++ ++|.+++... ...+++..+..++.||++||+|||+.+ |+|+||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 97 4777776432 345899999999999999999999998 9999999999999999999999999998654321
Q ss_pred cccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNT 717 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~ 717 (724)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.|+
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 112334678899999988764 4799999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=266.53 Aligned_cols=200 Identities=28% Similarity=0.418 Sum_probs=165.6
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHH-HHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMML-IAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~i-l~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++|++.+.||+|+||.||+++.. +++.||+|+++... .+...++..|+.+ ++.++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999875 58899999987542 2233455556665 566689999999999999999999999
Q ss_pred eeCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 590 YMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 590 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|++ ++|.+++... .....+++..+..++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6788777542 2345689999999999999999999986 6 99999999999999999999999999987532
Q ss_pred CcccccccccccccCccCcccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 21 1223467889999998865 4568899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=263.37 Aligned_cols=195 Identities=30% Similarity=0.491 Sum_probs=160.7
Q ss_pred eeeccCCceeEEeeeecC----CceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe-cCeEEEEEEeeC
Q 004912 519 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEKILILEYMP 592 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~-~~~~~lV~Ey~~ 592 (724)
+.||+|+||.||+|...+ ...+|+|++... .....+.+.+|+.+++.++||||+++++++.. ++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999997632 357999998643 33456788999999999999999999998764 556789999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc-
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ- 671 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~- 671 (724)
+++|.+++... ...+++..++.++.||++||+|||+.+ ++||||||+|||+++++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998542 234678888999999999999999988 999999999999999999999999999865432211
Q ss_pred -ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcC-CCCCC
Q 004912 672 -GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS-KKNTG 718 (724)
Q Consensus 672 -~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG-~~p~~ 718 (724)
.......++..|+|||.+.+..++.++||||||+++|||++| ..||.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 111233557789999999888999999999999999999995 55664
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=261.69 Aligned_cols=201 Identities=37% Similarity=0.572 Sum_probs=171.8
Q ss_pred cceeeeeccCCceeEEeeeecC-----CceeEEEeccccChh-hHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 515 FSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~-~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
|++.+.||+|+||.||++...+ +..||+|.+...... ..+.+..|+.++.+++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998754 378999999765433 5778999999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854221 12899999999999999999999998 999999999999999999999999999876543
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
...... ...+++.|+|||.+....++.++||||||++++||++ |+.||...
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 222111 2336789999999988889999999999999999998 88888643
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=269.42 Aligned_cols=199 Identities=30% Similarity=0.409 Sum_probs=169.5
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccChh-----hHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
+|++.+.||+|++|.||+|... +++.||||+++..... ....+..|+.++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999875 5889999999754322 345678899999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+ +++|.+++.... ..+++.++..++.||++||+|||+++ |+|+||||+||+++.++.++|+|||+++.+..
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999985322 36999999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.. .......+++.|+|||.+.+ ..++.++||||||+++|||++|..||...
T Consensus 155 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~ 206 (298)
T cd07841 155 PN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206 (298)
T ss_pred CC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence 22 12223456788999998855 46789999999999999999998777543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=261.32 Aligned_cols=202 Identities=25% Similarity=0.420 Sum_probs=174.5
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+|++.+.||+|+||.+|++... +++.+|+|++... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788999999999999999764 5789999998643 334556889999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++... ....+++.++++++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988542 2235789999999999999999999988 99999999999999999999999999987643221
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......+++.|+|||++.+..++.++||||||++++||++|+.||..++
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 1223457889999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=266.71 Aligned_cols=199 Identities=29% Similarity=0.416 Sum_probs=174.8
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++|++.+.||+|++|.||++.+. +++.+|+|++.... ....+++.+|++++++++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778889999999999999876 58899999987653 34567899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
+++++|.+++.... ..+++..+.+++.|+++||+|||+ .+ ++|+||||+||++++++.++|+|||.+..+....
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999985432 568899999999999999999999 77 9999999999999999999999999987653221
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 11256888999999999999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=267.22 Aligned_cols=205 Identities=26% Similarity=0.346 Sum_probs=174.1
Q ss_pred hccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccC---hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~ 585 (724)
...+|..+.+||+|+||.|-++..+. ...+|||++++.. .+..+--..|-++|+.. +-|.+++++.+++.-+..|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 34568888999999999999997654 4579999998642 23344456677777776 4688999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
.||||+.+|+|--.+. .-+.+.+..+..++..||-||-+||+++ ||.||||..|||||.+|++||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999977774 3344778888899999999999999999 999999999999999999999999999852
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSME 723 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~~e 723 (724)
-- ....+.+.+|||.|+|||++...+|...+|.||+||+|||||.|+.||+.++.+
T Consensus 501 i~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~ 556 (683)
T KOG0696|consen 501 IF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 556 (683)
T ss_pred cc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 11 123456789999999999999999999999999999999999999999987754
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=265.18 Aligned_cols=203 Identities=30% Similarity=0.473 Sum_probs=167.7
Q ss_pred cceeeeeccCCceeEEeeeec----CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC------
Q 004912 515 FSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 582 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~------ 582 (724)
|.+.+.||+|+||.||+|... .++.||||+++.. .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999753 3678999998653 3445678999999999999999999999886542
Q ss_pred eEEEEEEeeCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEec
Q 004912 583 EKILILEYMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF 659 (724)
..++++||+++++|..++.... ....+++..+.+++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875321 2235788999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
|+++.+.............+++.|++||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 99987643322222223345678999999999999999999999999999999 88998644
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=265.16 Aligned_cols=202 Identities=27% Similarity=0.439 Sum_probs=172.3
Q ss_pred CcceeeeeccCCceeEEeeeecC--CceeEEEecccc----------ChhhHHHHHHHHHHHHH-ccCCceeeEeeEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQ----------SGQGLKEFKNEMMLIAK-LQHRNLVRLLGCCVE 580 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~----------~~~~~~~f~~E~~il~~-l~Hpniv~l~~~~~~ 580 (724)
+|++.+.||+|+||.||++.+.. ++.+|||.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999998765 678999987532 22345667889988875 699999999999999
Q ss_pred cCeEEEEEEeeCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeccCCCCCEEEcCCCCEEEEe
Q 004912 581 QGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISD 658 (724)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~D 658 (724)
++..++||||+++++|.+++... .....+++..+.+++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887542 234568999999999999999999996 55 99999999999999999999999
Q ss_pred cCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 99998764432 2344578899999999999889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=282.42 Aligned_cols=202 Identities=26% Similarity=0.437 Sum_probs=177.9
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.+.|+++..||.|+||.||+|..++ +-..|-|.+...+++..++|.-|+.||+...||+||+|++.|..++..+++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 4568888999999999999998765 345678888888888999999999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+.||-.+.++.. -..+|++.++..+..|++.||.|||++. |||||||+.|||++-+|.++|+|||.+..... .
T Consensus 111 C~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred cCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 999999998854 3456999999999999999999999998 99999999999999999999999998865322 1
Q ss_pred cccccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
......+.|||.|||||+.+ ..+|+.++||||||+.|.||.-+.+|..--
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel 238 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL 238 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc
Confidence 22345689999999999874 567999999999999999999999997543
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=266.99 Aligned_cols=201 Identities=30% Similarity=0.441 Sum_probs=170.4
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+|+..+.||.|++|.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 58899999886432 23346789999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+. ++|..++... ....+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+....
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 96 6888887543 2356899999999999999999999998 9999999999999999999999999998654321
Q ss_pred cccccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......++..|+|||.+.+.. ++.++||||||+++|||++|+.||..++
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1122335688999999887654 6889999999999999999999997554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=281.42 Aligned_cols=202 Identities=32% Similarity=0.439 Sum_probs=174.4
Q ss_pred cCcceeeeeccCCceeEEeeeecC--Cc--eeEEEeccccChh-hHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLN--GQ--EVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~--g~--~vAVK~l~~~~~~-~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
+...+.++||+|.||.|++|.+.. |+ .||||.++..... ...+|++|+.+|.+|+|||+++|+|+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 344556899999999999997753 43 6899999876544 68899999999999999999999999887 678899
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
+|..+.|+|.+.|++ ..+..+-...+..++.|||.||.||..+. +|||||..+|+||-....+||+|||+.+-++.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999987 55667888889999999999999999998 99999999999999999999999999999865
Q ss_pred Ccc-cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004912 668 DEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 719 (724)
Q Consensus 668 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~ 719 (724)
++. ........-...|.|||.+....|+.++|||+|||.+|||+| |+.||-.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 432 222223344678999999999999999999999999999999 8888853
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=257.49 Aligned_cols=199 Identities=33% Similarity=0.520 Sum_probs=177.4
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeC
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 592 (724)
.|+..+.||+|++|.||++... ++..+++|++........+.+.+|+.++++++|||++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677899999999999999875 588999999977665567889999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccc
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 672 (724)
+++|.+++.... ..+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999985432 46899999999999999999999987 99999999999999999999999999987654321
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.....++..|+|||.+....++.++||||||++++||++|+.||...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23456889999999998888999999999999999999999999755
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=265.53 Aligned_cols=209 Identities=28% Similarity=0.467 Sum_probs=173.9
Q ss_pred chhhHHHhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEe-
Q 004912 504 SLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE- 580 (724)
Q Consensus 504 ~~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~- 580 (724)
++.++......|++.+.||+|+||.||+|+.. +++.+|+|.+.... ....++..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34444556678999999999999999999874 57889999986543 3446788999999999 69999999999853
Q ss_pred -----cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEE
Q 004912 581 -----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655 (724)
Q Consensus 581 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 655 (724)
....+++|||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||+|+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 45679999999999999988542 2345888889999999999999999998 99999999999999999999
Q ss_pred EEecCCccccCCCcccccccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 656 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
|+|||++....... .......|+..|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 228 (282)
T cd06636 162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228 (282)
T ss_pred EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence 99999987653211 1223456889999999886 35688899999999999999999999954
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=265.64 Aligned_cols=203 Identities=30% Similarity=0.445 Sum_probs=178.0
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.++.|+..+.||+|++|.||++.+. +++.+|+|.+..... ..+.+.+|++++++++|+|++++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4667888899999999999999886 588999999976544 56788999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++++|.+++.... ..+++.++..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999996533 36999999999999999999999988 9999999999999999999999999987654322
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1223457889999999998889999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=267.02 Aligned_cols=203 Identities=32% Similarity=0.470 Sum_probs=172.1
Q ss_pred cCcceeeeeccCCceeEEeeeec-----CCceeEEEeccccChh-hHHHHHHHHHHHHHccCCceeeEeeEEEe--cCeE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEK 584 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~-~~~~f~~E~~il~~l~Hpniv~l~~~~~~--~~~~ 584 (724)
+.|++.+.||+|+||.||+++.. .+..+|||.++..... ..+.|.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777799999999999999753 3678999999765443 56789999999999999999999999887 5578
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998543 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcc-cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 665 FGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
+..... ........++..|+|||.+.+..++.++||||||++++||++|+.|+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 753211 11112234556799999999889999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=262.95 Aligned_cols=198 Identities=27% Similarity=0.430 Sum_probs=172.4
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
-|++.+.||+|+||.||+|... ++..+|||.+.... ....+.+.+|+.++.+++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667789999999999999764 57899999986433 344577899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++++|.+++. ...+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999884 235889999999999999999999988 99999999999999999999999999987643221
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 122346788999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=264.56 Aligned_cols=191 Identities=29% Similarity=0.387 Sum_probs=158.4
Q ss_pred eeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHH---ccCCceeeEeeEEEecCeEEEEEEeeC
Q 004912 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAK---LQHRNLVRLLGCCVEQGEKILILEYMP 592 (724)
Q Consensus 520 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~---l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 592 (724)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..++.. .+|||++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 57899999886532 1222334455444443 479999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccc
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 672 (724)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||++..+....
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999998843 345899999999999999999999998 9999999999999999999999999997653321
Q ss_pred cccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.....|+..|+|||.+.+ ..++.++||||+|+++|||++|+.||...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 223468999999998864 56899999999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=265.05 Aligned_cols=197 Identities=26% Similarity=0.406 Sum_probs=172.2
Q ss_pred cceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
|...+.||+|++|.||++... +++.+|+|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999864 5789999998765555567789999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++....... ..
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PR 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--cc
Confidence 999999843 35889999999999999999999998 9999999999999999999999999987654322 11
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~ 218 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence 23356889999999999888999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=262.01 Aligned_cols=196 Identities=34% Similarity=0.514 Sum_probs=167.9
Q ss_pred cCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeC
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 592 (724)
++|++.+.||+|+||.||++.. .++.+|+|.++... ..+.+.+|+.++.+++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999975 67889999986532 346789999999999999999999998654 5789999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccc
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 672 (724)
+++|.+++.... ...+++..+++++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999986432 335889999999999999999999988 999999999999999999999999998764321
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 202 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence 112234568999999998999999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=265.44 Aligned_cols=190 Identities=26% Similarity=0.413 Sum_probs=161.2
Q ss_pred eeeccCCceeEEeeeecC--------CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 519 CKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+.||+|+||.||+|.... ..++|+|.+........+++.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997632 235888988765555667899999999999999999999999998999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC--------EEEEecCCc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--------PKISDFGLA 662 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~kL~DFGla 662 (724)
+++|+|..++... ...+++..+++++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998543 235899999999999999999999998 999999999999987765 699999998
Q ss_pred cccCCCcccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCC-CCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSK-KNTGL 719 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~-~p~~~ 719 (724)
..... .....++..|+|||++.+. .++.++||||||+++|||++|. .|+..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 75432 2234678899999999874 5799999999999999999985 56543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=265.34 Aligned_cols=202 Identities=27% Similarity=0.362 Sum_probs=167.7
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCe-----
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGE----- 583 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~----- 583 (724)
++|++.+.||+|+||.||+|... +++.||||.++... ......+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999875 58899999876532 223467889999999995 6999999999887665
Q ss_pred EEEEEEeeCCCChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-CCCEEEEecC
Q 004912 584 KILILEYMPNKSLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFG 660 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFG 660 (724)
.++||||+++ +|.+++..... ...+++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78888754322 346899999999999999999999998 999999999999998 8899999999
Q ss_pred CccccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
+++.+.... .......+++.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 998653321 11222356789999998865 45799999999999999999999999654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=260.25 Aligned_cols=203 Identities=28% Similarity=0.448 Sum_probs=173.3
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe--cCeEEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKILIL 588 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~--~~~~~lV~ 588 (724)
+|++.+.||.|+||.||++... +++.+|+|.+... .....+++.+|+.++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999764 5788999998643 34456778999999999999999999998764 34678999
Q ss_pred EeeCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 589 EYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLH-----QYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH-----~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
||+++++|.+++... .....+++..+..++.||++||+||| +.+ ++|+||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998653 22456899999999999999999999 555 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
..+..... ......+++.|+|||.+....++.++||||||++++||++|+.||...+
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 87754321 1233568999999999999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=263.76 Aligned_cols=193 Identities=29% Similarity=0.424 Sum_probs=166.8
Q ss_pred eccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCCh
Q 004912 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (724)
Q Consensus 521 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (724)
||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999764 58899999986432 22345678899999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccc
Q 004912 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676 (724)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 676 (724)
.+++..... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+... .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence 999864332 46899999999999999999999998 999999999999999999999999998765431 12233
Q ss_pred cccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
..++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 46788999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=266.24 Aligned_cols=200 Identities=30% Similarity=0.405 Sum_probs=169.5
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILI 587 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~~lV 587 (724)
++|++.+.||+|+||.||+|... +++.+|+|.++... ......+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888899999999999999875 47889999986543 22334677899999999999999999998877 789999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++ +|.+++... ...+++.++.+++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+..
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999974 888887542 236899999999999999999999998 99999999999999999999999999987644
Q ss_pred CcccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.. .......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||...
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 32 122334578899999988764 4689999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=261.28 Aligned_cols=192 Identities=28% Similarity=0.416 Sum_probs=168.7
Q ss_pred eccCCceeEEeeeecC-CceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCCh
Q 004912 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (724)
Q Consensus 521 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (724)
||.|++|.||+++... ++.+|+|.+.... ....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999998754 7899999986532 23457799999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccc
Q 004912 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676 (724)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 676 (724)
.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||+++...... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999843 345889999999999999999999988 9999999999999999999999999998764332 2233
Q ss_pred cccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
..++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 467889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=263.22 Aligned_cols=203 Identities=30% Similarity=0.457 Sum_probs=172.6
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecC------
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG------ 582 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~------ 582 (724)
..++|++.+.||+|++|.||+|... +++.+++|++..... ..+++.+|+.+++++ +||||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999875 577899999875543 447799999999999 6999999999997654
Q ss_pred eEEEEEEeeCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCC
Q 004912 583 EKILILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 661 (724)
..++||||+++++|.+++.... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999885422 2456899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
+....... .......++..|+|||.+.. ..++.++||||||++||||++|+.||..
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 97654321 22234568899999998753 3467899999999999999999999964
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-29 Score=257.20 Aligned_cols=202 Identities=30% Similarity=0.439 Sum_probs=177.3
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeEEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILIL 588 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~~lV~ 588 (724)
+|...+.||+|++|.||+|... +++.+++|++.... ....+.+.+|+.++++++||||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999876 68899999986654 25578899999999999999999999999988 8899999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++++|.+++... ..+++.++..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998543 26899999999999999999999988 999999999999999999999999999887544
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
..........++..|+|||.+....++.++||||||++++||++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32112334578899999999988889999999999999999999999997643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=260.49 Aligned_cols=197 Identities=24% Similarity=0.343 Sum_probs=163.8
Q ss_pred hHHHhccCcceeeee--ccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecC
Q 004912 507 SITAATENFSMQCKL--GEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 582 (724)
Q Consensus 507 ~i~~~~~~~~~~~~L--G~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~ 582 (724)
++....++|++.+.+ |+|+||.||++... ++..+|+|.++....... |+.....+ +||||+++++.+...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334445677777776 99999999999864 578899999865321111 22222222 6999999999999999
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC-CEEEEecCC
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGL 661 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGl 661 (724)
..++||||+++++|.+++... ..+++.++..++.||++||+|||+.+ ++||||||+||+++.++ .++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999998432 37899999999999999999999998 99999999999999988 999999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
++..... ....++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 157 CKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred ceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 9765422 2246789999999999999999999999999999999999999744
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=272.61 Aligned_cols=199 Identities=29% Similarity=0.355 Sum_probs=169.4
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec------
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------ 581 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~------ 581 (724)
..++|++.+.||+|+||.||++... +++.||||++... .....+++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3578999999999999999999874 6889999998643 334456788899999999999999999988643
Q ss_pred CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCC
Q 004912 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (724)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 661 (724)
...++||||+.+ +|.+.+.. .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 346999999964 77777632 2888999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
++...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 98764322 1233467889999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=284.48 Aligned_cols=200 Identities=24% Similarity=0.366 Sum_probs=159.5
Q ss_pred hccCcceeeeeccCCceeEEeeeecC--CceeEEE------------------eccccChhhHHHHHHHHHHHHHccCCc
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVK------------------RLSNQSGQGLKEFKNEMMLIAKLQHRN 570 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK------------------~l~~~~~~~~~~f~~E~~il~~l~Hpn 570 (724)
..++|++.++||+|+||.||++.... +...++| .+. ........+.+|+.+|.+++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999986532 2222222 111 12234567889999999999999
Q ss_pred eeeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE
Q 004912 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (724)
Q Consensus 571 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl 648 (724)
|+++++++...+..++|+|++. ++|.+++..... .......++..|+.||+.||+|||+++ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 466666643221 122345677889999999999999998 9999999999999
Q ss_pred cCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 004912 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 716 (724)
Q Consensus 649 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p 716 (724)
+.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||+||||++|+.+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999987643321 122346799999999999999999999999999999999998753
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=262.34 Aligned_cols=191 Identities=29% Similarity=0.394 Sum_probs=159.0
Q ss_pred eeccCCceeEEeeeec-CCceeEEEeccccCh---hhHHHHHHHHHH---HHHccCCceeeEeeEEEecCeEEEEEEeeC
Q 004912 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMML---IAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (724)
Q Consensus 520 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~i---l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 592 (724)
.||+|+||.||+++.. +++.||+|.+..... .....+..|..+ +....||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 478999998865321 222234444443 444579999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccc
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 672 (724)
+++|..++. ....+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999998884 3346999999999999999999999998 9999999999999999999999999997653321
Q ss_pred cccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 2234789999999998754 6899999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=262.75 Aligned_cols=201 Identities=29% Similarity=0.413 Sum_probs=167.1
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++|++.+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46899999999999999999875 58899999986532 2334678899999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-CCCEEEEecCCccccCCC
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGD 668 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~~ 668 (724)
|++ ++|.+++... ....+++..+..++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 4777776432 2234678888899999999999999998 999999999999985 567999999999765332
Q ss_pred cccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
. .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 11233467889999998866 45789999999999999999999999654
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=265.12 Aligned_cols=194 Identities=26% Similarity=0.406 Sum_probs=170.4
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCChh
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN 597 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~ 597 (724)
.+||+|+||.||++... +++.||||++........+.+.+|+.++++++|||++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 58999999999999874 68899999987655556677999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccccccc
Q 004912 598 VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677 (724)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 677 (724)
+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+.... ......
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 176 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 176 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccc
Confidence 88732 34789999999999999999999998 9999999999999999999999999987654322 112335
Q ss_pred ccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 678 ~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.++..|+|||.+.+..++.++||||+|+++|||++|+.||...+
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 68899999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=264.96 Aligned_cols=196 Identities=33% Similarity=0.487 Sum_probs=167.5
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.+.|++.+.||+|+||.||+|... +++.||+|.+... ..+..+++.+|+.++++++||||+++++++.+....++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 355888899999999999999875 5889999988643 233456789999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
+||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 5666665332 335899999999999999999999998 99999999999999999999999999876432
Q ss_pred CcccccccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
. ....++..|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 2 2346788999999874 45688999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=270.98 Aligned_cols=201 Identities=26% Similarity=0.405 Sum_probs=167.9
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC-----eE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~-----~~ 584 (724)
+++|++.+.||+|+||.||+|... +++.||||.++.. .......+.+|+.++.+++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 578999999999999999999764 5889999998643 2334567889999999999999999999876543 57
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++|+||+++ +|..++. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999975 7776662 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcc-cccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 665 FGGDEL-QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
...... ........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 643221 112233578899999998755 56899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=262.46 Aligned_cols=199 Identities=30% Similarity=0.446 Sum_probs=168.3
Q ss_pred cceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
|++.+.||.|++|.||+|... +|..||+|++.... ....+.+.+|+.++++++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999874 68899999986543 233467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
+ ++|.+++.... ...+++..+.+++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-- 153 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-- 153 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--
Confidence 5 68988875422 235899999999999999999999988 9999999999999999999999999997653221
Q ss_pred ccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 112223568899999988664 5789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=261.86 Aligned_cols=195 Identities=28% Similarity=0.393 Sum_probs=168.9
Q ss_pred eccCCceeEEeeeecC-CceeEEEeccccCh---hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCCh
Q 004912 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (724)
Q Consensus 521 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~---~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (724)
||+|+||.||+++..+ ++.+|+|.+..... ...+.+.+|+.++.+++||||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998864 88999999865433 4567889999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc------
Q 004912 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL------ 670 (724)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~------ 670 (724)
.+++... ..+++..+.+++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9998543 36899999999999999999999998 99999999999999999999999999876432211
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
........++..|+|||.+.....+.++||||||+++|||++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 112233567889999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=265.92 Aligned_cols=201 Identities=30% Similarity=0.425 Sum_probs=168.0
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh--hhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~~l 586 (724)
.++|++.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.++.+++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999875 588999999864322 2234567899999999999999999998765 46899
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+.+ +|.+++... ...+++.++..++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||++..+.
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 788877532 246899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 322 11222345788999999865 55799999999999999999999999644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=263.52 Aligned_cols=202 Identities=20% Similarity=0.235 Sum_probs=153.2
Q ss_pred ccCcceeeeeccCCceeEEeeeecCC----ceeEEEeccccChhhH-----------HHHHHHHHHHHHccCCceeeEee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQSGQGL-----------KEFKNEMMLIAKLQHRNLVRLLG 576 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g----~~vAVK~l~~~~~~~~-----------~~f~~E~~il~~l~Hpniv~l~~ 576 (724)
.++|++.+.||+|+||.||+|...++ ..+|+|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999987543 4566665432221110 11223344455668999999999
Q ss_pred EEEecC----eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC
Q 004912 577 CCVEQG----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 652 (724)
Q Consensus 577 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 652 (724)
++.... ..++++|++.. ++.+.+.. ....++..+..|+.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876554 33567776543 55555522 223578888999999999999999998 99999999999999999
Q ss_pred CEEEEecCCccccCCCcc-----cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 653 NPKISDFGLARMFGGDEL-----QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 653 ~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.++|+|||+|+.+..... ........||+.|+|||.+.+..++.++|||||||+||||++|+.||...
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999987642211 11122357999999999999999999999999999999999999999755
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=261.13 Aligned_cols=200 Identities=30% Similarity=0.444 Sum_probs=169.8
Q ss_pred cceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeEEEEEE
Q 004912 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILILE 589 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~~lV~E 589 (724)
|++.+.||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|+.++++++|||++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999875 47899999997653 33456788999999999999999999999988 78999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++ +|.+++... ...+++.++..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++..+....
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 888887432 246899999999999999999999998 9999999999999999999999999998764432
Q ss_pred ccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 12233456789999998765 457999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=257.81 Aligned_cols=191 Identities=26% Similarity=0.333 Sum_probs=161.6
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEeccccCh---hhHHHHHHHHHHH-HHccCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLI-AKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~il-~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+|++|.||+|... +++.||||.++.... .....+..|..++ ...+|||++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999874 578999999865432 2233445555444 445899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
++|..++.. ...+++..+.+++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999999843 345889999999999999999999998 99999999999999999999999999876432
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 223467889999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-31 Score=302.41 Aligned_cols=202 Identities=31% Similarity=0.449 Sum_probs=173.5
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
+-++.....||.|.||.||.|... +|...|||.++.+ .....+...+|+.+|..|+|||+|+.+|+-.+++..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 446666789999999999999764 5778899987654 3345667889999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|.+++.. .+..++.....+..|++.|++|||++| ||||||||.||+|+.+|.+|+.|||.|..+...
T Consensus 1314 EyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999843 334566666778999999999999999 999999999999999999999999999988553
Q ss_pred --cccccccccccccCccCcccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 669 --ELQGNTKQIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 669 --~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
..........||+.|||||++.+.. ...++||||||||.+||+||++||..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~ 1443 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE 1443 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh
Confidence 2333455678999999999997754 56789999999999999999999964
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=264.46 Aligned_cols=205 Identities=28% Similarity=0.419 Sum_probs=167.8
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecC-----
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----- 582 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~----- 582 (724)
..++|++.++||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3467999999999999999999875 58899999886432 223345678999999999999999999987654
Q ss_pred ---eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEec
Q 004912 583 ---EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659 (724)
Q Consensus 583 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF 659 (724)
..++||||+.+ +|..++.. ....+++.++..++.||+.||+|||+++ ++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 34999999975 77777643 2235899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCccc--ccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 660 GLARMFGGDELQ--GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 660 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
|++..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999876432211 122334678899999988664 47889999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-31 Score=232.83 Aligned_cols=110 Identities=47% Similarity=0.784 Sum_probs=82.8
Q ss_pred CCeEEEeecCCCCCCCC--CCeEEEeeCCcEEEecCCCCeEEEE-eccCCC-CCceEEEccCCCeEEecCCCCCCcccee
Q 004912 70 PDAVVWVANRDRPISDN--NAVLTISNNGNLVLLNQTNGTIWST-NVSSEV-KNPVAQLRDDGNLVIRDNSSGNATESYL 145 (724)
Q Consensus 70 ~~t~VW~ANr~~p~~~~--~~~L~l~~~g~l~l~~~~~~~~Wst-~~~~~~-~~~~a~lld~GNlVl~~~~~~~~~~~~l 145 (724)
++||||+|||+.|+... ..+|.|+.||+|||.|..++++|++ ++.+.+ ....|+|+|+|||||+|. .+.++
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~-----~~~~l 75 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS-----SGNVL 75 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET-----TSEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee-----cceEE
Confidence 47999999999999543 4789999999999999999999999 566554 678899999999999996 45899
Q ss_pred eeeccCCcchhhcccccccccccccceeEEeecCCCCCC
Q 004912 146 WQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS 184 (724)
Q Consensus 146 WqSFd~PtDtlLpg~kl~~~~~~~~~~~l~Sw~s~~dps 184 (724)
||||||||||+||+|+|+.+..++.+..++||++.+|||
T Consensus 76 W~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 76 WQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999999999988888888899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=254.31 Aligned_cols=198 Identities=33% Similarity=0.466 Sum_probs=174.8
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh--hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+|++.+.||+|++|.||++... +++.+|+|.+..... ...+.+.+|++++.+++|||++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999775 578999999976543 4567899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998433 56899999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
......++..|+|||.+.+..++.++||||+|++++||++|+.||..
T Consensus 155 --~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 155 --DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred --cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 12335678899999999888889999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=264.36 Aligned_cols=205 Identities=32% Similarity=0.431 Sum_probs=171.0
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccC-------hhhHHHHHHHHHHHHHccCCceeeEeeEEEe-cC
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QG 582 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-------~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~-~~ 582 (724)
.++|-+..+||+|+|+.|||+.+ ...+.||||+-.-.. +.-.+...+|..|-+.|.||-||++++++.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 35688889999999999999954 567889999864321 1113345689999999999999999999874 45
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC---CCCEEEEec
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDF 659 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DF 659 (724)
..+-|+||++|.+|+-+|. ....++++++..|+.||+.||.||.+.. .+|||-||||.||||-. -|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 6789999999999999994 3456999999999999999999999874 67999999999999954 478999999
Q ss_pred CCccccCCCccc-----ccccccccccCccCcccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 660 GLARMFGGDELQ-----GNTKQIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 660 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
|+++.+.++.+. ..++...||..|++||.+.-+ .++.|+||||+|||+|..|.|++||+.+
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 999998765433 234567899999999987433 4789999999999999999999999864
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=258.17 Aligned_cols=202 Identities=27% Similarity=0.447 Sum_probs=173.2
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.++++++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999875 4788999998653 223456788999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC-CEEEEecCCccccCCCc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGGDE 669 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~~~~~~ 669 (724)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++ .+||+|||.+..+....
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988542 2335799999999999999999999998 99999999999998885 46999999998764322
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......|++.|+|||++.+..++.++||||||++++||++|+.||...+
T Consensus 157 --~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 157 --ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred --ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 11223468899999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=262.00 Aligned_cols=203 Identities=30% Similarity=0.445 Sum_probs=176.5
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~lV 587 (724)
++|++.+.||+|++|.||++... +++.+|+|++... .....+.+.+|+.++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999875 6889999998653 2334567889999999998 99999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.+++++|+|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999853 336999999999999999999999998 99999999999999999999999999987644
Q ss_pred Cccc------------------ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 668 DELQ------------------GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 668 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.... .......++..|+|||.+....++.++||||||++++|+++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 3211 22234567899999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=257.47 Aligned_cols=212 Identities=26% Similarity=0.375 Sum_probs=185.6
Q ss_pred chhhHHHhccCcceeeeeccCCceeEEeeeec------CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEee
Q 004912 504 SLASITAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLG 576 (724)
Q Consensus 504 ~~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~ 576 (724)
...++.....+++...++-+|.||.||+|.+. +.+.|-||.++.. ++-+...+..|...+..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 35566667778988899999999999999553 3457889988765 4446778999999999999999999999
Q ss_pred EEEecC-eEEEEEEeeCCCChhHHHh-----hcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC
Q 004912 577 CCVEQG-EKILILEYMPNKSLNVFLF-----DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK 650 (724)
Q Consensus 577 ~~~~~~-~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~ 650 (724)
++.++. ..+++|.++.-|+|..||. +....+.++..++..++.|++.|++|||+++ +||.||.++|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 998764 5688899999999999997 4445566888999999999999999999998 999999999999999
Q ss_pred CCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 004912 651 DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTG 718 (724)
Q Consensus 651 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~ 718 (724)
..++||+|=.+++.+.+.++...-...-.+..||+||.+.+..|+.++|||||||+||||+| |+.|+.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya 500 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA 500 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc
Confidence 99999999999999988777766666667889999999999999999999999999999999 999984
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=268.87 Aligned_cols=201 Identities=30% Similarity=0.436 Sum_probs=168.5
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEec--CeEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ--GEKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~--~~~~ 585 (724)
.++|++.+.||+|+||.||+|... +++.+|||++... .......+.+|+.++.++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 567899999999999999999875 5789999988542 233456678899999999 999999999998654 3679
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..+
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 588888733 26889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc---ccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 666 GGDELQ---GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 666 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
...... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 433211 12334568999999998765 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=254.37 Aligned_cols=203 Identities=25% Similarity=0.435 Sum_probs=177.9
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+|++.+.||+|++|.||++... +++.+|+|++.... ....+++.+|++++++++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999875 58899999987543 25567889999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 591 MPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 591 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
+++++|.+++.... ....+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986532 2366999999999999999999999998 9999999999999999999999999998764432
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......|++.|+|||.+.+..++.++||||+|++++||++|+.||...+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 12233568889999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=266.22 Aligned_cols=203 Identities=31% Similarity=0.396 Sum_probs=170.3
Q ss_pred hhhHHHhccCcceeeeeccCCceeEEeeee-cCCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec
Q 004912 505 LASITAATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (724)
Q Consensus 505 ~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~ 581 (724)
..++...+++|++.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 445666789999999999999999999976 46889999998753 223456788999999999999999999988643
Q ss_pred ------CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEE
Q 004912 582 ------GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655 (724)
Q Consensus 582 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 655 (724)
...+++++++ +++|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 2367777776 788988773 234899999999999999999999998 99999999999999999999
Q ss_pred EEecCCccccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 656 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
|+|||+++.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999876432 1233467889999998876 56889999999999999999999999643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=256.30 Aligned_cols=201 Identities=31% Similarity=0.465 Sum_probs=175.5
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+|++.+.||+|++|.||++... +++.+|+|.+... ......++.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999764 5789999998653 234456788999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 591 MPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 591 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999985522 2356899999999999999999999998 999999999999999999999999999876443
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||...+
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223467889999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=260.14 Aligned_cols=200 Identities=29% Similarity=0.402 Sum_probs=169.9
Q ss_pred CcceeeeeccCCceeEEeeeec----CCceeEEEeccccC----hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~----~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~ 584 (724)
+|++.+.||+|++|.||+++.. ++..||||.++... ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999752 46789999986432 23456788999999999 599999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||+++++|.+++.. ...+++..+..++.|++++|+|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998843 345889999999999999999999988 99999999999999999999999999887
Q ss_pred cCCCcccccccccccccCccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
+..... .......++..|+|||.+.+.. .+.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 155 FLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred cccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 543321 1122346889999999987765 788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=261.81 Aligned_cols=203 Identities=29% Similarity=0.431 Sum_probs=168.6
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecC-----
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----- 582 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~----- 582 (724)
..++|++.+.||+|+||.||+|... +++.||||+++... ......+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999875 47899999986532 233456788999999999999999999987654
Q ss_pred -----eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEE
Q 004912 583 -----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 657 (724)
Q Consensus 583 -----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 657 (724)
..++|+||+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999986 666666332 346899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 658 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
|||++..+..... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999987643221 11222356788999998865 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=257.36 Aligned_cols=196 Identities=26% Similarity=0.367 Sum_probs=163.0
Q ss_pred cceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHcc-CCceeeEeeEEEec--CeEEEEEE
Q 004912 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQ--GEKILILE 589 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~--~~~~lV~E 589 (724)
|++.++||+|+||.||+|... +++.+|+|+++... ........+|+.++.++. |||++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999864 58899999987542 222234457888999985 99999999999987 88999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|++ ++|.+++... ...+++.++..++.||+.||+|||+.+ ++|+||+|+||+++. +.+||+|||+++.+....
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 4777776432 346899999999999999999999998 999999999999999 999999999998764322
Q ss_pred ccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
......++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 154 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 154 ---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred ---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 1223457889999997644 56789999999999999999999999654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=265.21 Aligned_cols=198 Identities=28% Similarity=0.403 Sum_probs=168.3
Q ss_pred HhccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC----
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG---- 582 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~---- 582 (724)
...++|++.+.||+|+||.||++... ++..||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34678999999999999999999764 6889999998543 2334567889999999999999999999987543
Q ss_pred --eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 583 --EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 583 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
..++||||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999998 778888773 235899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
++...... .....+++.|+|||.+.+ ..++.++|+||||+++|||++|+.||...
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99865322 223467889999999876 45889999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=269.40 Aligned_cols=200 Identities=25% Similarity=0.333 Sum_probs=177.3
Q ss_pred cCcceeeeeccCCceeEEeeeecCCc-eeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLNGQ-EVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~g~-~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
.+++.+..||-|+||.|-++...... .+|+|.+++. +..+.+....|-.||...+.|.||+++..+.+....||+|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666789999999999999775433 4899988764 3345566788999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
|-+-||.|...|.+ ++.++......++.-+++|++|||.++ ||.|||||+|.||+.+|-+||.|||+|+.++..
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999943 455888888889999999999999999 999999999999999999999999999998643
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
..+.+.+|||.|.|||++.++.++.++|.||||+++||||+|++||+.-+
T Consensus 574 ---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 574 ---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred ---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 46778999999999999999999999999999999999999999997644
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=260.25 Aligned_cols=201 Identities=28% Similarity=0.390 Sum_probs=165.6
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35566789999999999999875 47899999986542 345567899999999996 9999999999999999999999
Q ss_pred eeCCCChhHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 590 YMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 590 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
|++. ++..+... ......+++..+.+++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 55443211 12235689999999999999999999975 6 9999999999999999999999999997654
Q ss_pred CCcccccccccccccCccCcccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDG---LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 321 11234678899999998776 6899999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=267.62 Aligned_cols=202 Identities=23% Similarity=0.372 Sum_probs=169.1
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEe----cCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~----~~~~ 584 (724)
.++|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999865 58899999987542 2345678889999999999999999988753 3467
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||+. ++|..++. ....+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 58888873 3345899999999999999999999998 99999999999999999999999999977
Q ss_pred cCCCccc--ccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 665 FGGDELQ--GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 665 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 5432211 11234578899999998866 45889999999999999999999999644
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=260.53 Aligned_cols=194 Identities=33% Similarity=0.501 Sum_probs=166.2
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.|+..+.||+|+||.||+++.. ++..+|+|.+... ..+..+.+.+|+.++++++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4777889999999999999864 5789999998643 23345678899999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++ +|.+++... ...+++.++..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9975 777766432 345899999999999999999999998 99999999999999999999999999876432
Q ss_pred ccccccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.....++..|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 22346788999999874 45689999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=266.24 Aligned_cols=200 Identities=26% Similarity=0.393 Sum_probs=168.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec-----Ce
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GE 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~-----~~ 583 (724)
.++|.+.+.||+|+||.||+++.. +++.||||.++.. .......+.+|+.++.+++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999864 5889999998653 233456778899999999999999999987644 24
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.++|+||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 67888774 3346899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 764321 12233467889999998865 46899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=265.57 Aligned_cols=196 Identities=30% Similarity=0.433 Sum_probs=165.5
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC------
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 582 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~------ 582 (724)
.++|.+.+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999864 5889999998653 2233456889999999999999999999987542
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
..++|+||+.. +|..++ ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999864 666654 234889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 764321 223467889999999876 468999999999999999999999997654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=262.39 Aligned_cols=199 Identities=30% Similarity=0.423 Sum_probs=168.4
Q ss_pred HHhccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe-cCeE
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEK 584 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~-~~~~ 584 (724)
...+++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++.+++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345788999999999999999999765 6889999988542 22345678899999999999999999999876 4578
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++|+||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+|+||+|+||++++++.++|+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 568888773 235788888899999999999999998 99999999999999999999999999875
Q ss_pred cCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4321 223467889999998766 56899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=234.75 Aligned_cols=206 Identities=28% Similarity=0.377 Sum_probs=169.0
Q ss_pred HHhccCcceeeeeccCCceeEEeeee-cCCceeEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEE
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~ 585 (724)
....+...-++.||+|++|.|-+-++ .+|...|||+++.. ..+..++..+|+.+..+- ..|.+|+++|........+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 33445566668999999999999987 46889999999754 334566778888877665 6899999999999999999
Q ss_pred EEEEeeCCCChhHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 586 LILEYMPNKSLNVFLFD-STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
+.||.| ..+|+.+-.+ -.+...+++.-+-+|+..+.+||.|||++- .+||||+||+|||++.+|++||+|||++-.
T Consensus 122 IcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence 999998 4577776543 234566889999999999999999999865 699999999999999999999999999987
Q ss_pred cCCCcccccccccccccCccCcccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
+-+.- ..+...|-..|||||.+.. ..|+-|+||||||+.+.||.+++.||..+
T Consensus 199 L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 199 LVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 64321 1222457779999998754 36899999999999999999999999865
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=263.65 Aligned_cols=203 Identities=27% Similarity=0.373 Sum_probs=166.9
Q ss_pred ccCcc-eeeeeccCCceeEEeeeec-CCceeEEEeccccChhh--------------HHHHHHHHHHHHHccCCceeeEe
Q 004912 512 TENFS-MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG--------------LKEFKNEMMLIAKLQHRNLVRLL 575 (724)
Q Consensus 512 ~~~~~-~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~--------------~~~f~~E~~il~~l~Hpniv~l~ 575 (724)
.++|. +.+.||+|+||.||+|... .++.||||.++...... ...+.+|+.++.+++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34554 4567999999999999865 58899999886432211 12578999999999999999999
Q ss_pred eEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEE
Q 004912 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655 (724)
Q Consensus 576 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 655 (724)
+++...+..++||||++ ++|.+++. ....+++.....++.|+++||+|||+.+ |+|+||+|+||+++.++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 58888874 3345899999999999999999999998 99999999999999999999
Q ss_pred EEecCCccccCCCcc------------cccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 656 ISDFGLARMFGGDEL------------QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 656 L~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
|+|||++..+..... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987641110 1112233568899999998764 46899999999999999999999997543
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=261.22 Aligned_cols=200 Identities=23% Similarity=0.222 Sum_probs=165.8
Q ss_pred ceeeeeccCCceeEEeeeecCCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
.+.+.+|.|+++.|+++.. +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445566667777776655 6889999998654 345667899999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc---
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL--- 670 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~--- 670 (724)
++|.+++.... ...+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+..+.....
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999986432 235889999999999999999999998 99999999999999999999999999876532211
Q ss_pred --cccccccccccCccCcccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 --QGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 --~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
........++..|+|||++... .++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 1112334577899999998763 5889999999999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=247.14 Aligned_cols=200 Identities=24% Similarity=0.401 Sum_probs=175.6
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEecccc---ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~l 586 (724)
-++|.+.++||+|+++.|..+++.. .+.+|+|++++. ..+.++-.+.|-.++.+. +||.+|.++.+++.+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4678999999999999999998864 678999998764 344556677888888777 79999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
|.||+++|+|--++ ++.+.|+++.+..+...|.-||.|||+.| ||.||||..|||||.+|++||.|+|+++.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999985554 55667999999999999999999999999 9999999999999999999999999998521
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
. ....+++.+|||.|.|||.+.+..|...+|.|+|||+++||+.|+.||+.
T Consensus 403 ~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 403 G--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred C--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 1 12346678999999999999999999999999999999999999999964
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=254.90 Aligned_cols=199 Identities=31% Similarity=0.471 Sum_probs=166.9
Q ss_pred cceeeeeccCCceeEEeeeecC-CceeEEEeccccCh--hhHHHHHHHHHHHHHc---cCCceeeEeeEEEecCe-----
Q 004912 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--QGLKEFKNEMMLIAKL---QHRNLVRLLGCCVEQGE----- 583 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~f~~E~~il~~l---~Hpniv~l~~~~~~~~~----- 583 (724)
|++.+.||+|+||.||+|+... ++.+|+|+++.... .....+.+|+.++.++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999998864 88999999974322 2234566788877766 59999999999988776
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.+++|||+++ +|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 7888875422 235899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.+.... ......++..|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 156 IYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred eccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 764332 1223457889999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=258.26 Aligned_cols=199 Identities=26% Similarity=0.400 Sum_probs=166.2
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccC-hhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~lV~ 588 (724)
.++|++.+.||+|++|.||+|...+ ++.||||+++... .....++..|+.++.+.. ||||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4678889999999999999998865 8899999997543 234556777887777775 999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
||+++ +|..++... ...+++..+.+++.||++||+|||+ .+ |+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99854 677666432 2368999999999999999999997 46 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCcccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 221 12235788999999987654 78999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=256.77 Aligned_cols=199 Identities=32% Similarity=0.459 Sum_probs=170.5
Q ss_pred cceeeeeccCCceeEEeeeec-CCceeEEEeccccCh--hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
|++.+.||+|++|.||++... +++.+|+|++..... .....+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456789999999999999875 588899999865432 24567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++ +|.+++... ...+++..+..++.||++||+|||+.+ |+|+||||+||+++.++.++|+|||.+..+....
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 75 887777542 246899999999999999999999998 9999999999999999999999999998775432
Q ss_pred ccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 122234578899999998876 78999999999999999999999996544
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=260.93 Aligned_cols=203 Identities=30% Similarity=0.455 Sum_probs=165.9
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecC------
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 582 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~------ 582 (724)
.++|++.++||+|++|.||+|... +++.+|||++.... ......+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999875 57899999885432 222356788999999999999999999875443
Q ss_pred --eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 583 --EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 583 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
..++|+||+.. +|...+.. ....+++.++..++.||++||+|||+.+ |+|+||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46899999875 56666543 2345999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCccc---------ccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 661 LARMFGGDELQ---------GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 661 la~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
+++........ .......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 99876432211 112234678889999987654 5889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=261.31 Aligned_cols=201 Identities=29% Similarity=0.398 Sum_probs=165.1
Q ss_pred CcceeeeeccCCceeEEeeeecC---CceeEEEecccc--ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEec----Ce
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ----GE 583 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~----~~ 583 (724)
+|++.+.||+|+||.||+++... +..||||++... .....+.+.+|+.++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47888999999999999998753 678999998643 222356788999999999 599999999876433 34
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.++++||+. ++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 68888873 3446899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc--ccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 664 MFGGDELQ--GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 664 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.+...... .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 76432211 11233578999999998765 468999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=261.64 Aligned_cols=198 Identities=24% Similarity=0.290 Sum_probs=162.9
Q ss_pred eeeccC--CceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.||+| +||+||++++. .++.||||++... .....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 99999999874 6899999998643 334467889999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc--
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ-- 671 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-- 671 (724)
++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999885432 235889999999999999999999988 999999999999999999999999865433211100
Q ss_pred ---ccccccccccCccCcccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 672 ---GNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 672 ---~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 001112346679999998764 4789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=263.71 Aligned_cols=200 Identities=31% Similarity=0.423 Sum_probs=171.7
Q ss_pred CcceeeeeccCCceeEEeeeecC-CceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecC-----eEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKI 585 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~-----~~~ 585 (724)
+|++.+.||+|++|.||+|+... ++.+|||++.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47888999999999999998754 8899999987643 345678999999999999999999999988775 789
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||++ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 478888743 337999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcc-cccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 666 GGDEL-QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 666 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
..... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 44321 0123345678899999999888 7899999999999999999999999644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=262.78 Aligned_cols=206 Identities=23% Similarity=0.364 Sum_probs=174.5
Q ss_pred HhccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccCh---hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~---~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
....-|..++.||-|+||.|.+++..| ...+|+|.|++.+- ......+.|-.||+....+-||+|+--|++++.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 344568889999999999999996544 56789999976542 34456788999999999999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||++||++-.+|. +.+.+.+..+..++.++.-|+++.|..| +|||||||.|||||.+|++||.||||+.-+
T Consensus 706 FVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 9999999999999884 4456888888889999999999999998 999999999999999999999999998643
Q ss_pred C---------CCcc-------------------------------cccccccccccCccCcccccCCCCCchhhHHHHHH
Q 004912 666 G---------GDEL-------------------------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGI 705 (724)
Q Consensus 666 ~---------~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGv 705 (724)
. ..+. .......+||+.|+|||++....|+..+|.||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 1 0000 00012247999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 004912 706 LMLETLSSKKNTGLGS 721 (724)
Q Consensus 706 il~elltG~~p~~~~~ 721 (724)
|||||+.|+.||-.++
T Consensus 860 il~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADT 875 (1034)
T ss_pred HHHHHhhCCCCccCCC
Confidence 9999999999997654
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-28 Score=255.89 Aligned_cols=193 Identities=33% Similarity=0.485 Sum_probs=164.5
Q ss_pred cceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
|...+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666678999999999999874 5789999998643 223456788999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+. ++|.+++.. ....+++.++..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 567666643 2345899999999999999999999998 99999999999999999999999999865321
Q ss_pred cccccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.....|+..|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 23356888999999984 45688999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=263.64 Aligned_cols=200 Identities=27% Similarity=0.372 Sum_probs=166.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEec---------
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--------- 581 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--------- 581 (724)
..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367999999999999999999875 5789999998766666678899999999999999999999776543
Q ss_pred -----CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc-CCCCEE
Q 004912 582 -----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPK 655 (724)
Q Consensus 582 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~k 655 (724)
...++||||++ ++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 58888773 235889999999999999999999998 99999999999997 456789
Q ss_pred EEecCCccccCCCccc-ccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 656 ISDFGLARMFGGDELQ-GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 656 L~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
|+|||+++.+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 221 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999876432111 11223457889999998754 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=281.99 Aligned_cols=199 Identities=34% Similarity=0.501 Sum_probs=160.3
Q ss_pred HHhccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec-----
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ----- 581 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~----- 581 (724)
.+...+|+..+.||+||||.|||++.+ ||+.+|||++... +......+.+|++.|++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 445678999999999999999999875 8999999998654 344567789999999999999999987533210
Q ss_pred --------------------------------------------------------------------------------
Q 004912 582 -------------------------------------------------------------------------------- 581 (724)
Q Consensus 582 -------------------------------------------------------------------------------- 581 (724)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 004912 582 ----------------------------------GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627 (724)
Q Consensus 582 ----------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~y 627 (724)
...|+=|||++...|+.++....... ......+++++|+.||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 01356688888888887774322111 356788999999999999
Q ss_pred HHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC----C------------CcccccccccccccCccCcccccC
Q 004912 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG----G------------DELQGNTKQIVGTYGYMSPEYALD 691 (724)
Q Consensus 628 LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~ 691 (724)
+|+++ ||||||||.||+|+++..|||+|||+|.... . .......+..+||.-|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999 9999999999999999999999999998731 0 011113456789999999999876
Q ss_pred CC---CCchhhHHHHHHHHHHHHc
Q 004912 692 GL---FSIKSDVFSFGILMLETLS 712 (724)
Q Consensus 692 ~~---~s~k~DVwSlGvil~ellt 712 (724)
.. |+.|+|+|||||||+||+.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc
Confidence 54 9999999999999999986
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=226.78 Aligned_cols=201 Identities=26% Similarity=0.388 Sum_probs=167.6
Q ss_pred CcceeeeeccCCceeEEeeeecC-CceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+|...++||+|.+|+||||+..+ ++.||+|+.+-. ++.......+|+-+|+.++|.|||+++++...+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 34555799999999999998765 678999988643 223345678999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+. .+|..+.. .-++.++.+.+..++.|+++||.+.|+++ +.|||+||.|.|++.+|++||+|||+|+.++-...
T Consensus 83 cd-qdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 84 46776653 23456899999999999999999999998 99999999999999999999999999998764321
Q ss_pred cccccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLS-SKKNTGLGSM 722 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~ellt-G~~p~~~~~~ 722 (724)
..+..+-|..|.+|.++.+.. |+...|+||-|||+.|+.. |++.|...++
T Consensus 157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv 208 (292)
T KOG0662|consen 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_pred --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH
Confidence 223346689999999998865 8999999999999999998 6666765543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=280.83 Aligned_cols=208 Identities=34% Similarity=0.496 Sum_probs=175.2
Q ss_pred HHhccCcceeeeeccCCceeEEeeeecC--------CceeEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEE
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCC 578 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~ 578 (724)
....++..+.+.||+|.||.|++|.... ...||||.++.. .....+.+..|+++|..+ +||||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 3345566677799999999999997531 347999999764 335678899999999999 699999999999
Q ss_pred EecCeEEEEEEeeCCCChhHHHhhcC-----------CC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCC
Q 004912 579 VEQGEKILILEYMPNKSLNVFLFDST-----------KK--RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645 (724)
Q Consensus 579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~N 645 (724)
.+++..++|+||++.|+|.++|.... .. ..++..+++.++.|||.||+||++.. +|||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99999999999999999999997544 00 23899999999999999999999987 9999999999
Q ss_pred EEEcCCCCEEEEecCCccccCCCcccc-cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004912 646 ILLDKDMNPKISDFGLARMFGGDELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 719 (724)
Q Consensus 646 ILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~ 719 (724)
||+.++..+||+|||+|+......... ..+...-+..|||||.+....|+.|+|||||||+||||+| |..||..
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999765543332 1111113557999999999999999999999999999999 9999974
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-28 Score=280.30 Aligned_cols=146 Identities=29% Similarity=0.434 Sum_probs=131.2
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|.+.++||+|+||.||+|.+. +++.||||+++... ......+.+|+.++..++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367899999999999999999875 58899999986532 33457789999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
|||+++++|..++.. ...+++..+++|+.||+.||+|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999853 335888999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=248.50 Aligned_cols=193 Identities=31% Similarity=0.425 Sum_probs=169.0
Q ss_pred eccCCceeEEeeeec-CCceeEEEeccccCh---hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCCh
Q 004912 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (724)
Q Consensus 521 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (724)
||+|+||.||++... +++.+|+|.+..... ...+.+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 488999999865432 3456889999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccc
Q 004912 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676 (724)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 676 (724)
.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 999843 235899999999999999999999988 9999999999999999999999999998764321 12334
Q ss_pred cccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
..++..|+|||.+.+...+.++|+||||+++|||++|+.||...+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 568889999999988889999999999999999999999997554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=254.76 Aligned_cols=199 Identities=33% Similarity=0.447 Sum_probs=170.9
Q ss_pred cceeeeeccCCceeEEeeeecC-CceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
|+..+.||+|++|.||+|...+ ++.+|+|.+.... ....+.+..|+.++++++|||++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4567899999999999998764 8899999987653 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
+ ++|.+++.... ..+++..+.+++.|+++||+|||+.+ |+|+||+|+||++++++.++|+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58999985432 45899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||..++
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 22234567789999998776 78999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=253.77 Aligned_cols=198 Identities=30% Similarity=0.397 Sum_probs=167.2
Q ss_pred cceeeeeccCCceeEEeeeec-CCceeEEEeccccCh-hhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEEEEEEee
Q 004912 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
|++.+.||+|++|.||+|... +++.||||++..... .......+|+..+.+++ |||++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999885 478899999865422 22334567999999999 999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
+++|.+++.... ...+++.++..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 888988875432 346899999999999999999999998 9999999999999999999999999998764321
Q ss_pred ccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
......++..|+|||++.. ..++.++|+||||++++||++|+.||...
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 1233467889999998754 45789999999999999999999999644
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=240.99 Aligned_cols=202 Identities=25% Similarity=0.380 Sum_probs=166.1
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-ChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++.+.+..||.|..|+|++++.. .|..+|||.+.+. ..+..++++..+.++.+-+ .|.||+.+|++..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34455678999999999999875 4889999999764 4456778888888877765 8999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
.|. ..++.++.. .++++++.-+-++...+.+||.||.++. .|||||+||+|||+|+.|++||+|||++-.+-+.
T Consensus 172 lMs-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS- 245 (391)
T KOG0983|consen 172 LMS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS- 245 (391)
T ss_pred HHH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc-
Confidence 884 345555532 2445888888899999999999998765 5999999999999999999999999999776432
Q ss_pred ccccccccccccCccCcccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDG---LFSIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
...+...|-+.|||||.+.-. .|+.++||||||+.|+||.||+.||..-+.
T Consensus 246 --kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t 299 (391)
T KOG0983|consen 246 --KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT 299 (391)
T ss_pred --cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence 223445788999999998543 588999999999999999999999987443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-30 Score=249.08 Aligned_cols=201 Identities=29% Similarity=0.373 Sum_probs=163.5
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+.+-...||.|+||+|+|-.++ .|+..|||+++... +...++++.|.....+- +.||||+++|.+..++..++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3444578999999999999775 58999999997653 35667888888776555 689999999999999999999999
Q ss_pred eCCCChhHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 591 MPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 591 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
|. .+|+.+-.. ...+..+++.-+-.|..-+.+||.||-..- .|||||+||+||||+..|.+||+|||++-.+-..
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 94 466554321 223456888888899999999999998754 5999999999999999999999999998766332
Q ss_pred cccccccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
. ..+.-.|-..|||||.+.. ..|+.++||||||+.|||+.||+.|+.-+
T Consensus 222 i---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 222 I---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred H---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 1 2233577889999999854 34899999999999999999999999754
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=262.08 Aligned_cols=198 Identities=30% Similarity=0.424 Sum_probs=168.8
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe----
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE---- 583 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~---- 583 (724)
..++|++.+.||+|++|.||+|+.. +++.||||++... .....+.+.+|+.++++++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999875 4789999998653 23345667889999999999999999988766554
Q ss_pred --EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCC
Q 004912 584 --KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (724)
Q Consensus 584 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 661 (724)
.++|+||+ +++|.+++.. ..+++.++..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5689888742 45899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9875332 233467889999998865 467899999999999999999999996543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=255.44 Aligned_cols=195 Identities=34% Similarity=0.505 Sum_probs=165.6
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
+.|+..+.||+|+||.||+|+.. ++..+|+|.+... .....+++.+|+.++++++|||++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34677789999999999999875 4778999988632 3334567889999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+. ++|.+++... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 5777766432 345889999999999999999999998 999999999999999999999999998765322
Q ss_pred cccccccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 2346788999999874 35678899999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=249.10 Aligned_cols=201 Identities=29% Similarity=0.397 Sum_probs=166.9
Q ss_pred CcceeeeeccCCceeEEeeeecC-CceeEEEecccc-----ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~-----~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
+|.+.+.||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999997754 445666655432 222344677899999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 588 LEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
+||+++++|..++... .....+++.++..++.|+++||+|||+.+ ++|+||+|+||++++ +.++|+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988642 23456999999999999999999999998 999999999999975 569999999998764
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.... ......+++.|+|||.+.+..++.++|+||||+++|||++|..||...
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 3221 122346788999999998888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-29 Score=241.60 Aligned_cols=196 Identities=24% Similarity=0.318 Sum_probs=164.0
Q ss_pred hccCccee-eeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEe----cCe
Q 004912 511 ATENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE----QGE 583 (724)
Q Consensus 511 ~~~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~----~~~ 583 (724)
.+++|++. ++||-|-.|.|..+.++ .++.+|+|++... ....+|+++--+. .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35666664 58999999999999765 5889999999643 3346777765555 69999999999853 356
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC---CCCEEEEecC
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFG 660 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFG 660 (724)
..+|||.|+||.|...+.++ ....+++.++..|++||+.|+.|||+.+ |.||||||+|+|... +-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 78999999999999998553 3446999999999999999999999998 999999999999964 4569999999
Q ss_pred CccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
+|+.-.. .....+.+-|+.|.|||++...+|+..+|+||+|||+|-||+|-+||-
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence 9987432 334556788999999999999999999999999999999999999994
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=244.19 Aligned_cols=180 Identities=22% Similarity=0.175 Sum_probs=154.2
Q ss_pred CCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCChhHHHhh
Q 004912 524 GGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD 602 (724)
Q Consensus 524 G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 602 (724)
|.+|.||++++. +++.+|+|+++... .+.+|...+....||||+++++++.+....++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999875 57899999997543 234555566667899999999999999999999999999999998854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccC
Q 004912 603 STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682 (724)
Q Consensus 603 ~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~ 682 (724)
. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+..+... .....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 2 34899999999999999999999998 999999999999999999999999988765332 122345678
Q ss_pred ccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 683 y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
|+|||.+....++.++||||+|+++|||++|+.|+..
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 9999999888899999999999999999999987654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=262.96 Aligned_cols=204 Identities=23% Similarity=0.317 Sum_probs=155.1
Q ss_pred hccCcceeeeeccCCceeEEeeee-----------------cCCceeEEEeccccChhhHHHH--------------HHH
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL-----------------LNGQEVAVKRLSNQSGQGLKEF--------------KNE 559 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~-----------------~~g~~vAVK~l~~~~~~~~~~f--------------~~E 559 (724)
..++|++.++||+|+||.||+|.+ .+++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 2356799999865433333333 347
Q ss_pred HHHHHHccCCce-----eeEeeEEEe--------cCeEEEEEEeeCCCChhHHHhhcCC---------------------
Q 004912 560 MMLIAKLQHRNL-----VRLLGCCVE--------QGEKILILEYMPNKSLNVFLFDSTK--------------------- 605 (724)
Q Consensus 560 ~~il~~l~Hpni-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~--------------------- 605 (724)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788877654 667777653 3568999999999999999864211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccC
Q 004912 606 KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685 (724)
Q Consensus 606 ~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 685 (724)
...+++..+..++.|++++|+|||+.+ |+||||||+|||++.++.+||+|||+++.+..... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123567788999999999999999998 99999999999999999999999999976543211 11122345789999
Q ss_pred cccccCCCC----------------------CchhhHHHHHHHHHHHHcCCC-CCC
Q 004912 686 PEYALDGLF----------------------SIKSDVFSFGILMLETLSSKK-NTG 718 (724)
Q Consensus 686 PE~~~~~~~----------------------s~k~DVwSlGvil~elltG~~-p~~ 718 (724)
||.+..... ..+.||||+|||++||++|.. |+.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 998754321 134799999999999999875 664
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=214.79 Aligned_cols=109 Identities=34% Similarity=0.774 Sum_probs=104.9
Q ss_pred eecCcCCCCceeeeecc-cccceeeeeeecCcceEEEEEeecCCeeeEEEECcCCcEEEEEEecCCCceEEEeeccCCCC
Q 004912 210 TCSGHWDGAGFVSALSY-TDFLYKQFMMENKDECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYC 288 (724)
Q Consensus 210 ~~~g~w~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~~G~l~~~~w~~~~~~W~~~~~~p~~~C 288 (724)
||+|+|||..|.++|++ ....+.+.|+.+.+|.+|+|.+.+.+.++|++||++|+++++.|++..++|.+.|++|.|+|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 89999999999999999 67789999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccCCCCCCCcccccCCccCC
Q 004912 289 GKYGYCGANTICSLDQKPMCECLEGFKLES 318 (724)
Q Consensus 289 d~~g~CG~~g~C~~~~~~~C~C~~Gf~~~~ 318 (724)
|+|+.||+||+|+.+..|.|+||+||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 999999999999988899999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=256.74 Aligned_cols=196 Identities=24% Similarity=0.351 Sum_probs=169.2
Q ss_pred cCcceeeeeccCCceeEEeeeecC-CceeEEEeccccCh--------hhHHHHHHHHHHHHHcc---CCceeeEeeEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVE 580 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--------~~~~~f~~E~~il~~l~---Hpniv~l~~~~~~ 580 (724)
..|...+.+|.|+||.|+.+.++. ..+|+||.+.+..- ...-..-.|++||++++ |+||+++++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458889999999999999998864 56899998865421 11223557999999997 9999999999999
Q ss_pred cCeEEEEEEeeC-CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEec
Q 004912 581 QGEKILILEYMP-NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659 (724)
Q Consensus 581 ~~~~~lV~Ey~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF 659 (724)
++.+||+||-.. +-+|.+++ ..++.+++.++.-|++||+-|+++||+++ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999874 56788888 45566999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCcccccccccccccCccCcccccCCCCC-chhhHHHHHHHHHHHHcCCCCCC
Q 004912 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwSlGvil~elltG~~p~~ 718 (724)
|.|...... .....+||.+|.|||++.+.+|- ..-|||++|++||-++..+.||-
T Consensus 715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999876543 35567999999999999999884 55799999999999999999984
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=255.84 Aligned_cols=194 Identities=24% Similarity=0.343 Sum_probs=165.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++.|++...+|.|+|+.|-++.+. +++..+||++.+... +-.+|+.++.+. +||||+++.+++.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 678899999999999999999764 578899999976532 234677666666 69999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE-cCCCCEEEEecCCccccCCC
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL-DKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl-~~~~~~kL~DFGla~~~~~~ 668 (724)
.+.++-|.+.+.. .+... .++..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++...+.
T Consensus 397 ~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999988777632 22233 777889999999999999998 9999999999999 58999999999999886543
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
....+-|..|.|||++....|+.++|+||||++|||||+|+.||...+
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P 517 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP 517 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence 223467889999999999999999999999999999999999997654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=261.11 Aligned_cols=206 Identities=26% Similarity=0.455 Sum_probs=177.6
Q ss_pred hhHHHhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEe---
Q 004912 506 ASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE--- 580 (724)
Q Consensus 506 ~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~--- 580 (724)
..+...++.|++.++||.|.+|.||+++.. +++.+|||++.... +..+++..|..+|... .|||++.++|++..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 334445788999999999999999999764 58889999986543 3446778899999988 69999999999874
Q ss_pred --cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEe
Q 004912 581 --QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 658 (724)
Q Consensus 581 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 658 (724)
+++++|||||+.+|+..+++..-. ...+.|..+..|+..+++||.+||... ++|||||-.||||+.++.|||+|
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence 468999999999999999986644 667999999999999999999999987 99999999999999999999999
Q ss_pred cCCccccCCCcccccccccccccCccCcccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
||.+..+.. ...+..+..||+.|||||++... .|+.++|+||||++..||--|.+|+-
T Consensus 167 FGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~ 229 (953)
T KOG0587|consen 167 FGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC 229 (953)
T ss_pred eeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence 999987743 23445667999999999999643 47889999999999999999999974
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=233.06 Aligned_cols=199 Identities=34% Similarity=0.481 Sum_probs=173.3
Q ss_pred cceeeeeccCCceeEEeeeecC-CceeEEEeccccChh-hHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeC
Q 004912 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~-~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 592 (724)
|.+.+.||.|++|.||++...+ ++.+|+|.+...... ..+.+.+|+..+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999998865 789999999876554 67889999999999999999999999999899999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccc
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 672 (724)
+++|.+++..... .+++..+..++.++++++.+||+.+ ++|+||+|.||+++.++.++|+|||.+..+.... ..
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AA 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-cc
Confidence 9999999854221 1789999999999999999999997 9999999999999999999999999998764432 01
Q ss_pred cccccccccCccCcccc-cCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22345678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-27 Score=208.66 Aligned_cols=115 Identities=43% Similarity=0.724 Sum_probs=101.9
Q ss_pred cccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEecCCCCeEEEE
Q 004912 32 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWST 111 (724)
Q Consensus 32 ~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~~~~~~~Wst 111 (724)
++|++|++|+|++|.|++|||.+......+.+|||..++.++||.|||+.|. ...+.|.|+.||+|+|.|.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 5789999999999999999999876655999999987767899999999994 447889999999999999999999999
Q ss_pred eccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCC
Q 004912 112 NVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYP 152 (724)
Q Consensus 112 ~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~P 152 (724)
++++.....+|+|+|+|||||++.. +.++|||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC-----CCEEEcCCCCC
Confidence 9876345667899999999999974 48899999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-28 Score=235.01 Aligned_cols=203 Identities=28% Similarity=0.474 Sum_probs=164.5
Q ss_pred cCcceeeeeccCCceeEEeeeecC-CceeEEEeccc--cChhhHHHHHHHHHHHHHccCCceeeEeeEEEe--------c
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--------Q 581 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~--~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~--------~ 581 (724)
..|+-..+||+|.||.||+|+..+ ++.||+|+.-- ..+.--..-.+|+++|..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345666799999999999998754 77789886532 222223445789999999999999999988853 2
Q ss_pred CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCC
Q 004912 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (724)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 661 (724)
...+|||++++. +|..+|.+ ....++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 357899999865 67777743 2345889999999999999999999887 99999999999999999999999999
Q ss_pred ccccCCC--cccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 662 ARMFGGD--ELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 662 a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
++.+... ......+..+-|..|.+||.+.+. .|+++.|||.-||||.||+++.+-+...+
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt 233 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT 233 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence 9877432 222334456679999999998874 68999999999999999999999887654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=221.63 Aligned_cols=195 Identities=23% Similarity=0.414 Sum_probs=165.7
Q ss_pred hccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecC--eEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQG--EKIL 586 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~--~~~l 586 (724)
..++|++.+++|+|.++.||.|.. .++..++||++++. ..+.+.+|++||..|. ||||++|++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 357899999999999999999975 56788999999754 3467899999999997 999999999987654 5679
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC-CCEEEEecCCcccc
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMF 665 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DFGla~~~ 665 (724)
|+||+.+.+...+- +.|+..++..++.++++||.|+|+.| |+|||+||.|+++|.. ..++|+|+|+|..+
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998887664 34788889999999999999999999 9999999999999865 56999999999987
Q ss_pred CCCcccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.+.. .....+.+..|.-||.+..- .|+..-|+|||||+|.+|+..+.||-.+
T Consensus 184 Hp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG 236 (338)
T KOG0668|consen 184 HPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 236 (338)
T ss_pred CCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence 5532 22334567788999998764 5788999999999999999999999544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=260.65 Aligned_cols=200 Identities=23% Similarity=0.291 Sum_probs=142.5
Q ss_pred hccCcceeeeeccCCceeEEeeeecC-----CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeE------EE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC------CV 579 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~------~~ 579 (724)
..++|++.++||+|+||.||+|++.+ +..||||++...... +.+..| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 46789999999999999999998754 589999998643221 111111 1111122222222111 24
Q ss_pred ecCeEEEEEEeeCCCChhHHHhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCC
Q 004912 580 EQGEKILILEYMPNKSLNVFLFDSTKK-----------------RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642 (724)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlk 642 (724)
.+...++||||+++++|.+++...... .......+..++.||++||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999988542210 01123445679999999999999998 9999999
Q ss_pred CCCEEEcC-CCCEEEEecCCccccCCCcccccccccccccCccCcccccCCC----------------------CCchhh
Q 004912 643 ASNILLDK-DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL----------------------FSIKSD 699 (724)
Q Consensus 643 p~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------~s~k~D 699 (724)
|+|||+++ ++.+||+|||+|+.+.... ........+++.|||||.+.... ++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5799999999998764322 12234567899999999654322 345679
Q ss_pred HHHHHHHHHHHHcCCCCCC
Q 004912 700 VFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 700 VwSlGvil~elltG~~p~~ 718 (724)
||||||+||||+++..|++
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999876654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=230.95 Aligned_cols=186 Identities=34% Similarity=0.472 Sum_probs=165.4
Q ss_pred CceeEEeeeecC-CceeEEEeccccChhh-HHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCChhHHHhh
Q 004912 525 GFGPVYKGRLLN-GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD 602 (724)
Q Consensus 525 ~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~-~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 602 (724)
+||.||+|...+ ++.+|+|++....... .+.+.+|++.+++++|+|++++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998864 8899999997765444 78999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccC
Q 004912 603 STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682 (724)
Q Consensus 603 ~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~ 682 (724)
.. .+++..+..++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 22 2889999999999999999999998 9999999999999999999999999998765432 2334567889
Q ss_pred ccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 683 y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
|++||.+....++.++||||||++++||++|+.||..
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999988899999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=236.38 Aligned_cols=197 Identities=24% Similarity=0.296 Sum_probs=166.1
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHccC--Cc----eeeEeeEEEecCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RN----LVRLLGCCVEQGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~H--pn----iv~l~~~~~~~~~~ 584 (724)
+++|++...+|+|.||.|-++.+.. +..||||+++... .-.+.-+-|+.+|.++.+ |+ +|++.+++.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 7889999999999999999997643 6789999997543 334556779999999942 33 78888889999999
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC--------------
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-------------- 650 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-------------- 650 (724)
++|+|.+ |-++.++|.. .+..+++...+..|+.|+++++++||+.. ++|.||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999987 6689999843 23456888999999999999999999998 999999999999831
Q ss_pred ------CCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 651 ------DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 651 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
+..++|+|||.|..-... .+..+.|..|.|||++.+..++.++||||+||||.|+.+|...|-.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 235899999999874332 2567899999999999999999999999999999999999998854
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-28 Score=232.66 Aligned_cols=196 Identities=28% Similarity=0.392 Sum_probs=160.2
Q ss_pred ceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecC-----eEEEE
Q 004912 516 SMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKILI 587 (724)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~-----~~~lV 587 (724)
+-.+.||-|+||.||.+.++ +|+.||+|++...- -...+++.+|+++|.-++|.|++..++.-+-.. +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 44578999999999999774 69999999986532 234578889999999999999998887654322 45677
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
.|.| ..+|..++ .....++...+.-++.||++||.|||+.+ |.||||||.|.|++++..+||+|||+|+.-..
T Consensus 136 TELm-QSDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELM-QSDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHH-Hhhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 7776 34676666 34456888888889999999999999998 99999999999999999999999999998655
Q ss_pred CcccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
++. ...+..+-|..|.|||.+++. +|+.+.||||.|||+.|||-.+..|..
T Consensus 209 d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 209 RDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred hhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 443 234455678899999999885 589999999999999999998877743
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-27 Score=257.05 Aligned_cols=197 Identities=30% Similarity=0.417 Sum_probs=161.1
Q ss_pred cceeeeeccCCcee-EEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEEeeC
Q 004912 515 FSMQCKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMP 592 (724)
Q Consensus 515 ~~~~~~LG~G~fG~-Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~ 592 (724)
|.-.+.+|.|.-|+ ||+|.. ++++||||++-.. ..+...+|+..|..- +||||||+++.-.++...|+..|.+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44456789999985 799987 7889999998642 334567899999888 69999999999888999999999984
Q ss_pred CCChhHHHhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-----CCCEEEEecCCccccC
Q 004912 593 NKSLNVFLFDSTKKRL-LNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-----DMNPKISDFGLARMFG 666 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~-l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kL~DFGla~~~~ 666 (724)
-+|++++..+..... ......+.+..|+++||++||+.+ ||||||||.||||.. ..+++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 589999865311111 111445678999999999999987 999999999999965 2579999999999986
Q ss_pred CCcc-cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCC
Q 004912 667 GDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS-KKNTGL 719 (724)
Q Consensus 667 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG-~~p~~~ 719 (724)
.+.. ........||-+|+|||++....-+.++||+|+|||+|+.++| .+||+-
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 5432 2335667899999999999999889999999999999999995 899983
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=197.57 Aligned_cols=113 Identities=45% Similarity=0.768 Sum_probs=99.8
Q ss_pred cccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEecCCCCeEEEE
Q 004912 32 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWST 111 (724)
Q Consensus 32 ~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~~~~~~~Wst 111 (724)
+.|..|++|+|++|.|++|||.+... ..+.+|||+..+.++||+|||+.|+.. ++.|.|+.||+|||.|.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 56888999999999999999998654 689999998766789999999999876 4889999999999999999999999
Q ss_pred eccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccC
Q 004912 112 NVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (724)
Q Consensus 112 ~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~ 151 (724)
+++......+|+|+|+|||||++.. ++++||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYDSD-----GNFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC-----CCEEeCCCCC
Confidence 9873345667899999999999973 4799999997
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-25 Score=229.73 Aligned_cols=203 Identities=24% Similarity=0.285 Sum_probs=174.6
Q ss_pred HhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccC------CceeeEeeEEEecC
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH------RNLVRLLGCCVEQG 582 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~H------pniv~l~~~~~~~~ 582 (724)
....+|.+....|+|-|+.|.+|.+. .|..||||++.... .-.+.=+.|++||++|+. -|.++|+..|...+
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 34568999999999999999999875 47899999997643 333455789999999953 47999999999999
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC-CCEEEEecCC
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGL 661 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DFGl 661 (724)
++|||+|-+ ..+|.++|......-.|....+..++.|+.-||..|-..+ |+|.||||.||||++. ..+||||||.
T Consensus 508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence 999999977 5689999988878888999999999999999999999888 9999999999999876 4589999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
|.....++. +...-+..|.|||++.+.+|+...|+||.||.||||.||+..|...+
T Consensus 584 A~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 584 ASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred ccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 988765442 33445678999999999999999999999999999999999997654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-23 Score=204.57 Aligned_cols=183 Identities=40% Similarity=0.659 Sum_probs=159.2
Q ss_pred eccCCceeEEeeeecC-CceeEEEeccccChh-hHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCChhH
Q 004912 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNV 598 (724)
Q Consensus 521 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~-~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 598 (724)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..+++++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998864 889999999765433 45789999999999999999999999999899999999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-CCCEEEEecCCccccCCCccccccccc
Q 004912 599 FLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGDELQGNTKQI 677 (724)
Q Consensus 599 ~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~ 677 (724)
++.... ..+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985432 35889999999999999999999998 999999999999999 89999999999987643321 12334
Q ss_pred ccccCccCcccccCC-CCCchhhHHHHHHHHHHH
Q 004912 678 VGTYGYMSPEYALDG-LFSIKSDVFSFGILMLET 710 (724)
Q Consensus 678 ~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~el 710 (724)
.+...|++||.+... .++.++|+|++|++++||
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 678899999998887 888999999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=214.56 Aligned_cols=195 Identities=30% Similarity=0.352 Sum_probs=162.0
Q ss_pred cCcceeeeeccCCceeEEeeee-cCCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec------Ce
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------GE 583 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~------~~ 583 (724)
.+|.-.+.+|.|.- .|-.+.+ -.+++||+|++... .....++..+|...+..++|+|+++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888887 5555533 35889999988543 234567778999999999999999999998533 36
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.|+|||+| ..+|...+. -.++...+.+|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 78999999 457777764 23778889999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.-... -..+..+.|..|.|||++.+..+...+||||+|||+.||++|+--|...
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 75433 3456678899999999999999999999999999999999999887644
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=215.14 Aligned_cols=132 Identities=27% Similarity=0.340 Sum_probs=108.5
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHcc-----CC---ceeeEeeEEEe---
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----HR---NLVRLLGCCVE--- 580 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-----Hp---niv~l~~~~~~--- 580 (724)
.+|.+.++||-|.|++||++.+. ..+.||+|+.+... .-.+.-..|+++|++++ |+ +||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 58999999999999999999774 46789999986532 23455688999999994 33 59999999975
Q ss_pred -cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc
Q 004912 581 -QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649 (724)
Q Consensus 581 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 649 (724)
+.+.+||+|++ |-+|..+|.. ...+.++...+.+|+.||+.||.|||.++ +|||.||||+||||.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 45789999998 5566666643 33456999999999999999999999987 699999999999983
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=208.75 Aligned_cols=196 Identities=21% Similarity=0.360 Sum_probs=157.3
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeE-EEecCeEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGC-CVEQGEKILIL 588 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~-~~~~~~~~lV~ 588 (724)
.+.|.+.+.||+|.||.+-+++++. .+.+++|.+.... ...++|.+|...--.| .|.||+.-+++ ++..+.++.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4679999999999999999999864 6688999886543 3467888888765555 58999887765 45667788999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc--CCCCEEEEecCCccccC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDMNPKISDFGLARMFG 666 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kL~DFGla~~~~ 666 (724)
||+|.|+|.+-+. ...+.+....+++.|++.|+.|+|+++ +||||||.+||||- +..++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999987763 345778888899999999999999999 99999999999993 34589999999987653
Q ss_pred CCcccccccccccccCccCcccccCCC-----CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGL-----FSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.. ....--+..|-+||.+.... ..+.+|||.||+|++.+|+|+.||.-.
T Consensus 175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 22 11223456789999875432 367899999999999999999999643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=219.78 Aligned_cols=169 Identities=20% Similarity=0.213 Sum_probs=131.8
Q ss_pred HHhccCcceeeeeccCCceeEEeeeec--CCceeEEEecccc-----ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~-----~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~ 581 (724)
....++|++.+.||+|+||+||+|++. +++.+|||++... .....+.|.+|+++|.+++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999774 4677899987533 22345679999999999999999853322 2
Q ss_pred CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccC-CCCCEEEcCCCCEEEEecC
Q 004912 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL-KASNILLDKDMNPKISDFG 660 (724)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kL~DFG 660 (724)
+..++||||+++++|.... . .. ...++.|++++|+|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4679999999999996321 1 11 1467889999999999998 999999 9999999999999999999
Q ss_pred CccccCCCccccc------ccccccccCccCcccccCCC
Q 004912 661 LARMFGGDELQGN------TKQIVGTYGYMSPEYALDGL 693 (724)
Q Consensus 661 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~ 693 (724)
+|+.+........ .....+++.|+|||.+....
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 9998754321111 23567888999999886543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=214.89 Aligned_cols=202 Identities=25% Similarity=0.423 Sum_probs=167.7
Q ss_pred HHhccCcceeeeeccCCceeEEeeeec----CCceeEEEeccccChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCe
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGE 583 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~ 583 (724)
....+.|..+++||+|.|++||++.+. ..+.||+|.+...+ ...++.+|++.|..+. |.||+++.+++..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 334567888999999999999999764 35789999986543 3356899999999995 8999999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-CCCEEEEecCCc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLA 662 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla 662 (724)
..+|+||++.....++... ++..++..++..++.||+++|.+| ||||||||.|+|.+. .++-.|+|||+|
T Consensus 110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 9999999999999988743 678899999999999999999999 999999999999975 467899999999
Q ss_pred cccCCC----------------------------------ccc--------ccccccccccCccCcccccCCC-CCchhh
Q 004912 663 RMFGGD----------------------------------ELQ--------GNTKQIVGTYGYMSPEYALDGL-FSIKSD 699 (724)
Q Consensus 663 ~~~~~~----------------------------------~~~--------~~~~~~~gt~~y~aPE~~~~~~-~s~k~D 699 (724)
...... .+. .......||+||.|||++.... .++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 832100 000 0011247999999999998754 689999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCC
Q 004912 700 VFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 700 VwSlGvil~elltG~~p~~~~~ 721 (724)
|||.|||++-+++++.||-..+
T Consensus 261 iws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred eeeccceeehhhccccccccCc
Confidence 9999999999999999996543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-24 Score=231.75 Aligned_cols=198 Identities=27% Similarity=0.453 Sum_probs=174.3
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
..++|++...+|.|.+|.|||+++. .++..|||.++-......+-.+.|+.+++.-+||||+.++|-+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 4578999999999999999999875 578899999987777777888999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+.+|+|+++-+ ...++++.++....+..++||+|||+.+ =+|||||-.|||+++.+.+|++|||.+..+...
T Consensus 93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat- 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT- 165 (829)
T ss_pred ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-
Confidence 999999998863 4567999999999999999999999998 799999999999999999999999999876432
Q ss_pred ccccccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKN 716 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~p 716 (724)
-.+.....||+.|||||+.. .+.|..++|||++|+...|+---+.|
T Consensus 166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp 214 (829)
T KOG0576|consen 166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP 214 (829)
T ss_pred -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence 23455689999999999873 45689999999999999997655544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-21 Score=206.19 Aligned_cols=203 Identities=25% Similarity=0.300 Sum_probs=166.7
Q ss_pred CcceeeeeccCCceeEEeeeecCC--ceeEEEeccccChhhHHHHHHHHHHHHHccC----CceeeEeeEE-EecCeEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLLNG--QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH----RNLVRLLGCC-VEQGEKIL 586 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~~g--~~vAVK~l~~~~~~~~~~f~~E~~il~~l~H----pniv~l~~~~-~~~~~~~l 586 (724)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999987553 4788888765433333378889999999973 5888888888 46777899
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC-----CCEEEEecCC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-----MNPKISDFGL 661 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-----~~~kL~DFGl 661 (724)
||+.+ +.+|.++..... .+.++....++|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99875 889999875443 567999999999999999999999999 9999999999999765 4699999999
Q ss_pred cc--ccCCCc----cccc--ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 662 AR--MFGGDE----LQGN--TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 662 a~--~~~~~~----~~~~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
++ .+.... .... ....+||..|.+++.+.+...+.+.|+||++.++.|++.|..||...+
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 99 432211 1111 234669999999999999999999999999999999999999985443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-20 Score=196.50 Aligned_cols=202 Identities=36% Similarity=0.518 Sum_probs=171.7
Q ss_pred cceeeeeccCCceeEEeeeecCCceeEEEeccccChh---hHHHHHHHHHHHHHccCC-ceeeEeeEEEecCeEEEEEEe
Q 004912 515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQHR-NLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~---~~~~f~~E~~il~~l~Hp-niv~l~~~~~~~~~~~lV~Ey 590 (724)
|.+.+.||.|+|+.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +++++.+++......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999876 78899998765332 477899999999999988 799999999777778999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC-CEEEEecCCccccCCCc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGGDE 669 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~~~~~~ 669 (724)
+.++++.+++........+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976643221136889999999999999999999998 99999999999999988 79999999998665433
Q ss_pred ccc----cccccccccCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQG----NTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 3456789999999999988 578899999999999999999999976554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=187.38 Aligned_cols=201 Identities=23% Similarity=0.321 Sum_probs=167.5
Q ss_pred hccCcceeeeeccCCceeEEeee-ecCCceeEEEeccccChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~lV~ 588 (724)
..-+|.+.++||+|+||.++.|. +-+++.||||.-...++. -++..|....+.|. .++|...+-+..++..-.||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 45689999999999999999996 457999999987554432 35566777777774 688999888888888889999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-----CCCEEEEecCCcc
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-----DMNPKISDFGLAR 663 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kL~DFGla~ 663 (724)
|.+ |-+|.++..- ..+.++.+.++.||.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||||+
T Consensus 104 dLL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 987 7788887632 3445899999999999999999999998 999999999999954 3458999999999
Q ss_pred ccCCCcc-----cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 664 MFGGDEL-----QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 664 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.+.+... ....+...||.+||+=....+++.+.+.|+-|||-++++.|.|..||-.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 8855322 1234557899999999999999999999999999999999999999953
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.1e-21 Score=181.35 Aligned_cols=201 Identities=22% Similarity=0.300 Sum_probs=165.9
Q ss_pred hccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHccC-CceeeEeeEEEecCeEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~H-pniv~l~~~~~~~~~~~lV~ 588 (724)
...+|.++++||.|+||.+|.|.. .+|.+||||.-+.... ..++..|.++...|+| ..|.++..+..+...-.|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 356899999999999999999965 5799999999765432 2456788999999976 66777777888888889999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC---CCEEEEecCCcccc
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFGLARMF 665 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~DFGla~~~ 665 (724)
|.+ +.+|.++..-- ...++.+.++-++.|++.-++|+|.++ +|||||||+|+|+.-+ ..+.|+|||+|+.+
T Consensus 91 dLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 987 77888876322 234788899999999999999999998 9999999999999643 46899999999987
Q ss_pred CCCc-----ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 666 GGDE-----LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 666 ~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.+.. .........||.+|.+-..+.+...+.+.|+-|+|.+|.++..|..||..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence 5421 11223456899999999988888999999999999999999999999953
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=232.41 Aligned_cols=148 Identities=19% Similarity=0.220 Sum_probs=112.2
Q ss_pred HccC-CceeeEeeEE-------EecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 004912 565 KLQH-RNLVRLLGCC-------VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636 (724)
Q Consensus 565 ~l~H-pniv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 636 (724)
.++| +||+++++.+ .+....++++||+ +++|.++|... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3445 5777777776 2334567788887 56999999532 345999999999999999999999998 9
Q ss_pred EeccCCCCCEEEcCCC-------------------CEEEEecCCccccCCCc--------------ccccccccccccCc
Q 004912 637 IHRDLKASNILLDKDM-------------------NPKISDFGLARMFGGDE--------------LQGNTKQIVGTYGY 683 (724)
Q Consensus 637 iH~Dlkp~NILl~~~~-------------------~~kL~DFGla~~~~~~~--------------~~~~~~~~~gt~~y 683 (724)
+||||||+||||+..+ .+||+|||+++...... .........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999996544 45555666554321100 00001124578899
Q ss_pred cCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 684 MSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 684 ~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
||||++.+..++.++|||||||+||||++|..|+.
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 99999999999999999999999999999998875
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=186.59 Aligned_cols=171 Identities=16% Similarity=0.177 Sum_probs=134.2
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChh---hHHH------HHHHHHHHHHccCCceeeEeeEEEec
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---GLKE------FKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~---~~~~------f~~E~~il~~l~Hpniv~l~~~~~~~ 581 (724)
...+|...++||.|+||.||.... +++.+|||.+++.... ..+. +.+|+..+.+++||+|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999765 6778999999754322 2222 68999999999999999998886543
Q ss_pred --------CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC
Q 004912 582 --------GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (724)
Q Consensus 582 --------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 653 (724)
...++||||++|.+|.++.. ++. ....+++.++..+|+.+ ++|||++|.||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999987741 222 24569999999999998 99999999999999988
Q ss_pred EEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHH
Q 004912 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711 (724)
Q Consensus 654 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ell 711 (724)
++|+|||.......+... ..+.....|..++|+|+||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988764221100 11445556778999999999887643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=183.72 Aligned_cols=139 Identities=18% Similarity=0.166 Sum_probs=108.6
Q ss_pred eeeeccCCceeEEeeeecCCceeEEEeccccChh--h-------HHH-----------------HHHHHHHHHHccCCce
Q 004912 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--G-------LKE-----------------FKNEMMLIAKLQHRNL 571 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--~-------~~~-----------------f~~E~~il~~l~Hpni 571 (724)
.+.||+|+||.||+|...+|+.||||+++..... . ... ...|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998654211 1 112 2359999999988776
Q ss_pred eeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceEeccCCCCCEEEcC
Q 004912 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL-HQYSRFRIIHRDLKASNILLDK 650 (724)
Q Consensus 572 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~iiH~Dlkp~NILl~~ 650 (724)
.....+. ....++||||++++++..... ....++..++.+++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4333222 223489999999987765432 234588999999999999999999 6887 99999999999998
Q ss_pred CCCEEEEecCCcccc
Q 004912 651 DMNPKISDFGLARMF 665 (724)
Q Consensus 651 ~~~~kL~DFGla~~~ 665 (724)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=177.87 Aligned_cols=141 Identities=21% Similarity=0.235 Sum_probs=111.8
Q ss_pred eeeeccCCceeEEeeeecCCceeEEEeccccChh--------------------------hHHHHHHHHHHHHHccCCce
Q 004912 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--------------------------GLKEFKNEMMLIAKLQHRNL 571 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--------------------------~~~~f~~E~~il~~l~Hpni 571 (724)
...||+|++|+||+|.+.+|+.||||+++..... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998754211 01234689999999999987
Q ss_pred eeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeccCCCCCEEEcC
Q 004912 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDK 650 (724)
Q Consensus 572 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~ 650 (724)
.....+... ..++||||++++++..... ....++..+..+++.|++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544433332 3489999999886544321 22357788999999999999999999 87 99999999999999
Q ss_pred CCCEEEEecCCccccCC
Q 004912 651 DMNPKISDFGLARMFGG 667 (724)
Q Consensus 651 ~~~~kL~DFGla~~~~~ 667 (724)
++.++|+|||++..+..
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-18 Score=167.88 Aligned_cols=186 Identities=18% Similarity=0.137 Sum_probs=140.1
Q ss_pred eeeeeccCCceeEEeeeecCCceeEEEeccccChh----hHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEEEEEEee
Q 004912 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ----GLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~----~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
+...|++|+||+||.+.. ++.+++.+.++....- ....|.+|+++|++|+ |+++.+++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997765 6778888877654321 1236889999999995 5889999886 4568999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccC-CCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL-KASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
++.+|...+. . ....++.|++++|+++|+++ |+|||| ||+|||++.++.++|+|||+|........
T Consensus 81 ~G~~L~~~~~---~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP---R-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh---h-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9999865431 0 11357889999999999998 999999 79999999999999999999986543221
Q ss_pred c----c--c-----ccccccccCccCcccccCC-CCC-chhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 Q----G--N-----TKQIVGTYGYMSPEYALDG-LFS-IKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~----~--~-----~~~~~gt~~y~aPE~~~~~-~~s-~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
. . . ..-...++.|++|+...-. ..+ .+.+.++.|.-+|+++|++.++-.+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0 0 0012357888888854332 333 5679999999999999999877443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.7e-20 Score=178.36 Aligned_cols=197 Identities=24% Similarity=0.378 Sum_probs=156.6
Q ss_pred cceeeeeccCCceeEEeeeecCCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeC
Q 004912 515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 592 (724)
..+..+|.+...|..|+|+++ |..+++|++... +....++|.+|.-.|+-+.||||+++++.|.......++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344568899999999999995 455667777543 33445789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccc
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 672 (724)
.|+|...|+.. ..-..+..++.+++.+||+|++|||+..+. |.---|..+.|++|++.+++|.= +-++. ..
T Consensus 271 ~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarism-ad~kf------sf 341 (448)
T KOG0195|consen 271 FGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISM-ADTKF------SF 341 (448)
T ss_pred chHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheec-cccee------ee
Confidence 99999999763 334577889999999999999999998742 44557899999999999888741 11111 11
Q ss_pred cccccccccCccCcccccCCCCC---chhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDGLFS---IKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s---~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.....-.+.||+||.++.++-+ .++|+|||+++||||-|.+.||...+
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence 22233457899999999887754 57999999999999999999996543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.7e-19 Score=171.70 Aligned_cols=107 Identities=25% Similarity=0.204 Sum_probs=93.8
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
|+|.+++... +..+++.+++.|+.||++||+|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6888888542 346999999999999999999999875 999999999999999 99998754321
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
..||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 26889999999999999999999999999999999999999643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.4e-18 Score=166.51 Aligned_cols=136 Identities=23% Similarity=0.347 Sum_probs=106.5
Q ss_pred eeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHc-----cCCceeeEeeEEEecC---eEE-EEE
Q 004912 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-----QHRNLVRLLGCCVEQG---EKI-LIL 588 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-----~Hpniv~l~~~~~~~~---~~~-lV~ 588 (724)
.+.||+|+||.||. +++....+||++........+++.+|+.++.++ .||||+++++++.++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 46899999999996 544344479988765444567899999999999 5799999999998874 333 789
Q ss_pred Ee--eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCceEeccCCCCCEEEcC----CCCEEEEe-cC
Q 004912 589 EY--MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL-LYLHQYSRFRIIHRDLKASNILLDK----DMNPKISD-FG 660 (724)
Q Consensus 589 Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L-~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kL~D-FG 660 (724)
|| .++++|.+++.. ..+++. ..++.|++.++ +|||+++ |+||||||+|||++. +..++|+| ||
T Consensus 85 e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 558999999943 225554 35678888887 9999998 999999999999974 34799999 55
Q ss_pred Cccc
Q 004912 661 LARM 664 (724)
Q Consensus 661 la~~ 664 (724)
....
T Consensus 156 ~~~~ 159 (210)
T PRK10345 156 ESTF 159 (210)
T ss_pred Ccce
Confidence 4443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.3e-18 Score=198.64 Aligned_cols=199 Identities=21% Similarity=0.245 Sum_probs=161.0
Q ss_pred HHHhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHcc---CCceeeEeeEEEecCeE
Q 004912 508 ITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 508 i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~---Hpniv~l~~~~~~~~~~ 584 (724)
.....+.|.+.+.||+|+||+||+|...+|+.||+|+-+....-. |.--.+++.||+ -+-|+.+..++.-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 344567899999999999999999998889999999987654321 111223334444 23455555556667788
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-------CCCEEEE
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-------DMNPKIS 657 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-------~~~~kL~ 657 (724)
+||+||.+.|+|.+++. ..+.++|.....++.||++.+++||..+ |||+||||+|.||.. ..-++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999999999994 5567999999999999999999999998 999999999999942 3458999
Q ss_pred ecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 004912 658 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715 (724)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~ 715 (724)
|||-+-.+..-.........++|-.+-.+|+..+++++..+|.|.|+-+++-||.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999976643332345667789999999999999999999999999999999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.5e-19 Score=192.30 Aligned_cols=186 Identities=28% Similarity=0.352 Sum_probs=156.0
Q ss_pred eeccCCceeEEeeee----cCCceeEEEeccccChhh--HHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEEEEEEeeC
Q 004912 520 KLGEGGFGPVYKGRL----LNGQEVAVKRLSNQSGQG--LKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMP 592 (724)
Q Consensus 520 ~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~~~~--~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~lV~Ey~~ 592 (724)
++|+|.||.|+.++- +.+..+|+|.+++..... ......|..++...+ ||.+|++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998743 347789999887643221 124567888888997 9999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccc
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 672 (724)
+|.|...+. .....++.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+.+..-...
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--- 151 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--- 151 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence 999987773 3344667777778888999999999998 9999999999999999999999999998753322
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
..+||..|||||++. .+..++|.||||++++||++|-.||..
T Consensus 152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 128999999999887 677889999999999999999999976
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.4e-19 Score=199.77 Aligned_cols=199 Identities=24% Similarity=0.327 Sum_probs=157.6
Q ss_pred eeeeeccCCceeEEeeeec-CCceeEEEecc----c-cChh-hHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 517 MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS----N-QSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~----~-~~~~-~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
....+|.|++|.|+..... .....+.|.+. . ..+. ....+..|+.+-.+++|||++..+....+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3468999999977776432 33334444332 1 1111 12226678888888999999888877777766666699
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++ +|..++. ....+...++..++.|+++|+.|||..| |.|||+|++|+++..++.+||+|||.+..+.-..
T Consensus 402 ~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 9999883 3345888899999999999999999999 9999999999999999999999999998774433
Q ss_pred cc--ccccccccccCccCcccccCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 670 LQ--GNTKQIVGTYGYMSPEYALDGLFSIK-SDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 670 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~k-~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
.. ......+|+..|+|||++.+..|.+. .||||.|+++..|.+|+.||..-..
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~ 530 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK 530 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccc
Confidence 22 45567899999999999999999765 8999999999999999999976543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=5e-17 Score=164.55 Aligned_cols=150 Identities=17% Similarity=0.156 Sum_probs=115.7
Q ss_pred HHHhccCcceeeeeccCCceeEEeee--ecCCceeEEEeccccChh------------------------hHHHHHHHHH
Q 004912 508 ITAATENFSMQCKLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQ------------------------GLKEFKNEMM 561 (724)
Q Consensus 508 i~~~~~~~~~~~~LG~G~fG~Vy~~~--~~~g~~vAVK~l~~~~~~------------------------~~~~f~~E~~ 561 (724)
+......|++.+.||+|++|.||+|. ..+|+.||||+++..... ....+..|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33344568899999999999999998 567999999998643210 1123678999
Q ss_pred HHHHccCC--ceeeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEec
Q 004912 562 LIAKLQHR--NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 639 (724)
Q Consensus 562 il~~l~Hp--niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~ 639 (724)
++.++.+. .+.++++. ...++||||+++.+|..... ....+...+...++.||+.++++||+.+ .|+||
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~ 173 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHG 173 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence 99999763 34444442 23589999999988876542 2234566677899999999999999886 49999
Q ss_pred cCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 640 DLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 640 Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
||||+||+++ +++++|+|||.+.....
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhccCC
Confidence 9999999999 88999999999986543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.5e-17 Score=160.47 Aligned_cols=135 Identities=20% Similarity=0.286 Sum_probs=114.1
Q ss_pred eeeccCCceeEEeeeecCCceeEEEeccccCh--------hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--------~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
+.||+|++|.||+|+. .+..++||+...... .....+.+|+.++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 677899998654321 1134678999999999999988777777777888999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+++++|.+++... .. ++..++.+++.+|++||+.+ ++|+|++|.|||++ ++.++|+|||.+...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999988432 12 77899999999999999998 99999999999999 789999999998763
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-17 Score=167.64 Aligned_cols=202 Identities=21% Similarity=0.305 Sum_probs=134.6
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEecccc---ChhhHHHHHHHHHHHHHccC----------CceeeEeeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH----------RNLVRLLGC 577 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~H----------pniv~l~~~ 577 (724)
...+...+.||.|+++.||.+++.+ ++++|||++... .....+++++|......+.+ -.++-.++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 3456778899999999999999865 889999987432 23456778888766655432 122222222
Q ss_pred EE---------ec---C-----eEEEEEEeeCCCChhHHHh---hcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 004912 578 CV---------EQ---G-----EKILILEYMPNKSLNVFLF---DSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636 (724)
Q Consensus 578 ~~---------~~---~-----~~~lV~Ey~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 636 (724)
.. .. . ..+++|+-+ .++|..++. .... ...+....++.+..|+++.+++||.+| +
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---l 166 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---L 166 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---e
Confidence 21 11 1 225566665 667877753 2222 223445566778899999999999999 9
Q ss_pred EeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccC--------CCCCchhhHHHHHHHHH
Q 004912 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD--------GLFSIKSDVFSFGILML 708 (724)
Q Consensus 637 iH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DVwSlGvil~ 708 (724)
+|+||+|+|++++++|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 99999999999999999999999988765432111 234578999997644 24789999999999999
Q ss_pred HHHcCCCCCCCCCC
Q 004912 709 ETLSSKKNTGLGSM 722 (724)
Q Consensus 709 elltG~~p~~~~~~ 722 (724)
.|++|+.||+..+.
T Consensus 242 ~lWC~~lPf~~~~~ 255 (288)
T PF14531_consen 242 SLWCGRLPFGLSSP 255 (288)
T ss_dssp HHHHSS-STCCCGG
T ss_pred HHHHccCCCCCCCc
Confidence 99999999987653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.7e-18 Score=193.78 Aligned_cols=199 Identities=20% Similarity=0.218 Sum_probs=154.0
Q ss_pred CcceeeeeccCCceeEEeeeecCCceeEEEeccccCh-hhHHHHHHHHHH--HHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMML--IAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~f~~E~~i--l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++...+.||.+.|=+|.++++++|. |+||++-++.+ -..+.|+++++- ...++|||.+++.-+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677789999999999999998886 99999876553 344555444433 4555899999987775566666788888
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC----
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG---- 666 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~---- 666 (724)
..+ +|.+.| ..++.+...+...|+.|++.||.-+|..+ |+|||||.+||||+.-.-+.|+||..-+...
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 754 666666 34566888899999999999999999999 9999999999999999999999998776532
Q ss_pred -CCcccccccccccccCccCcccccCC----------C-CCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 667 -GDELQGNTKQIVGTYGYMSPEYALDG----------L-FSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 667 -~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
+.++.-...+...-..|+|||.+... . .+++.||||+||+++||++ |++||+..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS 242 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS 242 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH
Confidence 12222233334455689999987442 2 5788999999999999999 78888753
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-17 Score=131.54 Aligned_cols=66 Identities=50% Similarity=1.105 Sum_probs=59.4
Q ss_pred cCCCCeeEEecccCCCCccccccccccChHHHHHHHhhcCceEEEeeccccCCcceEEeccccccc
Q 004912 336 CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDA 401 (724)
Q Consensus 336 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~C~~w~~~l~~~ 401 (724)
|+.+|+|+++.+|++|++....++.++++++|++.|++||||+||+|.++.++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 556789999999999999877776779999999999999999999998776778999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=157.24 Aligned_cols=144 Identities=19% Similarity=0.201 Sum_probs=112.7
Q ss_pred hHHHhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccCh----------------------hhHHHHHHHHHHHH
Q 004912 507 SITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG----------------------QGLKEFKNEMMLIA 564 (724)
Q Consensus 507 ~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~----------------------~~~~~f~~E~~il~ 564 (724)
.+......|.+.+.||+|+||.||++...+|+.||||++..... .....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34444445788899999999999999988899999998654220 01123678999999
Q ss_pred HccCCc--eeeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCC
Q 004912 565 KLQHRN--LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642 (724)
Q Consensus 565 ~l~Hpn--iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlk 642 (724)
.+.|++ +.+.++ ....++||||+++++|..+.. ......++.+++.++.++|+.+ |+|+|||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 998874 444443 245589999999999876541 0234678899999999999988 9999999
Q ss_pred CCCEEEcCCCCEEEEecCCccccC
Q 004912 643 ASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 643 p~NILl~~~~~~kL~DFGla~~~~ 666 (724)
|+||++++++.++|+|||++..+.
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.2e-16 Score=156.37 Aligned_cols=131 Identities=23% Similarity=0.353 Sum_probs=107.5
Q ss_pred eeccCCceeEEeeeecCCceeEEEeccccCh--------hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 520 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--------~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.||+|++|.||+|.. ++..+++|....... ...+++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 678899998653211 12356789999999999887655555556667779999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
++++|.+++.... ..++.+++++|++||+.+ ++|+|++|+||+++ ++.++++|||+++..
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998873311 078999999999999998 99999999999999 889999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-16 Score=179.27 Aligned_cols=137 Identities=21% Similarity=0.338 Sum_probs=112.1
Q ss_pred cCcceeeeeccCCceeEEeeeecCCceeEEEe-cccc-C------hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR-LSNQ-S------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~-l~~~-~------~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~ 584 (724)
..|...+.||+|+||.||+|..... .+++|+ ..+. . ....+++.+|++++.+++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4445678999999999999987544 344443 2211 1 11245688999999999999998888888777788
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||+++++|.+++. ....++.|++++|.+||+.+ ++||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998873 34678999999999999998 9999999999999 678999999999987
Q ss_pred c
Q 004912 665 F 665 (724)
Q Consensus 665 ~ 665 (724)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 4
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.8e-15 Score=137.17 Aligned_cols=135 Identities=21% Similarity=0.245 Sum_probs=114.5
Q ss_pred eeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccC--CceeeEeeEEEecCeEEEEEEeeCCC
Q 004912 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQGEKILILEYMPNK 594 (724)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~H--pniv~l~~~~~~~~~~~lV~Ey~~~g 594 (724)
+.+.||+|.++.||++...+ ..++||....... ...+.+|+.++..++| +++.+++.+....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999998854 7899999866543 5678999999999987 58999998888778899999999988
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
.+..+ +......++.++++++++||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4556677899999999999986444599999999999999989999999999865
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.1e-15 Score=144.93 Aligned_cols=137 Identities=20% Similarity=0.251 Sum_probs=99.4
Q ss_pred eeeeccCCceeEEeeeecCCceeEEEeccccChh--hHHH----------------------HHHHHHHHHHccCCc--e
Q 004912 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--GLKE----------------------FKNEMMLIAKLQHRN--L 571 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--~~~~----------------------f~~E~~il~~l~Hpn--i 571 (724)
.+.||+|+||.||+|.+.+++.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999988653211 1111 135666676765443 4
Q ss_pred eeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeccCCCCCEEEcC
Q 004912 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDK 650 (724)
Q Consensus 572 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~ 650 (724)
.+.+++ ...++||||++++.+......... .. .+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 245899999999544321111000 11 5677899999999999999 77 99999999999999
Q ss_pred CCCEEEEecCCccccC
Q 004912 651 DMNPKISDFGLARMFG 666 (724)
Q Consensus 651 ~~~~kL~DFGla~~~~ 666 (724)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-15 Score=171.52 Aligned_cols=169 Identities=27% Similarity=0.344 Sum_probs=124.2
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
..+|..++.|..|++|.||..+++. .+.+|+|+-+... -.++ |+.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch-----hhhc---cccccCCccee------------------
Confidence 4578999999999999999998864 5678885432211 0001 22223344443
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC---
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG--- 667 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~--- 667 (724)
|+-...+. .-+.++. +++.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+.+..-.
T Consensus 136 ---gDc~tllk---~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLK---NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcc---cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 33333331 1122332 2377899999998 99999999999999999999999999876411
Q ss_pred ----------CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 004912 668 ----------DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSME 723 (724)
Q Consensus 668 ----------~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~~e 723 (724)
.......+.++||+.|.|||++....|...+|.|++|+|+||.+.|+.||..++.|
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe 264 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 264 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence 11122345679999999999999999999999999999999999999999888554
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.7e-14 Score=144.95 Aligned_cols=135 Identities=23% Similarity=0.279 Sum_probs=104.8
Q ss_pred eeec-cCCceeEEeeeecCCceeEEEeccccC-------------hhhHHHHHHHHHHHHHccCCce--eeEeeEEEecC
Q 004912 519 CKLG-EGGFGPVYKGRLLNGQEVAVKRLSNQS-------------GQGLKEFKNEMMLIAKLQHRNL--VRLLGCCVEQG 582 (724)
Q Consensus 519 ~~LG-~G~fG~Vy~~~~~~g~~vAVK~l~~~~-------------~~~~~~f~~E~~il~~l~Hpni--v~l~~~~~~~~ 582 (724)
..|| .|+.|+||++.. ++..++||++.... ......+.+|+.++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4677 888899999877 46789999885311 1223567899999999998874 67777654432
Q ss_pred ----eEEEEEEeeCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEE
Q 004912 583 ----EKILILEYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 657 (724)
Q Consensus 583 ----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 657 (724)
..++|||++++ .+|.+++.. ..++.. .+.+|+.+|++||+.+ |+|+||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 689888732 234443 3578999999999999 9999999999999998899999
Q ss_pred ecCCcccc
Q 004912 658 DFGLARMF 665 (724)
Q Consensus 658 DFGla~~~ 665 (724)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.1e-14 Score=155.83 Aligned_cols=153 Identities=32% Similarity=0.483 Sum_probs=126.9
Q ss_pred HHHccCCceeeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce-EeccC
Q 004912 563 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI-IHRDL 641 (724)
Q Consensus 563 l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i-iH~Dl 641 (724)
|+.+.|.|+.+++|.+.+++..+.|.+|+..|+|.+.+.. ..-.+++.-...++++|++||+|||... | .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 3567899999999999999999999999999999999965 3345888888999999999999999875 4 99999
Q ss_pred CCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCC-------CCchhhHHHHHHHHHHHHcCC
Q 004912 642 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL-------FSIKSDVFSFGILMLETLSSK 714 (724)
Q Consensus 642 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~k~DVwSlGvil~elltG~ 714 (724)
++.|++++....+||+|||+.................-..-|.|||.+.... .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987764211111112223455799999887642 467799999999999999999
Q ss_pred CCCCCC
Q 004912 715 KNTGLG 720 (724)
Q Consensus 715 ~p~~~~ 720 (724)
.||...
T Consensus 156 ~~~~~~ 161 (484)
T KOG1023|consen 156 GPFDLR 161 (484)
T ss_pred Cccccc
Confidence 999764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.7e-15 Score=158.46 Aligned_cols=124 Identities=31% Similarity=0.440 Sum_probs=109.4
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
..++.|+++...+|.++|.........++...+.++.|++.|++| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 467899999999999999765555667888899999999999999 55 999999999999999999999999999
Q ss_pred cccCCCc----ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc
Q 004912 663 RMFGGDE----LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712 (724)
Q Consensus 663 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt 712 (724)
....... .....+...||..||+||.+.+..|+.|+||||||+||+||++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8765443 3345667899999999999999999999999999999999998
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.5e-13 Score=149.79 Aligned_cols=141 Identities=23% Similarity=0.279 Sum_probs=103.0
Q ss_pred eeeccCCceeEEeeeecCCceeEEEeccccChhhH----------------------------------------HHHHH
Q 004912 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL----------------------------------------KEFKN 558 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~----------------------------------------~~f~~ 558 (724)
+.||.|++|+||+|++.+|+.||||+.++...+.. -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 68999999999999999999999999865421110 02556
Q ss_pred HHHHHHHcc----CCceeeEeeEEE-ecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 004912 559 EMMLIAKLQ----HRNLVRLLGCCV-EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ-GLLYLHQYS 632 (724)
Q Consensus 559 E~~il~~l~----Hpniv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-~L~yLH~~~ 632 (724)
|+..+.+++ |.+-+.+-.++. ..+..+|||||++|++|.++...... .. ...+++.++++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 777666663 333333333332 24567999999999999887643211 12 23456666666 478889888
Q ss_pred CCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 633 ~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
++|+|++|.||+++.+++++++|||++..+..
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999988753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.7e-13 Score=139.92 Aligned_cols=144 Identities=23% Similarity=0.351 Sum_probs=105.3
Q ss_pred cCCceeeEeeEEEe---------------------------cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHH
Q 004912 567 QHRNLVRLLGCCVE---------------------------QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE 619 (724)
Q Consensus 567 ~Hpniv~l~~~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 619 (724)
+|||||++.++|.+ ....|+||.-.+ .+|.+++... ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence 59999999887754 124577777653 4788887432 355666777999
Q ss_pred HHHHHHHHHHhcCCCceEeccCCCCCEEEc--CC--CCEEEEecCCccccCCC----cccccccccccccCccCcccccC
Q 004912 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLD--KD--MNPKISDFGLARMFGGD----ELQGNTKQIVGTYGYMSPEYALD 691 (724)
Q Consensus 620 qia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~--~~~kL~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 691 (724)
|+++|+.|||+++ |.|||+|.+||||. ++ -.+.|+|||.+---... ++..-.-...|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999993 33 34799999976432111 11111112356778999998765
Q ss_pred CCC------CchhhHHHHHHHHHHHHcCCCCCC
Q 004912 692 GLF------SIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 692 ~~~------s~k~DVwSlGvil~elltG~~p~~ 718 (724)
.+- -.|+|.|+.|.+.||++....||-
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY 458 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFY 458 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCccc
Confidence 431 368999999999999999999983
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=7e-15 Score=166.98 Aligned_cols=207 Identities=25% Similarity=0.325 Sum_probs=167.0
Q ss_pred ccCcceeeeeccCCceeEEeeeecC--CceeEEEeccccC--hhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~l 586 (724)
...|.+.+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3456677789999999998886633 4456777765442 333455566887777786 9999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCceEeccCCCCCEEEcCCC-CEEEEecCCccc
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH-QYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARM 664 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH-~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~ 664 (724)
+.||..++++...+... .....+......++.|+..++.|+| ..+ +.|+|+||+|.+++..+ ..+++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999998877311 1113555667789999999999999 777 99999999999999999 999999999998
Q ss_pred cCC-Cccccccccccc-ccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 665 FGG-DELQGNTKQIVG-TYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 665 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
+.. ..........+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|+...+.
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 866 555555566788 99999999998854 46789999999999999999999976554
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.5e-13 Score=112.48 Aligned_cols=71 Identities=21% Similarity=0.372 Sum_probs=60.6
Q ss_pred cCCCCeeEEecccCCCCccccccccccChHHHHHHHhh---cCceEEEeeccccCCcceEEecccc-ccccCCcccCCCc
Q 004912 336 CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK---NCSCRAYANSNVKESSGCLMWYGDL-IDARRPIRNFTGQ 411 (724)
Q Consensus 336 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~~~~~~~~C~~w~~~l-~~~~~~~~~~~~~ 411 (724)
|....+|+++.+|++|++.. ++++||++.|++ ||||+||+|.+. ++||++|++++ ++++++. ..+.
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~--~~gC~~W~~~l~~d~~~~~--~~g~ 74 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA--RKQCLWFPFNSMSGVRKEF--SHGF 74 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC--CCCeEEecCcchhhHHhcc--CCCc
Confidence 44557899999999998754 689999999999 999999999753 36899999999 9998775 4578
Q ss_pred eEEEe
Q 004912 412 SVYLR 416 (724)
Q Consensus 412 ~lylr 416 (724)
++|+|
T Consensus 75 ~Ly~r 79 (80)
T cd00129 75 DLYEN 79 (80)
T ss_pred eeEeE
Confidence 89997
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.4e-12 Score=109.76 Aligned_cols=80 Identities=41% Similarity=0.850 Sum_probs=64.5
Q ss_pred CcccCCC---CeeEEecccCCCCccccccccccChHHHHHHHhhcCceEEEeeccccCCcceEEeccccccccCCcccCC
Q 004912 333 SLECKSG---DQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFT 409 (724)
Q Consensus 333 ~l~C~~~---~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~C~~w~~~l~~~~~~~~~~~ 409 (724)
+++|..+ ++|+++.++++|++.... .++++++|++.|++||+|+||+|.+ ++++|++|.+++.+.+... ..
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~--~~~~C~~~~~~~~~~~~~~--~~ 75 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN--GSGGCLLWNGLLNNLRSLS--SG 75 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC--CCCeEEEEeceecceEeec--CC
Confidence 4557544 689999999999885543 6789999999999999999999974 3678999999999876543 33
Q ss_pred CceEEEeec
Q 004912 410 GQSVYLRVP 418 (724)
Q Consensus 410 ~~~lylrl~ 418 (724)
+.++|+|++
T Consensus 76 ~~~~yiKv~ 84 (84)
T cd01098 76 GGTLYLRLA 84 (84)
T ss_pred CcEEEEEeC
Confidence 567999975
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=7.2e-12 Score=120.41 Aligned_cols=130 Identities=23% Similarity=0.200 Sum_probs=98.2
Q ss_pred eeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCcee-eEeeEEEecCeEEEEEEeeCCCChh
Q 004912 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEYMPNKSLN 597 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv-~l~~~~~~~~~~~lV~Ey~~~gsL~ 597 (724)
+.|+.|.++.||+++.. ++.+++|....... ....+..|+.++..+.+.+++ +++.+ .....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 67899999999999874 77899999865432 234568899999999766554 34443 333458999999998875
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 598 VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS--RFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
... . ....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 430 1 11245678999999999886 22369999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.30 E-value=9.3e-12 Score=138.82 Aligned_cols=145 Identities=19% Similarity=0.248 Sum_probs=98.0
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccChhh------------------------------H----H--
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQG------------------------------L----K-- 554 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~------------------------------~----~-- 554 (724)
...|+. +.||.|++|+||+|++++ |+.||||+.++.-.+. . +
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 789999999999999987 9999999987542110 0 1
Q ss_pred ----HHHHHHHHHHHcc----CCceeeEeeEEEe-cCeEEEEEEeeCCCChhHHHhhcCCC---CCCCHHHHHHHHHHHH
Q 004912 555 ----EFKNEMMLIAKLQ----HRNLVRLLGCCVE-QGEKILILEYMPNKSLNVFLFDSTKK---RLLNWQARVRIIEGIA 622 (724)
Q Consensus 555 ----~f~~E~~il~~l~----Hpniv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qia 622 (724)
+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++..-...+ ..+....+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 2455666666653 4444444444443 45678999999999998753211111 11222223333333
Q ss_pred HHHHHHHhcCCCceEeccCCCCCEEEcCCC----CEEEEecCCccccCC
Q 004912 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFGLARMFGG 667 (724)
Q Consensus 623 ~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~DFGla~~~~~ 667 (724)
++..| ++|+|+||.||+++.++ +++++|||++..+..
T Consensus 276 -----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33456 99999999999999888 999999999988754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=9.5e-11 Score=113.86 Aligned_cols=136 Identities=15% Similarity=0.129 Sum_probs=99.6
Q ss_pred eeeccCCceeEEeeeecC-------CceeEEEeccccC----------------------hhhHHHHH----HHHHHHHH
Q 004912 519 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS----------------------GQGLKEFK----NEMMLIAK 565 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~----------------------~~~~~~f~----~E~~il~~ 565 (724)
..||.|..+.||.|...+ +..+|||+.+... ....+.+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999999997653 4789999874311 01122333 89999999
Q ss_pred ccC--CceeeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceEeccCC
Q 004912 566 LQH--RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL-HQYSRFRIIHRDLK 642 (724)
Q Consensus 566 l~H--pniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~iiH~Dlk 642 (724)
+.. -++.+.+++ ...++||||+.+..+..-.. +...++..+...+..+++.+|..| |+.+ |+|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 953 456666654 45689999998754422211 122355566778889999999999 7777 9999999
Q ss_pred CCCEEEcCCCCEEEEecCCcccc
Q 004912 643 ASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 643 p~NILl~~~~~~kL~DFGla~~~ 665 (724)
+.|||++ ++.+.|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 468999999998765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.2e-10 Score=113.04 Aligned_cols=142 Identities=18% Similarity=0.267 Sum_probs=110.5
Q ss_pred eeeccCCceeEEeeeecCCceeEEEeccccCh-hhHHHHHHHHHHHHHccC--CceeeEeeEEEecC---eEEEEEEeeC
Q 004912 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQG---EKILILEYMP 592 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~f~~E~~il~~l~H--pniv~l~~~~~~~~---~~~lV~Ey~~ 592 (724)
+.|+.|..+.||+++..+|+.+++|....... ....++..|++++..+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999887678999999865432 245678999999999976 34566777765532 5689999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS---------------------------------------- 632 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~---------------------------------------- 632 (724)
+.++...+.. ..++..++..++.+++++|++||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988765421 34677778888888999998888521
Q ss_pred -------------CCceEeccCCCCCEEEcC--CCCEEEEecCCccc
Q 004912 633 -------------RFRIIHRDLKASNILLDK--DMNPKISDFGLARM 664 (724)
Q Consensus 633 -------------~~~iiH~Dlkp~NILl~~--~~~~kL~DFGla~~ 664 (724)
+..++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.6e-10 Score=122.58 Aligned_cols=168 Identities=18% Similarity=0.240 Sum_probs=128.9
Q ss_pred eecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHH
Q 004912 533 RLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQ 612 (724)
Q Consensus 533 ~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 612 (724)
+..++.+|.|...+.......+..++-++.|+.++||||++++.....++..|+|+|-+ ..|..++.. +...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKE 104 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHH
Confidence 34468889999887766644566788899999999999999999999999999999976 456666632 3356
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCC
Q 004912 613 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692 (724)
Q Consensus 613 ~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 692 (724)
.....+.||+.||.+||+.+ .++|++|.-.-|+|++.|+.||++|.++........ ......---.|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 67778999999999999766 499999999999999999999999998865432211 11111222356667654333
Q ss_pred CCCchhhHHHHHHHHHHHHcCC
Q 004912 693 LFSIKSDVFSFGILMLETLSSK 714 (724)
Q Consensus 693 ~~s~k~DVwSlGvil~elltG~ 714 (724)
. -..|.|-||++++|++.|.
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcc
Confidence 3 3469999999999999993
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=9.3e-11 Score=127.64 Aligned_cols=201 Identities=26% Similarity=0.366 Sum_probs=156.8
Q ss_pred cCcceeeeecc--CCceeEEeeee---cCCceeEEEecccc--ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeE
Q 004912 513 ENFSMQCKLGE--GGFGPVYKGRL---LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 513 ~~~~~~~~LG~--G~fG~Vy~~~~---~~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~ 584 (724)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-+.. .+.....=.+|+....++ .|+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566678999 99999999976 35778999984432 223323334566666666 499999988888888888
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCceEeccCCCCCEEEcCC-CCEEEEec
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ----GLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDF 659 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DF 659 (724)
++-.|.. +.+|..+.+. ....++...+..+..+..+ ||.++|... ++|-|+||.||++..+ ...++.||
T Consensus 194 fiqtE~~-~~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeeccc-cchhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 8888876 4778777643 3344777888888888888 999999998 9999999999999998 89999999
Q ss_pred CCccccCCCccccc---ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 660 GLARMFGGDELQGN---TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 660 Gla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
|+...+........ .....|...|++|| +....++.+.|+|++|.+.+|...+..+...+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke-~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKE-LLNGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChh-hhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 99999876543221 22336788999999 45667789999999999999999988776544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.6e-09 Score=101.64 Aligned_cols=131 Identities=22% Similarity=0.347 Sum_probs=100.5
Q ss_pred eeeccCCceeEEeeeecCCceeEEEe-cccc--Chh-----hHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 519 CKLGEGGFGPVYKGRLLNGQEVAVKR-LSNQ--SGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~-l~~~--~~~-----~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
..+.+|+-+.+|.+... |..+++|. +++. .++ ..++-.+|+.+|.+++--.|.--.-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36789999999999663 34466663 3221 111 234568899999999765655555556678888999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
+++..|.+.+... ...++..+-+.+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999988443 2457778888899999998 99999999999997765 99999999975
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.5e-09 Score=97.98 Aligned_cols=143 Identities=24% Similarity=0.329 Sum_probs=105.1
Q ss_pred eeeeeccCCceeEEeeeecCCceeEEE-eccccC-------hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 517 MQCKLGEGGFGPVYKGRLLNGQEVAVK-RLSNQS-------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK-~l~~~~-------~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
....|-+|+-+.|+++.. .|+...|| ++.+.- .-..++.++|+++|.+++--.|.--.-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 346899999999999987 56666666 443321 113467889999999997555544444555666678999
Q ss_pred EeeCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC---CEEEEecCCccc
Q 004912 589 EYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKISDFGLARM 664 (724)
Q Consensus 589 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~DFGla~~ 664 (724)
||+++ .++.+++....... ........++.+|-+.+.-||..+ |||+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 57888876543332 222333678899999999999998 99999999999996654 368999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.9e-08 Score=100.32 Aligned_cols=133 Identities=17% Similarity=0.144 Sum_probs=97.6
Q ss_pred eeEEeeeecCCceeEEEeccccChh-hH----------HHHHHHHHHHHHccCCc--eeeEeeEEEe-----cCeEEEEE
Q 004912 527 GPVYKGRLLNGQEVAVKRLSNQSGQ-GL----------KEFKNEMMLIAKLQHRN--LVRLLGCCVE-----QGEKILIL 588 (724)
Q Consensus 527 G~Vy~~~~~~g~~vAVK~l~~~~~~-~~----------~~f~~E~~il~~l~Hpn--iv~l~~~~~~-----~~~~~lV~ 588 (724)
..|++... +|+.+.||+....... .. ..+.+|...+.++...+ ..+++++... ....++|+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34667655 6778999977443211 11 24789999999985433 4455555543 23468999
Q ss_pred EeeCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-------CCCEEEEecC
Q 004912 589 EYMPNK-SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-------DMNPKISDFG 660 (724)
Q Consensus 589 Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-------~~~~kL~DFG 660 (724)
|++++. +|.+++.... ....+......++.+++..++-||..| |+|+|++++|||++. +..+.|+||+
T Consensus 115 e~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 115 EDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred eeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 999986 8988874321 233556677889999999999999999 999999999999975 4689999999
Q ss_pred Cccc
Q 004912 661 LARM 664 (724)
Q Consensus 661 la~~ 664 (724)
.++.
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.6e-09 Score=107.39 Aligned_cols=155 Identities=25% Similarity=0.303 Sum_probs=116.7
Q ss_pred HHHHHccCCceeeEeeEEEec-----CeEEEEEEeeCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 004912 561 MLIAKLQHRNLVRLLGCCVEQ-----GEKILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRF 634 (724)
Q Consensus 561 ~il~~l~Hpniv~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~ 634 (724)
.-|-.+.|.|||+++.|+.+. .+..++.|||.-|+|..+|....+ ...+......++..||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 344556799999999987643 456889999999999999976433 345778888899999999999999976 5
Q ss_pred ceEeccCCCCCEEEcCCCCEEEEecCCcccc--CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc
Q 004912 635 RIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712 (724)
Q Consensus 635 ~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~--~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt 712 (724)
+|+|+++..+-|++..++-+|+.--.-.... .............+-++|.|||.=.....+.++|||+||+..+||--
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 6999999999999998888887421111000 00011112233456789999998777777889999999999999988
Q ss_pred CCCC
Q 004912 713 SKKN 716 (724)
Q Consensus 713 G~~p 716 (724)
++.-
T Consensus 278 lEiq 281 (458)
T KOG1266|consen 278 LEIQ 281 (458)
T ss_pred heec
Confidence 7643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=5.9e-10 Score=127.33 Aligned_cols=209 Identities=20% Similarity=0.239 Sum_probs=148.0
Q ss_pred HhccCcceeeeeccCCceeEEeeeecC-CceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
...+.+.+.+.+-.|.++.++.+.-.. +...++|..... .....+....+-.++-.-+||-+++..--+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 345778888899999999999875432 333344433211 1111222233333333334566665544444566789
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
||++|+.+++|...|+... ..+..-....+..+..+++|||... +.|+|++|.|+|....++.++.||+.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999998885433 3455455566677889999999886 899999999999999999999999854432
Q ss_pred CCC-------------------------ccc----ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 004912 666 GGD-------------------------ELQ----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 716 (724)
Q Consensus 666 ~~~-------------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p 716 (724)
+.- ... .......+|+.|.+||...+......+|.|+.|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 000 112335789999999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 004912 717 TGLGSMER 724 (724)
Q Consensus 717 ~~~~~~e~ 724 (724)
|.....+|
T Consensus 1035 ~na~tpq~ 1042 (1205)
T KOG0606|consen 1035 FNAETPQQ 1042 (1205)
T ss_pred CCCcchhh
Confidence 98876553
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.9e-08 Score=97.42 Aligned_cols=126 Identities=25% Similarity=0.305 Sum_probs=83.7
Q ss_pred eEEeeeecCCceeEEEeccccC---------------------h-----hhHHHHHHHHHHHHHccCC--ceeeEeeEEE
Q 004912 528 PVYKGRLLNGQEVAVKRLSNQS---------------------G-----QGLKEFKNEMMLIAKLQHR--NLVRLLGCCV 579 (724)
Q Consensus 528 ~Vy~~~~~~g~~vAVK~l~~~~---------------------~-----~~~~~f~~E~~il~~l~Hp--niv~l~~~~~ 579 (724)
.||.|...+|..+|||+.+... . ......++|.+.|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899998899999999864311 0 0123467899999999765 45566544
Q ss_pred ecCeEEEEEEeeC--CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCceEeccCCCCCEEEcCCCCEEE
Q 004912 580 EQGEKILILEYMP--NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY-LHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (724)
Q Consensus 580 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~y-LH~~~~~~iiH~Dlkp~NILl~~~~~~kL 656 (724)
. ..++||||++ +..+..+.... ++..+...++.++++.+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 ~--~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 N--RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp E--TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred e--CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 2 3479999999 66665544211 1123445677888886665 46777 9999999999999988 9999
Q ss_pred EecCCccccC
Q 004912 657 SDFGLARMFG 666 (724)
Q Consensus 657 ~DFGla~~~~ 666 (724)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.8e-09 Score=117.67 Aligned_cols=196 Identities=22% Similarity=0.259 Sum_probs=149.0
Q ss_pred hccCcceeeeeccCCceeEEeeee--cCCceeEEEeccccChhhHHHH--HHHHHHHHHc-cCCceeeEeeEEEecCeEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSGQGLKEF--KNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~--~~g~~vAVK~l~~~~~~~~~~f--~~E~~il~~l-~Hpniv~l~~~~~~~~~~~ 585 (724)
...+|..+..||.|.|+.|++... .++..+++|.+.+.......+. ..|+.+...+ .|.++++....+..-...+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 356788889999999999998754 3577899998876543332222 3566666666 5889998887777777788
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC-CCEEEEecCCccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARM 664 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DFGla~~ 664 (724)
+=-||++++++...+ .....+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 889999999887766 22334778888999999999999999887 9999999999999875 8889999999864
Q ss_pred cCCCcccccccccccccCcc--CcccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYM--SPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 717 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~ 717 (724)
+.-. .....+.-+++ +|+......+..++|++|||.-+.|.+++..--
T Consensus 417 ~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 417 LAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred ccee-----cccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence 3211 11122233444 566566677899999999999999999887543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.2e-08 Score=95.92 Aligned_cols=146 Identities=20% Similarity=0.214 Sum_probs=102.2
Q ss_pred hhhHHHhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccC----------------------hhhHHHHHHHHHH
Q 004912 505 LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----------------------GQGLKEFKNEMML 562 (724)
Q Consensus 505 ~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~----------------------~~~~~~f~~E~~i 562 (724)
+..+.....-..+..+||-|.-+.||.|..++|.++|||.-+... .......++|.++
T Consensus 83 L~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 83 LHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 333333333456678999999999999999999999999543211 0123345789999
Q ss_pred HHHccCC--ceeeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecc
Q 004912 563 IAKLQHR--NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRD 640 (724)
Q Consensus 563 l~~l~Hp--niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~D 640 (724)
|.+|.-. .+.+.+++ +...+||||+++..|...- ++....-.|+..|++-+.-+-..| |||+|
T Consensus 163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGD 227 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGD 227 (304)
T ss_pred HHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccC
Confidence 9999644 56666553 4567999999998775442 122223334444444444444556 99999
Q ss_pred CCCCCEEEcCCCCEEEEecCCcccc
Q 004912 641 LKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 641 lkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+.+-||+++++|.+.++||-.+...
T Consensus 228 lSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 228 LSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred CchheEEEecCCCEEEEeCcccccC
Confidence 9999999999999999999887654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.9e-07 Score=98.46 Aligned_cols=169 Identities=20% Similarity=0.281 Sum_probs=128.1
Q ss_pred ceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEE----ecCeEEEEEEeeCC-CChhHH
Q 004912 526 FGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV----EQGEKILILEYMPN-KSLNVF 599 (724)
Q Consensus 526 fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~----~~~~~~lV~Ey~~~-gsL~~~ 599 (724)
-.+.||+.. .+|..|++|+++....+.......-+++++++.|+|+|++..++. .+...++||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788865 479999999995443333323345678899999999999998886 34467899999985 677776
Q ss_pred HhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 600 LFDST------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 600 l~~~~------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
-+... .....++..++.++.|++.||.++|+.| +.-+-|.|++||++.+.+++|..-|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 2235788999999999999999999999 88899999999999999999988887765533
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 716 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p 716 (724)
+.. |-+ .--.+-|.=.||.+++.|.+|...
T Consensus 446 d~~----------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 220 101 112467999999999999999654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.6e-07 Score=104.51 Aligned_cols=142 Identities=16% Similarity=0.200 Sum_probs=96.9
Q ss_pred eeeccCCceeEEeeeecCCceeEEEeccccChh------------------------------hHH----------HHHH
Q 004912 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ------------------------------GLK----------EFKN 558 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~------------------------------~~~----------~f~~ 558 (724)
+.|+.++-|+||+|++++|+.||||+.++.-.+ ..+ +|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 689999999999999999999999998653211 011 2456
Q ss_pred HHHHHHHcc----CCceeeEeeEEE-ecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 004912 559 EMMLIAKLQ----HRNLVRLLGCCV-EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633 (724)
Q Consensus 559 E~~il~~l~----Hpniv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~ 633 (724)
|+.-+.+++ +..-+++=.++. -.+..+|+|||++|..+.++..... ..++.+.+.....++. +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f--~~q~~~dg- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAF--LRQLLRDG- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHH--HHHHHhcC-
Confidence 666666663 222233333333 3567899999999999988853322 3355444333322222 22222345
Q ss_pred CceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 634 ~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
++|.|..|.||+++.++++.+.|||+...+..
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999987754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.4e-06 Score=84.94 Aligned_cols=139 Identities=16% Similarity=0.174 Sum_probs=103.5
Q ss_pred eccCCceeEEeeeecCCceeEEEeccccC------hhhHHHHHHHHHHHHHccC--CceeeEeeEEEec----CeEEEEE
Q 004912 521 LGEGGFGPVYKGRLLNGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQ----GEKILIL 588 (724)
Q Consensus 521 LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~------~~~~~~f~~E~~il~~l~H--pniv~l~~~~~~~----~~~~lV~ 588 (724)
-|+||.+-|++..+ +|..+-+|+-.... +-+...|.+|...|.++.. -.+.+.+.+.... -.-+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46788999999876 44478899875221 4467789999999999964 2344555222221 1357999
Q ss_pred EeeCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC--EEEEecCCccc
Q 004912 589 EYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--PKISDFGLARM 664 (724)
Q Consensus 589 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kL~DFGla~~ 664 (724)
|-+++ .+|.+++.+.. ....+......++.++++.++-||..+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 68888874322 234677778899999999999999999 999999999999986667 99999987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.8e-07 Score=89.26 Aligned_cols=107 Identities=24% Similarity=0.274 Sum_probs=84.6
Q ss_pred HHHHHHHHHHHHHccC--CceeeEeeEEEecC----eEEEEEEeeCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 004912 553 LKEFKNEMMLIAKLQH--RNLVRLLGCCVEQG----EKILILEYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625 (724)
Q Consensus 553 ~~~f~~E~~il~~l~H--pniv~l~~~~~~~~----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L 625 (724)
.....+|...+.+++. -...+.+++..... ..++|+|++++ .+|.+++..... ++......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 3467788888888853 34556666665532 35899999998 489998854222 56667788999999999
Q ss_pred HHHHhcCCCceEeccCCCCCEEEcCCC---CEEEEecCCcccc
Q 004912 626 LYLHQYSRFRIIHRDLKASNILLDKDM---NPKISDFGLARMF 665 (724)
Q Consensus 626 ~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~DFGla~~~ 665 (724)
+-||..+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=7.6e-07 Score=92.93 Aligned_cols=193 Identities=14% Similarity=0.143 Sum_probs=126.2
Q ss_pred ceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEE------EecCe-EEEE
Q 004912 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCC------VEQGE-KILI 587 (724)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~------~~~~~-~~lV 587 (724)
.....||+|+.+.+|-.-- -+-.+-|+.+...+....+- +..|... .||-+-.=+.+- -+++. .-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3457899999999996421 12234566655443322222 2223333 465443311110 11222 4466
Q ss_pred EEeeCCCC-hhHHHh---hcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 588 LEYMPNKS-LNVFLF---DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 588 ~Ey~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
|.-+++.. ...++. ..+.....+|.-+++.++.++.+.+.||+.| .+-+|+.++|+|+.+++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 67666542 223322 1223345889999999999999999999999 8899999999999999999999865443
Q ss_pred ccCCCcccccccccccccCccCcccccCC-----CCCchhhHHHHHHHHHHHHcC-CCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSS-KKNTGL 719 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DVwSlGvil~elltG-~~p~~~ 719 (724)
... ........+|...|.+||...-+ .-+...|.|.|||+++++|.| ++||+.
T Consensus 166 i~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 166 INA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 321 11223345789999999965422 335678999999999999996 999974
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.41 E-value=5.7e-06 Score=83.28 Aligned_cols=140 Identities=16% Similarity=0.161 Sum_probs=86.0
Q ss_pred eeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCc--eeeEeeEEEecCeEEEEEEeeCCCC-
Q 004912 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCCVEQGEKILILEYMPNKS- 595 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpn--iv~l~~~~~~~~~~~lV~Ey~~~gs- 595 (724)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+.+....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 35567889886533 3345688999999986443 4667777777777789999999973
Q ss_pred hhHHHh--------------h-----cCC-CCCCCHHHH-HHHHHH----------HHH-HHHHHHh-cCCCceEeccCC
Q 004912 596 LNVFLF--------------D-----STK-KRLLNWQAR-VRIIEG----------IAQ-GLLYLHQ-YSRFRIIHRDLK 642 (724)
Q Consensus 596 L~~~l~--------------~-----~~~-~~~l~~~~~-~~i~~q----------ia~-~L~yLH~-~~~~~iiH~Dlk 642 (724)
+...+. . +.- ......... .++..+ +.+ ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 0 000 001111110 011000 011 1122221 122347899999
Q ss_pred CCCEEEcCCCCEEEEecCCccc
Q 004912 643 ASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 643 p~NILl~~~~~~kL~DFGla~~ 664 (724)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.40 E-value=8.9e-07 Score=72.87 Aligned_cols=72 Identities=38% Similarity=0.761 Sum_probs=53.4
Q ss_pred CeeEEecccCCCCccccccccccChHHHHHHHhh-cCceEEEeeccccCCcceEEec-cccccccCCcccCCCceEEEe
Q 004912 340 DQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK-NCSCRAYANSNVKESSGCLMWY-GDLIDARRPIRNFTGQSVYLR 416 (724)
Q Consensus 340 ~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~~~~~~~~~~C~~w~-~~l~~~~~~~~~~~~~~lylr 416 (724)
..|.++.++.+++..... ....++++|++.|++ +|+|.||.|.. ++++|.+|. +.+.+..... ..+.++|.+
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~--~~~~C~l~~~~~~~~~~~~~--~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN--GTKGCLLWSESSLGDARLFP--SGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC--CCCEEEEeeCCccccceecc--cCCceeEEe
Confidence 469999999998664432 346799999999999 99999999975 557899999 7766655222 334445543
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.5e-06 Score=81.93 Aligned_cols=153 Identities=19% Similarity=0.221 Sum_probs=100.9
Q ss_pred cchhhHHHhccCccee---eeeccCCceeEEeeeecCCceeEEEeccccChhh---------HHH---------------
Q 004912 503 FSLASITAATENFSMQ---CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG---------LKE--------------- 555 (724)
Q Consensus 503 ~~~~~i~~~~~~~~~~---~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~---------~~~--------------- 555 (724)
.++..+.....+..+. ..|..|..+.||+|...++..+|||+++...... ..+
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 3445555554444443 3677888889999988889999999986532111 011
Q ss_pred HHHHHHHHHHcc--CCceeeEeeEEEecCeEEEEEEeeCCCCh-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 004912 556 FKNEMMLIAKLQ--HRNLVRLLGCCVEQGEKILILEYMPNKSL-NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632 (724)
Q Consensus 556 f~~E~~il~~l~--Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~ 632 (724)
..+|..-|.++. +-.+.+-+.+ ..-.|||||+....+ .-.| +..++...+...+..++++.+.-|-...
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 235666666663 3333344433 234799999965421 1111 2222344467778888888888887733
Q ss_pred CCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 633 ~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
.+||+||..-|||+. ++.+.|+||+.|....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 399999999999999 8899999999997764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.1e-05 Score=79.12 Aligned_cols=138 Identities=17% Similarity=0.203 Sum_probs=94.0
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHH---------HHHHHHHHHccCC---ceeeEeeEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEF---------KNEMMLIAKLQHR---NLVRLLGCC 578 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f---------~~E~~il~~l~Hp---niv~l~~~~ 578 (724)
...+|...+++-......|.+-.. +|..+++|..+.......+.| .+++..+.+++.. ....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 356788888888887777777665 678999999876543322222 3445555555322 222322222
Q ss_pred E-----ecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC
Q 004912 579 V-----EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (724)
Q Consensus 579 ~-----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 653 (724)
. .....+|+|||++|..|.++.. +++ .++..+.+++.-||+.| +.|+|..|.|++++++ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence 2 2235578999999998866541 222 24566778899999999 9999999999999865 4
Q ss_pred EEEEecCCccc
Q 004912 654 PKISDFGLARM 664 (724)
Q Consensus 654 ~kL~DFGla~~ 664 (724)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.5e-06 Score=92.62 Aligned_cols=142 Identities=19% Similarity=0.225 Sum_probs=95.1
Q ss_pred eeeccCCceeEEeeeecCCceeEEEeccccChhh-------------------------------------HHHHHHHHH
Q 004912 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-------------------------------------LKEFKNEMM 561 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-------------------------------------~~~f~~E~~ 561 (724)
+.||..+.|+||+|++++|+.||||+-++.-.+. .=+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999876542111 012556666
Q ss_pred HHHHc----cCCc---eeeEeeEEEe-cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 004912 562 LIAKL----QHRN---LVRLLGCCVE-QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633 (724)
Q Consensus 562 il~~l----~Hpn---iv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~ 633 (724)
-..++ .|-+ -|.+=.++.+ ...++|+||||+|..+.+...- .+..++..++..-+.++..-+-+ ..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf--~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIF--KTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHH--hcC-
Confidence 66555 3555 1223333332 3578999999999988777432 22335655544433333222222 234
Q ss_pred CceEeccCCCCCEEEcC----CCCEEEEecCCccccCC
Q 004912 634 FRIIHRDLKASNILLDK----DMNPKISDFGLARMFGG 667 (724)
Q Consensus 634 ~~iiH~Dlkp~NILl~~----~~~~kL~DFGla~~~~~ 667 (724)
++|+|-.|.||++.. +.++.+.|||+...+..
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999984 67899999999987643
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.25 E-value=3.4e-06 Score=75.16 Aligned_cols=87 Identities=26% Similarity=0.341 Sum_probs=61.4
Q ss_pred EEEeeCCcEEEecCC-CCeEEEEeccCCC-CCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhcccccccccc
Q 004912 90 LTISNNGNLVLLNQT-NGTIWSTNVSSEV-KNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFK 167 (724)
Q Consensus 90 L~l~~~g~l~l~~~~-~~~~Wst~~~~~~-~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg~kl~~~~~ 167 (724)
+.+..||+||+.+.. +.++|++++.... ....+.|.++|||||++.. +.++|+|=.
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S~t----------------- 81 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD-----GRVVWSSNT----------------- 81 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC-----CCEEEEecc-----------------
Confidence 455689999999765 5899999975432 2356789999999999863 367888611
Q ss_pred cccceeEEeecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecC
Q 004912 168 NRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSG 213 (724)
Q Consensus 168 ~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g 213 (724)
....|.+.+.++.+|...++-.++ .+.|.+.
T Consensus 82 --------------~~~~~~~~~~L~ddGnlvl~~~~~-~~~W~Sf 112 (114)
T smart00108 82 --------------TGANGNYVLVLLDDGNLVIYDSDG-NFLWQSF 112 (114)
T ss_pred --------------cCCCCceEEEEeCCCCEEEECCCC-CEEeCCC
Confidence 112456788899999877654433 4567654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.3e-05 Score=80.80 Aligned_cols=144 Identities=22% Similarity=0.231 Sum_probs=86.0
Q ss_pred eeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCC--ceeeEeeEEEe---cCeEEEEEEeeC
Q 004912 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR--NLVRLLGCCVE---QGEKILILEYMP 592 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hp--niv~l~~~~~~---~~~~~lV~Ey~~ 592 (724)
++.|+.|..+.||+....+ +.+++|..... .....+.+|..++..+... .+.+++.+... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3689999999999998866 69999997654 4557788899999888533 34566664432 234689999999
Q ss_pred CCChhH----------------HH---hhc-CCCCCCCH-H--------HHHHH------------HHHHHH-HHHHHHh
Q 004912 593 NKSLNV----------------FL---FDS-TKKRLLNW-Q--------ARVRI------------IEGIAQ-GLLYLHQ 630 (724)
Q Consensus 593 ~gsL~~----------------~l---~~~-~~~~~l~~-~--------~~~~i------------~~qia~-~L~yLH~ 630 (724)
+..+.. .+ +.. ........ . ..... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 998877 11 111 01111111 0 00000 111222 2333332
Q ss_pred ----cCCCceEeccCCCCCEEEc-CCCCEEEEecCCccc
Q 004912 631 ----YSRFRIIHRDLKASNILLD-KDMNPKISDFGLARM 664 (724)
Q Consensus 631 ----~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~~ 664 (724)
.....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1334599999999999999 666668999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.2e-05 Score=80.26 Aligned_cols=141 Identities=14% Similarity=0.141 Sum_probs=85.8
Q ss_pred eeccCCc-eeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEEEEEEeeCCCChh
Q 004912 520 KLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSLN 597 (724)
Q Consensus 520 ~LG~G~f-G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~ 597 (724)
.|..|.. ..||+.... +..+.||+..... ...+.+|++++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3444555 789998764 4788889876543 345678999988884 444567777776666789999999998876
Q ss_pred HHH-------------------hhcCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----c
Q 004912 598 VFL-------------------FDSTK-KRLLNW--QARVRIIE--------------------GIAQGLLYLHQ----Y 631 (724)
Q Consensus 598 ~~l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------qia~~L~yLH~----~ 631 (724)
... +.... ...... ........ .+.+.+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 442 10000 001110 00000000 01111222211 1
Q ss_pred CCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 632 ~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
....++|+|+.|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 223589999999999999987789999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.1e-05 Score=72.20 Aligned_cols=87 Identities=24% Similarity=0.275 Sum_probs=61.2
Q ss_pred EEEee-CCcEEEecCC-CCeEEEEeccCC-CCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhccccccccc
Q 004912 90 LTISN-NGNLVLLNQT-NGTIWSTNVSSE-VKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (724)
Q Consensus 90 L~l~~-~g~l~l~~~~-~~~~Wst~~~~~-~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg~kl~~~~ 166 (724)
+.... ||+||+.+.. +.++|++|+... .....+.|.++|||||++.+ +.++|+|=-.
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S~~~--------------- 83 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS-----GTVVWSSNTT--------------- 83 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC-----CcEEEEeccc---------------
Confidence 44555 8999999765 589999997542 34556789999999999864 3678885321
Q ss_pred ccccceeEEeecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecC
Q 004912 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSG 213 (724)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g 213 (724)
.+.+.+.+.|+.+|...++-.+ ..+.|.+.
T Consensus 84 ----------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf 113 (116)
T cd00028 84 ----------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSF 113 (116)
T ss_pred ----------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCC
Confidence 1245678888888887765544 34567665
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.5e-05 Score=77.71 Aligned_cols=105 Identities=22% Similarity=0.239 Sum_probs=83.3
Q ss_pred HHHHHHHHHccC-CceeeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 004912 557 KNEMMLIAKLQH-RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635 (724)
Q Consensus 557 ~~E~~il~~l~H-pniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ 635 (724)
.+|..+|..+++ +++.+++|+| ..++|.||.+.+++...-..-..-...+|..+.+|+.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999976 6999999998 34678999987765422000011123689999999999999999999865556
Q ss_pred eEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 636 IIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 636 iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+.-+|++|+|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999877554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.7e-07 Score=97.97 Aligned_cols=189 Identities=16% Similarity=0.116 Sum_probs=134.0
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCc-eeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpn-iv~l~~~~~~~~~~~lV~Ey 590 (724)
++.+.....+++++.+.++|.+....+...++.+... ....-++++|.+.+||| .++.++-+..++..++++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3344444678899999999987655555555555332 33456788999999999 77777766677778899999
Q ss_pred eCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 591 MPNK-SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 591 ~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
...+ +-..... ...-.+..-+...+.+.-++++++||+.. =+|+| ||+..+ ...+..||+.+..+.+..
T Consensus 316 ~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 8776 2111110 01111333444556667778999999864 48888 777765 678999999988775433
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
......+++.++|||+.....+..+.|+|++|+-..++--|..|-.
T Consensus 386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3455789999999999999999999999999987777666666643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.00 E-value=9.7e-05 Score=88.76 Aligned_cols=79 Identities=18% Similarity=0.397 Sum_probs=58.2
Q ss_pred eeeeccCCceeEEeeeecCC---ceeEEEeccccC-hhhHHHHHHHHHHHHHcc-CCce--eeEeeEEEec---CeEEEE
Q 004912 518 QCKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNL--VRLLGCCVEQ---GEKILI 587 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~g---~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~-Hpni--v~l~~~~~~~---~~~~lV 587 (724)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |+++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46889999999999876553 467888765432 123456889999999995 6664 7778877664 457899
Q ss_pred EEeeCCCCh
Q 004912 588 LEYMPNKSL 596 (724)
Q Consensus 588 ~Ey~~~gsL 596 (724)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.4e-06 Score=96.83 Aligned_cols=99 Identities=23% Similarity=0.454 Sum_probs=77.4
Q ss_pred HHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC-ccc-----c-cccccccccCccCccccc
Q 004912 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD-ELQ-----G-NTKQIVGTYGYMSPEYAL 690 (724)
Q Consensus 618 ~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~-~~~-----~-~~~~~~gt~~y~aPE~~~ 690 (724)
+.+++.||.|+|..- ++||++|.|++|.++.++..||+.|+.+....+. ++. . ...-......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345569999999876 5999999999999999999999999988765431 111 1 111223567999999999
Q ss_pred CCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 004912 691 DGLFSIKSDVFSFGILMLETLS-SKKNTG 718 (724)
Q Consensus 691 ~~~~s~k~DVwSlGvil~ellt-G~~p~~ 718 (724)
+...+.++|++|+|+++|-+.. |+.-+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~ 211 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIA 211 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhh
Confidence 9888999999999999999984 554443
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.96 E-value=7.9e-05 Score=66.20 Aligned_cols=100 Identities=25% Similarity=0.404 Sum_probs=65.5
Q ss_pred CeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEee-cCCCCCCCCCCeEEEeeCCcEEEecCCCCeEEEEeccCC
Q 004912 38 EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVA-NRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSE 116 (724)
Q Consensus 38 ~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~A-Nr~~p~~~~~~~L~l~~~g~l~l~~~~~~~~Wst~~~~~ 116 (724)
+.+.+.+|.+.|-|-..|+ |-|.-. ..++||.. +...+.. ..+.+.|..||||||.|..+.++|++.. .
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~~~--~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~--~ 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLYDS--NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFD--Y 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEEET--TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTT--S
T ss_pred cccccccccccceECCCCe-----EEEEcC--CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecC--C
Confidence 4565655888888887665 555432 35679999 4344332 3678999999999999999999999942 2
Q ss_pred CCCceEEEcc--CCCeEEecCCCCCCccceeeeeccCCc
Q 004912 117 VKNPVAQLRD--DGNLVIRDNSSGNATESYLWQSFDYPT 153 (724)
Q Consensus 117 ~~~~~a~lld--~GNlVl~~~~~~~~~~~~lWqSFd~Pt 153 (724)
.........+ .||++ ... ...+.|.|=+.|+
T Consensus 82 ptdt~L~~q~l~~~~~~-~~~-----~~~~sw~s~~dps 114 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GKN-----DSLTSWSSNTDPS 114 (114)
T ss_dssp SS-EEEEEET--TSEEE-EES-----TSSEEEESS----
T ss_pred CccEEEeccCcccCCCc-ccc-----ceEEeECCCCCCC
Confidence 3345555666 88888 543 2367898876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00011 Score=71.81 Aligned_cols=132 Identities=18% Similarity=0.269 Sum_probs=93.9
Q ss_pred eeeccCCceeEEeeeecCCceeEEEeccccC----------------hhhHHHHHHHHHHHHHcc------CCceeeEee
Q 004912 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----------------GQGLKEFKNEMMLIAKLQ------HRNLVRLLG 576 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~----------------~~~~~~f~~E~~il~~l~------Hpniv~l~~ 576 (724)
..||+|+.-.||. +++.....||+..... ....+++.+|+.....+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 5799999999996 5666677888886544 223566777777777776 788999999
Q ss_pred EEEecCeEEEEEEeeCC--C----ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC
Q 004912 577 CCVEQGEKILILEYMPN--K----SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK 650 (724)
Q Consensus 577 ~~~~~~~~~lV~Ey~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~ 650 (724)
+...+-..-+|+|-+.+ | +|.+++ ....++. +..+.+. +-..||-+.. |+.+|++|.||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEEe
Confidence 99999888999998853 3 466666 3334555 4444444 3445666665 999999999999953
Q ss_pred C---C-CEEEEe-cCCcc
Q 004912 651 D---M-NPKISD-FGLAR 663 (724)
Q Consensus 651 ~---~-~~kL~D-FGla~ 663 (724)
. . .+.|+| ||-..
T Consensus 154 ~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred cCCCceEEEEEeCCCCcc
Confidence 3 2 588888 45443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00019 Score=75.55 Aligned_cols=79 Identities=14% Similarity=0.135 Sum_probs=58.2
Q ss_pred cceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccC---CceeeEeeEEEec---CeEEEEE
Q 004912 515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH---RNLVRLLGCCVEQ---GEKILIL 588 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~H---pniv~l~~~~~~~---~~~~lV~ 588 (724)
..-.+.||.|..+.||+....++ .+.+|..+.. .....|.+|+..|+.+.. ..+.++++++... +..++||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 34457899999999999876555 4667775431 123578999999999853 3577888877543 5689999
Q ss_pred EeeCCCCh
Q 004912 589 EYMPNKSL 596 (724)
Q Consensus 589 Ey~~~gsL 596 (724)
|++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.86 E-value=8.7e-05 Score=69.63 Aligned_cols=129 Identities=20% Similarity=0.278 Sum_probs=90.9
Q ss_pred ceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceee-EeeEEEecCeEEEEEEeeCCC
Q 004912 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR-LLGCCVEQGEKILILEYMPNK 594 (724)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~-l~~~~~~~~~~~lV~Ey~~~g 594 (724)
...+.|++|.+|.||++.. .|..+|+|+-... .....+..|+++|..++-.++.+ ++.|. +-++.|||+.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 4457899999999999988 4568999986543 34578999999999998766644 44432 224559999998
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCC-CCCEEEcCCCCEEEEecCCccc
Q 004912 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK-ASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlk-p~NILl~~~~~~kL~DFGla~~ 664 (724)
+|.+.-.. .+.+. +..+++.---|...| |-|+.|. |..++|-.+..+.|+||..|..
T Consensus 98 ~L~~~~~~------~~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIG------GDRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhc------ccHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 88766421 12222 334455544555556 9999886 6666665666999999999984
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00013 Score=73.98 Aligned_cols=73 Identities=12% Similarity=0.183 Sum_probs=46.3
Q ss_pred eeeccCCce-eEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCC---ceeeEeeEEEec---CeEEEEEEee
Q 004912 519 CKLGEGGFG-PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCVEQ---GEKILILEYM 591 (724)
Q Consensus 519 ~~LG~G~fG-~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hp---niv~l~~~~~~~---~~~~lV~Ey~ 591 (724)
+.|+.|+.. .||+. +..+++|..+... ....+.+|++++..+... .+.+.++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777776 48875 2357788765422 345788999999888532 233444433222 1347899999
Q ss_pred CCCChh
Q 004912 592 PNKSLN 597 (724)
Q Consensus 592 ~~gsL~ 597 (724)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.0003 Score=68.34 Aligned_cols=125 Identities=24% Similarity=0.397 Sum_probs=91.2
Q ss_pred cCcceeeeeccCCc-eeEEeeeecCCceeEEEeccc---cC-----------h-------hhHHHHHHHHHHHHHcc---
Q 004912 513 ENFSMQCKLGEGGF-GPVYKGRLLNGQEVAVKRLSN---QS-----------G-------QGLKEFKNEMMLIAKLQ--- 567 (724)
Q Consensus 513 ~~~~~~~~LG~G~f-G~Vy~~~~~~g~~vAVK~l~~---~~-----------~-------~~~~~f~~E~~il~~l~--- 567 (724)
.+++..+.||.|.- |.|||+++ +|+.+|+|.++. .. + .-.+-|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78999999999999 99999998 678999999421 00 0 11234788999999985
Q ss_pred CCce--eeEeeEEEec------------------CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 004912 568 HRNL--VRLLGCCVEQ------------------GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627 (724)
Q Consensus 568 Hpni--v~l~~~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~y 627 (724)
+.++ |+++|+..-. ....+|.||++... .+. .+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 3456 8999987422 12346777765543 122 2345677788889
Q ss_pred HHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 628 LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99998 999999999986 4589999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00024 Score=72.00 Aligned_cols=141 Identities=18% Similarity=0.243 Sum_probs=82.6
Q ss_pred eeeccCCceeEEeeeecC--CceeEEEeccccChhhHHHHHHHHHHHHHccCCcee-eEeeEEEecCeEEEEEEeeCCCC
Q 004912 519 CKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEYMPNKS 595 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv-~l~~~~~~~~~~~lV~Ey~~~gs 595 (724)
+.|..|-...+|+....+ +..+++|+........ ..-.+|+.++..+....++ ++++.. + ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~-~---~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATF-Q---NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEe-C---CcEEEEeeCCCc
Confidence 578888888999987654 6789999876543221 2235788888888544443 344332 2 247999999877
Q ss_pred hhHH-------H----------hhcCCC--------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 004912 596 LNVF-------L----------FDSTKK--------RLLN-WQARVRIIE----------------------GIAQGLLY 627 (724)
Q Consensus 596 L~~~-------l----------~~~~~~--------~~l~-~~~~~~i~~----------------------qia~~L~y 627 (724)
+... + +..... .... +..+..+.. .+.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 1 111110 0111 122212211 11111111
Q ss_pred ----HHhc-CCCceEeccCCCCCEEEcC-CCCEEEEecCCccc
Q 004912 628 ----LHQY-SRFRIIHRDLKASNILLDK-DMNPKISDFGLARM 664 (724)
Q Consensus 628 ----LH~~-~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~ 664 (724)
+... .+..++|+|+.+.|||+++ ++.+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1111 2335999999999999998 57899999998864
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00024 Score=73.18 Aligned_cols=139 Identities=14% Similarity=0.107 Sum_probs=79.9
Q ss_pred eeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCcee-eEeeEEEecCeEEEEEEeeCCCChhH
Q 004912 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEYMPNKSLNV 598 (724)
Q Consensus 520 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv-~l~~~~~~~~~~~lV~Ey~~~gsL~~ 598 (724)
.+..|-...+|+.. .+++.+++|..........-...+|..+++.+....++ +++... . ..+||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 45667778899887 35678889986543322112357888999888643332 333332 2 368999999876542
Q ss_pred H-----------------HhhcC-CCCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCceEeccCCCCC
Q 004912 599 F-----------------LFDST-KKRLLNWQA-RVRIIEGI---------AQGLLYLHQY-----SRFRIIHRDLKASN 645 (724)
Q Consensus 599 ~-----------------l~~~~-~~~~l~~~~-~~~i~~qi---------a~~L~yLH~~-----~~~~iiH~Dlkp~N 645 (724)
- +|... ....++... +.....++ .+.+..+... .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 111222221 11211111 1112222211 12348999999999
Q ss_pred EEEcCCCCEEEEecCCccc
Q 004912 646 ILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 646 ILl~~~~~~kL~DFGla~~ 664 (724)
|++++++ +.|+||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0007 Score=73.44 Aligned_cols=75 Identities=13% Similarity=0.194 Sum_probs=54.9
Q ss_pred eeeccCCceeEEeeeecCC-ceeEEEecccc-----C--hhhHHHHHHHHHHHHHcc-C--CceeeEeeEEEecCeEEEE
Q 004912 519 CKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQ-----S--GQGLKEFKNEMMLIAKLQ-H--RNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~~-----~--~~~~~~f~~E~~il~~l~-H--pniv~l~~~~~~~~~~~lV 587 (724)
+.||.|.+..||++...+| +.++||.-.+. . +-..+++..|.+.|..+. + .++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6899999999999998777 48999985421 1 224567788888888873 2 346667665 44557899
Q ss_pred EEeeCCCC
Q 004912 588 LEYMPNKS 595 (724)
Q Consensus 588 ~Ey~~~gs 595 (724)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00091 Score=70.40 Aligned_cols=143 Identities=18% Similarity=0.167 Sum_probs=86.6
Q ss_pred eeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCc--eeeEeeE------EEecCeEEEEEE
Q 004912 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGC------CVEQGEKILILE 589 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpn--iv~l~~~------~~~~~~~~lV~E 589 (724)
.+.|..|....+|+.... +..+++|+... ...++...|+.++..+.+.. +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 467888888899998664 45788998865 23355677888888885432 4444331 123456689999
Q ss_pred eeCCCChhH----HH----------hhcCC--------CCCCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 004912 590 YMPNKSLNV----FL----------FDSTK--------KRLLNWQARV----------RIIEGIAQGLLYLHQ----YSR 633 (724)
Q Consensus 590 y~~~gsL~~----~l----------~~~~~--------~~~l~~~~~~----------~i~~qia~~L~yLH~----~~~ 633 (724)
|++|..+.. .. +.... .....|.... .....+.+++.++.+ .-+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 11 11000 0111221110 011223344455543 112
Q ss_pred CceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 634 FRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 634 ~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
..++|+|+.|.|||++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3499999999999999987789999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0013 Score=69.57 Aligned_cols=142 Identities=26% Similarity=0.318 Sum_probs=84.7
Q ss_pred eeeccCCceeEEeeeecC-------CceeEEEeccccChhhHHHHHHHHHHHHHccCCcee-eEeeEEEecCeEEEEEEe
Q 004912 519 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEY 590 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv-~l~~~~~~~~~~~lV~Ey 590 (724)
+.|..|-...+|+....+ ++.+++|+...... ......+|.+++..+....+. ++++++. + .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 466777777899887654 47899999765432 234457888888888543333 4444443 2 358999
Q ss_pred eCCCChhHHH-----------------hhcCCCC------CCC--HHHHHH--------------------------HHH
Q 004912 591 MPNKSLNVFL-----------------FDSTKKR------LLN--WQARVR--------------------------IIE 619 (724)
Q Consensus 591 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 619 (724)
++|..+.... |...... ..+ +..+.+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9987764311 1111000 000 111111 112
Q ss_pred HHHHHHHHHHh------cCCCceEeccCCCCCEEEcCC----CCEEEEecCCcccc
Q 004912 620 GIAQGLLYLHQ------YSRFRIIHRDLKASNILLDKD----MNPKISDFGLARMF 665 (724)
Q Consensus 620 qia~~L~yLH~------~~~~~iiH~Dlkp~NILl~~~----~~~kL~DFGla~~~ 665 (724)
.+.+.+..|.. ..+..++|+|+.|.|||++++ +.++++||..|..-
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 22233334432 134568999999999999874 88999999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0028 Score=67.57 Aligned_cols=142 Identities=20% Similarity=0.225 Sum_probs=77.4
Q ss_pred eeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCc--eeeEee------EEEecCeEEEEEEe
Q 004912 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLG------CCVEQGEKILILEY 590 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpn--iv~l~~------~~~~~~~~~lV~Ey 590 (724)
+.|..|....+|+....+| .+++|+..... .+....|+.++..|.... +.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4677777788999876554 78899876222 233344555565553211 233332 11234567899999
Q ss_pred eCCCChhH-----------HH---hhcCC--------CCCC-CHHHHHH------------HHHH-HHHHHHHHHhc---
Q 004912 591 MPNKSLNV-----------FL---FDSTK--------KRLL-NWQARVR------------IIEG-IAQGLLYLHQY--- 631 (724)
Q Consensus 591 ~~~gsL~~-----------~l---~~~~~--------~~~l-~~~~~~~------------i~~q-ia~~L~yLH~~--- 631 (724)
++|..+.. .| +.... ...+ .|.+... .+.+ +...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 11 11100 0011 1111111 1111 11122333211
Q ss_pred -CCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 632 -SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 632 -~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
-+..++|+|+.|.|||++.+...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 123599999999999999765568999998854
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.00094 Score=69.63 Aligned_cols=142 Identities=18% Similarity=0.182 Sum_probs=96.9
Q ss_pred ceeeeeccCCceeEEeeeecCCceeEEEeccccC-------h---------------hhHHH----HHHHHHHHHHccCC
Q 004912 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS-------G---------------QGLKE----FKNEMMLIAKLQHR 569 (724)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-------~---------------~~~~~----f~~E~~il~~l~Hp 569 (724)
.+...|..|.-+.||.+.-.+|..+|||+++..- . ...+. ...|+.-|.+|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4456899999999999999999999999875320 0 01111 23577777777543
Q ss_pred ceeeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc
Q 004912 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649 (724)
Q Consensus 570 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 649 (724)
.|.-.--. .-...+|||+|+..... -....+...++..++..+-.|+++-|.-|-+.+ ++||.||.--|+|+.
T Consensus 227 GIP~PePI--lLk~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPI--LLKNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCce--eeecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 32110000 00134799999863221 111123445777888899999999999998877 599999999999985
Q ss_pred CCCCEEEEecCCcccc
Q 004912 650 KDMNPKISDFGLARMF 665 (724)
Q Consensus 650 ~~~~~kL~DFGla~~~ 665 (724)
+|.+.|+|.+.+...
T Consensus 300 -dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVEH 314 (520)
T ss_pred -CCEEEEEEccccccC
Confidence 568999999988654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0047 Score=66.41 Aligned_cols=142 Identities=18% Similarity=0.255 Sum_probs=83.8
Q ss_pred eeeccCCceeEEeeeecC-----CceeEEEeccccChhhHHHHHHHHHHHHHccCCcee-eEeeEEEecCeEEEEEEeeC
Q 004912 519 CKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEYMP 592 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv-~l~~~~~~~~~~~lV~Ey~~ 592 (724)
+.|-.|-.-.+|+....+ ++.+++|+..........+ .+|..++..+...++. ++++.+.. + .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 456567778899886532 3678999887655433333 7789998888654443 44554422 2 5899998
Q ss_pred CCChhHH-----------------HhhcC--C-CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 004912 593 NKSLNVF-----------------LFDST--K-KRLLNWQARVRIIEGI-----------------AQGLLYL----HQ- 630 (724)
Q Consensus 593 ~gsL~~~-----------------l~~~~--~-~~~l~~~~~~~i~~qi-----------------a~~L~yL----H~- 630 (724)
+.+|..- +|... . .....+.++.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776422 11110 0 0011223333332221 1112222 21
Q ss_pred cCCCceEeccCCCCCEEEcC-CCCEEEEecCCcccc
Q 004912 631 YSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMF 665 (724)
Q Consensus 631 ~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~ 665 (724)
.....++|+|+++.|||+++ ++.+.|+||..|..-
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 22345899999999999986 468999999988753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.00083 Score=68.91 Aligned_cols=142 Identities=13% Similarity=0.142 Sum_probs=96.8
Q ss_pred hHHHhccCcceeeeeccCCceeEEeeeecCCceeEEEecccc----------C----------hh--hHHHHHHHHHHHH
Q 004912 507 SITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ----------S----------GQ--GLKEFKNEMMLIA 564 (724)
Q Consensus 507 ~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~----------~----------~~--~~~~f~~E~~il~ 564 (724)
.+..-..-+.+.++||-|.-+.+|.+-..+|++.++|.-+-. . .. ..-...+|...|+
T Consensus 86 tL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmk 165 (465)
T KOG2268|consen 86 TLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMK 165 (465)
T ss_pred HHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHH
Confidence 333333357788999999999999999988999998843210 0 00 1123457888888
Q ss_pred Hcc-CCc-eeeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCC
Q 004912 565 KLQ-HRN-LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642 (724)
Q Consensus 565 ~l~-Hpn-iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlk 642 (724)
.|. |-. +.+.+++ +..++|||++.+-.|...-+ ..+... +...+..-+--|..+| +||+|+.
T Consensus 166 aL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFN 229 (465)
T KOG2268|consen 166 ALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPT---LYDDLMGLIVRLANHG---LIHGDFN 229 (465)
T ss_pred HHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChHH---HHHHHHHHHHHHHHcC---ceecccc
Confidence 885 322 4444443 45679999999888865431 123333 3333444455666777 9999999
Q ss_pred CCCEEEcCCCCEEEEecCCccc
Q 004912 643 ASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 643 p~NILl~~~~~~kL~DFGla~~ 664 (724)
--||+++++..++++||-....
T Consensus 230 EFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 230 EFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred hheeEEecCCCEEEeechHhhc
Confidence 9999999999999999976543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.007 Score=63.48 Aligned_cols=146 Identities=16% Similarity=0.221 Sum_probs=79.9
Q ss_pred eeeeccCCceeEEeeeecCCceeEEEecc-ccChhhHHHHHHHHHHHHHccC--CceeeEeeEEEecC--eEEEEEEeeC
Q 004912 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQG--EKILILEYMP 592 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~-~~~~~~~~~f~~E~~il~~l~H--pniv~l~~~~~~~~--~~~lV~Ey~~ 592 (724)
.+.+..|---.+|..... ++++++++-. ...........+|..+|+.+.- .-+.+.++.|.++. ..+.||+|.+
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 344433333334444332 7778888221 1222334556778888887743 33445667776665 6699999998
Q ss_pred CCChhHHHhhcC-----------------------------CCCCCCHHHHHHHHHH--------------HHHHHHHHH
Q 004912 593 NKSLNVFLFDST-----------------------------KKRLLNWQARVRIIEG--------------IAQGLLYLH 629 (724)
Q Consensus 593 ~gsL~~~l~~~~-----------------------------~~~~l~~~~~~~i~~q--------------ia~~L~yLH 629 (724)
+..+...+.... +.......++.+...+ ...-..+|+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 843222110000 0000000011111111 112233343
Q ss_pred hc-----CCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 630 QY-----SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 630 ~~-----~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
.+ ++..++|+|+++.||+++.+.-+-|.||+++..
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 22 335699999999999999998899999999875
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0047 Score=64.32 Aligned_cols=76 Identities=17% Similarity=0.224 Sum_probs=49.7
Q ss_pred cceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHcc---CCceeeEeeEEEecCeEEEEEEee
Q 004912 515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~---Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.+-.+.|+.|....+|+.. .+++.+.||.-. ......|..|++-|+.|. --.+.+.+++...++..+||+||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445789999999999987 577889999876 234467888999999884 344778888887777779999999
Q ss_pred CCC
Q 004912 592 PNK 594 (724)
Q Consensus 592 ~~g 594 (724)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.017 Score=61.08 Aligned_cols=144 Identities=19% Similarity=0.228 Sum_probs=82.4
Q ss_pred eeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCc--eeeEeeE------EEecCeEEEEEE
Q 004912 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGC------CVEQGEKILILE 589 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpn--iv~l~~~------~~~~~~~~lV~E 589 (724)
.+.++.|....+|+....++ .+++|+.+... ..++...|++++..|.... +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876444 67888875432 1234456677777774322 3344331 122456789999
Q ss_pred eeCCCChhH-----------H---HhhcCCC---------CCCCHHHHH------------HHHHHHHHHHHHHHh----
Q 004912 590 YMPNKSLNV-----------F---LFDSTKK---------RLLNWQARV------------RIIEGIAQGLLYLHQ---- 630 (724)
Q Consensus 590 y~~~gsL~~-----------~---l~~~~~~---------~~l~~~~~~------------~i~~qia~~L~yLH~---- 630 (724)
|++|..+.. . ++..... ..-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999865321 1 1110000 011111110 011223344555542
Q ss_pred cCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 631 ~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
.-+..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1223599999999999999887778999998853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.009 Score=62.09 Aligned_cols=71 Identities=10% Similarity=-0.017 Sum_probs=41.8
Q ss_pred eeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHcc-C-Cc-eeeEeeEEEecCeEEEEEEeeCCCCh
Q 004912 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-H-RN-LVRLLGCCVEQGEKILILEYMPNKSL 596 (724)
Q Consensus 520 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-H-pn-iv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (724)
..+.|-...|+.....+|+.+++|.-+.. .....+.+|+++|+.+. | |- +.+++. .+ .-.++|++++|..+
T Consensus 18 ~~~~g~~~~v~~i~~~~g~~~VlR~p~~~--~~~~~l~rE~~vL~~L~~~l~vpvP~~~~--~~--~~~~~y~~i~G~p~ 91 (276)
T cd05152 18 LNESGLDFQVVFAKDTDGVPWVLRIPRRP--DVSERAAAEKRVLALVRKHLPVQVPDWRV--HT--PELIAYPKLPGVPA 91 (276)
T ss_pred ecCCcceeEEEEEEcCCCCeEEEEecCCH--HHHHHHHHHHHHHHHHHhcCCCCCCceee--ec--CceEEEeccCCCcc
Confidence 34445455666665456889999987532 33456789999999985 3 21 122221 11 22566777776554
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0012 Score=53.60 Aligned_cols=49 Identities=18% Similarity=0.349 Sum_probs=35.0
Q ss_pred cccCCCCccccccccccChHHHHHHHhhcCceEEEeeccccCCcceEEeccc
Q 004912 346 DEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGD 397 (724)
Q Consensus 346 ~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~C~~w~~~ 397 (724)
.++.++.+..... ...+.++|++.|+.+|+|.||.|.. +.+.|+++.+.
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~--~~~~C~lk~~~ 58 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT--KSKKCFLKSSE 58 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC--CCCeEEcccCC
Confidence 3444444332222 2458999999999999999999973 45679998765
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.04 Score=59.79 Aligned_cols=73 Identities=10% Similarity=0.058 Sum_probs=50.2
Q ss_pred eeeeccCCceeEEeeeecCCceeEEEecccc-----C--hhhHHHHHHHHHHHHHcc---CCceeeEeeEEEecCeEEEE
Q 004912 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ-----S--GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~-----~--~~~~~~f~~E~~il~~l~---Hpniv~l~~~~~~~~~~~lV 587 (724)
.+.||.|..-.||+... +++.++||+-... . +....+-..|+..|..+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46899999999999876 4567999986521 1 123344445566666653 246777887766 446789
Q ss_pred EEeeCC
Q 004912 588 LEYMPN 593 (724)
Q Consensus 588 ~Ey~~~ 593 (724)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.024 Score=60.44 Aligned_cols=79 Identities=14% Similarity=0.174 Sum_probs=51.2
Q ss_pred eeccCCceeEEeeeecCC-ceeEEEeccc-------cChhhHHHHHHHHHHHHHcc--CCc-eeeEeeEEEecCeEEEEE
Q 004912 520 KLGEGGFGPVYKGRLLNG-QEVAVKRLSN-------QSGQGLKEFKNEMMLIAKLQ--HRN-LVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 520 ~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~-------~~~~~~~~f~~E~~il~~l~--Hpn-iv~l~~~~~~~~~~~lV~ 588 (724)
.||.|...-||++..+++ +.|+||.-.+ .-+-..++..-|...|.... -|. +.+++. .+++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 579999999999998654 5899997532 11334555667777776653 343 444444 3555667999
Q ss_pred EeeCCC-ChhHHH
Q 004912 589 EYMPNK-SLNVFL 600 (724)
Q Consensus 589 Ey~~~g-sL~~~l 600 (724)
|+++.. .|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999643 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.025 Score=60.50 Aligned_cols=141 Identities=16% Similarity=0.249 Sum_probs=81.4
Q ss_pred eeeccCCceeEEeeeecC----CceeEEEeccccChhhHHHHHHHHHHHHHccCCcee-eEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv-~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
+.|..|=.-.+|+....+ +..|++|+.......... -.+|..++..+..-++. ++++++ ..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~Id-R~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVID-RERELQAIKYLSAAGFGAKLLGVF-GNG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEec-hHHHHHHHHHHHhcCCCCceeEEe-CCc---EeehhhcC
Confidence 456557777889886543 237899988665443322 36788899888655553 455554 222 58999987
Q ss_pred CChhHH-------H----------hhcC--CCC-CCCHHHHHHHHHHH----------------------HHHHHHHH--
Q 004912 594 KSLNVF-------L----------FDST--KKR-LLNWQARVRIIEGI----------------------AQGLLYLH-- 629 (724)
Q Consensus 594 gsL~~~-------l----------~~~~--~~~-~l~~~~~~~i~~qi----------------------a~~L~yLH-- 629 (724)
..|..- + |... ... .--+..+.++..++ .+-+..+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 765321 1 1111 001 11233333332222 11111111
Q ss_pred --h-cCCCceEeccCCCCCEEEcC-CCCEEEEecCCccc
Q 004912 630 --Q-YSRFRIIHRDLKASNILLDK-DMNPKISDFGLARM 664 (724)
Q Consensus 630 --~-~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~ 664 (724)
. ..+..++|.|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 11234799999999999974 57899999998865
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.014 Score=69.26 Aligned_cols=157 Identities=19% Similarity=0.192 Sum_probs=112.9
Q ss_pred HHHHHHHHHHHHHccCCceeeEeeEEEecCeEE----EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 004912 553 LKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628 (724)
Q Consensus 553 ~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~----lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yL 628 (724)
......|...+.++.|+|+++++.|-.++...- +..|++..-++...+. ....++....+.+..++..||+|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHH
Confidence 344556788888899999999999877654332 3456667777776663 344578888888999999999999
Q ss_pred HhcCCCceEeccCCCC---CEEEcCCCCEEEE--ecCCccccCCCcccccccccccccCccCcccccCCCCCch--hhHH
Q 004912 629 HQYSRFRIIHRDLKAS---NILLDKDMNPKIS--DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIK--SDVF 701 (724)
Q Consensus 629 H~~~~~~iiH~Dlkp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k--~DVw 701 (724)
|+.. ..|.-+... +--.+..+.+.+. ||+..+.+...... .....+..+.+||......+..+ .|+|
T Consensus 303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHH
Confidence 9885 555555544 4455666777777 99988877543321 12234567888888877766544 7999
Q ss_pred HHHHHHHHHHcCCCCCC
Q 004912 702 SFGILMLETLSSKKNTG 718 (724)
Q Consensus 702 SlGvil~elltG~~p~~ 718 (724)
.+|..+..+..|..+-.
T Consensus 377 ~lgll~~~~~~~~~i~~ 393 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISE 393 (1351)
T ss_pred HHHHHHhhhhhcCcccc
Confidence 99999999999876654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.00095 Score=80.40 Aligned_cols=160 Identities=11% Similarity=-0.021 Sum_probs=114.3
Q ss_pred HHHHHHHHHHccCCceeeEeeEEE--ecCeEEEEEEeeCCCChhHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcC
Q 004912 556 FKNEMMLIAKLQHRNLVRLLGCCV--EQGEKILILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQYS 632 (724)
Q Consensus 556 f~~E~~il~~l~Hpniv~l~~~~~--~~~~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~~L~yLH~~~ 632 (724)
...|...++...|+++.+...-.. +..+.+.+++|+..|.+...|.+..++ ..++..-+.....+...+..-.|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 445555566678988776544322 334567889999999999988765443 33444333333333355555555432
Q ss_pred --CCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHH
Q 004912 633 --RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 710 (724)
Q Consensus 633 --~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~el 710 (724)
...-+|+++|+-|.+|..+.++|+.++|+.+...+ .........+++.|++|+....-.++.++|+|..|+-+|+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 23479999999999999999999999999994322 22234456778899999988888999999999999999998
Q ss_pred HcCCCCC
Q 004912 711 LSSKKNT 717 (724)
Q Consensus 711 ltG~~p~ 717 (724)
--|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8887765
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.0084 Score=59.68 Aligned_cols=30 Identities=40% Similarity=0.567 Sum_probs=21.6
Q ss_pred ceEeccCCCCCEEE-cCCCCEEEEecCCccc
Q 004912 635 RIIHRDLKASNILL-DKDMNPKISDFGLARM 664 (724)
Q Consensus 635 ~iiH~Dlkp~NILl-~~~~~~kL~DFGla~~ 664 (724)
.+.|+|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 724 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-41 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-37 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-23 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-19 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-19 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-18 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-18 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-17 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-17 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 337 bits (867), Expect = e-111
Identities = 89/228 (39%), Positives = 125/228 (54%), Gaps = 15/228 (6%)
Query: 500 LPLFSLASITAATENFSMQC------KLGEGGFGPVYKGRLLNGQEVAVKRLSN----QS 549
FS + T NF + K+GEGGFG VYKG + N VAVK+L+ +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 550 GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLL 609
+ ++F E+ ++AK QH NLV LLG + + L+ YMPN SL L L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669
+W R +I +G A G+ +LH+ IHRD+K++NILLD+ KISDFGLAR
Sbjct: 131 SWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 717
T +IVGT YM+PE L G + KSD++SFG+++LE ++
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 331 bits (851), Expect = e-108
Identities = 92/221 (41%), Positives = 138/221 (62%), Gaps = 3/221 (1%)
Query: 499 WLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLK-EFK 557
L FSL + A++NFS + LG GGFG VYKGRL +G VAVKRL + QG + +F+
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 558 NEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-LNWQARVR 616
E+ +I+ HRNL+RL G C+ E++L+ YM N S+ L + + + L+W R R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676
I G A+GL YLH + +IIHRD+KA+NILLD++ + DFGLA++ + T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA- 194
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 717
+ GT G+++PEY G S K+DVF +G+++LE ++ ++
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 308 bits (792), Expect = 1e-99
Identities = 86/215 (40%), Positives = 134/215 (62%), Gaps = 4/215 (1%)
Query: 503 FSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 562
L + AT NF + +G G FG VYKG L +G +VA+KR + +S QG++EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 563 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-LNWQARVRIIEGI 621
++ +H +LV L+G C E+ E ILI +YM N +L L+ S + ++W+ R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 681
A+GL YLH + IIHRD+K+ NILLD++ PKI+DFG+++ + + + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 716
GY+ PEY + G + KSDV+SFG+++ E L ++
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 1e-80
Identities = 60/232 (25%), Positives = 105/232 (45%), Gaps = 22/232 (9%)
Query: 503 FSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 562
++ + + G FG V+K +L + VAVK Q Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 563 IAKLQHRNLVRLLGCCVE----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 618
+ ++H N+++ +G + LI + SL+ FL K +++W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 619 EGIAQGLLYLHQ-------YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671
E +A+GL YLH+ + I HRD+K+ N+LL ++ I+DFGLA F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 672 GNTKQIVGTYGYMSPEYALDGL-----FSIKSDVFSFGILMLETLSSKKNTG 718
G+T VGT YM+PE + ++ D+++ G+++ E S
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 1e-68
Identities = 64/244 (26%), Positives = 107/244 (43%), Gaps = 32/244 (13%)
Query: 503 FSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 562
+ + + +N + +G G +G VYKG L + + VAVK S + Q K +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYR 60
Query: 563 IAKLQHRNLVRLLGCCVE-----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRI 617
+ ++H N+ R + + E +L++EY PN SL +L +W + R+
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRL 116
Query: 618 IEGIAQGLLYLHQ------YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG---- 667
+ +GL YLH + + I HRDL + N+L+ D ISDFGL+ G
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 668 --DELQGNTKQIVGTYGYMSPEYALDGLFSI--------KSDVFSFGILMLETLSSKKNT 717
E VGT YM+PE L+G ++ + D+++ G++ E +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 718 GLGS 721
G
Sbjct: 236 FPGE 239
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 3e-64
Identities = 65/204 (31%), Positives = 113/204 (55%), Gaps = 6/204 (2%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 570
+ +++ K+G G FG V++ +G +VAVK L Q + + EF E+ ++ +L+H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V +G + ++ EY+ SL L S + L+ + R+ + +A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
I+HR+LK+ N+L+DK K+ DFGL+R+ L +K GT +M+PE
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLR 212
Query: 691 DGLFSIKSDVFSFGILMLETLSSK 714
D + KSDV+SFG+++ E + +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-60
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+ ++ +G G FG V K + ++VA+K++ ++S K F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L G C+ L++EY SL L + + +QG+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 633 RFRIIHRDLKASNILLDKDMN-PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+IHRDLK N+LL KI DFG A ++Q + G+ +M+PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 692 GLFSIKSDVFSFGILMLETLSSKK 715
+S K DVFS+GI++ E ++ +K
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK 201
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 2e-60
Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 21/207 (10%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRL----SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
+G GGFG VY+ G EVAVK Q ++ + E L A L+H N++ L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
G C+++ L++E+ LN L + + V IA+G+ YLH +
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 636 IIHRDLKASNILLDKDMNP--------KISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
IIHRDLK+SNIL+ + + KI+DFGLAR + G Y +M+PE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPE 184
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSK 714
+FS SDV+S+G+L+ E L+ +
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 4e-60
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
LG+G FG K G+ + +K L + + F E+ ++ L+H N+++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+ I EY+ +L + W RV + IA G+ YLH IIH
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQ------------GNTKQIVGTYGYMSP 686
RDL + N L+ ++ N ++DFGLAR+ ++ Q +VG +M+P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSSKK 715
E + K DVFSFGI++ E +
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-58
Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 13/207 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 570
++ ++G G FG VYKG+ +G +VAVK L+ + Q L+ FKNE+ ++ K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
++ +G I + ++ SL L + + + I A+G+ YLH
Sbjct: 82 ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA 138
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE--- 687
S IIHRDLK++NI L +D KI DFGLA +Q+ G+ +M+PE
Sbjct: 139 KS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSK 714
+S +SDV++FGI++ E ++ +
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-58
Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 570
+ + KL E G ++KGR G ++ VK L + S + ++F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 571 LVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
++ +LG C I +MP SL L + T + + V+ +A+G+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFL 127
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H I L + ++++D+DM +IS + F + + +++PE
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE- 178
Query: 689 ALDG----LFSIKSDVFSFGILMLETLSSK 714
AL +D++SF +L+ E ++ +
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-58
Identities = 59/218 (27%), Positives = 113/218 (51%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG-------LKEFKNEMMLIA 564
+ ++G+GGFG V+KGRL+ + VA+K L +G +EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
L H N+V+L G +++E++P L L D K + W ++R++ IA G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDK-----DMNPKISDFGLARMFGGDELQGNTKQIVG 679
+ Y+ I+HRDL++ NI L + K++DFGL++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 680 TYGYMSPE--YALDGLFSIKSDVFSFGILMLETLSSKK 715
+ +M+PE A + ++ K+D +SF +++ L+ +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 9e-55
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGC 577
+G+G FG VY GR +G EVA++ + + + LK FK E+M + +H N+V +G
Sbjct: 40 LIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 578 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 637
C+ +I ++L + D K +L+ +I + I +G+ YLH I+
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---IL 152
Query: 638 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI---VGTYGYMSPE------- 687
H+DLK+ N+ D + I+DFGL + G + ++ G +++PE
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 688 --YALDGLFSIKSDVFSFGILMLETLSSK 714
FS SDVF+ G + E + +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 5e-54
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 27/226 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHR 569
+ ++ +G+G +G V++G G+ VAVK S++ K + E + L+H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHE 62
Query: 570 NLVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
N++ + + LI Y SL +L + L+ + +RI+ IA GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118
Query: 626 LYLHQYSRFR-----IIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIV 678
+LH I HRDLK+ NIL+ K+ I+D GLA M ++L V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 679 GTYGYMSPE------YALDGLFSIKSDVFSFGILMLETLSSKKNTG 718
GT YM+PE + D+++FG+++ E + G
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 6e-52
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHRN 570
+ M ++G+G +G V+ G+ G++VAVK + E + ++H N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92
Query: 571 LVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
++ + ++ LI +Y N SL +L K L+ ++ +++ GL
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 627 YLHQYSRFR-----IIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVG 679
+LH I HRDLK+ NIL+ K+ I+D GLA F +E+ VG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 680 TYGYMSPEYALDGL-------FSIKSDVFSFGILMLETLS 712
T YM PE LD I +D++SFG+++ E
Sbjct: 209 TKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR 247
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 3e-50
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHRNLVRL 574
+Q +G+G FG V++G+ G+EVAVK S++ + + E + L+H N++
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGF 101
Query: 575 LGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+ + L+ +Y + SL +L + + + +++ A GL +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 631 YSRFR-----IIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGY 683
I HRDLK+ NIL+ K+ I+D GLA D + VGT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 684 MSPEYALDGL-------FSIKSDVFSFGILMLETLS 712
M+PE LD ++D+++ G++ E
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR 252
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-49
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 570
E+ + ++G G FG V+ GRL + VAVK +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+VRL+G C ++ +++E + FL T+ L + ++++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEY 688
IHRDL A N L+ + KISDFG++R G +Q+ + +PE
Sbjct: 232 K---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEA 286
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
G +S +SDV+SFGIL+ ET S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFS 310
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-48
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL 566
LGEG FG V G+ VAVK L ++ Q +K E+ ++ L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 567 QHRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
H ++++ GCC + G L++EY+P SL +L + + + + I +G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQIVGT 680
+ YLH ++ IHRDL A N+LLD D KI DFGLA+ ++ + V
Sbjct: 147 MAYLH--AQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-- 201
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +PE + F SDV+SFG+ + E L+
Sbjct: 202 -FWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-47
Identities = 65/215 (30%), Positives = 111/215 (51%), Gaps = 27/215 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 567
+ +LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 568 HRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGI 621
H N+V+ G C G + LI+EY+P SL +L +LL + + I
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QI 154
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQI 677
+G+ YL ++ R IHRDL NIL++ + KI DFGL ++ D+ ++ +
Sbjct: 155 CKGMEYLG--TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ + +PE + FS+ SDV+SFG+++ E +
Sbjct: 212 I---FWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-47
Identities = 65/215 (30%), Positives = 111/215 (51%), Gaps = 27/215 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 567
+ +LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 568 HRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGI 621
H N+V+ G C G + LI+EY+P SL +L +LL + + I
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QI 123
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQI 677
+G+ YL ++ R IHRDL NIL++ + KI DFGL ++ D+ ++ +
Sbjct: 124 CKGMEYLG--TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ + +PE + FS+ SDV+SFG+++ E +
Sbjct: 181 I---FWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-47
Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 29/216 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 567
+ +LG+G FG V R G VAVK+L + ++F+ E+ ++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 568 HRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGI 621
+V+ G G + L++EY+P+ L FL RLL + + I
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QI 136
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 681
+G+ YL SR R +HRDL A NIL++ + + KI+DFGLA++ D+ +V
Sbjct: 137 CKGMEYLG--SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREP 189
Query: 682 G-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
G + +PE D +FS +SDV+SFG+++ E +
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL 566
LGEG FG V R G++VAVK L G + + K E+ ++ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 567 QHRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEG 620
H N+V+ G C E G LI+E++P+ SL +L + K+ L +
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV------Q 134
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQ 676
I +G+ YL + +HRDL A N+L++ + KI DFGL + D+ ++ +
Sbjct: 135 ICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
V + +PE + F I SDV+SFG+ + E L+
Sbjct: 192 PV---FWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-47
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+ ++G G FG V+ G LN +VA+K + + ++F E ++ KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L G C+EQ L+ E+M + L+ +L T++ L + + + + +G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 690
+IHRDL A N L+ ++ K+SDFG+ R D+ TK V + SPE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFS 178
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
+S KSDV+SFG+LM E S
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS 200
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 8e-47
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRLSNQSGQGLKEFKNEMMLIAKL 566
+ ++ +LGEG FG V+ N VAVK L + + K+F+ E L+ L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------FDSTKKRLLNWQA 613
QH ++V+ G C + I++ EYM + LN FL K L
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--EL 670
+ I IA G++YL + +HRDL N L+ ++ KI DFG++R ++ D +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
G+T + +M PE + F+ +SDV+SFG+++ E +
Sbjct: 192 GGHTMLPI---RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 8e-47
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 573 RLLGCCVEQGEKILI-LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+LLG VE+ + I EYM SL +L S + +L ++ + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMS 685
+HRDL A N+L+ +D K+SDFGL + + + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTA 182
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
PE + FS KSDV+SFGIL+ E S
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 38/219 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 566
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGIA 622
+ ++ RLLG C+ ++ I + MP L ++ + + LLNW IA
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
+G+ YL R++HRDL A N+L+ + KI+DFGLA++ G +E Y
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYH 175
Query: 683 Y---------MSPEYALDGLFSIKSDVFSFGILMLETLS 712
M+ E L +++ +SDV+S+G+ + E ++
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-46
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E ++ +LG G FG V G+ +VAVK + + EF E + KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+ G C ++ ++ EY+ N L +L + + L + + + +G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 690
+ IHRDL A N L+D+D+ K+SDFG+ R D+ TK V + +PE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV---KWSAPEVFH 178
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
+S KSDV++FGILM E S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS 200
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-46
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 27/221 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLKEFKNEMMLIAKL 566
+ ++ +LGEG FG V+ N VAVK L S ++F+ E L+ L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL------------FDSTKKRLLNWQAR 614
QH+++VR G C E +++ EYM + LN FL + L
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQ 671
+ + +A G++YL + +HRDL N L+ + + KI DFG++R ++ D +
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
G T + +M PE L F+ +SDV+SFG+++ E +
Sbjct: 218 GRTMLPI---RWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-46
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
++ + +LG G FG V G+ +VA+K + + EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L G C +Q +I EYM N L +L + Q + + + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 690
+ +HRDL A N L++ K+SDFGL+R DE +K V + PE +
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLM 194
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
FS KSD+++FG+LM E S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-46
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 573 RLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+LLG VE+ + ++ EYM SL +L S + +L ++ + + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+HRDL A N+L+ +D K+SDFGL + Q K V + +PE +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALRE 360
Query: 692 GLFSIKSDVFSFGILMLETLS 712
FS KSDV+SFGIL+ E S
Sbjct: 361 KKFSTKSDVWSFGILLWEIYS 381
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-46
Identities = 76/223 (34%), Positives = 110/223 (49%), Gaps = 29/223 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 565
+LGE FG VYKG L Q VA+K L G +EF++E ML A+
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------FDSTKKRLLNWQ 612
LQH N+V LLG + +I Y + L+ FL D T K L
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 613 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--E 669
V ++ IA G+ YL S ++H+DL N+L+ +N KISD GL R ++ D +
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
L GN+ + +M+PE + G FSI SD++S+G+++ E S
Sbjct: 186 LLGNSLLPI---RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-46
Identities = 63/203 (31%), Positives = 107/203 (52%), Gaps = 11/203 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
+ +M+ KLG G +G VY+G VAVK L + ++EF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
V+LLG C + +I E+M +L +L + ++ ++ + + I+ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYA 689
+ IHRDL A N L+ ++ K++DFGL+R+ GD K + + +PE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 184
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
FSIKSDV++FG+L+ E +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-45
Identities = 72/202 (35%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
RL ++ I I EYM N SL FL + L + + IA+G+ ++
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 690
IHRDL+A+NIL+ ++ KI+DFGLAR+ +E + K + + +PE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPEAIN 183
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
G F+IKSDV+SFGIL+ E ++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-45
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKL 566
LG G FG V+KG + E V +K + ++SG Q + + M+ I L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGIA 622
H ++VRLLG C ++ + +Y+P SL + + LLNW IA
Sbjct: 73 DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIA 125
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
+G+ YL ++HR+L A N+LL +++DFG+A + D+ KQ++ +
Sbjct: 126 KGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD-----KQLLYSEA 177
Query: 683 -----YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+ E G ++ +SDV+S+G+ + E ++
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-45
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 33/217 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 567
++ +G G G V GRL VA+K L + + + ++F +E ++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H N++RL G +++ EYM N SL+ FL T V ++ G+ G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY---- 683
L S +HRDL A N+L+D ++ K+SDFGL+R+ D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTT 212
Query: 684 --------MSPEYALDGLFSIKSDVFSFGILMLETLS 712
+PE FS SDV+SFG++M E L+
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-45
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG G FG V+ +VAVK + ++ F E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L ++ I I E+M SL FL + + IA+G+ ++
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 690
+ IHRDL+A+NIL+ + KI+DFGLAR+ +E + K + + +PE
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAIN 358
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
G F+IKSDV+SFGIL++E ++
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVT 380
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-45
Identities = 67/217 (30%), Positives = 108/217 (49%), Gaps = 23/217 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL--SNQSGQGLKEFKNEMMLIAKL 566
+ LGEG FG V +G L VAVK + N S + ++EF +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 567 QHRNLVRLLGCCVEQG-----EKILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRII 618
H N++RLLG C+E + ++IL +M L+ +L S T + + Q ++ +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTK 675
IA G+ YL S +HRDL A N +L DM ++DFGL++ ++ GD K
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
V +++ E D +++ KSDV++FG+ M E +
Sbjct: 211 MPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-44
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 565
E +M +LG+G FG VY+G + VA+K + S + EF NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------FDSTKKRLLNWQARVRII 618
++VRLLG + ++I+E M L +L ++ + +++
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTK 675
IA G+ YL + + +HRDL A N ++ +D KI DFG+ R ++ D G
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
V +MSPE DG+F+ SDV+SFG+++ E +
Sbjct: 202 LPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-44
Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 566
+ Q +G G FG VYKG L VA+K L + + + +F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
H N++RL G + ++I EYM N +L+ FL K + V ++ GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG---- 682
YL + +HRDL A NIL++ ++ K+SDFGL+R+ D T G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIP 213
Query: 683 --YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +PE F+ SDV+SFGI+M E ++
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-44
Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 34/223 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKL-Q 567
+ Q +GEG FG V K R+ A+KR+ S ++F E+ ++ KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------FDSTKKRLLNWQAR 614
H N++ LLG C +G L +EY P+ +L FL ++ L+ Q
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674
+ +A+G+ YL S+ + IHRDL A NIL+ ++ KI+DFGL+R G + T
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 199
Query: 675 KQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
G +M+ E +++ SDV+S+G+L+ E +S
Sbjct: 200 M------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-44
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 520 KLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
+G+G FG VY G ++ + A+K L Q ++ F E +L+ L H N++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 575 LGCCVEQGEKILI-LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
+G + + L YM + L F+ +R + + +A+G+ YL +
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYL---AE 142
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG-----YMSPEY 688
+ +HRDL A N +LD+ K++DFGLAR E + + + + E
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ---HRHARLPVKWTALES 199
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
F+ KSDV+SFG+L+ E L+
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-44
Identities = 61/201 (30%), Positives = 105/201 (52%), Gaps = 7/201 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
+ +M+ KLG G +G VY+G VAVK L + ++EF E ++ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
V+LLG C + +I E+M +L +L ++ ++ + + I+ + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+ IHR+L A N L+ ++ K++DFGL+R+ GD + + +PE
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393
Query: 692 GLFSIKSDVFSFGILMLETLS 712
FSIKSDV++FG+L+ E +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG----QEVAVKRL--SNQSGQGLKEFKNEMMLIAKL 566
+ F++ LG+G FG V + +L +VAVK L + ++EF E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 567 QHRNLVRLLGCCVEQGEKI------LILEYMPNKSLNVFLFDS---TKKRLLNWQARVRI 617
H ++ +L+G + K +IL +M + L+ FL S L Q VR
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNT 674
+ IA G+ YL S IHRDL A N +L +DM ++DFGL+R ++ GD +
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
K V +++ E D L+++ SDV++FG+ M E ++
Sbjct: 200 KLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 38/229 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 563
+ ++ LGEG FG V + VAVK L + + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 564 AKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-- 620
+ +H+N++ LLG C + G +I+EY +L +L + R+ E
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 621 -----------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD 668
+A+G+ YL + + IHRDL A N+L+ ++ KI+DFGLAR + D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 669 ELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ T G +M+PE D +++ +SDV+SFG+LM E +
Sbjct: 212 YYKKTTN------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-44
Identities = 68/234 (29%), Positives = 111/234 (47%), Gaps = 43/234 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 565
+N + LGEG FG V K + VAVK L N S L++ +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL---------------------FDST 604
+ H ++++L G C + G +LI+EY SL FL D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 605 KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR- 663
+R L + I+QG+ YL + +++HRDL A NIL+ + KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 664 MFGGDELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
++ D ++ G +M+ E D +++ +SDV+SFG+L+ E ++
Sbjct: 200 VYEEDSYVKRSQ------GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 66/231 (28%), Positives = 103/231 (44%), Gaps = 37/231 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 565
N +GEG FG V++ R VAVK L S +F+ E L+A+
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL---------------------FDST 604
+ N+V+LLG C L+ EYM LN FL S
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 605 KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR- 663
L+ ++ I +A G+ YL S + +HRDL N L+ ++M KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 664 MFGGD--ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
++ D + GN + +M PE ++ +SDV+++G+++ E S
Sbjct: 224 IYSADYYKADGNDAIPI---RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-44
Identities = 71/297 (23%), Positives = 131/297 (44%), Gaps = 50/297 (16%)
Query: 446 VFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSW-LPLFS 504
+ RR+ + + ++ + L+ ++ T T + + + W P
Sbjct: 24 IPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS-EYELPEDPKWEFPR-- 80
Query: 505 LASITAATENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKE 555
+ ++ LGEG FG V + VAVK L + + + L +
Sbjct: 81 --------DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 132
Query: 556 FKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------F 601
+EM ++ + +H+N++ LLG C + G +I+EY +L +L
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 602 DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661
+ + + ++ V +A+G+ YL + + IHRDL A N+L+ ++ KI+DFGL
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGL 249
Query: 662 AR-MFGGDELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
AR + D + T G +M+PE D +++ +SDV+SFG+LM E +
Sbjct: 250 ARDINNIDYYKKTTN------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-44
Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 37/228 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRL-SNQSGQGLKEFKNEMMLIAK 565
+ + LG G FG V + + VAVK L + + +E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 566 L-QHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG--- 620
+ H N+V LLG C + G + +I+E+ +L+ +L + + A + +
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 621 ----------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDE 669
+A+G+ +L + + IHRDL A NILL + KI DFGLAR ++ +
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 670 LQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 204 YVRKGD------ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-44
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 565
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL----FDSTKKRLLNWQARVRIIEGI 621
H+N+VR +G ++ + +++E M L FL ++ L + + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLAR-MFGGD--ELQGNTK 675
A G YL IHRD+ A N LL KI DFG+AR ++ G
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
V +M PE ++G+F+ K+D +SFG+L+ E S
Sbjct: 207 LPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-44
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 520 KLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
+G G FG VY G LL+ AVK L + +F E +++ H N++ L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 575 LGCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
LG C+ L +L YM + L F+ + + + +A+G+ YL +
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMSPE 687
+ +HRDL A N +LD+ K++DFGLAR D + G +M+ E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
F+ KSDV+SFG+L+ E ++
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 7e-44
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 38/219 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 566
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGIA 622
+ ++ RLLG C+ ++ I + MP L ++ + + LLNW IA
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
+G+ YL R++HRDL A N+L+ + KI+DFGLA++ G +E Y
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYH 175
Query: 683 Y---------MSPEYALDGLFSIKSDVFSFGILMLETLS 712
M+ E L +++ +SDV+S+G+ + E ++
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-44
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 573 RLLGCCVEQGEKILI-LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
RL+G C Q E +++ +E L+ FL K+ + ++ ++ G+ YL
Sbjct: 74 RLIGVC--QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL--- 126
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMS 685
+HRDL A N+LL KISDFGL++ G D+ + +
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKWYA 181
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
PE FS +SDV+S+G+ M E LS
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-43
Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 565
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL----FDSTKKRLLNWQARVRIIEGI 621
H+N+VR +G ++ + ++LE M L FL ++ L + + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLAR-MFGGD--ELQGNTK 675
A G YL IHRD+ A N LL KI DFG+AR ++ G
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
V +M PE ++G+F+ K+D +SFG+L+ E S
Sbjct: 248 LPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 567
N S+ +G G FG V GRL + VA+K L + + ++F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H N++RL G + +++ EYM N SL+ FL V ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY---- 683
L S +HRDL A NIL++ ++ K+SDFGL R+ D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----------EAAYTTR 208
Query: 684 --------MSPEYALDGLFSIKSDVFSFGILMLETLS 712
SPE F+ SDV+S+GI++ E +S
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-43
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 567
E + +GEG FG V++G ++ + VA+K + S ++F E + + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H ++V+L+G E I I+E L FL +K L+ + + ++ L Y
Sbjct: 75 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMS 685
L R +HRD+ A N+L+ + K+ DFGL+R K + +M+
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 185
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
PE F+ SDV+ FG+ M E L
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 520 KLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
+G G FG VY G LL+ AVK L + +F E +++ H N++ L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 575 LGCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
LG C+ L +L YM + L F+ + + + +A+G+ +L +
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG-----YMSPEY 688
+ +HRDL A N +LD+ K++DFGLAR E T +M+ E
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN---KTGAKLPVKWMALES 267
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
F+ KSDV+SFG+L+ E ++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 60/229 (26%), Positives = 93/229 (40%), Gaps = 38/229 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 565
S LG G FG V + + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 566 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG---- 620
L H N+V LLG C G ++I EY L FL + + + + +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 621 -----------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD 668
+A+G+ +L + IHRDL A NILL KI DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 669 ELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE + +++ +SDV+S+GI + E S
Sbjct: 200 NYVVKGN------ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 520 KLGEGGFGPVYKGRLLNG---QEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
+LG G FG V KG + VAVK L E E ++ +L + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 575 LGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
+G C + E L++E LN +L + R + + + ++ ++ G+ YL
Sbjct: 84 IGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EE 135
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQIVGTYGYMSPEYA 689
+HRDL A N+LL KISDFGL++ DE Q + K V + +PE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---KWYAPECI 192
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
FS KSDV+SFG+LM E S
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS 215
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 38/222 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL--------LNGQEVAVKRLSNQSGQGLKEFKNEMMLIA 564
E+ LG+G F ++KG L+ EV +K L + F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
KL H++LV G CV E IL+ E++ SL+ +L K +N ++ + + +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNP--------KISDFGLARMFGGDELQGNTKQ 676
+ +L +IH ++ A NILL ++ + K+SD G++ +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 677 IVGTYGY-----MSPEYALDG-LFSIKSDVFSFGILMLETLS 712
+ PE + ++ +D +SFG + E S
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAK 565
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
L HRNL+RL G + K+ + E P SL L + R +A+G+
Sbjct: 78 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGM 134
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT---YG 682
YL R IHRDL A N+LL KI DFGL R ++ ++ +
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFA 189
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +PE FS SD + FG+ + E +
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-43
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 567
E+ + LGEG FG VY+G N + VAVK + + ++F +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H ++V+L+G E+ I I+E P L +L K L V I + + Y
Sbjct: 72 HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMS 685
L +HRD+ NIL+ K+ DFGL+R ++ T+ + +MS
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI---KWMS 182
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
PE F+ SDV+ F + M E LS
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-43
Identities = 70/200 (35%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + F E ++ KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L E+ I + EYM SL FL + L V + IA G+ Y+
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
R +HRDL+A+NIL+ +++ K++DFGLAR+ +E + +PE AL G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 693 LFSIKSDVFSFGILMLETLS 712
F+IKSDV+SFGIL+ E +
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-42
Identities = 70/200 (35%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + F E ++ KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L E+ I + EYM SL FL + L V + IA G+ Y+
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
R +HRDL+A+NIL+ +++ K++DFGLAR+ +E + +PE AL G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 693 LFSIKSDVFSFGILMLETLS 712
F+IKSDV+SFGIL+ E +
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-42
Identities = 66/229 (28%), Positives = 108/229 (47%), Gaps = 38/229 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRL-SNQSGQGLKEFKNEMMLI 563
+ + LGEG FG V + +VAVK L S+ + + L + +EM ++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 564 AKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-- 620
+ +H+N++ LLG C + G +I+EY +L +L L E
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 621 -----------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD 668
+A+G+ YL + + IHRDL A N+L+ +D KI+DFGLAR + D
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 669 ELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ T G +M+PE D +++ +SDV+SFG+L+ E +
Sbjct: 246 YYKKTTN------GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 34/225 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 565
N LG G FG V + + VAVK L S + +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 566 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-----------FDSTKKRLLNWQA 613
L QH N+V LLG C G ++I EY L FL + + +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQG 672
+ +AQG+ +L + IHRD+ A N+LL KI DFGLAR +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 673 NTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE D +++++SDV+S+GIL+ E S
Sbjct: 223 KGN------ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-42
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 28/220 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
+F +G GGFG V+K + ++G+ +KR+ + ++ + E+ +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 572 VRLLGCCVEQGEKI----------------LILEYMPNKSLNVFLFDSTKKRLLNWQARV 615
V GC + +E+ +L ++ ++L A
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL- 125
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675
+ E I +G+ Y+H ++I+RDLK SNI L KI DFGL D G
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179
Query: 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
+ GT YMSPE + + D+++ G+++ E L
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-41
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
RL+G C + + ++E L+ FL K+ + ++ ++ G+ YL
Sbjct: 400 RLIGVCQAEALML-VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQIVGTYGYMSPEY 688
+HR+L A N+LL KISDFGL++ G D+ + K + + +PE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPEC 510
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
FS +SDV+S+G+ M E LS
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 27/221 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 570
+F LG GGFG V++ + ++ A+KR+ ++ E+ +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 571 LVRLLGCCVEQGEKI------------LILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 618
+VR +E+ + ++ ++L ++ + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ-- 676
IA+ + +LH ++HRDLK SNI D K+ DFGL DE +
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 677 --------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
VGT YMSPE +S K D+FS G+++ E
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-41
Identities = 63/234 (26%), Positives = 91/234 (38%), Gaps = 43/234 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 565
EN LG G FG V + VAVK L + +E+ ++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 566 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG---- 620
L H N+V LLG C G LI EY L +L +K +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 621 ----------------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR- 663
+A+G+ +L +HRDL A N+L+ KI DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 664 MFGGDELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +M+PE +G+++IKSDV+S+GIL+ E S
Sbjct: 222 IMSDSNYVVRGN------ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-40
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 567
E + +GEG FG V++G ++ + VA+K + S ++F E + + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H ++V+L+G E I I+E L FL +K L+ + + ++ L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMS 685
L R +HRD+ A N+L+ + K+ DFGL+R K + +M+
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 560
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
PE F+ SDV+ FG+ M E L
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
++G G F VYKG EVA + + + FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 577 CCVEQGEK----ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+ +L+ E M + +L +L + +++ + I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148
Query: 633 RFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
IIHRDLK NI + + KI D GLA + K ++GT +M+PE +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE 204
Query: 692 GLFSIKSDVFSFGILMLETLSSK 714
+ DV++FG+ MLE +S+
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-40
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 23/223 (10%)
Query: 507 SITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIA 564
S++ +S+ ++G GG V++ Q A+K L Q L ++NE+ +
Sbjct: 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 81
Query: 565 KLQHRNL--VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA 622
KLQ + +RL + +++E N LN +L KK + W+ + + +
Sbjct: 82 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERK-SYWKNML 137
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
+ + +HQ+ I+H DLK +N L+ K+ DFG+A D VGT
Sbjct: 138 EAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 683 YMSPE-----------YALDGLFSIKSDVFSFGILMLETLSSK 714
YM PE S KSDV+S G ++ K
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-40
Identities = 52/200 (26%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 569
E + K+GEG FG + +G++ +K +S S + +E + E+ ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N+V+ E G ++++Y L + ++ K L + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
+I+HRD+K+ NI L KD ++ DFG+AR+ +GT Y+SPE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 690 LDGLFSIKSDVFSFGILMLE 709
+ ++ KSD+++ G ++ E
Sbjct: 198 ENKPYNNKSDIWALGCVLYE 217
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 37/227 (16%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+F LG+G FG V K R L+ + A+K++ + + L +E+ML+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 571 LVRLLGCCVEQGEKI-------------LILEYMPNKSLNVFLFD--STKKRLLNWQARV 615
+VR +E+ + + +EY N +L +D ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF---------- 665
R+ I + L Y+H IIHRDLK NI +D+ N KI DFGLA+
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 666 --GGDELQGNTKQIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLE 709
N +GT Y++ E G ++ K D++S GI+ E
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 570
+S+ ++G GG V++ Q A+K L Q L ++NE+ + KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 571 L--VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+RL + +++E N LN +L KK + W+ + + + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTI 124
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE- 687
HQ+ I+H DLK +N L+ K+ DFG+A D VGT YM PE
Sbjct: 125 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 688 ----------YALDGLFSIKSDVFSFGILMLETLSSK 714
S KSDV+S G ++ K
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 5e-39
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 23/210 (10%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLL 575
++G GG V++ Q A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
+ +++E N LN +L KK + W+ + + + + + +HQ+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTIHQH---G 175
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE-------- 687
I+H DLK +N L+ D K+ DFG+A D VG YM PE
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 688 ---YALDGLFSIKSDVFSFGILMLETLSSK 714
S KSDV+S G ++ K
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 579
LG+G +G VY GR L N +A+K + + + + E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 580 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRII-EGIAQGLLYLHQYSRFRIIH 638
E G + +E +P SL+ L S L + + + + I +GL YLH +I+H
Sbjct: 90 ENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 639 RDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE---YALDGLF 694
RD+K N+L++ KISDFG ++ G + T+ GT YM+PE G +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRG-Y 202
Query: 695 SIKSDVFSFGILMLETLSSK 714
+D++S G ++E + K
Sbjct: 203 GKAADIWSLGCTIIEMATGK 222
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQH 568
NF ++ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV-RIIEGIAQGLLY 627
N+++ +E E ++LE L+ + K++ L + V + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
+H R++HRD+K +N+ + K+ D GL R F ++ +VGT YMSPE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSK 714
+ ++ KSD++S G L+ E + +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-38
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 10/205 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 569
E++ + +G G +G K R +G+ + K + + + +E+ L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 570 NLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARV-RIIEGIAQGLL 626
N+VR +++ L ++EY L + TK+R + V R++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 627 YLHQ--YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
H+ ++HRDLK +N+ LD N K+ DFGLAR+ D T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
SPE ++ KSD++S G L+ E
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYE 208
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 14/207 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKL-QH 568
++F +LG G +G V+K R +G+ AVK + + E+ K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
VRL E G L E SL ++ L Q + + L +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRD-TLLALAHL 173
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H ++H D+K +NI L K+ DFGL G + G YM+PE
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPE- 226
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKK 715
L G + +DVFS G+ +LE + +
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 56/192 (29%), Positives = 88/192 (45%), Gaps = 14/192 (7%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQHRNLVRLLG 576
LG+GGF ++ + A K + +E E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 577 CCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
E + + ++LE +SL +K L +AR + I G YLH+ R
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQYLHRN---R 135
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
+IHRDLK N+ L++D+ KI DFGLA D + + GT Y++PE S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 193
Query: 696 IKSDVFSFGILM 707
+ DV+S G +M
Sbjct: 194 FEVDVWSIGCIM 205
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 14/200 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 568
+ LG+GGF ++ + A K + +E E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 569 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
+++V G E + + ++LE +SL +K L +AR + I G Y
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQY 156
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH+ R+IHRDLK N+ L++D+ KI DFGLA D + + GT Y++PE
Sbjct: 157 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPE 211
Query: 688 YALDGLFSIKSDVFSFGILM 707
S + DV+S G +M
Sbjct: 212 VLSKKGHSFEVDVWSIGCIM 231
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-36
Identities = 52/220 (23%), Positives = 88/220 (40%), Gaps = 27/220 (12%)
Query: 508 ITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 566
+ +++ KLGEGGF V L +G A+KR+ Q +E + E +
Sbjct: 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83
Query: 567 QHRNLVRLLGCCVEQGEK----ILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEG 620
H N++RL+ C+ + L+L + +L + L Q ++ G
Sbjct: 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLG 142
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-----MFGGDELQGNTK 675
I +GL +H HRDLK +NILL + P + D G + G +
Sbjct: 143 ICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 676 QI--VGTYGYMSPE------YALDGLFSIKSDVFSFGILM 707
T Y +PE + + ++DV+S G ++
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVID---ERTDVWSLGCVL 236
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLL 575
KLG GG VY + +VA+K + + LK F+ E+ ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
E L++EY+ +L+ ++ L+ + I G+ + H R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
I+HRD+K NIL+D + KI DFG+A+ L T ++GT Y SPE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATD 190
Query: 696 IKSDVFSFGILMLETL 711
+D++S GI++ E L
Sbjct: 191 ECTDIYSIGIVLYEML 206
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+ Q ++G G FG V++ + G + AVK++ + + E++ A L
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPR 111
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLH 629
+V L G E + +E + SL + + L + R G +GL YLH
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP-EDRALYYLGQALEGLEYLH 167
Query: 630 QYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQ---IVGTYGYMS 685
RI+H D+KA N+LL D + + DFG A D L + I GT +M+
Sbjct: 168 TR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSK 714
PE + K D++S +ML L+
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 54/199 (27%), Positives = 103/199 (51%), Gaps = 10/199 (5%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+ ++ K+G+G G VY + GQEVA+++++ Q + NE++++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V L + E +++EY+ SL D + ++ + Q L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
++IHRD+K+ NILL D + K++DFG ++ + +T +VGT +M+PE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 691 DGLFSIKSDVFSFGILMLE 709
+ K D++S GI+ +E
Sbjct: 190 RKAYGPKVDIWSLGIMAIE 208
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 507 SITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEM-MLI 563
S+ ++ +LG G +G V K R + +GQ +AVKR+ + + Q K ++ + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV------RI 617
+ V G +G+ + +E M + SL+ F K++++ + +I
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKI 114
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677
I + L +LH S+ +IHRD+K SN+L++ K+ DFG++ D++ +
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID-- 169
Query: 678 VGTYGYMSPE----YALDGLFSIKSDVFSFGILMLE 709
G YM+PE +S+KSD++S GI M+E
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 568
E+F + LG+G F VY+ + G EVA+K + ++ G+ + +NE+ + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 569 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
+++ L E + L+LE N +N +L + K +AR + I G+LY
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEAR-HFMHQIITGMLY 127
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH I+HRDL SN+LL ++MN KI+DFGLA + T + GT Y+SPE
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPE 182
Query: 688 YALDGLFSIKSDVFSFGILMLETL 711
A ++SDV+S G + L
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLL 206
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
K+GEG G V R +G++VAVK + + Q + NE++++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V + + E +++E++ +L D + LN + + E + Q L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
+IHRD+K+ +ILL D K+SDFG D + + +VGT +M+PE
Sbjct: 160 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214
Query: 691 DGLFSIKSDVFSFGILMLE 709
L++ + D++S GI+++E
Sbjct: 215 RSLYATEVDIWSLGIMVIE 233
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 47/223 (21%), Positives = 85/223 (38%), Gaps = 34/223 (15%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKL-Q 567
T F K+G G FG V+K L+G A+KR + E+ A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLL 626
H ++VR E ++ EY SL + ++ + +A ++ + + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNP-------------------KISDFGLARMFGG 667
Y+H ++H D+K SNI + + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 668 DELQGNTKQIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLE 709
+ + G +++ E + K+D+F+ + ++
Sbjct: 185 ----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVC 223
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 56/204 (27%), Positives = 108/204 (52%), Gaps = 13/204 (6%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
E + + +LG+G FG VYK + G A K + +S + L+++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V+LLG G+ +++E+ P +++ + + L Q +V + + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE--- 687
RIIHRDLKA N+L+ + + +++DFG++ + ++ +GT +M+PE
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190
Query: 688 --YALDGLFSIKSDVFSFGILMLE 709
D + K+D++S GI ++E
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIE 214
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 11/226 (4%)
Query: 486 EANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKR 544
E D + + + ++F +LG G G V+K +G +A K
Sbjct: 6 ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 65
Query: 545 LS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS 603
+ + E+ ++ + +V G GE + +E+M SL+ L
Sbjct: 66 IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--- 122
Query: 604 TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663
K + Q ++ + +GL YL + +I+HRD+K SNIL++ K+ DFG++
Sbjct: 123 KKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
+ N+ VGT YMSPE +S++SD++S G+ ++E
Sbjct: 181 QL--IDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQ 567
E+F + LG+G FG VY R + +A+K L ++G + + E+ + + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H N++RL G + LILEY P ++ L + + I +A L Y
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTA-TYITELANALSY 124
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D--LCGTLDYLPPE 177
Query: 688 YALDGLFSIKSDVFSFGILMLETL 711
+ K D++S G+L E L
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 60/199 (30%), Positives = 105/199 (52%), Gaps = 10/199 (5%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
E F + KLGEG +G VYK GQ VA+K++ + L+E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V+ G + + +++EY S++ + K L + I++ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT-ILQSTLKGLEYLHF 143
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
R IHRD+KA NILL+ + + K++DFG+A + NT ++GT +M+PE
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQ 198
Query: 691 DGLFSIKSDVFSFGILMLE 709
+ ++ +D++S GI +E
Sbjct: 199 EIGYNCVADIWSLGITAIE 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-33
Identities = 40/200 (20%), Positives = 79/200 (39%), Gaps = 24/200 (12%)
Query: 520 KLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLG 576
+ GG G +Y +NG+ V +K L + + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 577 CCVEQGEKI-----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+++EY+ +SL + L + + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+++ DLK NI+L ++ K+ D G + GT G+ +PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRT 251
Query: 692 GLFSIKSDVFSFGILMLETL 711
G ++ +D+++ G +
Sbjct: 252 GP-TVATDIYTVGRTLAALT 270
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 56/200 (28%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 569
E F+ K+G+G FG V+KG + VA+K + + + +++ + E+ ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
+ + G ++ + +I+EY+ S D + L+ I+ I +GL YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
+ IHRD+KA+N+LL + K++DFG+A +++ NT VGT +M+PE
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 191
Query: 690 LDGLFSIKSDVFSFGILMLE 709
+ K+D++S GI +E
Sbjct: 192 KQSAYDSKADIWSLGITAIE 211
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLL 575
LG GG V+ R L + ++VAVK L + F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 576 --GCCVEQGEKI--LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
G + +++EY+ +L + + + + + +I Q L + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG-NTKQIVGTYGYMSPEYAL 690
+ IIHRD+K +NI++ K+ DFG+AR T ++GT Y+SPE A
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 691 DGLFSIKSDVFSFGILMLETL 711
+SDV+S G ++ E L
Sbjct: 193 GDSVDARSDVYSLGCVLYEVL 213
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 22/216 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 570
+ + LG+G V++GR G A+K +N S + E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 571 LVRLLGC--CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+V+L K+LI+E+ P SL L + + L + ++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 629 HQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
+ I+HR++K NI+ D K++DFG AR DE + GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYL 182
Query: 685 SPE--------YALDGLFSIKSDVFSFGILMLETLS 712
P+ + D++S G+ +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEM-MLIAKLQHR 569
E+ ++G G +G V K +GQ +AVKR+ S + K+ ++ +++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV------RIIEGIAQ 623
+V+ G +G+ + +E M + S + F K + +I +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
L +L +IIHRD+K SNILLD+ N K+ DFG++ + G Y
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPY 191
Query: 684 MSPE----YALDGLFSIKSDVFSFGILMLE 709
M+PE A + ++SDV+S GI + E
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 46/196 (23%), Positives = 80/196 (40%), Gaps = 11/196 (5%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLL 575
+G GG G VY+ + + VA+K +S + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
G+ + + + L L ++ L V I+ I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
HRD+K NIL+ D + DFG+A ++L VGT YM+PE + +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHAT 213
Query: 696 IKSDVFSFGILMLETL 711
++D+++ ++ E L
Sbjct: 214 YRADIYALTCVLYECL 229
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-32
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 22/211 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 570
+ + LG+G V++GR G A+K +N S + E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 571 LVRLLGC--CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+V+L K+LI+E+ P SL L + + L + ++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 629 HQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
+ I+HR++K NI+ D K++DFG AR DE + GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYL 182
Query: 685 SPE--------YALDGLFSIKSDVFSFGILM 707
P+ + D++S G+
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 51/233 (21%), Positives = 97/233 (41%), Gaps = 20/233 (8%)
Query: 485 GEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVK 543
G + GK + A + ++G G G V+K R G +AVK
Sbjct: 1 GSSGSSGKQTGYLT----IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK 56
Query: 544 RL-SNQSGQGLKEFKNEM-MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLF 601
++ + + + K ++ +++ +V+ G + + + +E M +
Sbjct: 57 QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE---KL 113
Query: 602 DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661
+ + + ++ I + L YL + +IHRD+K SNILLD+ K+ DFG+
Sbjct: 114 KKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGI 171
Query: 662 ARMFGGDELQGNTKQIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLE 709
+ D+ + G YM+PE + I++DV+S GI ++E
Sbjct: 172 SGRL-VDDKAKDR--SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-32
Identities = 49/214 (22%), Positives = 85/214 (39%), Gaps = 29/214 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEM-MLIAKLQHRNLV 572
+F + LG G G + + + ++VAVKR+ + E+ +L +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 573 RLLGCCVEQGEKI--LILEYMPNKSLNVFLFD---STKKRLLNWQARVRIIEGIAQGLLY 627
R C E+ + + +E L + L + +++ GL +
Sbjct: 82 RYF--CTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPI-TLLQQTTSGLAH 133
Query: 628 LHQYSRFRIIHRDLKASNILL-----DKDMNPKISDFGLARMFGGDEL-QGNTKQIVGTY 681
LH I+HRDLK NIL+ + ISDFGL + + GT
Sbjct: 134 LHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 682 GYMSPEY---ALDGLFSIKSDVFSFGILMLETLS 712
G+++PE + D+FS G + +S
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 23/212 (10%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 577
L EGGF VY+ + + +G+E A+KRL + + + E+ + KL H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 578 CVEQGEK-------ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
E+ L+L + L FL + L+ ++I + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI----------VGT 680
+ IIHRDLK N+LL K+ DFG A + Q T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 681 YGYMSPE-YALDGLFSI--KSDVFSFGILMLE 709
Y +PE L F I K D+++ G ++
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 39/227 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-----------------NQSGQGLKE 555
++ + L +G F + + + A+K+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 556 FKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL------NVFLFDSTKKRLL 609
FKNE+ +I +++ + G E +I EYM N S+ L + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669
+ II+ + Y+H + I HRD+K SNIL+DK+ K+SDFG + +
Sbjct: 150 IQVIK-CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 670 LQGNTKQIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLETL 711
++G GTY +M PE + +G K D++S GI +
Sbjct: 207 IKG----SRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMF 246
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 6e-31
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 571
+ M+ +LG GGFG V + G++VA+K+ + +E + E+ ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 572 VRLL------GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
V +L +EY L +L L ++ I+ L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 626 LYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
YLH+ RIIHRDLK NI+L + + KI D G A+ EL + VGT
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQ 188
Query: 683 YMSPEYALDGLFSIKSDVFSFGILM 707
Y++PE +++ D +SFG L
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLA 213
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQ 567
++F + LG+G FG VY R N +A+K L + G + + E+ + + L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLR 72
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGL 625
H N++R+ ++ L+LE+ P L + R ++ +E +A L
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSA-TFMEELADAL 127
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
Y H ++IHRD+K N+L+ KI+DFG + T + GT Y+
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RT--MCGTLDYLP 180
Query: 686 PEYALDGLFSIKSDVFSFGILMLETL 711
PE K D++ G+L E L
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFL 206
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 48/218 (22%), Positives = 84/218 (38%), Gaps = 16/218 (7%)
Query: 504 SLASITAATENFSMQCKLGEG--GFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKN 558
++S + + +G+G V R G+ V V+R L S + + +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 559 EMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 618
E+ + H N+V + E ++ +M S L + +N A I+
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYIL 134
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT---- 674
+G+ + L Y+H +HR +KAS+IL+ D +S +
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 675 -KQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLE 709
K V ++SPE L + KSD++S GI E
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 20/220 (9%)
Query: 503 FSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMM 561
L+++ F + +G G +G VYKGR + GQ A+K + + +G +E K E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72
Query: 562 LIAKL-QHRNLVRLLGCCVEQGEKI------LILEYMPNKSLNVFLFDSTKKRLLNWQAR 614
++ K HRN+ G +++ L++E+ S+ + ++ L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674
I I +GL +LHQ ++IHRD+K N+LL ++ K+ DFG++ + NT
Sbjct: 133 Y-ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 675 KQIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLE 709
+GT +M+PE D + KSD++S GI +E
Sbjct: 189 --FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ 567
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H N ++ GC + + L++EY + + L + KK L + + G QGL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAY 169
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH + +IHRD+KA NILL + K+ DFG A N+ VGT +M+PE
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGTPYWMAPE 220
Query: 688 ---YALDGLFSIKSDVFSFGILMLE 709
+G + K DV+S GI +E
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIE 245
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRN 570
+++ +Q +G G V ++VA+KR++ + Q + E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE--GIA------ 622
+V V + E L+++ + S+ D K + + + +++ IA
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 623 -QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL-ARMFGGDELQGNTKQ--IV 678
+GL YLH + IHRD+KA NILL +D + +I+DFG+ A + G ++ N + V
Sbjct: 131 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 679 GTYGYMSPEYALDGL-FSIKSDVFSFGILMLE 709
GT +M+PE + K+D++SFGI +E
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 56/190 (29%), Positives = 92/190 (48%), Gaps = 34/190 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 563
ENF K+GEG +G VYK R L G+ VA+K++ L E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRI 617
+L H N+V+LL + + L+ E++ + + + +Q
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----- 111
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677
+ QGL + H + R++HRDLK N+L++ + K++DFGLAR F G ++ T ++
Sbjct: 112 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEV 164
Query: 678 VGTYGYMSPE 687
V T Y +PE
Sbjct: 165 V-TLWYRAPE 173
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 34/189 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIA 564
E + K+GEG +G VYK + G+ VA+KR+ L E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRII 618
+L H N+V L+ + L+ E+M L DS K L +Q
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL-YQ------ 127
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 678
+ +G+ + HQ+ RI+HRDLK N+L++ D K++DFGLAR F G ++ T ++V
Sbjct: 128 --LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
Query: 679 GTYGYMSPE 687
T Y +P+
Sbjct: 182 -TLWYRAPD 189
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 57/224 (25%), Positives = 86/224 (38%), Gaps = 40/224 (17%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEM-MLIAKLQHRNLVRLLGCC 578
LG G G V G+ VAVKR+ E+ +L H N++R C
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYY--C 76
Query: 579 VEQGEK--ILILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
E ++ + LE N +L + D K + ++ IA G+ +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLHSL 134
Query: 632 SRFRIIHRDLKASNILLD-------------KDMNPKISDFGLARMFGGDE--LQGNTKQ 676
+IIHRDLK NIL+ +++ ISDFGL + + + N
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 677 IVGTYGYMSPEYALDGLFSI-------KSDVFSFGILMLETLSS 713
GT G+ +PE + D+FS G + LS
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 36/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 563
+ + K+GEG +G V+K + + VA+KR+ L + E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRI 617
+L+H+N+VRL + L+ E+ S N L K L +Q
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL-FQ----- 109
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677
+ +GL + H ++HRDLK N+L++++ K+++FGLAR F G ++ + ++
Sbjct: 110 ---LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEV 162
Query: 678 VGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKK 715
V T Y P+ L+S D++S G + E ++ +
Sbjct: 163 V-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 33/228 (14%), Positives = 65/228 (28%), Gaps = 24/228 (10%)
Query: 507 SITAATENFSMQCKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLKEFKNEM 560
++ + LGEG F VY+ N Q+ +K + M
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 561 MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN---VFLFDSTKKRLLNWQARVRI 617
+ ++ + Q +L+ E +L ++ +K +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILL-----------DKDMNPKISDFGLARMFG 666
+ + + +H IIH D+K N +L D + D G +
Sbjct: 179 MR-MLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
T G+ E + ++ + D F + L
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 25/246 (10%), Positives = 57/246 (23%), Gaps = 43/246 (17%)
Query: 501 PLFSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEF 556
+ ++ + L G V+ R + ++ A+K + S L+
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 557 KNEMMLIAKLQHRNLVRLLGCC-VEQGEKILILEYMPN-----------KSLNVFL---- 600
A+L + + + ++ P N L
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 601 -------------FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647
F + A + + + L ++H N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLF 226
Query: 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGI 705
+ D + D G Y E+ F+ + + G+
Sbjct: 227 IMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 706 LMLETL 711
+
Sbjct: 282 SIYRVW 287
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (298), Expect = 6e-29
Identities = 32/230 (13%), Positives = 68/230 (29%), Gaps = 43/230 (18%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQH-------- 568
LG+ + G+ V +K+ K E++ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 569 --------RNLVRLLGCC-----VEQGEKILILEY---MPNKSLNVFLF------DSTKK 606
+LV+ + +L P N+ F S+
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 607 RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666
+ L AR+++ + + L LH Y ++H L+ +I+LD+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 667 GDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETL 711
G + + L + D ++ G+ +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-29
Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 568
E +++ C LG+G FG V K + + QE AVK + ++ + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLL 626
N+++L + ++ E L FD +KR A RII+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 627 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
Y+H++ I+HRDLK NILL +KD + KI DFGL+ F + K +GT Y
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYY 189
Query: 684 MSPEYALDGLFSIKSDVFSFGILM 707
++PE L G + K DV+S G+++
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 66/204 (32%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 568
E +++ C LG+G FG V K + + QE AVK + ++ + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLL 626
N+++L + ++ E L FD +KR A RII+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 627 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
Y+H+++ I+HRDLK NILL +KD + KI DFGL+ F + K +GT Y
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYY 189
Query: 684 MSPEYALDGLFSIKSDVFSFGILM 707
++PE L G + K DV+S G+++
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 34/189 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIA 564
E + K+GEG +G VYK + G+ A+K++ L++ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRII 618
+L+H N+V+L + +L+ E++ L T K L Q
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-LQ------ 108
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 678
+ G+ Y H R++HRDLK N+L++++ KI+DFGLAR F G ++ T +IV
Sbjct: 109 --LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
Query: 679 GTYGYMSPE 687
T Y +P+
Sbjct: 163 -TLWYRAPD 170
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 62/192 (32%), Positives = 93/192 (48%), Gaps = 36/192 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN--------EMM 561
+ + LGEG F VYK R Q VA+K +L ++S E K+ E+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS-----EAKDGINRTALREIK 64
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARV 615
L+ +L H N++ LL + L+ ++M K ++ L S K +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM-LM--- 120
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675
QGL YLHQ+ I+HRDLK +N+LLD++ K++DFGLA+ F G + T
Sbjct: 121 -----TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTH 171
Query: 676 QIVGTYGYMSPE 687
Q+V T Y +PE
Sbjct: 172 QVV-TRWYRAPE 182
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-29
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 568
+E + KLG G +G V R + E A+K + ++ S + E+ ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLL 626
N+++L ++ L++E L FD + + A II+ + G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAA-VIIKQVLSGVT 150
Query: 627 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
YLH+++ I+HRDLK N+LL +KD KI DFGL+ +F + K+ +GT Y
Sbjct: 151 YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYY 204
Query: 684 MSPEYALDGLFSIKSDVFSFGILM 707
++PE L + K DV+S G+++
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVIL 227
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 33/194 (17%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-----LKEFKNEMMLI 563
+++ F KLG G + VYKG G VA+K + S +G ++E L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYM----------PNKSLNVFLFDSTKKRLLNWQA 613
+L+H N+VRL + + L+ E+M + + WQ
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ- 116
Query: 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673
+ QGL + H+ +I+HRDLK N+L++K K+ DFGLAR F G +
Sbjct: 117 -------LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTF 165
Query: 674 TKQIVGTYGYMSPE 687
+ ++V T Y +P+
Sbjct: 166 SSEVV-TLWYRAPD 178
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+ ++++ +G G +G V A K++ + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLLYL 628
++RL + + L++E LF+ K+ A RI++ + + Y
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYC 122
Query: 629 HQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
H+ + HRDLK N L D K+ DFGLA F ++ + VGT Y+S
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVS 176
Query: 686 PEYALDGLFSIKSDVFSFGILM 707
P+ L+GL+ + D +S G++M
Sbjct: 177 PQ-VLEGLYGPECDEWSAGVMM 197
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 28/201 (13%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
LGEG +G V + AVK L + G K E+ L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 576 G-CCVEQGEKI-LILEYMPNKSLNVFLFDS-TKKRLLNWQAR---VRIIEGIAQGLLYLH 629
E+ +K+ +++EY + DS +KR QA ++I+G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
I+H+D+K N+LL KIS G+A + G+ + PE A
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 690 L-----DGLFSIKSDVFSFGI 705
G K D++S G+
Sbjct: 184 NGLDTFSGF---KVDIWSAGV 201
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQ 567
++ + Q LG+G FG V + + GQE AVK +S + + E+ L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGL 625
H N+++L ++G L+ E L FD ++KR A RII + G+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RIIRQVLSGI 139
Query: 626 LYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
Y+H+ I+HRDLK N+LL KD N +I DFGL+ F + K +GT
Sbjct: 140 TYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAY 193
Query: 683 YMSPEYALDGLFSIKSDVFSFGILM 707
Y++PE L G + K DV+S G+++
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 23/207 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHR 569
+ F + KLG G FG V+ +G E +K ++ ++S +++ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNW------QARVRIIEGIAQ 623
N++++ + +++E L + +++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVA-ELMKQMMN 135
Query: 624 GLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
L Y H ++H+DLK NIL KI DFGLA +F DE GT
Sbjct: 136 ALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGT 189
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILM 707
YM+PE + K D++S G++M
Sbjct: 190 ALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 30/187 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-----LKEFKNEMMLIAKL 566
E + KLGEG + VYKG+ L VA+K + + +G ++E L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRIIEG 620
+H N+V L + L+ EY+ + K L +Q
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFL-FQ-------- 108
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
+ +GL Y H+ +++HRDLK N+L+++ K++DFGLAR + ++V T
Sbjct: 109 LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-T 163
Query: 681 YGYMSPE 687
Y P+
Sbjct: 164 LWYRPPD 170
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 46/189 (24%), Positives = 73/189 (38%), Gaps = 17/189 (8%)
Query: 546 SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK 605
S + ++ + +N V L + + ++ ++L ++
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 606 KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665
+ I IA+ + +LH ++HRDLK SNI D K+ DFGL
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 666 GGDELQGNTKQI----------VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
DE + VGT YMSPE +S K D+FS G+++ E L
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE-LLYSF 273
Query: 716 NTGLGSMER 724
+T MER
Sbjct: 274 STQ---MER 279
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 49/201 (24%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+ + + +LG G FG V++ G+ K ++ KNE+ ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 628
L+ L ++ E +LILE++ LFD + + ++ + + +GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 629 HQYSRFRIIHRDLKASNILL-DKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
H++ I+H D+K NI+ K + KI DFGLA DE K T + +P
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219
Query: 687 EYALDGLFSIKSDVFSFGILM 707
E +D+++ G+L
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
S LG G FG V+K G ++A K + + + +E KNE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+L + + +L++EY+ LFD + L + ++ I +G+ ++HQ
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 631 YSRFRIIHRDLKASNILL-DKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
I+H DLK NIL ++D KI DFGLAR + E K GT +++PE
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEV 259
Query: 689 ALDGLFSIKSDVFSFGILM 707
S +D++S G++
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 34/237 (14%), Positives = 71/237 (29%), Gaps = 54/237 (22%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ--------- 567
LG+ + G+ V +K+ K E++ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 568 ----------------HRNLVRLLGCC-VEQGEKILILEYMPNKSLNVF---LFD-STKK 606
+ ++R+ L +L F L S+
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 607 RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666
+ L AR+++ + + L LH Y ++H L+ +I+LD+ ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 667 GDELQGNTKQIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLS 712
G + G+ PE L + D ++ G+++
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 51/190 (26%), Positives = 78/190 (41%), Gaps = 35/190 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 563
E + K+GEG +G V+K R GQ VA+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRI 617
+L+H NLV LL + L+ EY + + + K + WQ
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSIT-WQ----- 110
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677
Q + + H++ IHRD+K NIL+ K K+ DFG AR+ ++
Sbjct: 111 ---TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEV 163
Query: 678 VGTYGYMSPE 687
T Y SPE
Sbjct: 164 A-TRWYRSPE 172
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 59/194 (30%), Positives = 84/194 (43%), Gaps = 39/194 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 563
+ + KLGEG +G VYK + + VA+KR+ L+ + E+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPN--KSL---NVFLFDSTKKRLLNWQARVRII 618
+LQHRN++ L LI EY N K N + K L +Q
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFL-YQ------ 140
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-----KISDFGLARMFGGDELQGN 673
+ G+ + H R +HRDLK N+LL KI DFGLAR F G ++
Sbjct: 141 --LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 674 TKQIVGTYGYMSPE 687
T +I+ T Y PE
Sbjct: 195 THEII-TLWYRPPE 207
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-27
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-------------NQSGQGLKEFK 557
E++ KLG G +G V + E A+K + + +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 558 NEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARV 615
NE+ L+ L H N+++L ++ L+ E+ L F+ + + A
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA- 149
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQG 672
I++ I G+ YLH+++ I+HRD+K NILL + +N KI DFGL+ F D
Sbjct: 150 NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205
Query: 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707
+ +GT Y++PE L ++ K DV+S G++M
Sbjct: 206 --RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 60/198 (30%), Positives = 88/198 (44%), Gaps = 29/198 (14%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 578
LGEG +G V + + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 579 VEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARV---RIIEGIAQGLLYLHQYSR 633
E + L LEY L FD + A+ +++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 687
I HRD+K N+LLD+ N KISDFGLA +F + + ++ GT Y++PE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 688 YALDGLFSIKSDVFSFGI 705
+ DV+S GI
Sbjct: 184 F--HAE---PVDVWSCGI 196
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 25/211 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKEFKNEMMLIAK 565
+ + + +G+G F V + GQ+ AVK + ++ G ++ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQ------ARVRIIE 619
L+H ++V LL G ++ E+M L KR A +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVAS-HYMR 137
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQ 676
I + L Y H IIHRD+K +LL + K+ FG+A G
Sbjct: 138 QILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGG 192
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707
VGT +M+PE + DV+ G+++
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 63/199 (31%), Positives = 96/199 (48%), Gaps = 29/199 (14%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGC 577
+G+G F V R +L G+EVA+K + + L++ E+ ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 578 CVEQGEKI-LILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+E + + LI+EY + FD R+ +AR I + Y H +
Sbjct: 83 -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEAR-SKFRQIVSAVQYCH---QK 133
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------Y 688
RI+HRDLKA N+LLD DMN KI+DFG + F G Y +PE Y
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKY 190
Query: 689 ALDGLFSIKSDVFSFGILM 707
DG + DV+S G+++
Sbjct: 191 --DGP---EVDVWSLGVIL 204
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 52/188 (27%), Positives = 83/188 (44%), Gaps = 31/188 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN----EMMLIAK 565
E + +GEG +G V K R G+ VA+K S+ K K E+ L+ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQ 80
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRIIE 619
L+H NLV LL C ++ L+ E++ + + L ++ L +Q
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYL-FQ------- 132
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
I G+ + H + IIHRD+K NIL+ + K+ DFG AR + ++
Sbjct: 133 -IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA- 186
Query: 680 TYGYMSPE 687
T Y +PE
Sbjct: 187 TRWYRAPE 194
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQH 568
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 569 RNLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
V+L Q ++ L L Y N L + R E I L
Sbjct: 90 PFFVKLYFTF--QDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTAE-IVSALE 144
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
YLH IIHRDLK NILL++DM+ +I+DFG A++ + Q VGT Y+SP
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 687 EYALDGLFSIKSDVFSFGILMLETLS 712
E + SD+++ G ++ + ++
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+++ + +LG G FG V++ G A K + + + E+ ++ L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 628
LV L + E ++I E+M LF+ + + ++ V + + +GL ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 629 HQYSRFRIIHRDLKASNILL-DKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
H+ + +H DLK NI+ K N K+ DFGL + + K GT + +P
Sbjct: 272 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAP 325
Query: 687 EYALDGLFSIKSDVFSFGILM 707
E A +D++S G+L
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLS 346
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 60/198 (30%), Positives = 88/198 (44%), Gaps = 29/198 (14%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 578
LGEG +G V + + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 579 VEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARV---RIIEGIAQGLLYLHQYSR 633
E + L LEY L FD + A+ +++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 687
I HRD+K N+LLD+ N KISDFGLA +F + + ++ GT Y++PE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 688 YALDGLFSIKSDVFSFGI 705
+ DV+S GI
Sbjct: 184 F--HAE---PVDVWSCGI 196
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 52/184 (28%), Positives = 83/184 (45%), Gaps = 19/184 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 568
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLL 626
N+VRL E+ L+ + + L F+ ++ A I+ I + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 119
Query: 627 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
Y H I+HR+LK N+LL K K++DFGLA E GT GY
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 173
Query: 684 MSPE 687
+SPE
Sbjct: 174 LSPE 177
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 26/206 (12%)
Query: 495 SKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--------RL 545
++D+ LP S EN+ + LG G V + +E AVK
Sbjct: 1 TRDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF 58
Query: 546 SNQSGQGLKE-FKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD- 602
S + Q L+E E+ ++ K+ H N+++L L+ + M L FD
Sbjct: 59 SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDY 114
Query: 603 -STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661
+ K L + R +I+ + + + LH+ I+HRDLK NILLD DMN K++DFG
Sbjct: 115 LTEKVTLSEKETR-KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 662 ARMFGGDELQGNTKQIVGTYGYMSPE 687
+ E +++ GT Y++PE
Sbjct: 171 SCQLDPGEK---LREVCGTPSYLAPE 193
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 564
+ + + +LG G F V K R G E A K + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQ 623
++ H N++ L + + +LILE + LFD +K L+ + I+ I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 624 GLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
G+ YLH I H DLK NI+L + K+ DFGLA K I G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILM 707
T +++PE +++D++S G++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 564
+ + + +LG G F V K R G E A K + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQ 623
++ H N++ L + + +LILE + LFD +K L+ + I+ I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 624 GLLYLHQYSRFRIIHRDLKASNILL-DKDMNP---KISDFGLARMFGGDELQGNTKQIVG 679
G+ YLH I H DLK NI+L DK++ K+ DFGLA K I G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILM 707
T +++PE +++D++S G++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 564
+++ M +LG G F V K R G+E A K RLS+ +E + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQ 623
+++H N++ L + + +LILE + LFD +K L + ++ I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEATQFLKQILD 119
Query: 624 GLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
G+ YLH RI H DLK NI+L + K+ DFG+A K I G
Sbjct: 120 GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFG 173
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILM 707
T +++PE +++D++S G++
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 48/249 (19%), Positives = 86/249 (34%), Gaps = 60/249 (24%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKEFKNEMMLIAK 565
+ + ++ +G+G +G V A+K ++ + + ++ K E+ L+ K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV---------- 615
L H N+ RL ++ L++E L D + + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHL----LDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 616 -------------------------------RIIEGIAQGLLYLHQYSRFRIIHRDLKAS 644
I+ I L YLH I HRD+K
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPE 197
Query: 645 NILL--DKDMNPKISDFGLARMFGGDELQGNT--KQIVGTYGYMSPE--YALDGLFSIKS 698
N L +K K+ DFGL++ F GT +++PE + + K
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 699 DVFSFGILM 707
D +S G+L+
Sbjct: 258 DAWSAGVLL 266
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+ F LG G F V+ + L G+ A+K + +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 628
+V L L+++ + LFD + A +I+ + + YL
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDAS-LVIQQVLSAVKYL 122
Query: 629 HQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
H+ I+HRDLK N+L +++ I+DFGL++M + GT GY++
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTPGYVA 175
Query: 686 PEYALDGLFSIKSDVFSFGILM 707
PE +S D +S G++
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVIT 197
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-26
Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 48/198 (24%)
Query: 519 CKLGEGGFGPVYKGR---LLNGQEVAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNL 571
CK+G G +G VYK + + ++ A+K++ S E+ L+ +L+H N+
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNV 80
Query: 572 VRLLGCCVEQGEKI--LILEYM--------------PNKSLNVFLFDSTKKRLLNWQARV 615
+ L + ++ L+ +Y V L K LL +Q
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL-YQ--- 136
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP----KISDFGLARMFG--GDE 669
I G+ YLH ++HRDLK +NIL+ + KI+D G AR+F
Sbjct: 137 -----ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 670 LQGNTKQIVGTYGYMSPE 687
L +V T+ Y +PE
Sbjct: 189 LADLDPVVV-TFWYRAPE 205
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 49/190 (25%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE---FKNEMML 562
+ + M LG G G V ++VA+K + + S + + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 563 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEG 620
+ KL H ++++ + + ++LE M L FD KRL +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 122
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQI 677
+ + YLH+ IIHRDLK N+LL ++D KI+DFG +++ G L + +
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 176
Query: 678 VGTYGYMSPE 687
GT Y++PE
Sbjct: 177 CGTPTYLAPE 186
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 8e-26
Identities = 49/188 (26%), Positives = 86/188 (45%), Gaps = 23/188 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-------RLSNQSGQGLKE-FKNEMML 562
+ + + +G G V + G E AVK RLS + + ++E + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 563 IAKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIE 619
+ ++ H +++ L+ L+ + M L FD + K L + R I+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMR 207
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
+ + + +LH I+HRDLK NILLD +M ++SDFG + E +++ G
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCG 261
Query: 680 TYGYMSPE 687
T GY++PE
Sbjct: 262 TPGYLAPE 269
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 45/201 (22%), Positives = 86/201 (42%), Gaps = 16/201 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
E + + LG G FG V++ + + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 628
++ L E ++I E++ +F+ +T LN + V + + + L +L
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 629 HQYSRFRIIHRDLKASNILL--DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
H ++ I H D++ NI+ + KI +FG AR + + + Y +P
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAP 172
Query: 687 EYALDGLFSIKSDVFSFGILM 707
E + S +D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 23/186 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHRN 570
++ +G G FG V++ +L+ EVA+K++ K FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 571 LVRLLGCCVEQGEKI------LILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIA 622
+V L G+K L+LEY+P +++ + K+ + ++ + + +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIKLYMYQ-LL 151
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTY 681
+ L Y+H I HRD+K N+LLD K+ DFG A++ + N I Y
Sbjct: 152 RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY 206
Query: 682 GYMSPE 687
Y +PE
Sbjct: 207 -YRAPE 211
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 43/200 (21%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKE-FKN----EMMLIA 564
+ K+G+G FG V+K R GQ+VA+K + N+ KE F E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-----KEGFPITALREIKILQ 71
Query: 565 KLQHRNLVRLLGCCVEQGEKI--------LILEYMPN------KSLNVFLFDSTKKRLLN 610
L+H N+V L+ C + L+ ++ + ++ V S KR++
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM- 130
Query: 611 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG---G 667
+ GL Y+H+ +I+HRD+KA+N+L+ +D K++DFGLAR F
Sbjct: 131 QM--------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 668 DELQGNTKQIVGTYGYMSPE 687
+ T ++V T Y PE
Sbjct: 180 SQPNRYTNRVV-TLWYRPPE 198
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 22/208 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 564
+ + +LG G F V K R G + A K R + +E + E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQ 623
++QH N++ L + + ILILE + LFD +K L + ++ I
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQILN 125
Query: 624 GLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
G+ YLH I H DLK NI+L KI DFGLA K I G
Sbjct: 126 GVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFG 179
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILM 707
T +++PE +++D++S G++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 26/190 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS--------NQSGQGLKEFKNEMML 562
+ + M LG G G V ++VA++ +S + + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 563 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEG 620
+ KL H ++++ + + ++LE M L FD KRL +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 247
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQI 677
+ + YLH+ IIHRDLK N+LL ++D KI+DFG +++ G L + +
Sbjct: 248 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 301
Query: 678 VGTYGYMSPE 687
GT Y++PE
Sbjct: 302 CGTPTYLAPE 311
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 28/209 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--------RLSNQSGQGLKEFKNEMMLIA 564
+S LG G FG V+ +EV VK L + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
+++H N++++L QG L++E + L++F F RL A I +
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLAS-YIFRQLVSA 142
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
+ YL IIHRD+K NI++ +D K+ DFG A +L GT Y
Sbjct: 143 VGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYC 196
Query: 685 SPE------YALDGLFSIKSDVFSFGILM 707
+PE Y G + +++S G+ +
Sbjct: 197 APEVLMGNPY--RGP---ELEMWSLGVTL 220
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 49/221 (22%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS-----------------NQSGQGLKEFKNEMML 562
+G+G +G V + A+K LS + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 563 ------IA---KLQHRNLVRLLGCCVEQGEK---ILILEYMPNKSLNVFLFD-STKKRLL 609
IA KL H N+V+L+ ++ + ++ E + + + T K L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF-GGD 668
QAR + + +G+ YLH +IIHRD+K SN+L+ +D + KI+DFG++ F G D
Sbjct: 136 EDQAR-FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 669 ELQGNTKQIVGTYGYMSPEYALDGLFSI----KSDVFSFGI 705
L NT VGT +M+PE +L I DV++ G+
Sbjct: 192 ALLSNT---VGTPAFMAPE-SLSETRKIFSGKALDVWAMGV 228
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 568
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLL 626
N+VRL E+ L+ + + LF+ ++ A I+ I + +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS-HCIQQILESIA 142
Query: 627 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
Y H I+HR+LK N+LL K K++DFGLA E GT GY
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 196
Query: 684 MSPEYALDGLFSIKSDVFSFGILM 707
+SPE +S D+++ G+++
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 50/177 (28%), Positives = 76/177 (42%), Gaps = 33/177 (18%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN----EMMLI 563
AT + ++G G +G VYK R +G VA+K R+ N G G E+ L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVALL 65
Query: 564 AKLQ---HRNLVRLLGCCVEQGEKI-----LILEYMPN------KSLNVFLFDSTKKRLL 609
+L+ H N+VRL+ C L+ E++ + + L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666
Q +GL +LH I+HRDLK NIL+ K++DFGLAR++
Sbjct: 126 MRQ--------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 33/174 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR--LLNGQEVAVKRL---SNQSG---QGLKEFKNEMMLIA 564
+ + ++GEG +G V+K R G+ VA+KR+ + + G ++E + +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRHLE 69
Query: 565 KLQHRNLVRLLGCCV----EQGEKI-LILEYMPN--KSL-----NVFLFDSTKKRLLNWQ 612
+H N+VRL C ++ K+ L+ E++ + + T K ++ +Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM-FQ 128
Query: 613 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666
+ +GL +LH + R++HRDLK NIL+ K++DFGLAR++
Sbjct: 129 --------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 58/187 (31%), Positives = 93/187 (49%), Gaps = 24/187 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHR 569
+++ +G G FG VY+ +L +G+ VA+K++ K FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 570 NLVRLLGCCVEQGEKI------LILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGI 621
N+VRL GEK L+L+Y+P +++ + K+ L ++ + + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQ-L 165
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGT 680
+ L Y+H F I HRD+K N+LLD D K+ DFG A+ E N I
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSR 220
Query: 681 YGYMSPE 687
Y Y +PE
Sbjct: 221 Y-YRAPE 226
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
LG G FG V G L G +VAVK L+ Q S + + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 577 CCVEQGEKI-LILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
+ +++EY+ L FD R+ +AR R+ + I + Y H R
Sbjct: 79 V-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEAR-RLFQQILSAVDYCH---R 129
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 687
++HRDLK N+LLD MN KI+DFGL+ M E + G+ Y +PE
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRL 186
Query: 688 YALDGLFSIKSDVFSFGILM 707
Y G + D++S G+++
Sbjct: 187 Y--AGP---EVDIWSCGVIL 201
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 50/178 (28%), Positives = 72/178 (40%), Gaps = 18/178 (10%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCC 578
LGEG V L+ QE AVK + Q G E+ ++ + Q HRN++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 579 VEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 637
E+ L+ E M S+ K+R N +++ +A L +LH I
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIA 133
Query: 638 HRDLKASNILL---DKDMNPKISDFGLARMF-----GGDELQGNTKQIVGTYGYMSPE 687
HRDLK NIL ++ KI DF L G+ YM+PE
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 52/209 (24%), Positives = 81/209 (38%), Gaps = 30/209 (14%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL------SNQSGQGLKEFKNEMMLIAKL 566
+ + LG GGFG VY G + + VA+K + E++L+ K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 567 QHR--NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIA 622
++RLL +LILE LFD + + L AR +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELAR-SFFWQVL 159
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTY 681
+ + + H ++HRD+K NIL+D + K+ DFG + GT
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTR 212
Query: 682 GYMSPEYAL----DGLFSIKSDVFSFGIL 706
Y PE+ G + V+S GIL
Sbjct: 213 VYSPPEWIRYHRYHGR---SAAVWSLGIL 238
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 18/192 (9%)
Query: 505 LASITAA--TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNE 559
+A+IT TE + + +LG+G F V + +L GQE A + S + ++ + E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 560 MMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRII 618
+ L+H N+VRL E+G LI + + L F+ + + I
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCI 116
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTK 675
+ I + +L+ HQ ++HR+LK N+LL K K++DFGLA G+ Q
Sbjct: 117 QQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWF 171
Query: 676 QIVGTYGYMSPE 687
GT GY+SPE
Sbjct: 172 GFAGTPGYLSPE 183
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 22/199 (11%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS----------NQSGQGLKEFKNEMMLIAKLQHR 569
LG+GGFG V+ G L + +VA+K + + S E + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
++RLL Q +L+LE P + ++F + + K L +R + + + H
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156
Query: 630 QYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
++HRD+K NIL+D K+ DFG + + GT Y PE+
Sbjct: 157 SR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEW 209
Query: 689 ALDGLFS-IKSDVFSFGIL 706
+ + + V+S GIL
Sbjct: 210 ISRHQYHALPATVWSLGIL 228
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 30/200 (15%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
LG G FG V G+ L G +VAVK L+ Q S + + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 577 CCVEQGEKI-LILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
+ I +++EY+ L FD RL ++R R+ + I G+ Y H R
Sbjct: 84 V-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESR-RLFQQILSGVDYCH---R 134
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 687
++HRDLK N+LLD MN KI+DFGL+ M E + G+ Y +PE
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRL 191
Query: 688 YALDGLFSIKSDVFSFGILM 707
Y G + D++S G+++
Sbjct: 192 Y--AGP---EVDIWSSGVIL 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 20/198 (10%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR-NLVRLL 575
+LG G F V + GQE A K + + E +E+ ++ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNW---QARVRIIEGIAQGLLYLHQYS 632
E ILILEY + F L +R+I+ I +G+ YLHQ
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN- 150
Query: 633 RFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
I+H DLK NILL + KI DFG++R G ++I+GT Y++PE
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEIL 205
Query: 690 LDGLFSIKSDVFSFGILM 707
+ +D+++ GI+
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 31/200 (15%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKE-FKNEMMLIAKLQHRNLVRLLG 576
LGEG FG V Q+VA+K +S Q + + E+ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 577 CCVEQGEKI-LILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
+ I +++EY + LFD KKR+ + R R + I + Y H R
Sbjct: 77 V-ITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---R 126
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 687
+I+HRDLK N+LLD ++N KI+DFGL+ + K G+ Y +PE
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKL 183
Query: 688 YALDGLFSIKSDVFSFGILM 707
Y G + DV+S GI++
Sbjct: 184 Y--AGP---EVDVWSCGIVL 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 42/182 (23%), Positives = 76/182 (41%), Gaps = 18/182 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
T+ + ++ +G G + + E AVK + +E +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLH 629
++ L + ++ E M L D +++ + + ++ I + + YLH
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 630 QYSRFRIIHRDLKASNILL-DKDMNP---KISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
++HRDLK SNIL D+ NP +I DFG A+ + G T +++
Sbjct: 134 AQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYTANFVA 188
Query: 686 PE 687
PE
Sbjct: 189 PE 190
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 50/198 (25%), Positives = 80/198 (40%), Gaps = 40/198 (20%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN----EMMLIAKL 566
+ F ++ G+G FG V G+ G VA+K++ F+N M +A L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQIMQDLAVL 76
Query: 567 QHRNLVRLLGCCVEQGEK-------ILILEYMP---------NKSLNVFLFDSTKKRLLN 610
H N+V+L GE+ +++EY+P V K L
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL- 135
Query: 611 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDE 669
+Q + + + LH S + HRD+K N+L+++ K+ DFG A+ E
Sbjct: 136 FQ--------LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 670 LQGNTKQIVGTYGYMSPE 687
N I Y Y +PE
Sbjct: 187 P--NVAYICSRY-YRAPE 201
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
++ F ++ +LG G VY+ + + A+K L + K + E+ ++ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 628
+++L E L+LE + L FD K A ++ I + + YL
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAA-DAVKQILEAVAYL 164
Query: 629 HQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
H+ I+HRDLK N+L D KI+DFGL+++ L K + GT GY +
Sbjct: 165 HEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCA 218
Query: 686 PEYALDGLFSIKSDVFSFGILM 707
PE + + D++S GI+
Sbjct: 219 PEILRGCAYGPEVDMWSVGIIT 240
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 47/201 (23%), Positives = 83/201 (41%), Gaps = 30/201 (14%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 577
LG G G V + GQ+ A+K L + + + E+ + ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90
Query: 578 CVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNW----QARVRIIEGIAQGLLYLH 629
+I+E M L F ++R +A I+ I + +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAA-EIMRDIGTAIQFLH 145
Query: 630 QYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
++ I HRD+K N+L +KD K++DFG A+ + L + T Y++P
Sbjct: 146 SHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAP 198
Query: 687 EYALDGLFSIKSDVFSFGILM 707
E + D++S G++M
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIM 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 18/194 (9%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 577
LGEG F K + Q AVK +S + + E+ + + H N+V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 578 CVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+Q L++E + L F+ KK+ + I+ + + ++H +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---V 127
Query: 637 IHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 693
+HRDLK N+L + ++ KI DFG AR+ D K T Y +PE
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQNG 185
Query: 694 FSIKSDVFSFGILM 707
+ D++S G+++
Sbjct: 186 YDESCDLWSLGVIL 199
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 6e-22
Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 13/204 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 568
F LG+GGFG V ++ ++ A K+L + +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 569 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
R +V L E + + L+L M L ++ + +A E I GL
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLED 301
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH R RI++RDLK NILLD + +ISD GLA + K VGT GYM+PE
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE 355
Query: 688 YALDGLFSIKSDVFSFGILMLETL 711
+ ++ D ++ G L+ E +
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMI 379
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 9e-22
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 22/209 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIA 564
+FS+ +G GGFG VY R + ++ A+K L L E + + L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 247
Query: 565 KLQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 623
+V + +K+ IL+ M L S R E I
Sbjct: 248 TGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRFYAAE-IIL 303
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
GL ++H +++RDLK +NILLD+ + +ISD GLA F + VGT+GY
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGY 356
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETL 711
M+PE G+ S D FS G ++ + L
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 57/197 (28%), Positives = 83/197 (42%), Gaps = 30/197 (15%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 578
+G G FG R L + VAVK + G + E + E++ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 579 VEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+ +I+EY L ++ R +AR + + G+ Y H +I
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEAR-FFFQQLLSGVSYCH---SMQI 137
Query: 637 IHRDLKASNILLDKD--MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------Y 688
HRDLK N LLD KI DFG ++ K VGT Y++PE Y
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEY 194
Query: 689 ALDGLFSIKSDVFSFGI 705
DG +DV+S G+
Sbjct: 195 --DGK---IADVWSCGV 206
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 568
+ F LG GGFG V+ ++ ++ A K+L+ + +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 569 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRI-IEGIAQGLL 626
R +V L E + L++ M + +++ + + R I GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
+LHQ II+RDLK N+LLD D N +ISD GLA + TK GT G+M+P
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAP 358
Query: 687 EYALDGLFSIKSDVFSFGILMLETL 711
E L + D F+ G+ + E +
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMI 383
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 42/201 (20%), Positives = 80/201 (39%), Gaps = 29/201 (14%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 577
LG G G V + ++ A+K L + + + E+ L + ++VR++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 123
Query: 578 CVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNW----QARVRIIEGIAQGLLYLH 629
+++E + L F + R +A I++ I + + YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 178
Query: 630 QYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
+ I HRD+K N+L + K++DFG A+ + T Y++P
Sbjct: 179 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAP 232
Query: 687 EYALDGLFSIKSDVFSFGILM 707
E + D++S G++M
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIM 253
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 23/197 (11%), Positives = 58/197 (29%), Gaps = 43/197 (21%)
Query: 520 KLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRL 574
G ++ L ++VA+ + Q L+E + + ++++ + R+
Sbjct: 38 FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
L + +++ E++ SL A +R ++ +A H R
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGA-IRAMQSLAAAADAAH---RA 148
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 694
+ S + + D + ++ M
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA------- 179
Query: 695 SIKSDVFSFGILMLETL 711
+ + D+ G + L
Sbjct: 180 NPQDDIRGIGASLYALL 196
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 45/199 (22%), Positives = 91/199 (45%), Gaps = 41/199 (20%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 561
+ + ++ +G G +G V + L + VA+K++ F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 562 LIAKLQHRNLVRLLGCCV----EQGEKI-LILEYMPN------KSLNVFLFDSTKKRLLN 610
++ +L H ++V++L + E+ +++ ++LE + ++ V+L + K LL
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLL- 162
Query: 611 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670
+ + G+ Y+H S I+HRDLK +N L+++D + K+ DFGLAR E
Sbjct: 163 YN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 671 QGNTKQIVGTYGYMSPEYA 689
+ I M+
Sbjct: 212 GNSQLPISPREDDMNLVTF 230
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 16/240 (6%)
Query: 478 TTRTNEYGEANGDGKDKSKDSWLPLFSLASITAAT-ENFSMQCKLGEGGFGPVYKGRL-L 535
+ E+ + K+K+ +L + S A + F LG G FG V +
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 536 NGQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592
+G A+K L Q LK+ NE ++ + LV+L + +++EY+
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 652
+ F R AR + I YLH +I+RDLK N+L+D+
Sbjct: 125 GGEM--FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQG 178
Query: 653 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+++DFG A+ ++G T + GT ++PE L ++ D ++ G+L+ E +
Sbjct: 179 YIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 17/209 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 568
E+F + +G G FG V +L N +V A+K L+ E F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 569 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
+ + L + + L+++Y L + L + RL AR + E + +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDS 190
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
+HQ +HRD+K NIL+D + + +++DFG D + VGT Y+SPE
Sbjct: 191 VHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPE 246
Query: 688 YALDGLFSIKS-----DVFSFGILMLETL 711
D +S G+ M E L
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEML 275
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 51/247 (20%), Positives = 103/247 (41%), Gaps = 57/247 (23%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHR 569
++ +S+ LG G FG V + + +G+ A+K++ +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 570 NLVRLLGCCVEQGEKI--------------------------------------LILEYM 591
N+++L+ G++ +I+EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 592 PNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649
P +L+ L F + + + + I + + + + ++H I HRD+K N+L++
Sbjct: 121 P-DTLHKVLKSFIRSGRSIPMNLISIYIYQ-LFRAVGFIHS---LGICHRDIKPQNLLVN 175
Query: 650 -KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILM 707
KD K+ DFG A+ + + I + Y +PE L ++ D++S G +
Sbjct: 176 SKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 708 LETLSSK 714
E + K
Sbjct: 233 GELILGK 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 48/211 (22%), Positives = 88/211 (41%), Gaps = 19/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 568
++F + +G G F V ++ +V A+K ++ E F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 569 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
R + +L + + L++EY L + L +R+ AR + E I +
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAE-IVMAIDS 177
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
+H+ +HRD+K NILLD+ + +++DFG D + VGT Y+SPE
Sbjct: 178 VHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPE 233
Query: 688 -------YALDGLFSIKSDVFSFGILMLETL 711
G + + D ++ G+ E
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 561
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76
Query: 562 LIAKLQHRNLVRLL-----GCCVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQ 612
L+ + H+N++ LL +E+ + + +++E M + + + L LL +Q
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL-YQ 135
Query: 613 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672
+ G+ +LH IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 136 --------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-- 182
Query: 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
V T Y +PE L + D++S G +M E +
Sbjct: 183 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 568
++F + LG G FG V+ R + A+K L + LK+ +E ++++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
++R+ G + + +I++Y+ L F +R N A+ E + L YL
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAE-VCLALEYL 122
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H II+RDLK NILLDK+ + KI+DFG A+ + T + GT Y++PE
Sbjct: 123 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
++ D +SFGIL+ E L+
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLA 198
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HR 569
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 570 NLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
N++ L + + L+ E++ N + L ++ R + E I + L Y
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYE-ILKALDY 145
Query: 628 LHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
H S I+HRD+K N+++D + ++ D+GLA Q ++ Y + P
Sbjct: 146 CH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKGP 199
Query: 687 EYALDGLFSIKS-DVFSFGILMLETLSSKK 715
E +D S D++S G ++ + K+
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-18
Identities = 53/226 (23%), Positives = 84/226 (37%), Gaps = 38/226 (16%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE--FKN---------EM 560
+++Q + G +G V G G VA+KR+ N G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 561 MLIAKLQHRNLVRLLGC----CVEQGEKI-LILEYMPN------KSLNVFLFDSTKKRLL 609
L+ H N++ L K+ L+ E M + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669
+ I GL LH+ ++HRDL NILL + + I DF LAR D
Sbjct: 141 -YH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 670 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 714
N V Y +PE + F+ D++S G +M E + K
Sbjct: 189 ---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 6e-18
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 561
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 562 LIAKLQHRNLVRLL------GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV 615
L+ + H+N++ LL E + L++E M L + L + +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSY 168
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675
+ + + G+ +LH S IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 169 LLYQ-MLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MT 221
Query: 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
V T Y +PE L + D++S G +M E + K
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 7e-18
Identities = 60/275 (21%), Positives = 95/275 (34%), Gaps = 81/275 (29%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-----------LKE 555
+ + LG G FG V + + VAVK L + L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 556 F----------------KNEMMLIAKL-QHRNLVRLLGCCVEQGE--KILILEYMPNKSL 596
+M+I + + NL L + K + K
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 597 NVFLFDSTKKRL------------------------------------LNWQARVRIIEG 620
+ K+RL L + +
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQI 677
+A+G+ +L + + IHRDL A NILL + KI DFGLAR D +G+ +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 259 L---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 568
E++ + +G G FG V R + ++V A+K LS + F E ++A
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+V+L + +++EYMP L + + + AR E + L +
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAE-VVLALDAI 184
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE- 687
H IHRD+K N+LLDK + K++DFG + + VGT Y+SPE
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEV 240
Query: 688 ---YALDGLFSIKSDVFSFGILMLETL 711
DG + + D +S G+ + E L
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEML 267
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKN---EMMLIAKLQH 568
++F + +G+G FG V + + +++ A+K ++ Q E +N E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 569 RNLVRLLGCCVEQ-GEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
LV L Q E + ++++ + L ++ I E + L
Sbjct: 75 PFLVNLWYSF--QDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKLFICE-LVMALD 129
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
YL RIIHRD+K NILLD+ + I+DF +A M + + GT YM+P
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAP 183
Query: 687 EYALDGLFSIKS---DVFSFGILMLETL 711
E + S D +S G+ E L
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELL 211
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 568
+ + +G G +G V +G++VA+K+LS QS K E++L+ +QH
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 569 RNLVRLL-----GCCVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQARVRIIE 619
N++ LL + L++ +M K + + + + L+ +Q
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-YQ------- 134
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
+ +GL Y+H ++HRDLK N+ +++D KI DFGLAR + V
Sbjct: 135 -MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVV 185
Query: 680 TYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 714
T Y +PE L ++ D++S G +M E L+ K
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 568
F LG+G FG V + A+K L + E E ++ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 569 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
L L + +++ ++EY L F S ++ +AR E I L Y
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDY 263
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMS 685
LH S +++RDLK N++LDKD + KI+DFGL + + G K GT Y++
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT----MKTFCGTPEYLA 317
Query: 686 PEYALDGLFSIKSDVFSFGILMLETL 711
PE D + D + G++M E +
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMM 343
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 42/202 (20%), Positives = 82/202 (40%), Gaps = 41/202 (20%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 561
+N+ ++ +G G +G VY + VA+K+++ F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKI-----LILEYMPN------KSLNVFLFDSTKKRLLN 610
++ +L+ ++RL + ++LE + K+ +FL + K +L
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTIL- 135
Query: 611 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670
+ + G ++H IIHRDLK +N LL++D + K+ DFGLAR ++
Sbjct: 136 YN--------LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 671 QGNTKQIVGTYGYMSPEYALDG 692
+ L
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKK 206
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 39/223 (17%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 561
++ +GEG +G V LN VA+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 562 LIAKLQHRNLVRLLGC----CVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQA 613
++ + +H N++ + +EQ + + ++ + M K L + +Q
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ- 136
Query: 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673
I +GL Y+H S ++HRDLK SN+LL+ + KI DFGLAR+ D
Sbjct: 137 -------ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 674 T-KQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 714
+ V T Y +PE L+ ++ D++S G ++ E LS++
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 32/224 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+ LG GG G V+ + VA+K++ Q +K E+ +I +L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 571 LVRLL--------------GCCVEQGEKILILEYMP---NKSLNVFLFDSTKKRLLNWQA 613
+V++ G E ++ EYM L RL +Q
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ- 128
Query: 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQG 672
+ +GL Y+H + ++HRDLK +N+ ++ +D+ KI DFGLAR+
Sbjct: 129 -------LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 673 NT-KQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSK 714
+ + T Y SP L ++ D+++ G + E L+ K
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 78.4 bits (192), Expect = 8e-16
Identities = 34/199 (17%), Positives = 60/199 (30%), Gaps = 46/199 (23%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRL--------SNQSGQGLKEFKNEMML 562
TE K+GEG FG V++ + VA+K + + + +E E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 563 IAKLQ---------HRNLVRLLGCCVEQGE--KILILEYM----PNKSLNVFL------- 600
+L + L QG +L+ + S N
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 601 -------------FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647
+ + +L + I+ + L R HRDL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 648 LDKDMNPKISDFGLARMFG 666
L K K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQ 567
E+F + LG+G FG V+ + A+K L + + M +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 568 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
H L + C + E + ++EY+ L + + +A E I GL
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAE-IILGLQ 132
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYM 684
+LH I++RDLK NILLDKD + KI+DFG+ + M G T GT Y+
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFCGTPDYI 185
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETL 711
+PE L ++ D +SFG+L+ E L
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEML 212
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 18/206 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 568
+F LG+G FG V R A+K L + E E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 569 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
L L + +++ ++EY L F S ++ +AR E I L Y
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEY 120
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMS 685
LH +++RD+K N++LDKD + KI+DFGL + + G K GT Y++
Sbjct: 121 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYLA 173
Query: 686 PEYALDGLFSIKSDVFSFGILMLETL 711
PE D + D + G++M E +
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMM 199
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 567
+F +G+G FG V R + AVK L ++ KE K+ M L+ ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 568 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
H LV L + +K+ +L+Y+ L F ++ L +AR E IA L
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALG 153
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYM 684
YLH + I++RDLK NILLD + ++DFGL + + T GT Y+
Sbjct: 154 YLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFCGTPEYL 206
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETL 711
+PE + D + G ++ E L
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEML 233
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 2e-15
Identities = 71/399 (17%), Positives = 136/399 (34%), Gaps = 23/399 (5%)
Query: 325 PIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSN 384
P C H+ +D + + N ++ S
Sbjct: 149 PSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSE 208
Query: 385 VKESSGCLM---WYGDLIDARRPIRNFTGQSVYLRVPASKLGNKKLLWILVILVIPVVLL 441
K+ + + R ++ + ++ + L
Sbjct: 209 SKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQ 268
Query: 442 PSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLP 501
+ + + +E E NV + + + + G+ ++K+ ++
Sbjct: 269 KAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISK 328
Query: 502 LFSLASITAAT-ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNE 559
+ + +F+ LG+G FG V E+ AVK L + +
Sbjct: 329 FDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT 388
Query: 560 MM----LIAKLQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQAR 614
M+ L + L +L C + +++ ++EY+ L R A
Sbjct: 389 MVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAV 445
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQG 672
E IA GL +L II+RDLK N++LD + + KI+DFG+ + ++ G
Sbjct: 446 FYAAE-IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---- 497
Query: 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
TK GT Y++PE + D ++FG+L+ E L
Sbjct: 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 567
++F + +G G + V RL + A+K + + ++
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 568 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
H LV L C + ++ ++EY+ L +++L AR E I+ L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAE-ISLALN 124
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYM 684
YLH+ II+RDLK N+LLD + + K++D+G+ + + GD T GT Y+
Sbjct: 125 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYI 177
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLS 712
+PE + D ++ G+LM E ++
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMA 205
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 568
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 569 RNLVRLL-----GCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA 622
N++ LL ++ L++ +M L + K L ++ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQML 138
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
+GL Y+H IIHRDLK N+ +++D KI DFGLAR + V T
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRW 190
Query: 683 YMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 714
Y +PE L+ ++ D++S G +M E ++ K
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 56/259 (21%), Positives = 105/259 (40%), Gaps = 19/259 (7%)
Query: 462 VETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKL 521
+ Y D ++ T G +++ + AS + ++F + +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVI 60
Query: 522 GEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQHRNLVRLLG 576
G G + V RL + A++ + + ++ H LV L
Sbjct: 61 GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH- 119
Query: 577 CCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
C + ++ ++EY+ L +++L AR E I+ L YLH+
Sbjct: 120 SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAE-ISLALNYLHE---RG 173
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALDGL 693
II+RDLK N+LLD + + K++D+G+ + + GD T GT Y++PE
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILRGED 229
Query: 694 FSIKSDVFSFGILMLETLS 712
+ D ++ G+LM E ++
Sbjct: 230 YGFSVDWWALGVLMFEMMA 248
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 567
+F+ LG+G FG V E+ AVK L + + M+ L +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 568 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
L +L C + +++ ++EY+ L R A E IA GL
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAE-IAIGLF 135
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYM 684
+L II+RDLK N++LD + + KI+DFG+ + ++ G TK GT Y+
Sbjct: 136 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYI 188
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETL 711
+PE + D ++FG+L+ E L
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEML 215
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 35/156 (22%), Positives = 64/156 (41%), Gaps = 26/156 (16%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGC 577
LG G G V + ++ A+K L + + + E+ L + Q ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 578 CVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNW----QARVRIIEGIAQGLLYLH 629
+++E + L F + R +A I++ I + + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 134
Query: 630 QYSRFRIIHRDLKASNILL---DKDMNPKISDFGLA 662
+ I HRD+K N+L + K++DFG A
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 34/215 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSNQSGQGLKEF---------KNE 559
F + LG+G FG V+ + ++G + A+K L K K E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKME 76
Query: 560 MMLIAKLQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 618
++ ++ H +V+L + K+ LIL+++ L F S + + +
Sbjct: 77 RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLA 133
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQ 676
E +A L +LH II+RDLK NILLD++ + K++DFGL++ + +
Sbjct: 134 E-LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK----AYS 185
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
GT YM+PE + +D +SFG+LM E L
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSNQS-GQGLKEF---KNEMMLIA 564
E F + LG+GG+G V++ R + G A+K L + K+ K E ++
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 565 KLQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 623
+++H +V L+ + G K+ LILEY+ L F+ + + A + E I+
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISM 132
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTY 681
L +LHQ II+RDLK NI+L+ + K++DFGL + + G T GT
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV----THTFCGTI 185
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETL 711
YM+PE + + D +S G LM + L
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 567
+NF LG+G FG V R+ ++ AVK L + + M L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 568 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
H L +L CC + +++ ++E++ L +R +AR E I L+
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAE-IISALM 138
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA--RMFGGDELQGNTKQIVGTYGYM 684
+LH II+RDLK N+LLD + + K++DFG+ + G T GT Y+
Sbjct: 139 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFCGTPDYI 191
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETL 711
+PE + L+ D ++ G+L+ E L
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEML 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 43/223 (19%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 561
E + +G G +G V G VAVK+LS F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 562 LIAKLQHRNLVRLL-----GCCVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQ 612
L+ ++H N++ LL +E+ + L+ M N + + L +Q
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 613 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672
I +GL Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 141 --------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTAD 184
Query: 673 NTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 714
V T Y +PE L+ ++ D++S G +M E L+ +
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 43/195 (22%), Positives = 83/195 (42%), Gaps = 40/195 (20%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 561
+ +F ++ LGEG +G V G+ VA+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 562 LIAKLQHRNLVRLLGC----CVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQA 613
++ +H N++ + E ++ +I E M ++ ++ + + +Q
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ- 120
Query: 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673
+ + LH + +IHRDLK SN+L++ + + K+ DFGLAR+ DE +
Sbjct: 121 -------TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAAD 168
Query: 674 TKQIVGTYGYMSPEY 688
+ G M E+
Sbjct: 169 NSEPTGQQSGMV-EF 182
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 34/198 (17%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 561
+ + KLG+G +G V+K G+ VAVK++ + F+N E+M
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 562 LIAKLQ-HRNLVRLLGCCV-EQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQARV 615
++ +L H N+V LL + + L+ +YM + + + + K+ + +Q
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ--- 117
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675
+ + + YLH S ++HRD+K SNILL+ + + K++DFGL+R F N
Sbjct: 118 -----LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 676 QIVGTYGYMSPEYALDGL 693
+ + + L
Sbjct: 170 PLSINENTENFDDDQPIL 187
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-13
Identities = 20/126 (15%), Positives = 42/126 (33%), Gaps = 19/126 (15%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
+ +T + G+ L + VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVE--PYHFIMQEDCNLVLYD--------HSTSVWASNTGIL-GK 50
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
+ ++GN V+ + ++W+++ N V L++DGN+VI + +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------I 102
Query: 146 WQSFDY 151
W + Y
Sbjct: 103 WSTGTY 108
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSNQSGQGLKEF-----------K 557
ENF + LG G +G V+ R ++G + A+K L K +
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQKAKTTEHTR 106
Query: 558 NEMMLIAKLQHRN-LVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARV 615
E ++ ++ LV L + K+ LIL+Y+ L F S ++R + ++
Sbjct: 107 TERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQI 163
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675
+ E I L +LH+ II+RD+K NILLD + + ++DFGL++ F DE +
Sbjct: 164 YVGE-IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AY 218
Query: 676 QIVGTYGYMSPEYALDGLFSIKSDV--FSFGILMLETL 711
GT YM+P+ G V +S G+LM E L
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 46/211 (21%), Positives = 86/211 (40%), Gaps = 30/211 (14%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFK-------NEMMLIAKLQH 568
KLG G F V+ + ++N VA+K + E K + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 569 RNLVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
++++LL +G ++ E + ++L + + + + +I + + G
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK-QISKQLLLG 143
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNP------KISDFGLARMFGGDELQGNTKQIV 678
L Y+H R IIH D+K N+L++ +P KI+D G A + + +
Sbjct: 144 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY----TNSI 196
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
T Y SPE L + +D++S L+ E
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFE 227
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-12
Identities = 27/123 (21%), Positives = 47/123 (38%), Gaps = 19/123 (15%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
++++ + + G L + L G VW +N
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNFVLYDSGK--------PVWASNTGGL--G 50
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
+ LT+ NNGNLV+ +Q+N IW T + + + V L+ D N+VI +
Sbjct: 51 SGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV--------V 102
Query: 146 WQS 148
W +
Sbjct: 103 WAT 105
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 43/194 (22%), Positives = 73/194 (37%), Gaps = 40/194 (20%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
NF + K+G G FG + G+ L + VA+K +S + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------LNWQARVRIIEGIAQGL 625
++ ++LE + SL LFD + + Q + +E
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRTFSLKTVLMIAIQL-ISRME------ 119
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPK-----ISDFGLARMFGGDELQGNTKQ---- 676
Y+H + +I+RD+K N L+ + N I DF LA+ + + TK+
Sbjct: 120 -YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY----IDPETKKHIPY 171
Query: 677 -----IVGTYGYMS 685
+ GT YMS
Sbjct: 172 REHKSLTGTARYMS 185
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 41/185 (22%), Positives = 79/185 (42%), Gaps = 22/185 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RN 570
+ + K+G G FG +Y G + G+EVA+K ++ E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+ + C E ++++E + SL LF+ ++ + + + + + + + Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFCSRK-FSLKTVLLLADQMISRIEYIHS 123
Query: 631 YSRFRIIHRDLKASNILLDKDMNPK---ISDFGLARMFGGDELQGNT-------KQIVGT 680
+ IHRD+K N L+ I DFGLA+ + + + + K + GT
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY--RDARTHQHIPYRENKNLTGT 178
Query: 681 YGYMS 685
Y S
Sbjct: 179 ARYAS 183
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 2e-11
Identities = 27/124 (21%), Positives = 51/124 (41%), Gaps = 18/124 (14%)
Query: 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPIS 84
+D + + G L + + L + + VW + +
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGK-- 48
Query: 85 DNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESY 144
+ VL + N+GNLV+ + + IW++N + + N L+ D N+VI D +S NA
Sbjct: 49 ASGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYD-NSNNA---- 102
Query: 145 LWQS 148
+W +
Sbjct: 103 IWAT 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-06
Identities = 18/69 (26%), Positives = 36/69 (52%), Gaps = 1/69 (1%)
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142
+++ + I N+ NLVL + N +W++ + + V ++++DGNLVI S
Sbjct: 16 LAEGGYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWAS 74
Query: 143 SYLWQSFDY 151
+ Q+ +Y
Sbjct: 75 NTNRQNGNY 83
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 32/201 (15%), Positives = 77/201 (38%), Gaps = 34/201 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR---------LLNGQEVAVKRLSNQSGQGLKEFK------ 557
+ ++ G +Y+ Q+ ++K L + G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 558 -----NEMMLIAKLQHRNLVRLLGCCVEQGE-KILILEYMPNKSLNVFLFDSTKKRLLNW 611
N+ + + +G V Q + + L+L + +SL D + K +L+
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSE 158
Query: 612 QARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI--SDFGLARMF--GG 667
++ +++ + L +LH+ +H ++ A NI +D + ++ + +G A + G
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 668 DEL---QGNTKQIVGTYGYMS 685
+ +G+ G ++S
Sbjct: 216 KHVAYVEGSRSPHEGDLEFIS 236
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 40/187 (21%), Positives = 83/187 (44%), Gaps = 24/187 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHR 569
++ + ++GEG FG +++G LLN Q+VA+K +S Q E++ +L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
+ + E +L+++ + SL L D ++ + + + + + +H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLG-PSLE-DLLDLCGRKF-SVKTVAMAAKQMLARVQSIH 123
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPK-----ISDFGLARMFGGDELQGN------TKQIV 678
+ S +++RD+K N L+ + + + DFG+ + + D + K +
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPYREKKNLS 179
Query: 679 GTYGYMS 685
GT YMS
Sbjct: 180 GTARYMS 186
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 26/208 (12%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 569
+ + +G+G FG V K + + VA+K + N+ Q E + L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR----LLELMNKHD 111
Query: 570 -----NLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIAQ 623
+V L + + L+ E + S N++ L +T R ++ + + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTY 681
LL+L IIH DLK NILL KI DFG + G + Q + +
Sbjct: 169 ALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIY----QYIQSR 222
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLE 709
Y SPE L + + D++S G +++E
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 5e-11
Identities = 21/123 (17%), Positives = 39/123 (31%), Gaps = 20/123 (16%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
+ + + L + + L + +W +N DR
Sbjct: 3 NVLLSGQTLHADHSLQAG--AYTLTIQNKCNLVKYQ--------NGRQIWASNTDR--RG 50
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
+ LT+ ++GNLV+ + N +W + + L+ DG VI L
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV--------L 102
Query: 146 WQS 148
W
Sbjct: 103 WSL 105
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 6e-11
Identities = 18/76 (23%), Positives = 33/76 (43%), Gaps = 10/76 (13%)
Query: 73 VVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVI 132
+W N N + +G LV++ N T+W + V+ + + V L+ D N+VI
Sbjct: 50 PIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI 107
Query: 133 RDNSSGNATESYLWQS 148
++ LW +
Sbjct: 108 YGDA--------LWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 5e-08
Identities = 19/77 (24%), Positives = 31/77 (40%), Gaps = 7/77 (9%)
Query: 73 VVWVANRDRPISDNNA-VLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLV 131
++ + + + + NLVL + N IW+TN A L+ DG LV
Sbjct: 16 ILHATESLEILFGTHVYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLV 74
Query: 132 IRDNSSGNATESYLWQS 148
+ N + +WQS
Sbjct: 75 VITNEN-----VTVWQS 86
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 1e-10
Identities = 25/123 (20%), Positives = 45/123 (36%), Gaps = 20/123 (16%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
+ + + GE L ++ R+ + +W N D
Sbjct: 2 NILYSGETLSPGEFL--NNGRYVFIMQEDCNLVLYDVDK--------PIWATNTGGL--D 49
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
L++ ++GNLV+ + N IW++N E N V L+ D N+VI +
Sbjct: 50 RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA--------R 101
Query: 146 WQS 148
W +
Sbjct: 102 WAT 104
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 39/201 (19%), Positives = 77/201 (38%), Gaps = 48/201 (23%)
Query: 520 KLGEGGFGPVYKGRLLNGQ------EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 573
+G+GGFG +Y + + + VK + +G E K Q + +R
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 574 LL-------------GCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRL-------LNW 611
G + G+ +I++ L ++++ KR L+
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ-KIYEANAKRFSRKTVLQLSL 159
Query: 612 QARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI--SDFGLARMFGGDE 669
+ + I+E Y+H++ +H D+KASN+LL+ ++ D+GLA + +
Sbjct: 160 RI-LDILE-------YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 670 L-----QGNTKQIVGTYGYMS 685
+ + GT + S
Sbjct: 209 VHKAYAADPKRCHDGTIEFTS 229
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 45/179 (25%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLV-RLL 575
K+G G FG +Y G + +EVA+K + ++ Q L E K + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK----IYRILQGGTGIPNVR 69
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
VE +L+++ + SL LF+ ++ L+ + + + + + + ++H S
Sbjct: 70 WFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS--- 123
Query: 636 IIHRDLKASNILLDKDMNPK---ISDFGLARMFGGDELQG------NTKQIVGTYGYMS 685
+HRD+K N L+ I DFGLA+ + D K + GT Y S
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNLTGTARYAS 181
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 5e-10
Identities = 20/112 (17%), Positives = 40/112 (35%), Gaps = 13/112 (11%)
Query: 21 VSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRD 80
+ + + + +L + + +L W +N
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN---------LVLYGGKYGWQSNTH 50
Query: 81 RPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVI 132
+ + L +++ G L++ + TIWS+ SS+ V L+DDG VI
Sbjct: 51 G--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-07
Identities = 16/71 (22%), Positives = 28/71 (39%), Gaps = 7/71 (9%)
Query: 78 NRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSS 137
D ++ N L + + NLVL W +N ++ +L G L+I+D+
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLYGGK--YGWQSNTHGNGEHCFLRLNHKGELIIKDDDF 73
Query: 138 GNATESYLWQS 148
+W S
Sbjct: 74 KT-----IWSS 79
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR------N 570
+G+G FG V K Q VA+K + N+ Q +E + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
++ +L + + E + S+N++ L K + + + I Q L LH
Sbjct: 161 VIHMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 630 QYSRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
+ RIIH DLK NILL + K+ DFG + + + + + Y +PE
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVY----TYIQSRFYRAPE 269
Query: 688 YALDGLFSIKSDVFSFGILMLE 709
L + + D++S G ++ E
Sbjct: 270 VILGARYGMPIDMWSLGCILAE 291
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 39/203 (19%), Positives = 73/203 (35%), Gaps = 55/203 (27%)
Query: 520 KLGEGGFGPVYKG-RLLNGQEVA---VKRLSNQSGQGLKEFKNEMML-----IAKLQHRN 570
K+G GGFG +Y ++ A VK ++G E K + I K R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 571 LVRLLG----------CCVEQGEKILILEYMPNKSLNVFLFDSTKK-----------RLL 609
+ LG + + +++E + L + R+L
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISGQNGTFKKSTVLQLGIRML 161
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI--SDFGLARMFGG 667
+ ++E Y+H+ +H D+KA+N+LL ++ +D+GL+ +
Sbjct: 162 D------VLE-------YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205
Query: 668 DEL-----QGNTKQIVGTYGYMS 685
+ + K GT + S
Sbjct: 206 NGNHKQYQENPRKGHNGTIEFTS 228
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-09
Identities = 22/126 (17%), Positives = 41/126 (32%), Gaps = 23/126 (18%)
Query: 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRP 82
L + + + L + F+L W +N
Sbjct: 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCNLVLYNGN-----------WQSNTAN- 46
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142
+ + LT+++ G LV+ N T+W + S N A + DG LV+ S
Sbjct: 47 -NGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPS------ 99
Query: 143 SYLWQS 148
+++
Sbjct: 100 --VFKI 103
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-08
Identities = 11/76 (14%), Positives = 31/76 (40%), Gaps = 10/76 (13%)
Query: 73 VVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVI 132
+VW + + + + ++G L + + T++ +N + + V L+ +G V+
Sbjct: 46 IVWESGTSG--RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV 103
Query: 133 RDNSSGNATESYLWQS 148
+ +W +
Sbjct: 104 YGPA--------VWST 111
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 8e-07
Identities = 13/67 (19%), Positives = 27/67 (40%), Gaps = 6/67 (8%)
Query: 83 ISDNNAVLTISNNGNLVL-LNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNAT 141
++ + L + ++ NLVL +W + S ++ +L G L I D+
Sbjct: 21 LATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNT-- 78
Query: 142 ESYLWQS 148
++ S
Sbjct: 79 ---VFVS 82
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 54.2 bits (129), Expect = 3e-08
Identities = 18/79 (22%), Positives = 27/79 (34%), Gaps = 10/79 (12%)
Query: 70 PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGN 129
D VW N + NG + +L N +W++ S V L+ D N
Sbjct: 167 RDDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 224
Query: 130 LVIRDNSSGNATESYLWQS 148
L I + LW +
Sbjct: 225 LAIYGGA--------LWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 7e-05
Identities = 23/122 (18%), Positives = 36/122 (29%), Gaps = 11/122 (9%)
Query: 71 DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNL 130
D VW +N + ++G LV+L N WS+ + N V L+ D +
Sbjct: 44 DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTV 100
Query: 131 VIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTY 190
I LW S +++ + S Y
Sbjct: 101 TIYG--------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPY 152
Query: 191 RL 192
RL
Sbjct: 153 RL 154
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 8e-05
Identities = 17/89 (19%), Positives = 37/89 (41%), Gaps = 6/89 (6%)
Query: 66 FQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLR 125
Q D + + + + L++ + NLVL + + +WSTN + + A L+
Sbjct: 130 STQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFD-RDDRVWSTNTAGKGTGCRAVLQ 188
Query: 126 DDGNLVIRDNSSGNATESYLWQSFDYPTD 154
+G + + N + +W S + +
Sbjct: 189 PNGRMDVLTNQN-----IAVWTSGNSRSA 212
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 9e-08
Identities = 84/624 (13%), Positives = 157/624 (25%), Gaps = 198/624 (31%)
Query: 156 LLQDMKLGWDFKNRLE--RYLSSWRSADD----PSPGNFTYRLDIHVLPKICTFNGSV-- 207
+D K+ + + + S D + T RL + + +
Sbjct: 25 FEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRL----FWTLLSKQEEMVQ 80
Query: 208 KFTCSGHWDGAGFVSALSYTDFLYKQFMMENKDECVYW--YEAYNRPSIMTLKLNPSGFV 265
KF ++Y FL E + + Y ++ V
Sbjct: 81 KFVEEVL--------RINY-KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV 131
Query: 266 TRQIWNENSNKWDELFSV-PDQY---CGKYGYCG----ANTICSLDQKPMCECLEGFKLE 317
+R + L + P + G G G A +C K C
Sbjct: 132 SRLQPYLKLRQA--LLELRPAKNVLIDGVLG-SGKTWVALDVCL-SYKVQC--------- 178
Query: 318 SQVNQPGPI------KCERSHSLECKSGDQFIELDEIKAPDF---IDVSLNQRMNLEQCK 368
I C ++ ++D P++ D S N ++ + +
Sbjct: 179 ---KMDFKIFWLNLKNCNSPETVLEMLQKLLYQID----PNWTSRSDHSSNIKLRIHSIQ 231
Query: 369 AECLKNCSCRAYANS-----NVKESS-------GCLMWYGDLIDAR-RPIRNFTGQSVYL 415
AE + + Y N NV+ + C + L+ R + + +F +
Sbjct: 232 AELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI----LLTTRFKQVTDFLSAATTT 287
Query: 416 RVPASKLGN-------KKLL--WI----------------LVILVIPVVL--LPSFYVFY 448
+ K LL ++ + +I + + + +
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW 347
Query: 449 RR---------RRKC--QEKETENVETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKD 497
+ + E + + L F + +I T
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL---------------- 391
Query: 498 SWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK 557
L L I + + +K L+ Q KE
Sbjct: 392 --LSLIWFDVIKSDVMVVVNKL----------HKYSLVEKQP--------------KEST 425
Query: 558 NEMMLIA---KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQAR 614
+ I K++ N L + ++ Y K+ FDS
Sbjct: 426 ISIPSIYLELKVKLENEYAL--------HRSIVDHYNIPKT-----FDSDDLIPPYLDQ- 471
Query: 615 VRIIEGIAQGLLYLHQY-----SRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGD 668
Y + + R + LD + KI A G
Sbjct: 472 ------------YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGS 519
Query: 669 ELQGNTKQIVGTY-GYMS---PEY 688
L NT Q + Y Y+ P+Y
Sbjct: 520 IL--NTLQQLKFYKPYICDNDPKY 541
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 4e-04
Identities = 54/328 (16%), Positives = 99/328 (30%), Gaps = 85/328 (25%)
Query: 397 DLIDARRPIRNFTGQSV--YLRVPASKLGNKKLLWIL-------VILVIPVVLLPSFYVF 447
D+ D + I + + + + + G +L W L V + VL + Y F
Sbjct: 37 DVQDMPKSI--LSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN-YKF 93
Query: 448 ----YRRRRKCQEKETENVETYQDLLAFD----INMNITTRTNEYGEANGDGKDKSKDSW 499
+ ++ T +D L D N++ R Y K + +
Sbjct: 94 LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPY--------LKLRQA- 143
Query: 500 LPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 559
L L +N + G G G K VA+ + Q +FK
Sbjct: 144 --LLELRP----AKNVLID---GVLGSG---K------TWVALDVCLSYKVQCKMDFK-- 183
Query: 560 MMLIAKLQHRNLVRLLGCCVEQGEKILILE-----YMPNKSLNVFLFDSTKKRLLNWQAR 614
I L L C + +L+ PN + + K R+ + QA
Sbjct: 184 ---IFWLN-------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE 233
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI----SDFGLARMFGGDEL 670
+R LL Y ++ +++ + +++ KI + D L
Sbjct: 234 LRR-------LLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT-----DFL 281
Query: 671 QGNTKQ---IVGTYGYMSPEYALDGLFS 695
T + ++P+ L
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVK-SLLL 308
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.2 bits (121), Expect = 4e-07
Identities = 13/69 (18%), Positives = 26/69 (37%), Gaps = 8/69 (11%)
Query: 84 SDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATES 143
+GNLV+ N +W ++ + V +L+ +G++ I D
Sbjct: 193 GKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGG-HASAVLRLQANGSIAILDEKP------ 245
Query: 144 YLWQSFDYP 152
+W F +
Sbjct: 246 -VWARFGFQ 253
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.3 bits (103), Expect = 8e-05
Identities = 33/157 (21%), Positives = 57/157 (36%), Gaps = 20/157 (12%)
Query: 22 SLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDR 81
+ + + G+ L+S +QRF+L G L I+ A VWVAN +
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQD---NGATVWVANEQQ 62
Query: 82 PIS------DNNAVLTISNNGNLVLLNQTNGTIW-----STNVSSEVKNPVAQLRDDGNL 130
P S + A L L + + +W + + + L+DDGN+
Sbjct: 63 PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122
Query: 131 VIRDNSSG-NATESYLWQSFDYPTDTLLQDMKLGWDF 166
V+ D+ + N T + + L +L
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGV 159
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 6e-07
Identities = 14/62 (22%), Positives = 24/62 (38%), Gaps = 2/62 (3%)
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142
+S +A + + NLVL N + +N + +L + G L I +S
Sbjct: 17 LSYESAAFVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVW 74
Query: 143 SY 144
Y
Sbjct: 75 VY 76
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-05
Identities = 14/81 (17%), Positives = 33/81 (40%), Gaps = 13/81 (16%)
Query: 71 DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGT---IWSTNVSSEVKNPVAQLRDD 127
+A + +N + L ++N G L + + + T ++ +V++ N A L D
Sbjct: 37 EAGGFQSNTHG--RGVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPD 94
Query: 128 GNLVIRDNSSGNATESYLWQS 148
++ I + +W +
Sbjct: 95 QHVTIYGPA--------IWST 107
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 45/226 (19%), Positives = 75/226 (33%), Gaps = 46/226 (20%)
Query: 515 FSMQCKLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR 569
+ + LGEG FG V + +VA+K + N E ++ K++ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN----VLKKIKEK 76
Query: 570 ------NLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIA 622
V + G + E + N F + + +
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-------------------KISDFGLAR 663
L +LH ++ H DLK NIL +++DFG A
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189
Query: 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
F + IV T Y PE L+ ++ DV+S G ++ E
Sbjct: 190 TFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 49/252 (19%), Positives = 88/252 (34%), Gaps = 72/252 (28%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ--------HRN 570
KLG G F V+ + + VA+K + + + +E+ L+ ++
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREM 102
Query: 571 LVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
+V+LL G ++ E + L ++ S + L + +II+ + QGL
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLD 160
Query: 627 YLHQYSRFRIIHRDLKASNILL-------------------------------------- 648
YLH ++ RIIH D+K NILL
Sbjct: 161 YLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 649 -----------DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIK 697
+ + KI+D G A + + T Y S E + ++
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNAC-WVHKHFTE----DIQTRQYRSLEVLIGSGYNTP 273
Query: 698 SDVFSFGILMLE 709
+D++S + E
Sbjct: 274 ADIWSTACMAFE 285
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 53/230 (23%), Positives = 87/230 (37%), Gaps = 50/230 (21%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 569
F + K+G+G FG V + + N + AVK + N E ++ K+Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDD 92
Query: 570 ----NLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIAQG 624
N+V+ G + LI E + +++ + + + I +
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPL---GPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNP-------------------------KISDF 659
L YL + + H DLK NILLD K+ DF
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
G A F D I+ T Y +PE L+ + + SD++SFG ++ E
Sbjct: 207 GCA-TFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 48/227 (21%), Positives = 81/227 (35%), Gaps = 48/227 (21%)
Query: 515 FSMQCKLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR 569
+ + LGEG FG V + G+ VAVK + N E + ++ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ----VLEHLNTT 71
Query: 570 ------NLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIA 622
V++L G ++ E + L+ + ++ I
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-------------------KISDFGLAR 663
+ + +LH ++ H DLK NIL + K+ DFG A
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA- 184
Query: 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLE 709
+ + +V T Y +PE L L +S DV+S G +++E
Sbjct: 185 TYDDEHH----STLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIE 226
|
| >2hz6_A Endoplasmic reticulum to nucleus signalling 1 isoform 1 variant; triangular beta-sheet cluster, signaling protein; 3.10A {Homo sapiens} Length = 369 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 11/92 (11%), Positives = 28/92 (30%), Gaps = 2/92 (2%)
Query: 76 VANRDRPISDNNAVLTISNNGNLVLLNQTNGTI-WSTNVSSEVKNPVAQLRDDGNLVIRD 134
+ + + + + +G +V ++ +G + W N +S V + +G +
Sbjct: 163 ASLPEDDVDYKMSHFVSNGDGLVVTVDSESGDVLWIQNYASPVVA-FYVWQREGLRKVMH 221
Query: 135 NSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166
+ T YL +
Sbjct: 222 INVAVETLRYLTFMSGEVGRITKWKYPFPKET 253
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 724 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.98 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.98 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.98 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.98 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.98 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.87 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.86 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.86 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.83 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.82 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.74 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.72 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.67 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.64 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.58 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.56 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.53 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.3 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.22 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.08 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.06 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.64 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.35 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.27 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.27 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.93 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.85 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.43 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.15 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.12 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.09 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.07 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.04 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.8 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.57 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.32 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.11 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.07 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 91.95 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 90.86 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 88.86 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.82 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=399.25 Aligned_cols=207 Identities=31% Similarity=0.499 Sum_probs=183.6
Q ss_pred ccCcceeeeeccCCceeEEeeeec------CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
.++|.+.++||+|+||.||+|++. ++..||||+++.......++|.+|+++|++++|||||+++++|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 467899999999999999999864 36789999998877778889999999999999999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEE
Q 004912 586 LILEYMPNKSLNVFLFDST----------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 655 (724)
|||||+++|+|.++|.... ....++|.++++|+.|||+||+|||+++ ||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999996532 2356999999999999999999999998 99999999999999999999
Q ss_pred EEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 656 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
|+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...+
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999997755443333445679999999999999999999999999999999999 999997543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=399.21 Aligned_cols=207 Identities=30% Similarity=0.490 Sum_probs=176.1
Q ss_pred ccCcceeeeeccCCceeEEeeeec------CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
.++|.+.++||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 467889999999999999999864 46789999998887778889999999999999999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC
Q 004912 586 LILEYMPNKSLNVFLFDSTK------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 653 (724)
|||||+++|+|.+++..... ...++|.++++|+.|||+||+|||+++ ||||||||+||||+++++
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999975422 346999999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 654 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||...+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 99999999998755444444455789999999999999999999999999999999999 999997543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=394.18 Aligned_cols=204 Identities=28% Similarity=0.416 Sum_probs=185.0
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|++.++||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 367999999999999999999874 5889999999653 234567899999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++|+|.+++.. .+.+++.++..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+.+..
T Consensus 111 mEy~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 111 LSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999954 346999999999999999999999998 99999999999999999999999999998865
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
..........+||+.|||||++.+..|+.++|||||||+||||++|+.||...+
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 238 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 544445667899999999999999999999999999999999999999998654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=392.81 Aligned_cols=206 Identities=34% Similarity=0.505 Sum_probs=180.5
Q ss_pred cCcceeeeeccCCceeEEeeeec------CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
..+++.++||+|+||.||+|++. +++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677899999999999999863 46789999997543 345688999999999999999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC
Q 004912 586 LILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 652 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 652 (724)
|||||+++|+|.++|..... ...+++.++++|+.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999964321 246999999999999999999999998 99999999999999999
Q ss_pred CEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 653 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 653 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
++||+|||+|+.+...+.........||+.|||||++.+..|+.++|||||||+||||+| |+.||...+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 999999999998755444444556789999999999999999999999999999999999 899997543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=394.85 Aligned_cols=203 Identities=27% Similarity=0.431 Sum_probs=176.2
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++|++.+.||+|+||.||+|++. +|+.||||+++.. .....++|.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999874 5899999999654 34557789999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++|+|.++|... +...+++.+++.|+.||+.||+|||+++ ||||||||+||||++++++||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 99999999999543 3446899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 122345689999999999999999999999999999999999999998654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=388.39 Aligned_cols=202 Identities=30% Similarity=0.482 Sum_probs=170.6
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
..+++++.++||+|+||+||+|++.+ .||||+++.. ..+..++|.+|+.+|++++|||||++++++.+ +..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 35678899999999999999998743 6999998643 44567889999999999999999999998754 5689999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|.++|... ...+++.++++|+.|||+||+|||+++ ||||||||+||||++++++||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999999643 346999999999999999999999998 999999999999999999999999999877544
Q ss_pred cccccccccccccCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.........+||+.|||||++.+ .+|+.++|||||||+||||+||+.||...
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~ 240 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI 240 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC
Confidence 33344556789999999999864 46999999999999999999999999753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=394.17 Aligned_cols=201 Identities=26% Similarity=0.388 Sum_probs=182.1
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.+.|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 357999999999999999999875 5899999999766555667789999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 224 (346)
T 4fih_A 153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 224 (346)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence 999999999853 35999999999999999999999998 9999999999999999999999999999875432
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+
T Consensus 225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 23456799999999999999999999999999999999999999997654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=395.89 Aligned_cols=201 Identities=26% Similarity=0.388 Sum_probs=182.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.+.|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 467999999999999999999875 5899999999766555667799999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++|+|.+++.. ..+++.++..|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 999999999843 34999999999999999999999998 9999999999999999999999999999875432
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 23456799999999999999999999999999999999999999997554
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=373.77 Aligned_cols=196 Identities=30% Similarity=0.464 Sum_probs=170.1
Q ss_pred cceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe----cCeEEEE
Q 004912 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKILI 587 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~----~~~~~lV 587 (724)
|++.++||+|+||.||+|++. +++.||||++... .....++|.+|+.+|++++|||||++++++.+ +...+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 467788999999999999875 5789999998643 34456789999999999999999999999875 3457999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-CCCEEEEecCCccccC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFG 666 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~~ 666 (724)
|||+++|+|.+++.. ...+++.++..++.||++||+|||+++. +||||||||+||||+. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999954 3469999999999999999999998753 4999999999999974 7899999999998643
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.. .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||..
T Consensus 184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 32 2445789999999998865 699999999999999999999999964
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=383.78 Aligned_cols=200 Identities=27% Similarity=0.302 Sum_probs=173.5
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.+.|++.++||+|+||.||+|++. +|+.||||+++.... ..+|+.+|++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456888999999999999999875 588999999975422 24799999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC-CEEEEecCCccccCCCc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGGDE 669 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~~~~~~ 669 (724)
+++|+|.++|.. .+.+++.++..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999954 346999999999999999999999998 99999999999999887 69999999999875432
Q ss_pred ccc---cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 670 LQG---NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 670 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...+.
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 261 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 211 22346899999999999999999999999999999999999999976553
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=370.62 Aligned_cols=199 Identities=28% Similarity=0.475 Sum_probs=163.9
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|+||+||+|+.. +++.||||++++. .....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999874 5899999999653 2334678999999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+ +|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6899998854 346999999999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. .....+||+.|||||++.+..| +.++||||+||+||||++|+.||...+
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~ 216 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 2 2345789999999999998886 579999999999999999999998654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=383.93 Aligned_cols=201 Identities=28% Similarity=0.371 Sum_probs=171.6
Q ss_pred cCcceeeeeccCCceeEEeeeec----CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
++|++.+.||+|+||+||+|+.. .++.||||++++.. .....++.+|+.+|++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999763 36789999996542 2234578899999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999954 346999999999999999999999998 9999999999999999999999999998754
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 322 23445789999999999999999999999999999999999999997654
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=374.00 Aligned_cols=233 Identities=18% Similarity=0.210 Sum_probs=181.6
Q ss_pred hcccccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCC----CCeEEEeeCCc
Q 004912 22 SLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDN----NAVLTISNNGN 97 (724)
Q Consensus 22 ~~~~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~----~~~L~l~~~g~ 97 (724)
+++.|+|++||+|++|++|+|++|+|+||||+++ ++|+ |+ ..+ +||+|||++|+.++ +++|+|+.||+
T Consensus 11 ~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G~ 82 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYVQ 82 (276)
T ss_dssp CTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEEEES
T ss_pred cccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeCCCc
Confidence 5678999999999999999999999999999543 6777 76 445 99999999999885 78999999999
Q ss_pred EEE--ecCCCCeEEEEeccCC-----CCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhccccccccccccc
Q 004912 98 LVL--LNQTNGTIWSTNVSSE-----VKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRL 170 (724)
Q Consensus 98 l~l--~~~~~~~~Wst~~~~~-----~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg~kl~~~~~~~~ 170 (724)
||| .|++|.+||+|+++.. ..+.+|+|+|+|||||+| + .+|||| |||||||||||||.+.++|.
T Consensus 83 Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~-----~~lWqS--~ptdtlLpg~~~~~~l~~g~ 153 (276)
T 3m7h_A 83 YGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--S-----LALWNG--TPAIPLVPGAIDSLLLAPGS 153 (276)
T ss_dssp SSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--E-----EEEEES--CTTSCCCCSCTTCEEECSSE
T ss_pred EEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--C-----ceeeCc--ccccccccccccccccccCc
Confidence 999 7888999999997642 245689999999999998 2 689999 99999999999999998876
Q ss_pred ceeEEeecCCCCCCCcceEEeecCCCCceEEEEc-CCeeeeecCcCCCCceeeeecccccceeeeeeecCcceEEEEEee
Q 004912 171 ERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFN-GSVKFTCSGHWDGAGFVSALSYTDFLYKQFMMENKDECVYWYEAY 249 (724)
Q Consensus 171 ~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~-~~~~~~~~g~w~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (724)
. | ++.+||++|.|+++++++|. +++++ ++.+||++|.|++... ...+....... +.++.. ..+.++..
T Consensus 154 ~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~--~l~l~~dGnLv-l~d~~~-~~vWsS~t 222 (276)
T 3m7h_A 154 E--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAV--RAVFQGDGNLV-VYGAGN-AVLWHSHT 222 (276)
T ss_dssp E--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCC--EEEECTTSCEE-EECTTS-CEEEECSC
T ss_pred c--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccE--EEEEcCCCeEE-EEeCCC-cEEEEecC
Confidence 5 6 67899999999999999994 44454 5689999999986431 11222222222 222222 12222222
Q ss_pred cCCeeeEEEECcCCcEEEEEEecCCCceEEEeeccC
Q 004912 250 NRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPD 285 (724)
Q Consensus 250 ~~~~~~rl~L~~~G~l~~~~w~~~~~~W~~~~~~p~ 285 (724)
.....+|++|+.||++++|.| ...|..++..|.
T Consensus 223 ~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 223 GGHASAVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp TTCTTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred CCCCCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 233458999999999999998 245777666654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=383.59 Aligned_cols=214 Identities=29% Similarity=0.438 Sum_probs=184.6
Q ss_pred hhhHHHhccCcceeeeeccCCceeEEeeeecC------CceeEEEeccccC-hhhHHHHHHHHHHHHHccC-CceeeEee
Q 004912 505 LASITAATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQH-RNLVRLLG 576 (724)
Q Consensus 505 ~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~H-pniv~l~~ 576 (724)
........++|++.++||+|+||.||+|++.. ++.||||+++... ....++|.+|+.+|.+++| ||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34445567899999999999999999997643 3579999997653 3456789999999999965 99999999
Q ss_pred EEEec-CeEEEEEEeeCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCC
Q 004912 577 CCVEQ-GEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642 (724)
Q Consensus 577 ~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlk 642 (724)
+|.+. +..++||||+++|+|.++|..... ...+++.+++.|+.|||+||+|||+++ |||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccC
Confidence 99765 468999999999999999965322 345899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 643 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 643 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
|+||||++++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||+||||+| |+.||...+
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999998755444444556789999999999999999999999999999999998 999997644
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=373.01 Aligned_cols=201 Identities=27% Similarity=0.386 Sum_probs=165.4
Q ss_pred cCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC----eEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----EKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~----~~~lV~ 588 (724)
++|.+.++||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++|||||++++++.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 5688999999999999999987 689999999975432 2233455677777899999999999998764 579999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS-----RFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~-----~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
||+++|+|.++|.. ..+++.++++|+.|+++||+|||++. ..+||||||||+||||+.++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999954 34899999999999999999999861 2249999999999999999999999999998
Q ss_pred ccCCCcc--cccccccccccCccCcccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 664 MFGGDEL--QGNTKQIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 664 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
....... .......+||+.|||||++.+. .++.++|||||||+||||+||+.|++.
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 7644321 1223446899999999998765 367899999999999999999887754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=366.42 Aligned_cols=200 Identities=29% Similarity=0.440 Sum_probs=163.4
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe-------
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE------- 583 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~------- 583 (724)
++|++.+.||+|+||+||+|+.. +++.||||+++... ....+++.+|+.+|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999874 58899999986543 3456789999999999999999999999876543
Q ss_pred -----EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEe
Q 004912 584 -----KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 658 (724)
Q Consensus 584 -----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 658 (724)
.++||||+++|+|.+++.........++..++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999976544445677888999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCccc----------ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 659 FGLARMFGGDELQ----------GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 659 FGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
||+|+.+...... ...+..+||+.|||||++.+..|+.++|||||||+||||++ ||.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 9999987543211 12344689999999999999999999999999999999997 765
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=364.88 Aligned_cols=203 Identities=25% Similarity=0.395 Sum_probs=174.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe------cC
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE------QG 582 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~------~~ 582 (724)
.++|++.+.||+|+||.||+|++. +|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999874 6899999999654 23456778999999999999999999998764 35
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
..||||||++ |+|.+++. ....+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 67988884 4457999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCc--ccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 663 RMFGGDE--LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 663 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.+.... ........+||+.|||||++.+. .++.++||||+|||+|||++|+.||...+
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 8774322 22234567999999999998875 46999999999999999999999997554
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.13 Aligned_cols=200 Identities=24% Similarity=0.366 Sum_probs=171.7
Q ss_pred HhccCcceeeeeccCCceeEEeeeec----CCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~ 584 (724)
...+.|++.++||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|.++ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34678999999999999999999763 36789999986543 345688999999998 699999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC-CCEEEEecCCcc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLAR 663 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DFGla~ 663 (724)
++||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999982 3899999999999999999999998 9999999999999876 799999999998
Q ss_pred ccCCCcc--------------------------cccccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCC
Q 004912 664 MFGGDEL--------------------------QGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKN 716 (724)
Q Consensus 664 ~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~p 716 (724)
....... .......+||+.|||||++.+.. |+.++||||+|||+|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6543211 01123457999999999998764 89999999999999999999999
Q ss_pred CCCC
Q 004912 717 TGLG 720 (724)
Q Consensus 717 ~~~~ 720 (724)
|..+
T Consensus 247 f~~~ 250 (361)
T 4f9c_A 247 FYKA 250 (361)
T ss_dssp SSCC
T ss_pred CCCC
Confidence 9544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=377.04 Aligned_cols=199 Identities=28% Similarity=0.377 Sum_probs=172.6
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHH---HHHHHHHHHccCCceeeEeeEEEecCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEF---KNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f---~~E~~il~~l~Hpniv~l~~~~~~~~~~ 584 (724)
-++|++.++||+|+||.||+|+.. +|+.||||++++.. ......+ ..++.++..++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999875 58899999996431 1222333 3446666677899999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
|+||||++||+|..+|.. .+.+++.++..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999954 346999999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
+... .....+||+.|||||++.+ ..|+.++|||||||+||||++|+.||...
T Consensus 342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 7543 2445799999999999975 57999999999999999999999999654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=372.90 Aligned_cols=202 Identities=24% Similarity=0.378 Sum_probs=182.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.++...+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999875 5889999999877666778899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC--CCEEEEecCCccccCCC
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD--MNPKISDFGLARMFGGD 668 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kL~DFGla~~~~~~ 668 (724)
+++|+|.++|.. +...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999998843 3346999999999999999999999998 9999999999999854 89999999999987543
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...+
T Consensus 311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~ 360 (573)
T 3uto_A 311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360 (573)
T ss_dssp S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 2 2345689999999999999999999999999999999999999997554
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=320.19 Aligned_cols=217 Identities=13% Similarity=0.137 Sum_probs=169.3
Q ss_pred cccccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEec
Q 004912 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLN 102 (724)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~ 102 (724)
++.|+|++||+|++|++| ++|.|+|||+.+++ +.+|. .+|+||+|||+.| +.+.|+|+.||||||.|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~ly~---~~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEEEE---CCEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 567999999999999999 59999999998765 34444 3799999999998 46899999999999999
Q ss_pred CCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchh-hccccccccc-cccc-----ceeEE
Q 004912 103 QTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTL-LQDMKLGWDF-KNRL-----ERYLS 175 (724)
Q Consensus 103 ~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtl-Lpg~kl~~~~-~~~~-----~~~l~ 175 (724)
++|.+||+|++........|+|+|+|||||++. ++||||||||||+ ||+| |.|. .+|+ +++|+
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~--------~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~ 142 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP--------GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH 142 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS--------EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEecC--------CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE
Confidence 999999999976544456899999999999852 7999999998776 5554 4444 4444 55677
Q ss_pred eecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecCcCCCCceeeeecccccceeeeeeecCcceEEEEEeecCCeee
Q 004912 176 SWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYTDFLYKQFMMENKDECVYWYEAYNRPSIM 255 (724)
Q Consensus 176 Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g~w~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (724)
| .+||++|.|+++++++| +++++++..+||++++|++. +...+++......+.+..+.++..+.|...+ ...+
T Consensus 143 s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~-~~~~ 215 (236)
T 1dlp_A 143 A---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRS-AGRY 215 (236)
T ss_dssp S---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEEEEETTTEEEEECCCCCS-SSCC
T ss_pred c---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEEEEeCCCcEEEEeCCCCC-CCCE
Confidence 4 78999999999999999 67888888899999999754 4455666433333333334444554444333 3468
Q ss_pred EEEECcCCcEEEEE
Q 004912 256 TLKLNPSGFVTRQI 269 (724)
Q Consensus 256 rl~L~~~G~l~~~~ 269 (724)
|++|++||++++|.
T Consensus 216 rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 216 VFVLQPDRNLAIYG 229 (236)
T ss_dssp EEEECSSSCEEEEC
T ss_pred EEEEcCCCcEEEeC
Confidence 99999999999984
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.69 Aligned_cols=215 Identities=40% Similarity=0.693 Sum_probs=189.6
Q ss_pred cchhhHHHhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC
Q 004912 503 FSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 582 (724)
Q Consensus 503 ~~~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~ 582 (724)
+.+.++....++|++.+.||+|+||.||+|++.+++.||||++........+++.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33445566788999999999999999999998889999999998777677889999999999999999999999999999
Q ss_pred eEEEEEEeeCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCC
Q 004912 583 EKILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 661 (724)
..++||||+++++|.+++..... ...+++.++++++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999854332 235899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
++...............||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 98764433333334457899999999999999999999999999999999999999654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=321.82 Aligned_cols=201 Identities=26% Similarity=0.425 Sum_probs=181.1
Q ss_pred hccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
..++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 356899999999999999999986 4688999999976655667889999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++++|.+++.. ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999854 24899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 219 (297)
T 3fxz_A 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (297)
T ss_dssp --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2234568999999999999999999999999999999999999999654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=341.87 Aligned_cols=211 Identities=23% Similarity=0.315 Sum_probs=182.5
Q ss_pred hhhHHHhccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEe
Q 004912 505 LASITAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 580 (724)
Q Consensus 505 ~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~ 580 (724)
+.++....++|++.++||+|+||.||+|++.. ++.||||++++.. ....+.+.+|+.++.+++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44555667899999999999999999998865 7889999996532 1223348899999999999999999999999
Q ss_pred cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999542 346999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+++.+..... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 9987644322 2234468999999999987 5678999999999999999999999997654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=328.45 Aligned_cols=202 Identities=26% Similarity=0.339 Sum_probs=179.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|++.+.||+|+||.||+++.. +++.||||++++. .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467999999999999999999875 5889999999753 233567789999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++|+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999999854 345899999999999999999999998 99999999999999999999999999986432
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.. ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 21 23445689999999999999999999999999999999999999997544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=326.98 Aligned_cols=201 Identities=28% Similarity=0.446 Sum_probs=180.0
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
.++|++.+.||+|+||.||+|++ .+|+.||||++... .....+++.+|+.++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 56899999999999999999987 56899999998654 3455678999999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++++|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||++.++++||+|||+++.+...
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999998543 45899999999999999999999998 999999999999999999999999999876433
Q ss_pred cccccccccccccCccCcccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. .....+||+.|+|||++.+..+. .++||||||+++|||++|+.||...+
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 2 34456899999999999988875 89999999999999999999997654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.98 Aligned_cols=211 Identities=28% Similarity=0.421 Sum_probs=186.2
Q ss_pred CccchhhHHHhccC----------cceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCC
Q 004912 501 PLFSLASITAATEN----------FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR 569 (724)
Q Consensus 501 ~~~~~~~i~~~~~~----------~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hp 569 (724)
+.++..++..+.+. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34666666666553 777889999999999999886 6899999999876666778899999999999999
Q ss_pred ceeeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc
Q 004912 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649 (724)
Q Consensus 570 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 649 (724)
||+++++++...+..++||||+++++|.+++. ...+++.++..++.||++||+|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 99999999999999999999999999999984 235899999999999999999999998 99999999999999
Q ss_pred CCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 650 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 650 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.++.+||+|||+++.+.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp TTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999998765432 1234467999999999999999999999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=330.58 Aligned_cols=208 Identities=30% Similarity=0.493 Sum_probs=182.1
Q ss_pred hccCcceeeeeccCCceeEEeeeec--------CCceeEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 580 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~ 580 (724)
..++|++.+.||+|+||.||+|+.. ++..||||+++.. .....+++.+|+.++.++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3578999999999999999999753 3457999999764 344567899999999999 89999999999999
Q ss_pred cCeEEEEEEeeCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEE
Q 004912 581 QGEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647 (724)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NIL 647 (724)
.+..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+++ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999965431 245899999999999999999999998 999999999999
Q ss_pred EcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 648 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999997755443334445667889999999999999999999999999999999 999997654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=330.94 Aligned_cols=203 Identities=26% Similarity=0.400 Sum_probs=174.7
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~ 585 (724)
..++|++.+.||+|+||.||+|+.. +++.||||++++. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999875 5889999999753 233556788999999998 6999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||+++|+|..++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999998543 45999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 322 123445689999999999999999999999999999999999999997654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=338.99 Aligned_cols=209 Identities=24% Similarity=0.305 Sum_probs=181.0
Q ss_pred hhhHHHhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEe
Q 004912 505 LASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 580 (724)
Q Consensus 505 ~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~ 580 (724)
+.++....++|++.++||+|+||.||+|+.. +++.||||++++.. ....+.+.+|+.++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3344556789999999999999999999886 47899999986522 1223458899999999999999999999999
Q ss_pred cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
.+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999999853 24899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCcccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+++.+..... ......+||+.|+|||++.+.. ++.++|||||||+||||++|+.||...+
T Consensus 214 ~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 214 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp TCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred eeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 9987654321 1234568999999999998765 8899999999999999999999997654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=317.97 Aligned_cols=204 Identities=28% Similarity=0.461 Sum_probs=180.6
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.++|++.+.||+|+||.||+|.+. +++.||+|++........+.|.+|+.++.+++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467999999999999999999875 5889999999877777888999999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++... ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999653 345899999999999999999999998 99999999999999999999999999987643321
Q ss_pred cc------------cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 QG------------NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~~------------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|..|+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 11 112457999999999999999999999999999999999999998643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=335.94 Aligned_cols=212 Identities=22% Similarity=0.311 Sum_probs=182.9
Q ss_pred chhhHHHhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEE
Q 004912 504 SLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 579 (724)
Q Consensus 504 ~~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~ 579 (724)
.+.++....++|++.++||+|+||.||+++.. +++.||||++++.. ....+.+.+|..++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455556789999999999999999999885 58899999996532 223345889999999999999999999999
Q ss_pred ecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEec
Q 004912 580 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659 (724)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF 659 (724)
+.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999999643 235899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCcccccccccccccCccCccccc-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYAL-------DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
|+++.+..... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 99987654321 1233468999999999987 4578999999999999999999999997654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=330.84 Aligned_cols=205 Identities=17% Similarity=0.161 Sum_probs=177.6
Q ss_pred HHhccCcceeeeeccCCceeEEeee------ecCCceeEEEeccccChhhHHHHHHHHHHHHHcc---CCceeeEeeEEE
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCV 579 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~------~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~---Hpniv~l~~~~~ 579 (724)
....++|.+.++||+|+||.||+|. ...++.||||+++... ..++..|+.++.+++ |+||+++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 4456789999999999999999994 3468899999997643 456788888888886 999999999999
Q ss_pred ecCeEEEEEEeeCCCChhHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-------
Q 004912 580 EQGEKILILEYMPNKSLNVFLFDST--KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK------- 650 (724)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~------- 650 (724)
..+..++||||+++|+|.+++.... ....+++.++..|+.||++||+|||+++ |+||||||+||||+.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence 9999999999999999999996432 3456999999999999999999999998 999999999999998
Q ss_pred ----CCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 651 ----DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 651 ----~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
++.+||+|||+|+.+............+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 899999999999765432223334556899999999999999999999999999999999999999853
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=332.10 Aligned_cols=200 Identities=24% Similarity=0.384 Sum_probs=175.9
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~l 586 (724)
.++|++.++||+|+||.||+++.. +++.||||++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999875 47889999997542 23345688999999887 89999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999998543 45999999999999999999999998 9999999999999999999999999998632
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 22 1234557899999999999999999999999999999999999999963
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.91 Aligned_cols=199 Identities=29% Similarity=0.417 Sum_probs=178.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|++.+.||+|+||.||+++.. +++.||||++++.. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999875 58899999997542 23467788999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999954 345899999999999999999999998 99999999999999999999999999987543
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 2334689999999999999999999999999999999999999997543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.20 Aligned_cols=204 Identities=26% Similarity=0.396 Sum_probs=179.2
Q ss_pred HhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~ 584 (724)
...++|++.+.||+|+||.||+|+.. +++.||||++++.. ....+.+..|..++.++ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 45678999999999999999999875 58899999997542 23456788999999987 899999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||+++|+|..++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999998543 35899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
..... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 43221 22445789999999999999999999999999999999999999997554
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.72 Aligned_cols=203 Identities=28% Similarity=0.449 Sum_probs=174.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|++.+.||+|+||.||++++. +++.||||++... .....+.|.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 568999999999999999999874 5889999998542 344567899999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++++|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||++.++++||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999998543 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.. ........||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 164 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 164 TS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred cc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 122344679999999999999999999999999999999999999997543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=324.04 Aligned_cols=201 Identities=28% Similarity=0.393 Sum_probs=179.1
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChh------hHHHHHHHHHHHHHccCCceeeEeeEEEecCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ------GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~------~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~ 584 (724)
.+.|++.+.||+|+||.||+++.. +|+.||||+++..... ..+.+.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 568999999999999999999875 5889999998754321 357899999999999999999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC----CEEEEecC
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 660 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~DFG 660 (724)
++||||+++|+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999984 3456999999999999999999999998 99999999999998776 79999999
Q ss_pred CccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+++.+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 998765432 2345679999999999999999999999999999999999999997543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=326.29 Aligned_cols=219 Identities=42% Similarity=0.699 Sum_probs=190.1
Q ss_pred CCCccchhhHHHhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccCh-hhHHHHHHHHHHHHHccCCceeeEeeE
Q 004912 499 WLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGC 577 (724)
Q Consensus 499 ~~~~~~~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~f~~E~~il~~l~Hpniv~l~~~ 577 (724)
.+..+++.++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++.+++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3556888999999999999999999999999999988899999999976432 233478999999999999999999999
Q ss_pred EEecCeEEEEEEeeCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEE
Q 004912 578 CVEQGEKILILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (724)
Q Consensus 578 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 656 (724)
+.+.+..++||||+++++|.+++.... ....+++..+..++.||+.||+|||++...+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999996543 2345999999999999999999999992122999999999999999999999
Q ss_pred EecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
+|||+++.+..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 176 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 176 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 99999987643322 22334569999999999999999999999999999999999999995
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.65 Aligned_cols=204 Identities=30% Similarity=0.408 Sum_probs=177.1
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 68899999986543 2334678999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++++|.+++. ....+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999983 3445999999999999999999999998 9999999999999999999999999998764333
Q ss_pred ccccccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.||...+
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 3333445789999999999988776 789999999999999999999997544
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=323.49 Aligned_cols=200 Identities=24% Similarity=0.390 Sum_probs=177.7
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~l 586 (724)
.++|++.+.||+|+||.||+++.. +++.||||++++. .....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467999999999999999999875 4789999999754 334567788999999998 89999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999998543 35899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 221 234456899999999999999999999999999999999999999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=326.31 Aligned_cols=201 Identities=25% Similarity=0.386 Sum_probs=177.9
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+|.+++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999875 47889999986532 33467889999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999853 446999999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. ......+||+.|+|||++.. ..++.++|||||||++|||++|+.||...+
T Consensus 168 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 168 E---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp T---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred C---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 2 23445789999999999874 458999999999999999999999997543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=324.64 Aligned_cols=203 Identities=26% Similarity=0.346 Sum_probs=178.8
Q ss_pred hccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccC---hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~ 585 (724)
..++|++.+.||+|+||.||+++... ++.||||++++.. ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35789999999999999999998864 7889999997542 23467788999999988 7999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||+++|+|..++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999998543 35899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 3221 23445689999999999999999999999999999999999999997654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=319.58 Aligned_cols=209 Identities=31% Similarity=0.515 Sum_probs=173.2
Q ss_pred HHhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
....++|++.+.||+|+||.||+|+. +++.||||++.... ....++|.+|+.++++++||||+++++++.+.+..++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 34467899999999999999999987 68899999986543 4456789999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++++|.+++........+++..++.++.||++||+|||+++. +|+||||||+|||++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999999654333459999999999999999999998852 49999999999999999999999999998653
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 191 STF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred ccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 322 22344679999999999999999999999999999999999999997543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=315.25 Aligned_cols=218 Identities=40% Similarity=0.602 Sum_probs=190.3
Q ss_pred CCCccchhhHHHhccCccee------eeeccCCceeEEeeeecCCceeEEEecccc----ChhhHHHHHHHHHHHHHccC
Q 004912 499 WLPLFSLASITAATENFSMQ------CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKLQH 568 (724)
Q Consensus 499 ~~~~~~~~~i~~~~~~~~~~------~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~----~~~~~~~f~~E~~il~~l~H 568 (724)
..+.|++.++...+++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 35668889999999988877 8999999999999987 6889999998653 23456789999999999999
Q ss_pred CceeeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE
Q 004912 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (724)
Q Consensus 569 pniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl 648 (724)
|||+++++++.+.+..++||||+++++|.+++........+++..+..++.||++||+|||+++ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999976555567999999999999999999999998 9999999999999
Q ss_pred cCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 649 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||...+
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 9999999999999987654332223344679999999998765 58999999999999999999999997644
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=320.65 Aligned_cols=202 Identities=29% Similarity=0.390 Sum_probs=168.7
Q ss_pred ccCcceeeeeccCCceeEEeeee----cCCceeEEEeccccC----hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~----~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~ 583 (724)
.++|++.+.||+|+||.||+++. .+++.||||+++... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999987 468899999997642 2345668899999999999999999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.++||||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999854 345889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 643221 12344679999999999999999999999999999999999999997653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=323.11 Aligned_cols=199 Identities=24% Similarity=0.320 Sum_probs=178.9
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467999999999999999999875 58899999986532 23467889999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999999543 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. ....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 2 334689999999999999999999999999999999999999997543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.20 Aligned_cols=201 Identities=28% Similarity=0.394 Sum_probs=178.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh------hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~ 584 (724)
.+.|++.+.||+|+||.||+++.. +++.||||+++.... ...+.+.+|+.++.+++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467999999999999999999875 588999999865432 2467899999999999999999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC----CEEEEecC
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 660 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~DFG 660 (724)
++||||+++++|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999984 3456999999999999999999999998 99999999999998887 89999999
Q ss_pred CccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+++.+.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 998764322 2344679999999999999999999999999999999999999996543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.74 Aligned_cols=201 Identities=22% Similarity=0.313 Sum_probs=178.7
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.++|++.+.||+|+||.||++... +++.+|+|.+.... ...+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999875 47899999987543 4456789999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC--CCCEEEEecCCccccCCC
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK--DMNPKISDFGLARMFGGD 668 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kL~DFGla~~~~~~ 668 (724)
+++++|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999843 2346999999999999999999999998 999999999999987 789999999999887543
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 2 2344678999999999999999999999999999999999999997654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.35 Aligned_cols=202 Identities=26% Similarity=0.405 Sum_probs=178.4
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
..++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3578999999999999999999875 5889999999654 344567899999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC---CEEEEecCCccc
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKISDFGLARM 664 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~DFGla~~ 664 (724)
|||+++++|.+++. ....+++.++..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999884 3456899999999999999999999998 99999999999998654 599999999987
Q ss_pred cCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 65332 2334689999999999999999999999999999999999999996543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.79 Aligned_cols=202 Identities=29% Similarity=0.458 Sum_probs=174.8
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC----eEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----EKIL 586 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~----~~~l 586 (724)
..++|++.++||+|+||.||+|+.. ++.||||+++... .....+..|+.++.+++||||+++++++.+.. ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 4578999999999999999999874 7899999997543 33455677999999999999999999998754 3699
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCceEeccCCCCCEEEcCCCCEEE
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY----------SRFRIIHRDLKASNILLDKDMNPKI 656 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~----------~~~~iiH~Dlkp~NILl~~~~~~kL 656 (724)
||||+++|+|.+++.. ..+++.++..++.||++||+|||+. + |+||||||+|||++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 9999999999999954 3489999999999999999999998 7 999999999999999999999
Q ss_pred EecCCccccCCCcccccccccccccCccCcccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+|||+++.+.............||+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 999999887654433344556899999999999873 46678999999999999999999997543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=325.48 Aligned_cols=216 Identities=29% Similarity=0.441 Sum_probs=183.8
Q ss_pred cchhhHHHhccCcceeeeeccCCceeEEeeee------cCCceeEEEeccccC-hhhHHHHHHHHHHHHHc-cCCceeeE
Q 004912 503 FSLASITAATENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRL 574 (724)
Q Consensus 503 ~~~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l-~Hpniv~l 574 (724)
+.........++|++.+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34555566788999999999999999999974 245789999997643 34567899999999999 79999999
Q ss_pred eeEEEecCe-EEEEEEeeCCCChhHHHhhcCC------------------------------------------------
Q 004912 575 LGCCVEQGE-KILILEYMPNKSLNVFLFDSTK------------------------------------------------ 605 (724)
Q Consensus 575 ~~~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------ 605 (724)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999965432
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 606 ---------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 606 ---------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
...+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122899999999999999999999998 99999999999999999999999999987654333
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
........||+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 333445678999999999999999999999999999999998 999997654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=317.00 Aligned_cols=203 Identities=28% Similarity=0.422 Sum_probs=174.7
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe------
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE------ 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~------ 583 (724)
.++|++.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999886 68899999996543 3456789999999999999999999999876542
Q ss_pred ---------------------------------------------------EEEEEEeeCCCChhHHHhhcCCCCCCCHH
Q 004912 584 ---------------------------------------------------KILILEYMPNKSLNVFLFDSTKKRLLNWQ 612 (724)
Q Consensus 584 ---------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 612 (724)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 79999999999999999776555667888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc----------ccccccccccC
Q 004912 613 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ----------GNTKQIVGTYG 682 (724)
Q Consensus 613 ~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~----------~~~~~~~gt~~ 682 (724)
.+++++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+...... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 999999999999999999999999999887543211 12334579999
Q ss_pred ccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004912 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 717 (724)
Q Consensus 683 y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~ 717 (724)
|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 99999999999999999999999999999998775
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=320.53 Aligned_cols=204 Identities=25% Similarity=0.340 Sum_probs=177.5
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-----hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
.+.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999875 58899999985421 124678999999999999999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC---EEEEecCC
Q 004912 586 LILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGL 661 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~DFGl 661 (724)
+||||+++++|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988875432 3345899999999999999999999998 999999999999987655 99999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
++.+.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 98875432 1234467999999999999999999999999999999999999999643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.87 Aligned_cols=203 Identities=29% Similarity=0.397 Sum_probs=174.4
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
..++|++.+.||+|+||.||+|+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 357899999999999999999999889999999986542 233577899999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++ +|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99985 77777743 3345899999999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (311)
T 3niz_A 173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224 (311)
T ss_dssp C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence 2 22334578999999999876 568999999999999999999999997543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.84 Aligned_cols=202 Identities=26% Similarity=0.399 Sum_probs=177.5
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecC--eEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~--~~~lV 587 (724)
.++|++.+.||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4679999999999999999998764 8899999997543 345678899999999999999999999998765 77999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE----cCCCCEEEEecCCcc
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLAR 663 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kL~DFGla~ 663 (724)
|||+++++|.+++........+++.++..++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555555999999999999999999999998 9999999999999 778889999999998
Q ss_pred ccCCCcccccccccccccCccCccccc--------CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYAL--------DGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.+.... ......||+.|+|||++. +..++.++||||||+++|||++|+.||..
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 765432 233457999999999886 57889999999999999999999999963
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=321.16 Aligned_cols=202 Identities=24% Similarity=0.335 Sum_probs=179.8
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.+|.+++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999875 5889999999876666667899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC--CCCEEEEecCCccccCCC
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK--DMNPKISDFGLARMFGGD 668 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kL~DFGla~~~~~~ 668 (724)
+++++|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+|||++. .+.+||+|||+++.+...
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999843 2345899999999999999999999998 999999999999974 577999999999887543
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 2 2234579999999999999999999999999999999999999997543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=327.05 Aligned_cols=205 Identities=29% Similarity=0.430 Sum_probs=178.9
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
..++|++.+.||+|+||.||+|+.. +++.||||+++... ....++|.+|+.+|++++||||+++++++.+.+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 4578999999999999999999886 68899999987543 344567899999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|.+++... ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999999643 235899999999999999999999998 999999999999999999999999999876443
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
..........+++.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~ 319 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32222223346788999999999999999999999999999999 99999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.50 Aligned_cols=204 Identities=30% Similarity=0.462 Sum_probs=175.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec----CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.++|++.+.||+|+||.||+|++. .+..||||+++.. .....+.|.+|+.++.+++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 567999999999999999999874 3446999999764 44556789999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++++|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999998542 345999999999999999999999998 9999999999999999999999999998875
Q ss_pred CCccc-ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 667 GDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 667 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 43211 12223456778999999999999999999999999999999 99999654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=320.08 Aligned_cols=213 Identities=29% Similarity=0.450 Sum_probs=183.0
Q ss_pred hhHHHhccCcceeeeeccCCceeEEeeeecC------CceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEE
Q 004912 506 ASITAATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578 (724)
Q Consensus 506 ~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~ 578 (724)
..+....++|++.+.||+|+||.||+|+..+ ++.||||+++.. .....+.|.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3445567899999999999999999998753 478999999765 344567899999999999999999999999
Q ss_pred EecCeEEEEEEeeCCCChhHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceE
Q 004912 579 VEQGEKILILEYMPNKSLNVFLFDSTK---------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 637 (724)
Q Consensus 579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ii 637 (724)
.+.+..++||||+++++|.+++..... ...+++.+++.++.||++||+|||+++ |+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 999999999999999999999965321 256999999999999999999999998 99
Q ss_pred eccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCC
Q 004912 638 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKN 716 (724)
Q Consensus 638 H~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p 716 (724)
||||||+|||++.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999987654333333445678899999999999999999999999999999999 9999
Q ss_pred CCCCC
Q 004912 717 TGLGS 721 (724)
Q Consensus 717 ~~~~~ 721 (724)
|...+
T Consensus 277 ~~~~~ 281 (343)
T 1luf_A 277 YYGMA 281 (343)
T ss_dssp TTTSC
T ss_pred CCCCC
Confidence 97543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.84 Aligned_cols=200 Identities=24% Similarity=0.362 Sum_probs=169.9
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh--------------------------hhHHHHHHHHHHHH
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--------------------------QGLKEFKNEMMLIA 564 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--------------------------~~~~~f~~E~~il~ 564 (724)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+++.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999874 578999999865321 12356899999999
Q ss_pred HccCCceeeEeeEEEe--cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCC
Q 004912 565 KLQHRNLVRLLGCCVE--QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642 (724)
Q Consensus 565 ~l~Hpniv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlk 642 (724)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++.++..++.||++||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999998765 3456999999999999999999999998 9999999
Q ss_pred CCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 643 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 643 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
|+|||++.++.+||+|||+++.+.... .......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999998765432 1233467999999999997765 47899999999999999999999975
Q ss_pred C
Q 004912 720 G 720 (724)
Q Consensus 720 ~ 720 (724)
.
T Consensus 243 ~ 243 (298)
T 2zv2_A 243 E 243 (298)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=318.08 Aligned_cols=201 Identities=26% Similarity=0.431 Sum_probs=176.5
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|.+.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999987 468899999986432 22346789999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+ +|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 78888888543 45899999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccccccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
.. .....+||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 213 (336)
T 3h4j_B 161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213 (336)
T ss_dssp SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS
T ss_pred Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH
Confidence 32 2344679999999999988876 7899999999999999999999976543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=318.78 Aligned_cols=205 Identities=27% Similarity=0.396 Sum_probs=170.1
Q ss_pred hccCcceeeeeccCCceeEEeeee-cCCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe---
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE--- 583 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~--- 583 (724)
..++|++.+.||+|+||.||++++ .+++.||||+++.. .....+.+.+|+.++.+++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 357899999999999999999987 46889999999764 33445689999999999999999999999876543
Q ss_pred -EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 584 -KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 584 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
.++||||+++++|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 49999999999999999543 35899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcc-cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 663 RMFGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 663 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.+..... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 87644321 122334678999999999999999999999999999999999999997543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=314.45 Aligned_cols=202 Identities=23% Similarity=0.265 Sum_probs=176.9
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 57899999999999999999986 4688999999865432 34688999999999 99999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC-----EEEEecCCccc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-----PKISDFGLARM 664 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kL~DFGla~~ 664 (724)
|+ +++|.+++... ...+++.+++.++.||++||+|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998653 346999999999999999999999998 999999999999998887 99999999987
Q ss_pred cCCCcccc-----cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 665 FGGDELQG-----NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 665 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 64432211 1345689999999999999999999999999999999999999997644
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=316.00 Aligned_cols=210 Identities=32% Similarity=0.474 Sum_probs=182.8
Q ss_pred HhccCcceeeeeccCCceeEEeeeec------CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 582 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~ 582 (724)
...++|.+.+.||+|+||.||+|... +++.||||+++.. .....+++.+|+.++++++||||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 34678999999999999999999762 3578999999754 3455678999999999999999999999999999
Q ss_pred eEEEEEEeeCCCChhHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccC
Q 004912 583 EKILILEYMPNKSLNVFLFDSTK---------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL 641 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dl 641 (724)
..++||||+++++|.+++..... ...+++.++.+++.||++||+|||+++ |+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 99999999999999999975432 234899999999999999999999998 999999
Q ss_pred CCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 642 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 642 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
||+|||++.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987755433333444567889999999999999999999999999999999 99999765
Q ss_pred CC
Q 004912 721 SM 722 (724)
Q Consensus 721 ~~ 722 (724)
+.
T Consensus 257 ~~ 258 (314)
T 2ivs_A 257 PP 258 (314)
T ss_dssp CG
T ss_pred CH
Confidence 43
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.83 Aligned_cols=203 Identities=32% Similarity=0.493 Sum_probs=179.7
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.++|++.+.||+|+||.||+|+..+++.||||++.... ...+++.+|+.++.+++||||+++++++.+++..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 46799999999999999999999888999999997543 33477999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++++|.+++.. ....+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 99999999854 3346899999999999999999999998 99999999999999999999999999987644321
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 22334567788999999999999999999999999999999 999997543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=326.91 Aligned_cols=204 Identities=26% Similarity=0.387 Sum_probs=177.7
Q ss_pred HhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
...++|++.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34678999999999999999999764 68899999986543 3456779999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc---CCCCEEEEecCCcc
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLAR 663 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kL~DFGla~ 663 (724)
||||+++|+|.+.+.. ...+++.++..++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999998854 345999999999999999999999998 99999999999998 46789999999998
Q ss_pred ccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 162 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~ 217 (444)
T 3soa_A 162 EVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217 (444)
T ss_dssp CCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence 765432 22344689999999999999999999999999999999999999996543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=321.24 Aligned_cols=209 Identities=30% Similarity=0.475 Sum_probs=182.8
Q ss_pred HhccCcceeeeeccCCceeEEeeeec--------CCceeEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCV 579 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~ 579 (724)
...++|++.+.||+|+||.||+|+.. .+..||||+++.. .....+++.+|+.++.++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34678999999999999999999753 2357999999764 344567899999999999 9999999999999
Q ss_pred ecCeEEEEEEeeCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCE
Q 004912 580 EQGEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 646 (724)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NI 646 (724)
+++..++||||+++++|.+++..... ...+++.++++++.||++||+|||+.+ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 99999999999999999999965432 245999999999999999999999998 99999999999
Q ss_pred EEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 647 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 647 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
|++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999988755443344455678899999999999999999999999999999999 999997543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=323.77 Aligned_cols=202 Identities=26% Similarity=0.316 Sum_probs=168.7
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHH-HHHccCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMML-IAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~i-l~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.++|++.+.||+|+||.||+++.. +++.||||++++.. ....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 468999999999999999999875 47789999996543 2334556677776 467899999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++|+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999854 345889999999999999999999998 9999999999999999999999999998643
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.. .......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 22 123455789999999999999999999999999999999999999997543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=331.58 Aligned_cols=205 Identities=28% Similarity=0.428 Sum_probs=181.5
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999885 58999999996532 23457789999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 588 LEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
|||+++|+|..++..... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999865432 446999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 432 12344589999999999999999999999999999999999999997643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.53 Aligned_cols=204 Identities=32% Similarity=0.494 Sum_probs=165.8
Q ss_pred ccCcceeeeeccCCceeEEeeeec----CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.++|++.+.||+|+||.||+|++. ++..||||+++.. .....++|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999875 4678999999764 34556789999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++++|.+++.. ....+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999954 2345899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 667 GDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 667 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 43211 11222345778999999999999999999999999999998 99999644
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=323.36 Aligned_cols=207 Identities=32% Similarity=0.484 Sum_probs=178.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec------CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~ 584 (724)
.++|++.+.||+|+||.||+|+.. +++.||||+++.. ......++.+|+.++.+++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467999999999999999999843 3668999999654 445567899999999999999999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC---CEEEE
Q 004912 585 ILILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKIS 657 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~ 657 (724)
++||||+++|+|.+++.... ....+++.+++.++.||++||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996543 2245899999999999999999999998 99999999999999554 59999
Q ss_pred ecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 658 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999986533322233344578999999999999999999999999999999998 999997543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=318.88 Aligned_cols=207 Identities=21% Similarity=0.276 Sum_probs=179.6
Q ss_pred hccCcceeeeeccC--CceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 511 ATENFSMQCKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 511 ~~~~~~~~~~LG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
..++|++.++||+| +||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35789999999999 99999999886 5889999998654 2445678899999999999999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||+++++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||.+...
T Consensus 103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999998653 2345899999999999999999999998 999999999999999999999999998754
Q ss_pred CCCc-----ccccccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 666 GGDE-----LQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 666 ~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2211 1112233578999999999987 679999999999999999999999997544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.28 Aligned_cols=200 Identities=26% Similarity=0.390 Sum_probs=171.4
Q ss_pred cCcceeeeeccCCceeEEeeeecCCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++|++.+.||+|+||.||+|+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998779999999986543 22347788999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++ +|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 986 88888753 2345899999999999999999999998 9999999999999999999999999998764321
Q ss_pred cccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.......||+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 123345789999999998764 5899999999999999999999999653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.61 Aligned_cols=198 Identities=29% Similarity=0.404 Sum_probs=170.8
Q ss_pred ceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCCC
Q 004912 516 SMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (724)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 594 (724)
...+.||+|+||.||+|+.. +++.||||+++.......+++.+|+.++.+++||||+++++++.+.+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33678999999999999874 58899999998776667788999999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE--cCCCCEEEEecCCccccCCCcccc
Q 004912 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL--DKDMNPKISDFGLARMFGGDELQG 672 (724)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl--~~~~~~kL~DFGla~~~~~~~~~~ 672 (724)
+|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 172 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--- 243 (373)
T 2x4f_A 172 ELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243 (373)
T ss_dssp EEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence 999988542 345899999999999999999999998 9999999999999 567899999999998875432
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2234579999999999999999999999999999999999999997543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=332.99 Aligned_cols=204 Identities=28% Similarity=0.395 Sum_probs=180.6
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
..++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+|.+++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999875 58899999996532 2345678999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++|+|..++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++.+.
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999986432 345899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 432 2334589999999999999999999999999999999999999997653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.25 Aligned_cols=204 Identities=31% Similarity=0.486 Sum_probs=169.8
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCc----eeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
.++|++.+.||+|+||.||+|++. +++ .||+|.+... .....++|.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467999999999999999999864 344 3588888543 3355688999999999999999999999998754 78
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+|+||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++++||+|||+++.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999998653 345999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 224 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence 65443333444567889999999999999999999999999999999 999997654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.97 Aligned_cols=210 Identities=29% Similarity=0.466 Sum_probs=163.6
Q ss_pred HHhccCcceeeeeccCCceeEEeeeecCCc----eeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 582 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~----~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~ 582 (724)
....++|++.+.||+|+||.||+|++.... .||||+++.. .....+++.+|+.++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 344678999999999999999999875432 7999999764 3455788999999999999999999999998776
Q ss_pred eE------EEEEEeeCCCChhHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC
Q 004912 583 EK------ILILEYMPNKSLNVFLFDSTK---KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (724)
Q Consensus 583 ~~------~lV~Ey~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 653 (724)
.. ++||||+++++|.+++..... ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 55 899999999999999864322 225899999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 654 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 99999999987754433333344567889999999999999999999999999999999 999997543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=303.57 Aligned_cols=203 Identities=32% Similarity=0.449 Sum_probs=179.5
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
..++|++.+.||+|+||.||+++..++..||||+++... ...+++.+|+.++.+++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 357899999999999999999998888899999997543 3447799999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999998653 235899999999999999999999998 99999999999999999999999999987654332
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 160 V-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp E-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred h-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 2 2233456778999999999899999999999999999999 99999754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=332.60 Aligned_cols=202 Identities=26% Similarity=0.327 Sum_probs=168.2
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|++.++||+|+||.||+++.. +++.||||+++.. .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999874 5889999999753 233456788999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
|||+++++|..++.. ...+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999854 3458999999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
... ......+||+.|+|||++.+..++.++||||||++||||++|+.||...+
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 322 22345789999999999999999999999999999999999999997554
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.11 Aligned_cols=203 Identities=31% Similarity=0.515 Sum_probs=173.5
Q ss_pred ccCcceeeeeccCCceeEEeeee-----cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~ 584 (724)
.++|++.+.||+|+||.||+++. .+++.||||++........+.|.+|+.++.+++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 57899999999999999999974 35789999999887777788999999999999999999999998654 458
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||+++++|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999999653 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcc-cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 665 FGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
+..... ........++..|+|||.+.+..++.++||||||+++|||++|..|+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 644321 1222334577889999999999999999999999999999999998864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=305.97 Aligned_cols=197 Identities=25% Similarity=0.398 Sum_probs=170.7
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999875 5889999998653 23345788999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++ +|.+.+.. ....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9986 45444432 2346999999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNT 717 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~p~ 717 (724)
.......||+.|+|||++.+.. ++.++||||||+++|||++|..|+
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 2234467899999999998766 899999999999999999998885
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=316.97 Aligned_cols=209 Identities=32% Similarity=0.464 Sum_probs=178.1
Q ss_pred HhccCcceeeeeccCCceeEEeeeec------CCceeEEEeccccC-hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEec
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 581 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~ 581 (724)
...++|++.+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 34678999999999999999999862 35689999997542 33457899999999999 899999999999999
Q ss_pred CeEEEEEEeeCCCChhHHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccC
Q 004912 582 GEKILILEYMPNKSLNVFLFDSTKK--------------------RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL 641 (724)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dl 641 (724)
+..++||||+++|+|.+++...... ..+++.+++.++.||++||+|||+++ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 9999999999999999999653321 34899999999999999999999998 999999
Q ss_pred CCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 642 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 642 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
||+|||++.++.+||+|||++..+.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987644332223344567889999999999999999999999999999998 99999765
Q ss_pred C
Q 004912 721 S 721 (724)
Q Consensus 721 ~ 721 (724)
+
T Consensus 279 ~ 279 (344)
T 1rjb_A 279 P 279 (344)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=315.59 Aligned_cols=200 Identities=26% Similarity=0.385 Sum_probs=161.8
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
..++|++.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4678999999999999999999886 47789999997543 34678899999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC---CCCEEEEecCCccccC
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLARMFG 666 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFGla~~~~ 666 (724)
|+++++|.+++. ....+++.++..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999984 3456899999999999999999999998 999999999999975 8899999999998764
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 322 2334679999999999999999999999999999999999999996543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.61 Aligned_cols=201 Identities=28% Similarity=0.375 Sum_probs=169.8
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEecccc--ChhhHHHHHHHHHHHHHccC--CceeeEeeEEEecCeEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~H--pniv~l~~~~~~~~~~~l 586 (724)
..++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| |||+++++++.++...++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 46779999999999999999999888999999998643 34456789999999999986 999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||| +.+++|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++ ++.+||+|||+++.+.
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 568899999854 346899999999999999999999998 99999999999997 5789999999998875
Q ss_pred CCcccccccccccccCccCcccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
............||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 4433333445689999999999865 6789999999999999999999999964
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=312.73 Aligned_cols=208 Identities=30% Similarity=0.497 Sum_probs=180.2
Q ss_pred hccCcceeeeeccCCceeEEeeeec--------CCceeEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 580 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~ 580 (724)
..++|++.+.||+|+||.||+|+.. ++..||||+++.. .....+++.+|+.++.++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999999999999763 4678999999764 344567899999999999 89999999999999
Q ss_pred cCeEEEEEEeeCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEE
Q 004912 581 QGEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647 (724)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NIL 647 (724)
.+..++||||+++++|.+++..... ...+++.+++.++.||++||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999965332 234899999999999999999999998 999999999999
Q ss_pred EcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 648 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999988755443333444567889999999999999999999999999999999 999997543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=325.94 Aligned_cols=201 Identities=27% Similarity=0.468 Sum_probs=179.0
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999875 68999999996532 23456889999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++++|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999984 3456999999999999999999999998 99999999999999999999999999988654
Q ss_pred CcccccccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.. .....+||+.|+|||++.+..+ +.++||||||+++|||++|+.||...+
T Consensus 169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 32 2344689999999999998876 689999999999999999999998654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=308.74 Aligned_cols=209 Identities=30% Similarity=0.409 Sum_probs=181.8
Q ss_pred HhccCcceeeeeccCCceeEEeeee------cCCceeEEEeccccC-hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEec
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 581 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~ 581 (724)
...++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3457899999999999999999975 246789999997653 34567899999999999 999999999999999
Q ss_pred CeEEEEEEeeCCCChhHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCE
Q 004912 582 GEKILILEYMPNKSLNVFLFDSTK---------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 646 (724)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NI 646 (724)
+..++||||+++++|.+++..... ...+++.++++++.||++||+|||+++ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 999999999999999999965432 225899999999999999999999998 99999999999
Q ss_pred EEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 647 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 647 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
|++.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999999999988755433333344567889999999999999999999999999999999 999997654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=313.61 Aligned_cols=209 Identities=27% Similarity=0.325 Sum_probs=181.9
Q ss_pred CccchhhHHHhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHcc-----CCceeeE
Q 004912 501 PLFSLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----HRNLVRL 574 (724)
Q Consensus 501 ~~~~~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-----Hpniv~l 574 (724)
..+++.......++|++.++||+|+||.||+|+.. +++.||||+++.. ....+.+..|+.++.+++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34555555566789999999999999999999874 5789999999743 345567888999999997 9999999
Q ss_pred eeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC----
Q 004912 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---- 650 (724)
Q Consensus 575 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---- 650 (724)
++++...+..++||||+ +++|.+++.... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 99999999999999999 999999986532 345899999999999999999999998 999999999999975
Q ss_pred ---------------------CCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHH
Q 004912 651 ---------------------DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709 (724)
Q Consensus 651 ---------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~e 709 (724)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||||+++||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 78999999999986532 2234678999999999999999999999999999999
Q ss_pred HHcCCCCCCCC
Q 004912 710 TLSSKKNTGLG 720 (724)
Q Consensus 710 lltG~~p~~~~ 720 (724)
|++|+.||...
T Consensus 252 ll~g~~pf~~~ 262 (360)
T 3llt_A 252 LYTGSLLFRTH 262 (360)
T ss_dssp HHHSSCSCCCS
T ss_pred HHHCCCCCCCC
Confidence 99999999754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=309.54 Aligned_cols=203 Identities=30% Similarity=0.427 Sum_probs=162.0
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999875 58899999986543 2345778899999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 590 YMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 590 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
|++ ++|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999885432 2245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 322 12334578999999999876 46899999999999999999999999754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=302.53 Aligned_cols=199 Identities=24% Similarity=0.387 Sum_probs=177.5
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.++|++.+.||+|+||.||+|.... +..+|+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 5679999999999999999998754 678999999776666678899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE---cCCCCEEEEecCCccccCC
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DFGla~~~~~ 667 (724)
+++++|.+++... ..+++.++..++.|+++||+|||+++ |+||||||+|||+ +.++.+||+|||++..+..
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999988543 45899999999999999999999998 9999999999999 7889999999999987654
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.. ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||...
T Consensus 162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (277)
T 3f3z_A 162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP 210 (277)
T ss_dssp TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC
Confidence 32 23345799999999987654 899999999999999999999999754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=304.72 Aligned_cols=204 Identities=30% Similarity=0.452 Sum_probs=177.1
Q ss_pred HhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
...++|++.+.||+|+||.||+++..++..||||+++... ...+++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 3467899999999999999999999888899999997643 234779999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++++|.+++... ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 99999999999542 345999999999999999999999998 9999999999999999999999999998764432
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 175 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 175 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp H-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred c-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 1 12233456788999999999999999999999999999998 99999754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=301.07 Aligned_cols=204 Identities=30% Similarity=0.408 Sum_probs=178.9
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999875 58899999986432 3456789999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++++|.+++. ....+++.++..++.||++||+|||+++ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999883 3346899999999999999999999998 9999999999999999999999999998764333
Q ss_pred ccccccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 2233445678999999999988775 789999999999999999999997654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=315.31 Aligned_cols=200 Identities=26% Similarity=0.337 Sum_probs=166.7
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
..++|++.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3578999999999999999999886 68899999997543 234678899999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC--EEEEecCCccccCC
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--PKISDFGLARMFGG 667 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kL~DFGla~~~~~ 667 (724)
|+++++|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999998543 35899999999999999999999998 999999999999987765 99999999975422
Q ss_pred CcccccccccccccCccCcccccCCCCCch-hhHHHHHHHHHHHHcCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIK-SDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-~DVwSlGvil~elltG~~p~~~~ 720 (724)
. .......||+.|+|||++.+..++.+ +||||||+++|||++|+.||...
T Consensus 171 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (361)
T 3uc3_A 171 H---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred c---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence 2 22344579999999999988888766 89999999999999999999754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=317.49 Aligned_cols=203 Identities=29% Similarity=0.442 Sum_probs=165.1
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecC--eE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQG--EK 584 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~--~~ 584 (724)
..++|++.+.||+|+||.||+|.+. +++.||||++... .....+++.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4678999999999999999999874 5889999998643 3445677889999999997 999999999998654 68
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||++ ++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 589888853 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCc-------------------ccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 665 FGGDE-------------------LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 665 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 63210 1112344689999999999987 678999999999999999999999997543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=313.16 Aligned_cols=204 Identities=28% Similarity=0.431 Sum_probs=172.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCce----eEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQE----VAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~----vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
.++|++.+.||+|+||.||+|++. +++. ||+|.+.... ....+++.+|+.++.+++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 457999999999999999999864 3443 7888775432 234466789999999999999999999885 56789
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++++||+|||+++.+
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999998542 346889999999999999999999998 999999999999999999999999999987
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.............+|..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 65443334455678889999999999999999999999999999999 999997654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=322.35 Aligned_cols=199 Identities=31% Similarity=0.472 Sum_probs=174.2
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC-eEEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-EKILILE 589 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~-~~~lV~E 589 (724)
..++|++.+.||+|+||.||+|... ++.||||+++... ..+.|.+|+.+|++++||||+++++++.+.. ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 4578999999999999999999874 7899999997643 4578999999999999999999999988765 7899999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 99999999999653 2334799999999999999999999998 999999999999999999999999999864321
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.....+++.|+|||.+.+..++.++||||||++||||++ |+.||...+
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 122367889999999999999999999999999999999 999997654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=314.27 Aligned_cols=210 Identities=23% Similarity=0.275 Sum_probs=173.6
Q ss_pred HHHhccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-----ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec
Q 004912 508 ITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (724)
Q Consensus 508 i~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-----~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~ 581 (724)
+....++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4556788999999999999999999874 5778999998643 334567899999999999999999999999999
Q ss_pred CeEEEEEEeeCCCChhHHHhhcC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 004912 582 GEKILILEYMPNKSLNVFLFDST-------------------------------------KKRLLNWQARVRIIEGIAQG 624 (724)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qia~~ 624 (724)
+..++||||+++++|.+++.... ....+++..+..++.||++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999984210 01224677888999999999
Q ss_pred HHHHHhcCCCceEeccCCCCCEEEcCCC--CEEEEecCCccccCCCc--ccccccccccccCccCcccccC--CCCCchh
Q 004912 625 LLYLHQYSRFRIIHRDLKASNILLDKDM--NPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYALD--GLFSIKS 698 (724)
Q Consensus 625 L~yLH~~~~~~iiH~Dlkp~NILl~~~~--~~kL~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~ 698 (724)
|+|||+++ |+||||||+|||++.++ .+||+|||+++.+.... .........||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 89999999998763321 1112345679999999999875 6789999
Q ss_pred hHHHHHHHHHHHHcCCCCCCCC
Q 004912 699 DVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 699 DVwSlGvil~elltG~~p~~~~ 720 (724)
||||||+++|||++|+.||...
T Consensus 258 DiwslG~il~el~~g~~pf~~~ 279 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGV 279 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=312.84 Aligned_cols=211 Identities=30% Similarity=0.444 Sum_probs=180.6
Q ss_pred HHHhccCcceeeeeccCCceeEEeeeecC-C-----ceeEEEeccccC-hhhHHHHHHHHHHHHHc-cCCceeeEeeEEE
Q 004912 508 ITAATENFSMQCKLGEGGFGPVYKGRLLN-G-----QEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCV 579 (724)
Q Consensus 508 i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g-----~~vAVK~l~~~~-~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~ 579 (724)
.....++|++.+.||+|+||.||+|.... + ..||||.+.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456889999999999999999998643 2 479999997643 34567899999999999 8999999999999
Q ss_pred ecCeEEEEEEeeCCCChhHHHhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE
Q 004912 580 EQGEKILILEYMPNKSLNVFLFDST-----------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (724)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl 648 (724)
+.+..++||||+++|+|.+++.... ....+++.+++.++.||++||+|||+++ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 9999999999999999999986432 1345899999999999999999999998 9999999999999
Q ss_pred cCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 649 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
+.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 9999999999999987644332222334567889999999999999999999999999999999 999997544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=312.37 Aligned_cols=212 Identities=28% Similarity=0.440 Sum_probs=182.2
Q ss_pred hhHHHhccCcceeeeeccCCceeEEeeeec------CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEE
Q 004912 506 ASITAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578 (724)
Q Consensus 506 ~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~ 578 (724)
.+.....++|++.+.||+|+||.||+|+.. .++.||||++.... .....++.+|+.++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 334456788999999999999999999764 36789999997543 34556799999999999999999999999
Q ss_pred EecCeEEEEEEeeCCCChhHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC
Q 004912 579 VEQGEKILILEYMPNKSLNVFLFDST-------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD 651 (724)
Q Consensus 579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~ 651 (724)
.+.+..++||||+++++|.+++.... ....+++.++++++.||++||+|||+++ |+||||||+|||++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence 99999999999999999999986422 1245789999999999999999999998 9999999999999999
Q ss_pred CCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 652 MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 652 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
+.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 9999999999987644333333344567889999999999999999999999999999999 89999654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=301.09 Aligned_cols=200 Identities=35% Similarity=0.532 Sum_probs=165.7
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccC----hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~----~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|++.+.||+|+||.||+|.+ .++.||||+++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999987 48899999986543 23357899999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC--------CCCEEEEec
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK--------DMNPKISDF 659 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--------~~~~kL~DF 659 (724)
|||+++++|.+++. ...+++..+..++.|+++||+|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999983 346899999999999999999999987656899999999999986 778999999
Q ss_pred CCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
|+++.+.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9998764322 22457899999999999999999999999999999999999999754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.62 Aligned_cols=200 Identities=28% Similarity=0.391 Sum_probs=178.0
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh------hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~ 584 (724)
.++|++.+.||+|+||.||+++.. +++.||||++..... ...+++.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 567999999999999999999875 588999999865432 1367899999999999999999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC----CEEEEecC
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 660 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~DFG 660 (724)
++||||+++++|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999953 346899999999999999999999998 99999999999999887 79999999
Q ss_pred CccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
+++.+.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 998765432 234457999999999999999999999999999999999999999654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=328.75 Aligned_cols=205 Identities=32% Similarity=0.458 Sum_probs=178.7
Q ss_pred HHhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
....++|++.+.||+|+||.||+|...++..||||+++... ...++|.+|+.+|++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 44567899999999999999999999888899999997644 45788999999999999999999999986 56789999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|.+++... ....+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 262 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred eecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999999532 1235889999999999999999999998 999999999999999999999999999876543
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
... ......+|+.|+|||++....++.++||||||++||||++ |+.||...
T Consensus 338 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 338 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp HHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 221 1233456789999999999999999999999999999999 99999653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=318.13 Aligned_cols=201 Identities=27% Similarity=0.365 Sum_probs=170.6
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEecccc--ChhhHHHHHHHHHHHHHcc--CCceeeEeeEEEecCeEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~--Hpniv~l~~~~~~~~~~~l 586 (724)
..+.|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.+|.+++ ||||+++++++...+..++
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 34579999999999999999999888999999998643 3456688999999999996 5999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||| +.+++|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||++ ++.+||+|||+++.+.
T Consensus 134 v~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEe-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999 5788999998543 36889999999999999999999998 99999999999995 5799999999998875
Q ss_pred CCcccccccccccccCccCcccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
............||+.|+|||++.+ ..++.++|||||||+||||++|+.||..
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 4433333445689999999999865 4689999999999999999999999964
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.97 Aligned_cols=197 Identities=27% Similarity=0.313 Sum_probs=166.8
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|++.++||+|+||.||+|++. +++.||||++... ......++..|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 467999999999999999999886 6899999998653 233445566666666666 899999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+ +++|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 67898888653 345999999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..|+.
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 32 2334579999999998876 78999999999999999999976654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.20 Aligned_cols=205 Identities=30% Similarity=0.498 Sum_probs=159.3
Q ss_pred hccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 356799999999999999999987 468899999986432 2235789999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++++|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999999854 2346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.
T Consensus 164 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 164 MPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred CCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 322 122345789999999999999999999999999999999999999986553
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=304.59 Aligned_cols=201 Identities=30% Similarity=0.364 Sum_probs=171.1
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999885 48899999886543 3345778899999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++++|..++.. ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999988743 345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 12334578999999999876 668999999999999999999999997543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=339.02 Aligned_cols=203 Identities=26% Similarity=0.348 Sum_probs=178.8
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~ 585 (724)
..++|++.++||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3578999999999999999999875 4778999999753 233456788999999988 7999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||+++|+|..++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999643 35999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 3222 23455789999999999999999999999999999999999999997654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=328.10 Aligned_cols=205 Identities=30% Similarity=0.478 Sum_probs=180.6
Q ss_pred hccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
..++|++.+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+.+|++++||||+++++++.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 45679999999999999999998865 7899999997643 346889999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++|+|.+++... ....+++..++.|+.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999653 2345899999999999999999999998 9999999999999999999999999998875433
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.. ......+++.|+|||++....++.++||||||++||||++ |+.||...+
T Consensus 373 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 373 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp EE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 22 2233456789999999999999999999999999999999 999997544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=309.83 Aligned_cols=191 Identities=25% Similarity=0.333 Sum_probs=151.4
Q ss_pred eeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEEEEEEeeCCCCh
Q 004912 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (724)
+.||+|+||.||++.+. +++.||||++... ....+.+|+.++.+++ ||||+++++++.++...++||||+++++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999875 5889999999643 3467789999999997 99999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC---CEEEEecCCccccCCCccccc
Q 004912 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~ 673 (724)
.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++...... ..
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~ 165 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QP 165 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Cc
Confidence 999954 346999999999999999999999998 99999999999997765 89999999998764332 22
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 34467899999999999999999999999999999999999999754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.63 Aligned_cols=203 Identities=20% Similarity=0.282 Sum_probs=169.0
Q ss_pred hccCcceeeeeccCCceeEEeeeecC------CceeEEEeccccChhhH-----------HHHHHHHHHHHHccCCceee
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-----------KEFKNEMMLIAKLQHRNLVR 573 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~-----------~~f~~E~~il~~l~Hpniv~ 573 (724)
..++|++.+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999998754 47899999876542211 12345666677788999999
Q ss_pred EeeEEEec----CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc
Q 004912 574 LLGCCVEQ----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649 (724)
Q Consensus 574 l~~~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 649 (724)
+++++... ...++||||+ +++|.+++... ...+++.+++.|+.||++||+|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998875 4579999999 99999998652 346999999999999999999999998 99999999999999
Q ss_pred --CCCCEEEEecCCccccCCCccc-----ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 650 --KDMNPKISDFGLARMFGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 650 --~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||++||||++|+.||..
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 8899999999999876433211 112345699999999999999999999999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=303.37 Aligned_cols=203 Identities=30% Similarity=0.451 Sum_probs=170.7
Q ss_pred hccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccC-----hhhHHHHHHHHHHHHHcc---CCceeeEeeEEEec
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQ 581 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-----~~~~~~f~~E~~il~~l~---Hpniv~l~~~~~~~ 581 (724)
..++|++.+.||+|+||.||+|++ .+++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 367899999999999999999986 468899999986432 112345677777777775 99999999999876
Q ss_pred C-----eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEE
Q 004912 582 G-----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (724)
Q Consensus 582 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 656 (724)
. ..++||||+. ++|.+++.... ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 59999985432 334899999999999999999999998 999999999999999999999
Q ss_pred EecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+|||+++.+... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 162 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 223 (308)
T 3g33_A 162 ADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223 (308)
T ss_dssp CSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred eeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999876432 22345688999999999999999999999999999999999999996543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=309.92 Aligned_cols=197 Identities=34% Similarity=0.486 Sum_probs=172.6
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.+.|++.+.||+|+||.||+|+. .+++.||||++.... ....+++.+|+.++++++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999986 468899999986432 33457799999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||++ |+|.+++... ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 6787777432 345899999999999999999999998 99999999999999999999999999987542
Q ss_pred CcccccccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.....||+.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 23457999999999984 567899999999999999999999998643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.11 Aligned_cols=200 Identities=27% Similarity=0.409 Sum_probs=177.1
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999875 5889999998653 3445678899999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC---EEEEecCCcccc
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGLARMF 665 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~DFGla~~~ 665 (724)
||+++++|.+.+... ..+++.++..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999999888543 45899999999999999999999998 999999999999986655 999999999876
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 210 (284)
T 3kk8_A 159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210 (284)
T ss_dssp CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence 4332 223467899999999999999999999999999999999999999654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=315.93 Aligned_cols=203 Identities=28% Similarity=0.383 Sum_probs=174.5
Q ss_pred ccCcceeeeeccCCceeEEeeee----cCCceeEEEeccccC----hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecC
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 582 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~----~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~ 582 (724)
.++|++.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999987 368899999986532 23446678899999999 6999999999999999
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
..++||||+++++|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999999643 35899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.+..... .......||+.|+|||++.+ ..++.++||||||++||||++|+.||....
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 87643221 22344679999999999986 347899999999999999999999997543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=299.89 Aligned_cols=202 Identities=21% Similarity=0.297 Sum_probs=176.5
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 56899999999999999999986 568899999986543 335678899999999 79999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC-----EEEEecCCccc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-----PKISDFGLARM 664 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kL~DFGla~~ 664 (724)
|+ +++|.+++... ...+++.++..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999999643 335999999999999999999999998 999999999999987776 99999999987
Q ss_pred cCCCccc-----ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 665 FGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 665 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 7543221 12345679999999999999999999999999999999999999997643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=323.38 Aligned_cols=198 Identities=29% Similarity=0.346 Sum_probs=167.0
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec------C
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------G 582 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~------~ 582 (724)
.++|++.+.||+|+||.||+|++. +++.||||++... .....+++.+|+.+|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999864 5889999999754 344567889999999999999999999998654 3
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
..++||||++++ |...+. ..+++.++..++.||++||+|||+++ |+||||||+|||++.++++||+|||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999865 555552 23899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+..... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 876432 22445689999999999999999999999999999999999999997543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=307.38 Aligned_cols=214 Identities=29% Similarity=0.436 Sum_probs=182.2
Q ss_pred hhhHHHhccCcceeeeeccCCceeEEeeee------cCCceeEEEeccccC-hhhHHHHHHHHHHHHHc-cCCceeeEee
Q 004912 505 LASITAATENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLG 576 (724)
Q Consensus 505 ~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l-~Hpniv~l~~ 576 (724)
........++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 444455678999999999999999999974 246789999997643 34567899999999999 7999999999
Q ss_pred EEEecC-eEEEEEEeeCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCC
Q 004912 577 CCVEQG-EKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642 (724)
Q Consensus 577 ~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlk 642 (724)
++...+ ..++||||+++++|.+++..... ...+++.++..++.||++||+|||+++ |+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence 988765 48999999999999999965332 223889999999999999999999998 9999999
Q ss_pred CCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 643 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 643 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
|+|||++.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999987654433333445678899999999999999999999999999999998 999997644
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.24 Aligned_cols=197 Identities=31% Similarity=0.425 Sum_probs=166.8
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHH--ccCCceeeEeeEEEec----CeEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCVEQ----GEKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~--l~Hpniv~l~~~~~~~----~~~~ 585 (724)
.++|++.+.||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 57899999999999999999987 6889999998653 34556677777777 7999999999987653 4578
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCceEeccCCCCCEEEcCCCCEEEE
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH--------QYSRFRIIHRDLKASNILLDKDMNPKIS 657 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--------~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 657 (724)
+||||+++|+|.+++. ...+++..+.+++.||++||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999993 346899999999999999999999 766 9999999999999999999999
Q ss_pred ecCCccccCCCccc--ccccccccccCccCcccccCC------CCCchhhHHHHHHHHHHHHcC----------CCCCCC
Q 004912 658 DFGLARMFGGDELQ--GNTKQIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSS----------KKNTGL 719 (724)
Q Consensus 658 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwSlGvil~elltG----------~~p~~~ 719 (724)
|||+++........ .......||+.|+|||.+.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999876433211 122345799999999999877 456799999999999999999 788743
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=319.07 Aligned_cols=200 Identities=26% Similarity=0.400 Sum_probs=168.5
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec-----Ce
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GE 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~-----~~ 583 (724)
.++|++.+.||+|+||.||+|+.. +++.||||+++.. .....+++.+|+.+|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 578999999999999999999875 4788999999753 334567899999999999999999999998766 57
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.++||||++ ++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 59999884 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc--------------------ccccccccccCccCcccc-cCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 664 MFGGDELQ--------------------GNTKQIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 664 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
.+...... ......+||+.|+|||++ ....++.++|||||||+||||++|..||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 86433211 123567899999999986 55679999999999999999998766654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=300.01 Aligned_cols=202 Identities=26% Similarity=0.362 Sum_probs=178.7
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|.+.+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 567999999999999999999886 4778999998653 334567899999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++++|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988542 45899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 168 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp TT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred Cc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 12334578999999999999999999999999999999999999997643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.52 Aligned_cols=204 Identities=26% Similarity=0.347 Sum_probs=171.1
Q ss_pred ccCccee-eeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEE
Q 004912 512 TENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 512 ~~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
.+.|++. +.||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4578874 78999999999999864 6889999999776666678899999999995 7999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC---EEEEecCCcccc
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGLARMF 665 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~DFGla~~~ 665 (724)
||+++++|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+++.+
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999643 45899999999999999999999998 999999999999988776 999999999865
Q ss_pred CCCcc-----cccccccccccCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 666 GGDEL-----QGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
..... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 32211 112233569999999999875 558899999999999999999999997543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=311.54 Aligned_cols=200 Identities=24% Similarity=0.367 Sum_probs=175.4
Q ss_pred hccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccCh--------hhHHHHHHHHHHHHHccCCceeeEeeEEEec
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~--------~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~ 581 (724)
..++|++.+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+.++.+++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999986 4588999999875421 1344678899999999999999999999999
Q ss_pred CeEEEEEEeeCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 582 GEKILILEYMPNK-SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 582 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
+..++||||+..| +|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99999843 345999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
+++.+.... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 998765432 2334679999999999988887 8899999999999999999999963
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.27 Aligned_cols=211 Identities=29% Similarity=0.470 Sum_probs=168.2
Q ss_pred HHHhccCcceeeeeccCCceeEEeeeecC----CceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec
Q 004912 508 ITAATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (724)
Q Consensus 508 i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~ 581 (724)
+....++|.+.+.||+|+||.||+|.... +..||||+++.. .....+.+.+|+.++.+++||||+++++++.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 34456789999999999999999997643 457999998754 344567899999999999999999999999876
Q ss_pred Ce-----EEEEEEeeCCCChhHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC
Q 004912 582 GE-----KILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (724)
Q Consensus 582 ~~-----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 653 (724)
+. .++||||+++++|.+++... .....+++.+++.++.||++||+|||+++ |+||||||+|||++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence 53 49999999999999998543 23456999999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 654 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 99999999987754433333344567889999999999999999999999999999999 899997543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=298.35 Aligned_cols=200 Identities=28% Similarity=0.407 Sum_probs=174.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh------hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~ 584 (724)
.++|++.+.||+|+||.||+++.. +++.||||.++.... ...+.+.+|+.++.+++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999886 588999999865321 2467899999999999999999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC----CEEEEecC
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 660 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~DFG 660 (724)
++||||+++++|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999854 345899999999999999999999998 99999999999998877 89999999
Q ss_pred CccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
++..+.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 214 (283)
T 3bhy_A 158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence 998764322 223457899999999999999999999999999999999999999754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.88 Aligned_cols=198 Identities=29% Similarity=0.464 Sum_probs=165.9
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.++|++.+.||+|+||.||+++. .++.||||++... ...+.|.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 46789999999999999999987 4788999999643 34578999999999999999999999876 3478999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC-EEEEecCCccccCCCcc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-PKISDFGLARMFGGDEL 670 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-~kL~DFGla~~~~~~~~ 670 (724)
++++|.+++........+++.+++.++.||++||+|||+.+..+|+||||||+|||++.++. +||+|||++..+...
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999976544456889999999999999999999932223999999999999998886 799999999765322
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 205 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence 2334689999999999999999999999999999999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.38 Aligned_cols=201 Identities=24% Similarity=0.367 Sum_probs=164.2
Q ss_pred HhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--------hhhHHHHHHHHHHHHHccCCceeeEeeEEEe
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 580 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--------~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~ 580 (724)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34678999999999999999999875 47899999986532 122335889999999999999999999974
Q ss_pred cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC---CEEEE
Q 004912 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKIS 657 (724)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~ 657 (724)
.+..++||||+++++|.+++. ....+++.++..++.||++||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 556899999999999998883 3456999999999999999999999998 99999999999997544 59999
Q ss_pred ecCCccccCCCcccccccccccccCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 658 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
|||+++.+.... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 999998764322 2345689999999999864 67889999999999999999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=306.49 Aligned_cols=203 Identities=26% Similarity=0.365 Sum_probs=179.6
Q ss_pred hccCcceeeeeccCCceeEEeeeecC-CceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
..++|.+.+.||+|+||.||+++..+ ++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 35689999999999999999998754 778999998653 33456789999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++++|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999988542 45899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 322 12334678999999999999999999999999999999999999997643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=298.07 Aligned_cols=202 Identities=31% Similarity=0.484 Sum_probs=178.7
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.++|++.+.||+|+||.||++...+++.||||++.... ...+++.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 46799999999999999999998888899999997643 23478999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++++|.+++... ...+++..+..++.||++||+|||+++ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999998643 345899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 12233467889999999999999999999999999999999 89999754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=318.43 Aligned_cols=202 Identities=26% Similarity=0.397 Sum_probs=176.4
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecC--eEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~--~~~lV 587 (724)
.++|++.+.||+|+||.||+|++.. ++.||||+++... ....+.+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4679999999999999999998764 8899999997543 344678889999999999999999999998765 67999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE----cCCCCEEEEecCCcc
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLAR 663 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kL~DFGla~ 663 (724)
|||+++++|.+++........+++.+++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999965544455999999999999999999999998 9999999999999 777889999999998
Q ss_pred ccCCCcccccccccccccCccCcccccC--------CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALD--------GLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 765432 2334679999999999865 5678899999999999999999999963
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=300.16 Aligned_cols=201 Identities=30% Similarity=0.431 Sum_probs=174.3
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
..++|++.+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3578999999999999999999875 46789999986532 2235678999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999998543 35899999999999999999999998 9999999999999999999999999986643
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 32 2334578999999999999999999999999999999999999997554
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.19 Aligned_cols=199 Identities=24% Similarity=0.375 Sum_probs=174.5
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.++|.+.+.||+|+||.||+++.. +++.||||+++.......+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 567999999999999999999875 6889999999866555567789999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE---cCCCCEEEEecCCccccCC
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DFGla~~~~~ 667 (724)
+++++|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999988543 35899999999999999999999998 9999999999999 7889999999999976532
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 2 233457899999999999999999999999999999999999999654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=323.58 Aligned_cols=204 Identities=33% Similarity=0.514 Sum_probs=172.1
Q ss_pred HhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
...++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3467899999999999999999999888889999997644 345789999999999999999999999866 67899999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++|+|.+++... ....+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 259 ~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999999532 2235899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
.. ......++..|+|||.+....++.++||||||++||||++ |+.||...
T Consensus 335 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 335 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 21 2233456789999999999999999999999999999999 99999653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.35 Aligned_cols=204 Identities=26% Similarity=0.373 Sum_probs=164.6
Q ss_pred hccCcceeeeeccCCceeEEeeeecC----CceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
..++|++.+.||+|+||.||+|.... +..||||+++.. .....+.+.+|+.++++++||||+++++++ .++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 35789999999999999999998743 456999998764 344567899999999999999999999997 456788
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||+++++|.+++... ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999998543 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
...... ......+|+.|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence 543221 2233456789999999999999999999999999999997 999997543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.69 Aligned_cols=197 Identities=22% Similarity=0.362 Sum_probs=171.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.++|++.+.||+|+||.||+++.. +++.||||+++.... .+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 567999999999999999999875 588999999975432 235688888888 79999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC----CCEEEEecCCcccc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD----MNPKISDFGLARMF 665 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kL~DFGla~~~ 665 (724)
|+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+.+. +.+||+|||+++.+
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999853 346999999999999999999999998 9999999999998543 35999999999876
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 171 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 171 RAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp BCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 4432 2234568899999999998888999999999999999999999999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=311.80 Aligned_cols=198 Identities=21% Similarity=0.293 Sum_probs=162.9
Q ss_pred ccCccee-eeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEe----cCeE
Q 004912 512 TENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE----QGEK 584 (724)
Q Consensus 512 ~~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~----~~~~ 584 (724)
.++|.+. +.||+|+||.||++.+. +++.||||+++.. ..+.+|+.++.++ +||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567776 68999999999999875 5789999999632 4567888887554 89999999999875 5578
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC---CCCEEEEecCC
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGL 661 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFGl 661 (724)
++||||+++|+|.+++... ....+++.++..|+.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999999642 2345999999999999999999999998 999999999999987 78999999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
++...... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||...+
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 98764322 2345688999999999999999999999999999999999999996543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=321.56 Aligned_cols=194 Identities=25% Similarity=0.409 Sum_probs=154.7
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec-----Ce
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GE 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~-----~~ 583 (724)
.++|++.+.||+|+||.||+|++. +++.||||++... .....+++.+|+.+|.+++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999875 5889999998653 334567899999999999999999999998543 46
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.++||||+ +++|..++. ....+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999997 578988884 3356999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcc-------------------------cccccccccccCccCcccc-cCCCCCchhhHHHHHHHHHHHHc
Q 004912 664 MFGGDEL-------------------------QGNTKQIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLS 712 (724)
Q Consensus 664 ~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwSlGvil~ellt 712 (724)
.+..... .......+||+.|+|||++ ....++.++||||||||||||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 7643211 0123456789999999986 55679999999999999999999
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=301.17 Aligned_cols=196 Identities=27% Similarity=0.422 Sum_probs=172.6
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-C-------ceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-G-------QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g-------~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~ 583 (724)
.++|++.+.||+|+||.||+|+... + ..||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4679999999999999999997653 2 4699999987776778899999999999999999999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC--------EE
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--------PK 655 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~k 655 (724)
.++||||+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999643 334899999999999999999999998 999999999999998887 99
Q ss_pred EEecCCccccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCC-CCCC
Q 004912 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK-KNTG 718 (724)
Q Consensus 656 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~-~p~~ 718 (724)
|+|||++..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|. .|+.
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~ 220 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence 999999976532 223467899999999987 77999999999999999999955 5544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=300.77 Aligned_cols=202 Identities=32% Similarity=0.493 Sum_probs=162.3
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
..++|++.+.||+|+||.||+|+.. ..||||+++.. .....+.|.+|+.++++++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3568999999999999999999764 35999998654 345567899999999999999999999965 556789999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++++|.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999999853 3345999999999999999999999998 999999999999999999999999999876543
Q ss_pred cccccccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
..........||+.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 3333344567999999999986 667899999999999999999999999653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.59 Aligned_cols=204 Identities=31% Similarity=0.489 Sum_probs=167.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCce----eEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQE----VAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~----vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
.++|++.++||+|+||.||+|++. +++. ||+|.+... .....+++.+|+.++.+++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999864 3444 577777543 3446788999999999999999999999998754 78
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+|+||+++++|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998653 345899999999999999999999998 999999999999999999999999999887
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 54433333344567889999999999999999999999999999999 999997644
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=297.13 Aligned_cols=204 Identities=29% Similarity=0.467 Sum_probs=175.6
Q ss_pred ccCcceee-eeccCCceeEEeeeec---CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~-~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.++|.+.+ .||+|+||.||+|... ++..||||+++.. .....+++.+|+.++.+++||||+++++++ +.+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45677776 9999999999999753 5778999999764 344577899999999999999999999998 5667899
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++++|.+++.. ....+++.++..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999853 3445999999999999999999999998 9999999999999999999999999998875
Q ss_pred CCcc-cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 667 GDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 667 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 4322 122233456889999999998999999999999999999998 999997543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=299.05 Aligned_cols=203 Identities=25% Similarity=0.399 Sum_probs=172.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.++|++.+.||+|+||.||+++.. ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467999999999999999999874 57899999986543 3456889999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE---cCCCCEEEEecCCcccc
Q 004912 590 YMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMF 665 (724)
Q Consensus 590 y~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DFGla~~~ 665 (724)
|+++++|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999885432 2356999999999999999999999998 9999999999999 45688999999999876
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||...+
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 4332 233457899999999875 568999999999999999999999997543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.26 Aligned_cols=200 Identities=27% Similarity=0.419 Sum_probs=178.8
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.+.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467999999999999999999864 58899999986543 3456889999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++++|.+++. ...+++.++..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999983 346899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 2234457899999999999999999999999999999999999999643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=307.83 Aligned_cols=206 Identities=22% Similarity=0.372 Sum_probs=178.7
Q ss_pred hhHHHhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--------hhhHHHHHHHHHHHHHc-cCCceeeEe
Q 004912 506 ASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKL-QHRNLVRLL 575 (724)
Q Consensus 506 ~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--------~~~~~~f~~E~~il~~l-~Hpniv~l~ 575 (724)
.......++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334445678999999999999999999885 68999999986543 12246788999999999 799999999
Q ss_pred eEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEE
Q 004912 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655 (724)
Q Consensus 576 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 655 (724)
+++...+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999998543 45899999999999999999999998 99999999999999999999
Q ss_pred EEecCCccccCCCcccccccccccccCccCcccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 656 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
|+|||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 99999998775432 2344689999999998863 35889999999999999999999999653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=302.62 Aligned_cols=203 Identities=23% Similarity=0.295 Sum_probs=167.4
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
..++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999875 58899999997542 3345789999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++++|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998543 45899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 4321 2233457899999999999999999999999999999999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=304.50 Aligned_cols=202 Identities=28% Similarity=0.406 Sum_probs=171.6
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
.++|++.+.||+|+||.||+++... ++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 4679999999999999999998754 8899999985543 334567889999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++++|..++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999988863 2345899999999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 178 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 178 G--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 123345789999999999875 78999999999999999999999997654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.07 Aligned_cols=206 Identities=30% Similarity=0.477 Sum_probs=181.5
Q ss_pred HhccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
...++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 356789999999999999999998864 7889999997543 45678999999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999999653 3356899999999999999999999998 999999999999999999999999999876543
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 165 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp SS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 22 22334567889999999999999999999999999999999 999997544
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=301.66 Aligned_cols=202 Identities=31% Similarity=0.507 Sum_probs=173.4
Q ss_pred ccCcceeeeeccCCceeEEeeee-----cCCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec--Ce
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GE 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~ 583 (724)
.+.|++.+.||+|+||.||+|+. .+++.||||+++.. .....+.+.+|+.++.+++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45689999999999999999983 35889999999754 334567899999999999999999999999876 66
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.++||||+++++|.+++.... ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 899999999999999985432 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcc-cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 664 MFGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 664 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
.+..... ........+|..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 8754321 122344568889999999999999999999999999999999998864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=311.34 Aligned_cols=200 Identities=26% Similarity=0.376 Sum_probs=176.6
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999875 5889999998764 34456789999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
|+++++|.+++... ..+++..+..++.||++||+|||+. + |+||||||+|||++.++.+||+|||++..+..
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 99999999999543 3589999999999999999999986 7 99999999999999999999999999976532
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12334578999999999999999999999999999999999999997543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=305.99 Aligned_cols=203 Identities=29% Similarity=0.441 Sum_probs=178.3
Q ss_pred ccCcceeeeeccCCceeEEeeee-----cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEE--ecCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV--EQGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~--~~~~~ 584 (724)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999984 357899999998877777788999999999999999999999987 44568
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||+++++|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 99999999999999986432 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcc-cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 665 FGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
+..... ........+|+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 753321 1223345688889999999999999999999999999999999999853
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=296.60 Aligned_cols=203 Identities=35% Similarity=0.496 Sum_probs=176.3
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
..++|++.+.||+|+||.||+|...+++.||||+++... ...+.+.+|+.++++++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 357899999999999999999998888899999997543 34678999999999999999999999876 4568899999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++++|.+++... ....+++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999998432 1225899999999999999999999998 99999999999999999999999999988754332
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
. ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred c-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 2 2233457889999999998999999999999999999999 99999654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=297.88 Aligned_cols=200 Identities=27% Similarity=0.399 Sum_probs=177.1
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999875 47789999986432 22357789999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++++|.+++... ..+++.++..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999998543 35899999999999999999999998 99999999999999999999999999976543
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 2 2234578999999999999999999999999999999999999997543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=309.91 Aligned_cols=197 Identities=27% Similarity=0.394 Sum_probs=167.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC------
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 582 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~------ 582 (724)
.++|++.+.||+|+||.||+|.+. +|+.||||++... .....+++.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 578999999999999999999874 5889999998543 3345678899999999999999999999987653
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899999854 35899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 176 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 176 RQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp EECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 87543 2344678999999999887 679999999999999999999999997543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.30 Aligned_cols=203 Identities=29% Similarity=0.387 Sum_probs=165.7
Q ss_pred HhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh--hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
...++|++.++||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+++..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999864 688999999965432 235678899999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc-----CCCCEEEEecCC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-----KDMNPKISDFGL 661 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~-----~~~~~kL~DFGl 661 (724)
||||+++ +|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||++ ..+.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999984 999988543 35899999999999999999999998 99999999999994 455699999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
++.+.... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||...+
T Consensus 184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 242 (329)
T 3gbz_A 184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 98764322 223445789999999999875 48999999999999999999999997543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=307.14 Aligned_cols=201 Identities=27% Similarity=0.407 Sum_probs=166.4
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChh-hHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999875 6889999998654322 122456799999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
++ ++|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 98 5888887543 345899999999999999999999998 9999999999999999999999999998654321
Q ss_pred cccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22334578999999999876 568999999999999999999999997654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=304.85 Aligned_cols=204 Identities=27% Similarity=0.441 Sum_probs=172.5
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEec-------
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------- 581 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~------- 581 (724)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++.+++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999987 468899999986543 22356788999999999999999999999873
Q ss_pred -CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 582 -GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 582 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
+..++||||+++ +|...+.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999985 66666643 2345999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCc--ccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 661 LARMFGGDE--LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 661 la~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+++.+.... .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 998764321 1223345678999999999876 458999999999999999999999997543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=307.90 Aligned_cols=201 Identities=20% Similarity=0.265 Sum_probs=166.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec----CCceeEEEeccccChh-----------hHHHHHHHHHHHHHccCCceeeEee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQ-----------GLKEFKNEMMLIAKLQHRNLVRLLG 576 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~-----------~~~~f~~E~~il~~l~Hpniv~l~~ 576 (724)
.++|++.+.||+|+||.||+|+.. .+..+|||++...... ..+.+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999875 5678999998754322 1234678889999999999999999
Q ss_pred EEEe----cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC
Q 004912 577 CCVE----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 652 (724)
Q Consensus 577 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 652 (724)
++.. ....++||||+ +++|.+++... ..+++.+++.++.||++||+|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67889999999 99999998432 36999999999999999999999998 99999999999999887
Q ss_pred --CEEEEecCCccccCCCcc-----cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 653 --NPKISDFGLARMFGGDEL-----QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 653 --~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.+||+|||+++.+..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999999987643211 1112446799999999999999999999999999999999999999954
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=319.06 Aligned_cols=201 Identities=16% Similarity=0.236 Sum_probs=165.5
Q ss_pred hccCcceeeeeccCCceeEEeeee-cCCceeEEEeccc---cChhhHHHHHHHH---HHHHHccCCceeeEe-------e
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSN---QSGQGLKEFKNEM---MLIAKLQHRNLVRLL-------G 576 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~---~~~~~~~~f~~E~---~il~~l~Hpniv~l~-------~ 576 (724)
..++|++.+.||+|+||.||+|++ .+++.||||++.. ......+.|.+|+ .++++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357899999999999999999986 4589999999863 2344568899999 555566899999998 6
Q ss_pred EEEecCe-----------------EEEEEEeeCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 004912 577 CCVEQGE-----------------KILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635 (724)
Q Consensus 577 ~~~~~~~-----------------~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ 635 (724)
++.+.+. .++||||+ +|+|.+++..... ...+++..++.|+.||++||+|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 6665532 78999999 6899999864321 123446888899999999999999998
Q ss_pred eEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCC-----------CCCchhhHHHHH
Q 004912 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-----------LFSIKSDVFSFG 704 (724)
Q Consensus 636 iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DVwSlG 704 (724)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999999999999999999986432 2334567 999999999887 899999999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 004912 705 ILMLETLSSKKNTGLGS 721 (724)
Q Consensus 705 vil~elltG~~p~~~~~ 721 (724)
|+||||++|+.||...+
T Consensus 301 ~il~elltg~~Pf~~~~ 317 (377)
T 3byv_A 301 LVIYWIWCADLPITKDA 317 (377)
T ss_dssp HHHHHHHHSSCCC----
T ss_pred HHHHHHHHCCCCCcccc
Confidence 99999999999997544
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=295.18 Aligned_cols=200 Identities=23% Similarity=0.329 Sum_probs=173.1
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~l 586 (724)
..++|++.+.||+|+||.||+|+.. +++.||||++... ......++.+|+.++.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3578999999999999999999875 6899999998753 234567788999999999 99999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC---------------
Q 004912 587 ILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK--------------- 650 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--------------- 650 (724)
||||+++++|.+++..... ...+++.++..++.||++||+|||+++ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999965322 256899999999999999999999998 999999999999984
Q ss_pred ----CCCEEEEecCCccccCCCcccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 651 ----DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 651 ----~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|+.|+..
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 4479999999998764322 23589999999999876 567899999999999999999987643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=304.55 Aligned_cols=208 Identities=31% Similarity=0.482 Sum_probs=174.1
Q ss_pred hccCcceeeeeccCCceeEEeeee------cCCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~ 583 (724)
..++|++.+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++.+++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 357899999999999999999974 24678999999754 34556789999999999999999999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC---CCCEEE
Q 004912 584 KILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKI 656 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL 656 (724)
.++||||+++++|.+++..... ...+++.+++.++.||++||+|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999975432 245899999999999999999999998 999999999999984 456999
Q ss_pred EecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
+|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 99999986644333333344578899999999999999999999999999999998 999997543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=302.69 Aligned_cols=204 Identities=32% Similarity=0.468 Sum_probs=169.6
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-----CceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
.++|++.+.||+|+||.||+|.... +..||||+++.. ......++.+|+.++.+++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4678899999999999999998653 235999999754 3345668999999999999999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||+++++|.+++... ...+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999998643 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 666 GGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 666 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 543211 11223356789999999999999999999999999999999 99999643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.91 Aligned_cols=201 Identities=29% Similarity=0.566 Sum_probs=171.2
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChh-------hHHHHHHHHHHHHHccCCceeeEeeEEEecC
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-------GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 582 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-------~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~ 582 (724)
..++|++.+.||+|+||.||+|++. +++.||||++...... ..+++.+|+.++.+++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3578999999999999999999874 6889999998653321 1267899999999999999999999986554
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC-----EEEE
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-----PKIS 657 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kL~ 657 (724)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||+++. +|+||||||+|||++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~-~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCCC-CeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999988854 34469999999999999999999998852 4999999999999988776 9999
Q ss_pred ecCCccccCCCcccccccccccccCccCcccc--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 658 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYA--LDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
|||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||...+
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 9999985432 23446789999999998 45568999999999999999999999997654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=305.06 Aligned_cols=212 Identities=25% Similarity=0.325 Sum_probs=163.8
Q ss_pred HHHhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEe-----
Q 004912 508 ITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVE----- 580 (724)
Q Consensus 508 i~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~----- 580 (724)
+.....+|++.++||+|+||.||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3445668999999999999999999874 68899999997777677788999999999996 9999999999853
Q ss_pred ---cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEE
Q 004912 581 ---QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 657 (724)
Q Consensus 581 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 657 (724)
....++||||+. |+|.+++........+++.++..++.||+.||+|||+++. +|+||||||+|||++.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSCEEBC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCCEEEe
Confidence 334789999996 7899988664455679999999999999999999998752 49999999999999999999999
Q ss_pred ecCCccccCCCccc----------ccccccccccCccCcccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 658 DFGLARMFGGDELQ----------GNTKQIVGTYGYMSPEYA---LDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 658 DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~---~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
|||+++.+...... .......||+.|+|||++ .+..++.++||||||+++|||++|+.||....
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99999876542211 111235689999999998 56778999999999999999999999997544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=296.79 Aligned_cols=202 Identities=31% Similarity=0.463 Sum_probs=172.8
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
+.|.....||+|+||.||+|... +++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34455569999999999999864 57899999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-CCCEEEEecCCccccCCCcc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~~~~ 670 (724)
++++|.+++........+++..+..++.||++||+|||+++ |+|+||||+||+++. ++.+||+|||+++.+....
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 99999999976544456789999999999999999999998 999999999999987 8999999999998764322
Q ss_pred cccccccccccCccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.......|++.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 1233457899999999987654 88999999999999999999999953
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.35 Aligned_cols=205 Identities=26% Similarity=0.441 Sum_probs=166.8
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|++.+.||+|+||.||+|.. .+++.||||+++.. .....+++.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45799999999999999999986 46889999998753 344567899999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 588 LEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
|||+++++|.+++.... ....+++.++..++.||++||+|||+.+ |+|+||||+||+++.++.+||+|||++..+.
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999986422 3456899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 322 12234578999999999999999999999999999999999999996543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=302.72 Aligned_cols=207 Identities=25% Similarity=0.316 Sum_probs=174.9
Q ss_pred HHhccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEe----cCe
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGE 583 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~----~~~ 583 (724)
....++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++.. ...
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 34467899999999999999999987 5688999999977666777889999999999999999999999873 346
Q ss_pred EEEEEEeeCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 584 KILILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
.++||||+++++|.+++.... ....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 789999999999999986532 3456999999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCccc-------ccccccccccCccCcccccCCC---CCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 663 RMFGGDELQ-------GNTKQIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 663 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
......... .......||+.|+|||.+.... ++.++||||||+++|||++|+.||.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 765321100 0112345799999999987654 6899999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=295.09 Aligned_cols=203 Identities=30% Similarity=0.414 Sum_probs=171.9
Q ss_pred hccCcceeeeeccCCceeEEeeeecC----CceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
..++|++.+.||+|+||.||+|+..+ +..||||.++.. .....+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45789999999999999999998643 336999999765 34456789999999999999999999999764 4568
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999999643 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 543221 2233467889999999999999999999999999999998 99999643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=307.32 Aligned_cols=209 Identities=28% Similarity=0.362 Sum_probs=171.5
Q ss_pred chhhHHHhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccC-----------hhhHHHHHHHHHHHHHccCCcee
Q 004912 504 SLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS-----------GQGLKEFKNEMMLIAKLQHRNLV 572 (724)
Q Consensus 504 ~~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-----------~~~~~~f~~E~~il~~l~Hpniv 572 (724)
...++....++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++.+++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3556677789999999999999999999998889999999985432 12347899999999999999999
Q ss_pred eEeeEEEec-----CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEE
Q 004912 573 RLLGCCVEQ-----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647 (724)
Q Consensus 573 ~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NIL 647 (724)
++++++... ...++||||++ ++|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998653 35799999998 578777753 3446999999999999999999999998 999999999999
Q ss_pred EcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 648 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
++.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999998653322 2334578999999999877 678999999999999999999999997643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=294.26 Aligned_cols=200 Identities=27% Similarity=0.441 Sum_probs=169.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999875 68899999986532 23467899999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++++|.+++... ..+++.++..++.||++||+|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999998543 35899999999999999999999998 99999999999999999999999999987644
Q ss_pred CcccccccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.. ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 32 1234578999999999988776 68999999999999999999999754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.22 Aligned_cols=202 Identities=27% Similarity=0.390 Sum_probs=167.7
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEE-----------
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV----------- 579 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~----------- 579 (724)
.++|++.+.||+|+||.||+|.... ++.||||++........+++.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999998864 8899999998777777889999999999999999999999873
Q ss_pred ---ecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc-CCCCEE
Q 004912 580 ---EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPK 655 (724)
Q Consensus 580 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~k 655 (724)
+....++||||++ ++|.+++. ...+++..+..++.||++||+|||+++ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 69999883 345899999999999999999999998 99999999999997 567999
Q ss_pred EEecCCccccCCCcc-cccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 656 ISDFGLARMFGGDEL-QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 656 L~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
|+|||+++.+..... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 999999987643211 122334567999999998865 678999999999999999999999997543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.14 Aligned_cols=210 Identities=27% Similarity=0.381 Sum_probs=177.6
Q ss_pred chhhHHHhccCccee-eeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHcc-CCceeeEeeEE
Q 004912 504 SLASITAATENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCC 578 (724)
Q Consensus 504 ~~~~i~~~~~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~-Hpniv~l~~~~ 578 (724)
.+.......+.|.+. +.||+|+||.||+|+.. +++.||||+++... ....+++.+|+.++.+++ ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344445566778887 89999999999999875 58899999987542 334678999999999995 69999999999
Q ss_pred EecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC---CCCEE
Q 004912 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPK 655 (724)
Q Consensus 579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~k 655 (724)
.+.+..++||||+++++|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+|
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence 9999999999999999999998432 2356999999999999999999999998 999999999999987 78999
Q ss_pred EEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 656 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
|+|||+++.+.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 175 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998764322 233467999999999999999999999999999999999999999654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=299.41 Aligned_cols=203 Identities=27% Similarity=0.465 Sum_probs=172.4
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
..++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3578999999999999999999886 488999999987766778899999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++++|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999998543 345899999999999999999999998 999999999999999999999999997643211
Q ss_pred ccccccccccccCccCcccc-----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYA-----LDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~-----~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
........||+.|+|||++ ....++.++||||||+++|||++|+.||...
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 1112335789999999988 4677899999999999999999999999754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=305.91 Aligned_cols=204 Identities=30% Similarity=0.420 Sum_probs=168.5
Q ss_pred HhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChh-----hHHHHHHHHHHHHHccCCceeeEeeEEEecCe
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~ 583 (724)
...++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34678999999999999999999875 4889999998653221 13468899999999999999999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.++||||+++ +|..++.. ....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 78888743 2345888999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.+.... .......||+.|+|||++.+. .++.++||||||+++|||++|..||...+
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~ 217 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 764322 223446789999999998764 58999999999999999999999987543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=309.88 Aligned_cols=204 Identities=29% Similarity=0.459 Sum_probs=163.1
Q ss_pred cCcceeeeeccCCceeEEeeeecC----CceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe-cCeEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEKIL 586 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~-~~~~~l 586 (724)
..|.+.+.||+|+||.||+|+..+ +..||||.++.. .....++|.+|+.++++++||||+++++++.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 457888999999999999998643 236899998654 33556889999999999999999999998764 457799
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++++|.+++.. ....+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999953 3345889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc--ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 667 GDELQ--GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~ 301 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence 33211 12233567889999999999999999999999999999999 677886543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=319.25 Aligned_cols=201 Identities=30% Similarity=0.468 Sum_probs=174.5
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
..++|++.++||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3577999999999999999999875 6889999998643 233567899999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc---CCCCEEEEecCCccc
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARM 664 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kL~DFGla~~ 664 (724)
|||+++++|.+.+... ..+++.++..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999988543 45899999999999999999999998 99999999999995 456799999999987
Q ss_pred cCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...+
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 64332 2344679999999998875 59999999999999999999999996543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=310.55 Aligned_cols=200 Identities=25% Similarity=0.381 Sum_probs=168.5
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe------EE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE------KI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~------~~ 585 (724)
..+|++.+.||+|+||.||+|++..+..+|+|++..... ...+|+.++++++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 457999999999999999999988777899998854322 12469999999999999999999976543 78
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc-CCCCEEEEecCCccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARM 664 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~~ 664 (724)
+||||++++.+............+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999988665555433334567999999999999999999999998 99999999999999 799999999999987
Q ss_pred cCCCcccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus 192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 64332 22345789999999998765 58999999999999999999999997654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=321.05 Aligned_cols=200 Identities=31% Similarity=0.464 Sum_probs=176.8
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 567999999999999999999875 68899999986432 34568899999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE---cCCCCEEEEecCCccc
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARM 664 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DFGla~~ 664 (724)
|||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999998853 345899999999999999999999998 9999999999999 5678999999999987
Q ss_pred cCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...+
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 64432 2344679999999998866 69999999999999999999999997543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=305.55 Aligned_cols=198 Identities=28% Similarity=0.340 Sum_probs=164.0
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC------
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 582 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~------ 582 (724)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999864 5889999998653 3345678899999999999999999999997664
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
..++||||+++ +|.+++. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999975 6777773 23889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8764321 2334678999999999999999999999999999999999999997543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=326.19 Aligned_cols=204 Identities=33% Similarity=0.512 Sum_probs=177.4
Q ss_pred HhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
...++|++.++||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3467899999999999999999999888889999997644 345789999999999999999999999866 67899999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++|+|.+++... ....+++.+++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999532 1235899999999999999999999998 9999999999999999999999999998765332
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
. .......++..|+|||.+....++.++||||||++||||++ |+.||...
T Consensus 418 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 418 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp H-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred e-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 12233456789999999999999999999999999999999 99999653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=317.63 Aligned_cols=201 Identities=29% Similarity=0.430 Sum_probs=173.6
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh-------------hhHHHHHHHHHHHHHccCCceeeEee
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-------------QGLKEFKNEMMLIAKLQHRNLVRLLG 576 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-------------~~~~~f~~E~~il~~l~Hpniv~l~~ 576 (724)
..++|++.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4678999999999999999999875 478999999865321 33577899999999999999999999
Q ss_pred EEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC---C
Q 004912 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---N 653 (724)
Q Consensus 577 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~ 653 (724)
++.+....++||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999988543 45899999999999999999999998 99999999999998775 6
Q ss_pred EEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 654 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+||+|||+++.+.... ......||+.|+|||++. ..++.++||||||+++|||++|+.||...+
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999998765432 234467999999999876 569999999999999999999999997654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=319.20 Aligned_cols=200 Identities=28% Similarity=0.418 Sum_probs=170.9
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
.+.|++.+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999875 57899999987542 334578899999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC---CCEEEEecCCcccc
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFGLARMF 665 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~DFGla~~~ 665 (724)
||+++|+|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||++.. +.+||+|||+++.+
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999888543 45899999999999999999999998 9999999999999764 45999999999876
Q ss_pred CCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||...+
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5432 234467999999999876 569999999999999999999999997543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.56 Aligned_cols=196 Identities=28% Similarity=0.480 Sum_probs=172.6
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEe---------
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--------- 580 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~--------- 580 (724)
...+|++.+.||+|+||.||+|+.. +++.||||+++... +.+.+|+.++.+++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999885 68999999997544 356789999999999999999998864
Q ss_pred -------cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC
Q 004912 581 -------QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (724)
Q Consensus 581 -------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 653 (724)
....++||||+++++|.+++... ....+++..+..++.||++||+|||+++ |+|+||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34578999999999999999643 2346899999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004912 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 717 (724)
Q Consensus 654 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~ 717 (724)
+||+|||+++.+.... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus 161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 221 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221 (284)
T ss_dssp EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence 9999999998775432 223457899999999999999999999999999999999999886
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=326.55 Aligned_cols=204 Identities=29% Similarity=0.460 Sum_probs=170.0
Q ss_pred ccCcceee-eeccCCceeEEeeeec---CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~-~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.+++.+.+ .||+|+||.||+|.+. ++..||||+++... ....++|.+|+.+|++++||||+++++++.. +..++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 44555555 8999999999999764 45679999997653 3467889999999999999999999999876 56899
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++|+|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 413 v~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999999999999853 3456999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcc-cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 667 GDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 667 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.... ........+++.|+|||++.+..++.++|||||||+||||++ |+.||...+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 3321 111222345789999999999999999999999999999998 999997543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=307.34 Aligned_cols=197 Identities=31% Similarity=0.412 Sum_probs=156.1
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec------C
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------G 582 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~------~ 582 (724)
.++|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 578999999999999999999864 5889999999653 334567889999999999999999999998754 5
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
..++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999998 7899888732 45999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 180 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 180 RHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 87532 2334678999999999887 678999999999999999999999997543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=309.36 Aligned_cols=200 Identities=23% Similarity=0.288 Sum_probs=174.2
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHc------cCCceeeEeeEEEecCe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL------QHRNLVRLLGCCVEQGE 583 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l------~Hpniv~l~~~~~~~~~ 583 (724)
...+|++.+.||+|+||.||+|... +++.||||+++.. ....+++.+|+.++..+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3567999999999999999999775 4789999999753 34456788899999988 46799999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC--EEEEecCC
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--PKISDFGL 661 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kL~DFGl 661 (724)
.++||||+. ++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 6898888653 2345899999999999999999999998 999999999999999887 99999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
++.... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...+
T Consensus 249 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 976532 2334578999999999999999999999999999999999999997654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=293.28 Aligned_cols=201 Identities=26% Similarity=0.358 Sum_probs=176.1
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---------hhhHHHHHHHHHHHHHcc-CCceeeEeeEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---------GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCV 579 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---------~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~ 579 (724)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999875 57899999986532 123567889999999996 999999999999
Q ss_pred ecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEec
Q 004912 580 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659 (724)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF 659 (724)
+....++||||+++++|.+++... ..+++.++..++.||+.||+|||+++ |+|+||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999999999998543 45899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCcccccccccccccCccCccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYAL------DGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
|++..+.... ......|++.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 9998765432 233457899999999885 456899999999999999999999999654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=312.40 Aligned_cols=199 Identities=28% Similarity=0.414 Sum_probs=164.8
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC------eE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~------~~ 584 (724)
..+|++.+.||+|+||.||+|++. +++.||||++.... +.+.+|+++|++++||||+++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346999999999999999999885 58899999986532 22347999999999999999999986431 35
Q ss_pred EEEEEeeCCCChhHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC-CCEEEEecCCc
Q 004912 585 ILILEYMPNKSLNVFLFD-STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLA 662 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DFGla 662 (724)
++||||+++ +|..++.. ......+++..+..++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 789999986 55555432 233456999999999999999999999998 9999999999999965 56899999999
Q ss_pred cccCCCcccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.+.... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||...+
T Consensus 205 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 205 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp EECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 8764332 22345789999999998765 79999999999999999999999997653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.54 Aligned_cols=211 Identities=28% Similarity=0.472 Sum_probs=172.7
Q ss_pred cchhhHHHhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEe
Q 004912 503 FSLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 580 (724)
Q Consensus 503 ~~~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~ 580 (724)
+.+..+....++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 444455566889999999999999999999874 68899999986543 3457889999999999 79999999999987
Q ss_pred ------cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCE
Q 004912 581 ------QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 654 (724)
Q Consensus 581 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 654 (724)
....++||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 46789999999999999998653 2356899999999999999999999998 9999999999999999999
Q ss_pred EEEecCCccccCCCcccccccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 655 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 655 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
||+|||++..+.... .......||+.|+|||++. +..++.++||||||+++|||++|+.||...
T Consensus 169 kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 999999998764321 1233457899999999987 567899999999999999999999999643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=298.75 Aligned_cols=199 Identities=31% Similarity=0.453 Sum_probs=171.6
Q ss_pred CcceeeeeccCCceeEEeeee-----cCCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 585 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~~ 585 (724)
.|++.+.||+|+||.||++.. .+++.||||+++... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 359999999999999988754 257889999997653 34567899999999999999999999999884 5789
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||+++++|.+++.. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 112 lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999843 34899999999999999999999998 999999999999999999999999999887
Q ss_pred CCCcc-cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 666 GGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 666 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
..... ........+|+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 54321 1223345678899999999999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=294.78 Aligned_cols=208 Identities=28% Similarity=0.433 Sum_probs=175.0
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe--cCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~--~~~~~l 586 (724)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999875 5889999998653 34456789999999999999999999998865 567899
Q ss_pred EEEeeCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 587 ILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSR--FRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~--~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
||||+++++|.+++.... ....+++..+..++.||++||+|||+.+. .+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986532 23459999999999999999999999761 249999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.+.... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 764322 11233578999999999999999999999999999999999999997543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=297.23 Aligned_cols=194 Identities=23% Similarity=0.388 Sum_probs=171.1
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEe--cCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVE--QGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~--~~~~~lV 587 (724)
.++|++.+.||+|+||.||+|+. .+++.||||+++.. ..+.+.+|+.++.+++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46899999999999999999976 46889999999753 3467899999999997 9999999999987 5678999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC-CEEEEecCCccccC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFG 666 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~~~ 666 (724)
|||+++++|.+++. .+++.++..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++.+.
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999873 2889999999999999999999998 99999999999999776 89999999998764
Q ss_pred CCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..+
T Consensus 183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 432 2334578999999999887 67899999999999999999999999543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=297.45 Aligned_cols=203 Identities=32% Similarity=0.450 Sum_probs=172.0
Q ss_pred hccCcceee-eeccCCceeEEeeeec---CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeE
Q 004912 511 ATENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 511 ~~~~~~~~~-~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~ 584 (724)
..++|.+.+ .||+|+||.||+|... .++.||||+++... ....+++.+|+.++.+++||||+++++++ +.+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 456788888 9999999999999542 36789999997543 33467899999999999999999999998 66778
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||+++++|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 999999999999999954 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 665 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
+...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 224 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 7543221 12223456789999999999899999999999999999999 99999754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=295.59 Aligned_cols=201 Identities=29% Similarity=0.453 Sum_probs=173.0
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
..++|++.+.||+|+||.||+|... +++.||||++.... ..+++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999875 48899999997543 34678999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++++|.+++... ...+++.++..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999998532 345899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 180 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 180 --AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp --SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred --cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 2233457899999999999999999999999999999999999999653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=309.23 Aligned_cols=198 Identities=13% Similarity=0.151 Sum_probs=156.0
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHc--cCCceeeEe-------eEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL--QHRNLVRLL-------GCC 578 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l--~Hpniv~l~-------~~~ 578 (724)
...|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999875 68899999997643 23456788886666666 599988755 555
Q ss_pred EecC-----------------eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCc
Q 004912 579 VEQG-----------------EKILILEYMPNKSLNVFLFDSTKKRLLNWQAR------VRIIEGIAQGLLYLHQYSRFR 635 (724)
Q Consensus 579 ~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~~L~yLH~~~~~~ 635 (724)
...+ ..++||||++ ++|.+++.... ..+.+..+ ..++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 4432 3799999999 89999996532 23455555 678899999999999998
Q ss_pred eEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcC
Q 004912 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSS 713 (724)
Q Consensus 636 iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG 713 (724)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||||++||||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999876432 113466799999999987 7799999999999999999999
Q ss_pred CCCCCCC
Q 004912 714 KKNTGLG 720 (724)
Q Consensus 714 ~~p~~~~ 720 (724)
+.||...
T Consensus 290 ~~Pf~~~ 296 (371)
T 3q60_A 290 FLPFGLV 296 (371)
T ss_dssp SCSTTBC
T ss_pred CCCCCCc
Confidence 9999765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=292.34 Aligned_cols=199 Identities=23% Similarity=0.381 Sum_probs=172.3
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec--CeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~--~~~~lV 587 (724)
.++|++.+.||+|+||.||+|+. +++.||||+++.. .....++|.+|+.++.+++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 46799999999999999999998 4889999999754 344567899999999999999999999999877 678999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++++|.+++... ....+++.++..++.||++||+|||+++. +|+||||||+|||++.++.++|.|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 9999999999999643 23358999999999999999999998752 49999999999999999999999999875432
Q ss_pred CcccccccccccccCccCcccccCCCCCc---hhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSI---KSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.....||+.|+|||.+.+..++. ++||||||+++|||++|+.||...
T Consensus 165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 22357899999999998766544 899999999999999999999754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.62 Aligned_cols=201 Identities=24% Similarity=0.370 Sum_probs=169.2
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC--------hhhHHHHHHHHHHHHHccCCceeeEeeEEEec
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--------~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~ 581 (724)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++.+++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3568999999999999999999875 47899999986532 12234688999999999999999999998765
Q ss_pred CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC---EEEEe
Q 004912 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISD 658 (724)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~D 658 (724)
. .++||||+++++|.+++. ....+++.++..++.||++||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999999884 3456899999999999999999999998 999999999999987664 99999
Q ss_pred cCCccccCCCcccccccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
||+++.+.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99998764322 123457899999999874 5678999999999999999999999997543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.85 Aligned_cols=203 Identities=33% Similarity=0.493 Sum_probs=171.3
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCce--eEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQE--VAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~--vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV 587 (724)
++|++.+.||+|+||.||+|+.. ++.. +|||+++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67899999999999999999875 4554 499998653 334566799999999999 899999999999999999999
Q ss_pred EEeeCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCE
Q 004912 588 LEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 654 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 654 (724)
|||+++++|.+++.... ....+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996532 2346999999999999999999999998 9999999999999999999
Q ss_pred EEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 655 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 655 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
||+|||+++.... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999975321 122233467889999999999999999999999999999998 999996543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.32 Aligned_cols=204 Identities=29% Similarity=0.457 Sum_probs=170.8
Q ss_pred ccCcceeeeeccCCceeEEeeeecC----CceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe-cCeEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~-~~~~~ 585 (724)
...|++.+.||+|+||.||+|+..+ ...+|||.+... .....+.+.+|+.++++++||||+++++++.+ ++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4578999999999999999998643 235899998764 34456789999999999999999999998654 45779
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||+++++|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999954 3345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc--ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 666 GGDELQ--GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 666 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence 543221 22334567889999999999999999999999999999999 55666543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=304.09 Aligned_cols=201 Identities=27% Similarity=0.412 Sum_probs=176.9
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChh-----------------hHHHHHHHHHHHHHccCCceeeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-----------------GLKEFKNEMMLIAKLQHRNLVRL 574 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-----------------~~~~f~~E~~il~~l~Hpniv~l 574 (724)
.++|++.+.||+|+||.||+|+. +++.||||++...... ..+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999999998 8999999998643211 12789999999999999999999
Q ss_pred eeEEEecCeEEEEEEeeCCCChhHH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeccCCCCCEE
Q 004912 575 LGCCVEQGEKILILEYMPNKSLNVF------LFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNIL 647 (724)
Q Consensus 575 ~~~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~Dlkp~NIL 647 (724)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||++||+|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 422 124679999999999999999999999 87 999999999999
Q ss_pred EcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCC-CCCc-hhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSI-KSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 648 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
++.++.+||+|||++..+... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||...+
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999876433 23446789999999999887 6766 9999999999999999999997654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=291.56 Aligned_cols=201 Identities=23% Similarity=0.324 Sum_probs=172.0
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEE-EecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC-VEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~-~~~~~~~lV~E 589 (724)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|+.++.+++|++++..+..+ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 57899999999999999999986 5688999999865432 24688999999999988866666555 56677899999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE---cCCCCEEEEecCCccccC
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFG 666 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DFGla~~~~ 666 (724)
|+ +++|.+++... ...+++.++..++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999998542 345999999999999999999999998 9999999999999 488899999999998875
Q ss_pred CCccc-----ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 667 GDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 667 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 43221 1234567999999999999999999999999999999999999999753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=304.07 Aligned_cols=202 Identities=26% Similarity=0.379 Sum_probs=173.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEec-----CeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~-----~~~ 584 (724)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 568999999999999999999875 57889999997543 34457899999999999999999999998765 368
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||++ ++|.+++.. ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 589888843 34899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcc-cccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 665 FGGDEL-QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
...... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 643321 112345689999999998754 558999999999999999999999997654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=292.70 Aligned_cols=202 Identities=23% Similarity=0.322 Sum_probs=168.7
Q ss_pred hccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEE-EecCeEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC-VEQGEKILIL 588 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~-~~~~~~~lV~ 588 (724)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|+.++.+++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999986 5688999998754332 24578899999999988877666655 5667889999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE---cCCCCEEEEecCCcccc
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMF 665 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DFGla~~~ 665 (724)
||+ +++|.+++... ...+++.++..++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998543 335999999999999999999999998 9999999999999 78999999999999887
Q ss_pred CCCccc-----ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 666 GGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 666 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCccc
Confidence 543221 1233567999999999999999999999999999999999999999754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=301.70 Aligned_cols=202 Identities=31% Similarity=0.535 Sum_probs=175.8
Q ss_pred ccCcceeeeeccCCceeEEeeee-----cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC--eE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~--~~ 584 (724)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46799999999999999999973 358899999998777777889999999999999999999999987654 67
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||+++++|.+++... ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 8999999999999999653 245899999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCccc-ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 665 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
+...... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 7543211 11233457788999999999999999999999999999999998875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=295.31 Aligned_cols=205 Identities=23% Similarity=0.312 Sum_probs=172.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC----hhhHHHHHHHHHHHHHccCCceeeEeeEEE--ecCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCV--EQGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~f~~E~~il~~l~Hpniv~l~~~~~--~~~~~ 584 (724)
.++|++.+.||+|+||.||++... +++.||||+++... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999874 57899999997542 245678999999999999999999999985 44578
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||++++ |.+++... ....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999887 66666443 3456999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccCccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 665 FGGDELQGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.............||+.|+|||++.+.. ++.++||||||+++|||++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 65433233334567899999999987654 4789999999999999999999997653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.29 Aligned_cols=201 Identities=24% Similarity=0.356 Sum_probs=167.4
Q ss_pred HhccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEec-------
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------- 581 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~------- 581 (724)
...++|++.+.||+|+||.||+|++ .+++.||||++..... ...+|+.++++++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999987 4688999999865432 234799999999999999999998543
Q ss_pred -------------------------------CeEEEEEEeeCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 004912 582 -------------------------------GEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLH 629 (724)
Q Consensus 582 -------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH 629 (724)
...++||||++ ++|.+.+... .....+++..+..++.||++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 23789999998 5877777542 23456999999999999999999999
Q ss_pred hcCCCceEeccCCCCCEEEc-CCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCC-CCchhhHHHHHHHH
Q 004912 630 QYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILM 707 (724)
Q Consensus 630 ~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil 707 (724)
+.+ |+||||||+|||++ .++.+||+|||+++.+.... ......+|+.|+|||.+.+.. ++.++||||||+++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 99999999999998 68899999999998764432 233457899999999988754 89999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 004912 708 LETLSSKKNTGLGS 721 (724)
Q Consensus 708 ~elltG~~p~~~~~ 721 (724)
|||++|+.||...+
T Consensus 233 ~ell~g~~pf~~~~ 246 (383)
T 3eb0_A 233 GELILGKPLFSGET 246 (383)
T ss_dssp HHHHHSSCSSCCSS
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999997543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=300.14 Aligned_cols=208 Identities=26% Similarity=0.399 Sum_probs=159.6
Q ss_pred HhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34678999999999999999999864 68899999986543 34467789999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 588 LEYMPNKSLNVFLFDS-----TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
|||+++++|.+++... .....+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998541 12456899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcc---cccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 663 RMFGGDEL---QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 663 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
..+..... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 87643211 112234578999999999876 56899999999999999999999999754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-34 Score=299.68 Aligned_cols=210 Identities=27% Similarity=0.356 Sum_probs=173.1
Q ss_pred cchhhHHHhccCcceeeeeccCCceeEEeeeecCCceeEEEecccc--ChhhHHHHHHHHHHHHHcc--CCceeeEeeEE
Q 004912 503 FSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLLGCC 578 (724)
Q Consensus 503 ~~~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~--Hpniv~l~~~~ 578 (724)
+.+..+....++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 4455556667889999999999999999999888999999998643 3456688999999999997 59999999999
Q ss_pred EecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEe
Q 004912 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 658 (724)
Q Consensus 579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 658 (724)
.+.+..++||| +.+++|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 99999999999 678899999854 346899999999999999999999998 999999999999965 8999999
Q ss_pred cCCccccCCCcccccccccccccCccCcccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
||+++.+.............||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 999987654333223344578999999999875 47889999999999999999999999643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=293.84 Aligned_cols=200 Identities=29% Similarity=0.420 Sum_probs=170.7
Q ss_pred cCcceeeeeccCCceeEEeeeecC----CceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeE-EE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK-IL 586 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~-~l 586 (724)
-.|.+.++||+|+||.||+|+..+ +..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 356677999999999999998643 2369999997643 34567899999999999999999999999876655 89
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+.+++|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999954 3456899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcc--cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004912 667 GDEL--QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 717 (724)
Q Consensus 667 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~ 717 (724)
.... ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 4321 12234457889999999999999999999999999999999965554
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=290.98 Aligned_cols=199 Identities=30% Similarity=0.447 Sum_probs=171.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe----cCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~----~~~~ 584 (724)
.+.|.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 456888999999999999999875 5778999998653 34556789999999999999999999999875 3457
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc-CCCCEEEEecCCcc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLAR 663 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~ 663 (724)
++||||+++++|.+++... ..+++..+..++.||++||+|||+.+. +|+||||||+|||++ .++.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999999543 458999999999999999999998752 499999999999997 78999999999997
Q ss_pred ccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
..... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||..
T Consensus 181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 65432 233457899999999876 4589999999999999999999999965
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=306.24 Aligned_cols=199 Identities=19% Similarity=0.232 Sum_probs=171.5
Q ss_pred ccCcceeeeeccCCceeEEeeeecC---------CceeEEEeccccChhhHHHHHHHHHHHHHccCCceee---------
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN---------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR--------- 573 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~---------g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~--------- 573 (724)
.++|++.+.||+|+||.||+|+... ++.||||++... +.+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999998763 789999998654 46789999999999999987
Q ss_pred ------EeeEEEe-cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCE
Q 004912 574 ------LLGCCVE-QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 646 (724)
Q Consensus 574 ------l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NI 646 (724)
+++++.. +...++||||+ +++|.+++... ....+++.+++.++.||++||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 67889999999 99999999643 2356999999999999999999999998 99999999999
Q ss_pred EEcCCC--CEEEEecCCccccCCCccc-----ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 647 LLDKDM--NPKISDFGLARMFGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 647 Ll~~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
|++.++ .+||+|||+++.+...... .......||+.|+|||.+.+..++.++||||||++||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876432211 122345799999999999999999999999999999999999999975
Q ss_pred C
Q 004912 720 G 720 (724)
Q Consensus 720 ~ 720 (724)
.
T Consensus 271 ~ 271 (352)
T 2jii_A 271 C 271 (352)
T ss_dssp G
T ss_pred C
Confidence 4
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=305.13 Aligned_cols=199 Identities=24% Similarity=0.298 Sum_probs=170.6
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHcc--------CCceeeEeeEEE---
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ--------HRNLVRLLGCCV--- 579 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~--------Hpniv~l~~~~~--- 579 (724)
.++|++.++||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+.++++++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999864 5789999999743 345678899999999996 788999999987
Q ss_pred -ecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeccCCCCCEEEcCCC-----
Q 004912 580 -EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDM----- 652 (724)
Q Consensus 580 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~----- 652 (724)
.....++||||+ +++|.+.+... ....+++.++..++.||++||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 455789999999 55665655432 234699999999999999999999998 7 99999999999998775
Q ss_pred --------------------------------------------CEEEEecCCccccCCCcccccccccccccCccCccc
Q 004912 653 --------------------------------------------NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688 (724)
Q Consensus 653 --------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 688 (724)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999876432 334578999999999
Q ss_pred ccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 689 ALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 689 ~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.+..++.++|||||||+||||++|+.||...+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 999999999999999999999999999997554
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=301.44 Aligned_cols=208 Identities=22% Similarity=0.307 Sum_probs=162.3
Q ss_pred hHHHhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe--
Q 004912 507 SITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE-- 583 (724)
Q Consensus 507 ~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~-- 583 (724)
......++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+|+..+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34566789999999999999999999875 58899999985532 333566788889999999999999999976543
Q ss_pred -----EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCceEeccCCCCCEEEcC-CCCEE
Q 004912 584 -----KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH--QYSRFRIIHRDLKASNILLDK-DMNPK 655 (724)
Q Consensus 584 -----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--~~~~~~iiH~Dlkp~NILl~~-~~~~k 655 (724)
.++||||++++.+..+.........+++..+..++.||+.||+||| +.+ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999987543333322345567899999999999999999999 877 999999999999997 89999
Q ss_pred EEecCCccccCCCcccccccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 656 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
|+|||+++.+.... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...+
T Consensus 173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 99999998765432 223457899999999987654 8999999999999999999999997653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.06 Aligned_cols=202 Identities=27% Similarity=0.375 Sum_probs=159.7
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-h-hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-G-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~-~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
..++|++.+.||+|+||.||+++.. +++.||||+++... . ...+.+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4578999999999999999999874 68899999997542 2 2234455566667888999999999999999999999
Q ss_pred EEeeCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 588 LEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
|||++ ++|.+++... .....+++..+..++.||+.||+|||++ + |+||||||+|||++.++.+||+|||+++.+
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 4887776432 2345699999999999999999999998 8 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccCcccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYA----LDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||..
T Consensus 161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 4332 22334789999999996 566789999999999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=299.99 Aligned_cols=202 Identities=25% Similarity=0.383 Sum_probs=171.8
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec-----CeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~-----~~~ 584 (724)
.++|++.+.||+|+||.||+|+.. +++.||||++... ......++.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 578999999999999999999875 5889999999754 334567789999999999999999999988754 678
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||++ ++|.+++.. ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 589888854 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccc--------cccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 665 FGGDELQG--------NTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 665 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 64321111 1233578999999998765 778999999999999999999999997543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.32 Aligned_cols=199 Identities=24% Similarity=0.335 Sum_probs=174.3
Q ss_pred ccCcceeeeeccCCceeEEeeee--cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCc------eeeEeeEEEecCe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN------LVRLLGCCVEQGE 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~--~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpn------iv~l~~~~~~~~~ 583 (724)
.++|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.++..++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 56899999999999999999986 35789999999754 345678899999999998765 9999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-------------
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK------------- 650 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~------------- 650 (724)
.++||||+ +++|.+++... ....+++.++..++.||++||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88999998543 2345899999999999999999999998 999999999999987
Q ss_pred ------CCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 651 ------DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 651 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999999875322 234578999999999999999999999999999999999999997543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=325.83 Aligned_cols=196 Identities=32% Similarity=0.448 Sum_probs=165.3
Q ss_pred eeeccCCceeEEeeeec---CCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
++||+|+||.||+|.+. .++.||||+++... ....++|.+|+.+|.+++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 48999999999999653 35789999997643 344688999999999999999999999986 4568899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc-cc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL-QG 672 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~ 672 (724)
|+|.+++.. ...+++.+++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999953 345899999999999999999999998 99999999999999999999999999988754321 12
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...+
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2333456889999999999999999999999999999998 999997543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.23 Aligned_cols=196 Identities=32% Similarity=0.515 Sum_probs=160.0
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHH--HHHccCCceeeEeeEEEec-----CeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML--IAKLQHRNLVRLLGCCVEQ-----GEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~i--l~~l~Hpniv~l~~~~~~~-----~~~ 584 (724)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+... ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 57899999999999999999977 68899999996543 2344444444 4558999999999866432 256
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCceEeccCCCCCEEEcCCCCEE
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY---------SRFRIIHRDLKASNILLDKDMNPK 655 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~---------~~~~iiH~Dlkp~NILl~~~~~~k 655 (724)
++||||+++|+|.+++... ..++..+.+++.||++||+|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 8999999999999999542 358899999999999999999998 7 99999999999999999999
Q ss_pred EEecCCccccCCCcc------cccccccccccCccCcccccC-------CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 656 ISDFGLARMFGGDEL------QGNTKQIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 656 L~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
|+|||+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+.
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 999999987653221 122234579999999999987 456789999999999999999977653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=307.53 Aligned_cols=203 Identities=26% Similarity=0.425 Sum_probs=155.4
Q ss_pred cCcce-eeeeccCCceeEEeeeec---CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEe--cCeEEE
Q 004912 513 ENFSM-QCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKIL 586 (724)
Q Consensus 513 ~~~~~-~~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~--~~~~~l 586 (724)
+.|++ .++||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.+|++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44665 458999999999999865 47789999997543 23568899999999999999999999965 568899
Q ss_pred EEEeeCCCChhHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE----cCCCCEEE
Q 004912 587 ILEYMPNKSLNVFLFDST------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKI 656 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kL 656 (724)
||||+++ +|.+++.... ....+++..+..|+.||+.||+|||+++ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 7777764211 2235999999999999999999999998 9999999999999 77889999
Q ss_pred EecCCccccCCCcc-cccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 657 SDFGLARMFGGDEL-QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 657 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||+||||++|+.||...+
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999987643211 1223456899999999999874 58999999999999999999999996543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-33 Score=296.12 Aligned_cols=194 Identities=29% Similarity=0.442 Sum_probs=161.5
Q ss_pred HHhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHc--cCCceeeEeeEEEec----C
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL--QHRNLVRLLGCCVEQ----G 582 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l--~Hpniv~l~~~~~~~----~ 582 (724)
....++|++.+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344578999999999999999999874 8899999986432 23445555555554 899999999999887 6
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCceEeccCCCCCEEEcCCCCE
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY--------SRFRIIHRDLKASNILLDKDMNP 654 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~--------~~~~iiH~Dlkp~NILl~~~~~~ 654 (724)
..++||||+++++|.+++.. ..+++.++..++.|++.||+|||++ + |+||||||+|||++.++.+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCE
T ss_pred ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCE
Confidence 88999999999999999953 2589999999999999999999988 6 9999999999999999999
Q ss_pred EEEecCCccccCCCccc--ccccccccccCccCcccccCCCCCch------hhHHHHHHHHHHHHcC
Q 004912 655 KISDFGLARMFGGDELQ--GNTKQIVGTYGYMSPEYALDGLFSIK------SDVFSFGILMLETLSS 713 (724)
Q Consensus 655 kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k------~DVwSlGvil~elltG 713 (724)
||+|||+++.+...... .......||+.|+|||++.+...+.+ +||||||+++|||++|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 99999999876443211 11234579999999999988776654 9999999999999999
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.37 Aligned_cols=199 Identities=32% Similarity=0.489 Sum_probs=166.5
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEec-CeEEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-GEKILILE 589 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~-~~~~lV~E 589 (724)
..++|++.+.||+|+||.||+++. .++.||||+++... ..+.+.+|+.++.+++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 357899999999999999999987 58899999997543 457899999999999999999999997654 46899999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++++|.+++.... ...+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 999999999985432 234789999999999999999999998 999999999999999999999999999865332
Q ss_pred ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 223467889999999999999999999999999999998 999997654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=296.51 Aligned_cols=203 Identities=28% Similarity=0.446 Sum_probs=172.1
Q ss_pred HhccCcceeeeeccCCceeEEeeee--cCCceeEEEeccccCh--hhHHHHHHHHHHHHHc---cCCceeeEeeEEE---
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKL---QHRNLVRLLGCCV--- 579 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~--~~g~~vAVK~l~~~~~--~~~~~f~~E~~il~~l---~Hpniv~l~~~~~--- 579 (724)
...++|++.+.||+|+||.||+|+. .+++.||||+++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3467899999999999999999987 3578999999864321 2233566777777766 8999999999987
Q ss_pred --ecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEE
Q 004912 580 --EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 657 (724)
Q Consensus 580 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 657 (724)
.....++||||++ ++|.+++.... ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 69999986532 345899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 658 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
|||+++.+... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 163 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 163 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp SCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999876432 1234467899999999999999999999999999999999999999754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=292.79 Aligned_cols=203 Identities=29% Similarity=0.398 Sum_probs=165.2
Q ss_pred ccCcceeeeeccCCceeEEeeeecC--Cc--eeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN--GQ--EVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~--g~--~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~ 584 (724)
.++|++.+.||+|+||.||+|++.. ++ .||||+++.. .....+++.+|+.++.+++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 5689999999999999999998632 33 6899998754 3345678999999999999999999999987654 7
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||+++++|.+++... ...+++.++.+++.||++||+|||+++ |+|+||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998653 245899999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCccc-ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 665 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
+...... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 7543221 12234567889999999999999999999999999999999 99999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=301.25 Aligned_cols=196 Identities=28% Similarity=0.417 Sum_probs=168.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeE----
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK---- 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~---- 584 (724)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+++.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 578999999999999999999875 5889999999753 334467889999999999999999999999877654
Q ss_pred --EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 585 --ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 585 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
++||||+. ++|.+++. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 68877762 23899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 192 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 192 RHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 86533 2334578999999999887 678999999999999999999999997543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=296.35 Aligned_cols=201 Identities=27% Similarity=0.388 Sum_probs=171.4
Q ss_pred HHhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHH--ccCCceeeEeeEEEecC----
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCVEQG---- 582 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~--l~Hpniv~l~~~~~~~~---- 582 (724)
....++|++.+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34467899999999999999999987 5889999999643 34677889999988 78999999999998876
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCceEeccCCCCCEEEcCCCCE
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH--------QYSRFRIIHRDLKASNILLDKDMNP 654 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--------~~~~~~iiH~Dlkp~NILl~~~~~~ 654 (724)
..++||||+++++|.+++.. ..+++.+++.++.||++||+||| +.+ |+||||||+|||++.++++
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999954 34899999999999999999999 666 9999999999999999999
Q ss_pred EEEecCCccccCCCccc--ccccccccccCccCcccccCC------CCCchhhHHHHHHHHHHHHcC----------CCC
Q 004912 655 KISDFGLARMFGGDELQ--GNTKQIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSS----------KKN 716 (724)
Q Consensus 655 kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwSlGvil~elltG----------~~p 716 (724)
||+|||+++........ .......||+.|+|||.+.+. .++.++||||||+++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 99999999876443211 123445799999999998776 334789999999999999999 778
Q ss_pred CCCC
Q 004912 717 TGLG 720 (724)
Q Consensus 717 ~~~~ 720 (724)
|...
T Consensus 267 ~~~~ 270 (342)
T 1b6c_B 267 YYDL 270 (342)
T ss_dssp TTTT
T ss_pred cccc
Confidence 7543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=305.71 Aligned_cols=201 Identities=23% Similarity=0.325 Sum_probs=172.3
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHccC-CceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~H-pniv~l~~~~~~~~~~~lV~E 589 (724)
.++|++.++||+|+||.||+|++ .+++.||||++..... .+++.+|++++..++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 57899999999999999999986 4688999998765432 2457899999999987 556666777778888999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE---cCCCCEEEEecCCccccC
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFG 666 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DFGla~~~~ 666 (724)
|+ +++|.+++... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998542 345999999999999999999999998 9999999999999 688999999999998875
Q ss_pred CCccc-----ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 667 GDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 667 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
..... .......||+.|+|||.+.+..++.++||||||++||||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~ 216 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 43221 1223568999999999999999999999999999999999999999754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-32 Score=296.43 Aligned_cols=202 Identities=25% Similarity=0.344 Sum_probs=172.3
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHcc-CC-----ceeeEeeEEEecCe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HR-----NLVRLLGCCVEQGE 583 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-Hp-----niv~l~~~~~~~~~ 583 (724)
..++|++.+.||+|+||.||+|+.. +++.||||+++.. ....+++..|+.++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4678999999999999999999875 5788999999753 344577888999999885 55 49999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc--CCCCEEEEecCC
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDMNPKISDFGL 661 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kL~DFGl 661 (724)
.++||||++ ++|.+++.... ...+++..+..++.||+.||+|||.+. .+|+||||||+|||++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999996 59999986532 245899999999999999999999521 1399999999999994 578899999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
++.+... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9876432 334678999999999999999999999999999999999999997543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.20 Aligned_cols=201 Identities=29% Similarity=0.455 Sum_probs=174.7
Q ss_pred HhccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
...++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999875 6889999998653 23456789999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC---CCEEEEecCCcc
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFGLAR 663 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~DFGla~ 663 (724)
||||+++++|.+++... ..+++.++..++.||++||+|||+++ |+|+||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999988543 35899999999999999999999998 9999999999999764 469999999998
Q ss_pred ccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.+.... ......+++.|+|||.+.+ .++.++||||||+++|||++|+.||...
T Consensus 173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (287)
T ss_dssp TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence 764322 2234568999999998865 4899999999999999999999999654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.50 Aligned_cols=196 Identities=28% Similarity=0.419 Sum_probs=167.6
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe-----
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE----- 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~----- 583 (724)
.++|.+.+.||+|+||.||+|++. +|+.||||++... .....+++.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999875 5889999999653 33446788999999999999999999999987653
Q ss_pred -EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 584 -KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 584 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
.++||||++ ++|.+++. ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 58877762 24899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 865322 234578999999999887 678999999999999999999999997543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=287.28 Aligned_cols=195 Identities=30% Similarity=0.483 Sum_probs=162.8
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEe----------
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE---------- 580 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~---------- 580 (724)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 567999999999999999999874 6889999999643 3456789999999999999999999998865
Q ss_pred ---cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEE
Q 004912 581 ---QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 657 (724)
Q Consensus 581 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 657 (724)
....++||||+++++|.+++... ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 35678999999999999999643 345788999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCc------------ccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHc
Q 004912 658 DFGLARMFGGDE------------LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLS 712 (724)
Q Consensus 658 DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~ellt 712 (724)
|||+++.+.... .........||+.|+|||.+.+. .++.++||||||+++|||++
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 999998764321 01123345789999999999865 68999999999999999998
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=317.10 Aligned_cols=205 Identities=26% Similarity=0.365 Sum_probs=172.6
Q ss_pred HHhccCcceeeeeccCCceeEEeeeecC----CceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~ 583 (724)
....++|++.+.||+|+||.||+|.+.. +..||||+++.. .....+.|.+|+.++++++||||+++++++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3446789999999999999999998743 457999998754 3445678999999999999999999999984 456
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.++||||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 89999999999999999643 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
.+..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 540 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 540 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 7654322 12233467789999999999999999999999999999997 99999754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.4e-32 Score=290.35 Aligned_cols=199 Identities=25% Similarity=0.343 Sum_probs=171.7
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CC-ceeEEEeccccChhhHHHHHHHHHHHHHccCCc------eeeEeeEEEecCe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN------LVRLLGCCVEQGE 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g-~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpn------iv~l~~~~~~~~~ 583 (724)
.++|++.+.||+|+||.||+|... ++ +.||||+++.. ....+.+.+|+.++.+++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 578999999999999999999874 33 68999999753 345677889999999998766 9999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEE---------------
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL--------------- 648 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl--------------- 648 (724)
.++||||+ +++|.+++... ....+++.++..++.||++||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 66666666442 2346899999999999999999999998 9999999999999
Q ss_pred ----cCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 649 ----DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 649 ----~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 66889999999999864322 234579999999999999999999999999999999999999997543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=296.72 Aligned_cols=199 Identities=23% Similarity=0.364 Sum_probs=169.7
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHcc-----------CCceeeEeeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLLGCCV 579 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-----------Hpniv~l~~~~~ 579 (724)
.++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999987 46889999999743 344577889999999986 899999999988
Q ss_pred ecC----eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeccCCCCCEEEc-----
Q 004912 580 EQG----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLD----- 649 (724)
Q Consensus 580 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~Dlkp~NILl~----- 649 (724)
..+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 689999999 899999986532 34589999999999999999999998 8 99999999999994
Q ss_pred -CCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 650 -KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 650 -~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
..+.+||+|||+++.+... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4457999999999876432 234578999999999999999999999999999999999999997543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=290.24 Aligned_cols=202 Identities=26% Similarity=0.372 Sum_probs=152.5
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHH-HHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~-il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
.++|++.+.||+|+||.||+|... +++.||||+++... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 578999999999999999999875 68899999997643 334455666666 667779999999999999999999999
Q ss_pred EeeCCCChhHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 589 EYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 589 Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
||+++ +|.+++.. ......+++..+.+++.|+++||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 77777642 12245689999999999999999999998 8 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccCcccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYA----LDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||...
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 4322 12334789999999998 4667899999999999999999999999753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=301.80 Aligned_cols=201 Identities=27% Similarity=0.336 Sum_probs=158.6
Q ss_pred cCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEEEee
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 456667899999999998776678999999998643 345678999999987 8999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC-------------CCE
Q 004912 592 PNKSLNVFLFDSTKKR----LLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-------------MNP 654 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-------------~~~ 654 (724)
. |+|.+++....... ...+..++.++.||+.||+|||+++ |+||||||+|||++.+ ..+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999986432211 1233456789999999999999998 9999999999999754 489
Q ss_pred EEEecCCccccCCCccc--ccccccccccCccCcccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 655 KISDFGLARMFGGDELQ--GNTKQIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 655 kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||...
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 99999999987543211 12334679999999999876 678999999999999999999 99999643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=291.70 Aligned_cols=201 Identities=25% Similarity=0.402 Sum_probs=165.2
Q ss_pred HHhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChh------hHHHHHHHHHHHHHc----cCCceeeEeeE
Q 004912 509 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ------GLKEFKNEMMLIAKL----QHRNLVRLLGC 577 (724)
Q Consensus 509 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~------~~~~f~~E~~il~~l----~Hpniv~l~~~ 577 (724)
....++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344678999999999999999999764 5789999999654321 233467899999999 89999999999
Q ss_pred EEecCeEEEEEEe-eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc-CCCCEE
Q 004912 578 CVEQGEKILILEY-MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPK 655 (724)
Q Consensus 578 ~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~k 655 (724)
+.+.+..++|||| +++++|.+++... ..+++.++..++.||++||+|||+++ |+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 7899999999643 35899999999999999999999998 99999999999999 889999
Q ss_pred EEecCCccccCCCcccccccccccccCccCcccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCC
Q 004912 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 656 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwSlGvil~elltG~~p~~~ 719 (724)
|+|||+++.+.... .....|++.|+|||++.+..+. .++||||||+++|||++|+.||..
T Consensus 181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 99999998875432 3345789999999999877764 589999999999999999999964
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=292.38 Aligned_cols=199 Identities=24% Similarity=0.367 Sum_probs=172.4
Q ss_pred hccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChh------hHHHHHHHHHHHHHcc--CCceeeEeeEEEec
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ------GLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQ 581 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~------~~~~f~~E~~il~~l~--Hpniv~l~~~~~~~ 581 (724)
..++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++.+++ ||||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 467899999999999999999976 46889999998654221 2345778999999996 59999999999999
Q ss_pred CeEEEEEEeeCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc-CCCCEEEEec
Q 004912 582 GEKILILEYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDF 659 (724)
Q Consensus 582 ~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DF 659 (724)
+..++|||++.+ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999986 899999854 345899999999999999999999998 99999999999999 7899999999
Q ss_pred CCccccCCCcccccccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
|+++.+.... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus 195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred cccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 9998765332 234578999999999987776 6889999999999999999999964
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-32 Score=290.08 Aligned_cols=198 Identities=22% Similarity=0.279 Sum_probs=147.0
Q ss_pred hccCcceee-eeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEe----cCeE
Q 004912 511 ATENFSMQC-KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEK 584 (724)
Q Consensus 511 ~~~~~~~~~-~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~----~~~~ 584 (724)
..++|.+.+ .||+|+||.||+|++. +++.||||++.... +...+....+..++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 357888854 6999999999999886 58899999986532 222233334566799999999999876 4457
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC---CCCEEEEecCC
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGL 661 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFGl 661 (724)
++||||+++|+|.+++... ....+++.++..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999999643 2346999999999999999999999998 999999999999976 45599999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
++..... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 9876432 233457899999999998899999999999999999999999999644
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=313.01 Aligned_cols=202 Identities=29% Similarity=0.420 Sum_probs=175.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe------cCe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE------QGE 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~------~~~ 583 (724)
.++|++.+.||+|+||.||+|.+. +++.||||+++.. .....+.+.+|+.++.+++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 468999999999999999999874 5889999998764 44556789999999999999999999998755 567
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCC---EEEEecC
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFG 660 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~DFG 660 (724)
.++||||+++++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7999999999999999976555556999999999999999999999998 999999999999997765 9999999
Q ss_pred CccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
++..+.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 998765432 23446799999999999999999999999999999999999999964
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-33 Score=300.31 Aligned_cols=191 Identities=19% Similarity=0.226 Sum_probs=163.2
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccC--------hhhHHHHHHHHHHHHHcc---------CCceeeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQ---------HRNLVRL 574 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--------~~~~~~f~~E~~il~~l~---------Hpniv~l 574 (724)
.++|++.+.||+|+||.||+|+. +++.||||+++... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999988 78999999997542 234578999999999996 8888888
Q ss_pred eeEEE------------------------------ecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHH
Q 004912 575 LGCCV------------------------------EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624 (724)
Q Consensus 575 ~~~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~ 624 (724)
.+++. +.+..++||||+++|++.+.+. +..+++.++..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 77653 2678999999999997666652 2458999999999999999
Q ss_pred HHHHH-hcCCCceEeccCCCCCEEEcCCC--------------------CEEEEecCCccccCCCcccccccccccccCc
Q 004912 625 LLYLH-QYSRFRIIHRDLKASNILLDKDM--------------------NPKISDFGLARMFGGDELQGNTKQIVGTYGY 683 (724)
Q Consensus 625 L~yLH-~~~~~~iiH~Dlkp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y 683 (724)
|+||| +++ |+||||||+|||++.++ .+||+|||+|+.+... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 888 99999999999999887 8999999999876432 34799999
Q ss_pred cCcccccCCCCCchhhHHHHHHH-HHHHHcCCCCCC
Q 004912 684 MSPEYALDGLFSIKSDVFSFGIL-MLETLSSKKNTG 718 (724)
Q Consensus 684 ~aPE~~~~~~~s~k~DVwSlGvi-l~elltG~~p~~ 718 (724)
||||++.+.. +.++||||++++ .+++++|..||.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 9999998776 899999998776 788999999984
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-33 Score=294.42 Aligned_cols=206 Identities=28% Similarity=0.432 Sum_probs=170.1
Q ss_pred HHHhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 508 ITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 508 i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
.....++|++.+.||+|+||.||+|+..+ .+|||+++... ....+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 34456789999999999999999998743 59999986532 334466889999999999999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||+++++|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+|||++ ++.+||+|||+++..
T Consensus 106 iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp EECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred EEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 99999999999999843 2345899999999999999999999998 99999999999998 679999999998765
Q ss_pred CCCc---ccccccccccccCccCcccccC---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 666 GGDE---LQGNTKQIVGTYGYMSPEYALD---------GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 666 ~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.... .........|++.|+|||.+.. ..++.++||||||+++|||++|+.||...+
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3211 1122334568999999999864 457899999999999999999999997543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=300.58 Aligned_cols=202 Identities=23% Similarity=0.354 Sum_probs=160.8
Q ss_pred HhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
....+|++.+.||+|+||.|+.....+++.||||++..... +.+.+|+.+|.++ +||||+++++++.+....++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 34557999999999999997655556889999999965432 2356899999999 7999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-----CCCEEEEecCCcc
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-----DMNPKISDFGLAR 663 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kL~DFGla~ 663 (724)
||++ |+|.+++.... ..+.+.++..++.||++||+|||+++ |+||||||+|||++. ...+||+|||+++
T Consensus 98 E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9996 59999985432 23445566789999999999999998 999999999999943 3468899999998
Q ss_pred ccCCCcc-cccccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004912 664 MFGGDEL-QGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLS-SKKNTGLG 720 (724)
Q Consensus 664 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~ellt-G~~p~~~~ 720 (724)
.+..... ........||+.|+|||++. ...++.++|||||||++|||++ |+.||+..
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 7753321 12334567999999999997 4567889999999999999999 99999644
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=317.64 Aligned_cols=192 Identities=21% Similarity=0.343 Sum_probs=167.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec--CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe-----
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE----- 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~----- 583 (724)
.++|++.+.||+|+||.||++.+. +++.||||++... .....+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999875 5889999998654 34556789999999999999999999999987765
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.++||||+++++|.+++.. .+++.+++.|+.||++||+|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999887632 5899999999999999999999998 9999999999999886 99999999998
Q ss_pred ccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.+... ....||+.|+|||++.+.. +.++||||||++||||++|..||..
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 76432 3457999999999887654 8999999999999999999988764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=284.20 Aligned_cols=200 Identities=23% Similarity=0.378 Sum_probs=152.3
Q ss_pred hccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh-h-hHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-Q-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~-~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
..++|++.+.||+|+||.||+|+.. +++.||||++..... . ..+.+.++..+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3568999999999999999999885 688999999975432 2 234455566678888999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
|||+ ++.+..+... ....+++..+..++.||++||+|||++ + |+|+||||+|||++.++.+||+|||++..+.
T Consensus 103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 4555555432 234589999999999999999999985 7 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
... ......||+.|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 322 223457899999999984 55689999999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=272.41 Aligned_cols=173 Identities=12% Similarity=0.101 Sum_probs=152.7
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-CceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
.++|++.+.||+|+||.||+|+... ++.||||++.... ....+.|.+|+.++.+++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 4679999999999999999998854 8899999997643 34457899999999999999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++++|.+++.. . ....++.+|+.||++||+|||+++ |+||||||+|||++.++.+||+++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~-------- 173 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP-------- 173 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC--------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec--------
Confidence 999999999999832 2 356678999999999999999998 999999999999999999999744
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+|++| ++.++||||||++||||++|+.||...+
T Consensus 174 --------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 174 --------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp --------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred --------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 34443 6889999999999999999999997654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-31 Score=288.34 Aligned_cols=201 Identities=16% Similarity=0.233 Sum_probs=156.8
Q ss_pred hccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccCh---hhHHHHHHHHHHHHHccC-Cce---------e----
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQH-RNL---------V---- 572 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~---~~~~~f~~E~~il~~l~H-pni---------v---- 572 (724)
....|...+.||+|+||.||+|++ .+|+.||||++..... ...+.|.+|+.++..++| +|. +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345688889999999999999986 4688999999874322 336789999999999987 221 1
Q ss_pred --eE------eeEEEe-----cCeEEEEEEeeCCCChhHHHhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 004912 573 --RL------LGCCVE-----QGEKILILEYMPNKSLNVFLFD----STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635 (724)
Q Consensus 573 --~l------~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ 635 (724)
.+ ..+... ....+++|++ .+++|.+++.. ......+++..++.|+.||++||+|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 11 111111 1234666665 46899988741 223455888899999999999999999998
Q ss_pred eEeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccc----------cCCCCCchhhHHHHHH
Q 004912 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA----------LDGLFSIKSDVFSFGI 705 (724)
Q Consensus 636 iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~k~DVwSlGv 705 (724)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999999875322 344577 999999999 5666899999999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 004912 706 LMLETLSSKKNTGLGS 721 (724)
Q Consensus 706 il~elltG~~p~~~~~ 721 (724)
+||||++|+.||...+
T Consensus 306 il~elltg~~Pf~~~~ 321 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDA 321 (413)
T ss_dssp HHHHHHHSSCCCCTTG
T ss_pred HHHHHHHCCCCCCCcc
Confidence 9999999999997653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=264.42 Aligned_cols=176 Identities=22% Similarity=0.320 Sum_probs=151.3
Q ss_pred ccCccee-eeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHH-HHccCCceeeEeeEEEe----cCeE
Q 004912 512 TENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLI-AKLQHRNLVRLLGCCVE----QGEK 584 (724)
Q Consensus 512 ~~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il-~~l~Hpniv~l~~~~~~----~~~~ 584 (724)
.++|.+. +.||+|+||.||++... +++.||||+++.. ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4567776 78999999999999874 5889999998642 4567888888 55589999999999987 6678
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC---CCCEEEEecCC
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGL 661 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFGl 661 (724)
++||||+++++|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999999653 2346999999999999999999999998 999999999999998 78899999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
++... +..++.++||||||+++|||++|+.||...
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 86532 234678999999999999999999999644
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-29 Score=283.02 Aligned_cols=183 Identities=16% Similarity=0.157 Sum_probs=130.9
Q ss_pred eeccCCceeEEeeee-cCCceeEEEecccc----------ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEE
Q 004912 520 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ----------SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 520 ~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~----------~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV 587 (724)
..+.|++|.+..++. .-|+.+|||.+... .+...++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 567777777776643 45889999998643 123457799999999999 799999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||++|++|.++|.. ...++.. +|+.||++||+|||+++ ||||||||+||||++++++||+|||+|+.+..
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999953 3456654 58899999999999999 99999999999999999999999999987644
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~ 714 (724)
.. ......+||+.|||||++.+ .+..++|+||+|++++++.++.
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 32 23455789999999998865 4677899999999988776553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7e-26 Score=256.48 Aligned_cols=186 Identities=18% Similarity=0.185 Sum_probs=148.1
Q ss_pred ceeeeeccCCceeEEeeeecCCceeEEEeccccCh--------hhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEE
Q 004912 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--------~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
...++||+|+||.||++.. .++.+++|+...... ...++|.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3356899999999999954 578889997643211 1245689999999999999999777777788888999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++++|.+++.. +..++.||++||+|||+++ |+||||||+|||++. ++||+|||+++.+..
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 4689999999999999998 999999999999998 999999999998754
Q ss_pred Ccccc-----cccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 668 DELQG-----NTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 668 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
..... ......||+.|||||++.. ..|+...|+|+..+-.++-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32111 1235689999999999987 568888999999999999998888774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.6e-23 Score=212.47 Aligned_cols=166 Identities=17% Similarity=0.150 Sum_probs=130.3
Q ss_pred hhhHHHhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccCh------------------hhHHHHHHHHHHHHHc
Q 004912 505 LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------------------QGLKEFKNEMMLIAKL 566 (724)
Q Consensus 505 ~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~------------------~~~~~f~~E~~il~~l 566 (724)
+..+......|++.+.||+|+||.||+|...+|+.||||.++.... .....+.+|+.++.++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3444555667888899999999999999987789999999964321 1356789999999999
Q ss_pred cCCceeeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCE
Q 004912 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 646 (724)
Q Consensus 567 ~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NI 646 (724)
+ | +++.+++.. +..++||||+++++|.+ +. . .+...++.||++||+|||+.+ |+||||||+||
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~--~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR-------V--ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc-------h--hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 9 4 555555433 45699999999999988 41 1 224579999999999999998 99999999999
Q ss_pred EEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccC----------CCCCchhhHHHH
Q 004912 647 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD----------GLFSIKSDVFSF 703 (724)
Q Consensus 647 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~s~k~DVwSl 703 (724)
|++ ++.+||+|||+|+. +..++|||++.+ +.|...+|+|.+
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 999 99999999999864 235789998754 345556677654
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.7e-22 Score=171.48 Aligned_cols=104 Identities=16% Similarity=0.364 Sum_probs=92.7
Q ss_pred ccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEecCCC
Q 004912 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTN 105 (724)
Q Consensus 26 ~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~~~~ 105 (724)
|+|.+||.|.+|+.|+| |.|.|.|...++ |.++. ..++||+|||+.|... .+.|+|+.||||||.|+++
T Consensus 2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~---~~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~~~ 70 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD---HSTSTWASNTEIGGKS-GCSAVLQSDGNFVVYDSSG 70 (105)
T ss_dssp CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTCC-SCEEEECTTSCEEEECTTC
T ss_pred CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE---CCEEEEEecCCCCCCc-cEEEEEeCCccEEEECCCc
Confidence 78999999999999998 889999998776 77765 4689999999999865 6789999999999999999
Q ss_pred CeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeee
Q 004912 106 GTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (724)
Q Consensus 106 ~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqS 148 (724)
.+||+|++++......|+|+|+|||||++. .||||
T Consensus 71 ~~vWss~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S 105 (105)
T 4h3o_A 71 RSLWASHSTRGSGNYILILQDDGNVIIYGS--------DIWST 105 (105)
T ss_dssp CEEEECCCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred EEEEEecCCCCCCCEEEEEeCCCeEEEECC--------cEecC
Confidence 999999987665667899999999999973 49998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=174.16 Aligned_cols=108 Identities=19% Similarity=0.372 Sum_probs=94.5
Q ss_pred cccccccCCcccCCCCeEE--eCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEE
Q 004912 23 LAADTVTPASFIRDGEKLV--SSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVL 100 (724)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~--S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l 100 (724)
++.|+|.+||+|.+|++|+ |++|.|+|+|+.+|+ + +||++ +++||+|||+.| +.++.|+|..||||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 5679999999999999999 999999999999876 3 57875 899999999877 3358899999999999
Q ss_pred ecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeee
Q 004912 101 LNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (724)
Q Consensus 101 ~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqS 148 (724)
.|.++.++|+|++........++|+|+|||||++. ++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~~--------~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEECc--------cEeCC
Confidence 99999999999976554566789999999999872 69998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.2e-21 Score=169.42 Aligned_cols=110 Identities=25% Similarity=0.432 Sum_probs=95.3
Q ss_pred cccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEecCC
Q 004912 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (724)
Q Consensus 25 ~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~~~ 104 (724)
+|+|.+||.|.+|++|+ ++|.|+|+|+..|+ | ++|+ ..++||.||++.|. .++.|+|..||||||.|.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD--SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE--TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE--CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECCC
Confidence 48999999999999999 99999999998776 3 5676 47999999998773 3578999999999999999
Q ss_pred CCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCc
Q 004912 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPT 153 (724)
Q Consensus 105 ~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~Pt 153 (724)
|.++|+|++........++|+|+|||||++. .+||||+||.
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~ 110 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP--------VVWATGSGPA 110 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEECSCCC-
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEECC--------CEecCCCcCC
Confidence 9999999976555556789999999999863 5999999984
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.7e-20 Score=166.41 Aligned_cols=110 Identities=21% Similarity=0.383 Sum_probs=93.9
Q ss_pred cccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEecCC
Q 004912 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (724)
Q Consensus 25 ~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~~~ 104 (724)
.|||.+||+|.+|++|+ +|.|+|+|+.+|+ +. +|+ ..++||+|||+.|. .++.|+|..||||||.|.+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----lv-ly~--~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----LV-KYQ--NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----EE-EEE--TTEEEEECSCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----EE-EEe--CCEEEEeCCCCCCC--CceEEEECCCCcEEEECCC
Confidence 58999999999999998 8999999988775 33 354 48999999999884 3678999999999999998
Q ss_pred CCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcc
Q 004912 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTD 154 (724)
Q Consensus 105 ~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtD 154 (724)
+.++|+|++........++|+|+|||||++. ++||||.+++.
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYGP--------VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEECC--------CEEECCCCCCc
Confidence 9999999976444556789999999999852 69999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.82 E-value=6e-20 Score=162.19 Aligned_cols=110 Identities=23% Similarity=0.460 Sum_probs=92.9
Q ss_pred cccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEecCC
Q 004912 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (724)
Q Consensus 25 ~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~~~ 104 (724)
+|||.+||+|.+|++| ++|.|+|+|+.+|+ + ++|+. .++||+||++.+ +.++.|+|..||||||.| +
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 5899999999999999 58999999999886 3 35664 789999999764 335789999999999999 8
Q ss_pred CCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCC
Q 004912 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYP 152 (724)
Q Consensus 105 ~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~P 152 (724)
+.++|+|++........++|+++|||||++. .+.++||||++.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~-----~~~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDN-----SNNAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECT-----TSCEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEECC-----CCceEEECCCcc
Confidence 8899999876554556789999999999974 246899999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.3e-19 Score=156.37 Aligned_cols=105 Identities=26% Similarity=0.439 Sum_probs=89.1
Q ss_pred cccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEecCC
Q 004912 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (724)
Q Consensus 25 ~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~~~ 104 (724)
.+||.|||.|.+|++|+ +|.|+|+|+..|+ +.+ |+. .++||+||++.+ +..+.|+|..||||||.|.+
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence 37899999999999997 7999999998876 444 543 689999999876 33578999999999999999
Q ss_pred CCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeec
Q 004912 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSF 149 (724)
Q Consensus 105 ~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSF 149 (724)
+.++|+|++.+.....+|+|+|+|||||++. ++|||=
T Consensus 69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~--------~~W~s~ 105 (109)
T 3dzw_A 69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT--------ARWATG 105 (109)
T ss_dssp SCEEEECCCCCSSSCEEEEECTTSCEEEEES--------CCCCCC
T ss_pred CCEEEECCCCCCCCCEEEEEeCCCEEEEECC--------CEEeCC
Confidence 9999999986555556899999999999974 589983
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=8.5e-19 Score=179.59 Aligned_cols=138 Identities=16% Similarity=0.192 Sum_probs=107.9
Q ss_pred cCcceeeeeccCCceeEEeeee-cCCce--eEEEeccccChh------------------------hHHHHHHHHHHHHH
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQE--VAVKRLSNQSGQ------------------------GLKEFKNEMMLIAK 565 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~--vAVK~l~~~~~~------------------------~~~~f~~E~~il~~ 565 (724)
.-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.+|.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3477889999999999999988 67888 999987543111 12368899999999
Q ss_pred ccCCce--eeEeeEEEecCeEEEEEEeeCC-C----ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCceE
Q 004912 566 LQHRNL--VRLLGCCVEQGEKILILEYMPN-K----SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH-QYSRFRII 637 (724)
Q Consensus 566 l~Hpni--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH-~~~~~~ii 637 (724)
++|+++ ..++.. ...++||||+.+ | +|.++... .++.++..++.||+.+|+||| +.+ |+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 998864 334432 356899999942 4 66665422 224466789999999999999 887 99
Q ss_pred eccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 638 HRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 638 H~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999865
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.74 E-value=6.5e-18 Score=148.11 Aligned_cols=106 Identities=20% Similarity=0.345 Sum_probs=87.2
Q ss_pred hcccccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEe
Q 004912 22 SLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLL 101 (724)
Q Consensus 22 ~~~~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~ 101 (724)
..|.|||.+||.|..|+.|+| |.|.|-|...|+ |.+ |.. ++||.+|++.. +..+.|+|..||||||.
T Consensus 3 ~~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~ 69 (110)
T 3r0e_B 3 PFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIK 69 (110)
T ss_dssp CCBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred ccccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence 357899999999999999998 458887766554 666 543 58999999863 33578999999999999
Q ss_pred cCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeee
Q 004912 102 NQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (724)
Q Consensus 102 ~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqS 148 (724)
|.++.++|++++.+.....+|+|+|+|||||++. .+|+|
T Consensus 70 d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~~--------~~W~t 108 (110)
T 3r0e_B 70 DDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGP--------AIFET 108 (110)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEES
T ss_pred eCCCCEEEEcCCcCCCCCEEEEEcCCccEEEecC--------CEecC
Confidence 9999999999986544457899999999999973 59987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.72 E-value=5.3e-17 Score=143.12 Aligned_cols=108 Identities=14% Similarity=0.278 Sum_probs=90.4
Q ss_pred cccccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEec
Q 004912 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLN 102 (724)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~ 102 (724)
.+.|+|.+||.|.+|+.|.+ |.|.|-|...|+ |.++.. ...++||.+|+..+- ..+.|.|..||||||.|
T Consensus 4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~-~~~~~vWssnt~~~~--~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKG-SKTNIVWESGTSGRG--QHCFMRLGHSGELDITD 73 (113)
T ss_dssp CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEET-TTTEEEEECCCTTSC--SSCEEEECTTSCEEEEC
T ss_pred ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEEC-CCCEEEEECCcccCC--cCEEEEEeCCCcEEEEC
Confidence 46799999999999999974 889999987775 777542 147899999998763 35789999999999999
Q ss_pred CCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeee
Q 004912 103 QTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (724)
Q Consensus 103 ~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqS 148 (724)
.++.++|++++.+.....+|+|+|+|||||++. .+|+|
T Consensus 74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~~--------~~W~s 111 (113)
T 3mez_B 74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYGP--------AVWST 111 (113)
T ss_dssp TTSCEEEECSCCCSSSCCEEEECTTSCEEEECS--------EEEES
T ss_pred CCCCEEEECCCcCCCCCEEEEEcCCceEEEecC--------CEecC
Confidence 999999999986544457899999999999973 59997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.5e-16 Score=140.26 Aligned_cols=97 Identities=23% Similarity=0.434 Sum_probs=79.2
Q ss_pred CCCCCCCeEEEeeCCcEEEecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhcccc
Q 004912 82 PISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMK 161 (724)
Q Consensus 82 p~~~~~~~L~l~~~g~l~l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg~k 161 (724)
|+.+...+|.|..||+|||.+. +++||++++.+......|+|+|+|||||+| ++ .++||||+
T Consensus 15 ~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~-----~~~W~S~~----------- 76 (112)
T 1xd5_A 15 SLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GS-----RAIWASNT----------- 76 (112)
T ss_dssp EEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TT-----EEEEECCC-----------
T ss_pred EEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CC-----EEEEECCc-----------
Confidence 4434467899999999999987 789999998655456789999999999998 32 68999994
Q ss_pred cccccccccceeEEeecCCCCCCCcceEEeecCCCCceEEEEc-CCeeeeecCcCCCC
Q 004912 162 LGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFN-GSVKFTCSGHWDGA 218 (724)
Q Consensus 162 l~~~~~~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~-~~~~~~~~g~w~g~ 218 (724)
||++|.|++.++++|. ++++. +..+||++++|+|.
T Consensus 77 --------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g~ 112 (112)
T 1xd5_A 77 --------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp --------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCCC
T ss_pred --------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccCC
Confidence 4567899999999997 45554 57889999999873
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-16 Score=138.91 Aligned_cols=103 Identities=21% Similarity=0.380 Sum_probs=85.8
Q ss_pred cccccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEec
Q 004912 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLN 102 (724)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~ 102 (724)
.|.|||.|||.|..|+.| .+|.|.|.|...|+ |-+ |.. +|.+|+..+ ..++.|+|..||||||.|
T Consensus 1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG-----NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ETT-----TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 378999999999999999 57999999987775 444 332 699998865 336889999999999999
Q ss_pred CCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeee
Q 004912 103 QTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (724)
Q Consensus 103 ~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqS 148 (724)
.++.++|++++.+.....+|+|+|+|||||++. .+|+|
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~~--------~~W~s 103 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGP--------SVFKI 103 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEECS--------EEEEE
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEec--------CEECC
Confidence 999999999976544456899999999999973 59997
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.6e-17 Score=175.48 Aligned_cols=146 Identities=13% Similarity=0.141 Sum_probs=104.1
Q ss_pred hhHHHhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccCh--------------hhHHH--------HHHHHHHH
Q 004912 506 ASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------------QGLKE--------FKNEMMLI 563 (724)
Q Consensus 506 ~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--------------~~~~~--------f~~E~~il 563 (724)
..+.....-|++.+.||+|+||.||+|...+|+.||||+++.... ..... ..+|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 334444445999999999999999999998999999998753210 01111 23456666
Q ss_pred HHccCCceeeEeeEEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCC
Q 004912 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKA 643 (724)
Q Consensus 564 ~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp 643 (724)
.++.+.++.-..-+... ..+|||||+++++|..+.. ..+...++.||+.+|.+||+.+ ||||||||
T Consensus 168 ~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp 233 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNE 233 (397)
T ss_dssp HHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred HHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence 66654443211111112 2379999999998865531 1234568899999999999998 99999999
Q ss_pred CCEEEcCCC----------CEEEEecCCcccc
Q 004912 644 SNILLDKDM----------NPKISDFGLARMF 665 (724)
Q Consensus 644 ~NILl~~~~----------~~kL~DFGla~~~ 665 (724)
.|||+++++ .+.|+||+.+...
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999998776 3899999988654
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=4.1e-16 Score=136.80 Aligned_cols=88 Identities=20% Similarity=0.362 Sum_probs=73.8
Q ss_pred CCeEEEeeCCcEEEecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhccccccccc
Q 004912 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (724)
Q Consensus 87 ~~~L~l~~~g~l~l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg~kl~~~~ 166 (724)
..+|.|+.||||||++ .+++||++|+.+......|+|+|+|||||++.+ +.++||||
T Consensus 21 ~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~-----~~~~W~S~----------------- 77 (110)
T 3a0c_A 21 SYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS-----NRVIWQTK----------------- 77 (110)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECC-----------------
T ss_pred CEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC-----CcEEEecC-----------------
Confidence 6789999999999998 589999999865555678999999999999863 47899999
Q ss_pred ccccceeEEeecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecCcC
Q 004912 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGHW 215 (724)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g~w 215 (724)
+++++|.|++.++++|. ++++++ +||+++++
T Consensus 78 --------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 --------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp --------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred --------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 35678999999999997 455665 79999874
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.58 E-value=5.9e-15 Score=131.08 Aligned_cols=87 Identities=24% Similarity=0.336 Sum_probs=72.4
Q ss_pred CCeEEEeeCCcEEEecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhccccccccc
Q 004912 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (724)
Q Consensus 87 ~~~L~l~~~g~l~l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg~kl~~~~ 166 (724)
..+|.|..||||||++. +++||++|+.....+..|+|+|+|||||+|.+ +.++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~-----~~~lW~S~----------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQSP----------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECS-----------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCC-----CcEEEcCC-----------------
Confidence 35699999999999987 89999999865555678999999999999863 47999999
Q ss_pred ccccceeEEeecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecCc
Q 004912 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGH 214 (724)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (724)
+||++|.|++.++++|. +++++ .+||++|+
T Consensus 88 --------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred --------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 35678999999999997 45555 38999986
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.3e-14 Score=128.31 Aligned_cols=91 Identities=25% Similarity=0.333 Sum_probs=75.4
Q ss_pred CCeEEEeeCCcEEEecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhccccccccc
Q 004912 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (724)
Q Consensus 87 ~~~L~l~~~g~l~l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg~kl~~~~ 166 (724)
...|.|..||||||.+ .+++||++|+.+...+..++|+++|||||+|.+ +.++|||||+
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~-----~~~vW~S~~~--------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN-----NNDVWGSACW--------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECCCC---------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCC-----ceEEEEcCCC---------------
Confidence 5679999999999998 578999999765544568899999999999863 4789999997
Q ss_pred ccccceeEEeecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecCcCCCC
Q 004912 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGHWDGA 218 (724)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g~w~g~ 218 (724)
+++|.|++.++++|. +++++. +||++++|...
T Consensus 80 ----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 356789999999997 555654 89999999754
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.53 E-value=3.1e-14 Score=124.86 Aligned_cols=103 Identities=16% Similarity=0.261 Sum_probs=82.9
Q ss_pred cccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEecCC
Q 004912 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (724)
Q Consensus 25 ~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~~~ 104 (724)
.|+|.+||.|.+|+.|. +|.|.|.|...|+ |.+ |.. .. ||.+|+..+. ..+.|+|..||||||.|.+
T Consensus 2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-~~~--~~-vW~snt~~~~--~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCN-----LVL-YNE--AG-GFQSNTHGRG--VDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEEE--ETTEEEEECTTSC-----EEE-ECS--SC-CEECCCTTSC--SSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEEe--cCCEEEEEccCCe-----EEE-ECC--CC-EEECCcccCC--cCEEEEEcCCCcEEEEeCC
Confidence 58999999999999994 7899999987775 555 432 23 9999998763 3578999999999999988
Q ss_pred CC-eEEEEeccC--CCCCceEEEccCCCeEEecCCCCCCccceeeee
Q 004912 105 NG-TIWSTNVSS--EVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (724)
Q Consensus 105 ~~-~~Wst~~~~--~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqS 148 (724)
+. ++|+|++.. .....+++|+|+|||||++ ..+|+|
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~--------~~~W~s 107 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG--------PAIWST 107 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC--------SEEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEec--------cCEEcc
Confidence 76 599999642 2245678999999999997 358987
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=4.5e-12 Score=129.62 Aligned_cols=146 Identities=16% Similarity=0.111 Sum_probs=115.3
Q ss_pred HhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEEEEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~lV~ 588 (724)
..-+.|.+...++.|+.+.||++.. +++.+++|+...........+.+|+.+++.+. |..+.++++++.+.+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3446788888999999999999975 46899999987532223346889999999995 677889999999888999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS------------------------------------ 632 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~------------------------------------ 632 (724)
||++|.+|.+.+. +..+...++.+++++|+.||+..
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999977631 11223468899999999999821
Q ss_pred --------------------CCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 633 --------------------RFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 633 --------------------~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998766667999998754
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=5e-12 Score=129.27 Aligned_cols=113 Identities=20% Similarity=0.401 Sum_probs=87.6
Q ss_pred cccccccCCcc----cCCCCeEEeCCCeEEEEEeCCC--CCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCC
Q 004912 23 LAADTVTPASF----IRDGEKLVSSSQRFELGFFSPG--KSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNG 96 (724)
Q Consensus 23 ~~~~~~~~~~~----l~~~~~l~S~~g~F~lgF~~~~--~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g 96 (724)
..+||+.||+. |..|+.|+|+ ..++.|+|... .... +-+ |++ ..+++|.+++..+- ...|.+..||
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGn--lvL-y~~-~~~~yW~Sgt~~~~---~~~l~l~~dG 205 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGN--LVA-YGP-NGAATWNAGTQGKG---AVRAVFQGDG 205 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSC--EEE-ECT-TSSEEEECCCTTTT---CCEEEECTTS
T ss_pred ccccccccccccccccccCcccccC-CCCCCceEEEeecCCce--EEE-EeC-CCeEEEECCCCCCc---cEEEEEcCCC
Confidence 57899999999 8899998654 56666666432 1223 333 322 36899999998763 2789999999
Q ss_pred cEEEecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccC
Q 004912 97 NLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (724)
Q Consensus 97 ~l~l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~ 151 (724)
+|++.|.++.++|++++.+. ....|+|+++|||||++. .++||||||
T Consensus 206 nLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~-------~~~Wqsf~~ 252 (276)
T 3m7h_A 206 NLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE-------KPVWARFGF 252 (276)
T ss_dssp CEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE-------EEEEESSSC
T ss_pred eEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC-------CCeEEccCc
Confidence 99999998899999997644 357899999999999974 479999997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.22 E-value=2.9e-11 Score=106.29 Aligned_cols=95 Identities=17% Similarity=0.283 Sum_probs=72.2
Q ss_pred CCCCCCCCCeEEEeeCCcEEEecC-CCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhc
Q 004912 80 DRPISDNNAVLTISNNGNLVLLNQ-TNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQ 158 (724)
Q Consensus 80 ~~p~~~~~~~L~l~~~g~l~l~~~-~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLp 158 (724)
+.|+.+...+|.+..||||||.+. .+.++|++++.+......++|+++|||||+|.+ +.++|||=.+
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~-----~~~iW~S~t~------- 85 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR-----LNTVFVSNTV------- 85 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEECSCC-------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCC-----CCEEEECCCc-------
Confidence 455555567899999999999998 589999999865545668899999999999863 3679997321
Q ss_pred ccccccccccccceeEEeecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecCc
Q 004912 159 DMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGH 214 (724)
Q Consensus 159 g~kl~~~~~~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (724)
...|.|.+.++.+|...++ + .+.|.+|+
T Consensus 86 ------------------------~~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 86 ------------------------GQEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp ------------------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred ------------------------CCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 0124588899999977655 3 57888874
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.21 E-value=3.1e-11 Score=105.66 Aligned_cols=94 Identities=19% Similarity=0.245 Sum_probs=70.7
Q ss_pred CCCCCCCeEEEeeCCcEEEecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhcccc
Q 004912 82 PISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMK 161 (724)
Q Consensus 82 p~~~~~~~L~l~~~g~l~l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg~k 161 (724)
++......|.+..||||||.+.++ +|++++.+......++|+++|||||++.++ +.++|||.-+
T Consensus 16 ~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~----~~~vW~S~t~---------- 79 (111)
T 3mez_A 16 QLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANS----NTPVWVYPRS---------- 79 (111)
T ss_dssp EEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSC----SSCSEEESSS----------
T ss_pred EEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCC----CEEEEEeccc----------
Confidence 333345679999999999999877 999998765555788999999999998642 2359998721
Q ss_pred cccccccccceeEEeecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecCc
Q 004912 162 LGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGH 214 (724)
Q Consensus 162 l~~~~~~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (724)
.....|.|.+.++.+|...++ . .++|.++.
T Consensus 80 -------------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t 109 (111)
T 3mez_A 80 -------------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA 109 (111)
T ss_dssp -------------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred -------------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence 011347789999999987765 2 67888774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=4e-11 Score=121.99 Aligned_cols=140 Identities=17% Similarity=0.187 Sum_probs=104.6
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCc--eeeEeeEEEecCeEEEEE
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpn--iv~l~~~~~~~~~~~lV~ 588 (724)
....+.+....+.|..+.||++...+|+.++||..... ....+.+|+.+++.+.+.+ +.+++++...++..++||
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 34456654444466669999998777888999997653 2246788999999996545 456888888777889999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS------------------------------------ 632 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~------------------------------------ 632 (724)
||++|.+|. . . . .+ ...++.++++.|+.||+..
T Consensus 95 e~i~G~~l~--~-~--~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 95 GEVPGQDLL--S-S--H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp ECCSSEETT--T-S--C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EecCCcccC--c-C--c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999884 2 1 1 12 1356788888888888743
Q ss_pred -------------------CCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 633 -------------------RFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 633 -------------------~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998876677999999865
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.08 E-value=2.9e-10 Score=99.26 Aligned_cols=85 Identities=21% Similarity=0.327 Sum_probs=65.1
Q ss_pred CCeEEEeeCCcEEEecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhccccccccc
Q 004912 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (724)
Q Consensus 87 ~~~L~l~~~g~l~l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg~kl~~~~ 166 (724)
+..|.+..||||||++. .++|++++.+......++|+|+|||||+|.+ +.++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~-----~~~iW~S~t~~-------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDD-----FKTIWSSRSSS-------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTT-----CCEEEECCCCC--------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCC-----CCEEEEcCCcC--------------
Confidence 56799999999999886 5899999876555568899999999999863 36899975311
Q ss_pred ccccceeEEeecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecC
Q 004912 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSG 213 (724)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g 213 (724)
..|.|.+.++.+|...++ + .+.|.+|
T Consensus 84 -----------------~~~~~~~~L~~dGNlvly--~--~~~W~t~ 109 (110)
T 3r0e_B 84 -----------------KQGEYVLILQDDGFGVIY--G--PAIFETS 109 (110)
T ss_dssp -----------------SSSCCEEEECTTSCEEEE--C--SEEEESC
T ss_pred -----------------CCCCEEEEEcCCccEEEe--c--CCEecCC
Confidence 124578889999877654 3 3678776
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=4.7e-10 Score=97.86 Aligned_cols=86 Identities=24% Similarity=0.349 Sum_probs=65.6
Q ss_pred CCeEEEeeCCcEEEecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhccccccccc
Q 004912 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (724)
Q Consensus 87 ~~~L~l~~~g~l~l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg~kl~~~~ 166 (724)
...|.|..||||||++. +.++|++++.+......++|+++|||||+|.+ +.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~-----~~~~W~S~t~~-------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPR-----NNPIWASNTGG-------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTT-----SCEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCC-----CCEEEECCCCC--------------
Confidence 46799999999999987 78999999865544568899999999999863 36899975421
Q ss_pred ccccceeEEeecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecC
Q 004912 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSG 213 (724)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g 213 (724)
..+.|.+.++.+|...++ +. +.|.++
T Consensus 80 -----------------~~~~~~~~L~ddGNlvly--~~--~~W~s~ 105 (109)
T 3dzw_A 80 -----------------ENGNYVCVLQKDRNVVIY--GT--ARWATG 105 (109)
T ss_dssp -----------------SSSCEEEEECTTSCEEEE--ES--CCCCCC
T ss_pred -----------------CCCCEEEEEeCCCEEEEE--CC--CEEeCC
Confidence 124578889999877654 22 567665
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.01 E-value=6.1e-10 Score=97.03 Aligned_cols=92 Identities=22% Similarity=0.361 Sum_probs=68.7
Q ss_pred CCCCCCCCCeEEEeeCCcEEEecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhcc
Q 004912 80 DRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQD 159 (724)
Q Consensus 80 ~~p~~~~~~~L~l~~~g~l~l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg 159 (724)
+.|+.+....|.+..||||||.++ +|+|++.+......++|+++|||||+|.+ +.++|+|-.
T Consensus 15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~-----~~~vWss~t--------- 76 (109)
T 3r0e_A 15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGD-----GSTVWKSGA--------- 76 (109)
T ss_dssp TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEECCC---------
T ss_pred CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCC-----CCEEEcCCC---------
Confidence 344444467899999999999985 79999876555678899999999999863 367887521
Q ss_pred cccccccccccceeEEeecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecCcC
Q 004912 160 MKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGHW 215 (724)
Q Consensus 160 ~kl~~~~~~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g~w 215 (724)
....+.|.+.++.+|...++ . .+.|.++.|
T Consensus 77 ----------------------~~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~ 106 (109)
T 3r0e_A 77 ----------------------QSVKGNYAAVVHPDGRLVVF--G--PSVFKIDPW 106 (109)
T ss_dssp ----------------------CCSSSCCEEEEETTTEEEEE--C--SEEEEECTT
T ss_pred ----------------------cCCCcCEEEEEcCCCeEEEE--e--cCEECCCCc
Confidence 01235678899999976655 3 578999886
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=2e-09 Score=115.30 Aligned_cols=142 Identities=15% Similarity=0.249 Sum_probs=107.5
Q ss_pred eeeeeccCCceeEEeeeecCCceeEEEecc--ccC-hhhHHHHHHHHHHHHHcc--CCceeeEeeEEEec---CeEEEEE
Q 004912 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLS--NQS-GQGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQ---GEKILIL 588 (724)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~--~~~-~~~~~~f~~E~~il~~l~--Hpniv~l~~~~~~~---~~~~lV~ 588 (724)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3578999999999999875 4688899876 322 123456888999999997 45678888888766 3478999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS------------------------------------ 632 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~------------------------------------ 632 (724)
||+++..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998874321 123678888899999999999999731
Q ss_pred -------------------CCceEeccCCCCCEEEcCCCC--EEEEecCCccc
Q 004912 633 -------------------RFRIIHRDLKASNILLDKDMN--PKISDFGLARM 664 (724)
Q Consensus 633 -------------------~~~iiH~Dlkp~NILl~~~~~--~kL~DFGla~~ 664 (724)
+..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987653 68999999865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=9e-10 Score=115.11 Aligned_cols=186 Identities=18% Similarity=0.216 Sum_probs=123.8
Q ss_pred eeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHcc-CCc--eeeEeeEEEecC---eEEEEEEeeC
Q 004912 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRN--LVRLLGCCVEQG---EKILILEYMP 592 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-Hpn--iv~l~~~~~~~~---~~~lV~Ey~~ 592 (724)
+.++.|....||+.. ..+++|+.... .....+.+|+.+|+.+. +.. +.+++....... ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 568999999999874 57899986532 44577899999999984 433 334444433322 2478999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 004912 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS---------------------------------------- 632 (724)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~---------------------------------------- 632 (724)
|.+|..... ..++..++..++.++++.|+.||+..
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 999875432 23677788889999999999999621
Q ss_pred ---------------CCceEeccCCCCCEEEcC--CCCEEEEecCCccccCCCc-cccccc-----------ccccccCc
Q 004912 633 ---------------RFRIIHRDLKASNILLDK--DMNPKISDFGLARMFGGDE-LQGNTK-----------QIVGTYGY 683 (724)
Q Consensus 633 ---------------~~~iiH~Dlkp~NILl~~--~~~~kL~DFGla~~~~~~~-~~~~~~-----------~~~gt~~y 683 (724)
...++|+|++|.||++++ ...+.|+||+.+..-.+.. ...... ......+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 134899999999999998 5568899999986532210 000000 00001111
Q ss_pred cC-cccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004912 684 MS-PEYALDGLFSIKSDVFSFGILMLETLSSKKNT 717 (724)
Q Consensus 684 ~a-PE~~~~~~~s~k~DVwSlGvil~elltG~~p~ 717 (724)
.. |+.... .....+.|+++.++|++.+|+.+|
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 12 222111 122368999999999999998765
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.64 E-value=1.3e-07 Score=81.61 Aligned_cols=77 Identities=27% Similarity=0.409 Sum_probs=58.0
Q ss_pred CeEEEeeCCcEEEecCCCCeEEEEeccCCC-CCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhccccccccc
Q 004912 88 AVLTISNNGNLVLLNQTNGTIWSTNVSSEV-KNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (724)
Q Consensus 88 ~~L~l~~~g~l~l~~~~~~~~Wst~~~~~~-~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg~kl~~~~ 166 (724)
-+|.+..||||||.+. +.+||++|+.... ....+.|.++|||||+|.+ +.++|+|-.
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~-----~~~vWss~t---------------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS-----GRSLWASHS---------------- 78 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTT-----CCEEEECCC----------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCC-----cEEEEEecC----------------
Confidence 4589999999999984 5799999975433 3457889999999999974 367887621
Q ss_pred ccccceeEEeecCCCCCCCcceEEeecCCCCceEE
Q 004912 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKIC 201 (724)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~ 201 (724)
....+.+.+.++.+|...++
T Consensus 79 ---------------~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 ---------------TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp ---------------CCCSSCEEEEECTTSCEEEE
T ss_pred ---------------CCCCCCEEEEEeCCCeEEEE
Confidence 12345688889888876654
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.53 E-value=1.4e-07 Score=94.43 Aligned_cols=86 Identities=23% Similarity=0.359 Sum_probs=66.0
Q ss_pred CCeEEEeeCCcEEEecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhccccccccc
Q 004912 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (724)
Q Consensus 87 ~~~L~l~~~g~l~l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg~kl~~~~ 166 (724)
.-+|.++.||+|+|.+.+ .++|++++.+.....+++|+++||||+++.+ +..+||||.+
T Consensus 151 ~~~l~l~~dG~LvL~~~~-~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~-----~~~vw~s~~~--------------- 209 (236)
T 1dlp_A 151 PYRLSMETDCNLVLFDRD-DRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ-----NIAVWTSGNS--------------- 209 (236)
T ss_dssp SCEEEEETTTEEEEEBTT-BCCSCCCCCSSCSSCEEEEETTTEEEEEETT-----TEEEEECCCC---------------
T ss_pred cEEEEECCCCcEEEEcCC-EeEEeCCCcCCCCceEEEECCCCcEEEEeCC-----CcEEEEeCCC---------------
Confidence 457999999999999865 6899999764434567899999999999853 3689999943
Q ss_pred ccccceeEEeecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecC
Q 004912 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSG 213 (724)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g 213 (724)
| ++|.|.+.+|++|..+++ . ..||.+|
T Consensus 210 ----------~------~~~~~rl~Ld~dG~l~ly--~--~~~W~sg 236 (236)
T 1dlp_A 210 ----------R------SAGRYVFVLQPDRNLAIY--G--GALWTTG 236 (236)
T ss_dssp ----------C------SSSCCEEEECSSSCEEEE--C--CCCCBC-
T ss_pred ----------C------CCCCEEEEEcCCCcEEEe--C--CCCccCC
Confidence 1 246789999999987765 2 2688765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.7e-06 Score=90.13 Aligned_cols=136 Identities=22% Similarity=0.204 Sum_probs=97.6
Q ss_pred eeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCC---ceeeEeeEEE-ecCeEEEEEEeeCC
Q 004912 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCV-EQGEKILILEYMPN 593 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hp---niv~l~~~~~-~~~~~~lV~Ey~~~ 593 (724)
.+.++.|....||+. ++.++||+.. .......+.+|+.+|..+.+. .+.+.+.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 357888888899987 5778999853 234457889999999999752 3556666664 34557899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS----------------------------------------- 632 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~----------------------------------------- 632 (724)
.+|...... .++..+...++.++++.|+.||+..
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 988764311 1345555666666666666666432
Q ss_pred ----------------CCceEeccCCCCCEEEcC---CCC-EEEEecCCccc
Q 004912 633 ----------------RFRIIHRDLKASNILLDK---DMN-PKISDFGLARM 664 (724)
Q Consensus 633 ----------------~~~iiH~Dlkp~NILl~~---~~~-~kL~DFGla~~ 664 (724)
+..++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224699999999999987 455 48999998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=3.9e-06 Score=85.52 Aligned_cols=135 Identities=19% Similarity=0.189 Sum_probs=98.3
Q ss_pred eeccCCce-eEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEEEEEEeeCCCCh
Q 004912 520 KLGEGGFG-PVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (724)
Q Consensus 520 ~LG~G~fG-~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (724)
.+..|..+ .||+.... ++..++||+-... ....+.+|+..|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45555554 68987664 4567899986532 3456888999998884 44467888899999999999999999988
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 004912 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY--------------------------------------------- 631 (724)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~--------------------------------------------- 631 (724)
.+..... ..+...+..++++.|+.||..
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7765321 122335666777777777742
Q ss_pred ----------CCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 632 ----------SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 632 ----------~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
....++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 111379999999999999887778999998865
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=1.4e-06 Score=92.84 Aligned_cols=80 Identities=8% Similarity=0.016 Sum_probs=56.7
Q ss_pred eeee-ccCCceeEEeeeec-------CCceeEEEeccccC---hhhHHHHHHHHHHHHHcc-C--CceeeEeeEEEec--
Q 004912 518 QCKL-GEGGFGPVYKGRLL-------NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQ-H--RNLVRLLGCCVEQ-- 581 (724)
Q Consensus 518 ~~~L-G~G~fG~Vy~~~~~-------~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~-H--pniv~l~~~~~~~-- 581 (724)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4678 88999999998764 26788999875432 101245778888888884 3 3567788776554
Q ss_pred -CeEEEEEEeeCCCChh
Q 004912 582 -GEKILILEYMPNKSLN 597 (724)
Q Consensus 582 -~~~~lV~Ey~~~gsL~ 597 (724)
+..++||||+++..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999987764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.93 E-value=6.1e-05 Score=79.22 Aligned_cols=141 Identities=15% Similarity=0.152 Sum_probs=81.1
Q ss_pred eeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHcc-----CCceeeEe-e--EEEecCeEEEEEEe
Q 004912 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----HRNLVRLL-G--CCVEQGEKILILEY 590 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-----Hpniv~l~-~--~~~~~~~~~lV~Ey 590 (724)
+.|+.|....||+....++ .+++|+.... ..++..|+.++..|. .|.++... | +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4676677899999977554 5899998752 133445555555553 24433310 1 12346678999999
Q ss_pred eCCCChh-----------H---HHhhcCC----C-------CCCCHHHH-------------------------------
Q 004912 591 MPNKSLN-----------V---FLFDSTK----K-------RLLNWQAR------------------------------- 614 (724)
Q Consensus 591 ~~~gsL~-----------~---~l~~~~~----~-------~~l~~~~~------------------------------- 614 (724)
++|..+. . .++.... . ..-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9987542 0 1111100 0 01123211
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 615 VRIIEGIAQGLLYLHQ----------YSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 615 ~~i~~qia~~L~yLH~----------~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
..+..++.+++++|+. ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1112234445666763 1234599999999999998888999999998854
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=2.5e-05 Score=84.45 Aligned_cols=75 Identities=9% Similarity=0.156 Sum_probs=50.6
Q ss_pred eeeeccCCceeEEeeeec-CCceeEEEeccccCh-------hhHHHHHHHHHHHHHccC--Cc-eeeEeeEEEecCeEEE
Q 004912 518 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-------QGLKEFKNEMMLIAKLQH--RN-LVRLLGCCVEQGEKIL 586 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-------~~~~~f~~E~~il~~l~H--pn-iv~l~~~~~~~~~~~l 586 (724)
.+.||.|..+.||++... +++.++||....... ...+++..|++++..+.+ |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999764 467899998653211 123567789999988843 43 3345543 4455689
Q ss_pred EEEeeCCC
Q 004912 587 ILEYMPNK 594 (724)
Q Consensus 587 V~Ey~~~g 594 (724)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.88 E-value=5.1e-05 Score=78.04 Aligned_cols=81 Identities=16% Similarity=0.251 Sum_probs=60.3
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCC---ceeeEeeEEEecCeEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hp---niv~l~~~~~~~~~~~lV~ 588 (724)
.....-.+.+|.|..+.||+.++.+|+.+.||+...........|..|+..|+.|... -+.+++++ + ..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEE
Confidence 3456667899999999999999999999999997655444455788999999988422 24444443 2 237899
Q ss_pred EeeCCCCh
Q 004912 589 EYMPNKSL 596 (724)
Q Consensus 589 Ey~~~gsL 596 (724)
||++.+..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.85 E-value=0.0001 Score=76.53 Aligned_cols=139 Identities=22% Similarity=0.131 Sum_probs=93.7
Q ss_pred eeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHcc---CCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~---Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
-.+.|+.|....+|+... +++.++||+.... ....|..|+..|+.|. ...+.+++.++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356899999999999876 5678899987542 3567889999999884 25688888888878889999999998
Q ss_pred CChhH--------H---HhhcCC-C------------------CCCCHHHHH---HHHH----------------HHHHH
Q 004912 594 KSLNV--------F---LFDSTK-K------------------RLLNWQARV---RIIE----------------GIAQG 624 (724)
Q Consensus 594 gsL~~--------~---l~~~~~-~------------------~~l~~~~~~---~i~~----------------qia~~ 624 (724)
..+.. . |+.... . ..-+|.+.. ++.. ++++.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 86521 1 222111 0 012454322 1111 11111
Q ss_pred -HHHHHh-cCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 625 -LLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 625 -L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
...|.. ..+..++|+|+.+.||+++.++ +.|+|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123322 2345699999999999999887 9999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00027 Score=76.84 Aligned_cols=73 Identities=11% Similarity=0.127 Sum_probs=45.9
Q ss_pred eeeeccCCceeEEeeeecCCceeEEEecccc------C-h--hhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEE
Q 004912 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ------S-G--QGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~------~-~--~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV 587 (724)
.+.||.|....||++.. +++.++||..... . . .....+..|+..+..- .+..+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46899999999999965 5678999943211 0 1 1233444454443322 234566666654 5667899
Q ss_pred EEee-CC
Q 004912 588 LEYM-PN 593 (724)
Q Consensus 588 ~Ey~-~~ 593 (724)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00041 Score=72.29 Aligned_cols=144 Identities=16% Similarity=0.154 Sum_probs=81.1
Q ss_pred eeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCc--eeeEeeE------EEecCeEEEEEE
Q 004912 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGC------CVEQGEKILILE 589 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpn--iv~l~~~------~~~~~~~~lV~E 589 (724)
.+.|+.|....+|+....++ .+++|...... ..+++..|+.++..+.... +.+++.. ....+..+++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 35677888899999977555 78899886521 1234556777777774222 2333311 123456789999
Q ss_pred eeCCCChhH----H----------HhhcCC----C--CCC---CHHHHHH------------HHHHHHHHHHHHHhc---
Q 004912 590 YMPNKSLNV----F----------LFDSTK----K--RLL---NWQARVR------------IIEGIAQGLLYLHQY--- 631 (724)
Q Consensus 590 y~~~gsL~~----~----------l~~~~~----~--~~l---~~~~~~~------------i~~qia~~L~yLH~~--- 631 (724)
|++|..+.. . ++.... . ... .|..... +...+.+.++.+++.
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 999865421 0 111100 0 001 1222110 011244455556532
Q ss_pred -CCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 632 -SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 632 -~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
.+..++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 123599999999999998876668999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00072 Score=69.81 Aligned_cols=138 Identities=12% Similarity=0.095 Sum_probs=76.7
Q ss_pred eeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCce-eeEeeEEEecCeEEEEEEee-CCCC
Q 004912 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILEYM-PNKS 595 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpni-v~l~~~~~~~~~~~lV~Ey~-~~gs 595 (724)
.+.|+.|....+|+. +.+++|+........ ....+|+.+++.+....+ .+++++ +.+..++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 468999999999998 678899886543221 123568888877753333 345543 344457899999 6655
Q ss_pred hhHHH------------------hhcCC--CCCCCH-HHHHHHHHH--------------HHHHH----HHHHh-cCCCc
Q 004912 596 LNVFL------------------FDSTK--KRLLNW-QARVRIIEG--------------IAQGL----LYLHQ-YSRFR 635 (724)
Q Consensus 596 L~~~l------------------~~~~~--~~~l~~-~~~~~i~~q--------------ia~~L----~yLH~-~~~~~ 635 (724)
|.... |.... ...... ..+..+... +.+.+ +.|.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 53210 11000 000111 111111110 11111 11111 12335
Q ss_pred eEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 636 IIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 636 iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667889999998864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0012 Score=70.40 Aligned_cols=141 Identities=19% Similarity=0.250 Sum_probs=83.5
Q ss_pred eeeccCCceeEEeeeecC--------CceeEEEeccccChhhHHHHHHHHHHHHHccCCc-eeeEeeEEEecCeEEEEEE
Q 004912 519 CKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpn-iv~l~~~~~~~~~~~lV~E 589 (724)
+.|..|-...+|+....+ ++.+++|+..... .......+|..+++.+.-.+ ..++++++. + .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEE
Confidence 567778888899987642 4689999864322 23456678999998885322 345565543 2 28999
Q ss_pred eeCCCChhHH-----------------HhhcC--CCCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 004912 590 YMPNKSLNVF-----------------LFDST--KKRLLN--WQARVRIIEGIAQ-------------------GLLYL- 628 (724)
Q Consensus 590 y~~~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~qia~-------------------~L~yL- 628 (724)
|+++..|..- |+... ...... +.++.++..++.. .++.|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665321 01110 011122 4555555544422 22333
Q ss_pred ---Hhc-CCCceEeccCCCCCEEEcCC----CCEEEEecCCccc
Q 004912 629 ---HQY-SRFRIIHRDLKASNILLDKD----MNPKISDFGLARM 664 (724)
Q Consensus 629 ---H~~-~~~~iiH~Dlkp~NILl~~~----~~~kL~DFGla~~ 664 (724)
... .+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 23458999999999999876 7899999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00065 Score=73.99 Aligned_cols=73 Identities=22% Similarity=0.328 Sum_probs=49.7
Q ss_pred eeeeccCCceeEEeeeecC--------CceeEEEeccccChhhHHHHHHHHHHHHHccCCce-eeEeeEEEecCeEEEEE
Q 004912 518 QCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILIL 588 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpni-v~l~~~~~~~~~~~lV~ 588 (724)
.+.|+.|....+|+....+ ++.+++|+..... ..+.+.+|..++..+...++ .++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 3678889899999998653 4689999884421 12455679999988854343 45665542 2 2899
Q ss_pred EeeCCCCh
Q 004912 589 EYMPNKSL 596 (724)
Q Consensus 589 Ey~~~gsL 596 (724)
||+++.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.002 Score=67.50 Aligned_cols=141 Identities=13% Similarity=0.137 Sum_probs=72.2
Q ss_pred eeeccCCcee-EEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccC--CceeeEeeEEEecCeEEEEEEeeCCCC
Q 004912 519 CKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQGEKILILEYMPNKS 595 (724)
Q Consensus 519 ~~LG~G~fG~-Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~H--pniv~l~~~~~~~~~~~lV~Ey~~~gs 595 (724)
+.|+.|.... +|+....+++.+++|....... ..+..|+.++..+.. -.+.+++.+..+. -+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4565554443 6676554466777876543321 234456667766642 2345566653322 378999998766
Q ss_pred hhHHHhhc-------------------C--C--CCCCCHHHHHH--------------------HHHHHHHHHHHHH---
Q 004912 596 LNVFLFDS-------------------T--K--KRLLNWQARVR--------------------IIEGIAQGLLYLH--- 629 (724)
Q Consensus 596 L~~~l~~~-------------------~--~--~~~l~~~~~~~--------------------i~~qia~~L~yLH--- 629 (724)
+.+.+... . . ...++...... ....+.+.++.|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65433110 0 0 01122111100 0011112222221
Q ss_pred hcCCCceEeccCCCCCEEEcCC----CCEEEEecCCccc
Q 004912 630 QYSRFRIIHRDLKASNILLDKD----MNPKISDFGLARM 664 (724)
Q Consensus 630 ~~~~~~iiH~Dlkp~NILl~~~----~~~kL~DFGla~~ 664 (724)
......++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123459999999999999874 6899999998865
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0045 Score=64.45 Aligned_cols=142 Identities=14% Similarity=0.156 Sum_probs=83.0
Q ss_pred eeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCc--eeeEeeE-----EEecCeEEEEEEee
Q 004912 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGC-----CVEQGEKILILEYM 591 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpn--iv~l~~~-----~~~~~~~~lV~Ey~ 591 (724)
..|+ |....||+....+|+.+++|...... .....+..|..++..+.... +.+++.. ....+..++|||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 77889999877777789999986431 13456677888888774222 3444432 22345668899999
Q ss_pred CCCChhH-----H---------HhhcC------CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 004912 592 PNKSLNV-----F---------LFDST------KKRLLNWQAR----VRI---------------IEGIAQGLLYLHQY- 631 (724)
Q Consensus 592 ~~gsL~~-----~---------l~~~~------~~~~l~~~~~----~~i---------------~~qia~~L~yLH~~- 631 (724)
++..+.. + ++... ....+++... ..+ ...+.+.++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8865421 1 11100 0112222211 001 11111223333221
Q ss_pred ---CCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 632 ---SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 632 ---~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
.+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234589999999999999 4 899999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.003 Score=69.20 Aligned_cols=74 Identities=12% Similarity=0.101 Sum_probs=48.5
Q ss_pred eeeeccCCceeEEeeeecC-CceeEEEeccccChhhHHHHHHHHHHHHHccCCce-eeEeeEEEecCeEEEEEEeeCCCC
Q 004912 518 QCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILEYMPNKS 595 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpni-v~l~~~~~~~~~~~lV~Ey~~~gs 595 (724)
.+.|+.|-...+|+....+ +..+++|+.......... -.+|..++..|...++ .++++++ .+ .+||||+++..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id-R~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN-REREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC-HHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC-HHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence 3678889899999998755 478889987543322111 2578999999865544 4566655 23 25999998755
Q ss_pred h
Q 004912 596 L 596 (724)
Q Consensus 596 L 596 (724)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0023 Score=68.08 Aligned_cols=74 Identities=14% Similarity=0.120 Sum_probs=45.0
Q ss_pred eeeeccCCceeEEeeeecC---------CceeEEEeccccChhhHHHHHHHHHHHHHccCCc-eeeEeeEEEecCeEEEE
Q 004912 518 QCKLGEGGFGPVYKGRLLN---------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQGEKILI 587 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~---------g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpn-iv~l~~~~~~~~~~~lV 587 (724)
.+.|+.|..-.+|+....+ ++.+++|+....... ......|..++..+...+ ..++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3578888888999987654 267888887553322 122367888888885333 33555443 2 2689
Q ss_pred EEeeCCCCh
Q 004912 588 LEYMPNKSL 596 (724)
Q Consensus 588 ~Ey~~~gsL 596 (724)
|||+++..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999997654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0099 Score=62.36 Aligned_cols=68 Identities=10% Similarity=0.075 Sum_probs=43.6
Q ss_pred ccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccC---CceeeEeeE------EEecCeEEEEEEeeC
Q 004912 522 GEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH---RNLVRLLGC------CVEQGEKILILEYMP 592 (724)
Q Consensus 522 G~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~H---pniv~l~~~------~~~~~~~~lV~Ey~~ 592 (724)
|.|....||+....+| .+++|+...... ..|+..+..|.. |++.+.+.. ....+..++||||++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3333678999987666 899998765431 355666666531 224444432 233567899999999
Q ss_pred CCCh
Q 004912 593 NKSL 596 (724)
Q Consensus 593 ~gsL 596 (724)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8766
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.11 E-value=0.081 Score=57.05 Aligned_cols=141 Identities=15% Similarity=0.172 Sum_probs=85.0
Q ss_pred eeeeccCCceeEEeeeecC--------CceeEEEeccccChhhHHHHHHHHHHHHHccCCc-eeeEeeEEEecCeEEEEE
Q 004912 518 QCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpn-iv~l~~~~~~~~~~~lV~ 588 (724)
.+.|..|-...+|+....+ ++.+++|+......... .-.+|..+++.+...+ ..++++. ..+ ++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~--~~~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIAD--FPE--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEE--ETT--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEE--cCC--CEEE
Confidence 3678888888999998753 57899998755432221 2357888888885323 3445542 222 6899
Q ss_pred EeeCCCChhH-------H-------H---hh--c-----C---CCCCCCHHHHHHHHHHHH-------------------
Q 004912 589 EYMPNKSLNV-------F-------L---FD--S-----T---KKRLLNWQARVRIIEGIA------------------- 622 (724)
Q Consensus 589 Ey~~~gsL~~-------~-------l---~~--~-----~---~~~~l~~~~~~~i~~qia------------------- 622 (724)
||+++..|.. . | |. . . ...+.-+.++.++..++-
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999876421 0 0 11 1 0 111122444444443321
Q ss_pred HHHHHHHh---------------------cCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 623 QGLLYLHQ---------------------YSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 623 ~~L~yLH~---------------------~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
..+..|.+ ..+..++|+|+.+.||+ +.++.+.|+||..|..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22233321 11245899999999999 8888999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.07 E-value=0.22 Score=53.29 Aligned_cols=29 Identities=28% Similarity=0.438 Sum_probs=25.1
Q ss_pred eEeccCCCCCEEE------cCCCCEEEEecCCccc
Q 004912 636 IIHRDLKASNILL------DKDMNPKISDFGLARM 664 (724)
Q Consensus 636 iiH~Dlkp~NILl------~~~~~~kL~DFGla~~ 664 (724)
++|+|+.+.|||+ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999998864
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=91.95 E-value=5.9 Score=39.41 Aligned_cols=73 Identities=12% Similarity=0.274 Sum_probs=44.8
Q ss_pred EEEEEccCCCeEEEeecCCCC--CCC----CCCeEEEeeCCcEEEecCCCCeEEEEeccCCCCCceEEEccCCCeEEecC
Q 004912 62 LGIRFQQIPDAVVWVANRDRP--ISD----NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDN 135 (724)
Q Consensus 62 ~giw~~~~~~t~VW~ANr~~p--~~~----~~~~L~l~~~g~l~l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~ 135 (724)
+.+| +.-..+++|...+..+ +.+ +++.+-++.++.+...|++|..+|.-.+........+..+.+||+++-+.
T Consensus 17 v~~~-d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~ 95 (276)
T 3no2_A 17 IAII-NKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWC 95 (276)
T ss_dssp EEEE-ETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEE
T ss_pred EEEE-ECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEec
Confidence 5555 2225678898887542 111 23444455556667778889999998763222233456778888888764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=90.86 E-value=0.59 Score=44.97 Aligned_cols=99 Identities=15% Similarity=0.062 Sum_probs=64.6
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccccc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 673 (724)
-+|.++|.. .+.++++.+++-++.|.+.+|.-+-... .+ ..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 378888854 4567999999999999999987763211 01 1233457899999999988764 1110
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc
Q 004912 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712 (724)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt 712 (724)
.....+.|||... ...+.+.=|||||+++|.-+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123567888653 455788899999999999875
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=88.86 E-value=0.44 Score=37.96 Aligned_cols=35 Identities=26% Similarity=0.535 Sum_probs=29.4
Q ss_pred ccChHHHHHHHhhcCceEEEeeccccCCcceEEeccc
Q 004912 361 RMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGD 397 (724)
Q Consensus 361 ~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~C~~w~~~ 397 (724)
..++++|+..|+.+=.|.||.|+. ....|++..+.
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN~--~s~~CflKs~~ 63 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYNV--KSGLCYPKRGK 63 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEET--TTTEEEEEESS
T ss_pred CCCHHHHHHHhhccCCCCeEEecc--CCCceEcccCC
Confidence 468999999999999999999973 44679998654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.82 E-value=0.22 Score=54.44 Aligned_cols=61 Identities=11% Similarity=0.106 Sum_probs=18.5
Q ss_pred eeeeeccCCceeEEeeeecC-CceeEE------Eecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe
Q 004912 517 MQCKLGEGGFGPVYKGRLLN-GQEVAV------KRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 580 (724)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~~-g~~vAV------K~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~ 580 (724)
+.+.|| ||.||+|.+.. ..+||| |..+.. ..+....|.+|..++..++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345676 99999998754 368898 766542 23345678899999999999999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 724 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-61 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-25 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-22 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-04 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 6e-15 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 6e-15 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 6e-05 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 4e-10 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 9e-14 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 1e-09 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 5e-08 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-61
Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 11/206 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGL-KEFKNEMMLIAKLQH 568
++F +LG G G V+K +G +A K + + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+V G GE + +E+M SL+ L K + Q ++ + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
+ +I+HRD+K SNIL++ K+ DFG++ VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
+S++SD++S G+ ++E +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-61
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 9/206 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
++ ++G G FG VYKG+ V + ++ + Q L+ FKNE+ ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+G + ++ ++ SL L + + I AQG+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-- 690
IIHRDLK++NI L +D+ KI DFGLA + +Q+ G+ +M+PE
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 691 -DGLFSIKSDVFSFGILMLETLSSKK 715
+S +SDV++FGI++ E ++ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQL 207
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-58
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 7/203 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+ ++G G FG V+ G LN +VA+K + + ++F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L G C+EQ L+ E+M + L + T++ L + + + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCL--SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA- 120
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
+IHRDL A N L+ ++ K+SDFG+ R D+ ++ + SPE
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 693 LFSIKSDVFSFGILMLETLSSKK 715
+S KSDV+SFG+LM E S K
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK 200
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-57
Identities = 71/203 (34%), Positives = 105/203 (51%), Gaps = 7/203 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
RL Q +I EYM N SL FL + +L + + IA+G+ ++ + +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
IHRDL+A+NIL+ ++ KI+DFGLAR+ +E + +PE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 693 LFSIKSDVFSFGILMLETLSSKK 715
F+IKSDV+SFGIL+ E ++ +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR 208
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-56
Identities = 55/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+ + + +LG+G FG VYK + A K + +S + L+++ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V+LL + +++E+ +++ + + +R L + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
+IIHRDLKA NIL D + K++DFG++ + ++ +GT +M+PE +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
Query: 691 -----DGLFSIKSDVFSFGILMLETLSSK 714
D + K+DV+S GI ++E +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 8e-56
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 569
E++ + +G G +G K R +G+ + K L + + + +E+ L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 570 NLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKR-LLNWQARVRIIEGIAQGLL 626
N+VR +++ L ++EY L + TK+R L+ + +R++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 627 YLHQYSR--FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
H+ S ++HRDLK +N+ LD N K+ DFGLAR+ D K VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYM 181
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
SPE ++ KSD++S G L+ E
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYE 206
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-55
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 7/203 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
++ + +LG G FG V G+ +VA+K + S EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L G C +Q +I EYM N L + + Q + + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
+ +HRDL A N L++ K+SDFGL+R DE + + PE +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYS 176
Query: 693 LFSIKSDVFSFGILMLETLSSKK 715
FS KSD+++FG+LM E S K
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK 199
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-55
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+ + +G+G FG V G G +VAVK + N + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 573 RLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+LLG VE+ + ++ EYM SL +L + +L ++ + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+HRDL A N+L+ +D K+SDFGL + E + +PE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174
Query: 692 GLFSIKSDVFSFGILMLETLSSKK 715
FS KSDV+SFGIL+ E S +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR 198
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (480), Expect = 4e-55
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ 567
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H N ++ GC + + L++EY + ++ K+ L + G QGL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH + +IHRD+KA NILL + K+ DFG A + VGT +M+PE
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 688 YAL---DGLFSIKSDVFSFGILMLETLSSK 714
L +G + K DV+S GI +E K
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 5e-55
Identities = 69/203 (33%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L + ++ EYM SL FL T K L V + IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
+HRDL+A+NIL+ +++ K++DFGLAR+ +E + +PE AL G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189
Query: 693 LFSIKSDVFSFGILMLETLSSKK 715
F+IKSDV+SFGIL+ E + +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGR 212
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 7e-55
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 9/205 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 570
E++ + LGEG +G V + VAVK + ++ + K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V+ G E + L LEY L + + R + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
I HRD+K N+LLD+ N KISDFGLA +F + + ++ GT Y++PE
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 691 DGLF-SIKSDVFSFGILMLETLSSK 714
F + DV+S GI++ L+ +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE 203
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-53
Identities = 56/212 (26%), Positives = 106/212 (50%), Gaps = 10/212 (4%)
Query: 504 SLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMML 562
S+ S+ + ++ K+G+G G VY + GQEVA+++++ Q + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 563 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA 622
+ + ++ N+V L + E +++EY+ S L D + ++ +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECL 126
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
Q L +LH ++IHRD+K+ NILL D + K++DFG + Q +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
+M+PE + K D++S GI+ +E + +
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-53
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 12/211 (5%)
Query: 511 ATENFSMQ-CKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 565
+N + +LG G FG V +G +VA+K L + + +E E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
L + +VRL+G C + +L++E L+ FL K+ + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK-QIVGTYGYM 684
YL + +HRDL A N+LL KISDFGL++ G D+ + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
+PE FS +SDV+S+G+ M E LS +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 4e-53
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
++G G F VYKG EVA L ++ + + FK E ++ LQH N+VR
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 577 CCVEQGEK----ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+ +L+ E M + +L +L + +++ + I +GL +LH +
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 633 RFRIIHRDLKASNILL-DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
IIHRDLK NI + + KI D GLA + K ++GT +M+PE +
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YE 186
Query: 692 GLFSIKSDVFSFGILMLETLSSKK 715
+ DV++FG+ MLE +S+
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEY 210
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 182 bits (463), Expect = 8e-53
Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 22/230 (9%)
Query: 503 FSLASITAATENFS---------MQCKLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQ 548
F+ A F+ ++ +G G FG V G L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 549 SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL 608
+ + ++F +E ++ + H N++ L G + ++I E+M N SL+ FL + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 609 LNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668
V ++ GIA G+ YL +HRDL A NIL++ ++ K+SDFGL+R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 669 ELQGNTKQIVG---TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
+G + +PE F+ SDV+S+GI+M E +S +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 182 bits (462), Expect = 8e-53
Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 7/204 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
+ +M+ KLG G +G VY+G VAVK L + + ++EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
V+LLG C + +I E+M +L +L + ++ ++ + + I+ + YL +
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKK 134
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
IHRDL A N L+ ++ K++DFGL+R+ GD + + +PE
Sbjct: 135 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190
Query: 692 GLFSIKSDVFSFGILMLETLSSKK 715
FSIKSDV++FG+L+ E +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGM 214
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 1e-52
Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQH 568
E+F + LG+G FG VY R + +A+K L + + + E+ + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
N++RL G + LILEY P ++ L K + Q I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
+ K D++S G+L E L K
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-52
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 579
+G+G FG V++G+ G+EVAVK S++ + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 580 EQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ----- 630
+ L+ +Y + SL +L + + + +++ A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEY 688
+ I HRDLK+ NIL+ K+ I+D GLA D + VGT YM+PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 689 ALDGL------FSIKSDVFSFGILMLETLSSKKNTG 718
D + ++D+++ G++ E G
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-52
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 520 KLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQG--LKEFKNEMMLIAKLQHRNLVRL 574
+LG G FG V KG + VAVK L N++ E E ++ +L + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+G C E +L++E LN +L + R + + + ++ ++ G+ YL +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK-QIVGTYGYMSPEYALDGL 693
+HRDL A N+LL KISDFGL++ DE + + +PE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 694 FSIKSDVFSFGILMLETLSSKK 715
FS KSDV+SFG+LM E S +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQ 208
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (456), Expect = 8e-52
Identities = 62/240 (25%), Positives = 103/240 (42%), Gaps = 31/240 (12%)
Query: 504 SLASITAATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-KEF 556
L S+ N +GEG FG V++ R VAVK L ++ + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 557 KNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------- 608
+ E L+A+ + N+V+LLG C L+ EYM LN FL + +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 609 -------------LNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655
L+ ++ I +A G+ YL + + +HRDL N L+ ++M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
I+DFGL+R + +M PE ++ +SDV+++G+++ E S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-51
Identities = 65/231 (28%), Positives = 97/231 (41%), Gaps = 31/231 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 565
EN LG G FG V +VAVK L ++ + +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 566 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKK------------------ 606
L H N+V LLG C G LI EY L +L +K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 607 --RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664
+L ++ + +A+G+ +L +HRDL A N+L+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
D +M+PE +G+++IKSDV+S+GIL+ E S
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-50
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 520 KLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 574
+G G FG VY G LL+ AVK L+ + G + +F E +++ H N++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 575 LGCCVE-QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
LG C+ +G +++L YM + L F + + + +A+G+ +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDL--RNFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ--IVGTYGYMSPEYALD 691
+ +HRDL A N +LD+ K++DFGLAR E + +M+ E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 692 GLFSIKSDVFSFGILMLETLSSKK 715
F+ KSDV+SFG+L+ E ++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGA 232
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 6e-50
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 568
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
V+L + + L Y N L + R A+ + L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTR----FYTAEIVSAL 121
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
IIHRDLK NILL++DM+ +I+DFG A++ + Q VGT Y+SPE
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
+ SD+++ G ++ + ++
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-49
Identities = 62/226 (27%), Positives = 91/226 (40%), Gaps = 26/226 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 565
S LG G FG V + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 566 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL---------------L 609
L H N+V LLG C G ++I EY L FL + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669
+ + + +A+G+ +L IHRDL A NILL KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
+M+PE + +++ +SDV+S+GI + E S
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 5e-49
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 12/209 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLS-NQSGQGLKEFKNEMMLIAKL 566
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
+ ++ RLLG C+ LI + MP L + K + Q + IA+G+
Sbjct: 69 DNPHVCRLLGICLT-STVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
YL R++HRDL A N+L+ + KI+DFGLA++ G +E + + + +M+
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSSKK 715
E L +++ +SDV+S+G+ + E ++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 173 bits (440), Expect = 5e-49
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
+++ + +LG G FG V++ G A K + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
V L + E ++I E+M L + D + ++ V + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 632 SRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
+H DLK NI+ + K+ DFGL + + K GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197
Query: 690 LDGLFSIKSDVFSFGILMLETLSSK 714
+D++S G+L LS
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-48
Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 24/221 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG---QEVAVKRLS-NQSGQGLKEFKNEMMLIAKL-Q 567
+ Q +GEG FG V K R+ + A+KR+ S ++F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------FDSTKKRLLNWQAR 614
H N++ LLG C +G L +EY P+ +L FL ++ L+ Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674
+ +A+G+ YL Q + IHRDL A NIL+ ++ KI+DFGL+R
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
+M+ E +++ SDV+S+G+L+ E +S
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 3e-48
Identities = 58/211 (27%), Positives = 87/211 (41%), Gaps = 14/211 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAK 565
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
L HRNL+RL G ++ E P SL + R +A+G+
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSL--LDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG-NTKQIVGTYGYM 684
YL R IHRDL A N+LL KI DFGL R ++ + + +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
+PE FS SD + FG+ + E + +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-47
Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSGQG-LKEFKNEMMLIAKL 566
+ Q +G G FG VYKG L VA+K L + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
H N++RL G + ++I EYM N +L+ FL + K + V ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT-KQIVGTYGYMS 685
YL +HRDL A NIL++ ++ K+SDFGL+R+ D T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSKK 715
PE F+ SDV+SFGI+M E ++ +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE 211
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 169 bits (428), Expect = 2e-47
Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
+ + + +LG G FG V++ G+ K ++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+ L ++ E +LILE++ L F + + ++ + + +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 632 SRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
I+H D+K NI+ + KI DFGLA DE+ K T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 690 LDGLFSIKSDVFSFGILMLETLSSK 714
+D+++ G+L LS
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-46
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 12/208 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQ 567
E + +GEG FG V++G ++ VA+K N + ++E F E + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H ++V+L+G E +I+E L F +K L+ + + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGEL--RSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
L R +HRD+ A N+L+ + K+ DFGL+R + +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSKK 715
F+ SDV+ FG+ M E L
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV 207
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 5e-45
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 17/217 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLKEFKNEMMLIAK 565
E +M +LG+G FG VY+G VA+K ++ S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------LNWQARVRII 618
++VRLLG + ++I+E M L +L + +++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 678
IA G+ YL+ + +HRDL A N ++ +D KI DFG+ R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
+MSPE DG+F+ SDV+SFG+++ E + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-44
Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 563
+ + LGEG FG V + +VAVK L S+ + + L + +EM ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 564 AKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLF-------------DSTKKRLL 609
+ +H+N++ LLG C + G +I+EY +L +L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669
+ + V +A+G+ YL + IHRDL A N+L+ +D KI+DFGLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
T +M+PE D +++ +SDV+SFG+L+ E +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 5e-44
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 25/222 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQG-LKEFKNEM-MLIA 564
+ + LG G FG V + + VAVK L + + +E+ +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 565 KLQHRNLVRLLGCCVEQGEKILIL-EYMPNKSLNVFLF-------------DSTKKRLLN 610
H N+V LLG C + G ++++ E+ +L+ +L + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 611 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670
+ + +A+G+ +L + IHRDL A NILL + KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 231
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 9e-44
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 7/207 (3%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 569
++ +GEG +G V +N VA+K++S Q + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N++ + + + Y+ + L+ K + L+ + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT-KQIVGTYGYMSPEY 688
++HRDLK SN+LL+ + KI DFGLAR+ D + V T Y +PE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 689 ALDGLFSIKS-DVFSFGILMLETLSSK 714
L+ KS D++S G ++ E LS++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 158 bits (401), Expect = 2e-43
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNE---MMLIAK 565
+FS+ +G GGFG VY R G+ A+K L + QG NE + L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
+V + + IL+ M L+ L + + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
++H +++RDLK +NILLD+ + +ISD GLA F + VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 686 PEYALDGL-FSIKSDVFSFGILMLETLSSK 714
PE G+ + +D FS G ++ + L
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (397), Expect = 2e-43
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 568
++F + LG G FG V+ R NG+ A+K L + + ++ +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
++R+ G + + +I++Y+ L F +R N A+ A+ L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYA----AEVCLAL 117
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
II+RDLK NILLDK+ + KI+DFG A+ + T + GT Y++PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKK 715
++ D +SFGIL+ E L+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-43
Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 12/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
E + + LG G FG V++ + + K + + G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+ L E ++I E++ + + +T LN + V + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 632 SRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
I H D++ NI+ + KI +FG AR + N + + Y +PE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175
Query: 690 LDGLFSIKSDVFSFGILMLETLSSK 714
+ S +D++S G L+ LS
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGI 200
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (391), Expect = 4e-43
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 15/212 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQ 567
++ + + LG GG V+ R L ++VAVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 568 HRNLVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 623
H +V + + +++EY+ +L + + + + + +I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG-GDELQGNTKQIVGTYG 682
L + H + IIHRD+K +NI++ K+ DFG+AR T ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
Y+SPE A +SDV+S G ++ E L+ +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 6e-43
Identities = 47/205 (22%), Positives = 84/205 (40%), Gaps = 8/205 (3%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 569
+ + + LG G F V + VA+K ++ ++ +G +NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N+V L G LI++ + L + +K + R+I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
+ LD+D ISDFGL++M + GT GY++PE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181
Query: 690 LDGLFSIKSDVFSFGILMLETLSSK 714
+S D +S G++ L
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-42
Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 13/207 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQ 567
E+F + LG+G FG V+ Q A+K L + + + +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H L + + ++EY+ L + + I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH I++RDLK NILLDKD + KI+DFG+ + + + NT GT Y++PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSK 714
L ++ D +SFG+L+ E L +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (384), Expect = 4e-42
Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGL---------KEFKNEMML 562
EN+ + LG G V + +E AVK + G + E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 563 IAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 621
+ K+ H N+++L L+ + M L +L T+K L+ + +I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 681
+ + LH + I+HRDLK NILLD DMN K++DFG + E +++ GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 682 GYMSPEYALDGL------FSIKSDVFSFGILMLETLSSK 714
Y++PE + + + D++S G++M L+
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 569
ENF K+GEG +G VYK R L G+ VA+K RL ++ E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N+V+LL + + L+ E++ D++ + + + QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE-Y 688
+ R++HRDLK N+L++ + K++DFGLAR FG V T Y +PE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
+S D++S G + E ++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-40
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQHRNLVR 573
LGEG F VYK R N Q VA+K++ K+ E+ L+ +L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
LL + L+ ++M + +L + QGL YLHQ+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLE---VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-G 692
I+HRDLK +N+LLD++ K++DFGLA+ FG V T Y +PE
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGAR 176
Query: 693 LFSIKSDVFSFGILMLETLSSK 714
++ + D+++ G ++ E L
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV 198
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (370), Expect = 4e-40
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRN 570
E + K+GEG +G VYK + G+ A+K RL + E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V+L + +L+ E++ + + L + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
R++HRDLK N+L++++ KI+DFGLAR FG + T Y +P+ +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLM 173
Query: 691 -DGLFSIKSDVFSFGILMLETLSSK 714
+S D++S G + E ++
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 6e-40
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+++ +G G FG VY+ +L +G+ VA+K++ + E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 573 RLLGCCVEQGEK------ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
RL GEK L+L+Y+P V S K+ L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 627 YLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
Y+H + I HRD+K N+LLD D K+ DFG A+ E + + + Y +
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 686 PEYALDGL-FSIKSDVFSFGILMLETLSSK 714
PE ++ DV+S G ++ E L +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 9e-40
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 16/214 (7%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQSGQG--LKEFKNE---MMLI 563
A + + ++GEG +G V+K R L G+ VA+KR+ Q+G+ E + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN---VFLFDSTKKRLLNWQARVRIIEG 620
+H N+VRL C + + ++ D + + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
+ +GL +LH R++HRDLK NIL+ K++DFGLAR++ Q +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
Y +PE L ++ D++S G + E K
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (365), Expect = 2e-39
Identities = 41/213 (19%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
++ + ++GEG FG +++G LLN Q+VA+K +S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+ + ++G +++ + SL L R + + + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 632 SRFRIIHRDLKASNILLDKDMNP-----KISDFGLARMFGGDELQGN-----TKQIVGTY 681
+++RD+K N L+ + + + DFG+ + + + + K + GT
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
YMS L S + D+ + G + + L
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 20/213 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL------SNQSGQGLKEFKNEMMLIAK 565
+ + +LG G F V K R G + A K + S++ G ++ + E+ ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
+QH N++ L + + ILILE + L +K L + ++ I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGEL---FDFLAEKESLTEEEATEFLKQILNG- 125
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNP----KISDFGLARMFGGDELQGNTKQIVGTY 681
++ +I H DLK NI+L P KI DFGLA K I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
+++PE +++D++S G++ LS
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 8e-38
Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 569
+ K+G+G FG V+K R GQ+VA+K++ N+ E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 570 NLVRLLGCCVEQGEKI--------LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 621
N+V L+ C + L+ ++ + + K R+++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT--KQIVG 679
GL Y+H+ +I+HRD+KA+N+L+ +D K++DFGLAR F + V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 680 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSK 714
T Y PE L + + D++ G +M E +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 8e-38
Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 20/211 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE------FKNEMMLIAKLQ 567
+ + LG GGFG VY G + + VA+K + E E++L+ K+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 568 --HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
++RLL +LILE T++ L + + + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAV 123
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
+ H ++HRD+K NIL+D + K+ DFG + GT Y
Sbjct: 124 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYS 176
Query: 685 SPEYAL-DGLFSIKSDVFSFGILMLETLSSK 714
PE+ + V+S GIL+ + +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (353), Expect = 1e-37
Identities = 45/204 (22%), Positives = 82/204 (40%), Gaps = 16/204 (7%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
K+G G FG +Y G + G+EVA+K ++ + E + +Q + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+G+ +++ + SL + R + + + + + + + Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSL--EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIH 126
Query: 639 RDLKASNIL---LDKDMNPKISDFGLARMFGGDELQGN-----TKQIVGTYGYMSPEYAL 690
RD+K N L K I DFGLA+ + + K + GT Y S L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 691 DGLFSIKSDVFSFGILMLETLSSK 714
S + D+ S G +++
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGS 210
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-37
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 12/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 568
+F LG+G FG V R G+ A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
L L ++EY LF + + + R R A+ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFY--GAEIVSAL 118
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
+++RD+K N++LDKD + KI+DFGL + D K GT Y++PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
D + D + G++M E + +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-35
Identities = 48/206 (23%), Positives = 92/206 (44%), Gaps = 10/206 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 569
+ + K+GEG +G V+K + + VA+K RL + E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N+VRL + L+ E+ F + + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
++HRDLK N+L++++ K+++FGLAR F G ++ + ++V +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 690 LDGLFSIKSDVFSFGILMLETLSSKK 715
L+S D++S G + E ++ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 3e-35
Identities = 41/198 (20%), Positives = 79/198 (39%), Gaps = 21/198 (10%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCC 578
LG G G V + ++ A+K L + + + E+ L + Q ++VR++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 579 ----VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+ ++++E + L + D + + I++ I + + YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHSI--- 130
Query: 635 RIIHRDLKASNILLDKDMNP---KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
I HRD+K N+L K++DFG A+ T Y++PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187
Query: 692 GLFSIKSDVFSFGILMLE 709
+ D++S G++M
Sbjct: 188 EKYDKSCDMWSLGVIMYI 205
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (335), Expect = 1e-34
Identities = 47/206 (22%), Positives = 86/206 (41%), Gaps = 15/206 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 568
+ F LG G FG V + +G A+K L Q + ++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
LV+L + +++EY+ + L + + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H +I+RDLK N+L+D+ +++DFG A+ +G T + GT ++PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEI 209
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
L ++ D ++ G+L+ E +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-33
Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 569
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 570 NLVRLLGCCVEQG------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 623
N++ LL + L++ +M + K L ++ + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
GL Y+H IIHRDLK N+ +++D KI DFGLAR + V T Y
Sbjct: 133 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184
Query: 684 MSPEYALDGL-FSIKSDVFSFGILMLETLSSK 714
+PE L+ + ++ D++S G +M E ++ K
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 9e-33
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 18/213 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLS----NQSGQGLKEFKNEMMLIA 564
ENF + LG G +G V+ R + G+ A+K L Q + + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 565 KLQHR-NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 623
++ LV L + + LIL+Y+ L L + Q + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
+L L + II+RD+K NILLD + + ++DFGL++ F DE + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 684 MSPEYALDGL--FSIKSDVFSFGILMLETLSSK 714
M+P+ G D +S G+LM E L+
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 125 bits (315), Expect = 3e-32
Identities = 44/208 (21%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRN 570
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 571 LVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
++ L + + L+ E++ N + L ++ R + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIR-FYMYEILKALDYC 145
Query: 629 HQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
H I+HRD+K N+++D + ++ D+GLA + + V + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSSK 714
+D ++ D++S G ++ + K
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 9e-31
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHR 569
+ + +G G G V + + VA+K+LS Q+ K E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 570 NLVRLLGCCVEQG------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 623
N++ LL Q + L++E M V + L+ + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLC 130
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
G+ +LH IIHRDLK SNI++ D KI DFGLAR G + V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
+PE L + D++S G +M E + K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-29
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 568
E + +G G +G V G VAVK+LS QS K E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 569 RNLVRLLGCCVEQ-----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 623
N++ LL + ++ ++ L + K + L +I I +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD----LNNIVKCQKLTDDHVQFLIYQILR 132
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
GL Y+H IIHRDLK SN+ +++D KI DFGLAR V T Y
Sbjct: 133 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWY 184
Query: 684 MSPEYALDGL-FSIKSDVFSFGILMLETLSSK 714
+PE L+ + ++ D++S G +M E L+ +
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (286), Expect = 3e-28
Identities = 41/210 (19%), Positives = 84/210 (40%), Gaps = 18/210 (8%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
KLG G F V+ + ++N VA+K + + ++E+ L+ ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 579 VEQGEKIL-------------ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
K+L ++ + + L + R + +I + + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 626 LYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
Y+H+ R IIH D+K N+L++ D + +A + + + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSK 714
SPE L + +D++S L+ E ++
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (255), Expect = 1e-25
Identities = 28/158 (17%), Positives = 57/158 (36%), Gaps = 28/158 (17%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLK--------EFKNEMMLIAKLQHR 569
+GEG V+ E VK ++ + S + +K F + A+ + R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 570 NLVRLLGCCV----EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
L +L G V +++E + K + + + +++ I + +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEEV 116
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663
+ I+H DL N+L+ + I DF +
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 90.0 bits (223), Expect = 3e-22
Identities = 22/118 (18%), Positives = 47/118 (39%), Gaps = 13/118 (11%)
Query: 34 IRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTIS 93
+ +GE L + Q ++ + + L + VW +N +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGILG-KKGCKAVLQ 58
Query: 94 NNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151
++GN V+ + ++W+++ N V L++DGN+VI + +W + Y
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------IWSTGTY 108
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 38.8 bits (90), Expect = 3e-04
Identities = 17/78 (21%), Positives = 32/78 (41%), Gaps = 2/78 (2%)
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNP-VAQLRDDGNLVIRDNSSGNAT 141
+ + + NLVL + + ++W++N K A L+ DGN V+ D +
Sbjct: 16 LDVEPYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLW 74
Query: 142 ESYLWQSFDYPTDTLLQD 159
S+ + L +D
Sbjct: 75 ASHSVRGNGNYVLVLQED 92
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 69.4 bits (169), Expect = 6e-15
Identities = 26/130 (20%), Positives = 50/130 (38%), Gaps = 18/130 (13%)
Query: 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPIS 84
+D + + G L + + + VW + + S
Sbjct: 1 SDRLNSGHQLDTGGSLAEG--GYLFIIQNDCNLVLYD--------NNRAVWASGTNGKAS 50
Query: 85 DNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESY 144
VL + N+GNLV+ + + IW++N + + N L+ D N+VI DNS+ +
Sbjct: 51 --GCVLKMQNDGNLVIYSGSR-AIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 145 LWQSFDYPTD 154
+W + +
Sbjct: 103 IWATHTNVGN 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 68.9 bits (168), Expect = 6e-15
Identities = 26/126 (20%), Positives = 45/126 (35%), Gaps = 20/126 (15%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
+ + + GE L + F L + D +W N
Sbjct: 2 NILYSGETLSTGEFL--NYGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--S 49
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
+ L++ +GNLV+ N +N IW++N + N V L+ D N+VI
Sbjct: 50 RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD--------R 101
Query: 146 WQSFDY 151
W + +
Sbjct: 102 WATGTH 107
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 40.8 bits (95), Expect = 6e-05
Identities = 18/80 (22%), Positives = 35/80 (43%), Gaps = 1/80 (1%)
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142
++ + V + + NLVL + + IW+TN ++ ++ DGNLV+ + S+
Sbjct: 16 LNYGSFVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWA 74
Query: 143 SYLWQSFDYPTDTLLQDMKL 162
S L +D +
Sbjct: 75 SNTGGQNGNYVCILQKDRNV 94
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 68.8 bits (168), Expect = 1e-14
Identities = 16/89 (17%), Positives = 37/89 (41%), Gaps = 8/89 (8%)
Query: 71 DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNL 130
D + + + + L++ + NLVL ++ + +WSTN + + A L+ +G +
Sbjct: 20 DNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRM 78
Query: 131 VIRDNSSGNATESYLWQSFD--YPTDTLL 157
+ N + +W S + +
Sbjct: 79 DVLTNQN-----IAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 55.7 bits (134), Expect = 4e-10
Identities = 19/96 (19%), Positives = 34/96 (35%), Gaps = 5/96 (5%)
Query: 41 VSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVL 100
+ ++Q +L + L + + D VW N + NG + +
Sbjct: 26 LHATQSLQLSPYRLSMETDCNLVLFDR---DDRVWSTNT--AGKGTGCRAVLQPNGRMDV 80
Query: 101 LNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNS 136
L N +W++ S V L+ D NL I +
Sbjct: 81 LTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGGA 116
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 66.2 bits (161), Expect = 9e-14
Identities = 19/112 (16%), Positives = 41/112 (36%), Gaps = 18/112 (16%)
Query: 40 LVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLV 99
++ + + + L + + +W N N + +G LV
Sbjct: 25 ILFGTHVYRFIMQTDCN-----LVLYD---NNNPIWATNTGGL--GNGCRAVLQPDGVLV 74
Query: 100 LLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151
++ N T+W + V+ + + V L+ D N+VI ++ LW +
Sbjct: 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDA--------LWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 54.2 bits (130), Expect = 1e-09
Identities = 26/134 (19%), Positives = 43/134 (32%), Gaps = 23/134 (17%)
Query: 12 SLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD 71
+++F LS T+ A + F S L + D
Sbjct: 2 NILFGLS-HEGSHPQTLHAAQSLELS--------SFRFTMQSDCN-----LVLFD---SD 44
Query: 72 AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLV 131
VW +N + ++G LV+L N WS+ + N V L+ D +
Sbjct: 45 VRVWASNTA---GATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVT 101
Query: 132 IRDN---SSGNATE 142
I SG + +
Sbjct: 102 IYGPGLWDSGTSNK 115
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 49.6 bits (118), Expect = 5e-08
Identities = 20/128 (15%), Positives = 39/128 (30%), Gaps = 38/128 (29%)
Query: 66 FQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLR 125
+ + + + ++ T+ ++ NLVL + + +W++N + A L+
Sbjct: 6 GLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRAVLQ 63
Query: 126 DDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP 185
DG LVI + + W S S
Sbjct: 64 SDGLLVILTAQN-----TIRWSSGT-------------------------------KGSI 87
Query: 186 GNFTYRLD 193
GN+ L
Sbjct: 88 GNYVLVLQ 95
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 724 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.86 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.84 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.84 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.67 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.62 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.52 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.45 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.16 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.95 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.84 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.74 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.6 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.03 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.49 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.94 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.47 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.26 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 87.95 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 82.26 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 80.34 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=373.91 Aligned_cols=203 Identities=30% Similarity=0.410 Sum_probs=178.0
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++|++.++||+|+||.||+|++. +++.||||+++... .+..+++.+|+.+|++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999875 58899999986543 33456799999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++|+|.+++. ....+++.++..++.||++||+|||+++ |+||||||+|||+++++++||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999983 3456999999999999999999999998 99999999999999999999999999998754443
Q ss_pred cccccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......+||+.|||||++.+..+ +.++|||||||+||||++|+.||...+
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 344556789999999999988876 578999999999999999999997543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=371.03 Aligned_cols=200 Identities=26% Similarity=0.433 Sum_probs=181.0
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
++|++.++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999874 58999999997665566788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.+....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence 99999998743 35999999999999999999999998 9999999999999999999999999999875432
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 23345689999999999999999999999999999999999999996543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=366.43 Aligned_cols=199 Identities=30% Similarity=0.431 Sum_probs=179.2
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|+||.||+|++. +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999885 5889999998643 2334678999999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999854 345999999999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......||+.|||||++.+..++.++|||||||+||||++|+.||...+
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence 2345689999999999999999999999999999999999999997654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=371.35 Aligned_cols=203 Identities=29% Similarity=0.418 Sum_probs=177.9
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|+||+||+|+.. +++.||||++++. .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999874 5889999998643 2345678999999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|.+++.. .+.+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999998854 345999999999999999999999998 999999999999999999999999999987654
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.........+||+.|||||++.+..|+.++|||||||+||||++|+.||...+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC
Confidence 43444555789999999999999999999999999999999999999997654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-44 Score=368.28 Aligned_cols=202 Identities=27% Similarity=0.444 Sum_probs=179.8
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
+.|++.+.||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 57899999999999999999875 58899999998777677788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++|+|.+++... ...+++.++..++.||++||+|||+++ |+||||||+|||++.++++||+|||+|+.+... .
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~ 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence 999999987543 345999999999999999999999998 999999999999999999999999999765321 1
Q ss_pred ccccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......||+.|||||++. +..|+.++|||||||+||||++|+.||...+
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~ 219 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence 2234568999999999984 4568999999999999999999999997544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-44 Score=366.34 Aligned_cols=201 Identities=32% Similarity=0.491 Sum_probs=169.6
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.++|++.+.||+|+||.||+|+.. ..||||+++.. ..+..++|.+|+.+|.+++|||||++++++. ++..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 567899999999999999999864 36999998643 4556789999999999999999999999875 456899999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+++|+|.+++... +..+++.++++|+.||++||+|||+++ ||||||||+||||+.++++||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999998542 345999999999999999999999998 9999999999999999999999999998875444
Q ss_pred ccccccccccccCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.........||+.|||||++.+ ..|+.++|||||||+||||+||+.||...
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence 3344556789999999999864 45899999999999999999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=377.38 Aligned_cols=200 Identities=26% Similarity=0.376 Sum_probs=178.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.++|++.++||+|+||+||+|+.. +|+.||||+++.. .....+++.+|+.+|++++|||||++++++.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999874 5889999998754 33446789999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
|+++|+|.+++... ..+++..+..++.||++||.|||++ + |+||||||+||||++++++||+|||+|+.+..
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 99999999999543 4599999999999999999999974 6 99999999999999999999999999987632
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+
T Consensus 158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 22345689999999999999999999999999999999999999997654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=364.20 Aligned_cols=208 Identities=28% Similarity=0.433 Sum_probs=169.1
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe--cCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~--~~~~~l 586 (724)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.. .+...+.|.+|+++|++++|||||++++++.+ .+..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 467999999999999999999874 5889999998654 34456789999999999999999999999875 456799
Q ss_pred EEEeeCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 587 ILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSR--FRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~--~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+++. .+|+||||||+||||+.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999986432 34569999999999999999999998652 359999999999999999999999999999
Q ss_pred ccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.+.... .......||+.|||||++.+..|+.++|||||||++|||++|+.||...+
T Consensus 163 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 163 ILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence 875432 22345789999999999999999999999999999999999999997654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=360.65 Aligned_cols=202 Identities=31% Similarity=0.491 Sum_probs=168.7
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.++|++.++||+|+||.||+|++.+++.||||+++... ...++|.+|+.++++++|||||++++++.+++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 35789999999999999999999888899999997543 44578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++|+|.+++.. ....+++..+++|+.|||+||+|||+++ |+||||||+||||++++.+||+|||+++.+.....
T Consensus 83 ~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~- 156 (263)
T d1sm2a_ 83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 156 (263)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-
Confidence 99999999854 3356899999999999999999999998 99999999999999999999999999987754332
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS-KKNTGLG 720 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG-~~p~~~~ 720 (724)
.......||+.|||||++.+..|+.++|||||||+||||+|+ +.||...
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~ 206 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence 223346789999999999999999999999999999999995 5666543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-43 Score=363.34 Aligned_cols=203 Identities=31% Similarity=0.490 Sum_probs=179.3
Q ss_pred HhccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
...++|++.+.||+|+||+||+|++. +++.||||+++... ...++|.+|+.+|++++|||||++++++.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34678999999999999999999875 48899999997543 45678999999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|..++... ....+++..+++|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 93 E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 93 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999998653 3456999999999999999999999998 999999999999999999999999999987543
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
.. .......|++.|||||++.+..|+.++|||||||++|||++|..|+.
T Consensus 169 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 169 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp SS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred Cc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 32 22334568999999999999999999999999999999999776653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-43 Score=360.16 Aligned_cols=200 Identities=35% Similarity=0.519 Sum_probs=174.7
Q ss_pred hccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
..++|++.+.||+|+||.||+|++++++.||||+++... ...++|.+|+.+|++++|||||++++++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 356899999999999999999999888899999997543 445789999999999999999999998754 567899999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++|+|.+++... ....+++.++++|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+.....
T Consensus 89 ~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9999999987432 2235899999999999999999999998 99999999999999999999999999998754432
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 717 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~ 717 (724)
. ......||+.|||||++.+..++.++|||||||+||||+||..|+
T Consensus 165 ~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~ 210 (272)
T d1qpca_ 165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210 (272)
T ss_dssp E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred c-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence 2 234467899999999999999999999999999999999965554
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-42 Score=362.80 Aligned_cols=205 Identities=30% Similarity=0.463 Sum_probs=166.8
Q ss_pred ccCcceeeeeccCCceeEEeeeecC-C---ceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.++|++.++||+|+||+||+|++.. + ..||||++... .....++|.+|+.+|++++|||||++++++.+++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3568888999999999999998743 2 25899998654 44566789999999999999999999999999999999
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++|+|.+++.. ....+++.++++++.||++||+|||+++ |+||||||+||||+.++++||+|||+|+.+.
T Consensus 105 v~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999998853 3346999999999999999999999998 9999999999999999999999999998875
Q ss_pred CCcccc---cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 667 GDELQG---NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
...... ......||+.|||||.+.+..++.++|||||||+||||+| |+.||...+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 432221 1223467899999999999999999999999999999998 899997543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.9e-42 Score=366.74 Aligned_cols=202 Identities=24% Similarity=0.383 Sum_probs=181.9
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
-++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999874 6889999999877766778899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc--CCCCEEEEecCCccccCCC
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kL~DFGla~~~~~~ 668 (724)
+++|+|.+++.. ....+++.++..|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999843 3346999999999999999999999998 99999999999995 4678999999999987543
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||...+
T Consensus 180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 229 (350)
T d1koaa2 180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229 (350)
T ss_dssp S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence 2 2345689999999999999999999999999999999999999997554
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=366.06 Aligned_cols=201 Identities=26% Similarity=0.342 Sum_probs=180.8
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++++.||+|+||.||+|+.. +++.||||++++. .....+.+.+|+.+|++++||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999874 6899999999753 2335678899999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999854 345899999999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+
T Consensus 159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 2 23445789999999999999999999999999999999999999998665
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-42 Score=363.04 Aligned_cols=198 Identities=29% Similarity=0.423 Sum_probs=178.5
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|+||+||+|++. +|+.||||++++. .....+.+.+|+.+|++++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56999999999999999999874 5899999998653 2345678999999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+.+...
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999998853 345889999999999999999999998 999999999999999999999999999886432
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
....+||+.|||||++.+..|+.++|||||||+||||++|+.||...+
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence 335689999999999999999999999999999999999999997654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=352.58 Aligned_cols=196 Identities=30% Similarity=0.460 Sum_probs=169.3
Q ss_pred cceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe----cCeEEEE
Q 004912 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKILI 587 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~----~~~~~lV 587 (724)
|++.++||+|+||+||+|++. +++.||||++... .....+.|.+|+++|++++|||||++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 467789999999999999875 5789999998653 34456789999999999999999999999875 3457899
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc-CCCCEEEEecCCccccC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFG 666 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~~~~ 666 (724)
|||+++|+|.+++.. ...+++.++..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999954 345899999999999999999999875 3499999999999996 57899999999998653
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
.. .....+||+.|||||++.+ .++.++|||||||+||||++|+.||..
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~ 214 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 214 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence 32 2345689999999998865 599999999999999999999999964
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-42 Score=362.43 Aligned_cols=201 Identities=26% Similarity=0.369 Sum_probs=162.5
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
.+.|++.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999875 58899999997543 2334678899999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc---CCCCEEEEecCCccccC
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARMFG 666 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kL~DFGla~~~~ 666 (724)
|+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999943 456999999999999999999999998 99999999999994 57899999999998764
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...+
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence 332 2345689999999999999999999999999999999999999997543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-42 Score=354.88 Aligned_cols=204 Identities=29% Similarity=0.457 Sum_probs=176.2
Q ss_pred ccCcceeee-eccCCceeEEeeeec---CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCK-LGEGGFGPVYKGRLL---NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~-LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.++|.+.+. ||+|+||.||+|.+. ++..||||+++.. .....++|.+|+++|++++|||||++++++.+ +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 467788774 999999999999764 3457999999764 34457889999999999999999999999864 56899
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++|+|.+++.. .+..+++.++++++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999999743 3346999999999999999999999998 9999999999999999999999999999875
Q ss_pred CCcc-cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 667 GDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 667 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.... ........||+.|||||++.+..++.++|||||||++|||+| |+.||...+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 4332 223344578999999999999999999999999999999998 999997544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-42 Score=350.47 Aligned_cols=203 Identities=31% Similarity=0.460 Sum_probs=181.3
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.++|++.++||+|+||.||+|++++++.||||+++... ...++|++|+.++++++||||++++|++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 36789999999999999999999888899999997643 34578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++|+|..++.. ....+++..+.+++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 82 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999999754 3445899999999999999999999998 999999999999999999999999999877544322
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
......||+.|+|||.+.+..++.++||||||+++|||+| |+.||+..+
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred -eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence 3334678999999999999999999999999999999998 899997654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.2e-42 Score=364.03 Aligned_cols=202 Identities=25% Similarity=0.340 Sum_probs=181.5
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999874 6899999999877666677899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEc--CCCCEEEEecCCccccCCC
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kL~DFGla~~~~~~ 668 (724)
+++|+|.+++.. ....+++.++..|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999887732 3346999999999999999999999998 99999999999997 5789999999999987543
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. ......||+.|||||++.+..++.++|||||||+||||++|+.||...+
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2344689999999999999999999999999999999999999997543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=364.60 Aligned_cols=209 Identities=31% Similarity=0.457 Sum_probs=177.7
Q ss_pred hccCcceeeeeccCCceeEEeeeecCC------ceeEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecC
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 582 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g------~~vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~ 582 (724)
..++|++.++||+|+||+||+|+.... ..||||++... .....+.|.+|+.+|.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 357899999999999999999986432 36999998654 334456899999999998 8999999999999999
Q ss_pred eEEEEEEeeCCCChhHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCC
Q 004912 583 EKILILEYMPNKSLNVFLFDSTK--------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlk 642 (724)
..++||||+++|+|.++|..... ...+++.+++.|+.||++||+|||+++ |||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 99999999999999999965321 235899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 643 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 643 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
|+|||++.++++||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||...+
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987654433333445678999999999999999999999999999999998 899997654
Q ss_pred C
Q 004912 722 M 722 (724)
Q Consensus 722 ~ 722 (724)
.
T Consensus 272 ~ 272 (325)
T d1rjba_ 272 V 272 (325)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=353.66 Aligned_cols=201 Identities=28% Similarity=0.404 Sum_probs=178.8
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC------hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~------~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~ 584 (724)
.++|++.+.||+|+||.||+|+.. +|+.||||++++.. ....+.|.+|+.+|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999874 68899999986432 22467899999999999999999999999999999
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC----CEEEEecC
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 660 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~DFG 660 (724)
++||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999998543 45999999999999999999999998 99999999999998776 59999999
Q ss_pred CccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+|+.+.... ......||+.|||||++.+..++.++|||||||+||||++|+.||...+
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 998874332 2345678999999999999999999999999999999999999997554
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-42 Score=357.92 Aligned_cols=196 Identities=33% Similarity=0.501 Sum_probs=173.6
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
+.|+..+.||+|+||.||+|+.. +++.||||+++... ....+.|.+|+.+|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999864 58899999986543 344577999999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+++|+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 99999999877643 346999999999999999999999998 99999999999999999999999999986532
Q ss_pred cccccccccccccCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||...
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~ 217 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence 234579999999999864 46899999999999999999999999643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=353.44 Aligned_cols=196 Identities=32% Similarity=0.447 Sum_probs=166.8
Q ss_pred eeeccCCceeEEeeeecC---CceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEeeCC
Q 004912 519 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (724)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 593 (724)
++||+|+||.||+|.+.+ ++.||||+++.. ++...++|.+|+.+|++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999997643 467999999653 33446789999999999999999999999864 567899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc-cc
Q 004912 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL-QG 672 (724)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~ 672 (724)
|+|.+++.. ...+++.++++|+.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999854 345999999999999999999999998 99999999999999999999999999998754322 22
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
......||+.|||||.+.+..++.++|||||||++|||++ |+.||...+
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 2344678999999999999999999999999999999998 899997543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-41 Score=361.26 Aligned_cols=198 Identities=24% Similarity=0.323 Sum_probs=179.2
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~ 588 (724)
++|++.+.||+|+||.||+|++. +|+.||||++++. .....+.+.+|+.+|++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999874 6899999998643 2344678999999999999999999999999999999999
Q ss_pred EeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCC
Q 004912 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (724)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 668 (724)
||+.+|+|..++... ..+++.++..++.||+.||.|||+++ ||||||||+||||+.++++||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999998543 35999999999999999999999998 999999999999999999999999999986432
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.....||+.|||||++.+..++.++|||||||+||||++|+.||...+
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence 334689999999999999999999999999999999999999997654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=349.61 Aligned_cols=202 Identities=32% Similarity=0.482 Sum_probs=167.2
Q ss_pred ccCcceeeeeccCCceeEEeeeecCC-----ceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g-----~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
.+.|++.++||+|+||.||+|.+... ..||||+++.. .....++|.+|+.++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688999999999999999987542 36999999654 3445668999999999999999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||+.++++.+++... ...+++.++++++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 86 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999999887543 345999999999999999999999998 999999999999999999999999999886
Q ss_pred CCCcc-cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 666 GGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 666 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
..... ........||+.|||||++.+..++.++|||||||+||||++|..|+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 54322 122334578999999999999999999999999999999999766554
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=350.94 Aligned_cols=202 Identities=34% Similarity=0.537 Sum_probs=170.3
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEee
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 591 (724)
.++|++.+.||+|+||+||+|++.+++.||||+++... ...++|.+|+.++.+++|||||++++++. ++..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 46899999999999999999999888899999997543 44578999999999999999999999985 45678999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++|+|..++.... ...+++.++++|+.||++||+|||+++ |+||||||+||||+.++++||+|||+|+.+.....
T Consensus 94 ~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~- 168 (285)
T d1fmka3 94 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 168 (285)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence 9999999885432 345999999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.......||+.|+|||++....++.++||||||++||||++|.+|+...
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~ 217 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence 2233467899999999999999999999999999999999977666443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-41 Score=352.42 Aligned_cols=201 Identities=27% Similarity=0.408 Sum_probs=177.5
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc---ChhhHHHHHHHHHHHH-HccCCceeeEeeEEEecCeEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIA-KLQHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~il~-~l~Hpniv~l~~~~~~~~~~~lV 587 (724)
++|++.++||+|+||+||+|++. +++.||||++++. .....+.+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999875 5889999999653 2334566777777765 68999999999999999999999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 667 (724)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999999543 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.. .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence 32 23445689999999999999999999999999999999999999998655
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.3e-41 Score=346.12 Aligned_cols=204 Identities=27% Similarity=0.389 Sum_probs=170.9
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC----e
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----E 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~----~ 583 (724)
.++|++.+.||+|+||.||+|++ .+++.||||+++.. .....++|.+|+.++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 57899999999999999999987 46889999999754 3344678999999999999999999999998654 3
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.++||||+++++|.+++... +.+++.++..++.||++||+|||+++ |+||||||+|||++.++..+|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999988543 45999999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCc-ccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 664 MFGGDE-LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 664 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
...... ........+||+.|||||++.+..++.++|||||||+||||++|+.||...+
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 664322 2223445689999999999999999999999999999999999999997654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-41 Score=352.36 Aligned_cols=214 Identities=29% Similarity=0.448 Sum_probs=182.3
Q ss_pred hhhHHHhccCcceeeeeccCCceeEEeeeec------CCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeE
Q 004912 505 LASITAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGC 577 (724)
Q Consensus 505 ~~~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~ 577 (724)
+.+++...++|++.+.||+|+||.||+|+.. +++.||||+++... .+..++|.+|+.+|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3445556788999999999999999999864 35789999997643 3456789999999999999999999999
Q ss_pred EEecCeEEEEEEeeCCCChhHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 004912 578 CVEQGEKILILEYMPNKSLNVFLFDST---------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636 (724)
Q Consensus 578 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 636 (724)
+.+.+..++||||+++|+|.+++.... ....+++.++++|+.||+.||+|||+++ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 999999999999999999999996422 1234899999999999999999999998 9
Q ss_pred EeccCCCCCEEEcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCC-C
Q 004912 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK-K 715 (724)
Q Consensus 637 iH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~-~ 715 (724)
|||||||+||||+.++++||+|||+|+.+.............||+.|+|||.+.+..|+.++|||||||+||||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998775544444445567899999999999999999999999999999999986 5
Q ss_pred CCCCCC
Q 004912 716 NTGLGS 721 (724)
Q Consensus 716 p~~~~~ 721 (724)
||...+
T Consensus 242 p~~~~~ 247 (301)
T d1lufa_ 242 PYYGMA 247 (301)
T ss_dssp TTTTSC
T ss_pred CCCCCC
Confidence 676543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.9e-41 Score=357.05 Aligned_cols=200 Identities=29% Similarity=0.378 Sum_probs=172.3
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccC---hhhHHHHHH---HHHHHHHccCCceeeEeeEEEecCeEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKN---EMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~---E~~il~~l~Hpniv~l~~~~~~~~~~~ 585 (724)
++|++.++||+|+||.||+|+.. +|+.||||++.+.. ......+.+ |+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999875 58999999986432 122333444 466666778999999999999999999
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
+||||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999954 345889999999999999999999998 999999999999999999999999999977
Q ss_pred CCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGSM 722 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~~ 722 (724)
... ......||+.|||||++.. ..|+.++|||||||+||||++|+.||...+.
T Consensus 158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 543 2345689999999999875 5689999999999999999999999976543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-41 Score=351.75 Aligned_cols=203 Identities=31% Similarity=0.490 Sum_probs=170.9
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCc----eeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
++|++.++||+|+||+||+|++. +|+ .||||+++.. ..+..++|.+|+.++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999864 343 5899988653 445678899999999999999999999999865 5678
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
++||+.+++|.+++... ...+++..+++++.||++||+|||+++ |+||||||+||||+.++++||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999999987543 456999999999999999999999998 9999999999999999999999999999876
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
............||+.|||||++.+..|+.++|||||||+||||+| |+.||...+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 5444444445678999999999999999999999999999999999 899997654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-40 Score=340.93 Aligned_cols=201 Identities=27% Similarity=0.373 Sum_probs=177.1
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccCh---------hhHHHHHHHHHHHHHcc-CCceeeEeeEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG---------QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVE 580 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~---------~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~ 580 (724)
.++|++.+.||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999987 4688999999865321 12356889999999997 9999999999999
Q ss_pred cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
++..++||||+++|+|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999954 346999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCcccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+++.+.... ......||+.|+|||++.+ ..++.++||||+||+||||++|+.||...+
T Consensus 156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 999875432 2345689999999999853 457899999999999999999999998654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-40 Score=346.06 Aligned_cols=201 Identities=22% Similarity=0.312 Sum_probs=178.2
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.++|++.+.||+|+||+||+|.+. +++.||||+++... .....+.+|+++|++++||||+++++++.+++..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999875 58899999997654 3346688999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCC--CCEEEEecCCccccCCC
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD--MNPKISDFGLARMFGGD 668 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kL~DFGla~~~~~~ 668 (724)
+++|+|.+++.. ....+++.++..|+.||++||+|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999843 2335999999999999999999999998 9999999999999854 58999999999876443
Q ss_pred cccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
. ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~ 207 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC
Confidence 2 2344678999999999999999999999999999999999999997654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-40 Score=344.17 Aligned_cols=209 Identities=30% Similarity=0.450 Sum_probs=170.0
Q ss_pred HhccCcceeeeeccCCceeEEeeeec------CCceeEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEec
Q 004912 510 AATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 581 (724)
Q Consensus 510 ~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~ 581 (724)
...++|++.++||+|+||.||+|+.. +++.||||+++.. .....+++.+|..++.++ +|+||+++++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 34578999999999999999999763 2468999999754 344567788899888888 689999999998765
Q ss_pred C-eEEEEEEeeCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEE
Q 004912 582 G-EKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647 (724)
Q Consensus 582 ~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NIL 647 (724)
+ ..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+++ |+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence 4 57999999999999999965321 345899999999999999999999998 999999999999
Q ss_pred EcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCC
Q 004912 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK-KNTGLGS 721 (724)
Q Consensus 648 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~-~p~~~~~ 721 (724)
|++++++||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++|. .||...+
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999998775544444455678999999999999999999999999999999999974 6786544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=339.95 Aligned_cols=203 Identities=27% Similarity=0.376 Sum_probs=165.1
Q ss_pred ccCcceeeeeccCCceeEEeeeecC----CceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~l 586 (724)
.++|++.+.||+|+||.||+|++.. +..||||.++.. .....+.|.+|+.+|++++||||+++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4689999999999999999998643 346899998654 3445678999999999999999999999985 567899
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccC
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 666 (724)
||||+++|+|..++.. ....+++.+++.++.||++||+|||+++ |+||||||+||++++++.+||+|||+|+.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998754 3346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
.... .......||+.|+|||++.+..++.++|||||||+||||++ |+.||...+
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 4322 23344678999999999999999999999999999999998 899997654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=338.54 Aligned_cols=204 Identities=29% Similarity=0.388 Sum_probs=166.1
Q ss_pred ccCcceeeeeccCCceeEEeeeecC--C--ceeEEEecccc---ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~--g--~~vAVK~l~~~---~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~ 584 (724)
.++|++.+.||+|+||.||+|+... + ..||||++++. ..+..++|.+|+.+|++++||||+++++++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3679999999999999999997632 2 37899998653 33456789999999999999999999999965 467
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
++||||+++|+|.+++... ...+++..+++++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 8999999999999987643 345999999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCcc-cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 665 FGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
+..... ........|+..|+|||.+.+..++.++||||||+++|||+| |+.||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 754322 223344568889999999999999999999999999999998 899997543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=344.22 Aligned_cols=198 Identities=21% Similarity=0.297 Sum_probs=170.6
Q ss_pred ccCcceee-eeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEe----cCeE
Q 004912 512 TENFSMQC-KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE----QGEK 584 (724)
Q Consensus 512 ~~~~~~~~-~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~----~~~~ 584 (724)
.++|++.+ .||+|+||.||+|++ .+++.||||+++.. +.+.+|+.++.++ +|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788765 699999999999987 46889999998642 4567899987665 89999999999875 3568
Q ss_pred EEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC---CCCEEEEecCC
Q 004912 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGL 661 (724)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFGl 661 (724)
++||||+++|+|.+++... ....+++.++..|+.||+.||+|||+++ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999642 2346999999999999999999999998 999999999999975 56799999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
|+...... ......||+.|||||++.+..|+.++|||||||+||||++|+.||...+
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence 98875433 2345689999999999999999999999999999999999999996543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-40 Score=341.68 Aligned_cols=196 Identities=29% Similarity=0.389 Sum_probs=167.1
Q ss_pred eeeeeccCCceeEEeeeec-CCceeEEEeccccChh-----hHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 517 MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
.+++||+|+||+||+|++. +|+.||||+++..... ..+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4579999999999999875 5889999998653221 234688999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
++++++..+. .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~- 154 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 154 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-
Confidence 9998777665 34456899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
......+||+.|||||++... .|+.++|||||||++|||++|+.||...
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 223446899999999998754 5799999999999999999999999654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=337.28 Aligned_cols=199 Identities=32% Similarity=0.492 Sum_probs=166.9
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEec-CeEEEEEEe
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-GEKILILEY 590 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~-~~~~lV~Ey 590 (724)
.++|++.++||+|+||.||+|++ .|+.||||+++.. ...++|.+|++++++++||||+++++++.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 45788999999999999999998 5789999999754 3457899999999999999999999998654 567999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+++|+|.+++... ....+++..+++|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999999999643 2235899999999999999999999998 999999999999999999999999999875332
Q ss_pred cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGSM 722 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~~ 722 (724)
.....+|+.|+|||++.+..++.++||||||+++|||+| |+.||...+.
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~ 206 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 206 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH
Confidence 233568899999999999999999999999999999998 7888876543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=337.89 Aligned_cols=208 Identities=30% Similarity=0.478 Sum_probs=177.5
Q ss_pred hccCcceeeeeccCCceeEEeeeecC--------CceeEEEeccccC-hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 580 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~ 580 (724)
..++|++.+.||+|+||.||+|+... +..||||+++... .....++.+|+..+.++ +|||||++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 35789999999999999999997632 2479999997653 34568899999999999 89999999999999
Q ss_pred cCeEEEEEEeeCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEE
Q 004912 581 QGEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647 (724)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NIL 647 (724)
++..++||||+++|+|.+++..... ...+++.++++++.||++||+|||+++ ||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 9999999999999999999965431 245899999999999999999999998 999999999999
Q ss_pred EcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 648 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
++.++.+||+|||+++...............+|+.|+|||.+.+..|+.++||||||+++|||++ |+.||...+
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999999999999998765544445556789999999999999999999999999999999998 788887554
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=338.25 Aligned_cols=202 Identities=29% Similarity=0.430 Sum_probs=172.1
Q ss_pred cCcceeeeeccCCceeEEeeee-cCCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++|++.++||+|+||+||+|++ .+++.||||+++... ....+++.+|+.+|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999987 468899999996543 2345789999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
|+.++.+.... . .....+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~-~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMD-A-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHH-H-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhh-h-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99765444333 2 23456999999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||...+
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 2344468999999999987766 4789999999999999999999997543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=339.69 Aligned_cols=208 Identities=30% Similarity=0.421 Sum_probs=180.2
Q ss_pred hccCcceeeeeccCCceeEEeeeec------CCceeEEEeccccC-hhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecC
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 582 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~ 582 (724)
..++|++.++||+|+||.||+|++. +++.||||+++... .....+|.+|+.++.++ +|||||++++++.+++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 4578999999999999999999752 35689999997643 34566899999999999 6999999999999999
Q ss_pred eEEEEEEeeCCCChhHHHhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEE
Q 004912 583 EKILILEYMPNKSLNVFLFDST---------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NIL 647 (724)
..++||||+++|+|.+++.... ....+++.++++++.||++||+|||+++ |+||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 9999999999999999996533 2235899999999999999999999998 999999999999
Q ss_pred EcCCCCEEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004912 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 721 (724)
Q Consensus 648 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~p~~~~~ 721 (724)
++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |++||...+
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999998765443444456789999999999999999999999999999999999 555565443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=338.31 Aligned_cols=204 Identities=27% Similarity=0.388 Sum_probs=166.2
Q ss_pred ccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC----eEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----EKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~----~~~lV 587 (724)
.+.|.+.+.||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++||||+++++++.+++ ..++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 35688999999999999999987 688999999965432 2222344566667789999999999998764 57899
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS-----RFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~-----~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
|||+++|+|.+++.. ..+++.++++++.|++.||+|||+.. ..+|+||||||+||||+.++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999954 24899999999999999999999741 234999999999999999999999999999
Q ss_pred cccCCCcc--cccccccccccCccCcccccCCC------CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 663 RMFGGDEL--QGNTKQIVGTYGYMSPEYALDGL------FSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 663 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.+..... ........||+.|||||++.+.. ++.|+|||||||+||||+||..|++..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 88744321 22334578999999999987653 6789999999999999999999886544
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-39 Score=335.48 Aligned_cols=198 Identities=30% Similarity=0.487 Sum_probs=170.5
Q ss_pred eeeeccCCceeEEeeeecCC----ceeEEEeccc-cChhhHHHHHHHHHHHHHccCCceeeEeeEEEec-CeEEEEEEee
Q 004912 518 QCKLGEGGFGPVYKGRLLNG----QEVAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-GEKILILEYM 591 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~g----~~vAVK~l~~-~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~-~~~~lV~Ey~ 591 (724)
.++||+|+||+||+|++.++ ..||||+++. ......++|.+|+++|++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999987542 2589999975 3555678899999999999999999999998764 5789999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCccc
Q 004912 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (724)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 671 (724)
++|+|.+++.. ....+++.++++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++.+......
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999854 3445788999999999999999999998 999999999999999999999999999987543222
Q ss_pred --ccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 672 --GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 672 --~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
.......||+.|+|||.+....++.++||||||++||||++|+.||..+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 2233457899999999999999999999999999999999988887543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-39 Score=336.80 Aligned_cols=208 Identities=30% Similarity=0.450 Sum_probs=180.2
Q ss_pred hccCcceeeeeccCCceeEEeeeec------CCceeEEEecccc-ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCe
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~ 583 (724)
..++|++.+.||+|+||.||+|.+. +++.||||+++.. ..+....|.+|+.++++++||||+++++++..++.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3578999999999999999999763 3578999999754 34455679999999999999999999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEE
Q 004912 584 KILILEYMPNKSLNVFLFDS-------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 656 (724)
.++||||+++|+|.+++... .....+++..+.+++.||++||.|||+++ |+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence 99999999999999998642 12235789999999999999999999998 999999999999999999999
Q ss_pred EecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCC
Q 004912 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK-KNTGLGS 721 (724)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~-~p~~~~~ 721 (724)
+|||+|+.+.............||+.|+|||.+.+..++.++||||||++||||+||. .||...+
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~ 240 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence 9999998775544334445567899999999999999999999999999999999985 6775443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.9e-39 Score=332.96 Aligned_cols=200 Identities=25% Similarity=0.380 Sum_probs=173.2
Q ss_pred cCcceeeeeccCCceeEEeeeecCCceeEEEeccccC--hhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEEe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~Ey 590 (724)
++|++.++||+|+||+||+|++++|+.||||+++... ....+++.+|+.+|++++||||+++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999999889999999996543 33467899999999999999999999999999999999999
Q ss_pred eCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCcc
Q 004912 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (724)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 670 (724)
+.++.+..+. .....+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9888777776 34466999999999999999999999998 99999999999999999999999999988654322
Q ss_pred cccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 671 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 23345789999999998765 5699999999999999999999999643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-39 Score=336.30 Aligned_cols=202 Identities=33% Similarity=0.491 Sum_probs=171.0
Q ss_pred cCcceeeeeccCCceeEEeeeecC-Cc--eeEEEecccc-ChhhHHHHHHHHHHHHHc-cCCceeeEeeEEEecCeEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 587 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~-~~~~~~~f~~E~~il~~l-~Hpniv~l~~~~~~~~~~~lV 587 (724)
++|++.++||+|+||.||+|++.+ +. .||||+++.. ..+..++|.+|+++|.++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678999999999999999998754 33 5788988643 344567899999999999 799999999999999999999
Q ss_pred EEeeCCCChhHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCE
Q 004912 588 LEYMPNKSLNVFLFDS-------------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 654 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 654 (724)
|||+++|+|.++|+.. .....+++.++.+++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999643 23456999999999999999999999998 9999999999999999999
Q ss_pred EEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCC
Q 004912 655 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK-KNTGLG 720 (724)
Q Consensus 655 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~-~p~~~~ 720 (724)
||+|||+|+..... .......||..|+|||.+.+..++.++|||||||++|||++|. .||...
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence 99999999865322 1223457899999999999999999999999999999999976 467543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=333.66 Aligned_cols=197 Identities=24% Similarity=0.374 Sum_probs=169.3
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEeccccCh------hhHHHHHHHHHHHHHcc--CCceeeEeeEEEecCe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQGE 583 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~il~~l~--Hpniv~l~~~~~~~~~ 583 (724)
++|++.++||+|+||.||+|+.. +++.||||+++.... ...+++.+|+.+|++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999874 689999999864321 12345778999999996 8999999999999999
Q ss_pred EEEEEEeeCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-CCCEEEEecCC
Q 004912 584 KILILEYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGL 661 (724)
Q Consensus 584 ~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGl 661 (724)
.++||||+.+ +++.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 677777743 345999999999999999999999998 999999999999985 47999999999
Q ss_pred ccccCCCcccccccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
|+..... ..+...||+.|||||++.+..+ +.++|||||||+||||++|+.||..
T Consensus 158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 9875432 2345689999999999987776 5679999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-38 Score=331.84 Aligned_cols=203 Identities=28% Similarity=0.420 Sum_probs=169.6
Q ss_pred hccCcceeeeeccCCceeEEeeeec-C-CceeEEEeccccC--hhhHHHHHHHHHHHHHc---cCCceeeEeeEEEe---
Q 004912 511 ATENFSMQCKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVE--- 580 (724)
Q Consensus 511 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~-g~~vAVK~l~~~~--~~~~~~f~~E~~il~~l---~Hpniv~l~~~~~~--- 580 (724)
..++|++.++||+|+||+||+|++. + ++.||||+++... ......+.+|+.+|+.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3578999999999999999999874 3 5679999986432 22233466777777666 79999999999864
Q ss_pred --cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEe
Q 004912 581 --QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 658 (724)
Q Consensus 581 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 658 (724)
....+++|||++++.+..... .....+++..+..++.||+.||+|||+++ |+||||||+|||++..+.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 246789999999887765543 34456899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
||+++..... .......||+.|||||++.+..|+.++||||+||++|||++|+.||...+
T Consensus 160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 9999865332 23455789999999999999999999999999999999999999997543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-37 Score=321.14 Aligned_cols=202 Identities=21% Similarity=0.289 Sum_probs=173.7
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccC-CceeeEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~H-pniv~l~~~~~~~~~~~lV~E 589 (724)
.++|++.++||+|+||+||+|++. +|+.||||+++.... .+.+.+|++++..++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999875 588999999865432 2457789999999975 899999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC-----CCCEEEEecCCccc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-----DMNPKISDFGLARM 664 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kL~DFGla~~ 664 (724)
|+ +++|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+|||++. .+.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 68998887543 345899999999999999999999998 999999999999964 57899999999998
Q ss_pred cCCCcc-----cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 665 FGGDEL-----QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 665 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+..... .......+||+.|||||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 743211 122345689999999999999999999999999999999999999997544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-37 Score=329.14 Aligned_cols=203 Identities=26% Similarity=0.379 Sum_probs=170.0
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccC-hhhHHHHHHHHHHHHHccCCceeeEeeEEEecC----eEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----EKI 585 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~----~~~ 585 (724)
+++|++.++||+|+||+||+|+. .+|+.||||+++... ....+++.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 56799999999999999999986 468999999997543 345678999999999999999999999987653 235
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcccc
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 665 (724)
++++|+.+|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55677889999999853 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcc-cccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 666 GGDEL-QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
..... .......+||+.|+|||++.. ..++.++||||+||++|||++|+.||...+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 44322 223455679999999999854 567899999999999999999999997543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-37 Score=324.25 Aligned_cols=202 Identities=27% Similarity=0.429 Sum_probs=169.4
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEe--------
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-------- 580 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~-------- 580 (724)
.++|++.++||+|+||+||+|++. +|+.||||++... .....+++.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999874 6899999998543 33345778999999999999999999998865
Q ss_pred cCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecC
Q 004912 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (724)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 660 (724)
....++||||++++.+..+. .....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34578999999888776554 34456899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCccc--ccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004912 661 LARMFGGDELQ--GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGL 719 (724)
Q Consensus 661 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~ 719 (724)
+++.+...... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 99877543221 223345799999999998765 689999999999999999999999964
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-37 Score=329.06 Aligned_cols=198 Identities=29% Similarity=0.409 Sum_probs=166.7
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC------eEEE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKIL 586 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~------~~~l 586 (724)
.|+..++||+|+||+||+|++. +|+.||||+++.... .+.+|+.+|++++||||+++++++.... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999885 588999999975432 2347999999999999999999986432 4689
Q ss_pred EEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC-CEEEEecCCcccc
Q 004912 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMF 665 (724)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~~ 665 (724)
||||++++.+..+.........+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987765555443344567999999999999999999999998 99999999999999775 8999999999877
Q ss_pred CCCcccccccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 666 GGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+
T Consensus 174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 5432 2334689999999998875 468999999999999999999999997543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=326.76 Aligned_cols=204 Identities=28% Similarity=0.404 Sum_probs=175.0
Q ss_pred cCcceeeeeccCCceeEEeeeec----CCceeEEEecccc----ChhhHHHHHHHHHHHHHccC-CceeeEeeEEEecCe
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGE 583 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~----~~~~~~~f~~E~~il~~l~H-pniv~l~~~~~~~~~ 583 (724)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999752 3789999998643 22345678899999999977 899999999999999
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.++||||+.+|+|.+++... ..+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999998543 34778899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCcccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGLGSME 723 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~elltG~~p~~~~~~e 723 (724)
.+...... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||...+.+
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~ 238 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 76543322 23446899999999999765 4688999999999999999999999776543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-37 Score=327.93 Aligned_cols=197 Identities=27% Similarity=0.393 Sum_probs=165.7
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecC------
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 582 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~------ 582 (724)
.++|++.++||+|+||+||+|++. +|+.||||+++.. .....+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 578999999999999999999874 5889999999753 3345678999999999999999999999997654
Q ss_pred eEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCc
Q 004912 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (724)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 662 (724)
..++||||+ +.+|..++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 567777663 235999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
+.... ..+...||+.|+|||++.+. .++.++||||+||++|||++|+.||...+
T Consensus 169 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 169 RQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp EECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 87643 23456899999999998764 56899999999999999999999997543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-36 Score=317.15 Aligned_cols=202 Identities=22% Similarity=0.293 Sum_probs=166.8
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEeccccChhhHHHHHHHHHHHHHccCCcee-eEeeEEEecCeEEEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILE 589 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpniv-~l~~~~~~~~~~~lV~E 589 (724)
.++|++.+.||+|+||.||+|++ .+++.||||++..... .+++..|++++++++|+|++ .+..+..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 46799999999999999999987 4588999999865432 24578999999999877654 55556677788899999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcC---CCCEEEEecCCccccC
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLARMFG 666 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFGla~~~~ 666 (724)
|+. ++|...+.. ....+++..++.++.|+++||+|||+++ |+||||||+|||++. +..+||+|||+|+.+.
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EcC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 984 556555533 2345999999999999999999999998 999999999999853 5579999999999875
Q ss_pred CCcc-----cccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 667 GDEL-----QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 667 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
.... ........||+.|||||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 4321 122345689999999999999999999999999999999999999997544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.3e-36 Score=319.61 Aligned_cols=195 Identities=23% Similarity=0.386 Sum_probs=169.3
Q ss_pred ccCcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEec--CeEEEE
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQ--GEKILI 587 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~--~~~~lV 587 (724)
.++|++.++||+|+||+||+|++. +++.||||+++.. ..+++.+|+.+|.+++ ||||+++++++... ...++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 367999999999999999999874 6889999999754 3467899999999995 99999999998854 468999
Q ss_pred EEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCC-CEEEEecCCccccC
Q 004912 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFG 666 (724)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~~~ 666 (724)
|||+++++|..+. +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999997664 34899999999999999999999998 99999999999998655 69999999998765
Q ss_pred CCcccccccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 667 GDELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
... ......+|+.|+|||.+.+.. ++.++||||+|+++|||++|+.||..+.
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 432 234567899999999987754 7999999999999999999999997543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-36 Score=314.17 Aligned_cols=198 Identities=25% Similarity=0.368 Sum_probs=174.1
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEecCeEEEEEE
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~~~~~lV~E 589 (724)
++|++.++||+|+||+||+|++. +++.||||+++.. .....+++.+|+.+|+.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999874 6788999998643 33457889999999999999999999999999999999999
Q ss_pred eeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCccccCCCc
Q 004912 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (724)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 669 (724)
++.+++|..++. ....+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988774 3456889999999999999999999998 9999999999999999999999999998875432
Q ss_pred ccccccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCC
Q 004912 670 LQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTG 718 (724)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~p~~ 718 (724)
. ......+++.|+|||.+.... ++.++|||||||++|||++|+.||.
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 2 233346788999999987765 6999999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-36 Score=319.48 Aligned_cols=198 Identities=30% Similarity=0.401 Sum_probs=168.1
Q ss_pred ccCcceeeeeccCCceeEEeeee-cCCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec-----Ce
Q 004912 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GE 583 (724)
Q Consensus 512 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~-----~~ 583 (724)
.++|++.++||+|+||+||+|++ .+|+.||||+++.. .....+++.+|+.+|++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999986 46899999999754 334556789999999999999999999998643 34
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.++++||+.+|+|.+++. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 567788889999999983 235999999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCcccccccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
... .......|++.|+|||.+.+.. ++.++|||||||++|||++|+.||...+
T Consensus 170 ~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 643 2334567999999999877765 6899999999999999999999997543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-35 Score=316.62 Aligned_cols=197 Identities=29% Similarity=0.348 Sum_probs=161.2
Q ss_pred cCcceeeeeccCCceeEEeeeec-CCceeEEEecccc--ChhhHHHHHHHHHHHHHccCCceeeEeeEEEec------Ce
Q 004912 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------GE 583 (724)
Q Consensus 513 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~il~~l~Hpniv~l~~~~~~~------~~ 583 (724)
++|++.++||+|+||+||+|++. +|+.||||+++.. .....+++.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999875 5899999999653 344567789999999999999999999998643 57
Q ss_pred EEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEEEecCCcc
Q 004912 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (724)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 663 (724)
.++||||+.++.+..+. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999776554332 34899999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004912 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 721 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~~ 721 (724)
..... .......+|+.|+|||++.+..++.++||||+||+++||++|+.||...+
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 76432 23445679999999999999999999999999999999999999997543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.3e-31 Score=286.85 Aligned_cols=198 Identities=22% Similarity=0.314 Sum_probs=163.9
Q ss_pred CcceeeeeccCCceeEEeeeec-CCceeEEEeccccChhhHHHHHHHHHHHHHcc-----------CCceeeEeeEEEec
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLLGCCVEQ 581 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-----------Hpniv~l~~~~~~~ 581 (724)
+|+++++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5999999999999999999874 68999999997543 33567889999998886 47899999887643
Q ss_pred --CeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeccCCCCCEEEcCCCC-----
Q 004912 582 --GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMN----- 653 (724)
Q Consensus 582 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~----- 653 (724)
...++++++...+..............+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 4667788887766555544445566678999999999999999999998 66 999999999999986553
Q ss_pred -EEEEecCCccccCCCcccccccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004912 654 -PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 720 (724)
Q Consensus 654 -~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p~~~~ 720 (724)
++|+|||.+..... ......||+.|+|||++....++.++||||+||+++||++|+.||...
T Consensus 170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 99999999986532 234467999999999999999999999999999999999999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=7.7e-23 Score=197.52 Aligned_cols=164 Identities=17% Similarity=0.187 Sum_probs=121.8
Q ss_pred cceeeeeccCCceeEEeeeecCCceeEEEeccccCh------------------hhHHHHHHHHHHHHHccCCceeeEee
Q 004912 515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------------------QGLKEFKNEMMLIAKLQHRNLVRLLG 576 (724)
Q Consensus 515 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~------------------~~~~~f~~E~~il~~l~Hpniv~l~~ 576 (724)
+.+.++||+|+||.||+|++.+|+.||||+++.... .....+..|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356889999999999999988899999998753210 11234567889999999999998876
Q ss_pred EEEecCeEEEEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeccCCCCCEEEcCCCCEEE
Q 004912 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (724)
Q Consensus 577 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 656 (724)
+. ..+++|||+++..+.. ++.....+++.|++++|+|||+++ |+||||||+|||++++ .++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 52 2379999998876543 233445679999999999999998 9999999999999865 5899
Q ss_pred EecCCccccCCCcccccccccccccCccC------cccccCCCCCchhhHHHHHHHH
Q 004912 657 SDFGLARMFGGDELQGNTKQIVGTYGYMS------PEYALDGLFSIKSDVFSFGILM 707 (724)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~k~DVwSlGvil 707 (724)
+|||+|......... .|.. .| ...+.|+.++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~----------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR----------EILERDVRNIIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH----------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH----------HHHHHHHHHHHH-HHcCCCCCcccHHHHHHHH
Confidence 999999875422110 1111 11 1236678899999985443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.86 E-value=1.4e-21 Score=170.44 Aligned_cols=112 Identities=24% Similarity=0.411 Sum_probs=96.6
Q ss_pred cccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEecCC
Q 004912 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (724)
Q Consensus 25 ~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~~~ 104 (724)
+|||.|||.|.+|+.|+| |.|+|+|...|+ |.++. ..++||.||++.|.. .+.|.|+.||+|||.|.
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET-
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc---CCcEEEEccCccCCC--CcEEEEeccccEEEEec-
Confidence 599999999999999985 999999998886 77765 578999999998854 46799999999999996
Q ss_pred CCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcc
Q 004912 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTD 154 (724)
Q Consensus 105 ~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtD 154 (724)
+.++|++++.+.....+|+|+|+|||||++.+ +.++|||+.+|+|
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~-----~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECCC-----CcEEecCCCccCC
Confidence 56788888766656678999999999999863 4789999999985
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.84 E-value=3.2e-21 Score=166.38 Aligned_cols=107 Identities=24% Similarity=0.355 Sum_probs=94.1
Q ss_pred cccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEecCC
Q 004912 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (724)
Q Consensus 25 ~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~~~ 104 (724)
.|+|.+||.|.+|+.|. +|.|.|.|+.+|+ |.|+. ..++||.||++.|.. .+.|.|..||+|||.|++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~~--~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGLSR--SCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe---CCceeeEeCCCCCCC--ccEEEEeccceEEEECCC
Confidence 47899999999999995 6999999999887 88876 578999999998853 468999999999999999
Q ss_pred CCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccC
Q 004912 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (724)
Q Consensus 105 ~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~ 151 (724)
|.+||+|++.+.....+|+|+|+|||||++. .+||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT--------DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC--------CCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeCC--------CcccCCCC
Confidence 9999999987666667889999999999974 38999998
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.84 E-value=6e-21 Score=164.69 Aligned_cols=107 Identities=20% Similarity=0.347 Sum_probs=93.1
Q ss_pred ccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEecCCC
Q 004912 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTN 105 (724)
Q Consensus 26 ~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~~~~ 105 (724)
|+|.|||.|.+|+.|+ +|.|.|+|...|+ |.++. ..++||+||++.|... .+.|.|+.||+|||.|++|
T Consensus 2 ~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----Lvl~~---~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~~g 70 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----LVLYD---HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAEG 70 (109)
T ss_dssp CEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECSSS
T ss_pred CCccCCCEEeCCCEEE--eCCEEEEecCCCe-----EEEEe---CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeCCC
Confidence 7899999999999997 4889999998776 66654 5689999999999865 6789999999999999999
Q ss_pred CeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccC
Q 004912 106 GTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (724)
Q Consensus 106 ~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~ 151 (724)
.+||+|+++......+|+|+|+|||||+++ .+|||+-|
T Consensus 71 ~~vW~s~t~~~~~~~~l~L~ddGNlvly~~--------~~W~S~t~ 108 (109)
T d1kj1a_ 71 RSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DIWSTGTY 108 (109)
T ss_dssp CEEEECCCCCCSSCCEEEECTTSCEEEECC--------EEEECCCC
T ss_pred cEEEEEeeECCCCCEEEEEeCCCcEEEECC--------CEecCCCc
Confidence 999999987555667889999999999974 39999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.67 E-value=2.8e-17 Score=143.76 Aligned_cols=102 Identities=21% Similarity=0.324 Sum_probs=86.9
Q ss_pred EEEEccC-CCeEEEeecCCCCCCCCCCeEEEeeCCcEEEecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCc
Q 004912 63 GIRFQQI-PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNAT 141 (724)
Q Consensus 63 giw~~~~-~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~ 141 (724)
-|||..+ .++++|++|++.|+....-+|.+..||||||.+. +.++|++++.+.+....|+|+++|||||++.+
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~----- 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ----- 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETT-----
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCC-----
Confidence 4888888 7899999999999988777899999999999986 67899999877766778999999999999974
Q ss_pred cceeeeeccCCcchhhcccccccccccccceeEEeecCCCCCCCcceEEeecCCCCceEE
Q 004912 142 ESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKIC 201 (724)
Q Consensus 142 ~~~lWqSFd~PtDtlLpg~kl~~~~~~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~ 201 (724)
++++||||. +.++|.|.+.++++|...++
T Consensus 85 ~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 85 NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 478999984 34678899999999987654
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.62 E-value=6.7e-16 Score=134.39 Aligned_cols=105 Identities=17% Similarity=0.338 Sum_probs=86.1
Q ss_pred ccccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEecC
Q 004912 24 AADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQ 103 (724)
Q Consensus 24 ~~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~~ 103 (724)
..++|.++|+| .+.+..|.|.|.|...|+ |.++ + ..++||.||+..|.. .+.|.|..||+|+|.|+
T Consensus 13 ~~~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVLy-~--~~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~ 78 (119)
T d1b2pa_ 13 HPQILHATESL----EILFGTHVYRFIMQTDCN-----LVLY-D--NNNPIWATNTGGLGN--GCRAVLQPDGVLVVITN 78 (119)
T ss_dssp CCCEEETTCEE----EEEETTEEEEEEECTTSC-----EEEE-E--TTEEEEECCCTTSCS--SCEEEECTTSCEEEECT
T ss_pred CCCEEeCCCeE----EEecCCceEEEEECCCCc-----EEEE-E--CCeEEEEecCCCCCc--ceEEEEEeCCCEEEECC
Confidence 34667777766 357789999999999887 6664 3 578999999987753 47899999999999999
Q ss_pred CCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeecc
Q 004912 104 TNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFD 150 (724)
Q Consensus 104 ~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd 150 (724)
+|.+||++++.+.....+|+|+|+|||||++. .+|||-.
T Consensus 79 ~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg~--------~~W~S~T 117 (119)
T d1b2pa_ 79 ENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWATQT 117 (119)
T ss_dssp TCCEEEECSCCCCSSCEEEEECTTSCEEEEES--------EEEECCC
T ss_pred CCcEEEECCCcCCCCceEEEEcCCCCEEEECC--------CEeccCC
Confidence 99999999987665666789999999999963 5999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.52 E-value=2.9e-15 Score=129.35 Aligned_cols=109 Identities=23% Similarity=0.290 Sum_probs=87.8
Q ss_pred EEEccC-CCeEEEeecCCCCCCCCCCeEEEeeCCcEEEecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCcc
Q 004912 64 IRFQQI-PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142 (724)
Q Consensus 64 iw~~~~-~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~ 142 (724)
|||.-. +.+..|..+.+.++.....+|.|..||||||.+ .+.++|++++.+. .+..|.|+|+|||||++.+ +
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~-~~~~l~l~~dGNLvl~d~~-----~ 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGA-TGCRAVLQSDGLLVILTAQ-----N 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSC-SCCBCCBCSSSCBCCBCTT-----T
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCC-CceEEEEeccCCEEEEccC-----C
Confidence 566544 667779999999998877789999999999988 5689999997653 4677899999999999874 4
Q ss_pred ceeeeeccCCcchhhcccccccccccccceeEEeecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecCc
Q 004912 143 SYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGH 214 (724)
Q Consensus 143 ~~lWqSFd~PtDtlLpg~kl~~~~~~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (724)
.++|||+- +.++|.|.+.|+++|...++ ..++|.+|.
T Consensus 76 ~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt 112 (115)
T d1dlpa1 76 TIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGT 112 (115)
T ss_dssp CCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSC
T ss_pred CEEEEcCC-------------------------------CCCCCCEEEEECCCCcEEEe----CCCeecCCC
Confidence 78999863 34689999999999986543 346898874
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.45 E-value=2.4e-14 Score=123.52 Aligned_cols=104 Identities=23% Similarity=0.319 Sum_probs=82.1
Q ss_pred hhhcccccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEE
Q 004912 20 KVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLV 99 (724)
Q Consensus 20 ~~~~~~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~ 99 (724)
+...+.+||.++|+| .+|.|.|.|...|+ |.++. ..++||.+|...+ ..+.+.|..|||||
T Consensus 9 ~~~~~~~tl~~~~~l--------~~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~~---~~~~l~l~~dGNLv 69 (115)
T d1dlpa1 9 HEGSHPQTLHAAQSL--------ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAGA---TGCRAVLQSDGLLV 69 (115)
T ss_dssp SSSCSCSCCCTTCEE--------CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCSC---SCCBCCBCSSSCBC
T ss_pred CCCCCcceecCCCcE--------EcCCEEEEECCCCe-----EEEEc---CCeeEEEcccCCC---CceEEEEeccCCEE
Confidence 344555666666665 35779999998887 77754 4678999997542 35789999999999
Q ss_pred EecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeecc
Q 004912 100 LLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFD 150 (724)
Q Consensus 100 l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd 150 (724)
|.|.++.+||++++.......+++|+++|||||++. .+|+|-.
T Consensus 70 l~d~~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~~--------~~Wssgt 112 (115)
T d1dlpa1 70 ILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP--------GLWDSGT 112 (115)
T ss_dssp CBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS--------EEEECSC
T ss_pred EEccCCCEEEEcCCCCCCCCEEEEECCCCcEEEeCC--------CeecCCC
Confidence 999999999999987666667789999999999963 5899853
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.16 E-value=4.5e-11 Score=103.69 Aligned_cols=97 Identities=22% Similarity=0.334 Sum_probs=72.3
Q ss_pred ccccCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEccCCCeEEEeecCCCCCCCCCCeEEEeeCCcEEEecCCC
Q 004912 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTN 105 (724)
Q Consensus 26 ~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~VW~ANr~~p~~~~~~~L~l~~~g~l~l~~~~~ 105 (724)
+++.++|+|. .|.|.|.|-..|+ |.|+- ...+||.+|- +.....+.+.|..+|||||.|.++
T Consensus 24 ~~l~~~q~l~--------~g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t--~~~~~~~~~~l~~~GnLvl~d~~~ 85 (120)
T d1dlpa2 24 QTLHATQSLQ--------LSPYRLSMETDCN-----LVLFD---RDDRVWSTNT--AGKGTGCRAVLQPNGRMDVLTNQN 85 (120)
T ss_dssp CEECSSCCCB--------CSSCEEEEETTTE-----EEEEB---TTBCCSCCCC--CSSCSSCEEEEETTTEEEEEETTT
T ss_pred cEEcCCCeeE--------cCCEEEEEcCCCc-----EEEec---CCcEEEEEcc--ccCCCcEEEEEeCCeeEEEEcCCC
Confidence 4555555554 4557777766664 65543 4567899874 333445789999999999999999
Q ss_pred CeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeee
Q 004912 106 GTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (724)
Q Consensus 106 ~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqS 148 (724)
.++|++++.......++.|+++|||||++. .+|.|
T Consensus 86 ~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~~--------~~W~t 120 (120)
T d1dlpa2 86 IAVWTSGNSRSAGRYVFVLQPDRNLAIYGG--------ALWTT 120 (120)
T ss_dssp EEEEECCCCCSSSCCEEEECSSSCEEEECC--------CCCBC
T ss_pred CEEEEeCCCCCCCcEEEEECCCCcEEEeCC--------CcccC
Confidence 999999987665666789999999999963 37875
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.95 E-value=1.1e-09 Score=93.18 Aligned_cols=85 Identities=26% Similarity=0.420 Sum_probs=64.8
Q ss_pred CeEEEeeCCcEEEecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhcccccccccc
Q 004912 88 AVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFK 167 (724)
Q Consensus 88 ~~L~l~~~g~l~l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg~kl~~~~~ 167 (724)
-+|.+..||||||.+ .+.+||++++.+......+.|.++|||||++.+ +.++|+|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~-----g~~vWsS------------------- 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS-----NKPIWAS------------------- 75 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEEC-------------------
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCC-----ccceEEc-------------------
Confidence 358899999999987 457999999877666678899999999999874 4788875
Q ss_pred cccceeEEeecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecC
Q 004912 168 NRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSG 213 (724)
Q Consensus 168 ~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g 213 (724)
.+..+++.|.+.|+.+|...++ . .+.|.++
T Consensus 76 ------------~t~~~~~~~~l~L~ddGNlVly--~--~~~W~S~ 105 (108)
T d1jpca_ 76 ------------NTGGQNGNYVCILQKDRNVVIY--G--TDRWATG 105 (108)
T ss_dssp ------------CCCCSCSCEEEEECTTSCEEEE--E--CCCCCCC
T ss_pred ------------cccCCCCcEEEEEcCCCCEEEe--C--CCcccCC
Confidence 1222456788899999977654 2 2456655
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.84 E-value=6.2e-09 Score=89.63 Aligned_cols=85 Identities=26% Similarity=0.331 Sum_probs=65.8
Q ss_pred eEEEeeCCcEEEecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhccccccccccc
Q 004912 89 VLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKN 168 (724)
Q Consensus 89 ~L~l~~~g~l~l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg~kl~~~~~~ 168 (724)
.|.+..||||||.++ +.++|++++.+......+.|.++|||||++.+ +.++|+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~-----g~~vWsS~t------------------ 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQSPV------------------ 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECSC------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCC-----CcEEEECCC------------------
Confidence 488999999999875 56899999876666778999999999999974 367887531
Q ss_pred ccceeEEeecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecCc
Q 004912 169 RLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGH 214 (724)
Q Consensus 169 ~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (724)
.-+.|.|.+.|+.+|...++ ..+.|.++.
T Consensus 89 -------------~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~T 117 (119)
T d1b2pa_ 89 -------------AGKAGHYVLVLQPDRNVVIY----GDALWATQT 117 (119)
T ss_dssp -------------CCCSSCEEEEECTTSCEEEE----ESEEEECCC
T ss_pred -------------cCCCCceEEEEcCCCCEEEE----CCCEeccCC
Confidence 12456788999999987764 235787764
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.74 E-value=3.1e-08 Score=83.90 Aligned_cols=86 Identities=26% Similarity=0.371 Sum_probs=63.6
Q ss_pred CeEEEeeCCcEEEecCCCCeEEEEeccCCC-CCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhccccccccc
Q 004912 88 AVLTISNNGNLVLLNQTNGTIWSTNVSSEV-KNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (724)
Q Consensus 88 ~~L~l~~~g~l~l~~~~~~~~Wst~~~~~~-~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg~kl~~~~ 166 (724)
-.|.|..||||||.+ .+.+||++++.... ....+.|.++|||||++.+ +.++|+|
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~s------------------ 76 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE-----GRSLWAS------------------ 76 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS-----SCEEEEC------------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC-----CcEEEEE------------------
Confidence 458889999999987 56799999976443 3566889999999999974 4778876
Q ss_pred ccccceeEEeecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecCc
Q 004912 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGH 214 (724)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (724)
.+..+.|.|.+.++++|...++ + .+.|.++.
T Consensus 77 -------------~t~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t 107 (109)
T d1kj1a_ 77 -------------HSVRGNGNYVLVLQEDGNVVIY--G--SDIWSTGT 107 (109)
T ss_dssp -------------CCCCCSSCCEEEECTTSCEEEE--C--CEEEECCC
T ss_pred -------------eeECCCCCEEEEEeCCCcEEEE--C--CCEecCCC
Confidence 1112356788999999877654 3 35787764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.60 E-value=1.1e-07 Score=94.24 Aligned_cols=149 Identities=17% Similarity=0.131 Sum_probs=105.0
Q ss_pred hHHHhccCcceeeeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHcc-CCceeeEeeEEEecCeEE
Q 004912 507 SITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKI 585 (724)
Q Consensus 507 ~i~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~-Hpniv~l~~~~~~~~~~~ 585 (724)
++...-+.|+..+..+.++...||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444556777776655555678998864 56678899887655444556788888888774 444667788888888899
Q ss_pred EEEEeeCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 004912 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS--------------------------------- 632 (724)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--------------------------------- 632 (724)
+||+++++.++.+..... .....++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999999886654211 112234556666666666420
Q ss_pred -----------------------CCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 633 -----------------------RFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 633 -----------------------~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11279999999999999877677999998864
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.54 E-value=1.8e-07 Score=79.76 Aligned_cols=89 Identities=26% Similarity=0.434 Sum_probs=65.3
Q ss_pred CCeEEEeeCCcEEEecCCCCeEEEEeccCCCCCceEEEccCCCeEEecCCCCCCccceeeeeccCCcchhhccccccccc
Q 004912 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (724)
Q Consensus 87 ~~~L~l~~~g~l~l~~~~~~~~Wst~~~~~~~~~~a~lld~GNlVl~~~~~~~~~~~~lWqSFd~PtDtlLpg~kl~~~~ 166 (724)
.-.|.|..||||||.+ .+.+||++++.+......+.|..+|||||++.. +.+|.|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~------~~~w~s------------------ 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGS------RAIWAS------------------ 74 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEETT------EEEEEC------------------
T ss_pred CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEecC------CeEEEE------------------
Confidence 3569999999999987 568999999776556678899999999999852 345543
Q ss_pred ccccceeEEeecCCCCCCCcceEEeecCCCCceEEEEcCCeeeeecCc
Q 004912 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGH 214 (724)
Q Consensus 167 ~~~~~~~l~Sw~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (724)
.+.-..|.|.+.++.+|...++- ....+.|.++.
T Consensus 75 -------------~t~~~~~~~~l~L~ddGNlvly~-~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -------------NTNRQNGNYYLILQRDRNVVIYD-NSNNAIWATHT 108 (112)
T ss_dssp -------------CCCCSCCCCEEEECTTSCEEEEC-TTSCEEEECCC
T ss_pred -------------eeccCCCceEEEEcCCCCEEEEC-CCCcEEecCCC
Confidence 22224567889999999876542 23456788764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.03 E-value=1.4e-05 Score=77.94 Aligned_cols=131 Identities=18% Similarity=0.175 Sum_probs=87.1
Q ss_pred eeccCCc-eeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccC--CceeeEeeEEEecCeEEEEEEeeCCCCh
Q 004912 520 KLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQGEKILILEYMPNKSL 596 (724)
Q Consensus 520 ~LG~G~f-G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~H--pniv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (724)
.+..|.. +.||+....++..+++|....... ..+..|+..++.+.. -.+.+++.+..+++..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455543 679999887788889998765432 346778888877743 3356778888888889999999998766
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 004912 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH----------------------------------------------- 629 (724)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH----------------------------------------------- 629 (724)
.+.. +... .++.++++.|+-||
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3321 1111 11222333333333
Q ss_pred ----hc----CCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 630 ----QY----SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 630 ----~~----~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
.. .+..++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 112379999999999999877778999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.49 E-value=9.8e-05 Score=76.98 Aligned_cols=76 Identities=11% Similarity=0.138 Sum_probs=49.3
Q ss_pred eeeeccCCceeEEeeeecC-CceeEEEecccc-------ChhhHHHHHHHHHHHHHcc-C-C-ceeeEeeEEEecCeEEE
Q 004912 518 QCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-------SGQGLKEFKNEMMLIAKLQ-H-R-NLVRLLGCCVEQGEKIL 586 (724)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~-------~~~~~~~f~~E~~il~~l~-H-p-niv~l~~~~~~~~~~~l 586 (724)
.+.||.|..-.||+....+ ++.++||.-... .+....+...|.+.|..+. + | .+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3579999999999998754 678999965321 1123345566888887763 3 2 35555544 5556689
Q ss_pred EEEeeCCCC
Q 004912 587 ILEYMPNKS 595 (724)
Q Consensus 587 V~Ey~~~gs 595 (724)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.94 E-value=0.00082 Score=67.78 Aligned_cols=135 Identities=14% Similarity=0.151 Sum_probs=79.1
Q ss_pred eeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCce--eeEe-----eEEEecCeEEEEEEeeCCCChhH-
Q 004912 527 GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLL-----GCCVEQGEKILILEYMPNKSLNV- 598 (724)
Q Consensus 527 G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpni--v~l~-----~~~~~~~~~~lV~Ey~~~gsL~~- 598 (724)
-.||+++..+|+.+++|+.+... ...+++..|...+..|....+ +..+ ......+..+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 47999999999999999986542 245677888888888853222 1111 12234567889999998654321
Q ss_pred ----H------H---hh------cCCCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCCce
Q 004912 599 ----F------L---FD------STKKRLLNWQ-------------------ARVRIIEGIAQGLLYLHQ----YSRFRI 636 (724)
Q Consensus 599 ----~------l---~~------~~~~~~l~~~-------------------~~~~i~~qia~~L~yLH~----~~~~~i 636 (724)
+ + +. ......++.. ....+...+.+.++.+.. ..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 1 0 10 0011111211 111122223333333332 223458
Q ss_pred EeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 637 IHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 637 iH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 56899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.47 E-value=0.0025 Score=65.99 Aligned_cols=76 Identities=21% Similarity=0.339 Sum_probs=49.9
Q ss_pred CcceeeeeccCCceeEEeeeecCC--------ceeEEEeccccChhhHHHHHHHHHHHHHccCCce-eeEeeEEEecCeE
Q 004912 514 NFSMQCKLGEGGFGPVYKGRLLNG--------QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEK 584 (724)
Q Consensus 514 ~~~~~~~LG~G~fG~Vy~~~~~~g--------~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpni-v~l~~~~~~~~~~ 584 (724)
.+++ +.|+.|-.=.+|+...+++ +.|.+++... .. ..-...+|..+++.+.-.++ .++++++. +
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~-- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFS--G-- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--
Confidence 4444 6788898899999987543 3466666542 22 23345689999988853344 46666653 2
Q ss_pred EEEEEeeCCCCh
Q 004912 585 ILILEYMPNKSL 596 (724)
Q Consensus 585 ~lV~Ey~~~gsL 596 (724)
.+|+||+++..|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 578999987654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.26 E-value=0.059 Score=53.02 Aligned_cols=158 Identities=13% Similarity=0.046 Sum_probs=80.8
Q ss_pred chhhHHHhccCccee-----eeeccCCceeEEeeeecCCceeEEEeccccChhhHHHHHHHHHHHHHccCCce--eeEee
Q 004912 504 SLASITAATENFSMQ-----CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLLG 576 (724)
Q Consensus 504 ~~~~i~~~~~~~~~~-----~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~il~~l~Hpni--v~l~~ 576 (724)
+.+++....++|.+. +.|..|---+.|+....+| .+++|+..... ..+++..|+.++..|.+.++ ...+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 344455555566553 3455676678899887554 58999986532 22344556667777643221 11110
Q ss_pred ------EEEecCeEEEEEEeeCCCChhHH-----------H---hhc------CCCCC------------------CCHH
Q 004912 577 ------CCVEQGEKILILEYMPNKSLNVF-----------L---FDS------TKKRL------------------LNWQ 612 (724)
Q Consensus 577 ------~~~~~~~~~lV~Ey~~~gsL~~~-----------l---~~~------~~~~~------------------l~~~ 612 (724)
+.........++.++.+...... + +.. ..... ....
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11234456677777766432110 0 000 00000 0011
Q ss_pred HHHHHHHHHHHHHHHHHh-cCCCceEeccCCCCCEEEcCCCCEEEEecCCccc
Q 004912 613 ARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (724)
Q Consensus 613 ~~~~i~~qia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 664 (724)
.....+..+...+...+. .-+.++||+|+.+.||+++.+...-|+||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 111222222222333222 1123599999999999999887779999998864
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.95 E-value=0.061 Score=33.10 Aligned_cols=32 Identities=31% Similarity=0.579 Sum_probs=25.2
Q ss_pred CCCCCCCCCCCCCccCCC-CCCCcccccCCccCC
Q 004912 286 QYCGKYGYCGANTICSLD-QKPMCECLEGFKLES 318 (724)
Q Consensus 286 ~~Cd~~g~CG~~g~C~~~-~~~~C~C~~Gf~~~~ 318 (724)
|+|.+-..|| ||.|+.- ..-.|.|-.||+|..
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 6899999998 6888743 345699999999854
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.26 E-value=0.17 Score=33.18 Aligned_cols=32 Identities=22% Similarity=0.463 Sum_probs=24.7
Q ss_pred CCCCCC-CCCCCCCCccCCC-CCCCcccccCCcc
Q 004912 285 DQYCGK-YGYCGANTICSLD-QKPMCECLEGFKL 316 (724)
Q Consensus 285 ~~~Cd~-~g~CG~~g~C~~~-~~~~C~C~~Gf~~ 316 (724)
.|+|.. ...|..+|.|... ..-.|.|++||+-
T Consensus 3 ideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G 36 (42)
T d2vj3a1 3 VDECSLGANPCEHAGKCINTLGSFECQCLQGYTG 36 (42)
T ss_dssp CCTTTSSSCSSSTTCEEEECSSSEEEECCTTEES
T ss_pred CccccCCCCCCCCCcEeECCCCCEEeECCCCCcC
Confidence 367875 5789999999754 3457999999963
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.34 E-value=0.41 Score=30.68 Aligned_cols=30 Identities=30% Similarity=0.646 Sum_probs=23.0
Q ss_pred CCCCCCCCCCCCCccCCC-CCCCcccccCCcc
Q 004912 286 QYCGKYGYCGANTICSLD-QKPMCECLEGFKL 316 (724)
Q Consensus 286 ~~Cd~~g~CG~~g~C~~~-~~~~C~C~~Gf~~ 316 (724)
|+|. ...|...|.|... ..-.|.|++||+-
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G 31 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEG 31 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEET
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCc
Confidence 4565 4779999999754 4568999999964
|